data_1j7m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1j7m _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 122.429 1.109 . . . . 0.0 113.494 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.688 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.2 OUTLIER -127.75 164.48 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 177.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.688 ' N ' HG21 ' A' ' 6' ' ' VAL . . . 63.27 -146.6 50.46 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 117.728 -2.177 . . . . 0.0 111.1 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.636 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 46.29 -140.23 6.38 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 114.327 0.491 . . . . 0.0 114.327 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--O 1.223 -0.297 0 CA-C-O 120.474 0.178 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 37.9 Cg_exo -59.44 136.22 70.2 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.762 2.308 . . . . 0.0 112.777 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 7.2 m -67.95 128.2 35.65 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.541 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 90.1 t -95.25 112.94 28.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.643 0.259 . . . . 0.0 110.654 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.532 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 70.0 m-85 -111.51 139.96 22.61 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.264 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.2 134.51 21.51 Favored 'Cis proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.321 -1.533 . . . . 0.0 111.93 -0.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.541 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 45.8 p90 -103.59 133.57 48.4 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.93 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 76.3 m -96.53 121.32 38.21 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.349 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.726 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 45.4 t80 -115.64 130.33 56.82 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.12 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.613 HD11 ' CD1' ' A' ' 21' ' ' PHE . 6.7 mp 44.64 33.44 0.94 Allowed 'General case' 0 N--CA 1.436 -1.133 0 O-C-N 124.363 1.039 . . . . 0.0 113.685 175.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.77 -15.9 40.55 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 115.696 1.038 . . . . 0.0 115.696 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.586 ' O ' ' HA ' ' A' ' 20' ' ' THR . 62.8 m-80 -110.68 146.72 35.74 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 119.267 1.533 . . . . 0.0 112.299 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -86.76 122.17 30.27 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.726 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 28.6 m-85 -107.21 116.77 32.52 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.69 0.757 . . . . 0.0 110.63 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -92.88 -17.04 24.53 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.275 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 p -129.6 -178.12 4.55 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.28 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 81.8 m -66.6 165.23 15.11 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.706 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.52 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 9.2 t -140.4 167.64 21.66 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.314 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.475 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 12.6 p -122.03 19.65 10.8 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.86 139.66 58.34 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 113.661 -1.609 . . . . 0.0 111.263 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.95 -2.83 54.01 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.369 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.625 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.9 mtp85 . . . . . 0 N--CA 1.446 -0.662 0 CA-C-N 117.105 0.452 . . . . 0.0 110.667 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.625 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.371 0 CA-C-O 120.691 0.281 . . . . 0.0 111.385 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.475 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 54.4 mtt -87.91 149.66 23.95 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.611 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.4 p-90 -131.87 -166.36 1.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.13 0.49 . . . . 0.0 111.577 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 28.1 p -156.9 148.99 22.91 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.442 ' HB2' ' CB ' ' A' ' 19' ' ' PHE . . . -84.98 148.91 25.95 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 119.455 -0.898 . . . . 0.0 108.939 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.8 p -102.2 12.9 36.0 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.448 0.642 . . . . 0.0 110.433 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.45 HG21 ' HB2' ' A' ' 52' ' ' LYS . 76.3 p -135.89 153.97 51.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.982 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.5 85.27 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.189 0.518 . . . . 0.0 110.942 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -114.49 108.32 16.71 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 1.019 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 27.4 t80 -73.89 -35.65 64.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.009 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -48.47 -33.99 10.35 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -90.88 -64.18 1.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.707 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 19.8 m-20 -69.01 -34.27 74.98 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.649 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 9.3 mtm180 50.26 45.21 26.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.707 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 34.3 mttt -111.45 119.8 40.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 1.019 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 6.9 p-90 -132.17 173.17 11.52 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -175.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.636 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.26 144.11 8.77 Favored Glycine 0 C--O 1.22 -0.731 0 CA-C-N 113.732 -1.576 . . . . 0.0 110.284 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 14.8 m-30 -57.03 155.19 8.55 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.414 0.626 . . . . 0.0 112.099 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.498 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 16.6 t . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.295 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.446 -0.629 0 CA-C-O 121.727 0.775 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.719 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -113.15 -168.04 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.04 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.439 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.45 -126.28 1.28 Allowed Glycine 0 N--CA 1.46 0.274 0 O-C-N 123.955 0.784 . . . . 0.0 113.04 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.686 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 38.59 -142.94 0.33 Allowed Glycine 0 C--N 1.331 0.3 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.449 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 114.784 -0.708 . . . . 0.0 110.333 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.98 0.419 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -88.55 170.17 5.57 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.183 2.589 . . . . 0.0 112.188 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.4 m -76.07 140.54 41.93 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 84.1 t -106.65 108.6 25.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.531 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 50.9 m-85 -109.66 141.32 23.41 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-O 120.831 0.348 . . . . 0.0 111.411 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.571 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 3.8 Cg_endo -85.7 134.05 17.64 Favored 'Cis proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.254 -1.561 . . . . 0.0 111.718 -0.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.531 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 43.9 p90 -102.81 -171.17 1.91 Allowed 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.356 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 96.6 m -145.56 119.17 9.13 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.242 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.737 ' CE1' HD22 ' A' ' 22' ' ' LEU . 72.4 t80 -109.46 131.16 55.33 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.746 ' H ' HD21 ' A' ' 22' ' ' LEU . 3.8 mm? 35.63 44.06 0.19 Allowed 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 124.511 1.132 . . . . 0.0 113.859 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.2 -10.81 63.69 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 114.581 -1.191 . . . . 0.0 116.038 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 52.5 m-80 -113.23 134.01 54.8 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.887 1.843 . . . . 0.0 111.951 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -78.1 122.93 26.25 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.368 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.583 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 17.3 m-30 -110.89 118.23 35.54 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.749 0.785 . . . . 0.0 110.912 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.571 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 47.9 mt-10 -96.93 -12.81 22.93 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.356 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 p -132.69 -175.12 3.66 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 89.5 m -64.66 171.72 3.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.248 0.547 . . . . 0.0 110.052 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.4 t -151.11 173.13 14.74 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.849 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 p -133.24 24.65 4.17 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.53 137.48 58.16 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 113.172 -1.831 . . . . 0.0 111.786 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.87 -2.68 31.98 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.234 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.4 mtp85 . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 120.762 0.315 . . . . 0.0 111.417 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 44.2 mttp . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.503 0.192 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.3 mtm -83.93 146.77 27.86 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.621 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 21.3 p-90 -136.97 -168.1 2.21 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.336 0.589 . . . . 0.0 111.675 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 24.5 p -160.17 156.09 26.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.075 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB1' ' CG ' ' A' ' 19' ' ' PHE . . . -84.17 145.81 28.18 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.556 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.8 p -102.07 11.12 38.9 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.494 0.664 . . . . 0.0 110.291 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 p -133.33 152.0 51.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.389 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.91 82.24 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.828 0.347 . . . . 0.0 111.415 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -120.58 109.77 15.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 1.002 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 28.6 t80 -70.81 -37.25 73.23 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.737 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.42 -35.48 60.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.418 . . . . 0.0 111.609 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -76.12 -69.39 0.5 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -85.74 -18.05 34.13 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 23.0 mtm180 44.57 52.34 7.65 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -113.95 122.18 46.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 1.002 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 7.8 p-90 -129.76 173.13 10.93 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.481 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.4 140.72 6.43 Favored Glycine 0 C--O 1.223 -0.583 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.871 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.719 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.2 m-30 -63.09 158.13 20.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.364 0.582 . . . . 0.0 111.852 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 68.5 m . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.003 177.581 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.448 -0.573 0 CA-C-O 121.395 0.617 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.703 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -114.21 -165.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 176.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.556 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.27 -125.49 1.16 Allowed Glycine 0 C--N 1.319 -0.385 0 O-C-N 124.173 0.92 . . . . 0.0 113.569 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.69 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 38.15 -141.19 0.42 Allowed Glycine 0 C--N 1.333 0.387 0 N-CA-C 115.754 1.062 . . . . 0.0 115.754 177.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 114.74 -0.73 . . . . 0.0 109.781 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.543 0.211 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -84.72 170.41 10.15 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.951 2.434 . . . . 0.0 111.942 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.5 m -79.9 138.57 37.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.509 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.526 HG13 ' HA ' ' A' ' 45' ' ' ALA . 97.0 t -100.68 109.79 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -112.9 139.59 23.08 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.607 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.594 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.1 Cg_endo -86.72 136.79 18.58 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.097 -1.626 . . . . 0.0 112.373 -0.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.604 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 40.7 p90 -99.27 -171.58 2.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.172 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 32.2 m -142.94 127.94 18.46 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.156 0.503 . . . . 0.0 111.515 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.852 ' CD2' ' HB2' ' A' ' 32' ' ' ALA . 1.4 t80 -133.87 140.7 47.01 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.335 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.739 ' H ' HD11 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 39.46 33.92 0.12 Allowed 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 125.12 1.368 . . . . 0.0 114.103 178.023 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.94 -11.43 60.66 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.625 -0.798 . . . . 0.0 114.975 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 20' ' ' THR . 68.3 m-80 -109.47 154.81 22.13 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 118.513 1.156 . . . . 0.0 111.976 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -94.31 126.04 39.32 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 20.9 m-85 -110.88 110.67 21.37 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.724 0.773 . . . . 0.0 111.213 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.594 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 54.1 mt-10 -90.43 -10.26 44.44 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.824 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 p -136.84 -170.8 2.78 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.5 m -70.2 167.12 18.56 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.802 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.504 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 9.4 t -144.35 169.03 18.7 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.768 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.407 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 19.6 p -124.41 17.12 8.98 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.852 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -60.23 142.4 54.57 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 113.736 -1.574 . . . . 0.0 111.588 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.0 -5.73 12.32 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.642 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.477 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 25.2 mtp85 . . . . . 0 N--CA 1.443 -0.812 0 O-C-N 122.654 -0.321 . . . . 0.0 110.987 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.509 ' H ' ' CD ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 121.113 0.482 . . . . 0.0 112.043 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.407 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 71.3 mtp -100.15 150.72 22.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.677 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.0 p-90 -135.3 -170.28 2.56 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.913 0.387 . . . . 0.0 111.303 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 20.5 p -155.68 141.58 18.13 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.604 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -76.42 145.81 39.08 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.976 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.9 p -99.33 10.47 41.35 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.377 0.608 . . . . 0.0 109.91 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.6 p -128.13 153.51 46.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.053 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.526 ' HA ' HG13 ' A' ' 16' ' ' VAL . . . -58.24 -38.66 77.31 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.089 0.471 . . . . 0.0 110.452 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -123.99 111.35 15.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.743 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 59.4 t80 -70.13 -40.67 74.71 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.71 -30.64 70.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.089 0.471 . . . . 0.0 111.768 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -61.13 1.9 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.751 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -95.81 -23.85 16.74 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 5.7 mtm180 53.7 52.05 13.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -117.84 119.09 33.81 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.743 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.2 p-90 -129.84 174.28 9.88 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -175.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.38 141.41 7.19 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 113.93 -1.487 . . . . 0.0 110.024 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.703 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 4.7 m-30 -60.28 157.8 12.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.898 0.849 . . . . 0.0 111.668 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.001 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.451 -0.396 0 CA-C-O 121.722 0.772 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -117.89 -167.26 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.044 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.453 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 36.78 -121.7 0.75 Allowed Glycine 0 N--CA 1.46 0.289 0 O-C-N 124.13 0.894 . . . . 0.0 113.248 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.65 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 30.21 -135.11 0.08 OUTLIER Glycine 0 C--N 1.337 0.632 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 114.815 -0.692 . . . . 0.0 110.422 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.166 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -86.53 171.74 7.21 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.898 2.399 . . . . 0.0 112.416 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 78.7 m -95.67 112.24 24.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.1 t -73.59 115.34 14.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.87 0.367 . . . . 0.0 111.544 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -113.03 141.18 25.16 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 120.91 0.386 . . . . 0.0 110.572 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -85.68 139.87 26.72 Favored 'Cis proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.386 -1.922 . . . . 0.0 111.707 -0.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 40.3 p90 -103.81 -174.32 2.52 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.147 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 94.3 m -142.67 120.03 11.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.865 0.364 . . . . 0.0 110.286 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.844 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 66.3 t80 -115.97 135.09 54.3 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.535 HD21 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 34.68 47.18 0.22 Allowed 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 124.589 1.18 . . . . 0.0 114.01 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.32 -7.74 80.03 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 116.546 1.378 . . . . 0.0 116.546 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' THR . 54.4 m-80 -112.79 143.14 44.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.567 1.684 . . . . 0.0 111.823 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -86.81 129.38 34.9 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.844 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 88.0 m-85 -116.75 118.22 31.93 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.394 0.616 . . . . 0.0 111.089 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -94.28 -16.62 23.42 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.845 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.7 p -130.67 -177.59 4.42 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.485 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 77.8 m -66.91 161.93 22.96 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -138.28 167.83 21.03 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.12 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.66 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 11.0 p -121.22 20.16 11.4 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -60.88 134.47 57.12 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 113.751 -1.568 . . . . 0.0 111.779 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.83 -5.71 37.77 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.136 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.437 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 20.4 mtp85 . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 120.797 0.332 . . . . 0.0 111.282 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.45 ' H ' ' CD ' ' A' ' 38' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.445 -0.678 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.66 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.2 mpt? -95.69 154.65 17.11 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.635 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.6 p-90 -139.88 -163.21 1.46 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.1 0.476 . . . . 0.0 111.144 -178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p -169.45 155.98 6.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.264 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 15' ' ' CYS . . . -79.61 152.86 29.8 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 120.911 0.386 . . . . 0.0 111.464 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.1 p -102.12 6.87 41.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.95 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.7 p -130.73 150.66 51.81 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.295 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.02 -35.44 71.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.969 0.414 . . . . 0.0 110.986 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -124.47 109.99 13.95 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 1.012 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 30.6 t80 -75.38 -34.84 61.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.345 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -52.26 -32.87 39.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.885 0.374 . . . . 0.0 111.324 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -83.17 -58.54 2.8 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.815 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 56.2 m-20 -91.31 -19.8 22.57 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 3.2 mtm105 46.57 43.72 12.69 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.815 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 22.2 mtpt -110.57 124.0 51.02 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 1.012 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 7.8 p-90 -131.58 172.66 11.97 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.565 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.65 145.78 11.3 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 113.646 -1.616 . . . . 0.0 110.255 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.684 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 7.0 m-30 -66.62 160.56 25.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.465 0.65 . . . . 0.0 112.318 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.867 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.723 0.773 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.65 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.1 OUTLIER -132.0 161.73 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 177.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.728 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.73 -154.33 46.15 Favored Glycine 0 C--N 1.309 -0.921 0 C-N-CA 118.068 -2.015 . . . . 0.0 111.544 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.6 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 48.94 -150.42 3.82 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 115.45 0.94 . . . . 0.0 115.45 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 114.835 -0.682 . . . . 0.0 109.625 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.406 ' HB2' ' HB ' ' A' ' 43' ' ' THR . . . . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 120.433 0.159 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -85.61 -177.21 2.53 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.834 2.356 . . . . 0.0 111.308 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.9 m -87.75 122.42 31.39 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.241 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 74.6 t -85.06 110.16 18.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.733 0.301 . . . . 0.0 110.329 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -116.26 138.55 24.36 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-O 120.95 0.405 . . . . 0.0 111.013 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.618 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 6.4 Cg_endo -86.47 137.85 20.67 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.136 -1.61 . . . . 0.0 112.002 -0.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.63 ' CG ' ' HB1' ' A' ' 42' ' ' ALA . 47.1 p90 -103.09 -169.66 1.68 Allowed 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.9 m -144.31 128.93 18.15 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.947 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.877 ' CD2' ' HB2' ' A' ' 32' ' ' ALA . 1.1 t80 -132.49 142.3 49.16 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.82 HD23 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 41.12 35.81 0.41 Allowed 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 124.557 1.143 . . . . 0.0 112.812 178.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.13 -6.6 83.31 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 115.01 0.764 . . . . 0.0 115.01 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.493 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.1 m-80 -107.07 136.87 46.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.508 1.154 . . . . 0.0 111.638 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -78.03 123.09 26.42 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.691 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 14.8 m-30 -107.03 112.17 24.99 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.805 0.812 . . . . 0.0 110.884 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.618 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 45.6 mt-10 -91.54 -18.0 24.78 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.366 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 p -129.89 -174.17 3.24 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 80.8 m -62.92 166.66 5.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.54 0.686 . . . . 0.0 110.36 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -147.65 169.5 19.52 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.32 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.572 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 55.1 p -128.55 17.7 6.39 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.877 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -59.79 138.25 57.83 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 113.96 -1.473 . . . . 0.0 111.086 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.06 -9.31 26.15 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.289 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.624 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.7 mtp85 . . . . . 0 N--CA 1.445 -0.69 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.682 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 24.7 mmmt . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.572 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 60.8 mtt -81.8 149.5 28.34 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.605 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 21.6 p-90 -136.61 -172.76 3.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.563 0.697 . . . . 0.0 112.297 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 25.0 p -151.05 140.46 21.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.739 -1.118 . . . . 0.0 108.693 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.63 ' HB1' ' CG ' ' A' ' 19' ' ' PHE . . . -75.61 151.24 37.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.347 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 13' ' ' ALA . 65.1 p -108.04 14.81 24.86 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.798 0.808 . . . . 0.0 110.199 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.0 p -137.23 150.05 47.58 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.94 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.407 ' HA ' HG13 ' A' ' 16' ' ' VAL . . . -56.23 -42.25 76.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.879 0.371 . . . . 0.0 111.205 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -118.09 106.24 12.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.72 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 75.8 t80 -74.44 -35.28 63.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.231 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -54.44 -39.51 67.44 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -84.08 -49.78 8.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -83.02 -34.09 26.36 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 4.3 mmm-85 55.19 44.46 27.69 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -111.53 118.36 35.53 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.72 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 11.5 p-90 -129.45 174.88 9.23 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -175.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.571 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.17 141.22 7.08 Favored Glycine 0 C--O 1.221 -0.683 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.107 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.728 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 6.1 m-85 -65.75 163.38 16.74 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 117.344 0.572 . . . . 0.0 111.989 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 63.1 m . . . . . 0 N--CA 1.453 -0.284 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.755 178.351 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.442 -0.853 0 CA-C-O 121.665 0.745 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.695 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.2 OUTLIER -126.74 160.76 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 177.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.794 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 68.53 -144.78 42.87 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 117.887 -2.102 . . . . 0.0 111.612 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.617 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 43.12 -145.86 1.04 Allowed Glycine 0 C--N 1.331 0.275 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 114.878 -0.661 . . . . 0.0 109.506 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.079 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -84.63 160.99 12.47 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.744 2.296 . . . . 0.0 112.43 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 91.8 m -83.37 123.12 29.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.469 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.8 t -90.31 120.02 38.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.715 0.293 . . . . 0.0 110.922 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.599 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 58.6 m-85 -114.74 141.88 27.44 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.483 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.3 Cg_endo -86.49 132.75 14.61 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.308 -1.538 . . . . 0.0 112.14 -0.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.656 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 22.5 p90 -98.56 128.03 44.73 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.517 ' OG1' ' HD2' ' A' ' 25' ' ' LYS . 13.9 m -91.38 125.64 36.21 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.432 0.634 . . . . 0.0 112.148 -177.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.842 ' CG ' HD23 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -130.36 145.97 51.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.41 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.842 HD23 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.24 36.88 0.21 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.461 1.104 . . . . 0.0 113.099 178.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.27 -5.52 84.96 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.412 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 68.6 m-80 -110.29 135.7 50.63 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.587 1.194 . . . . 0.0 112.202 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.517 ' HD2' ' OG1' ' A' ' 20' ' ' THR . 25.1 mmmt -77.42 117.13 18.6 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.832 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.5 m-30 -101.77 104.4 15.19 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.02 0.914 . . . . 0.0 111.361 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 15.5 mt-10 -84.46 -17.42 39.2 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.215 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 p -129.06 -178.45 4.64 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.639 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.9 m -66.64 159.52 27.45 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.725 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.61 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.5 t -137.74 178.48 7.08 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.703 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.7 p -128.77 17.44 6.29 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.799 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -60.87 142.96 55.78 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.107 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.06 -5.26 19.79 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.536 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.618 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 12.2 mtp85 . . . . . 0 N--CA 1.449 -0.504 0 CA-C-N 117.33 0.565 . . . . 0.0 111.565 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.618 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 5.7 mptt . . . . . 0 CA--C 1.515 -0.367 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.427 ' HB3' ' HE1' ' A' ' 39' ' ' MET . 51.0 mtp -89.86 156.82 18.21 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.61 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 18.6 p-90 -143.85 -172.06 3.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.417 0.627 . . . . 0.0 111.332 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.4 p -159.3 139.26 11.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.044 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.656 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -72.01 155.48 40.28 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.372 0.606 . . . . 0.0 111.511 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.4 p -101.93 11.24 38.88 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.767 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.9 p -133.08 151.82 52.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.912 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.96 -32.57 67.97 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.163 0.506 . . . . 0.0 111.358 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -126.69 120.2 28.84 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.84 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 64.5 t80 -86.17 -31.42 21.8 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.325 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -61.13 -30.94 70.68 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.05 -45.23 8.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -100.32 -18.51 16.76 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.1 mtm105 43.5 51.28 6.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -114.82 119.39 36.45 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.84 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.2 p-90 -132.99 176.48 8.45 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -174.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -167.28 142.55 7.63 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 112.95 -1.932 . . . . 0.0 109.222 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.794 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 12.9 m-85 -60.76 157.37 14.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.407 0.622 . . . . 0.0 112.081 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.486 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.9 t . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.055 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.546 HG21 ' O ' ' A' ' 13' ' ' ALA . 3.2 p . . . . . 0 N--CA 1.448 -0.545 0 CA-C-O 121.987 0.899 . . . . 0.0 112.742 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.725 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.2 OUTLIER -132.75 163.91 36.58 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.032 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 178.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.725 ' N ' HG21 ' A' ' 6' ' ' VAL . . . 65.16 -149.94 51.7 Favored Glycine 0 C--N 1.312 -0.782 0 C-N-CA 117.716 -2.183 . . . . 0.0 111.014 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.627 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 48.47 -150.51 3.34 Favored Glycine 0 C--N 1.332 0.326 0 N-CA-C 114.641 0.616 . . . . 0.0 114.641 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.402 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.418 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.546 ' O ' HG21 ' A' ' 5' ' ' THR . . . . . . . . 0 CA--C 1.521 -0.163 0 CA-C-O 120.809 0.338 . . . . 0.0 111.513 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 14.2 Cg_exo -65.51 154.31 74.29 Favored 'Trans proline' 0 C--N 1.334 -0.219 0 C-N-CA 122.896 2.397 . . . . 0.0 111.472 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.2 m -73.78 134.58 43.44 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.534 HG13 ' HA ' ' A' ' 45' ' ' ALA . 96.0 t -95.06 113.87 30.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.834 0.35 . . . . 0.0 110.426 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.612 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 47.4 m-85 -118.64 139.94 27.72 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.538 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.717 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 35.9 Cg_endo -87.06 136.12 17.05 Favored 'Cis proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.51 -1.871 . . . . 0.0 112.379 -0.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.707 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 34.3 p90 -101.93 -168.02 1.49 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 76.0 m -149.47 126.28 11.12 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.433 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.788 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 36.8 t80 -123.03 131.64 53.79 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.988 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.724 HD23 ' CE2' ' A' ' 21' ' ' PHE . 6.7 mp 41.76 33.56 0.34 Allowed 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 124.531 1.144 . . . . 0.0 113.502 174.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.68 -18.16 32.41 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 115.422 0.929 . . . . 0.0 115.422 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.453 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 43.8 m-80 -112.6 132.01 55.34 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.888 1.344 . . . . 0.0 112.181 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 46.5 mtpt -78.17 127.03 31.67 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.788 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.4 m-85 -111.91 121.2 44.38 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.683 0.754 . . . . 0.0 111.223 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.717 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 99.1 mt-10 -94.87 -14.67 24.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.224 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.3 p -130.08 -175.37 3.6 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.63 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.7 m -67.1 166.29 14.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.774 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.3 t -146.15 165.36 29.38 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.098 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 p -121.53 23.8 10.13 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.582 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -66.04 139.73 58.22 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.022 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.65 -6.45 17.79 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.612 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.487 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.9 mtp85 . . . . . 0 N--CA 1.449 -0.48 0 CA-C-N 117.401 0.601 . . . . 0.0 111.211 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.778 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 1.5 mppt? . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.0 mtm -104.61 159.07 16.05 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.722 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.567 ' HA ' ' N ' ' A' ' 56' ' ' CYS . 13.9 p-90 -142.5 -165.7 2.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.369 0.604 . . . . 0.0 111.94 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.3 p -161.04 152.79 19.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.672 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.707 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -86.85 148.53 25.33 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.401 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 16' ' ' VAL . 73.3 p -103.12 8.02 38.71 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.536 0.684 . . . . 0.0 109.877 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.9 p -130.07 152.63 49.31 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.663 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.534 ' HA ' HG13 ' A' ' 16' ' ' VAL . . . -57.73 -47.74 81.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.756 0.313 . . . . 0.0 111.518 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -115.4 104.61 11.94 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.961 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 43.4 t80 -69.28 -37.6 77.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.792 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -53.0 -28.82 25.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.96 0.41 . . . . 0.0 111.762 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -87.48 -70.6 0.61 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.59 -21.18 55.94 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.626 ' HB3' ' NH1' ' A' ' 51' ' ' ARG . 0.9 OUTLIER 46.98 50.77 13.53 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 179.166 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -114.13 118.37 33.83 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.961 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.8 p-90 -129.85 171.21 12.96 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -174.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.627 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.61 142.64 7.83 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 113.122 -1.854 . . . . 0.0 109.502 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 13.7 m-30 -55.15 155.65 4.63 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 117.043 0.422 . . . . 0.0 111.249 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.567 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.7 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.577 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 121.466 0.651 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.681 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -116.5 -164.96 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 177.059 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.533 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.64 -125.51 1.31 Allowed Glycine 0 N--CA 1.463 0.47 0 O-C-N 123.814 0.696 . . . . 0.0 113.307 177.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.632 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 30.55 -136.4 0.07 OUTLIER Glycine 0 C--N 1.338 0.693 0 N-CA-C 116.049 1.179 . . . . 0.0 116.049 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.46 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 114.729 -0.736 . . . . 0.0 110.083 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.563 0.22 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -86.12 166.52 9.62 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.62 2.213 . . . . 0.0 112.254 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.7 m -81.08 133.92 35.56 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.523 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 82.9 t -96.48 115.76 36.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.742 0.306 . . . . 0.0 110.29 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -118.15 139.54 26.81 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.314 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.64 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 6.0 Cg_endo -85.64 136.12 20.61 Favored 'Cis proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.288 -1.547 . . . . 0.0 111.571 -0.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.654 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 43.8 p90 -104.1 -170.04 1.71 Allowed 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.364 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.7 m -148.18 126.86 12.53 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.094 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.794 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 67.9 t80 -117.95 132.73 56.37 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.599 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.508 HD21 ' CD1' ' A' ' 21' ' ' PHE . 3.8 mm? 33.28 45.45 0.08 Allowed 'General case' 0 N--CA 1.432 -1.332 0 O-C-N 124.792 1.308 . . . . 0.0 114.034 174.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.77 -19.01 51.61 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.432 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 32.4 m-80 -111.86 133.67 53.91 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.787 1.794 . . . . 0.0 112.418 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 11.4 mtmt -75.59 127.11 32.37 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.361 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.794 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.9 m-85 -115.97 109.7 17.93 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 122.244 1.021 . . . . 0.0 110.384 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.64 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 24.4 mt-10 -87.81 -10.47 50.8 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.498 -1.683 . . . . 0.0 110.648 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.5 p -133.15 -168.2 2.05 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.6 m -74.52 167.63 21.34 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.412 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 13.4 t -146.71 169.97 17.94 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.309 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.422 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 11.8 p -122.32 20.15 10.52 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.515 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -60.12 140.55 56.83 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.233 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.4 -1.07 45.16 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.51 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.654 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.6 mtp85 . . . . . 0 N--CA 1.447 -0.58 0 CA-C-N 116.944 0.372 . . . . 0.0 111.076 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.75 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 2.9 mppt? . . . . . 0 N--CA 1.446 -0.645 0 CA-C-O 120.939 0.399 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.422 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 47.1 mtt -91.18 151.06 21.1 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.632 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.6 p-90 -130.08 -167.07 1.76 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.187 0.518 . . . . 0.0 111.533 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 10.6 p -159.72 143.97 14.81 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.401 ' HB1' ' CD1' ' A' ' 19' ' ' PHE . . . -76.11 149.72 37.35 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 59.8 p -104.74 13.86 30.67 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.677 0.751 . . . . 0.0 109.788 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.8 p -139.33 154.98 47.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.835 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.85 -48.01 83.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.772 0.32 . . . . 0.0 111.325 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -114.49 106.68 14.57 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 1.033 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 20.3 t80 -75.81 -34.39 60.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.196 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.13 -39.81 21.68 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.92 -35.71 11.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -89.82 -30.86 17.66 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.507 ' HB3' HH11 ' A' ' 51' ' ' ARG . 0.3 OUTLIER 48.62 47.09 20.99 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -117.77 118.07 31.06 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 1.033 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 10.2 p-90 -132.57 173.7 11.05 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -175.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.564 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.7 147.22 11.39 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 113.437 -1.711 . . . . 0.0 109.571 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.681 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 11.5 m-30 -61.04 155.71 19.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.752 0.776 . . . . 0.0 111.592 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.541 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 11.3 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.639 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 121.492 0.663 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.57 -50.1 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-O 123.194 1.473 . . . . 0.0 109.716 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.65 ' H ' ' HB2' ' A' ' 55' ' ' PHE . . . -83.38 -162.29 32.75 Favored Glycine 0 C--N 1.278 -2.692 0 CA-C-N 111.054 -2.794 . . . . 0.0 111.85 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 53' ' ' TRP . . . 75.62 -157.89 49.67 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.693 -0.765 . . . . 0.0 114.419 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.857 0.361 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 3.1 Cg_exo -78.45 154.54 27.86 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.894 2.396 . . . . 0.0 112.008 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.8 m -76.99 141.75 40.26 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.0 t -109.39 92.11 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.726 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.695 ' CE1' ' HE1' ' A' ' 19' ' ' PHE . 6.5 m-85 -94.32 143.98 27.25 Favored Pre-proline 0 N--CA 1.447 -0.624 0 CA-C-O 121.657 0.741 . . . . 0.0 111.331 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.3 Cg_endo -84.14 129.91 14.73 Favored 'Cis proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.402 -1.916 . . . . 0.0 111.964 -0.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.695 ' HE1' ' CE1' ' A' ' 17' ' ' PHE . 2.0 p90 -86.7 -163.68 0.94 Allowed 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.485 ' HG1' ' C ' ' A' ' 19' ' ' PHE . 7.5 m -149.19 121.75 8.56 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.918 ' HB2' ' CE2' ' A' ' 26' ' ' TYR 0.494 0.5 OUTLIER -104.09 -171.38 1.92 Allowed 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 119.264 3.061 . . . . 0.0 119.264 171.964 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.779 HD23 ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -52.93 45.6 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 110.086 -3.234 . . . . 0.0 113.684 -173.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 21' ' ' PHE . . . 118.19 1.46 16.34 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.318 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.865 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 1.9 m-80 -138.67 136.57 36.0 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 118.572 1.186 . . . . 0.0 113.016 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.53 122.34 26.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 175.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.918 ' CE2' ' HB2' ' A' ' 21' ' ' PHE . 22.1 m-30 -95.42 98.35 10.49 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 122.39 1.09 . . . . 0.0 112.824 -175.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 16.4 mt-10 -78.21 -12.66 60.01 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.778 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.6 p -138.57 -179.84 6.04 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.4 m -64.6 163.28 13.97 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.503 -0.879 . . . . 0.0 109.209 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -143.92 170.27 16.22 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.583 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 61.2 p -122.77 15.63 10.16 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.497 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -64.52 147.89 51.85 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.001 -1.454 . . . . 0.0 111.336 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.94 -4.59 37.4 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.158 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.588 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 28.3 mtp85 . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 120.751 0.31 . . . . 0.0 111.242 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.705 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 7.1 mptt . . . . . 0 N--CA 1.448 -0.542 0 CA-C-O 120.732 0.301 . . . . 0.0 110.762 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.583 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 56.2 mtt -91.34 142.88 27.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.766 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 18.3 p-90 -122.93 -170.82 2.17 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.504 0.668 . . . . 0.0 110.979 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 8.3 p -157.56 134.49 10.08 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.0 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . . . -72.49 149.43 44.14 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.011 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.5 p -101.99 13.74 33.93 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.538 0.685 . . . . 0.0 110.335 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.8 p -135.69 148.28 48.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.014 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -55.81 -36.64 67.66 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.894 0.378 . . . . 0.0 110.978 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -119.58 116.9 26.99 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.705 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 60.9 t80 -87.56 -43.78 11.75 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.343 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -42.94 -37.89 2.03 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -91.29 -67.88 0.83 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.438 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 2.2 m-20 -63.97 -26.13 68.44 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.9 mtm-85 44.33 52.62 7.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.438 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 25.7 mttm -116.94 115.64 25.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.705 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 16.6 p-90 -129.73 175.09 9.11 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.978 0.894 . . . . 0.0 112.758 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.477 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -164.8 142.6 7.87 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 113.617 -1.629 . . . . 0.0 109.191 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.65 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 4.3 m-30 -60.66 147.39 42.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.688 0.744 . . . . 0.0 111.0 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.426 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.6 t . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.192 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 122.019 0.914 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -134.62 160.94 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.012 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.836 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 68.63 -147.54 47.02 Favored Glycine 0 C--N 1.309 -0.956 0 C-N-CA 117.487 -2.292 . . . . 0.0 111.612 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.635 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 47.25 -147.18 3.68 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 114.441 0.537 . . . . 0.0 114.441 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 120.823 0.344 . . . . 0.0 110.733 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 120.434 0.159 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -88.87 167.33 5.78 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.805 2.337 . . . . 0.0 111.932 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.7 m -76.56 141.08 41.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.562 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 88.1 t -111.4 115.1 48.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -116.43 144.16 32.58 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.935 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.595 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.7 Cg_endo -84.21 133.49 19.73 Favored 'Cis proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.485 -1.465 . . . . 0.0 111.285 -0.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.793 ' HZ ' HG22 ' A' ' 30' ' ' THR . 17.5 p90 -103.37 162.6 12.88 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.2 m -118.84 122.44 42.36 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.943 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.777 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 60.6 t80 -119.9 133.71 55.48 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.5 HD21 ' CD1' ' A' ' 21' ' ' PHE . 3.5 mm? 36.19 46.76 0.41 Allowed 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.5 -4.05 86.49 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 114.225 -1.352 . . . . 0.0 116.318 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 26' ' ' TYR . 40.2 m-80 -110.14 155.71 21.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.673 1.737 . . . . 0.0 111.571 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -94.65 131.33 40.56 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.157 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.777 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 88.9 m-85 -123.77 107.56 11.57 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.697 0.761 . . . . 0.0 112.041 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.595 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 93.6 mt-10 -93.39 -14.32 26.96 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.591 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.6 p -128.14 -177.06 3.99 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.605 -1.179 . . . . 0.0 108.158 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.6 m -67.08 168.91 9.28 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.284 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.793 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 10.6 t -143.99 169.17 18.33 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.184 0.516 . . . . 0.0 110.787 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.434 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 32.4 p -123.52 15.51 9.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.757 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -55.9 136.86 51.38 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.405 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.26 -18.59 3.36 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.147 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' A' ' 32' ' ' ALA . 21.7 mtp85 . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 120.795 0.331 . . . . 0.0 110.519 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.763 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 7.0 mptt . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.434 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.5 mpt? -96.41 152.62 18.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.584 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.6 p-90 -133.4 -166.08 1.72 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.326 0.584 . . . . 0.0 111.531 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 29.3 p -158.58 149.69 20.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.008 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.865 ' HB3' ' HD2' ' A' ' 47' ' ' TYR . . . -84.27 148.33 26.75 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 16' ' ' VAL . 71.2 p -102.41 10.61 38.91 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.665 0.745 . . . . 0.0 110.32 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.2 p -133.56 151.31 51.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.924 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -55.78 -37.66 68.86 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.971 0.415 . . . . 0.0 111.077 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -125.51 112.44 16.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 1.033 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 30.6 t80 -73.95 -36.93 64.67 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.538 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -54.22 -35.08 62.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.148 0.499 . . . . 0.0 111.103 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.57 -71.42 0.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -81.47 -18.85 43.78 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.629 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 11.1 mtm180 45.2 55.65 6.17 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -119.49 120.86 38.03 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 1.033 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.7 p-90 -128.35 169.8 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.573 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.57 140.72 6.71 Favored Glycine 0 C--O 1.22 -0.78 0 CA-C-N 113.377 -1.738 . . . . 0.0 109.819 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.836 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.2 m-85 -58.93 154.41 15.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 117.59 0.695 . . . . 0.0 111.233 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.424 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.5 t . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.955 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.776 0.798 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.657 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -127.8 -168.24 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 177.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.469 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 35.84 -131.22 0.78 Allowed Glycine 0 CA--C 1.522 0.511 0 O-C-N 124.079 0.862 . . . . 0.0 113.496 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.663 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 40.31 -144.59 0.46 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 114.983 0.753 . . . . 0.0 114.983 177.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.27 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -81.74 154.36 17.76 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.118 1.879 . . . . 0.0 111.513 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.7 m -74.17 131.4 41.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.2 t -86.55 109.39 18.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.51 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 35.4 m-85 -116.59 139.31 25.33 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-O 120.749 0.309 . . . . 0.0 111.684 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.677 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 3.8 Cg_endo -86.22 134.78 17.5 Favored 'Cis proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.312 -1.537 . . . . 0.0 111.211 -1.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.573 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 43.5 p90 -96.95 -168.66 1.74 Allowed 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.437 178.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 73.9 m -144.43 122.98 12.45 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.002 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.831 ' CD2' ' HB2' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -125.0 142.94 51.16 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.81 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 40.91 27.94 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.758 1.223 . . . . 0.0 113.562 178.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.02 -7.02 62.35 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 114.819 0.688 . . . . 0.0 114.819 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 20' ' ' THR . 60.7 m-80 -105.5 149.33 26.31 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.512 1.156 . . . . 0.0 111.921 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -88.46 119.07 28.56 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.575 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 28.1 m-85 -104.64 112.52 25.63 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.72 0.772 . . . . 0.0 110.587 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.677 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 46.6 mt-10 -92.04 -17.75 24.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.475 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 p -129.62 -175.67 3.67 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 78.2 m -65.77 164.17 15.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.474 0.654 . . . . 0.0 110.613 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.528 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 8.8 t -142.34 167.71 21.47 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.867 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.69 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 27.9 p -121.95 18.57 10.93 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.831 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -64.48 139.17 58.74 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.718 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.81 -4.29 45.74 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.1 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.648 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.2 mtp85 . . . . . 0 N--CA 1.451 -0.391 0 CA-C-N 117.425 0.612 . . . . 0.0 110.844 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.721 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 8.8 mptt . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.885 0.374 . . . . 0.0 111.948 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.69 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 70.0 mtm -78.27 142.13 38.04 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.613 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 14.1 p-90 -128.75 -167.37 1.77 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.433 0.635 . . . . 0.0 112.04 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 17.7 p -152.7 141.86 21.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.918 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.573 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -75.99 148.56 38.01 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.178 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.1 p -103.27 11.96 36.13 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.594 0.711 . . . . 0.0 109.712 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.571 HG21 ' HB2' ' A' ' 52' ' ' LYS . 42.3 p -137.62 153.3 49.91 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.762 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.56 -50.09 72.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 110.303 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -105.18 102.83 12.3 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.772 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 71.8 t80 -75.67 -34.31 60.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.936 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.36 -38.91 55.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -85.55 -71.2 0.54 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.519 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 72.9 m-20 -63.54 -26.42 68.7 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 15.4 mtm180 44.2 52.09 7.18 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.571 ' HB2' HG21 ' A' ' 44' ' ' THR . 42.8 mttt -116.35 118.93 34.1 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.772 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.7 p-90 -133.89 176.28 8.71 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.548 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.94 150.07 19.1 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.295 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.657 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.7 m-30 -65.44 162.02 18.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.96 0.88 . . . . 0.0 112.374 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.433 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 5.6 t . . . . . 0 C--N 1.33 -0.254 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.849 0.833 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.51 HG23 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -128.08 164.96 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 178.045 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.682 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 61.36 -149.97 44.95 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 118.229 -1.938 . . . . 0.0 111.51 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.558 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 49.79 -145.28 8.66 Favored Glycine 0 C--N 1.33 0.24 0 N-CA-C 114.169 0.428 . . . . 0.0 114.169 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.444 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.445 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 CA--C 1.522 -0.134 0 CA-C-O 120.859 0.361 . . . . 0.0 111.372 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 85.7 Cg_endo -90.3 169.44 4.11 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.4 2.733 . . . . 0.0 112.038 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.9 m -79.52 142.31 35.89 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.424 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.3 t -116.22 87.99 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.722 0.296 . . . . 0.0 111.318 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.543 ' CE1' ' HE1' ' A' ' 19' ' ' PHE . 8.8 m-85 -90.3 146.11 34.03 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-O 121.443 0.639 . . . . 0.0 111.082 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.67 132.26 18.69 Favored 'Cis proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.4 -1.917 . . . . 0.0 112.197 -0.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.551 ' CB ' ' HB2' ' A' ' 42' ' ' ALA . 0.4 OUTLIER -90.07 -168.19 2.05 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.357 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.454 ' HG1' ' C ' ' A' ' 19' ' ' PHE . 77.2 m -151.13 124.06 8.66 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.983 ' HB2' ' CE2' ' A' ' 26' ' ' TYR 0.471 0.5 OUTLIER -96.5 -173.81 2.87 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 119.068 2.988 . . . . 0.0 119.068 171.698 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.743 HD23 ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -56.29 43.46 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 109.804 -3.362 . . . . 0.0 112.89 -173.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 21' ' ' PHE . . . 122.62 -0.48 10.19 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 114.083 -1.417 . . . . 0.0 113.014 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.824 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 1.8 m-80 -137.9 134.57 35.19 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 118.171 0.986 . . . . 0.0 112.256 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -83.65 127.86 34.09 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.983 ' CE2' ' HB2' ' A' ' 21' ' ' PHE . 6.4 m-85 -107.7 110.89 22.85 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 122.896 1.331 . . . . 0.0 113.249 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.27 -13.6 46.25 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 112.763 -2.017 . . . . 0.0 111.325 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 p -135.57 -177.61 4.75 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.1 m -65.68 153.39 41.82 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.139 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -131.39 175.89 8.76 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.442 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 1.4 p -130.41 17.8 5.38 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.591 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -64.69 154.48 36.46 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.511 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.36 -2.36 15.37 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.877 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.614 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.3 mtp85 . . . . . 0 N--CA 1.451 -0.419 0 CA-C-O 120.807 0.337 . . . . 0.0 111.094 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.755 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 8.5 mptt . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 120.718 0.294 . . . . 0.0 110.291 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.442 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 80.7 mtp -84.89 149.98 25.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.038 0.447 . . . . 0.0 110.828 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.696 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 24.0 p-90 -131.15 -171.94 2.71 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.62 0.724 . . . . 0.0 111.242 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 25.6 p -156.12 137.6 14.03 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.273 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.551 ' HB2' ' CB ' ' A' ' 19' ' ' PHE . . . -76.34 144.67 40.01 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.594 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.3 p -98.17 17.2 19.1 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.669 0.747 . . . . 0.0 110.01 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.9 p -141.67 146.48 36.18 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.75 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -54.4 -32.35 56.99 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.266 0.354 . . . . 0.0 111.886 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -125.66 121.47 33.6 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 1.02 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 30.9 t80 -88.46 -43.53 11.39 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.26 -31.91 1.73 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -93.23 -63.91 1.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -73.19 -20.28 60.92 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.4 mtm-85 41.86 52.34 4.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -118.28 117.81 30.11 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 1.02 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 8.9 p-90 -130.81 174.26 10.14 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -175.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.426 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -169.3 136.84 4.23 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-N 113.673 -1.603 . . . . 0.0 110.578 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.696 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 10.8 m-30 -60.21 158.83 10.76 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.377 0.671 . . . . 0.0 112.189 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.349 178.452 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.44 -0.955 0 CA-C-O 121.885 0.85 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.663 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.2 OUTLIER -126.39 162.93 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 177.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.731 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 67.03 -144.23 44.53 Favored Glycine 0 C--N 1.309 -0.919 0 C-N-CA 117.747 -2.168 . . . . 0.0 111.077 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.487 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 39.48 -138.08 1.14 Allowed Glycine 0 C--N 1.332 0.309 0 N-CA-C 114.888 0.715 . . . . 0.0 114.888 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.465 -0.368 . . . . 0.0 111.664 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.699 0.285 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -89.27 161.82 5.64 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.902 2.401 . . . . 0.0 112.664 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 86.6 m -79.99 133.94 36.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.119 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.57 114.4 44.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.724 0.297 . . . . 0.0 111.254 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.46 ' CE2' ' HE1' ' A' ' 19' ' ' PHE . 90.6 m-85 -108.27 146.5 33.71 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-O 120.751 0.31 . . . . 0.0 110.639 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.21 131.63 16.93 Favored 'Cis proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.479 -1.467 . . . . 0.0 111.579 -0.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.618 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 23.9 p90 -101.22 126.65 47.97 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 86.2 m -89.85 124.77 34.97 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.386 0.612 . . . . 0.0 111.739 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.834 ' CE1' HD12 ' A' ' 22' ' ' LEU . 1.8 t80 -124.11 141.53 51.98 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.834 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER 40.64 32.26 0.14 Allowed 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 124.294 1.038 . . . . 0.0 113.03 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.26 -11.15 69.3 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 115.117 0.807 . . . . 0.0 115.117 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.497 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.5 m-80 -105.54 136.1 45.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 118.564 1.182 . . . . 0.0 112.027 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -78.82 120.45 23.46 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.705 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.9 m-30 -103.26 110.61 22.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.044 0.926 . . . . 0.0 111.181 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -88.98 -18.91 26.46 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.73 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -128.36 177.72 6.77 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.1 m -64.57 161.28 17.78 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.688 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.5 t -136.61 171.84 13.89 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.987 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.615 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 29.4 p -124.39 16.73 8.99 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.65 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -61.71 145.46 52.29 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.787 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.62 -16.74 29.19 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.618 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.597 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 3.6 mtp-105 . . . . . 0 N--CA 1.453 -0.318 0 CA-C-N 117.671 0.735 . . . . 0.0 110.749 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.597 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 10.5 mptt . . . . . 0 N--CA 1.441 -0.88 0 CA-C-O 121.252 0.549 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.615 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 51.4 mtt -119.55 147.15 44.81 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.659 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 19.9 p-90 -136.96 -168.62 2.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.493 0.663 . . . . 0.0 111.689 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.551 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.6 p -162.18 140.31 8.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.23 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.618 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -69.9 149.11 48.17 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.407 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 81.2 p -95.03 14.63 21.2 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.518 0.675 . . . . 0.0 109.936 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.3 p -137.62 160.79 38.21 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.325 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.593 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -63.3 -32.94 74.48 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.03 0.443 . . . . 0.0 111.16 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -127.04 115.81 19.76 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.764 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 66.0 t80 -81.4 -31.61 33.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -56.89 -34.26 67.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.67 -62.62 1.43 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.35 -24.68 64.84 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 9.0 mtm180 40.51 48.74 2.55 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -120.47 121.72 39.1 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.764 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.8 p-90 -135.44 174.14 10.95 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -175.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.487 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.86 141.84 7.1 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.155 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.731 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.7 m-85 -57.0 154.37 9.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.217 0.532 . . . . 0.0 111.549 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.453 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 4.6 t . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.081 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.523 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 61.7 p . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 121.242 0.544 . . . . 0.0 112.11 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.844 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -96.35 -168.1 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 176.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.663 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 39.06 -124.29 1.72 Allowed Glycine 0 C--O 1.237 0.282 0 O-C-N 123.954 0.784 . . . . 0.0 113.18 177.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.671 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 36.68 -144.57 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 176.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.283 0 CA-C-N 114.546 -0.827 . . . . 0.0 110.391 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 110.725 -0.102 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -91.69 175.6 2.15 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.251 2.634 . . . . 0.0 111.889 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.9 m -78.62 124.55 28.29 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.427 HG13 ' HA ' ' A' ' 45' ' ' ALA . 82.0 t -94.88 106.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.834 0.35 . . . . 0.0 110.102 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -104.46 139.88 20.54 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.514 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -87.32 131.98 12.52 Favored 'Cis proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.748 -1.355 . . . . 0.0 111.932 -0.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.606 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 16.3 p90 -99.42 130.75 45.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.3 m -96.24 123.44 39.87 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.537 0.684 . . . . 0.0 111.681 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.923 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 13.1 t80 -128.36 141.0 51.56 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.33 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.691 HD12 ' CD1' ' A' ' 21' ' ' PHE . 2.8 mp 48.77 31.92 3.36 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 123.794 0.684 . . . . 0.0 112.302 176.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.46 -0.6 87.05 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.683 -0.689 . . . . 0.0 114.289 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.4 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 62.6 m-80 -114.96 137.27 52.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 118.072 0.936 . . . . 0.0 112.676 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -77.43 125.08 28.76 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.336 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.923 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.5 m-30 -112.6 111.16 21.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.982 0.896 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -92.65 -6.69 48.81 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.71 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 p -138.31 -172.66 3.33 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 98.3 m -69.52 163.54 25.16 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.487 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.1 t -140.77 169.05 18.36 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.665 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.625 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 12.3 p -122.89 15.75 10.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.478 ' CB ' ' HD2' ' A' ' 21' ' ' PHE . . . -60.38 138.64 57.95 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.809 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.86 -8.28 23.05 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.051 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.549 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 26.0 mtp85 . . . . . 0 N--CA 1.446 -0.669 0 CA-C-O 121.088 0.471 . . . . 0.0 110.528 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.702 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 1.9 mptt . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.807 0.337 . . . . 0.0 111.893 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.625 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 56.4 mtt -83.73 150.8 25.59 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.673 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 14.3 p-90 -130.32 -171.31 2.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.495 0.664 . . . . 0.0 112.505 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.1 p -154.02 140.7 18.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.603 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.561 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -80.05 156.5 27.08 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.129 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.3 p -108.19 17.93 21.7 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.838 0.828 . . . . 0.0 110.209 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.7 p -138.83 146.61 41.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.596 -1.184 . . . . 0.0 108.498 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -53.1 -46.56 68.75 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.131 0.491 . . . . 0.0 110.675 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -116.36 106.82 14.06 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.791 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 77.6 t80 -71.08 -46.2 62.3 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.866 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -44.3 -34.53 1.97 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -86.69 -62.75 1.44 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -80.63 -17.93 49.72 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.637 ' HG3' ' O ' ' A' ' 47' ' ' TYR . 21.6 mtm105 33.35 64.68 0.3 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -125.22 112.93 17.0 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.791 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.7 p-90 -120.42 177.07 5.18 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.673 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -158.59 163.52 33.1 Favored Glycine 0 C--O 1.22 -0.769 0 CA-C-N 113.314 -1.766 . . . . 0.0 108.856 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.844 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 1.9 m-85 -88.22 164.51 15.6 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 118.56 1.18 . . . . 0.0 112.683 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.237 0.424 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.166 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.66 HG22 ' HA3' ' A' ' 54' ' ' GLY . 40.7 p . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 1.1 t -127.74 6.49 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-O 122.934 1.35 . . . . 0.0 110.317 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.434 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . -158.17 -156.05 7.82 Favored Glycine 0 C--N 1.284 -2.338 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.444 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.649 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 75.05 -144.19 31.88 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.297 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.482 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.663 0 CA-C-O 121.282 0.563 . . . . 0.0 109.623 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.59 ' O ' HG21 ' A' ' 5' ' ' THR . . . . . . . . 0 C--O 1.225 -0.231 0 CA-C-O 120.687 0.279 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.6 Cg_exo -73.14 126.81 11.46 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.696 2.264 . . . . 0.0 112.354 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' A' ' 5' ' ' THR . 88.3 m -65.07 141.65 58.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.366 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.498 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 48.3 t -107.78 132.27 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.708 0.29 . . . . 0.0 111.139 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.479 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 59.8 m-85 -125.39 142.7 42.41 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.308 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.565 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 6.7 Cg_endo -84.91 130.87 14.99 Favored 'Cis proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.324 -1.531 . . . . 0.0 112.014 -0.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.688 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 31.5 p90 -102.72 130.15 49.57 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 62.6 m -93.23 121.54 34.7 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.303 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.805 ' CE2' HD23 ' A' ' 22' ' ' LEU . 56.1 t80 -112.95 129.45 56.47 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.598 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.805 HD23 ' CE2' ' A' ' 21' ' ' PHE . 7.4 mp 42.96 36.83 0.95 Allowed 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 124.349 1.031 . . . . 0.0 112.908 175.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.0 -15.48 56.63 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 20' ' ' THR . 49.8 m-80 -109.65 129.98 55.55 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 119.367 1.583 . . . . 0.0 112.557 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.3 mtmt -77.36 119.59 21.2 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.001 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.798 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.5 m-85 -108.66 114.04 27.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.743 0.782 . . . . 0.0 111.498 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.565 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 35.0 mt-10 -89.98 -8.78 50.85 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.871 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.4 p -136.72 -177.22 4.64 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.0 m -67.05 165.24 16.17 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.064 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.461 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 9.0 t -144.45 170.09 16.7 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.131 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.451 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 22.9 p -123.78 18.6 9.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.632 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -61.91 136.58 58.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 113.922 -1.49 . . . . 0.0 112.045 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.31 -4.13 9.43 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.775 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.583 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 10.0 mtp85 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 121.578 0.704 . . . . 0.0 112.177 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.695 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 7.9 mptt . . . . . 0 N--CA 1.443 -0.777 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.451 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 50.3 mtt -75.7 153.43 37.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.664 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.7 p-90 -137.46 -165.7 1.81 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.351 0.596 . . . . 0.0 110.977 -178.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.3 p -167.9 141.32 3.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.962 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.611 ' HB3' ' HD2' ' A' ' 47' ' ' TYR . . . -72.3 156.15 39.42 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.025 0.44 . . . . 0.0 111.273 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.8 p -104.58 13.79 31.03 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.796 0.808 . . . . 0.0 109.506 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.0 p -136.89 142.57 42.75 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.819 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.688 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -54.89 -39.89 69.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.979 0.419 . . . . 0.0 110.947 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -119.17 103.11 9.23 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 1.001 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 32.6 t80 -72.59 -32.99 66.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.177 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -51.22 -28.51 11.66 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -95.12 -60.79 1.6 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -82.19 -19.54 39.62 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 8.1 mtm180 44.3 44.67 6.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -109.13 114.96 29.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 1.001 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.6 p-90 -126.84 175.9 7.68 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -175.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.66 ' HA3' HG22 ' A' ' 5' ' ' THR . . . -172.59 154.58 21.41 Favored Glycine 0 C--O 1.217 -0.946 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.558 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 5' ' ' THR . 15.1 m-30 -64.26 164.59 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.492 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 31.5 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.342 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.432 HG23 ' SG ' ' A' ' 15' ' ' CYS . 77.5 p . . . . . 0 C--O 1.234 0.26 0 N-CA-C 112.53 0.566 . . . . 0.0 112.53 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.784 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 1.5 t -106.37 -67.96 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 CA-C-O 123.298 1.523 . . . . 0.0 109.88 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.811 ' H ' ' HB2' ' A' ' 55' ' ' PHE . . . -76.61 -156.23 6.83 Favored Glycine 0 C--N 1.284 -2.338 0 CA-C-N 111.167 -2.742 . . . . 0.0 112.599 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.576 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 74.14 -139.56 26.16 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.487 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.407 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.092 0.472 . . . . 0.0 110.421 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 120.597 0.237 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.05 170.69 12.11 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.512 2.142 . . . . 0.0 112.144 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.7 m -85.49 135.14 33.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.573 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 65.5 t -97.14 115.58 37.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -113.53 138.67 22.65 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-O 120.886 0.374 . . . . 0.0 111.246 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -85.45 136.5 21.66 Favored 'Cis proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.466 -1.889 . . . . 0.0 112.654 -0.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.651 ' CG ' ' HB1' ' A' ' 42' ' ' ALA . 28.5 p90 -102.26 136.4 42.16 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 91.3 m -98.48 122.28 41.47 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.614 -0.835 . . . . 0.0 112.618 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.713 ' CE1' HD12 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -123.37 147.34 47.17 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.713 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 37.25 37.06 0.08 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.276 1.03 . . . . 0.0 113.676 178.447 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.15 -1.01 87.66 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.112 0.805 . . . . 0.0 115.112 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 20' ' ' THR . 68.7 m-80 -112.38 144.34 41.98 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 118.617 1.208 . . . . 0.0 111.985 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -87.46 120.44 28.77 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.596 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 16.6 m-85 -102.19 116.41 32.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.645 0.736 . . . . 0.0 111.315 -177.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -89.8 -24.17 21.53 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.616 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.8 p -126.12 -176.76 3.73 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.3 m -65.28 164.82 12.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.512 0.672 . . . . 0.0 109.891 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.48 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 11.5 t -139.61 171.57 14.06 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.272 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.2 p -126.07 19.7 7.66 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.711 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -67.24 138.46 56.93 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 113.503 -1.68 . . . . 0.0 112.009 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.67 -1.08 59.37 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.182 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.597 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 12.8 mtp85 . . . . . 0 N--CA 1.448 -0.565 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.534 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.597 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 62.4 mmtt . . . . . 0 N--CA 1.462 0.128 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 52.1 mtt -92.27 145.2 24.67 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.648 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.5 p-90 -133.23 -167.75 1.97 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.299 0.571 . . . . 0.0 111.881 -177.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 3.4 p -158.34 138.34 12.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.677 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.651 ' HB1' ' CG ' ' A' ' 19' ' ' PHE . . . -71.72 151.18 43.81 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.911 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.9 p -102.44 15.82 28.09 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.564 0.697 . . . . 0.0 110.58 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.7 p -138.39 156.34 47.68 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.32 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.38 -35.01 76.31 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.056 0.455 . . . . 0.0 110.941 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -124.53 113.3 17.91 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.666 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 58.8 t80 -80.58 -33.61 35.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.985 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -56.22 -34.48 66.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -83.9 -62.3 1.6 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.15 -29.6 61.87 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 4.0 mtm180 45.55 45.91 10.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.841 0.829 . . . . 0.0 113.052 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -115.24 119.7 37.23 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.666 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.6 p-90 -131.14 179.97 5.69 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -174.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -170.31 151.32 16.22 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 113.873 -1.512 . . . . 0.0 109.323 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.811 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 11.6 m-85 -65.74 162.77 17.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.625 1.212 . . . . 0.0 112.718 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.435 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.5 t . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.783 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.552 HG22 ' SG ' ' A' ' 41' ' ' CYS . 76.2 p . . . . . 0 N--CA 1.444 -0.757 0 CA-C-O 122.336 1.065 . . . . 0.0 113.844 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.718 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -112.87 -152.89 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 176.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.692 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 28.66 -122.28 0.07 OUTLIER Glycine 0 N--CA 1.463 0.456 0 O-C-N 124.671 1.232 . . . . 0.0 114.099 176.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.687 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 39.59 -144.7 0.34 Allowed Glycine 0 C--N 1.331 0.284 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 114.49 -0.855 . . . . 0.0 109.94 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--O 1.226 -0.137 0 CA-C-O 120.311 0.1 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 11.9 Cg_exo -70.27 157.15 60.28 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.085 2.523 . . . . 0.0 112.727 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.6 m -79.82 135.51 36.49 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.7 t -100.16 112.43 32.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.669 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 55.0 m-85 -108.39 141.94 24.3 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.852 0.358 . . . . 0.0 111.408 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.495 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.4 Cg_endo -86.87 136.03 17.42 Favored 'Cis proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.531 -1.445 . . . . 0.0 111.981 -0.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.841 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 33.5 p90 -103.29 129.18 50.22 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.7 m -92.43 127.25 37.85 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.233 0.539 . . . . 0.0 112.124 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.852 ' CE1' HD12 ' A' ' 22' ' ' LEU . 1.2 t80 -130.36 144.21 51.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.852 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 40.37 36.86 0.38 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.462 1.105 . . . . 0.0 112.899 178.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.23 -9.84 73.49 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 114.709 0.644 . . . . 0.0 114.709 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -107.6 134.45 50.58 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.453 1.127 . . . . 0.0 111.827 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -79.71 121.14 24.96 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.791 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.821 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.2 m-30 -104.52 110.31 22.54 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.982 0.896 . . . . 0.0 111.086 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 33.2 mt-10 -88.04 -16.69 32.94 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.295 -1.321 . . . . 0.0 110.742 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 p -129.28 -175.24 3.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.9 m -65.43 163.42 15.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.465 0.65 . . . . 0.0 110.177 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.527 HG22 ' CZ ' ' A' ' 19' ' ' PHE . 11.9 t -138.73 -176.78 4.6 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.645 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.436 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 10.1 p -141.07 18.62 2.28 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.766 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -64.84 145.69 55.92 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 113.281 -1.781 . . . . 0.0 112.503 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.09 5.13 32.05 Favored Glycine 0 C--O 1.235 0.198 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.847 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.411 ' NH1' ' HA ' ' A' ' 39' ' ' MET . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 117.128 0.464 . . . . 0.0 110.982 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.653 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 3.9 mptt . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.436 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 87.8 mtp -158.42 145.55 17.76 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.609 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 23.5 p-90 -135.59 -174.64 3.7 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 5' ' ' THR . 6.5 p -152.76 136.85 16.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.161 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.841 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -73.04 151.14 41.84 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.013 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.3 p -100.61 17.67 21.22 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.733 0.777 . . . . 0.0 109.275 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.489 HG21 ' HB2' ' A' ' 52' ' ' LYS . 71.7 p -135.6 151.7 50.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.213 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.656 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -60.72 -37.67 82.52 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.121 0.486 . . . . 0.0 110.878 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -124.26 107.85 11.62 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.685 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 56.4 t80 -74.75 -32.31 62.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.301 -0.408 . . . . 0.0 112.047 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -55.97 -33.66 65.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -94.96 -56.87 2.6 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -77.54 -20.93 53.4 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 17.5 mtm180 39.63 52.45 2.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.489 ' HB2' HG21 ' A' ' 44' ' ' THR . 88.6 mttt -122.47 117.9 27.05 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.687 ' CE2' ' HA2' ' A' ' 8' ' ' GLY . 9.2 p-90 -125.73 172.73 9.56 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -158.64 154.13 25.23 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.29 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.718 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 1.0 OUTLIER -80.34 156.79 26.58 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -178.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 C--N 1.328 -0.368 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.74 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.406 HG22 ' SG ' ' A' ' 41' ' ' CYS . 16.1 p . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 121.666 0.746 . . . . 0.0 112.47 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -116.78 -168.23 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.072 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.463 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 36.73 -122.7 0.82 Allowed Glycine 0 N--CA 1.462 0.4 0 O-C-N 124.056 0.848 . . . . 0.0 113.076 178.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.699 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 35.15 -141.36 0.13 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 115.616 1.006 . . . . 0.0 115.616 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.205 -0.497 . . . . 0.0 110.213 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.913 0.387 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -87.04 167.75 8.02 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.927 2.418 . . . . 0.0 112.015 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.7 m -79.73 139.75 37.2 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.312 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.1 t -107.5 112.42 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -114.02 143.7 30.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.723 0.297 . . . . 0.0 111.103 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -85.75 137.25 21.97 Favored 'Cis proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.495 -1.46 . . . . 0.0 111.836 -0.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.523 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 41.3 p90 -102.79 -178.36 3.65 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.453 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.8 m -135.03 126.2 28.02 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.664 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.821 ' CE1' HD12 ' A' ' 22' ' ' LEU . 1.9 t80 -134.24 141.58 47.05 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.821 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER 40.87 38.42 0.65 Allowed 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.746 1.219 . . . . 0.0 113.706 178.607 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.17 -1.65 88.57 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -107.89 154.88 20.94 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 118.439 1.119 . . . . 0.0 111.26 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -94.83 126.36 40.11 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 21.8 m-85 -113.88 111.92 22.51 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.68 0.752 . . . . 0.0 111.784 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -96.03 -8.33 33.88 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.09 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 p -136.57 -172.75 3.23 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.8 m -69.31 168.64 13.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.128 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.445 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 10.2 t -144.48 167.12 23.25 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.594 0.711 . . . . 0.0 110.738 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.493 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 61.3 p -120.54 12.64 11.58 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -56.05 136.74 52.08 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.67 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.37 -10.86 19.99 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.018 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.7 mtp85 . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.059 0.457 . . . . 0.0 110.272 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.617 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.493 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 80.9 mtp -80.6 148.37 30.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.651 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 16.5 p-90 -128.31 -165.11 1.45 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.382 0.61 . . . . 0.0 111.627 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.5 p -159.68 146.9 16.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.968 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.523 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -81.0 143.57 32.42 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.473 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.0 p -97.14 13.97 27.43 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.778 0.799 . . . . 0.0 110.113 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.661 HG21 ' HB2' ' A' ' 52' ' ' LYS . 38.1 p -134.09 158.76 42.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.157 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -65.39 -26.54 68.04 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.193 0.52 . . . . 0.0 110.624 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -132.71 117.44 17.85 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.794 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 65.6 t80 -86.18 -34.78 20.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -54.36 -37.06 64.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.967 0.413 . . . . 0.0 111.791 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.76 -66.37 0.93 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.33 -20.37 63.0 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.649 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 26.2 mtt180 38.55 51.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.661 ' HB2' HG21 ' A' ' 44' ' ' THR . 89.8 mttt -113.71 119.22 36.64 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 176.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.794 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 5.3 p-90 -132.25 171.68 13.39 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -174.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.568 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -166.07 143.9 8.76 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 113.3 -1.773 . . . . 0.0 109.838 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.667 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.4 m-30 -60.51 151.51 28.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.399 0.6 . . . . 0.0 111.63 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.483 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 4.5 t . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.0 p . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 121.605 0.717 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.771 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -113.77 -166.54 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 176.376 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.632 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 34.7 -126.11 0.58 Allowed Glycine 0 N--CA 1.463 0.47 0 O-C-N 124.069 0.856 . . . . 0.0 114.117 177.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.573 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 40.74 -149.1 0.2 Allowed Glycine 0 C--N 1.337 0.611 0 N-CA-C 115.77 1.068 . . . . 0.0 115.77 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 114.826 -0.687 . . . . 0.0 110.435 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -87.86 167.13 7.12 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.914 2.409 . . . . 0.0 112.136 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.2 m -83.44 129.67 34.99 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.493 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 92.7 t -96.87 112.25 28.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.707 0.289 . . . . 0.0 110.305 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -107.0 138.37 19.8 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.562 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -86.25 132.25 14.48 Favored 'Cis proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.21 -1.579 . . . . 0.0 112.263 -0.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.606 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 17.9 p90 -99.93 126.28 46.06 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.244 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 91.2 m -91.67 122.46 34.25 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.963 0.411 . . . . 0.0 110.565 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.833 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 68.3 t80 -115.2 130.09 56.82 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.604 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.487 HD23 ' H ' ' A' ' 22' ' ' LEU . 3.7 mm? 35.28 45.11 0.19 Allowed 'General case' 0 N--CA 1.428 -1.536 0 O-C-N 124.775 1.297 . . . . 0.0 113.319 175.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.72 -23.07 32.21 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 116.497 1.359 . . . . 0.0 116.497 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -111.26 132.51 54.31 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 120.027 1.914 . . . . 0.0 113.12 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 39.7 mtpt -77.71 126.67 31.22 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.833 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.3 m-85 -110.77 118.67 36.79 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.898 0.856 . . . . 0.0 111.643 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -89.62 -12.44 39.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.76 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.4 p -136.08 -171.21 2.82 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.0 m -70.19 166.24 20.41 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.499 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -143.91 171.22 14.54 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.335 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.464 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 71.3 p -125.41 20.88 7.97 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.453 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -60.45 132.83 55.13 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.971 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.02 -8.04 40.12 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.095 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.0 mtp85 . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 120.594 0.235 . . . . 0.0 111.28 179.993 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.58 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 2.0 mptt . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.464 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 58.2 mtt -94.71 153.21 17.9 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.628 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.8 p-90 -133.6 -166.51 1.79 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.216 0.532 . . . . 0.0 111.777 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 8.4 p -160.07 143.99 14.28 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.633 ' HB3' ' HD2' ' A' ' 47' ' ' TYR . . . -78.77 152.57 31.38 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.563 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.436 ' O ' HG22 ' A' ' 16' ' ' VAL . 81.0 p -102.98 9.94 38.44 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.656 0.741 . . . . 0.0 110.553 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.0 p -133.03 153.12 51.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.989 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.44 -42.01 81.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 111.341 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -120.83 111.36 17.46 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 1.033 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 34.3 t80 -77.16 -31.82 55.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.938 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -51.94 -32.8 34.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -90.08 -71.55 0.61 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.25 -27.81 68.24 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 24.0 mtm-85 45.15 51.0 9.31 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -117.04 119.04 34.04 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 1.033 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.8 p-90 -127.42 172.09 10.97 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -175.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.44 147.38 13.8 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 113.292 -1.777 . . . . 0.0 109.466 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.771 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 6.1 m-30 -62.84 158.37 19.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.329 1.065 . . . . 0.0 110.989 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.512 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 25.2 t . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.167 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 122.328 1.061 . . . . 0.0 112.95 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.663 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.2 OUTLIER -129.9 163.45 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 178.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.698 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 62.12 -141.35 47.23 Favored Glycine 0 C--N 1.316 -0.561 0 C-N-CA 118.059 -2.02 . . . . 0.0 111.861 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.61 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 39.67 -139.09 1.03 Allowed Glycine 0 C--N 1.334 0.468 0 N-CA-C 115.676 1.03 . . . . 0.0 115.676 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.273 -0.463 . . . . 0.0 110.569 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.319 0 CA-C-O 120.799 0.333 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -84.25 164.41 13.01 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.726 2.284 . . . . 0.0 111.527 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.9 m -72.33 138.39 47.29 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.444 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 59.7 t -107.88 113.32 43.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.581 0.229 . . . . 0.0 110.681 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -115.82 140.24 25.91 Favored Pre-proline 0 N--CA 1.454 -0.268 0 CA-C-O 120.845 0.355 . . . . 0.0 110.963 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 5.4 Cg_endo -87.0 132.88 13.84 Favored 'Cis proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.292 -1.545 . . . . 0.0 111.754 -0.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.444 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 46.3 p90 -98.48 -175.11 3.0 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.844 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 18.9 m -140.0 119.58 13.19 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.727 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.82 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 68.3 t80 -117.83 133.21 56.15 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.556 ' H ' HD21 ' A' ' 22' ' ' LEU . 3.6 mm? 34.62 47.53 0.24 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.697 1.248 . . . . 0.0 113.797 175.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.99 -9.11 75.79 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 116.402 1.321 . . . . 0.0 116.402 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' THR . 51.5 m-80 -110.12 150.01 29.23 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.821 1.811 . . . . 0.0 112.363 -178.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -91.57 125.74 36.41 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.82 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 88.7 m-85 -115.59 114.3 24.75 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.612 0.72 . . . . 0.0 111.574 -178.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 41.3 mt-10 -93.21 -12.82 29.33 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.234 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.5 p -133.05 -166.47 1.76 Allowed 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.7 m -76.35 170.17 16.86 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.863 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.5 t -147.76 169.5 19.61 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.346 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.9 p -123.59 20.28 9.48 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.85 133.15 55.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 113.523 -1.672 . . . . 0.0 112.101 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.73 -0.22 45.39 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.468 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.442 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 22.3 mtp85 . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.442 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 21.8 mmmt . . . . . 0 CA--C 1.516 -0.357 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -90.28 147.05 23.76 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.627 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.5 p-90 -128.59 -169.61 2.11 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.303 0.573 . . . . 0.0 111.834 -178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.0 p -154.41 142.2 20.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.761 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.76 143.13 40.09 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.509 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.1 p -99.07 10.35 41.63 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.581 0.705 . . . . 0.0 110.043 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.5 p -136.14 146.85 47.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.729 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.32 -48.24 79.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.768 0.318 . . . . 0.0 111.146 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.412 ' OD1' ' HB2' ' A' ' 48' ' ' ASP . 20.1 t-20 -109.24 99.68 8.92 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.859 ' CE2' ' HB3' ' A' ' 53' ' ' TRP . 47.5 t80 -72.16 -32.91 67.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.559 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.412 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . 54.2 m-20 -45.48 -39.83 7.68 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.8 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -95.97 -55.69 2.9 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -69.23 -35.04 75.76 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.2 mmm180 51.15 37.98 19.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -107.57 118.67 37.33 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.859 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 11.0 p-90 -128.66 174.22 9.61 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.404 -175.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.603 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.08 142.05 7.47 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.751 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.698 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 9.2 m-85 -59.03 154.13 16.23 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.376 0.608 . . . . 0.0 111.639 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.456 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 5.1 t . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.483 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 11.0 p . . . . . 0 N--CA 1.448 -0.558 0 CA-C-O 121.676 0.75 . . . . 0.0 112.639 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.747 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -110.07 -163.44 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.119 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.418 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 34.62 -121.86 0.44 Allowed Glycine 0 N--CA 1.463 0.447 0 O-C-N 124.282 0.988 . . . . 0.0 112.999 177.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.683 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 29.36 -135.28 0.06 OUTLIER Glycine 0 C--N 1.338 0.66 0 N-CA-C 115.986 1.154 . . . . 0.0 115.986 176.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.2 p30 . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 114.722 -0.739 . . . . 0.0 109.214 179.568 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.64 0.257 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 42.0 Cg_endo -85.78 165.56 10.31 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.941 2.427 . . . . 0.0 112.721 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 5.6 m -71.79 127.7 33.41 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.3 t -102.68 101.83 12.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.033 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.653 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 47.7 m-85 -103.45 143.3 26.34 Favored Pre-proline 0 N--CA 1.45 -0.45 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.751 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.83 136.02 22.55 Favored 'Cis proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.578 -1.843 . . . . 0.0 112.355 -0.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.653 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 29.9 p90 -102.77 -171.97 2.04 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.289 177.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.2 m -145.76 127.43 15.22 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.705 -177.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.817 ' CE1' HD12 ' A' ' 22' ' ' LEU . 1.5 t80 -134.42 143.02 47.33 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.817 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 41.75 35.41 0.5 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 124.416 1.087 . . . . 0.0 112.976 178.953 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.34 -9.46 77.42 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.473 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 70.7 m-80 -107.73 138.13 44.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 118.368 1.084 . . . . 0.0 112.294 -178.426 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -79.5 123.31 27.44 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.758 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 15.3 m-30 -106.01 114.52 28.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.762 0.791 . . . . 0.0 110.821 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -86.81 -24.75 24.89 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.068 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 p -122.75 -173.24 2.65 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.306 179.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.1 m -72.32 166.92 21.52 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.937 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.9 t -141.61 166.03 25.87 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.408 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.9 p -120.8 18.77 11.85 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.772 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -59.91 139.07 57.63 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 113.656 -1.611 . . . . 0.0 111.466 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.01 -1.45 68.99 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.2 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.56 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 24.2 mtp85 . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.56 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 66.4 mttt . . . . . 0 C--O 1.226 -0.164 0 CA-C-O 120.286 0.089 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 43.8 mtt -75.01 143.04 43.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.98 0.419 . . . . 0.0 110.271 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.709 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.1 p-90 -131.24 -167.68 1.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.432 -178.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 15.1 p -157.68 149.54 22.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.006 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.456 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -81.9 151.75 27.12 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.66 178.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 34.5 p -116.23 10.08 14.76 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.016 -178.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.593 HG21 ' HB2' ' A' ' 52' ' ' LYS . 73.4 p -123.03 12.08 9.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.346 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . 70.01 -35.99 0.33 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.336 0.655 . . . . 0.0 111.45 -178.449 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 44' ' ' THR . 21.5 t-20 -129.49 110.48 11.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.877 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 49.5 t80 -87.85 -28.68 21.45 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -177.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -58.23 -34.7 70.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -92.94 -53.28 4.21 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.64 -43.98 52.71 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.203 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.583 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER 61.34 39.55 15.25 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.868 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.593 ' HB2' HG21 ' A' ' 44' ' ' THR . 4.6 mppt? -113.76 118.71 35.04 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.877 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.5 p-90 -130.73 174.96 9.42 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -174.246 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.602 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.4 148.04 13.35 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 113.194 -1.821 . . . . 0.0 109.615 178.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.747 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 7.1 m-30 -60.81 157.81 14.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.58 0.705 . . . . 0.0 111.787 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.479 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 29.3 t . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.823 -178.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 122.273 1.035 . . . . 0.0 113.222 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -137.9 161.33 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 178.188 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.605 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 62.42 -147.78 49.29 Favored Glycine 0 C--N 1.311 -0.816 0 C-N-CA 118.254 -1.927 . . . . 0.0 111.306 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.731 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 49.3 -148.27 5.58 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 121.607 -0.33 . . . . 0.0 113.766 178.127 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.214 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.51 178.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -81.56 149.78 16.66 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.636 2.224 . . . . 0.0 112.323 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 72.3 m -77.3 126.14 30.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 43.9 t -95.92 121.43 46.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.871 0.367 . . . . 0.0 110.924 -178.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.531 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 52.7 m-85 -115.86 139.43 24.92 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-O 121.248 0.547 . . . . 0.0 111.308 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.628 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 27.7 Cg_endo -86.79 137.53 19.27 Favored 'Cis proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.669 -1.804 . . . . 0.0 112.359 -0.75 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.647 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 42.8 p90 -102.87 129.38 49.55 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.662 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.633 HG21 ' HG3' ' A' ' 25' ' ' LYS . 5.4 m -91.84 127.75 37.41 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.27 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.841 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.1 t80 -129.61 144.81 51.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.783 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 40.36 35.97 0.32 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.15 0.98 . . . . 0.0 113.243 178.381 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.0 -10.06 75.25 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.033 -0.603 . . . . 0.0 114.502 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -111.98 133.62 54.04 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 118.438 1.119 . . . . 0.0 111.794 -179.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.639 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 3.7 mptt -82.07 123.22 28.75 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.548 -179.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.841 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 15.7 m-85 -104.91 110.9 23.46 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.72 0.771 . . . . 0.0 111.031 -178.034 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.628 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 48.7 mt-10 -84.95 -15.76 43.28 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.86 -179.487 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p -130.97 -176.45 4.0 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 68.6 m -67.47 162.62 22.8 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.28 179.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.431 HG22 ' CZ ' ' A' ' 19' ' ' PHE . 11.7 t -139.13 -177.48 4.92 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.7 p -135.88 22.15 3.3 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.71 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -66.72 150.18 49.46 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 113.91 -1.496 . . . . 0.0 113.096 -178.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.97 7.53 50.16 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 114.963 -1.017 . . . . 0.0 114.468 178.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 34' ' ' ARG . 5.4 mtp-105 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 118.148 0.974 . . . . 0.0 112.557 -179.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.647 ' HD3' ' CZ ' ' A' ' 55' ' ' PHE . 45.0 mttp . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -99.47 144.98 27.94 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.601 -0.839 . . . . 0.0 108.88 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.666 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 18.6 p-90 -139.68 -172.09 3.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.224 0.535 . . . . 0.0 111.519 -178.344 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.6 p -156.94 139.5 14.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.206 178.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.534 ' HB1' ' CG ' ' A' ' 19' ' ' PHE . . . -72.78 152.68 41.46 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 120.989 0.423 . . . . 0.0 110.856 -179.293 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.7 p -100.27 16.39 24.49 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.641 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.402 HG22 ' CB ' ' A' ' 50' ' ' ASP . 70.8 p -135.21 154.83 51.46 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.179 179.271 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -62.18 -35.06 77.69 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.254 0.55 . . . . 0.0 110.399 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -125.77 110.24 13.49 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.693 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 61.9 t80 -76.6 -33.97 58.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.281 -177.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -53.67 -36.23 61.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.27 -63.72 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.402 ' CB ' HG22 ' A' ' 44' ' ' THR . 32.7 m-20 -72.53 -36.51 68.33 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -177.47 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.8 mmm180 54.67 50.77 15.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -120.92 116.61 25.46 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 176.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.693 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.9 p-90 -129.71 172.67 11.38 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -174.012 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.731 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -160.43 146.69 12.9 Favored Glycine 0 C--O 1.221 -0.701 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.969 178.421 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.647 ' CZ ' ' HD3' ' A' ' 38' ' ' LYS . 3.9 m-30 -61.27 163.29 6.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.578 0.704 . . . . 0.0 112.69 -179.427 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.6 t . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.417 179.806 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.9 p . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 121.919 0.866 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.761 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -127.48 -171.06 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.153 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.554 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.49 -120.6 0.79 Allowed Glycine 0 CA--C 1.521 0.412 0 O-C-N 123.786 0.679 . . . . 0.0 113.306 177.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.689 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 25.88 -136.12 0.02 OUTLIER Glycine 0 C--N 1.343 0.926 0 N-CA-C 116.383 1.313 . . . . 0.0 116.383 177.53 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.414 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 114.62 -0.79 . . . . 0.0 110.133 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.141 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -86.22 167.96 9.1 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.54 2.16 . . . . 0.0 112.4 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 74.9 m -87.81 133.23 33.92 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.564 179.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.2 t -95.49 125.9 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.668 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.587 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 49.5 m-85 -122.63 138.97 30.18 Favored Pre-proline 0 N--CA 1.444 -0.727 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.592 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -86.66 133.27 14.87 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.415 -1.494 . . . . 0.0 112.328 -0.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.818 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 27.3 p90 -99.77 130.4 45.97 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.239 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.4 m -91.19 125.39 35.95 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.375 0.607 . . . . 0.0 111.894 -178.031 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.803 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 2.1 t80 -129.7 141.58 50.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.658 HD23 ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER 42.11 36.95 0.76 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.129 0.971 . . . . 0.0 113.078 178.678 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.37 -6.15 83.9 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.83 -0.7 . . . . 0.0 114.751 178.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.53 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.3 m-80 -112.27 136.46 51.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.434 1.117 . . . . 0.0 111.947 -178.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -80.35 122.36 26.83 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.803 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 15.4 m-30 -104.99 111.2 23.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.779 0.799 . . . . 0.0 111.104 -177.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -89.38 -19.55 25.08 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.608 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.9 p -127.33 -179.34 4.84 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.6 m -67.04 156.55 35.76 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.683 178.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.0 t -131.25 173.28 11.21 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.936 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.444 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 24.1 p -127.42 18.34 6.95 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 176.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.616 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . . . -63.4 151.48 40.88 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 113.808 -1.542 . . . . 0.0 111.403 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.69 -1.53 57.66 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.205 178.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.647 ' NH1' ' H ' ' A' ' 38' ' ' LYS . 1.8 mtp-105 . . . . . 0 N--CA 1.444 -0.751 0 CA-C-N 117.17 0.485 . . . . 0.0 111.223 -179.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.647 ' H ' ' NH1' ' A' ' 34' ' ' ARG . 40.9 mttp . . . . . 0 CA--C 1.514 -0.42 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.444 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 49.7 mtm -59.32 137.05 58.12 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.142 0.496 . . . . 0.0 110.746 -178.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.661 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.8 p-90 -133.51 -169.4 2.28 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.213 -178.591 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.2 p -160.43 138.12 9.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.006 178.237 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.818 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -69.83 155.11 41.03 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.107 0.479 . . . . 0.0 111.019 -178.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.3 p -102.87 13.65 33.86 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.037 0.922 . . . . 0.0 109.559 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.8 p -133.55 153.5 51.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.969 179.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -59.92 -37.25 78.93 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.057 0.456 . . . . 0.0 110.842 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -123.23 110.45 15.25 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.737 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 64.8 t80 -76.75 -33.14 58.11 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.085 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -57.35 -31.9 66.21 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -88.83 -62.07 1.57 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.13 -27.38 60.84 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.437 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 3.1 mmm180 48.58 49.24 18.78 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -120.59 117.53 27.83 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.737 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.9 p-90 -129.19 177.6 7.03 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -174.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.611 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.44 147.19 11.44 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.638 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.761 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 6.0 m-30 -62.66 157.6 20.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.704 0.752 . . . . 0.0 112.293 -179.056 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.49 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 27.0 t . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.599 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.477 HG22 ' HA3' ' A' ' 54' ' ' GLY . 68.7 p . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.18 5.98 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 CA-C-O 122.561 1.172 . . . . 0.0 111.2 -179.3 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.445 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . -154.75 -155.24 7.2 Favored Glycine 0 C--N 1.282 -2.448 0 CA-C-N 113.319 -1.764 . . . . 0.0 111.651 -178.161 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.708 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 72.2 -168.35 52.35 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.846 179.007 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.537 ' H ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.738 0 CA-C-O 120.937 0.399 . . . . 0.0 110.542 178.783 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.996 0.427 . . . . 0.0 111.614 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 3.4 Cg_exo -76.8 164.91 29.46 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.452 2.768 . . . . 0.0 112.055 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 84.5 m -87.4 142.93 27.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.864 0.364 . . . . 0.0 110.769 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -108.52 120.86 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.952 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.496 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 62.9 m-85 -118.6 143.8 34.12 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-O 121.016 0.436 . . . . 0.0 111.223 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.635 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 28.5 Cg_endo -87.47 140.22 20.72 Favored 'Cis proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.706 -1.789 . . . . 0.0 111.98 -0.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.69 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 35.6 p90 -104.26 -174.06 2.45 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.518 178.064 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.1 m -141.56 127.1 18.91 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.86 -179.033 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.785 ' CD2' ' HB2' ' A' ' 32' ' ' ALA . 0.9 OUTLIER -131.7 144.9 51.33 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.033 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.648 HD12 ' CD1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.17 35.02 0.08 Allowed 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.61 1.164 . . . . 0.0 113.837 178.022 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.12 -3.74 84.45 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 115.026 0.77 . . . . 0.0 115.026 178.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.551 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 59.0 m-80 -110.2 138.7 46.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.371 1.086 . . . . 0.0 111.508 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -79.46 122.0 25.89 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.672 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.4 m-30 -108.35 106.9 17.25 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.836 0.827 . . . . 0.0 110.902 -178.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.635 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 92.1 mt-10 -91.23 -15.55 29.05 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.363 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -129.15 -177.78 4.37 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.5 m -66.19 164.61 15.36 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.684 178.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.428 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 13.0 t -141.99 175.53 9.66 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.772 -179.063 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.412 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 23.3 p -128.64 17.54 6.35 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.785 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -65.26 153.75 40.15 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 114.118 -1.401 . . . . 0.0 112.025 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.28 -0.1 42.4 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.69 -0.686 . . . . 0.0 114.082 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.748 ' NH1' ' H ' ' A' ' 38' ' ' LYS . 2.3 mtp-105 . . . . . 0 N--CA 1.451 -0.39 0 CA-C-N 117.781 0.791 . . . . 0.0 111.428 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.748 ' H ' ' NH1' ' A' ' 34' ' ' ARG . 66.0 mttm . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.412 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.1 mpt? -56.57 137.42 53.67 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.587 0.708 . . . . 0.0 111.36 -178.048 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.677 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.6 p-90 -134.34 -165.21 1.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.295 -178.149 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.5 p -162.99 145.16 10.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.977 178.419 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.69 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -71.36 149.8 45.68 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.172 -178.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.3 p -97.95 7.44 46.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.453 0.644 . . . . 0.0 109.869 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.9 p -129.35 155.7 45.22 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.284 178.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.605 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -61.54 -32.34 72.41 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.978 0.418 . . . . 0.0 110.942 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -127.49 111.36 13.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.826 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 65.2 t80 -78.39 -35.25 47.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.92 -177.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -53.75 -29.74 41.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.134 0.493 . . . . 0.0 112.05 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -85.04 -71.15 0.54 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.518 -179.238 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.98 -29.69 63.24 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 4.4 mtm180 51.61 47.45 24.78 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -114.05 118.22 33.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.826 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.2 p-90 -129.38 177.29 7.29 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.267 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -171.7 150.33 13.21 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.619 179.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 14.5 m-30 -61.42 159.24 13.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -177.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.432 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.5 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 114.299 -1.318 . . . . 0.0 108.83 178.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.431 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 63.7 p . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 121.298 0.57 . . . . 0.0 111.963 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.789 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -105.05 -166.31 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 176.155 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.625 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 39.57 -123.96 1.93 Allowed Glycine 0 C--N 1.319 -0.404 0 O-C-N 123.903 0.752 . . . . 0.0 113.112 177.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.621 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 37.2 -148.64 0.05 OUTLIER Glycine 0 C--N 1.334 0.464 0 N-CA-C 116.198 1.239 . . . . 0.0 116.198 177.144 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 114.502 -0.849 . . . . 0.0 110.795 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.678 0.275 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -84.33 166.4 12.42 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.764 2.309 . . . . 0.0 111.538 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 2.7 m -74.69 120.83 20.77 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.22 105.28 16.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.092 0.472 . . . . 0.0 110.516 179.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.659 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 46.2 m-85 -100.47 139.23 20.48 Favored Pre-proline 0 N--CA 1.447 -0.588 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.416 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 7.2 Cg_endo -87.68 127.98 9.2 Favored 'Cis proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.377 -1.51 . . . . 0.0 112.711 -0.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.659 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 15.6 p90 -92.26 127.07 37.6 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.279 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 14.8 m -90.65 121.65 32.75 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.428 0.632 . . . . 0.0 112.455 -177.408 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.87 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.9 t80 -127.8 142.94 51.16 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.356 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.842 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 43.5 35.55 0.98 Allowed 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.187 0.995 . . . . 0.0 112.674 178.896 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.71 -6.27 83.69 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.935 -0.575 . . . . 0.0 114.466 179.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.523 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 66.4 m-80 -109.96 132.87 53.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.319 1.06 . . . . 0.0 111.942 -178.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 53.3 mtpt -83.9 118.32 23.9 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.87 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 12.4 m-85 -99.66 112.03 24.3 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.811 0.815 . . . . 0.0 112.191 -177.343 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -83.23 -17.62 42.08 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.615 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 p -131.42 -173.25 3.06 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 70.7 m -64.22 166.2 8.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.595 0.712 . . . . 0.0 110.395 179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.474 HG22 ' CZ ' ' A' ' 19' ' ' PHE . 14.5 t -144.65 171.42 14.41 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.137 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.486 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 15.8 p -129.19 19.02 5.92 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.181 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.782 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -61.7 138.25 58.3 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.122 179.628 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.89 -3.4 44.79 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.935 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.414 ' HD2' ' HE1' ' A' ' 55' ' ' PHE . 17.0 mtp85 . . . . . 0 N--CA 1.448 -0.552 0 CA-C-O 120.649 0.261 . . . . 0.0 110.763 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.786 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 3.8 mptt . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.12 0.486 . . . . 0.0 112.047 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.486 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 47.2 mtt -98.15 154.2 17.92 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.006 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.604 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.3 p-90 -136.46 -172.6 3.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.591 0.71 . . . . 0.0 112.461 -178.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 12.3 p -154.11 143.28 21.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.658 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.546 ' O ' ' HA ' ' A' ' 15' ' ' CYS . . . -81.88 158.34 24.03 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.31 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.1 p -107.74 16.38 23.68 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.542 0.687 . . . . 0.0 110.387 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.7 p -137.2 148.51 46.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.431 178.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -55.91 -42.11 75.56 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.152 0.501 . . . . 0.0 110.821 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -116.31 104.7 11.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.475 178.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.74 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 69.0 t80 -75.96 -29.21 58.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.526 -178.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -57.26 -34.65 68.85 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -96.02 -53.6 3.6 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.068 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -81.13 -19.24 43.97 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -177.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 13.1 mtm180 38.04 55.97 1.65 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -117.89 120.54 38.18 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.74 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.0 p-90 -132.94 177.35 7.72 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -174.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.431 ' HA3' ' HB ' ' A' ' 5' ' ' THR . . . -165.54 146.74 11.44 Favored Glycine 0 C--O 1.22 -0.745 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.959 179.206 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.789 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.1 m-85 -70.17 159.6 33.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.787 0.794 . . . . 0.0 111.919 -179.104 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 32.9 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.08 178.057 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.57 HG21 ' O ' ' A' ' 13' ' ' ALA . 23.2 p . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 122.156 0.979 . . . . 0.0 113.4 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.722 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -136.08 -162.98 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.256 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 44.64 -87.05 0.01 OUTLIER Glycine 0 N--CA 1.465 0.586 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 176.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.607 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . -36.77 161.89 0.01 OUTLIER Glycine 0 N--CA 1.465 0.621 0 N-CA-C 116.77 1.468 . . . . 0.0 116.77 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.434 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -178.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.57 ' O ' HG21 ' A' ' 5' ' ' THR . . . . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.707 0.289 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.9 Cg_exo -77.66 143.23 21.15 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.523 2.148 . . . . 0.0 111.84 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 5.2 m -72.32 117.52 14.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.023 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.601 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 73.1 t -83.18 108.89 16.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.57 0.224 . . . . 0.0 110.625 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.402 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 50.8 m-85 -107.4 138.51 19.95 Favored Pre-proline 0 N--CA 1.45 -0.444 0 CA-C-O 120.59 0.233 . . . . 0.0 110.768 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.11 134.1 21.0 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.493 -1.461 . . . . 0.0 111.988 -0.642 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.601 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 23.7 p90 -103.39 136.45 43.12 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.121 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 88.9 m -99.07 121.32 40.83 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.596 -178.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.778 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 77.0 t80 -112.06 131.24 55.55 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.609 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.509 HD21 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 34.25 44.62 0.1 Allowed 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 124.851 1.345 . . . . 0.0 113.727 175.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.48 -19.23 45.83 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 116.96 1.544 . . . . 0.0 116.96 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 20' ' ' THR . 54.0 m-80 -109.16 146.44 34.1 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 120.042 1.921 . . . . 0.0 111.866 -178.522 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 25.3 mtmt -89.07 125.83 35.18 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.653 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.778 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 39.3 m-85 -112.85 116.41 30.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.815 0.816 . . . . 0.0 111.43 -178.316 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -90.85 -22.18 21.09 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.679 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.4 p -123.28 -176.63 3.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.633 179.026 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.6 m -64.37 169.42 4.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.438 0.637 . . . . 0.0 110.562 179.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.5 t -147.6 176.27 10.21 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.315 179.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.1 p -139.14 25.48 2.48 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.133 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.507 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -63.76 139.38 58.76 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 113.063 -1.881 . . . . 0.0 112.558 -179.108 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.15 -5.64 40.74 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.694 -0.685 . . . . 0.0 113.069 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.64 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 14.3 mtp85 . . . . . 0 N--CA 1.449 -0.498 0 CA-C-O 121.244 0.545 . . . . 0.0 111.478 -179.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.64 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 33.9 mmtt . . . . . 0 CA--C 1.518 -0.278 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 68.9 mtm -97.92 144.04 27.88 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.675 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.9 p-90 -138.09 -167.18 2.11 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.396 0.617 . . . . 0.0 111.63 -178.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 22.3 p -159.65 148.94 18.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.115 179.836 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.778 ' HB3' ' HD2' ' A' ' 47' ' ' TYR . . . -81.84 144.13 31.24 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.552 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.8 p -101.69 17.12 23.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.789 0.804 . . . . 0.0 110.69 -178.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.493 HG21 ' HB2' ' A' ' 52' ' ' LYS . 45.4 p -136.14 152.78 51.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.976 178.26 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.63 -39.44 84.34 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.133 0.492 . . . . 0.0 110.823 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -122.5 109.83 14.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.465 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.857 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 46.7 t80 -75.61 -35.1 60.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.206 -178.932 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -48.86 -37.9 20.89 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -86.61 -63.46 1.31 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.492 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 0.9 OUTLIER -77.68 -24.4 49.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -176.98 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.686 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 13.6 mtm180 44.2 50.48 7.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.493 ' HB2' HG21 ' A' ' 44' ' ' THR . 56.6 mttt -108.99 119.34 39.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 177.531 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.857 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 15.3 p-90 -131.82 172.54 12.18 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -175.251 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.607 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -170.78 146.04 9.42 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.804 178.765 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.722 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 14.9 m-30 -62.28 158.68 16.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.339 0.57 . . . . 0.0 111.396 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.1 m . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.311 178.95 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.232 0.153 0 CA-C-O 122.202 1.001 . . . . 0.0 113.654 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -138.08 164.61 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 179.098 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.492 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.19 -149.16 51.35 Favored Glycine 0 C--N 1.315 -0.599 0 C-N-CA 118.23 -1.938 . . . . 0.0 111.853 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.463 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 50.33 -146.61 8.48 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 114.134 0.414 . . . . 0.0 114.134 177.728 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.166 -0.517 . . . . 0.0 110.36 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.491 0.186 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.05 137.35 71.18 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.757 2.304 . . . . 0.0 112.148 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.2 m -75.06 126.87 31.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.832 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 75.8 t -87.1 121.68 38.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.702 0.287 . . . . 0.0 111.121 -179.518 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.62 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 51.5 m-85 -116.96 139.2 25.49 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.307 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.8 Cg_endo -86.21 129.89 12.15 Favored 'Cis proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.641 -1.399 . . . . 0.0 112.303 -0.363 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.635 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 19.7 p90 -94.59 128.58 41.31 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.056 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.8 m -92.19 123.66 35.69 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.521 0.677 . . . . 0.0 112.652 -177.63 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.841 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.1 t80 -127.49 143.83 51.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.642 178.012 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.83 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 42.41 31.35 0.27 Allowed 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.168 0.987 . . . . 0.0 113.16 178.636 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.33 -1.33 79.39 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 178.464 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 65.4 m-80 -113.21 135.59 53.66 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.195 0.998 . . . . 0.0 111.675 -179.033 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -77.76 119.36 21.16 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.841 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.2 m-30 -103.56 105.88 16.25 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.88 0.848 . . . . 0.0 110.775 -179.179 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -83.84 -15.35 48.55 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.668 -179.571 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 p -132.96 -175.86 3.92 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.194 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.5 m -66.21 163.73 17.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.532 0.682 . . . . 0.0 109.895 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.565 HG22 ' CZ ' ' A' ' 19' ' ' PHE . 15.3 t -139.83 176.36 8.81 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.158 -179.388 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.439 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 13.0 p -128.52 16.49 6.5 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.429 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.765 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -63.29 139.89 58.82 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.496 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.2 -11.84 21.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.276 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.607 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.3 mtp85 . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.92 0.39 . . . . 0.0 110.244 179.38 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.833 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 2.2 mppt? . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.439 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 55.6 mtm -77.45 158.44 29.99 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.556 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.645 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 19.5 p-90 -141.98 -169.57 2.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.14 0.495 . . . . 0.0 111.28 -178.784 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.499 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 4.0 p -160.61 144.15 13.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.982 177.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.635 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -76.95 153.91 34.13 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.425 -178.72 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 64.5 p -101.71 9.1 41.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.748 0.785 . . . . 0.0 109.672 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.7 p -130.81 153.94 48.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.253 178.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -59.84 -48.89 79.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 111.452 -179.564 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -111.45 108.77 18.43 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.814 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 71.6 t80 -78.47 -30.36 47.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.031 -178.503 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.61 -32.7 65.54 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -90.59 -57.87 2.68 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -178.649 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -77.73 -30.94 51.93 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 7.9 mmm180 49.49 44.95 24.24 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -110.75 117.77 34.34 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.814 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 10.1 p-90 -133.57 174.92 9.9 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -173.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.463 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.3 144.03 9.31 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 113.219 -1.81 . . . . 0.0 109.907 178.479 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.537 ' HD1' ' HB3' ' A' ' 40' ' ' TRP . 5.3 m-30 -60.0 158.55 10.77 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.516 0.674 . . . . 0.0 112.681 -179.533 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.486 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.6 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.451 179.386 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.51 HG21 ' O ' ' A' ' 13' ' ' ALA . 21.3 p . . . . . 0 N--CA 1.449 -0.508 0 CA-C-O 122.466 1.126 . . . . 0.0 113.688 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.662 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -127.49 -166.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.25 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.427 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 36.04 -127.89 0.9 Allowed Glycine 0 N--CA 1.465 0.617 0 O-C-N 123.818 0.698 . . . . 0.0 113.61 177.436 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.587 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 42.61 -148.54 0.54 Allowed Glycine 0 C--N 1.334 0.458 0 N-CA-C 115.796 1.078 . . . . 0.0 115.796 177.127 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.486 HD22 ' HA ' ' A' ' 52' ' ' LYS . 10.9 p30 . . . . . 0 C--N 1.327 -0.376 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.51 ' O ' HG21 ' A' ' 5' ' ' THR . . . . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 120.742 0.306 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -56.84 132.59 52.65 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.888 2.392 . . . . 0.0 112.368 179.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 52.6 m -74.78 130.59 39.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.789 0.328 . . . . 0.0 111.009 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.8 t -83.22 117.89 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -118.28 142.08 30.63 Favored Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-O 120.947 0.403 . . . . 0.0 111.353 -179.406 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -85.63 139.32 25.89 Favored 'Cis proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.038 -1.651 . . . . 0.0 111.763 -0.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.673 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 19.5 p90 -99.83 -166.48 1.34 Allowed 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.79 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.0 m -148.87 126.38 11.64 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.055 0.455 . . . . 0.0 111.115 -178.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.771 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 29.5 t80 -129.4 139.15 51.76 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.652 179.072 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.495 HD21 ' CG ' ' A' ' 21' ' ' PHE . 3.5 mm? 34.08 47.49 0.2 Allowed 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 124.65 1.218 . . . . 0.0 114.24 174.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.18 -12.21 70.17 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 114.345 -1.298 . . . . 0.0 116.022 177.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.433 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 61.1 m-80 -115.19 134.53 55.06 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 119.224 1.512 . . . . 0.0 112.387 -178.525 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -78.98 125.05 28.87 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.359 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.771 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.4 m-30 -109.79 118.81 37.5 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.831 0.824 . . . . 0.0 111.219 -178.816 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.7 -8.61 46.51 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.903 -179.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.3 p -140.67 -164.86 1.81 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.159 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.5 m -72.5 168.2 19.03 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.849 178.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.4 t -149.75 166.71 28.61 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.229 -179.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.516 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 29.6 p -120.52 21.6 11.53 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 176.755 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -60.77 140.49 57.56 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 113.826 -1.533 . . . . 0.0 112.167 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.36 -8.03 10.44 Favored Glycine 0 N--CA 1.454 -0.122 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.778 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.624 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 22.8 mtp85 . . . . . 0 N--CA 1.443 -0.805 0 CA-C-O 120.818 0.342 . . . . 0.0 110.845 -179.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.772 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 4.3 mptt . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.516 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 52.1 mtt -87.9 146.42 25.57 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.618 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.609 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.3 p-90 -134.32 -164.42 1.5 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.142 0.496 . . . . 0.0 111.158 -178.47 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.2 p -169.58 155.85 6.27 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.41 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.673 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -82.86 146.26 29.0 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.113 -179.268 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 71.0 p -97.93 11.84 36.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.743 0.782 . . . . 0.0 109.853 179.339 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.6 p -134.76 158.91 42.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.549 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.81 -44.9 95.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.922 0.392 . . . . 0.0 111.238 -179.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -116.61 106.88 14.04 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.89 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 72.7 t80 -72.0 -39.42 69.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.86 -178.707 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -49.82 -37.39 30.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.559 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -87.65 -58.49 2.55 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.36 -23.77 54.18 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -177.089 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 7.5 mtm180 45.1 49.32 9.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 179.247 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.486 ' HA ' HD22 ' A' ' 9' ' ' ASN . 28.4 mtpp -116.93 117.62 30.18 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.537 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.89 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.3 p-90 -129.15 172.15 11.71 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -175.258 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.587 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.05 144.93 9.73 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 113.58 -1.645 . . . . 0.0 110.578 179.353 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.662 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.6 m-30 -63.39 158.45 20.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.327 0.563 . . . . 0.0 111.879 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.843 178.592 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.5 p . . . . . 0 N--CA 1.446 -0.639 0 CA-C-O 121.876 0.846 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -129.21 163.97 32.91 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 178.226 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.723 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.85 -145.14 46.29 Favored Glycine 0 C--N 1.308 -0.984 0 C-N-CA 117.434 -2.317 . . . . 0.0 111.148 -179.136 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.619 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 43.47 -149.41 0.67 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 116.077 1.191 . . . . 0.0 116.077 176.717 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 114.836 -0.682 . . . . 0.0 110.073 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.157 0 CA-C-O 120.71 0.29 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -85.15 171.36 9.14 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.772 2.315 . . . . 0.0 111.404 179.254 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.3 m -75.58 148.24 39.0 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.194 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 98.7 t -114.23 117.43 55.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.241 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.61 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 66.0 m-85 -114.22 139.04 23.28 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.944 0.402 . . . . 0.0 111.117 -179.509 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -86.13 131.82 14.22 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.409 -1.496 . . . . 0.0 112.187 -0.17 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.623 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 27.9 p90 -99.59 128.92 45.71 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.194 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -91.72 123.03 34.81 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.335 -178.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.827 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 62.0 t80 -117.94 129.98 55.94 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.826 178.547 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.462 HD21 ' CG ' ' A' ' 21' ' ' PHE . 3.5 mm? 35.87 49.03 0.54 Allowed 'General case' 0 N--CA 1.424 -1.738 0 O-C-N 125.055 1.472 . . . . 0.0 113.33 175.984 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.09 -19.82 51.46 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 114.354 -1.294 . . . . 0.0 116.298 178.099 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -114.99 133.62 55.87 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 120.075 1.937 . . . . 0.0 113.523 -177.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -77.67 125.67 29.7 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.645 178.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.827 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 17.3 m-30 -111.06 118.64 36.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.794 0.807 . . . . 0.0 112.037 -178.559 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -89.27 -19.33 25.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.938 179.454 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 p -127.7 -178.29 4.43 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.167 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 87.7 m -67.79 170.47 7.93 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.908 179.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.428 HG22 ' CZ ' ' A' ' 19' ' ' PHE . 15.1 t -146.96 173.28 12.58 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.254 0.549 . . . . 0.0 110.615 -178.706 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.599 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 17.4 p -125.4 19.58 8.11 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.057 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.85 135.47 57.71 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.745 -179.668 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.83 -8.34 11.61 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.252 -179.494 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.9 mtp85 . . . . . 0 N--CA 1.446 -0.633 0 CA-C-O 121.038 0.446 . . . . 0.0 111.225 -179.513 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.454 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 27.1 mmtm . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.599 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 71.5 mtm -89.55 146.56 24.5 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.235 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.621 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.3 p-90 -129.11 -167.38 1.78 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.4 0.619 . . . . 0.0 112.655 -177.224 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 21.8 p -158.92 143.4 15.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.697 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.411 ' HB1' ' CB ' ' A' ' 19' ' ' PHE . . . -78.44 151.54 32.64 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.424 -0.911 . . . . 0.0 109.605 179.45 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.0 p -103.4 13.22 34.12 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.582 0.706 . . . . 0.0 109.914 -179.573 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.8 p -135.0 149.01 50.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.508 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.78 -37.47 68.61 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.98 0.419 . . . . 0.0 111.498 -179.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -125.04 111.32 15.24 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.52 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.838 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 48.5 t80 -76.26 -34.5 59.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.91 -178.274 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -53.94 -31.17 49.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -89.3 -58.73 2.43 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -179.308 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.27 -19.29 28.5 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.671 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 11.3 mtm180 44.89 49.54 9.1 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 179.558 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -108.63 117.15 33.42 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.32 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.838 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.4 p-90 -126.63 173.31 9.57 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -175.918 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.55 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.77 138.37 5.11 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.587 179.248 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.723 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 12.2 m-85 -56.61 153.67 9.96 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.33 0.586 . . . . 0.0 110.995 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.484 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 9.1 t . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.236 -179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.524 HG21 ' O ' ' A' ' 13' ' ' ALA . 4.5 p . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 122.008 0.908 . . . . 0.0 113.132 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.533 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.2 OUTLIER -138.04 160.68 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 177.518 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.544 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.38 -154.92 44.41 Favored Glycine 0 C--N 1.313 -0.726 0 C-N-CA 117.804 -2.141 . . . . 0.0 110.637 -178.641 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.695 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 40.52 -141.68 0.84 Allowed Glycine 0 N--CA 1.464 0.558 0 N-CA-C 114.311 0.484 . . . . 0.0 114.311 177.625 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.524 ' O ' HG21 ' A' ' 5' ' ' THR . . . . . . . . 0 C--O 1.224 -0.245 0 CA-C-O 120.656 0.265 . . . . 0.0 111.521 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.4 Cg_exo -76.02 149.68 32.95 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.019 2.479 . . . . 0.0 111.895 179.181 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 94.9 m -71.85 129.87 39.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.621 0.248 . . . . 0.0 110.372 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.507 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 65.2 t -100.32 128.22 52.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.938 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.0 143.28 35.03 Favored Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.432 179.253 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.0 Cg_endo -84.0 131.96 17.73 Favored 'Cis proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.446 -1.481 . . . . 0.0 111.958 -0.33 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.634 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 48.6 p90 -100.24 131.62 46.07 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.79 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.0 m -92.37 123.79 35.94 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -176.41 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.799 ' CE1' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -125.56 144.17 50.68 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.264 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.799 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.88 35.16 0.11 Allowed 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.456 1.102 . . . . 0.0 113.26 178.896 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.86 -4.65 84.92 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 115.018 0.767 . . . . 0.0 115.018 178.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.571 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 62.4 m-80 -108.69 137.7 46.21 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 118.623 1.211 . . . . 0.0 112.031 -178.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -79.02 118.81 21.35 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.688 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.3 m-30 -103.25 108.44 19.66 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.71 0.767 . . . . 0.0 111.378 -178.482 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -88.77 -17.01 30.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.392 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 p -129.5 175.04 9.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.4 m -62.0 162.9 8.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.534 178.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.444 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 15.3 t -138.91 179.46 6.48 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.083 -178.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 p -133.38 15.93 4.08 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 177.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.783 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -59.98 139.04 57.69 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.384 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.99 -5.94 29.98 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.299 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.531 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 28.5 mtp85 . . . . . 0 N--CA 1.45 -0.462 0 CA-C-N 116.612 0.206 . . . . 0.0 111.102 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.531 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 39.4 mttp . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.605 0.241 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.6 mtt -85.49 146.61 26.85 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.271 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.676 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 21.4 p-90 -135.68 -169.78 2.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.408 0.623 . . . . 0.0 112.041 -178.466 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.0 p -159.86 145.26 15.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.143 178.823 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.467 ' HB3' ' HD1' ' A' ' 47' ' ' TYR . . . -77.82 151.46 33.94 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.477 -179.363 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 38.4 p -96.7 8.87 43.26 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.495 0.664 . . . . 0.0 110.382 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.4 p -133.07 155.56 49.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.221 179.256 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -62.34 -28.91 70.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.41 . . . . 0.0 111.025 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -125.93 114.42 18.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.412 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.859 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 66.4 t80 -89.03 -29.12 19.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.288 -179.305 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -52.61 -38.8 60.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.859 0.362 . . . . 0.0 111.526 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -92.97 -63.94 1.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.579 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.5 m-20 -64.36 -28.34 69.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -177.408 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.597 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER 42.96 49.46 5.24 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 179.306 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.579 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 9.5 mtpp -114.81 116.85 29.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.859 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.6 p-90 -128.85 176.97 7.42 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -175.278 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.695 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -172.32 145.83 8.84 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 113.107 -1.861 . . . . 0.0 108.94 179.002 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 13.6 m-30 -59.78 160.69 7.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 117.346 0.573 . . . . 0.0 111.853 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.439 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 1.8 t . . . . . 0 CA--C 1.527 0.078 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 177.188 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.419 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 24.2 p . . . . . 0 N--CA 1.446 -0.669 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.735 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -121.72 -164.5 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 175.588 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.425 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 33.85 -123.45 0.39 Allowed Glycine 0 N--CA 1.465 0.61 0 O-C-N 123.903 0.752 . . . . 0.0 113.528 177.654 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.633 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 36.44 -145.38 0.08 OUTLIER Glycine 0 C--N 1.335 0.517 0 N-CA-C 115.744 1.057 . . . . 0.0 115.744 176.945 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.221 0 CA-C-N 115.251 -0.475 . . . . 0.0 111.542 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.191 0 CA-C-O 120.787 0.327 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -61.6 131.36 35.36 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.698 2.266 . . . . 0.0 112.14 179.792 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 53.7 m -71.7 120.73 17.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.175 179.462 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 62.3 t -76.65 116.24 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 111.893 -179.301 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.558 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 40.5 m-85 -118.49 139.89 27.54 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.043 179.866 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.421 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.9 Cg_endo -83.4 138.15 31.99 Favored 'Cis proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.311 -1.537 . . . . 0.0 111.99 -0.447 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.558 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 40.4 p90 -102.97 -173.54 2.34 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.182 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.4 m -140.54 123.64 16.61 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.195 -179.508 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.666 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 56.8 t80 -122.46 133.33 54.6 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.99 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.54 HD21 ' CD1' ' A' ' 21' ' ' PHE . 3.8 mm? 32.61 47.76 0.11 Allowed 'General case' 0 N--CA 1.432 -1.357 0 O-C-N 124.915 1.384 . . . . 0.0 114.238 175.685 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.39 -11.92 66.75 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 116.205 1.242 . . . . 0.0 116.205 177.544 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.517 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 59.6 m-80 -109.47 154.94 21.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.417 1.608 . . . . 0.0 112.15 -178.585 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -95.66 126.98 41.31 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.107 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.666 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 37.9 m-85 -119.08 122.42 42.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.542 0.687 . . . . 0.0 112.054 -178.253 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.421 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 82.9 mt-10 -100.02 -18.06 17.21 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.904 178.987 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.3 p -129.04 -173.33 2.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.743 179.423 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.98 167.34 13.99 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 120.297 -0.561 . . . . 0.0 109.586 178.764 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.406 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 13.6 t -145.76 170.09 17.22 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.459 -178.895 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.778 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 56.6 p -122.21 18.66 10.72 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.752 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -58.92 133.69 56.27 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.748 -179.922 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.6 -5.01 54.34 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.315 -179.774 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.0 mtp85 . . . . . 0 N--CA 1.45 -0.43 0 CA-C-O 121.083 0.468 . . . . 0.0 110.402 -179.443 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 89.4 mttt . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.531 0.205 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.778 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 77.0 mtm -64.15 134.49 54.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 109.934 179.693 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.696 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.1 p-90 -125.12 -161.28 1.01 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.387 -177.518 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 3.5 p -169.53 154.52 5.64 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.594 178.189 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.475 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -78.8 147.81 33.14 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 120.835 0.35 . . . . 0.0 110.998 -179.252 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 66.0 p -100.88 7.06 43.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.636 0.731 . . . . 0.0 109.843 179.545 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.5 p -128.4 157.87 39.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.005 178.402 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.86 99.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.101 0.476 . . . . 0.0 110.759 -179.937 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -119.57 106.07 11.84 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.32 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.973 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 34.2 t80 -71.58 -38.33 70.92 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 -179.078 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -45.59 -36.76 4.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.437 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.79 -63.74 1.23 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -179.28 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.39 -18.64 59.89 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.815 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 34.74 56.3 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -179.868 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -114.32 116.25 28.66 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.492 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.973 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 8.4 p-90 -125.27 169.51 12.21 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -174.859 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.633 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.51 146.68 10.89 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.345 179.339 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.735 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 14.8 m-30 -62.06 163.23 8.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.366 0.603 . . . . 0.0 112.328 -179.21 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.5 179.241 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 p . . . . . 0 C--O 1.233 0.199 0 CA-C-O 122.306 1.051 . . . . 0.0 113.762 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -132.07 163.52 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 104.945 -2.242 . . . . 0.0 104.945 178.728 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.588 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 64.14 -145.55 49.75 Favored Glycine 0 C--N 1.313 -0.714 0 C-N-CA 118.067 -2.016 . . . . 0.0 110.725 -179.369 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.635 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 44.35 -145.94 1.73 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 114.724 0.65 . . . . 0.0 114.724 177.791 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.462 0 CA-C-O 120.895 0.379 . . . . 0.0 110.686 178.681 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.294 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.67 170.86 8.74 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.768 2.312 . . . . 0.0 111.997 179.662 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.2 m -74.81 142.96 44.16 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.954 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 92.6 t -111.63 117.38 54.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 178.767 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.559 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 47.3 m-85 -114.69 142.08 27.73 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.752 -179.778 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.23 136.65 28.62 Favored 'Cis proline' 0 N--CA 1.464 -0.259 0 C-N-CA 123.369 -1.513 . . . . 0.0 112.005 -0.498 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.559 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 32.3 p90 -107.08 132.56 52.84 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.315 178.387 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 68.1 m -94.41 124.46 38.45 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.438 -179.239 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.712 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 41.7 t80 -124.76 137.38 54.33 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.901 178.995 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.472 HD21 ' CG ' ' A' ' 21' ' ' PHE . 3.4 mm? 37.0 49.23 0.78 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 175.293 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.92 -8.97 73.98 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 114.312 -1.313 . . . . 0.0 116.351 177.626 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' THR . 62.7 m-80 -113.69 153.85 28.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 119.515 1.658 . . . . 0.0 112.287 -178.614 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -93.37 122.48 35.83 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.804 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.712 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 15.0 m-85 -110.22 121.81 46.15 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.857 0.837 . . . . 0.0 111.56 -178.272 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -95.44 -21.06 18.57 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.883 179.676 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p -127.26 -174.67 3.22 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.894 179.953 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.6 m -66.64 170.35 6.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.3 0.571 . . . . 0.0 109.558 178.604 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.45 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 12.1 t -148.43 169.18 20.78 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.592 -179.693 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.0 p -121.98 17.72 10.9 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.21 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -62.32 137.07 58.19 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.721 -179.473 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.08 -0.09 63.84 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.718 179.862 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.443 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.0 mtp85 . . . . . 0 N--CA 1.448 -0.55 0 CA-C-N 116.508 0.154 . . . . 0.0 111.297 -179.581 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.443 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 31.1 mmtm . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 120.989 0.423 . . . . 0.0 111.801 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.8 mtm -102.96 151.17 22.78 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.523 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.638 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 11.3 p-90 -137.09 -170.08 2.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.288 0.566 . . . . 0.0 112.35 -178.082 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 21.4 p -155.85 146.84 22.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.966 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.98 149.42 30.8 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.754 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.1 p -100.22 16.02 25.63 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.77 0.795 . . . . 0.0 110.056 -179.775 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.2 p -143.77 152.88 41.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.059 178.372 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.81 -40.71 80.58 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.963 0.411 . . . . 0.0 111.515 -179.351 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -119.44 107.04 12.85 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.918 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.863 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 58.1 t80 -73.58 -39.8 64.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.68 -178.494 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -49.75 -38.37 33.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.47 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.44 -38.9 12.29 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -178.482 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -93.5 -24.45 17.99 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.524 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 14.4 mtm180 43.17 49.57 5.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 178.977 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -116.91 120.12 37.47 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.014 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.863 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.6 p-90 -130.66 169.33 15.78 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -175.647 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.635 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.16 145.6 11.19 Favored Glycine 0 C--O 1.22 -0.772 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.629 178.732 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.588 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 4.8 m-30 -63.44 159.71 17.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.313 0.578 . . . . 0.0 111.849 179.938 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.272 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.764 HG22 ' HA3' ' A' ' 54' ' ' GLY . 27.5 p . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.443 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 1.0 OUTLIER -127.2 6.62 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 CA-C-O 122.799 1.285 . . . . 0.0 109.964 179.922 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.425 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . -156.16 -160.12 9.82 Favored Glycine 0 C--N 1.282 -2.421 0 CA-C-N 112.874 -1.966 . . . . 0.0 111.008 -178.138 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.697 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 74.38 168.33 19.19 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.635 178.572 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.535 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.55 -0.325 . . . . 0.0 111.527 178.782 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.527 ' O ' HG21 ' A' ' 5' ' ' THR . . . . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 120.392 0.139 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.03 151.01 16.11 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.219 1.946 . . . . 0.0 112.252 -179.967 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.441 ' SG ' HG23 ' A' ' 5' ' ' THR . 72.3 m -78.33 138.55 38.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.218 179.668 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.412 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 47.9 t -104.83 118.08 51.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.578 0.228 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.418 ' CE2' ' HE1' ' A' ' 19' ' ' PHE . 69.6 m-85 -111.27 146.34 34.37 Favored Pre-proline 0 N--CA 1.447 -0.577 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.42 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.504 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -82.64 134.37 24.81 Favored 'Cis proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.431 -1.487 . . . . 0.0 112.106 -0.237 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.627 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 20.8 p90 -108.27 127.79 54.16 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.473 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 91.7 m -91.69 127.09 37.01 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.105 0.479 . . . . 0.0 111.39 -178.81 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.806 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 56.3 t80 -123.32 135.06 54.01 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.789 179.282 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.588 ' H ' HD21 ' A' ' 22' ' ' LEU . 3.6 mm? 35.1 46.92 0.25 Allowed 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 124.491 1.119 . . . . 0.0 113.799 175.197 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.27 -20.7 49.45 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 116.237 1.255 . . . . 0.0 116.237 177.71 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -112.14 134.11 53.88 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 119.545 1.673 . . . . 0.0 112.644 -178.138 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 34.7 mtpt -79.04 125.33 29.24 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.709 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.806 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 17.9 m-85 -109.91 123.15 49.1 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.608 0.718 . . . . 0.0 111.589 -178.588 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.504 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 51.6 mt-10 -100.61 -9.96 21.43 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.817 179.283 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 p -130.88 172.12 12.4 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.3 m -63.72 160.87 16.16 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.616 179.285 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 t -138.74 174.06 10.92 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.159 -178.761 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 p -127.42 21.99 6.55 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 177.039 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.646 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -61.02 138.8 58.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.025 -179.384 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.01 -6.15 28.99 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.047 179.639 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.632 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 13.8 mtp85 . . . . . 0 N--CA 1.45 -0.434 0 CA-C-N 117.169 0.484 . . . . 0.0 111.224 -179.678 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.632 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.543 0 CA-C-O 120.593 0.235 . . . . 0.0 110.843 . . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.4 mtt -89.44 143.91 26.46 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.779 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.651 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 12.3 p-90 -132.17 -165.57 1.61 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.49 0.662 . . . . 0.0 111.39 -178.725 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -169.32 150.21 4.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.068 179.447 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.628 ' HB3' ' HD1' ' A' ' 47' ' ' TYR . . . -76.41 149.86 36.85 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.786 -179.23 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.2 p -96.42 9.08 42.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.777 0.798 . . . . 0.0 109.383 179.442 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.0 p -132.67 150.9 52.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.38 178.71 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.627 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.09 -36.48 72.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.07 0.462 . . . . 0.0 111.218 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -123.19 112.03 17.2 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.393 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.893 ' HE1' ' HB3' ' A' ' 53' ' ' TRP . 51.9 t80 -76.11 -39.06 56.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.806 -178.411 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -46.38 -35.96 5.99 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.956 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -82.52 -77.99 0.22 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -179.742 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.644 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 1.4 m-20 -67.83 -20.69 65.19 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -176.84 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 18.9 mtm180 43.24 50.73 5.8 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.943 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.644 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 59.1 mttt -111.69 118.24 35.09 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.113 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.893 ' HB3' ' HE1' ' A' ' 47' ' ' TYR . 7.6 p-90 -128.88 177.31 7.18 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -175.072 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.764 ' HA3' HG22 ' A' ' 5' ' ' THR . . . -176.76 154.63 16.67 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 113.691 -1.595 . . . . 0.0 110.013 179.227 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 15.4 m-30 -66.11 161.12 22.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.106 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.433 ' O ' HG22 ' A' ' 6' ' ' VAL . 18.8 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.393 178.729 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.446 -0.671 0 CA-C-O 121.936 0.874 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.531 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.2 OUTLIER -131.32 165.39 31.7 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.035 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 178.091 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.549 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 61.07 -148.34 46.2 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 118.187 -1.958 . . . . 0.0 111.667 -179.935 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.556 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 51.97 -152.54 6.3 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 114.801 0.68 . . . . 0.0 114.801 177.352 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.416 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.889 0.376 . . . . 0.0 111.025 179.763 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.677 0.275 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.43 174.4 5.98 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.93 2.42 . . . . 0.0 111.852 179.888 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.8 m -85.02 128.21 34.53 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.817 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 99.3 t -95.45 108.26 20.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.048 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -110.22 142.14 25.36 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.141 -179.081 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -82.55 139.37 38.96 Favored 'Cis proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.821 -1.741 . . . . 0.0 111.276 -0.783 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.483 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 36.3 p90 -105.98 135.76 46.85 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.703 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 41.4 m -96.76 120.32 36.87 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.376 0.608 . . . . 0.0 110.76 -179.139 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.694 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 50.2 t80 -116.34 134.07 55.3 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.741 178.951 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.51 HD21 ' CD1' ' A' ' 21' ' ' PHE . 3.7 mm? 33.36 45.41 0.08 Allowed 'General case' 0 N--CA 1.435 -1.224 0 O-C-N 124.872 1.358 . . . . 0.0 114.224 174.789 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.04 -10.86 62.12 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 116.584 1.394 . . . . 0.0 116.584 177.331 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.491 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 41.0 m-80 -115.35 156.43 25.53 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.87 1.835 . . . . 0.0 112.8 -178.123 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -91.66 122.2 34.01 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.788 179.047 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.694 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 42.8 m-85 -115.22 111.25 20.67 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.725 0.774 . . . . 0.0 111.141 -179.414 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -91.26 -9.21 46.0 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.899 -179.769 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 p -138.91 -166.55 2.04 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.43 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.4 m -71.38 167.28 19.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.416 0.627 . . . . 0.0 110.52 179.018 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.451 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 11.5 t -146.85 173.22 12.6 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.601 179.979 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 p -127.03 19.33 7.07 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.386 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.49 139.6 58.59 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.43 -179.124 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.9 -0.64 44.11 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.036 179.437 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.634 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.8 mtp85 . . . . . 0 N--CA 1.45 -0.46 0 CA-C-O 121.155 0.503 . . . . 0.0 111.741 -179.194 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.634 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 44.6 mmtt . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -73.85 149.98 41.24 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.922 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.597 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 13.0 p-90 -137.26 -163.81 1.49 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.152 0.501 . . . . 0.0 111.375 -178.527 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 23.5 p -160.09 153.79 22.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.846 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.476 ' HB3' ' HD1' ' A' ' 47' ' ' TYR . . . -89.38 144.73 25.84 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.318 178.347 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -99.56 13.54 33.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.804 0.812 . . . . 0.0 110.349 -179.353 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.9 p -136.76 147.52 46.71 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.501 178.212 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.16 -48.99 64.64 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.166 0.507 . . . . 0.0 111.053 -179.439 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -113.6 112.09 22.94 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.086 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.848 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 56.7 t80 -73.23 -40.2 64.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.837 -178.432 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -48.22 -36.07 13.1 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.086 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.46 -68.4 0.68 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.716 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.84 -23.16 52.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.87 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 24.7 mtm180 45.4 50.57 10.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -179.617 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -112.51 117.13 31.52 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.019 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.848 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.1 p-90 -127.78 169.7 13.57 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.297 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.48 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -159.2 137.51 5.19 Favored Glycine 0 C--O 1.221 -0.688 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.473 178.647 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.549 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 2.5 m-30 -58.47 158.28 7.76 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.289 0.636 . . . . 0.0 111.738 179.686 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.405 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.0 t . . . . . 0 C--N 1.319 -0.737 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.674 179.983 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 121.372 0.606 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.733 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -113.67 -166.93 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 176.8 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 36.99 -125.98 1.08 Allowed Glycine 0 N--CA 1.462 0.419 0 O-C-N 124.038 0.836 . . . . 0.0 113.226 177.592 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.671 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 31.85 -141.42 0.04 OUTLIER Glycine 0 C--N 1.335 0.474 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 176.801 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.512 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 114.693 -0.753 . . . . 0.0 109.792 179.894 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.757 0.313 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -84.03 165.74 13.12 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.533 2.155 . . . . 0.0 111.688 179.486 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.5 m -79.93 136.7 36.7 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.829 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.3 t -96.39 107.35 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.688 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.545 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 38.0 m-85 -111.44 138.23 21.34 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-O 121.046 0.45 . . . . 0.0 111.066 -179.59 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.569 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 9.4 Cg_endo -88.5 134.15 12.38 Favored 'Cis proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.239 -1.567 . . . . 0.0 112.415 -0.555 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.747 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 37.3 p90 -97.26 -168.32 1.67 Allowed 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 119.707 -0.797 . . . . 0.0 108.85 178.063 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.4 m -147.36 127.46 13.74 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.421 -179.006 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.817 ' CE1' HD12 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -129.91 144.07 51.13 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.704 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.817 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.06 36.32 0.11 Allowed 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.863 1.265 . . . . 0.0 113.343 178.733 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.4 -12.63 69.24 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 115.19 0.836 . . . . 0.0 115.19 178.667 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -106.0 135.72 46.94 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 118.667 1.234 . . . . 0.0 111.923 -178.932 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 88.8 mttt -78.94 126.15 30.32 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.915 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.789 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.4 m-30 -108.57 114.6 28.56 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.763 0.792 . . . . 0.0 111.199 -179.123 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.569 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 50.8 mt-10 -90.49 -20.34 22.81 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.586 -179.568 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 p -125.61 -175.71 3.41 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.501 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.5 m -67.64 162.54 23.37 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.451 179.039 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.552 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 9.0 t -138.12 171.07 14.94 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.173 -179.349 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.6 p -126.18 21.95 7.3 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.244 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.733 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -66.26 140.61 58.15 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.299 -179.63 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.92 -3.59 50.17 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.553 179.579 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.678 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 16.9 mtp85 . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 121.155 0.502 . . . . 0.0 110.823 -179.341 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.678 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 81.2 mttt . . . . . 0 CA--C 1.518 -0.259 0 CA-C-O 120.69 0.281 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.7 mtm -69.87 139.04 52.98 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.202 -179.604 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.64 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.1 p-90 -129.08 -165.96 1.58 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.411 -178.899 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.4 p -157.37 150.02 23.12 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.304 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.747 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -84.97 148.05 26.4 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.396 179.596 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 49.7 p -102.98 10.97 37.92 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.841 0.829 . . . . 0.0 109.732 179.805 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.457 HG21 ' HB2' ' A' ' 52' ' ' LYS . 39.5 p -131.0 149.88 52.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.884 178.149 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.38 -43.28 83.46 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.124 0.488 . . . . 0.0 111.036 -179.572 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -117.26 109.05 16.37 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.225 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.822 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 73.7 t80 -77.12 -34.97 56.61 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.866 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -51.12 -35.03 33.43 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.791 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -86.57 -76.8 0.34 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.343 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.74 -19.2 65.81 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -176.824 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 45.2 mtm-85 39.24 54.6 2.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 179.253 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.457 ' HB2' HG21 ' A' ' 44' ' ' THR . 46.4 mttp -112.88 119.21 37.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.525 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.822 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.5 p-90 -129.55 173.13 10.87 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -174.701 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.565 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -164.32 144.61 9.56 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 113.327 -1.76 . . . . 0.0 109.529 178.793 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.733 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.3 m-30 -61.89 156.75 20.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 117.69 0.745 . . . . 0.0 111.843 -179.646 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.438 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 7.6 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.404 178.365 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 122.605 1.193 . . . . 0.0 114.026 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -138.71 162.36 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 177.844 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.579 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.89 -147.47 50.72 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 117.629 -2.224 . . . . 0.0 111.512 -179.46 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.697 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 47.88 -137.87 12.51 Favored Glycine 0 N--CA 1.461 0.309 0 N-CA-C 114.111 0.404 . . . . 0.0 114.111 177.788 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.966 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.189 0 CA-C-O 120.506 0.193 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -77.3 139.67 18.88 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.994 1.796 . . . . 0.0 112.474 -179.831 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 87.9 m -71.14 124.49 24.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.246 179.468 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 64.1 t -89.95 122.13 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.184 -179.57 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.472 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 54.1 m-85 -117.89 140.36 27.65 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.02 179.422 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -86.19 133.21 15.66 Favored 'Cis proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.181 -1.591 . . . . 0.0 112.136 0.152 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.669 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 37.7 p90 -102.4 132.69 48.25 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.63 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 m -95.37 127.31 41.31 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -177.475 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.842 ' CE1' HD12 ' A' ' 22' ' ' LEU . 1.1 t80 -127.16 144.31 51.06 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.182 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.842 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.95 32.62 0.12 Allowed 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 124.298 1.039 . . . . 0.0 113.324 178.505 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.29 -8.43 77.44 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 178.793 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.413 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 67.9 m-80 -107.98 135.81 48.74 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 118.354 1.077 . . . . 0.0 111.859 -179.148 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -78.64 123.12 26.79 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.998 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.797 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.8 m-30 -107.59 110.7 22.66 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.84 0.829 . . . . 0.0 111.183 -178.901 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -86.28 -21.92 27.09 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.108 -1.406 . . . . 0.0 110.37 -179.619 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 p -126.1 -175.2 3.3 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.788 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.9 m -65.9 163.4 17.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.393 0.616 . . . . 0.0 109.758 178.896 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.53 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.7 t -138.22 172.84 12.32 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.269 -179.311 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.4 p -125.39 12.9 8.18 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 177.762 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.769 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -60.9 138.27 58.16 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 113.881 -1.508 . . . . 0.0 111.691 -179.697 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.15 -10.12 43.49 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.779 179.767 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.613 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.6 mtp85 . . . . . 0 C--O 1.236 0.361 0 CA-C-N 117.424 0.612 . . . . 0.0 110.96 179.567 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.782 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 8.2 mptt . . . . . 0 N--CA 1.455 -0.221 0 CA-C-O 120.722 0.296 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 43.6 mtt -86.11 150.86 24.13 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.459 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.659 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.3 p-90 -137.43 -167.91 2.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.966 0.412 . . . . 0.0 111.184 -178.548 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.7 p -161.76 142.55 10.78 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.556 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.407 ' HB1' ' CD1' ' A' ' 19' ' ' PHE . . . -71.69 154.45 41.35 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.102 0.477 . . . . 0.0 110.737 -179.324 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.5 p -103.5 10.11 37.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.68 0.752 . . . . 0.0 110.119 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.1 p -133.46 155.81 48.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.901 178.766 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -59.15 -35.74 74.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.906 0.384 . . . . 0.0 111.432 -179.67 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -124.98 113.09 17.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.493 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.794 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 80.3 t80 -78.06 -31.05 50.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.028 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -58.76 -34.92 71.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.527 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -79.11 -64.43 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.938 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.925 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.3 m-20 -72.86 -36.56 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.466 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 7.9 mmm-85 54.65 45.26 27.19 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.365 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.925 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 12.4 mtpt -116.74 120.4 38.47 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 176.894 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.794 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 10.4 p-90 -132.5 172.15 12.87 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.437 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.697 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -160.89 147.33 13.91 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 112.984 -1.916 . . . . 0.0 109.708 178.209 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.579 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 10.6 m-30 -58.83 163.54 3.34 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.262 0.553 . . . . 0.0 111.719 -179.862 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.565 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.2 t . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.286 179.753 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 122.07 0.938 . . . . 0.0 111.953 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -132.99 159.42 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 177.63 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.809 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 67.2 -147.45 49.1 Favored Glycine 0 C--N 1.308 -1.002 0 C-N-CA 117.587 -2.245 . . . . 0.0 111.078 -179.032 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.607 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 45.25 -144.55 2.83 Favored Glycine 0 C--N 1.328 0.108 0 N-CA-C 115.157 0.823 . . . . 0.0 115.157 177.318 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 121.19 0.519 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.438 ' HB2' ' HB ' ' A' ' 43' ' ' THR . . . . . . . . 0 C--O 1.225 -0.188 0 CA-C-O 120.301 0.096 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -87.59 166.17 7.64 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.443 2.095 . . . . 0.0 111.697 179.409 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 71.7 m -81.13 118.77 22.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.581 179.829 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 59.6 t -82.67 117.75 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.854 -179.799 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -114.55 134.52 22.33 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.596 179.875 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.691 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 9.4 Cg_endo -85.97 136.92 20.83 Favored 'Cis proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.246 -1.564 . . . . 0.0 112.901 -0.158 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.685 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 29.9 p90 -100.96 129.42 46.8 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.778 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.5 m -91.49 127.0 36.76 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.334 0.588 . . . . 0.0 112.552 -177.395 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.812 ' CD2' ' HB2' ' A' ' 32' ' ' ALA . 1.4 t80 -131.3 142.32 50.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.469 178.356 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.751 HD23 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.38 38.96 0.41 Allowed 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.624 1.17 . . . . 0.0 113.665 178.278 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.37 -8.71 79.24 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 115.216 0.846 . . . . 0.0 115.216 178.426 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.539 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 68.3 m-80 -110.39 137.99 47.37 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 118.461 1.13 . . . . 0.0 112.068 -179.082 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -81.5 121.11 25.88 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.498 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.752 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.3 m-30 -104.51 104.7 14.59 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.892 0.854 . . . . 0.0 110.977 -178.129 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.691 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 27.5 mt-10 -84.47 -9.34 58.46 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.159 -1.382 . . . . 0.0 111.259 -179.231 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.0 p -137.58 -167.67 2.17 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.402 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 81.2 m -70.52 170.89 11.17 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.189 -0.605 . . . . 0.0 109.982 178.597 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.587 HG22 ' CZ ' ' A' ' 19' ' ' PHE . 14.3 t -150.11 172.4 15.33 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.279 -179.983 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.6 p -127.11 20.53 6.89 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.07 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.812 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -65.25 142.72 58.19 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 114.067 -1.424 . . . . 0.0 112.234 -179.613 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.58 -4.3 21.47 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.892 179.396 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.673 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 20.6 mtp85 . . . . . 0 N--CA 1.449 -0.525 0 CA-C-O 121.255 0.55 . . . . 0.0 111.688 -179.216 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.673 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.875 0.369 . . . . 0.0 111.651 . . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.4 mtt -98.02 149.92 21.94 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.736 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.591 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.4 p-90 -141.11 -171.85 3.36 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.334 0.587 . . . . 0.0 111.434 -178.331 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.7 p -156.7 137.3 13.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.827 177.969 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.698 ' HB3' ' HD1' ' A' ' 47' ' ' TYR . . . -71.09 151.07 44.87 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.436 0.636 . . . . 0.0 111.458 -178.553 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 13' ' ' ALA . 80.1 p -100.75 7.51 43.78 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.915 179.236 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.1 p -127.92 143.83 51.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.754 179.459 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.48 -49.33 70.37 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.916 0.389 . . . . 0.0 110.98 179.958 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -112.46 103.53 11.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.052 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.8 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 56.9 t80 -76.19 -29.25 57.59 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.274 -178.04 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -55.67 -37.77 68.73 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.562 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -86.57 -52.28 5.65 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.298 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.689 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 13.5 m-20 -77.39 -45.98 24.21 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.477 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER 61.46 37.03 16.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.895 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.689 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 5.0 mppt? -105.11 118.09 35.65 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.183 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.8 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.9 p-90 -128.66 174.88 9.03 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -174.067 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.607 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -157.68 145.9 12.62 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 112.789 -2.005 . . . . 0.0 108.733 178.274 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.809 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 6.2 m-85 -66.86 163.93 18.44 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 117.772 0.786 . . . . 0.0 112.106 -179.402 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.482 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 2.2 t . . . . . 0 C--N 1.329 -0.286 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.592 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.449 -0.519 0 CA-C-O 121.788 0.804 . . . . 0.0 112.99 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.51 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -133.23 164.01 36.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.979 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.976 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.674 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 77.19 -80.44 1.26 Allowed Glycine 0 N--CA 1.463 0.463 0 C-N-CA 118.194 -1.955 . . . . 0.0 113.928 178.932 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.799 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . -45.98 166.22 0.07 OUTLIER Glycine 0 N--CA 1.468 0.813 0 CA-C-N 114.502 -0.849 . . . . 0.0 115.174 -179.16 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.783 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.274 0 CA-C-O 120.867 0.365 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.91 147.33 68.07 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.169 2.58 . . . . 0.0 113.018 -179.724 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 86.4 m -82.47 116.5 21.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.336 178.777 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.6 t -77.27 119.32 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -116.09 137.6 23.53 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.057 0.456 . . . . 0.0 111.22 -179.591 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -84.02 142.67 40.96 Favored 'Cis proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.428 -1.905 . . . . 0.0 112.795 -0.172 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.491 ' CZ ' ' HA ' ' A' ' 41' ' ' CYS . 21.6 p90 -104.68 128.77 52.85 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.74 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.3 m -95.6 122.63 38.55 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.433 0.635 . . . . 0.0 111.967 -177.933 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.717 ' CD2' HD23 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -104.44 -140.36 0.36 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.151 178.298 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.717 HD23 ' CD2' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -49.67 52.81 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.825 2.05 . . . . 0.0 114.884 -177.626 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 21' ' ' PHE . . . 86.2 8.4 78.44 Favored Glycine 0 C--N 1.296 -1.654 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.613 179.562 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.464 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 53.0 m-80 -125.89 134.29 51.65 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.34 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -79.6 118.38 21.39 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.381 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.654 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.3 m-85 -105.67 109.58 21.6 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.877 0.846 . . . . 0.0 111.323 -178.522 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.75 -15.91 37.96 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.079 -179.874 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 p -128.23 179.56 5.55 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.168 179.058 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.0 m -66.42 160.45 24.82 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.891 178.963 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.6 t -136.62 170.95 15.23 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.021 -179.509 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.3 p -123.59 15.25 9.52 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 177.023 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.547 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -60.59 140.5 57.37 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.41 -179.893 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.25 -7.55 16.71 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.528 -179.837 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.2 mtp85 . . . . . 0 N--CA 1.449 -0.476 0 CA-C-O 120.901 0.381 . . . . 0.0 110.842 -179.8 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt . . . . . 0 CA--C 1.521 -0.166 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -101.42 148.38 25.24 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 176.616 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.687 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.8 p-90 -135.63 -167.94 2.11 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.193 0.52 . . . . 0.0 111.701 -177.89 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.0 p -162.71 142.39 9.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.253 178.851 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.47 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -73.39 150.78 41.51 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.927 -179.223 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.1 p -100.34 14.76 29.98 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.332 179.373 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.1 p -136.18 154.34 50.98 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.819 179.104 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.94 -41.03 95.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.079 0.466 . . . . 0.0 110.512 -179.814 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -118.31 111.87 19.31 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.58 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.762 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 76.8 t80 -79.62 -28.96 40.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.381 -177.626 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -57.76 -38.26 75.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.053 0.454 . . . . 0.0 112.013 -179.55 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -79.32 -61.05 2.13 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.578 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -81.74 -25.72 35.15 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.763 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.8 mtm180 48.81 45.56 22.07 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -110.97 118.78 37.01 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.277 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.762 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 17.1 p-90 -130.37 174.54 9.76 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -174.645 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.799 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -168.24 142.83 7.71 Favored Glycine 0 C--O 1.222 -0.652 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.04 179.113 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.674 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 13.9 m-30 -59.18 160.31 6.51 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.317 0.579 . . . . 0.0 111.804 -179.396 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.9 t . . . . . 0 C--N 1.32 -0.702 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.933 179.834 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.347 0.594 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.714 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -117.98 -173.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 177.027 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.425 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 37.27 -129.67 1.23 Allowed Glycine 0 CA--C 1.523 0.578 0 O-C-N 123.932 0.77 . . . . 0.0 113.208 178.158 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.544 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 39.96 -145.47 0.34 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 177.081 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.403 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 114.915 -0.642 . . . . 0.0 110.639 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.188 0 CA-C-O 120.929 0.395 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -86.36 174.69 5.9 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.028 2.485 . . . . 0.0 111.987 179.281 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.6 m -79.36 137.8 37.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.619 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.434 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 65.9 t -102.31 113.33 38.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.642 0.258 . . . . 0.0 110.323 179.633 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.611 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 36.6 m-85 -117.53 137.48 24.21 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-O 120.838 0.351 . . . . 0.0 111.237 -179.632 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.65 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 37.7 Cg_endo -87.04 138.88 20.09 Favored 'Cis proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.659 -1.809 . . . . 0.0 112.339 -0.744 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.619 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 34.2 p90 -105.1 -169.03 1.55 Allowed 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.041 178.121 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.454 ' OG1' ' HD2' ' A' ' 25' ' ' LYS . 86.5 m -145.81 124.05 12.25 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.738 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.774 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 66.0 t80 -116.6 129.36 56.12 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.812 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.649 ' H ' HD21 ' A' ' 22' ' ' LEU . 3.8 mm? 33.92 45.18 0.1 Allowed 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 125.114 1.509 . . . . 0.0 113.619 175.583 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.54 -16.94 51.53 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 116.459 1.344 . . . . 0.0 116.459 178.002 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.435 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 54.1 m-80 -110.93 135.64 51.15 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 119.929 1.864 . . . . 0.0 112.73 -177.958 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HD2' ' OG1' ' A' ' 20' ' ' THR . 12.3 mmmm -76.33 120.69 21.92 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.853 178.844 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.774 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.5 m-30 -112.83 118.75 35.81 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.646 0.736 . . . . 0.0 111.275 179.919 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.65 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 38.8 mt-10 -97.9 -12.71 21.78 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.999 179.798 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 p -130.66 -174.28 3.31 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.608 179.086 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.9 m -70.93 165.51 23.2 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.724 179.091 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -146.16 171.18 15.31 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.343 -178.715 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.482 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 66.0 p -123.35 18.68 9.79 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 177.061 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.69 134.62 56.36 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.872 -179.424 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.53 -3.15 60.47 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.377 -179.611 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.563 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.6 mtp85 . . . . . 0 N--CA 1.446 -0.66 0 CA-C-O 121.026 0.441 . . . . 0.0 111.182 -179.757 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.563 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 14.7 mmtp . . . . . 0 CA--C 1.518 -0.252 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.482 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 73.7 mtp -76.87 138.03 39.52 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.138 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.642 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.6 p-90 -121.85 -163.6 1.08 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.51 0.672 . . . . 0.0 111.941 -178.006 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 7.4 p -160.79 140.57 10.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.634 -179.722 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.569 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -72.68 149.38 43.87 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.113 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.4 p -104.34 13.51 31.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.465 0.65 . . . . 0.0 110.16 179.728 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.9 p -135.36 154.34 51.53 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.692 178.48 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.26 -43.37 98.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.844 0.354 . . . . 0.0 110.909 -179.809 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -117.97 106.97 13.49 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.693 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.976 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 25.5 t80 -77.17 -31.64 55.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.707 -179.142 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.27 -36.52 14.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.878 0.371 . . . . 0.0 111.799 179.631 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.13 -57.29 2.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -178.25 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.09 -27.4 60.87 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -176.771 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.637 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.5 mtm180 44.33 49.4 8.0 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 179.0 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -114.7 120.89 41.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.608 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.976 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.7 p-90 -128.47 172.85 10.74 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -175.312 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.544 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -163.82 143.96 9.06 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.737 179.751 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.714 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 10.9 m-30 -60.99 155.13 20.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 118.139 0.969 . . . . 0.0 111.864 -179.394 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.49 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 14.8 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.472 179.228 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.449 -0.508 0 CA-C-O 121.672 0.748 . . . . 0.0 112.175 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -130.79 162.81 38.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.998 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 177.652 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.769 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 69.07 -148.13 47.26 Favored Glycine 0 C--N 1.312 -0.766 0 C-N-CA 117.565 -2.255 . . . . 0.0 111.413 -179.251 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.64 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 41.58 -140.49 1.54 Allowed Glycine 0 CA--C 1.52 0.347 0 N-CA-C 115.623 1.009 . . . . 0.0 115.623 177.219 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.464 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.79 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.817 0.341 . . . . 0.0 111.401 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -85.73 164.98 10.48 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.147 2.565 . . . . 0.0 111.718 178.871 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.8 m -72.31 136.75 46.31 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.499 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.85 95.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.743 0.306 . . . . 0.0 111.564 -179.874 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.605 ' CE1' ' HE1' ' A' ' 19' ' ' PHE . 9.2 m-85 -96.61 146.41 31.26 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-O 121.416 0.627 . . . . 0.0 111.412 177.886 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.803 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.1 Cg_endo -83.44 131.3 17.52 Favored 'Cis proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.32 -1.95 . . . . 0.0 111.896 -0.507 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.605 ' HE1' ' CE1' ' A' ' 17' ' ' PHE . 0.6 OUTLIER -85.84 -160.37 0.53 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.056 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.436 ' HG1' ' C ' ' A' ' 19' ' ' PHE . 1.8 m -144.14 120.81 11.15 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -178.706 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.763 ' CD1' HD12 ' A' ' 22' ' ' LEU 0.53 0.5 OUTLIER -127.16 123.66 37.23 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 119.949 3.314 . . . . 0.0 119.949 175.152 . . . . . . . . 4 4 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.763 HD12 ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER 26.26 52.75 0.03 OUTLIER 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 108.912 -3.767 . . . . 0.0 112.92 174.723 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.51 -4.53 56.73 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 114.213 -1.358 . . . . 0.0 115.174 178.333 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.887 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 3.5 m-80 -126.16 141.6 51.87 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 118.572 1.186 . . . . 0.0 112.944 -177.779 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.595 ' HZ1' ' HB3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -81.17 119.27 23.38 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.226 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.887 ' CE1' ' HB2' ' A' ' 24' ' ' ASN . 14.2 m-30 -97.0 95.22 7.66 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.459 1.123 . . . . 0.0 111.779 -177.224 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.803 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 39.7 mt-10 -78.45 -13.12 59.98 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 113.18 -1.827 . . . . 0.0 111.877 -178.466 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p -134.01 178.65 6.79 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.721 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 98.5 m -64.88 163.07 15.05 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 119.496 -0.882 . . . . 0.0 108.8 178.172 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.505 HG22 ' HD2' ' A' ' 26' ' ' TYR . 9.2 t -141.24 177.4 8.12 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.755 -179.609 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 p -126.64 10.56 7.2 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.698 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.693 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -61.04 146.92 45.45 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.504 179.094 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.33 -10.99 7.15 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.229 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.544 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 21.2 mtp85 . . . . . 0 N--CA 1.451 -0.389 0 O-C-N 122.642 -0.328 . . . . 0.0 111.362 -179.86 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.794 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 3.7 mptt . . . . . 0 CA--C 1.518 -0.279 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.0 mtm -85.39 153.72 22.33 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.341 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.687 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 17.7 p-90 -132.64 -173.48 3.19 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.399 0.619 . . . . 0.0 110.92 -178.94 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 6.4 p -154.66 134.31 12.79 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.722 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.667 ' HB3' ' HD2' ' A' ' 47' ' ' TYR . . . -73.05 149.22 43.37 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.277 -179.231 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.3 p -101.07 15.68 27.9 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.608 0.718 . . . . 0.0 109.48 179.774 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.474 HG21 ' HB2' ' A' ' 52' ' ' LYS . 41.6 p -136.77 142.19 42.97 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.236 178.794 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -52.22 -30.77 28.94 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.363 0.414 . . . . 0.0 111.85 -179.639 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -128.18 119.27 24.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.334 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.876 ' CE2' ' HB3' ' A' ' 53' ' ' TRP . 42.8 t80 -86.23 -52.17 5.82 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.936 -178.205 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.52 -32.76 0.59 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 179.647 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.5 -60.83 1.95 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.074 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -84.17 -25.11 29.82 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.027 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 8.4 mtm180 49.81 46.13 24.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 179.553 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.474 ' HB2' HG21 ' A' ' 44' ' ' THR . 39.1 mtpt -113.56 115.34 27.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.149 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.876 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 15.4 p-90 -126.67 177.62 6.43 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.336 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.45 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -166.77 138.99 5.49 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 112.873 -1.967 . . . . 0.0 108.986 178.852 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.769 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 16.1 m-85 -59.2 150.83 24.44 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 117.62 0.71 . . . . 0.0 111.273 -179.967 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.477 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 6.1 t . . . . . 0 C--N 1.33 -0.279 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.818 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.447 -0.621 0 CA-C-O 122.114 0.959 . . . . 0.0 113.145 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.598 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.1 OUTLIER -129.95 159.63 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 177.618 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.845 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.4 -154.08 51.99 Favored Glycine 0 C--N 1.307 -1.069 0 C-N-CA 117.126 -2.464 . . . . 0.0 110.664 -178.818 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.625 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 44.43 -139.13 4.56 Favored Glycine 0 C--O 1.236 0.227 0 N-CA-C 114.773 0.669 . . . . 0.0 114.773 177.004 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.475 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 CA--C 1.531 0.226 0 CA-C-O 120.355 0.121 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 12.6 Cg_exo -67.44 148.71 79.7 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.984 2.456 . . . . 0.0 112.352 179.796 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 90.5 m -79.24 122.35 26.2 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.488 179.458 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.1 t -82.15 119.8 32.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.954 -179.827 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.504 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 57.3 m-85 -119.73 135.81 24.41 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.746 179.755 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.777 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 5.3 Cg_endo -87.95 132.2 11.78 Favored 'Cis proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.273 -1.553 . . . . 0.0 112.251 -0.15 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.64 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 20.8 p90 -91.84 -170.28 2.52 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.651 -0.82 . . . . 0.0 108.908 177.98 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.8 m -144.9 125.64 14.24 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.657 -178.707 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.81 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -132.2 143.65 50.1 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.91 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.802 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.33 38.2 0.33 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.526 1.13 . . . . 0.0 113.457 178.207 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 -6.6 83.39 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 115.311 0.884 . . . . 0.0 115.311 178.296 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.417 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 66.5 m-80 -112.11 136.26 51.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 118.455 1.127 . . . . 0.0 112.013 -178.78 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -79.06 127.86 32.53 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.674 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.81 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.1 m-30 -110.38 111.88 23.45 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 121.709 0.766 . . . . 0.0 111.205 -178.969 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.777 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 36.7 mt-10 -91.17 -11.99 36.74 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.555 -179.768 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 p -133.53 178.87 6.58 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.978 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.3 m -65.92 156.08 34.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.484 179.067 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.3 t -131.88 175.56 9.11 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.11 -179.2 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.2 p -129.15 15.85 6.19 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.35 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.437 ' HB1' ' HD2' ' A' ' 21' ' ' PHE . . . -59.39 141.03 55.54 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.716 -179.74 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.02 -10.99 8.31 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.226 -179.952 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.51 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 25.5 mtp85 . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 120.722 0.296 . . . . 0.0 110.832 -179.992 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.76 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 4.7 mptt . . . . . 0 C--O 1.233 0.185 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -94.0 156.22 16.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.592 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.656 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 23.4 p-90 -142.98 -169.13 2.95 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.032 0.444 . . . . 0.0 110.986 -178.949 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.6 p -161.37 143.95 12.23 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.162 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.43 153.62 35.49 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.891 0.377 . . . . 0.0 110.888 -178.973 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.5 p -102.83 8.13 39.33 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.58 0.705 . . . . 0.0 109.731 179.644 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.6 p -132.55 153.69 50.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.948 178.928 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.46 94.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.432 179.972 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -113.93 109.48 18.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.765 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.839 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 82.9 t80 -83.06 -31.59 27.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.935 -178.419 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -53.18 -37.12 61.65 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.613 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.8 -66.81 0.86 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -68.05 -29.88 68.96 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.439 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.6 mmm180 47.39 46.67 17.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 179.711 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -110.46 117.31 33.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.708 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.839 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.0 p-90 -127.4 -177.52 4.11 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -174.853 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.625 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -174.03 139.85 5.19 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 113.625 -1.625 . . . . 0.0 109.885 179.375 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.845 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.7 m-85 -61.15 152.72 27.79 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.407 0.622 . . . . 0.0 112.165 -179.437 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.424 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.4 t . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.441 179.702 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.442 -0.854 0 CA-C-O 122.331 1.063 . . . . 0.0 113.515 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.573 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.2 OUTLIER -128.82 162.98 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 103.456 -2.794 . . . . 0.0 103.456 176.578 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.733 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.24 -142.47 42.9 Favored Glycine 0 C--N 1.308 -0.983 0 C-N-CA 117.392 -2.337 . . . . 0.0 111.45 -179.205 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.619 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 38.08 -143.81 0.23 Allowed Glycine 0 N--CA 1.467 0.733 0 N-CA-C 116.34 1.296 . . . . 0.0 116.34 177.12 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.319 0 CA-C-N 115.203 -0.498 . . . . 0.0 111.018 -179.274 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.298 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -81.08 128.14 6.34 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 121.777 1.651 . . . . 0.0 112.212 179.642 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 91.2 m -62.46 126.78 28.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.174 179.8 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 58.2 t -91.86 123.59 44.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.743 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.619 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 59.7 m-85 -118.76 141.03 29.3 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.14 178.925 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.99 134.11 21.28 Favored 'Cis proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.631 -1.404 . . . . 0.0 112.201 -0.492 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.619 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 28.5 p90 -105.06 128.03 53.15 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.281 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.0 m -89.63 123.34 33.6 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.755 -178.892 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.718 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 66.4 t80 -117.11 131.33 56.93 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.402 178.949 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.442 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 3.6 mm? 35.85 46.08 0.32 Allowed 'General case' 0 N--CA 1.427 -1.593 0 O-C-N 124.722 1.263 . . . . 0.0 113.576 175.892 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.02 -15.46 62.52 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 114.489 -1.232 . . . . 0.0 115.872 177.83 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.556 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 61.0 m-80 -111.72 135.17 52.68 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.838 1.819 . . . . 0.0 112.014 -178.376 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -78.9 121.58 25.03 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.411 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.718 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.5 m-30 -108.9 113.97 27.33 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.628 0.728 . . . . 0.0 111.556 -178.2 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -90.13 -17.33 27.85 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.482 179.481 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.2 p -127.75 -174.51 3.21 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.74 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.2 m -68.57 169.53 10.84 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.991 178.82 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.404 HG22 ' CD2' ' A' ' 26' ' ' TYR . 11.6 t -146.47 174.02 11.77 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.016 0.436 . . . . 0.0 110.15 -178.88 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.8 p -129.63 22.57 5.47 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.694 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.555 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . . . -68.9 135.7 51.45 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 113.762 -1.563 . . . . 0.0 112.108 -179.255 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.0 6.52 87.41 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.99 179.563 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.585 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 9.8 mtp85 . . . . . 0 N--CA 1.452 -0.361 0 CA-C-N 117.325 0.562 . . . . 0.0 111.489 -179.645 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.585 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 17.7 mmtp . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.6 mtm -65.62 144.31 57.03 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.474 -0.49 . . . . 0.0 109.788 -179.664 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.668 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 19.0 p-90 -133.4 -169.05 2.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.394 -178.839 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.5 p -162.53 144.34 10.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.452 178.357 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.456 ' CB ' ' HD2' ' A' ' 47' ' ' TYR . . . -73.91 157.03 37.02 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.261 0.553 . . . . 0.0 110.926 -179.109 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.7 p -106.28 9.66 31.94 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.863 -179.803 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.2 p -131.88 151.17 51.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.24 178.785 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.42 -37.45 72.79 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.066 0.46 . . . . 0.0 110.891 -179.784 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -123.93 115.12 20.74 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.186 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.946 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 33.6 t80 -80.73 -31.08 36.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.878 -178.116 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -53.16 -35.71 60.09 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.64 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -84.42 -67.15 0.82 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.074 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -73.29 -27.6 61.63 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -177.275 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.6 mtm180 47.56 48.14 17.09 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.971 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -112.32 122.91 49.06 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.44 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.946 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 11.7 p-90 -131.51 174.53 10.0 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -175.778 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.619 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -169.23 141.1 6.49 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.725 178.77 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.733 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.4 m-85 -55.42 151.9 9.49 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.443 0.639 . . . . 0.0 111.632 -179.82 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.619 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 18.0 t . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.632 -179.696 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.547 HG22 ' HA3' ' A' ' 54' ' ' GLY . 50.4 p . . . . . 0 C--O 1.236 0.358 0 CA-C-O 121.649 0.738 . . . . 0.0 112.539 . . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.425 HG11 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -122.6 -53.22 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.966 0 CA-C-O 123.425 1.583 . . . . 0.0 108.545 179.232 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.685 ' H ' ' HB2' ' A' ' 55' ' ' PHE . . . -83.49 -164.25 36.18 Favored Glycine 0 C--N 1.279 -2.627 0 CA-C-N 110.503 -3.044 . . . . 0.0 111.622 178.919 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.604 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 75.94 -175.04 52.55 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.344 -0.932 . . . . 0.0 113.338 178.573 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 120.57 0.224 . . . . 0.0 111.255 179.542 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -81.17 148.89 17.06 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.174 1.916 . . . . 0.0 111.957 -179.787 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 88.0 m -80.26 138.78 36.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.746 0.308 . . . . 0.0 110.665 -179.967 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 84.9 t -99.01 125.54 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.119 -179.711 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.419 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 48.5 m-85 -124.81 139.21 32.88 Favored Pre-proline 0 N--CA 1.445 -0.707 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.958 -179.806 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -86.5 135.85 18.13 Favored 'Cis proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.558 -1.851 . . . . 0.0 111.862 -0.458 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.696 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 45.1 p90 -101.47 -171.11 1.93 Allowed 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.476 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 m -146.85 124.77 11.98 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.673 -179.022 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.825 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 63.2 t80 -118.03 130.43 56.16 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.492 179.8 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.46 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . 3.7 mm? 33.74 45.09 0.09 Allowed 'General case' 0 N--CA 1.427 -1.611 0 O-C-N 125.075 1.484 . . . . 0.0 114.108 175.233 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.45 -15.82 49.39 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 115.903 1.121 . . . . 0.0 115.903 177.887 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.523 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 28.3 m-80 -115.82 134.84 54.59 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.789 1.795 . . . . 0.0 112.116 -178.425 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -80.53 126.37 31.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.723 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.825 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.9 m-85 -113.7 123.52 50.1 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.661 0.743 . . . . 0.0 111.531 -178.812 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -93.98 -20.83 19.61 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.181 179.926 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 p -128.38 -173.29 2.91 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.858 179.004 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 70.9 m -65.62 161.97 19.32 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.339 178.726 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -138.63 168.68 19.26 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.322 -178.461 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.2 p -124.76 23.37 7.99 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.056 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.53 136.57 57.65 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 113.912 -1.495 . . . . 0.0 111.591 -179.781 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.69 -6.3 54.37 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.727 -179.126 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.58 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.8 mtp85 . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 120.682 0.277 . . . . 0.0 110.356 179.809 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.58 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 37.6 mttp . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.9 mtm -98.76 151.35 20.87 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.064 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.681 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 28.6 p-90 -141.4 -170.23 3.04 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.035 0.445 . . . . 0.0 111.102 -178.1 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.56 149.42 11.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.277 178.461 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.557 ' HB1' ' CD1' ' A' ' 19' ' ' PHE . . . -73.25 148.15 43.94 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.787 -179.281 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 69.6 p -100.41 8.06 43.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.663 0.744 . . . . 0.0 109.842 179.382 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.4 p -130.88 157.97 41.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.799 -1.092 . . . . 0.0 109.112 178.542 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.65 -39.54 80.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.912 0.387 . . . . 0.0 111.144 -179.54 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -125.41 114.09 18.39 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.001 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.846 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 58.9 t80 -69.82 -40.62 75.78 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.361 -177.936 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.13 -33.19 51.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.951 0.405 . . . . 0.0 111.933 -179.117 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.29 -68.42 0.53 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.194 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.99 -18.76 29.92 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -176.819 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 24.7 mtm-85 44.4 53.79 6.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 179.434 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -117.75 118.85 33.17 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.549 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.846 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.8 p-90 -127.53 170.47 12.57 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 122.078 0.942 . . . . 0.0 113.365 -175.537 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.604 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.44 147.95 13.2 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.411 179.275 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.685 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 7.0 m-30 -64.0 160.67 17.39 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.519 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.418 179.987 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.444 -0.757 0 CA-C-O 122.234 1.016 . . . . 0.0 113.267 . . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.69 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -118.84 -166.8 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 176.948 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.441 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 35.58 -126.19 0.76 Allowed Glycine 0 N--CA 1.465 0.568 0 O-C-N 124.007 0.817 . . . . 0.0 113.065 177.842 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.615 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 34.05 -139.29 0.14 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 115.248 0.859 . . . . 0.0 115.248 177.384 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.408 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.056 0.455 . . . . 0.0 110.827 179.252 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.22 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -84.94 160.1 11.79 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.434 2.089 . . . . 0.0 112.344 -179.684 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.7 m -89.52 130.9 35.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.619 179.66 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -89.68 120.57 38.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.842 -179.866 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.609 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 65.2 m-85 -116.1 139.0 24.58 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-O 120.772 0.32 . . . . 0.0 110.767 179.908 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -87.05 136.84 17.72 Favored 'Cis proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.615 -1.827 . . . . 0.0 112.636 -0.135 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.609 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 26.3 p90 -101.2 129.05 47.06 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.096 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 98.9 m -92.62 123.71 36.11 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.485 0.659 . . . . 0.0 112.496 -177.972 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.87 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.5 t80 -126.42 145.46 50.46 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.714 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.776 HD23 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.28 36.59 0.2 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.442 1.097 . . . . 0.0 113.384 179.185 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.8 -2.43 87.19 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 114.85 0.7 . . . . 0.0 114.85 178.637 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.559 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 45.2 m-20 -111.33 135.74 51.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.265 1.033 . . . . 0.0 111.95 -179.007 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -81.45 118.05 22.38 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.379 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.87 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.5 m-30 -101.82 113.06 25.92 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.844 0.831 . . . . 0.0 111.492 -178.553 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -86.98 -20.56 27.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.127 179.646 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -126.44 179.66 5.19 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.37 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.1 m -64.77 162.93 15.06 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.779 179.321 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.6 t -137.48 169.34 17.95 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.222 -178.738 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.56 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 41.8 p -121.61 15.76 11.13 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.894 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.828 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -61.09 142.56 56.59 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.936 179.72 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.51 -16.27 6.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.893 -179.482 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 . . . . . 0 N--CA 1.445 -0.686 0 CA-C-O 120.753 0.311 . . . . 0.0 110.465 179.681 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.905 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 3.1 mptt . . . . . 0 C--O 1.234 0.265 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 . . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.56 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 3.5 mpp? -99.63 153.46 19.05 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.569 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.648 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 22.0 p-90 -138.1 -168.78 2.43 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.084 0.469 . . . . 0.0 110.77 -178.815 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.3 p -163.16 141.1 7.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.39 177.826 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.88 148.53 46.02 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.304 0.573 . . . . 0.0 110.929 -178.662 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 43.9 p -98.31 11.96 36.31 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.092 179.215 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.4 p -131.01 155.19 47.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.974 179.265 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -62.02 -40.06 94.43 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.915 0.388 . . . . 0.0 110.913 -179.995 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -120.11 111.89 18.43 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.802 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.817 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 74.7 t80 -82.18 -31.62 30.33 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.072 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -57.03 -33.29 67.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.127 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -92.35 -56.05 3.18 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.153 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -74.75 -26.89 60.09 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.544 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 12.8 mtm180 43.46 50.67 6.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 179.576 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -119.61 120.35 36.41 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.432 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.817 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.4 p-90 -133.98 177.68 7.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -173.99 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.615 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -169.27 146.24 10.03 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.724 178.82 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.69 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.3 m-30 -60.29 157.78 12.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.606 0.703 . . . . 0.0 111.725 -179.08 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.453 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.5 t . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.529 -179.844 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.654 HG23 ' SG ' ' A' ' 41' ' ' CYS . 50.1 p . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 . . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.828 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -129.18 -160.47 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.668 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 34.4 -123.1 0.46 Allowed Glycine 0 N--CA 1.464 0.51 0 O-C-N 124.105 0.878 . . . . 0.0 113.182 177.679 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.536 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 34.45 -144.68 0.05 OUTLIER Glycine 0 C--N 1.337 0.615 0 N-CA-C 116.097 1.199 . . . . 0.0 116.097 177.062 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 114.844 -0.678 . . . . 0.0 110.093 179.732 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.587 ' O ' HG21 ' A' ' 5' ' ' THR . . . . . . . . 0 C--O 1.222 -0.364 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 . . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -65.08 131.82 29.93 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.202 1.935 . . . . 0.0 111.768 179.666 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.8 m -66.04 135.37 54.56 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.811 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 86.8 t -98.83 113.65 34.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.648 0.261 . . . . 0.0 111.109 179.871 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 15' ' ' CYS . 99.4 m-85 -112.84 143.22 28.63 Favored Pre-proline 0 N--CA 1.446 -0.665 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.287 179.172 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -85.45 133.57 17.48 Favored 'Cis proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.38 -1.508 . . . . 0.0 112.034 -0.174 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.671 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 46.7 p90 -105.5 130.77 53.5 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.436 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.9 m -95.75 128.51 42.69 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -176.974 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.87 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.2 t80 -132.53 146.6 52.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.68 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.664 HD12 ' CD1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.51 37.4 0.29 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.557 1.143 . . . . 0.0 113.466 178.535 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.14 -6.06 82.5 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 114.606 0.602 . . . . 0.0 114.606 178.929 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -111.73 133.25 54.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.351 1.075 . . . . 0.0 112.057 -178.721 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -79.03 122.81 26.66 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.889 179.187 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.87 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.5 m-85 -106.15 114.52 28.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.784 0.802 . . . . 0.0 111.504 -178.361 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -93.56 -15.65 25.23 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.288 179.434 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.3 p -130.34 178.58 6.48 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.015 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.5 m -60.9 163.69 5.55 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.566 0.698 . . . . 0.0 110.648 179.274 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.0 t -144.71 169.41 18.07 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.253 179.908 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.56 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 15.7 p -125.7 23.78 7.28 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.066 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.79 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -61.93 140.4 58.31 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 113.969 -1.468 . . . . 0.0 111.015 -179.944 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.02 -8.9 13.42 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.723 -179.452 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.6 mtp85 . . . . . 0 N--CA 1.448 -0.571 0 CA-C-O 120.972 0.415 . . . . 0.0 110.663 -179.699 . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.796 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 8.3 mptt . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 120.79 0.329 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.56 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 61.8 mtt -98.63 160.33 14.35 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.306 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.629 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.1 p-90 -144.08 -173.27 3.96 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.544 0.688 . . . . 0.0 111.974 -178.981 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.654 ' SG ' HG23 ' A' ' 5' ' ' THR . 8.5 p -154.81 138.57 16.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.959 -1.018 . . . . 0.0 108.85 179.769 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.579 ' HB1' ' CG ' ' A' ' 19' ' ' PHE . . . -76.45 153.82 35.28 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.333 179.961 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.4 p -104.55 14.29 30.21 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.851 0.834 . . . . 0.0 110.015 -179.694 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.9 p -137.3 147.5 45.69 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.592 178.89 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.651 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -51.63 -43.77 62.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.929 0.395 . . . . 0.0 111.4 -179.688 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -119.38 107.43 13.35 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.909 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.795 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 79.7 t80 -71.86 -32.04 67.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.364 -178.027 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.689 ' HA ' ' NH1' ' A' ' 51' ' ' ARG . 25.8 m-20 -66.26 -25.45 66.89 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.016 0.436 . . . . 0.0 111.523 -179.764 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -84.4 -58.99 2.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.374 -179.634 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -87.84 -19.4 27.49 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -176.681 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.689 ' NH1' ' HA ' ' A' ' 48' ' ' ASP . 7.8 mtt-85 45.97 51.0 11.1 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 179.978 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -119.84 121.76 39.81 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 176.443 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.795 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.5 p-90 -136.59 176.92 8.26 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -175.597 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.576 ' HA3' ' HB ' ' A' ' 5' ' ' THR . . . -170.07 149.14 12.5 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.289 178.237 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.828 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.6 m-30 -64.72 165.71 9.96 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.859 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 37.8 m . . . . . 0 C--N 1.325 -0.491 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 176.42 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.49 HG22 ' SG ' ' A' ' 41' ' ' CYS . 23.6 p . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.478 0.656 . . . . 0.0 112.207 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.806 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -107.94 -168.13 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 176.793 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.54 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 40.05 -123.23 2.03 Favored Glycine 0 N--CA 1.46 0.288 0 O-C-N 123.827 0.704 . . . . 0.0 113.116 177.829 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.648 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 32.19 -143.13 0.03 OUTLIER Glycine 0 C--N 1.336 0.529 0 N-CA-C 116.836 1.495 . . . . 0.0 116.836 177.065 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.492 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 114.597 -0.801 . . . . 0.0 110.6 179.961 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.147 0 CA-C-O 120.768 0.318 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -88.38 178.61 2.9 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.133 2.556 . . . . 0.0 111.812 179.475 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.6 m -81.8 149.03 28.56 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.53 -179.88 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.6 t -115.94 118.41 58.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.516 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.613 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 59.6 m-85 -121.11 143.59 37.47 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-O 121.019 0.437 . . . . 0.0 111.878 -179.084 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.764 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 8.6 Cg_endo -87.5 135.99 15.96 Favored 'Cis proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.029 -1.655 . . . . 0.0 111.6 -0.817 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.662 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 37.6 p90 -103.02 -169.88 1.72 Allowed 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.208 178.647 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.412 ' OG1' ' HD3' ' A' ' 25' ' ' LYS . 63.6 m -147.54 126.89 13.09 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.53 -179.505 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.845 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 59.8 t80 -123.87 133.45 53.76 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.12 179.383 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.446 HD21 ' CG ' ' A' ' 21' ' ' PHE . 3.6 mm? 35.38 48.28 0.39 Allowed 'General case' 0 N--CA 1.427 -1.603 0 O-C-N 124.713 1.258 . . . . 0.0 113.711 175.451 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.73 -11.09 71.75 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 116.334 1.294 . . . . 0.0 116.334 177.763 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -115.61 135.14 54.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 119.555 1.677 . . . . 0.0 112.53 -178.351 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.412 ' HD3' ' OG1' ' A' ' 20' ' ' THR . 65.5 mmtt -76.44 125.15 28.7 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.943 178.875 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.845 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.8 m-85 -115.58 118.37 32.95 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.567 0.698 . . . . 0.0 111.067 -179.985 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.764 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 49.9 mt-10 -96.28 -16.08 21.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.101 179.573 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.9 p -126.19 -177.37 3.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.138 178.233 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.2 m -67.87 165.73 17.0 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.413 178.762 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 t -142.91 173.03 11.91 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.075 -178.704 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.526 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 57.8 p -129.02 22.82 5.7 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.37 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.646 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -62.92 141.05 58.87 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 114.012 -1.449 . . . . 0.0 112.35 -179.069 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.68 -1.71 36.02 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.728 179.56 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.773 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 8.4 mtp85 . . . . . 0 N--CA 1.448 -0.543 0 CA-C-O 120.829 0.347 . . . . 0.0 110.858 -179.721 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.773 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 76.7 mttt . . . . . 0 N--CA 1.461 0.123 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.526 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.5 mpt? -87.58 141.96 28.21 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.688 179.214 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.637 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 13.0 p-90 -129.99 -162.78 1.24 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.176 -178.856 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.49 ' SG ' HG22 ' A' ' 5' ' ' THR . 26.3 p -163.58 151.09 12.71 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.75 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.506 ' HB1' ' CG ' ' A' ' 19' ' ' PHE . . . -83.11 144.99 29.5 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.294 179.417 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 79.6 p -99.95 13.21 34.7 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.945 0.878 . . . . 0.0 109.704 179.919 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.6 p -137.04 151.08 48.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.94 178.598 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.29 -40.95 78.86 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.891 0.377 . . . . 0.0 111.478 -179.387 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -123.71 109.84 14.2 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.599 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 1.031 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 23.7 t80 -75.83 -34.51 60.11 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.703 -178.492 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -50.75 -34.75 28.43 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.474 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -96.39 -52.69 3.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.464 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.39 -26.2 35.65 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.021 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.637 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 13.5 mtm180 45.36 50.65 9.89 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 179.117 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -114.66 121.82 44.56 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.14 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 1.031 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 12.2 p-90 -128.7 173.35 10.39 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -175.699 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.422 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.94 140.5 6.26 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.543 179.601 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.806 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 8.3 m-30 -60.16 153.29 22.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.783 0.791 . . . . 0.0 111.183 -179.661 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.445 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.7 t . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.706 -179.983 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.3 p . . . . . 0 C--O 1.236 0.348 0 CA-C-O 122.348 1.071 . . . . 0.0 113.126 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -142.58 161.8 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 178.587 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.557 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 65.5 -149.82 51.67 Favored Glycine 0 C--N 1.313 -0.695 0 C-N-CA 117.958 -2.068 . . . . 0.0 111.157 -179.453 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.708 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 50.58 -152.2 4.68 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 114.778 0.671 . . . . 0.0 114.778 177.802 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.0 p30 . . . . . 0 C--N 1.328 -0.369 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.924 . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.261 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.35 147.29 18.02 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.01 1.807 . . . . 0.0 112.466 -179.891 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.2 m -78.03 115.69 17.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.504 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 55.3 t -79.83 108.83 13.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.91 0.386 . . . . 0.0 110.616 -179.604 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -109.72 138.51 20.68 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.969 -179.614 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.726 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 58.4 Cg_endo -85.34 138.58 25.6 Favored 'Cis proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.834 -1.736 . . . . 0.0 112.895 -0.327 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.604 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 35.1 p90 -105.55 132.65 51.45 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.184 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 90.3 m -93.78 128.46 40.02 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.412 0.625 . . . . 0.0 112.394 -177.57 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.75 ' CE1' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -130.69 142.71 50.44 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.596 -1.184 . . . . 0.0 107.83 178.166 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.75 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.37 39.54 0.3 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.757 1.223 . . . . 0.0 113.497 178.17 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.32 -5.67 84.69 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 114.859 0.704 . . . . 0.0 114.859 178.419 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.668 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 50.8 m-20 -110.76 136.39 49.91 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 118.448 1.124 . . . . 0.0 111.511 -178.723 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -82.04 120.03 24.75 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.805 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.718 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.5 m-30 -102.96 110.29 22.15 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.594 0.711 . . . . 0.0 111.38 -177.621 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.726 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 94.5 mt-10 -91.5 -4.86 55.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.131 -179.69 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.3 p -140.96 -171.43 3.25 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.325 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 87.3 m -69.65 166.17 19.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.939 178.882 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -146.38 175.72 10.32 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.665 -179.489 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.3 p -130.94 20.98 4.95 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.382 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.512 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -66.74 143.03 57.18 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 113.918 -1.492 . . . . 0.0 112.215 -179.346 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.33 2.27 47.7 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.659 178.67 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.685 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.5 mtp85 . . . . . 0 N--CA 1.448 -0.546 0 CA-C-N 117.349 0.574 . . . . 0.0 111.412 -179.493 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.685 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 24.9 mmtm . . . . . 0 CA--C 1.521 -0.148 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.422 ' HE1' ' HB2' ' A' ' 39' ' ' MET . 52.1 mtm -85.49 144.08 28.16 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 179.303 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.614 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.2 p-90 -135.78 -168.6 2.24 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.371 0.605 . . . . 0.0 112.121 -177.819 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 23.8 p -153.05 138.95 18.06 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.166 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.97 146.73 35.28 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.795 179.97 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.2 p -101.04 17.64 21.84 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.833 0.825 . . . . 0.0 110.203 -179.695 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.89 152.97 50.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.856 178.643 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -60.19 -39.57 86.98 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.206 0.527 . . . . 0.0 111.188 -179.665 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -122.18 107.84 12.61 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.582 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.767 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 64.2 t80 -74.71 -30.44 61.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.852 -178.149 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -55.19 -37.05 66.57 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.262 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.87 -72.23 0.49 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.823 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.74 -19.49 62.73 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -177.508 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 21.6 mtm180 41.17 53.86 3.44 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 179.886 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.402 ' HG3' ' HZ1' ' A' ' 52' ' ' LYS . 48.2 mttp -112.77 118.28 34.54 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.564 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.767 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 11.9 p-90 -133.03 171.24 14.25 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -174.667 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.708 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.14 142.04 7.78 Favored Glycine 0 C--O 1.221 -0.708 0 CA-C-N 113.122 -1.854 . . . . 0.0 109.313 178.236 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.557 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 7.9 m-30 -56.21 159.34 3.53 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.777 0.789 . . . . 0.0 111.19 179.699 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.518 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 5.5 t . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.572 179.929 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 122.196 0.998 . . . . 0.0 112.874 . . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.701 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.2 OUTLIER -139.36 164.58 24.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.047 0 N-CA-C 104.667 -2.345 . . . . 0.0 104.667 179.418 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.701 ' N ' HG21 ' A' ' 6' ' ' VAL . . . 64.91 -149.78 51.62 Favored Glycine 0 C--N 1.313 -0.701 0 C-N-CA 118.025 -2.036 . . . . 0.0 111.367 -179.733 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.629 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 51.6 -149.26 8.5 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 114.256 0.463 . . . . 0.0 114.256 177.998 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.685 -0.258 . . . . 0.0 111.147 179.697 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 120.592 0.234 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 16.3 Cg_exo -65.7 144.49 78.27 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.604 2.203 . . . . 0.0 112.315 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.7 m -72.16 148.43 45.64 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.657 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 64.6 t -108.76 109.67 29.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.627 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.58 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 38.6 m-85 -114.69 143.09 29.33 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-O 121.229 0.538 . . . . 0.0 111.503 -179.312 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.775 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.3 Cg_endo -87.41 136.91 16.97 Favored 'Cis proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.263 -1.557 . . . . 0.0 111.469 -0.97 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.58 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 34.3 p90 -101.4 -170.77 1.88 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.27 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.8 m -148.79 127.44 12.46 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.999 -178.996 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.796 ' CG ' HD23 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -111.11 -143.73 0.39 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 118.342 -0.837 . . . . 0.0 108.915 179.111 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.796 HD23 ' CG ' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -49.11 55.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.916 2.086 . . . . 0.0 114.958 -177.215 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 21' ' ' PHE . . . 86.72 6.87 79.42 Favored Glycine 0 C--N 1.296 -1.651 0 CA-C-N 114.41 -1.268 . . . . 0.0 113.345 178.821 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.522 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 20.7 m-80 -127.56 135.57 50.49 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 117.862 0.831 . . . . 0.0 112.151 -178.76 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -78.75 126.64 31.0 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.26 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.634 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.9 m-85 -112.23 107.65 16.59 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 122.138 0.97 . . . . 0.0 110.91 -179.19 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.775 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 32.0 mt-10 -86.11 -19.95 29.42 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.484 -179.395 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 p -126.53 -172.99 2.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 178.386 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.5 m -68.27 160.06 30.06 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.027 179.077 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.482 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 9.9 t -137.14 168.95 18.61 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.909 -179.587 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.8 p -122.82 24.55 9.02 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 122.042 0.925 . . . . 0.0 108.677 177.857 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.768 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -70.99 148.42 47.66 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.417 -179.667 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.57 -7.14 14.02 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.508 -0.769 . . . . 0.0 114.02 178.526 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.619 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 8.2 mtp-105 . . . . . 0 N--CA 1.453 -0.294 0 CA-C-N 118.2 1.0 . . . . 0.0 110.793 -179.659 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.619 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 7.5 mptt . . . . . 0 N--CA 1.447 -0.584 0 CA-C-O 121.349 0.595 . . . . 0.0 112.225 . . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -116.91 160.46 20.86 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.995 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.63 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 17.7 p-90 -146.87 -169.1 3.21 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.153 0.501 . . . . 0.0 110.924 -178.774 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 24.5 p -156.23 146.04 21.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.26 179.718 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.555 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -80.68 146.64 31.0 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.054 -0.659 . . . . 0.0 109.565 179.346 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.3 p -100.45 19.43 16.78 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.888 0.851 . . . . 0.0 109.479 179.458 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.4 p -141.15 153.71 45.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.101 179.067 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.86 -31.74 71.19 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.321 0.582 . . . . 0.0 111.252 -179.842 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -129.1 118.58 22.72 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.937 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.835 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 59.5 t80 -82.46 -32.96 28.63 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.856 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -52.32 -39.12 60.18 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.676 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.0 -74.49 0.26 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.82 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.445 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 45.7 m-20 -72.85 -19.74 61.25 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -176.292 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 35.4 mtm-85 40.11 55.69 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 179.709 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 50' ' ' ASP . 49.7 mtmt -114.54 120.42 40.15 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.941 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.835 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.6 p-90 -133.17 170.78 14.91 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.949 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.629 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.82 141.44 7.18 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.46 178.806 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 7.1 m-30 -56.98 162.01 2.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.263 0.554 . . . . 0.0 111.446 179.829 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.46 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 12.6 t . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.7 -178.46 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.378 0.609 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.856 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -107.43 -168.1 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 176.819 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.647 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 38.08 -127.26 1.59 Allowed Glycine 0 C--N 1.318 -0.438 0 O-C-N 123.846 0.716 . . . . 0.0 113.719 177.552 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.586 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 39.49 -149.55 0.11 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 116.115 1.206 . . . . 0.0 116.115 177.127 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.432 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 114.633 -0.784 . . . . 0.0 111.058 -179.755 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.294 0 CA-C-O 120.575 0.226 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -72.19 172.23 15.24 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.646 2.231 . . . . 0.0 111.71 179.284 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.7 m -85.36 150.1 24.98 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.562 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.549 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 75.8 t -108.66 110.64 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.251 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -112.34 137.9 21.71 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.969 -178.995 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.7 Cg_endo -86.11 132.15 14.61 Favored 'Cis proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.485 -1.465 . . . . 0.0 112.255 -0.18 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.711 ' HZ ' HG22 ' A' ' 30' ' ' THR . 43.9 p90 -98.57 124.36 43.29 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.569 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 29.9 m -87.61 121.68 30.35 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.502 0.668 . . . . 0.0 112.194 -177.261 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.85 ' CE1' HD12 ' A' ' 22' ' ' LEU . 1.4 t80 -125.7 143.81 50.88 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.527 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.85 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER 39.58 32.88 0.1 Allowed 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.823 1.249 . . . . 0.0 113.582 178.364 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.91 -11.73 64.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.894 -0.67 . . . . 0.0 114.767 178.604 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 20' ' ' THR . 69.6 m-80 -110.01 133.56 53.06 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 118.406 1.103 . . . . 0.0 112.425 -178.759 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 50.6 mttp -79.83 115.31 19.35 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.124 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.846 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.0 m-85 -96.97 111.99 23.95 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.908 0.861 . . . . 0.0 111.562 -177.814 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.47 -14.36 43.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.279 179.692 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.8 p -129.92 -173.54 3.06 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.828 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.5 m -71.03 167.85 18.35 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.823 178.486 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.711 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.7 t -145.55 175.33 10.43 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.13 -179.0 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.513 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 9.8 p -129.52 18.52 5.8 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.189 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.815 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -63.52 144.41 57.01 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 113.978 -1.464 . . . . 0.0 111.879 -179.715 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.3 -1.4 34.82 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.841 179.464 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.721 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 7.7 mtp85 . . . . . 0 N--CA 1.448 -0.537 0 CA-C-N 117.056 0.428 . . . . 0.0 111.58 -179.333 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.721 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 111.306 . . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.513 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 59.8 mtm -89.25 149.15 23.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.194 0.521 . . . . 0.0 110.871 -179.531 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.601 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 13.5 p-90 -138.37 -168.33 2.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.518 0.675 . . . . 0.0 112.129 -178.435 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 21.0 p -156.16 136.64 13.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.34 178.742 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.527 ' HB1' ' CG ' ' A' ' 19' ' ' PHE . . . -74.75 151.35 39.17 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.442 -179.599 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 64.2 p -101.51 11.21 39.42 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.712 179.675 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.9 p -135.85 151.43 50.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.459 178.757 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.87 -48.45 79.8 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.915 0.388 . . . . 0.0 111.62 -179.537 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -111.43 104.15 12.56 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.81 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.839 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 70.7 t80 -75.49 -32.27 60.5 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.532 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.78 -36.44 64.88 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.373 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -88.75 -61.7 1.65 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.504 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.89 -34.8 78.58 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.89 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 12.9 mtm-85 48.56 47.87 20.09 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.383 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -115.25 117.8 31.5 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.737 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.839 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 11.8 p-90 -131.59 175.48 9.13 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -174.21 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.4 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -164.34 142.64 7.93 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.616 178.876 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.856 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 8.7 m-85 -59.82 158.49 10.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.065 0.933 . . . . 0.0 111.417 -179.582 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.461 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 5.6 t . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.796 -179.085 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.465 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 32.8 p . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.432 0.634 . . . . 0.0 112.357 . . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.805 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -106.46 -166.26 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 176.191 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.6 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.15 -127.1 1.19 Allowed Glycine 0 C--N 1.321 -0.281 0 O-C-N 124.072 0.857 . . . . 0.0 112.994 177.774 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.592 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 31.34 -138.66 0.07 OUTLIER Glycine 0 C--N 1.336 0.537 0 N-CA-C 116.083 1.193 . . . . 0.0 116.083 176.997 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 114.857 -0.671 . . . . 0.0 109.782 -179.986 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.536 0.207 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -93.41 175.06 1.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.305 2.67 . . . . 0.0 111.254 179.097 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.8 m -84.17 142.86 30.03 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.458 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.412 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 63.4 t -107.81 121.91 61.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.81 0.338 . . . . 0.0 110.216 178.962 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -121.49 144.29 39.88 Favored Pre-proline 0 N--CA 1.447 -0.616 0 CA-C-O 120.783 0.325 . . . . 0.0 111.277 -179.446 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -85.9 137.03 21.18 Favored 'Cis proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.718 -1.784 . . . . 0.0 111.698 -0.811 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.5 ' CD1' ' HB1' ' A' ' 42' ' ' ALA . 23.3 p90 -104.87 175.35 5.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.055 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 94.7 m -130.26 124.08 31.6 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.833 -179.446 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.694 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 42.5 t80 -126.26 138.78 53.65 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.907 179.029 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.558 ' H ' HD21 ' A' ' 22' ' ' LEU . 3.4 mm? 35.27 46.42 0.25 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 175.318 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.85 -7.01 81.81 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 114.469 -1.241 . . . . 0.0 116.157 177.738 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.511 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 62.0 m-80 -109.14 155.89 20.48 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 119.286 1.543 . . . . 0.0 111.674 -179.023 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -95.84 125.34 40.34 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.405 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.694 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 28.6 m-85 -113.64 119.7 38.35 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.809 0.814 . . . . 0.0 112.072 -177.599 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -96.58 -20.53 18.26 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.385 -1.279 . . . . 0.0 110.318 179.608 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 p -130.09 -174.03 3.21 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.333 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.9 m -68.16 163.46 22.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.605 178.837 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.449 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 11.1 t -142.3 163.76 31.99 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.721 -178.577 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.517 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 26.2 p -116.07 20.66 14.26 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 176.487 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.654 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -59.1 142.14 52.26 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.432 -179.455 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.99 -7.39 9.77 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.246 179.264 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.709 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 22.4 mtp85 . . . . . 0 N--CA 1.447 -0.619 0 CA-C-N 117.035 0.417 . . . . 0.0 111.339 -179.17 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.709 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 2.0 mptp? . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 120.781 0.324 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.517 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 44.0 mtm -83.87 143.55 29.82 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.038 179.743 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.639 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 15.2 p-90 -128.2 -166.98 1.7 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.565 -179.716 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 9.9 p -160.39 146.41 15.26 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.744 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.69 ' HB3' ' HD1' ' A' ' 47' ' ' TYR . . . -78.09 142.59 38.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.115 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 78.7 p -96.17 16.48 18.04 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.436 0.636 . . . . 0.0 110.486 -179.552 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.7 p -139.63 161.11 38.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.741 179.293 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -64.24 -30.33 71.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.002 0.43 . . . . 0.0 111.196 179.946 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -132.69 115.52 15.48 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.908 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.858 ' HE1' ' HB3' ' A' ' 53' ' ' TRP . 44.5 t80 -81.23 -38.3 27.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.196 -178.883 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -47.03 -36.36 7.85 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.536 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -95.11 -56.13 2.84 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.781 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.527 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.5 m-20 -67.22 -43.17 82.68 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -177.73 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 5.3 mmm180 57.59 40.87 26.47 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 179.415 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.527 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 4.2 mppt? -114.28 122.32 46.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.586 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.858 ' HB3' ' HE1' ' A' ' 47' ' ' TYR . 11.4 p-90 -132.67 170.8 14.7 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -175.022 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.494 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.24 143.26 8.33 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.863 179.254 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.805 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.2 m-30 -61.35 156.61 18.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.969 0.885 . . . . 0.0 111.499 -179.641 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.4 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 4.3 t . . . . . 0 C--N 1.327 -0.372 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 3' ' ' MET . 58.5 p . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 120.46 0.171 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 60.05 39.22 20.08 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.358 0.599 . . . . 0.0 109.595 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.496 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 66.3 mtt -128.29 127.44 42.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.252 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.4 m -83.24 159.69 21.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 p -94.99 164.66 12.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.429 1.109 . . . . 0.0 113.494 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.688 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.2 OUTLIER -127.75 164.48 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 177.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.688 ' N ' HG21 ' A' ' 6' ' ' VAL . . . 63.27 -146.6 50.46 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 117.728 -2.177 . . . . 0.0 111.1 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.636 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 46.29 -140.23 6.38 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 114.327 0.491 . . . . 0.0 114.327 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.22 17.24 0.35 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.406 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 1.4 p -77.4 -37.66 51.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.13 0.491 . . . . 0.0 111.099 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.31 16.43 34.87 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.519 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.2 47.19 1.17 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.182 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -101.34 140.32 21.17 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.474 0.178 . . . . 0.0 110.722 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 3' ' ' MET . 37.9 Cg_exo -59.44 136.22 70.2 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.762 2.308 . . . . 0.0 112.777 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 7.2 m -67.95 128.2 35.65 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.541 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 90.1 t -95.25 112.94 28.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.643 0.259 . . . . 0.0 110.654 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.532 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 70.0 m-85 -111.51 139.96 22.61 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.264 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.2 134.51 21.51 Favored 'Cis proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.321 -1.533 . . . . 0.0 111.93 -0.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.541 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 45.8 p90 -103.59 133.57 48.4 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.93 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 76.3 m -96.53 121.32 38.21 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.349 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.726 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 45.4 t80 -115.64 130.33 56.82 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.12 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.613 HD11 ' CD1' ' A' ' 21' ' ' PHE . 6.7 mp 44.64 33.44 0.94 Allowed 'General case' 0 N--CA 1.436 -1.133 0 O-C-N 124.363 1.039 . . . . 0.0 113.685 175.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.77 -15.9 40.55 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 115.696 1.038 . . . . 0.0 115.696 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.586 ' O ' ' HA ' ' A' ' 20' ' ' THR . 62.8 m-80 -110.68 146.72 35.74 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 119.267 1.533 . . . . 0.0 112.299 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -86.76 122.17 30.27 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.726 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 28.6 m-85 -107.21 116.77 32.52 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.69 0.757 . . . . 0.0 110.63 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -92.88 -17.04 24.53 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.275 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 p -129.6 -178.12 4.55 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.28 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 81.8 m -66.6 165.23 15.11 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.706 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.52 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 9.2 t -140.4 167.64 21.66 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.314 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.475 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 12.6 p -122.03 19.65 10.8 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.86 139.66 58.34 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 113.661 -1.609 . . . . 0.0 111.263 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.95 -2.83 54.01 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.369 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.625 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.9 mtp85 -116.36 139.73 50.1 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 117.105 0.452 . . . . 0.0 110.667 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.4 m -120.12 22.35 11.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.351 0.596 . . . . 0.0 110.537 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.32 -79.84 0.53 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.006 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.5 -29.16 0.08 OUTLIER Glycine 0 C--N 1.314 -0.694 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.765 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.625 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -62.81 119.69 9.83 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.691 0.281 . . . . 0.0 111.385 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.475 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 54.4 mtt -87.91 149.66 23.95 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.611 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.4 p-90 -131.87 -166.36 1.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.13 0.49 . . . . 0.0 111.577 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 28.1 p -156.9 148.99 22.91 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.442 ' HB2' ' CB ' ' A' ' 19' ' ' PHE . . . -84.98 148.91 25.95 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 119.455 -0.898 . . . . 0.0 108.939 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.8 p -102.2 12.9 36.0 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.448 0.642 . . . . 0.0 110.433 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.45 HG21 ' HB2' ' A' ' 52' ' ' LYS . 76.3 p -135.89 153.97 51.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.982 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.5 85.27 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.189 0.518 . . . . 0.0 110.942 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -114.49 108.32 16.71 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 1.019 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 27.4 t80 -73.89 -35.65 64.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.009 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -48.47 -33.99 10.35 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -90.88 -64.18 1.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.707 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 19.8 m-20 -69.01 -34.27 74.98 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.649 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 9.3 mtm180 50.26 45.21 26.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.707 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 34.3 mttt -111.45 119.8 40.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 1.019 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 6.9 p-90 -132.17 173.17 11.52 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -175.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.636 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.26 144.11 8.77 Favored Glycine 0 C--O 1.22 -0.731 0 CA-C-N 113.732 -1.576 . . . . 0.0 110.284 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 14.8 m-30 -57.03 155.19 8.55 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.414 0.626 . . . . 0.0 112.099 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.576 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 16.6 t -69.65 143.7 92.98 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.295 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.576 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 87.3 Cg_endo -71.88 -149.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.938 2.425 . . . . 0.0 112.58 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 34.3 t70 -61.53 116.31 4.61 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.612 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -98.3 29.25 3.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.01 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.845 0 CA-C-O 118.339 -1.256 . . . . 0.0 112.019 179.728 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.487 0.184 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -86.71 130.68 34.38 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.1 ptp -81.91 72.49 8.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.181 0.515 . . . . 0.0 111.097 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.3 m -72.22 161.34 31.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.81 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.0 p -101.73 172.07 7.17 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.727 0.775 . . . . 0.0 112.244 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.719 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -113.15 -168.04 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.04 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.439 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.45 -126.28 1.28 Allowed Glycine 0 N--CA 1.46 0.274 0 O-C-N 123.955 0.784 . . . . 0.0 113.04 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.686 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 38.59 -142.94 0.33 Allowed Glycine 0 C--N 1.331 0.3 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.449 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -147.22 4.98 0.83 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.784 -0.708 . . . . 0.0 110.333 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.6 m -94.88 -58.12 2.25 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.801 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.16 -81.84 1.4 Allowed Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.613 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.43 -19.35 76.09 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.175 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.86 138.77 49.98 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.98 0.419 . . . . 0.0 110.903 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -88.55 170.17 5.57 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.183 2.589 . . . . 0.0 112.188 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.4 m -76.07 140.54 41.93 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 84.1 t -106.65 108.6 25.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.531 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 50.9 m-85 -109.66 141.32 23.41 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-O 120.831 0.348 . . . . 0.0 111.411 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.571 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 3.8 Cg_endo -85.7 134.05 17.64 Favored 'Cis proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.254 -1.561 . . . . 0.0 111.718 -0.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.531 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 43.9 p90 -102.81 -171.17 1.91 Allowed 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.356 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 96.6 m -145.56 119.17 9.13 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.242 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.737 ' CE1' HD22 ' A' ' 22' ' ' LEU . 72.4 t80 -109.46 131.16 55.33 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.746 ' H ' HD21 ' A' ' 22' ' ' LEU . 3.8 mm? 35.63 44.06 0.19 Allowed 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 124.511 1.132 . . . . 0.0 113.859 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.2 -10.81 63.69 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 114.581 -1.191 . . . . 0.0 116.038 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 52.5 m-80 -113.23 134.01 54.8 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.887 1.843 . . . . 0.0 111.951 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -78.1 122.93 26.25 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.368 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.583 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 17.3 m-30 -110.89 118.23 35.54 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.749 0.785 . . . . 0.0 110.912 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.571 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 47.9 mt-10 -96.93 -12.81 22.93 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.356 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 p -132.69 -175.12 3.66 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 89.5 m -64.66 171.72 3.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.248 0.547 . . . . 0.0 110.052 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.4 t -151.11 173.13 14.74 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.849 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 p -133.24 24.65 4.17 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.53 137.48 58.16 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 113.172 -1.831 . . . . 0.0 111.786 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.87 -2.68 31.98 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.234 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.4 mtp85 -112.04 -78.59 0.58 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.762 0.315 . . . . 0.0 111.417 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.2 m 65.54 22.05 11.77 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.966 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.49 -35.54 9.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.49 0.662 . . . . 0.0 110.22 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.9 -42.41 0.92 Allowed Glycine 0 C--N 1.313 -0.741 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.771 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 44.2 mttp -65.54 106.75 1.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.503 0.192 . . . . 0.0 110.688 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.3 mtm -83.93 146.77 27.86 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.621 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 21.3 p-90 -136.97 -168.1 2.21 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.336 0.589 . . . . 0.0 111.675 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 24.5 p -160.17 156.09 26.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.075 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB1' ' CG ' ' A' ' 19' ' ' PHE . . . -84.17 145.81 28.18 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.556 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.8 p -102.07 11.12 38.9 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.494 0.664 . . . . 0.0 110.291 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 p -133.33 152.0 51.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.389 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.91 82.24 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.828 0.347 . . . . 0.0 111.415 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -120.58 109.77 15.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 1.002 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 28.6 t80 -70.81 -37.25 73.23 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.737 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.42 -35.48 60.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.418 . . . . 0.0 111.609 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -76.12 -69.39 0.5 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -85.74 -18.05 34.13 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 23.0 mtm180 44.57 52.34 7.65 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -113.95 122.18 46.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 1.002 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 7.8 p-90 -129.76 173.13 10.93 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.481 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.4 140.72 6.43 Favored Glycine 0 C--O 1.223 -0.583 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.871 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.719 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.2 m-30 -63.09 158.13 20.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.364 0.582 . . . . 0.0 111.852 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 68.5 m -95.49 130.94 30.67 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.003 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -78.52 9.37 3.21 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 C-N-CA 123.089 2.526 . . . . 0.0 114.975 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -124.78 85.41 2.41 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.394 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -79.37 157.42 27.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.077 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.578 -1.123 . . . . 0.0 112.441 179.886 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.77 0.319 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -121.97 -15.04 7.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.357 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -123.07 20.57 9.89 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.9 t 46.36 -150.64 0.09 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.509 0.671 . . . . 0.0 111.763 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.8 p -114.53 170.41 8.33 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.039 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.703 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -114.21 -165.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 176.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.556 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.27 -125.49 1.16 Allowed Glycine 0 C--N 1.319 -0.385 0 O-C-N 124.173 0.92 . . . . 0.0 113.569 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.69 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 38.15 -141.19 0.42 Allowed Glycine 0 C--N 1.333 0.387 0 N-CA-C 115.754 1.062 . . . . 0.0 115.754 177.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.24 -21.22 0.34 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.74 -0.73 . . . . 0.0 109.781 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 m -57.48 -43.69 84.3 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.805 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.73 -80.72 1.3 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.968 -0.634 . . . . 0.0 114.028 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.21 40.98 2.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.369 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.83 139.54 35.94 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 117.224 0.512 . . . . 0.0 110.805 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -84.72 170.41 10.15 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.951 2.434 . . . . 0.0 111.942 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.5 m -79.9 138.57 37.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.509 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.526 HG13 ' HA ' ' A' ' 45' ' ' ALA . 97.0 t -100.68 109.79 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -112.9 139.59 23.08 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.607 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.594 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.1 Cg_endo -86.72 136.79 18.58 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.097 -1.626 . . . . 0.0 112.373 -0.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.604 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 40.7 p90 -99.27 -171.58 2.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.172 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 32.2 m -142.94 127.94 18.46 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.156 0.503 . . . . 0.0 111.515 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.852 ' CD2' ' HB2' ' A' ' 32' ' ' ALA . 1.4 t80 -133.87 140.7 47.01 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.335 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.739 ' H ' HD11 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 39.46 33.92 0.12 Allowed 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 125.12 1.368 . . . . 0.0 114.103 178.023 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.94 -11.43 60.66 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.625 -0.798 . . . . 0.0 114.975 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 20' ' ' THR . 68.3 m-80 -109.47 154.81 22.13 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 118.513 1.156 . . . . 0.0 111.976 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -94.31 126.04 39.32 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 20.9 m-85 -110.88 110.67 21.37 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.724 0.773 . . . . 0.0 111.213 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.594 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 54.1 mt-10 -90.43 -10.26 44.44 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.824 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 p -136.84 -170.8 2.78 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.5 m -70.2 167.12 18.56 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.802 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.504 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 9.4 t -144.35 169.03 18.7 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.768 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.407 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 19.6 p -124.41 17.12 8.98 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.852 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -60.23 142.4 54.57 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 113.736 -1.574 . . . . 0.0 111.588 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.0 -5.73 12.32 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.642 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.477 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 25.2 mtp85 -106.7 -72.92 0.7 Allowed 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 122.654 -0.321 . . . . 0.0 110.987 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m 60.87 24.59 14.57 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.313 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.54 -33.5 8.08 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.164 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.23 -61.45 0.4 Allowed Glycine 0 C--N 1.313 -0.712 0 CA-C-N 115.028 -0.987 . . . . 0.0 113.04 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.509 ' H ' ' CD ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -58.84 134.66 57.09 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.113 0.482 . . . . 0.0 112.043 -179.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.407 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 71.3 mtp -100.15 150.72 22.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.677 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.0 p-90 -135.3 -170.28 2.56 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.913 0.387 . . . . 0.0 111.303 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 20.5 p -155.68 141.58 18.13 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.604 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -76.42 145.81 39.08 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.976 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.9 p -99.33 10.47 41.35 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.377 0.608 . . . . 0.0 109.91 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.6 p -128.13 153.51 46.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.053 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.526 ' HA ' HG13 ' A' ' 16' ' ' VAL . . . -58.24 -38.66 77.31 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.089 0.471 . . . . 0.0 110.452 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -123.99 111.35 15.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.743 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 59.4 t80 -70.13 -40.67 74.71 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.71 -30.64 70.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.089 0.471 . . . . 0.0 111.768 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -61.13 1.9 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.751 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -95.81 -23.85 16.74 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 5.7 mtm180 53.7 52.05 13.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -117.84 119.09 33.81 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.743 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.2 p-90 -129.84 174.28 9.88 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -175.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.38 141.41 7.19 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 113.93 -1.487 . . . . 0.0 110.024 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.703 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 4.7 m-30 -60.28 157.8 12.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.898 0.849 . . . . 0.0 111.668 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.66 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 2.1 t -64.75 150.55 94.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.66 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 60.8 Cg_endo -63.65 -146.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.476 0.468 0 C-N-CA 122.932 2.421 . . . . 0.0 114.218 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.442 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 5.7 t0 -48.64 110.9 0.39 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.921 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 74.8 mt-30 -124.19 158.91 31.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.236 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.746 0 CA-C-O 118.368 -1.24 . . . . 0.0 111.513 179.598 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.788 0.328 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -106.39 60.14 0.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.058 0.456 . . . . 0.0 110.4 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.419 ' O ' ' HB3' ' A' ' 14' ' ' PRO . 22.6 ptp -83.23 -164.54 0.9 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.246 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -107.63 164.37 12.28 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.412 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 p -111.86 171.98 7.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.722 0.772 . . . . 0.0 112.661 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -117.89 -167.26 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.044 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.453 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 36.78 -121.7 0.75 Allowed Glycine 0 N--CA 1.46 0.289 0 O-C-N 124.13 0.894 . . . . 0.0 113.248 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.65 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 30.21 -135.11 0.08 OUTLIER Glycine 0 C--N 1.337 0.632 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -161.8 34.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.815 -0.692 . . . . 0.0 110.422 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.36 -36.81 9.47 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.353 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.55 -68.69 2.6 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.13 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -137.02 5.43 3.62 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.827 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.09 147.6 88.33 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.707 0.253 . . . . 0.0 110.574 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 3' ' ' MET . 83.7 Cg_endo -86.53 171.74 7.21 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.898 2.399 . . . . 0.0 112.416 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 78.7 m -95.67 112.24 24.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.1 t -73.59 115.34 14.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.87 0.367 . . . . 0.0 111.544 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -113.03 141.18 25.16 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 120.91 0.386 . . . . 0.0 110.572 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -85.68 139.87 26.72 Favored 'Cis proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.386 -1.922 . . . . 0.0 111.707 -0.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 40.3 p90 -103.81 -174.32 2.52 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.147 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 94.3 m -142.67 120.03 11.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.865 0.364 . . . . 0.0 110.286 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.844 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 66.3 t80 -115.97 135.09 54.3 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.535 HD21 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 34.68 47.18 0.22 Allowed 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 124.589 1.18 . . . . 0.0 114.01 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.32 -7.74 80.03 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 116.546 1.378 . . . . 0.0 116.546 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' THR . 54.4 m-80 -112.79 143.14 44.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.567 1.684 . . . . 0.0 111.823 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -86.81 129.38 34.9 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.844 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 88.0 m-85 -116.75 118.22 31.93 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.394 0.616 . . . . 0.0 111.089 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -94.28 -16.62 23.42 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.845 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.7 p -130.67 -177.59 4.42 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.485 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 77.8 m -66.91 161.93 22.96 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -138.28 167.83 21.03 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.12 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.66 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 11.0 p -121.22 20.16 11.4 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -60.88 134.47 57.12 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 113.751 -1.568 . . . . 0.0 111.779 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.83 -5.71 37.77 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.136 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.437 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 20.4 mtp85 -110.44 -81.33 0.58 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.797 0.332 . . . . 0.0 111.282 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 68.6 m 57.84 29.44 17.51 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.829 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -103.05 -42.78 5.68 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.901 0.858 . . . . 0.0 109.732 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 168.95 -55.57 0.21 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 114.167 -1.379 . . . . 0.0 112.337 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.45 ' H ' ' CD ' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -71.79 130.69 41.71 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.147 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.66 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.2 mpt? -95.69 154.65 17.11 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.635 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.6 p-90 -139.88 -163.21 1.46 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.1 0.476 . . . . 0.0 111.144 -178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p -169.45 155.98 6.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.264 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 15' ' ' CYS . . . -79.61 152.86 29.8 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 120.911 0.386 . . . . 0.0 111.464 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.1 p -102.12 6.87 41.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.95 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.7 p -130.73 150.66 51.81 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.295 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.02 -35.44 71.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.969 0.414 . . . . 0.0 110.986 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -124.47 109.99 13.95 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 1.012 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 30.6 t80 -75.38 -34.84 61.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.345 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -52.26 -32.87 39.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.885 0.374 . . . . 0.0 111.324 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -83.17 -58.54 2.8 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.815 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 56.2 m-20 -91.31 -19.8 22.57 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 3.2 mtm105 46.57 43.72 12.69 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.815 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 22.2 mtpt -110.57 124.0 51.02 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 1.012 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 7.8 p-90 -131.58 172.66 11.97 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.565 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.65 145.78 11.3 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 113.646 -1.616 . . . . 0.0 110.255 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.684 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 7.0 m-30 -66.62 160.56 25.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.465 0.65 . . . . 0.0 112.318 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.677 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 8.8 t -84.59 149.88 55.39 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.677 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 89.9 Cg_endo -70.4 -150.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.282 1.988 . . . . 0.0 113.418 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.481 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 2.1 m-20 -56.65 134.94 55.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.073 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -80.38 95.5 6.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.484 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.616 0 CA-C-O 118.746 -1.03 . . . . 0.0 111.953 179.639 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.752 0.311 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -82.46 87.09 6.66 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.511 ' HB3' ' HE1' ' A' ' 3' ' ' MET . 78.4 mtp -104.56 96.74 6.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.337 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 t 63.71 -159.88 0.3 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.05 0.453 . . . . 0.0 110.057 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -109.6 -176.64 3.07 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.723 0.773 . . . . 0.0 111.832 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.65 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.1 OUTLIER -132.0 161.73 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 177.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.728 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.73 -154.33 46.15 Favored Glycine 0 C--N 1.309 -0.921 0 C-N-CA 118.068 -2.015 . . . . 0.0 111.544 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.6 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 48.94 -150.42 3.82 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 115.45 0.94 . . . . 0.0 115.45 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -153.16 31.93 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.835 -0.682 . . . . 0.0 109.625 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -51.23 67.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.005 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.02 45.24 6.37 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.46 62.54 1.7 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.14 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.406 ' HB2' ' HB ' ' A' ' 43' ' ' THR . . . -150.4 144.38 17.39 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.824 0.312 . . . . 0.0 110.933 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -85.61 -177.21 2.53 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.834 2.356 . . . . 0.0 111.308 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.9 m -87.75 122.42 31.39 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.241 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 74.6 t -85.06 110.16 18.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.733 0.301 . . . . 0.0 110.329 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -116.26 138.55 24.36 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-O 120.95 0.405 . . . . 0.0 111.013 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.618 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 6.4 Cg_endo -86.47 137.85 20.67 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.136 -1.61 . . . . 0.0 112.002 -0.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.63 ' CG ' ' HB1' ' A' ' 42' ' ' ALA . 47.1 p90 -103.09 -169.66 1.68 Allowed 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.9 m -144.31 128.93 18.15 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.947 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.877 ' CD2' ' HB2' ' A' ' 32' ' ' ALA . 1.1 t80 -132.49 142.3 49.16 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.82 HD23 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 41.12 35.81 0.41 Allowed 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 124.557 1.143 . . . . 0.0 112.812 178.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.13 -6.6 83.31 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 115.01 0.764 . . . . 0.0 115.01 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.493 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.1 m-80 -107.07 136.87 46.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.508 1.154 . . . . 0.0 111.638 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -78.03 123.09 26.42 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.691 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 14.8 m-30 -107.03 112.17 24.99 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.805 0.812 . . . . 0.0 110.884 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.618 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 45.6 mt-10 -91.54 -18.0 24.78 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.366 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 p -129.89 -174.17 3.24 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 80.8 m -62.92 166.66 5.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.54 0.686 . . . . 0.0 110.36 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -147.65 169.5 19.52 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.32 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.572 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 55.1 p -128.55 17.7 6.39 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.877 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -59.79 138.25 57.83 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 113.96 -1.473 . . . . 0.0 111.086 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.06 -9.31 26.15 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.289 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.624 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.7 mtp85 -111.2 -39.91 4.6 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 51.1 m 78.53 -59.5 0.42 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -175.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.0 -106.13 0.32 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 175.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.501 ' O ' ' NE ' ' A' ' 34' ' ' ARG . . . 27.54 47.09 0.05 OUTLIER Glycine 0 C--O 1.209 -1.426 0 O-C-N 124.43 1.081 . . . . 0.0 114.646 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.682 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 24.7 mmmt 66.67 145.64 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 125.402 1.481 . . . . 0.0 113.728 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.572 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 60.8 mtt -81.8 149.5 28.34 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.605 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 21.6 p-90 -136.61 -172.76 3.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.563 0.697 . . . . 0.0 112.297 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 25.0 p -151.05 140.46 21.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.739 -1.118 . . . . 0.0 108.693 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.63 ' HB1' ' CG ' ' A' ' 19' ' ' PHE . . . -75.61 151.24 37.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.347 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 13' ' ' ALA . 65.1 p -108.04 14.81 24.86 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.798 0.808 . . . . 0.0 110.199 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.0 p -137.23 150.05 47.58 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.94 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.407 ' HA ' HG13 ' A' ' 16' ' ' VAL . . . -56.23 -42.25 76.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.879 0.371 . . . . 0.0 111.205 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -118.09 106.24 12.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.72 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 75.8 t80 -74.44 -35.28 63.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.231 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -54.44 -39.51 67.44 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -84.08 -49.78 8.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -83.02 -34.09 26.36 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 4.3 mmm-85 55.19 44.46 27.69 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -111.53 118.36 35.53 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.72 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 11.5 p-90 -129.45 174.88 9.23 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -175.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.571 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.17 141.22 7.08 Favored Glycine 0 C--O 1.221 -0.683 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.107 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.728 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 6.1 m-85 -65.75 163.38 16.74 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 117.344 0.572 . . . . 0.0 111.989 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 63.1 m -101.3 153.99 37.48 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.755 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.436 ' HB2' ' H ' ' A' ' 58' ' ' ASP . 93.5 Cg_endo -71.12 -146.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.439 2.76 . . . . 0.0 113.767 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.436 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 38.2 t70 -49.25 121.51 5.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.118 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -63.98 108.82 1.6 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.032 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.531 -1.15 . . . . 0.0 111.873 179.852 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.417 ' HB3' ' H ' ' A' ' 3' ' ' MET . 0.1 OUTLIER 62.48 -145.68 0.38 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.417 ' H ' ' HB3' ' A' ' 2' ' ' TRP . 10.2 ptt? -81.74 89.56 6.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.287 0.565 . . . . 0.0 109.887 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.602 ' HB3' ' O ' ' A' ' 11' ' ' GLY . 69.1 m -127.1 -170.32 2.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.147 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -122.59 177.79 5.28 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 121.665 0.745 . . . . 0.0 111.805 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.695 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.2 OUTLIER -126.74 160.76 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 177.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.794 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 68.53 -144.78 42.87 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 117.887 -2.102 . . . . 0.0 111.612 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.617 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 43.12 -145.86 1.04 Allowed Glycine 0 C--N 1.331 0.275 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.73 -30.87 1.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.878 -0.661 . . . . 0.0 109.506 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 m -58.88 -58.7 7.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.579 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.602 ' O ' ' HB3' ' A' ' 4' ' ' SER . . . 76.08 -74.87 1.59 Allowed Glycine 0 C--O 1.225 -0.447 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.519 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.42 27.93 6.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.055 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.96 144.62 43.54 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -84.63 160.99 12.47 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.744 2.296 . . . . 0.0 112.43 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 91.8 m -83.37 123.12 29.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.469 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.8 t -90.31 120.02 38.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.715 0.293 . . . . 0.0 110.922 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.599 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 58.6 m-85 -114.74 141.88 27.44 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.483 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.3 Cg_endo -86.49 132.75 14.61 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.308 -1.538 . . . . 0.0 112.14 -0.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.656 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 22.5 p90 -98.56 128.03 44.73 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.517 ' OG1' ' HD2' ' A' ' 25' ' ' LYS . 13.9 m -91.38 125.64 36.21 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.432 0.634 . . . . 0.0 112.148 -177.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.842 ' CG ' HD23 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -130.36 145.97 51.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.41 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.842 HD23 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.24 36.88 0.21 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.461 1.104 . . . . 0.0 113.099 178.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.27 -5.52 84.96 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.412 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 68.6 m-80 -110.29 135.7 50.63 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.587 1.194 . . . . 0.0 112.202 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.517 ' HD2' ' OG1' ' A' ' 20' ' ' THR . 25.1 mmmt -77.42 117.13 18.6 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.832 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.5 m-30 -101.77 104.4 15.19 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.02 0.914 . . . . 0.0 111.361 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 15.5 mt-10 -84.46 -17.42 39.2 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.215 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 p -129.06 -178.45 4.64 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.639 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.9 m -66.64 159.52 27.45 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.725 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.61 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.5 t -137.74 178.48 7.08 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.703 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.7 p -128.77 17.44 6.29 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.799 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -60.87 142.96 55.78 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.107 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.06 -5.26 19.79 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.536 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.618 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 12.2 mtp85 -100.66 155.67 17.75 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 117.33 0.565 . . . . 0.0 111.565 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 p -132.17 13.06 4.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.805 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -104.92 -79.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.178 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 176.81 -31.74 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.411 -0.9 . . . . 0.0 114.418 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.618 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 5.7 mptt -63.22 135.14 56.93 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 117.633 0.716 . . . . 0.0 112.344 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.427 ' HB3' ' HE1' ' A' ' 39' ' ' MET . 51.0 mtp -89.86 156.82 18.21 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.61 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 18.6 p-90 -143.85 -172.06 3.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.417 0.627 . . . . 0.0 111.332 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.4 p -159.3 139.26 11.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.044 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.656 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -72.01 155.48 40.28 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.372 0.606 . . . . 0.0 111.511 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.4 p -101.93 11.24 38.88 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.767 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.9 p -133.08 151.82 52.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.912 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.96 -32.57 67.97 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.163 0.506 . . . . 0.0 111.358 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -126.69 120.2 28.84 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.84 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 64.5 t80 -86.17 -31.42 21.8 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.325 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -61.13 -30.94 70.68 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.05 -45.23 8.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -100.32 -18.51 16.76 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.1 mtm105 43.5 51.28 6.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -114.82 119.39 36.45 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.84 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.2 p-90 -132.99 176.48 8.45 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -174.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -167.28 142.55 7.63 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 112.95 -1.932 . . . . 0.0 109.222 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.794 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 12.9 m-85 -60.76 157.37 14.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.407 0.622 . . . . 0.0 112.081 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.486 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.9 t -75.25 117.03 59.99 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.055 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.62 -162.36 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.718 2.279 . . . . 0.0 112.406 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 t0 29.18 66.71 0.1 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.061 1.345 . . . . 0.0 113.405 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -122.88 -68.82 0.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.051 0.453 . . . . 0.0 110.058 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.762 0 CA-C-O 118.599 -1.112 . . . . 0.0 111.401 -179.722 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.66 0.266 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.435 ' HA ' ' CE3' ' A' ' 2' ' ' TRP . 3.9 t-105 -76.54 -88.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.116 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.9 mmt -102.77 164.1 11.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.728 0.299 . . . . 0.0 110.934 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.6 m -101.5 -171.14 1.93 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.546 HG21 ' O ' ' A' ' 13' ' ' ALA . 3.2 p -82.08 154.74 25.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.987 0.899 . . . . 0.0 112.742 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.725 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.2 OUTLIER -132.75 163.91 36.58 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.032 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 178.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.725 ' N ' HG21 ' A' ' 6' ' ' VAL . . . 65.16 -149.94 51.7 Favored Glycine 0 C--N 1.312 -0.782 0 C-N-CA 117.716 -2.183 . . . . 0.0 111.014 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.627 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 48.47 -150.51 3.34 Favored Glycine 0 C--N 1.332 0.326 0 N-CA-C 114.641 0.616 . . . . 0.0 114.641 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.402 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -130.36 -6.64 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.418 178.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 m -78.79 -51.49 9.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.44 72.03 0.64 Allowed Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.774 -0.648 . . . . 0.0 114.23 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.02 -42.69 1.29 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.835 -1.174 . . . . 0.0 113.196 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.546 ' O ' HG21 ' A' ' 5' ' ' THR . . . -66.11 135.3 95.06 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.809 0.338 . . . . 0.0 111.513 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 14.2 Cg_exo -65.51 154.31 74.29 Favored 'Trans proline' 0 C--N 1.334 -0.219 0 C-N-CA 122.896 2.397 . . . . 0.0 111.472 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.401 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 5.2 m -73.78 134.58 43.44 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.534 HG13 ' HA ' ' A' ' 45' ' ' ALA . 96.0 t -95.06 113.87 30.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.834 0.35 . . . . 0.0 110.426 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.612 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 47.4 m-85 -118.64 139.94 27.72 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.538 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.717 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 35.9 Cg_endo -87.06 136.12 17.05 Favored 'Cis proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.51 -1.871 . . . . 0.0 112.379 -0.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.707 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 34.3 p90 -101.93 -168.02 1.49 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 76.0 m -149.47 126.28 11.12 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.433 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.788 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 36.8 t80 -123.03 131.64 53.79 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.988 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.724 HD23 ' CE2' ' A' ' 21' ' ' PHE . 6.7 mp 41.76 33.56 0.34 Allowed 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 124.531 1.144 . . . . 0.0 113.502 174.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.68 -18.16 32.41 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 115.422 0.929 . . . . 0.0 115.422 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.453 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 43.8 m-80 -112.6 132.01 55.34 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.888 1.344 . . . . 0.0 112.181 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 46.5 mtpt -78.17 127.03 31.67 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.788 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.4 m-85 -111.91 121.2 44.38 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.683 0.754 . . . . 0.0 111.223 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.717 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 99.1 mt-10 -94.87 -14.67 24.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.224 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.3 p -130.08 -175.37 3.6 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.63 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.7 m -67.1 166.29 14.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.774 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.3 t -146.15 165.36 29.38 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.098 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 p -121.53 23.8 10.13 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.582 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -66.04 139.73 58.22 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.022 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.65 -6.45 17.79 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.612 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.487 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.9 mtp85 -100.84 -78.67 0.52 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 117.401 0.601 . . . . 0.0 111.211 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 m 66.13 14.81 9.82 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.718 0.636 . . . . 0.0 109.957 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.48 -34.03 12.22 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.196 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.65 -65.73 0.31 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.224 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.778 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 1.5 mppt? -61.92 149.7 39.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.0 mtm -104.61 159.07 16.05 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.722 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.567 ' HA ' ' N ' ' A' ' 56' ' ' CYS . 13.9 p-90 -142.5 -165.7 2.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.369 0.604 . . . . 0.0 111.94 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.3 p -161.04 152.79 19.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.672 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.707 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -86.85 148.53 25.33 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.401 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 16' ' ' VAL . 73.3 p -103.12 8.02 38.71 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.536 0.684 . . . . 0.0 109.877 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.9 p -130.07 152.63 49.31 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.663 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.534 ' HA ' HG13 ' A' ' 16' ' ' VAL . . . -57.73 -47.74 81.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.756 0.313 . . . . 0.0 111.518 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -115.4 104.61 11.94 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.961 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 43.4 t80 -69.28 -37.6 77.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.792 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -53.0 -28.82 25.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.96 0.41 . . . . 0.0 111.762 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -87.48 -70.6 0.61 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.59 -21.18 55.94 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.626 ' HB3' ' NH1' ' A' ' 51' ' ' ARG . 0.9 OUTLIER 46.98 50.77 13.53 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 179.166 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -114.13 118.37 33.83 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.961 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.8 p-90 -129.85 171.21 12.96 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -174.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.627 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.61 142.64 7.83 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 113.122 -1.854 . . . . 0.0 109.502 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 13.7 m-30 -55.15 155.65 4.63 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 117.043 0.422 . . . . 0.0 111.249 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.567 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.7 t -53.87 137.71 54.77 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.577 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.408 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 74.8 Cg_endo -69.77 4.97 1.89 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.029 2.486 . . . . 0.0 113.384 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.428 ' H ' ' C ' ' A' ' 56' ' ' CYS . 38.7 t70 -141.52 78.3 1.63 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.024 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 56' ' ' CYS . 15.6 mm100 -94.2 -44.86 7.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.956 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.293 -1.282 . . . . 0.0 111.379 -179.899 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.2 m . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 121.041 0.448 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.451 ' HE3' ' HG3' ' A' ' 14' ' ' PRO . 7.5 m0 -114.59 -109.51 0.36 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.6 mtt -90.23 163.27 14.85 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.9 m -123.92 162.04 24.16 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.995 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -120.77 161.64 21.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.35 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.681 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -116.5 -164.96 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 177.059 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.533 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.64 -125.51 1.31 Allowed Glycine 0 N--CA 1.463 0.47 0 O-C-N 123.814 0.696 . . . . 0.0 113.307 177.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.632 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 30.55 -136.4 0.07 OUTLIER Glycine 0 C--N 1.338 0.693 0 N-CA-C 116.049 1.179 . . . . 0.0 116.049 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.46 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -158.75 31.61 0.22 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.729 -0.736 . . . . 0.0 110.083 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.38 -45.66 9.31 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.516 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.19 -75.92 1.17 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.676 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.39 18.84 4.36 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.782 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.17 143.13 36.59 Favored Pre-proline 0 C--N 1.328 -0.339 0 O-C-N 122.665 -0.315 . . . . 0.0 110.598 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HG3' ' HE3' ' A' ' 2' ' ' TRP . 71.8 Cg_endo -86.12 166.52 9.62 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.62 2.213 . . . . 0.0 112.254 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.7 m -81.08 133.92 35.56 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.523 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 82.9 t -96.48 115.76 36.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.742 0.306 . . . . 0.0 110.29 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -118.15 139.54 26.81 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.314 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.64 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 6.0 Cg_endo -85.64 136.12 20.61 Favored 'Cis proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.288 -1.547 . . . . 0.0 111.571 -0.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.654 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 43.8 p90 -104.1 -170.04 1.71 Allowed 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.364 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.7 m -148.18 126.86 12.53 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.094 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.794 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 67.9 t80 -117.95 132.73 56.37 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.599 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.508 HD21 ' CD1' ' A' ' 21' ' ' PHE . 3.8 mm? 33.28 45.45 0.08 Allowed 'General case' 0 N--CA 1.432 -1.332 0 O-C-N 124.792 1.308 . . . . 0.0 114.034 174.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.77 -19.01 51.61 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.432 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 32.4 m-80 -111.86 133.67 53.91 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.787 1.794 . . . . 0.0 112.418 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 11.4 mtmt -75.59 127.11 32.37 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.361 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.794 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.9 m-85 -115.97 109.7 17.93 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 122.244 1.021 . . . . 0.0 110.384 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.64 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 24.4 mt-10 -87.81 -10.47 50.8 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.498 -1.683 . . . . 0.0 110.648 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.5 p -133.15 -168.2 2.05 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.6 m -74.52 167.63 21.34 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.412 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 13.4 t -146.71 169.97 17.94 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.309 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.422 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 11.8 p -122.32 20.15 10.52 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.515 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -60.12 140.55 56.83 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.233 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.4 -1.07 45.16 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.51 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.654 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.6 mtp85 -108.04 -64.71 1.19 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.944 0.372 . . . . 0.0 111.076 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.4 t 66.67 15.78 10.21 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.357 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.72 -84.32 0.45 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.036 0.446 . . . . 0.0 110.548 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.62 -46.83 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.244 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.75 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 2.9 mppt? -63.56 122.18 15.68 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 120.939 0.399 . . . . 0.0 111.259 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.422 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 47.1 mtt -91.18 151.06 21.1 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.632 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.6 p-90 -130.08 -167.07 1.76 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.187 0.518 . . . . 0.0 111.533 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 10.6 p -159.72 143.97 14.81 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.401 ' HB1' ' CD1' ' A' ' 19' ' ' PHE . . . -76.11 149.72 37.35 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 59.8 p -104.74 13.86 30.67 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.677 0.751 . . . . 0.0 109.788 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.8 p -139.33 154.98 47.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.835 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.85 -48.01 83.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.772 0.32 . . . . 0.0 111.325 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -114.49 106.68 14.57 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 1.033 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 20.3 t80 -75.81 -34.39 60.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.196 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.13 -39.81 21.68 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.92 -35.71 11.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -89.82 -30.86 17.66 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.507 ' HB3' HH11 ' A' ' 51' ' ' ARG . 0.3 OUTLIER 48.62 47.09 20.99 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -117.77 118.07 31.06 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 1.033 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 10.2 p-90 -132.57 173.7 11.05 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -175.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.564 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.7 147.22 11.39 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 113.437 -1.711 . . . . 0.0 109.571 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.681 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 11.5 m-30 -61.04 155.71 19.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.752 0.776 . . . . 0.0 111.592 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.591 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 11.3 t -63.66 144.88 97.77 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.639 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.591 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 62.0 Cg_endo -65.63 2.59 1.52 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.164 2.576 . . . . 0.0 114.413 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 56' ' ' CYS . 55.5 t0 -121.22 97.01 5.32 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.275 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -99.68 47.63 0.95 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.237 0.541 . . . . 0.0 110.611 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.92 0 CA-C-O 118.543 -1.143 . . . . 0.0 112.146 179.755 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.0 m . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.98 0.419 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -97.55 125.43 42.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.855 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.0 tpt -67.76 115.26 7.12 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.5 m -82.0 -161.94 0.5 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.762 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p -68.79 170.3 9.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.843 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.57 -50.1 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-O 123.194 1.473 . . . . 0.0 109.716 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.65 ' H ' ' HB2' ' A' ' 55' ' ' PHE . . . -83.38 -162.29 32.75 Favored Glycine 0 C--N 1.278 -2.692 0 CA-C-N 111.054 -2.794 . . . . 0.0 111.85 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 53' ' ' TRP . . . 75.62 -157.89 49.67 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.693 -0.765 . . . . 0.0 114.419 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.03 -29.84 6.55 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 m -52.15 -47.26 65.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.761 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.68 -86.83 1.52 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.493 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.06 43.55 1.68 Allowed Glycine 0 C--N 1.329 0.158 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.913 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -113.33 145.13 32.61 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 120.857 0.361 . . . . 0.0 110.807 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 3.1 Cg_exo -78.45 154.54 27.86 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.894 2.396 . . . . 0.0 112.008 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.8 m -76.99 141.75 40.26 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.0 t -109.39 92.11 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.726 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.695 ' CE1' ' HE1' ' A' ' 19' ' ' PHE . 6.5 m-85 -94.32 143.98 27.25 Favored Pre-proline 0 N--CA 1.447 -0.624 0 CA-C-O 121.657 0.741 . . . . 0.0 111.331 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.3 Cg_endo -84.14 129.91 14.73 Favored 'Cis proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.402 -1.916 . . . . 0.0 111.964 -0.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.695 ' HE1' ' CE1' ' A' ' 17' ' ' PHE . 2.0 p90 -86.7 -163.68 0.94 Allowed 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.485 ' HG1' ' C ' ' A' ' 19' ' ' PHE . 7.5 m -149.19 121.75 8.56 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.918 ' HB2' ' CE2' ' A' ' 26' ' ' TYR 0.494 0.5 OUTLIER -104.09 -171.38 1.92 Allowed 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 119.264 3.061 . . . . 0.0 119.264 171.964 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.779 HD23 ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -52.93 45.6 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 110.086 -3.234 . . . . 0.0 113.684 -173.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 21' ' ' PHE . . . 118.19 1.46 16.34 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.318 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.865 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 1.9 m-80 -138.67 136.57 36.0 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 118.572 1.186 . . . . 0.0 113.016 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.53 122.34 26.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 175.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.918 ' CE2' ' HB2' ' A' ' 21' ' ' PHE . 22.1 m-30 -95.42 98.35 10.49 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 122.39 1.09 . . . . 0.0 112.824 -175.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 16.4 mt-10 -78.21 -12.66 60.01 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.778 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.6 p -138.57 -179.84 6.04 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.4 m -64.6 163.28 13.97 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.503 -0.879 . . . . 0.0 109.209 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -143.92 170.27 16.22 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.583 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 61.2 p -122.77 15.63 10.16 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.497 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -64.52 147.89 51.85 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.001 -1.454 . . . . 0.0 111.336 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.94 -4.59 37.4 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.158 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.588 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 28.3 mtp85 -112.1 -64.7 1.26 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.751 0.31 . . . . 0.0 111.242 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.6 m 69.83 13.83 8.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.803 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.6 -83.75 0.34 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.145 0.498 . . . . 0.0 110.609 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.48 -35.27 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.394 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.705 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 7.1 mptt -69.8 119.96 14.82 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.732 0.301 . . . . 0.0 110.762 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.583 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 56.2 mtt -91.34 142.88 27.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.766 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 18.3 p-90 -122.93 -170.82 2.17 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.504 0.668 . . . . 0.0 110.979 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 8.3 p -157.56 134.49 10.08 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.0 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . . . -72.49 149.43 44.14 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.011 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.5 p -101.99 13.74 33.93 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.538 0.685 . . . . 0.0 110.335 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.8 p -135.69 148.28 48.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.014 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -55.81 -36.64 67.66 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.894 0.378 . . . . 0.0 110.978 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -119.58 116.9 26.99 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.705 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 60.9 t80 -87.56 -43.78 11.75 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.343 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -42.94 -37.89 2.03 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -91.29 -67.88 0.83 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.438 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 2.2 m-20 -63.97 -26.13 68.44 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.9 mtm-85 44.33 52.62 7.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.438 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 25.7 mttm -116.94 115.64 25.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.705 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 16.6 p-90 -129.73 175.09 9.11 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.978 0.894 . . . . 0.0 112.758 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.477 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -164.8 142.6 7.87 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 113.617 -1.629 . . . . 0.0 109.191 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.65 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 4.3 m-30 -60.66 147.39 42.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.688 0.744 . . . . 0.0 111.0 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.426 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.6 t -57.62 133.7 82.42 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.192 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HB2' ' H ' ' A' ' 58' ' ' ASP . 83.1 Cg_endo -73.61 -142.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.187 2.591 . . . . 0.0 112.571 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 50.6 t0 -63.1 104.59 0.59 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.057 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -79.97 101.52 8.69 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.77 0.319 . . . . 0.0 110.592 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.711 0 CA-C-O 118.619 -1.1 . . . . 0.0 111.761 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 120.677 0.275 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -83.99 153.26 23.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.161 0.505 . . . . 0.0 111.43 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 58.5 mtt -87.36 -177.21 5.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.724 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 t -77.49 175.59 9.68 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.263 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.3 p -100.64 173.27 6.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.019 0.914 . . . . 0.0 112.669 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -134.62 160.94 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.012 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.836 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 68.63 -147.54 47.02 Favored Glycine 0 C--N 1.309 -0.956 0 C-N-CA 117.487 -2.292 . . . . 0.0 111.612 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.635 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 47.25 -147.18 3.68 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 114.441 0.537 . . . . 0.0 114.441 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.82 17.61 2.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.823 0.344 . . . . 0.0 110.733 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 p -75.38 -67.45 0.66 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.56 -60.36 0.33 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.941 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.75 26.54 2.51 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.571 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.8 143.75 27.33 Favored Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 122.656 -0.32 . . . . 0.0 111.253 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -88.87 167.33 5.78 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.805 2.337 . . . . 0.0 111.932 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.7 m -76.56 141.08 41.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.562 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 88.1 t -111.4 115.1 48.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -116.43 144.16 32.58 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.935 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.595 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.7 Cg_endo -84.21 133.49 19.73 Favored 'Cis proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.485 -1.465 . . . . 0.0 111.285 -0.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.793 ' HZ ' HG22 ' A' ' 30' ' ' THR . 17.5 p90 -103.37 162.6 12.88 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.2 m -118.84 122.44 42.36 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.943 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.777 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 60.6 t80 -119.9 133.71 55.48 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.5 HD21 ' CD1' ' A' ' 21' ' ' PHE . 3.5 mm? 36.19 46.76 0.41 Allowed 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.5 -4.05 86.49 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 114.225 -1.352 . . . . 0.0 116.318 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 26' ' ' TYR . 40.2 m-80 -110.14 155.71 21.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.673 1.737 . . . . 0.0 111.571 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -94.65 131.33 40.56 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.157 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.777 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 88.9 m-85 -123.77 107.56 11.57 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.697 0.761 . . . . 0.0 112.041 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.595 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 93.6 mt-10 -93.39 -14.32 26.96 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.591 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.6 p -128.14 -177.06 3.99 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.605 -1.179 . . . . 0.0 108.158 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.6 m -67.08 168.91 9.28 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.284 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.793 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 10.6 t -143.99 169.17 18.33 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.184 0.516 . . . . 0.0 110.787 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.434 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 32.4 p -123.52 15.51 9.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.757 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -55.9 136.86 51.38 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.405 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.26 -18.59 3.36 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.147 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' A' ' 32' ' ' ALA . 21.7 mtp85 -96.25 -80.76 0.42 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.795 0.331 . . . . 0.0 110.519 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.7 m 62.42 16.16 8.38 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.943 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.37 -35.26 13.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.639 0.733 . . . . 0.0 109.569 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.52 -65.86 0.23 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.59 -1.186 . . . . 0.0 113.359 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.763 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 7.0 mptt -63.0 134.37 56.06 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.434 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.5 mpt? -96.41 152.62 18.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.584 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.6 p-90 -133.4 -166.08 1.72 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.326 0.584 . . . . 0.0 111.531 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 29.3 p -158.58 149.69 20.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.008 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.865 ' HB3' ' HD2' ' A' ' 47' ' ' TYR . . . -84.27 148.33 26.75 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 16' ' ' VAL . 71.2 p -102.41 10.61 38.91 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.665 0.745 . . . . 0.0 110.32 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.2 p -133.56 151.31 51.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.924 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -55.78 -37.66 68.86 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.971 0.415 . . . . 0.0 111.077 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -125.51 112.44 16.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 1.033 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 30.6 t80 -73.95 -36.93 64.67 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.538 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -54.22 -35.08 62.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.148 0.499 . . . . 0.0 111.103 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.57 -71.42 0.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -81.47 -18.85 43.78 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.629 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 11.1 mtm180 45.2 55.65 6.17 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -119.49 120.86 38.03 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 1.033 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.7 p-90 -128.35 169.8 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.573 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.57 140.72 6.71 Favored Glycine 0 C--O 1.22 -0.78 0 CA-C-N 113.377 -1.738 . . . . 0.0 109.819 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.836 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.2 m-85 -58.93 154.41 15.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 117.59 0.695 . . . . 0.0 111.233 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.608 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 8.5 t -67.46 143.41 97.13 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.955 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.608 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 73.9 Cg_endo -67.39 -144.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.379 2.719 . . . . 0.0 113.313 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.446 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 39.0 t70 -48.03 106.62 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.871 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -83.85 135.13 34.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.503 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.76 0 CA-C-O 118.007 -1.44 . . . . 0.0 111.439 179.807 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.8 p . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.47 0.176 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 37.1 t90 65.01 105.63 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.792 0.682 . . . . 0.0 112.786 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.0 ptp -103.56 136.38 43.39 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -85.4 -178.46 6.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.191 0.52 . . . . 0.0 111.777 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -111.07 -178.53 3.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.776 0.798 . . . . 0.0 112.5 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.657 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -127.8 -168.24 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 177.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.469 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 35.84 -131.22 0.78 Allowed Glycine 0 CA--C 1.522 0.511 0 O-C-N 124.079 0.862 . . . . 0.0 113.496 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.663 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 40.31 -144.59 0.46 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 114.983 0.753 . . . . 0.0 114.983 177.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.37 -13.6 1.15 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.98 44.82 1.07 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.29 178.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -53.37 99.76 0.05 OUTLIER Glycine 0 C--N 1.333 0.381 0 O-C-N 123.668 0.605 . . . . 0.0 112.365 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.37 -29.6 3.62 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.312 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.36 145.91 69.24 Favored Pre-proline 0 CA--C 1.518 -0.27 0 CA-C-N 116.785 0.292 . . . . 0.0 110.25 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -81.74 154.36 17.76 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.118 1.879 . . . . 0.0 111.513 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.7 m -74.17 131.4 41.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.2 t -86.55 109.39 18.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.51 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 35.4 m-85 -116.59 139.31 25.33 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-O 120.749 0.309 . . . . 0.0 111.684 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.677 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 3.8 Cg_endo -86.22 134.78 17.5 Favored 'Cis proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.312 -1.537 . . . . 0.0 111.211 -1.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.573 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 43.5 p90 -96.95 -168.66 1.74 Allowed 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.437 178.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 73.9 m -144.43 122.98 12.45 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.002 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.831 ' CD2' ' HB2' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -125.0 142.94 51.16 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.81 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 40.91 27.94 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.758 1.223 . . . . 0.0 113.562 178.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.02 -7.02 62.35 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 114.819 0.688 . . . . 0.0 114.819 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 20' ' ' THR . 60.7 m-80 -105.5 149.33 26.31 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.512 1.156 . . . . 0.0 111.921 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -88.46 119.07 28.56 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.575 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 28.1 m-85 -104.64 112.52 25.63 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.72 0.772 . . . . 0.0 110.587 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.677 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 46.6 mt-10 -92.04 -17.75 24.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.475 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 p -129.62 -175.67 3.67 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 78.2 m -65.77 164.17 15.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.474 0.654 . . . . 0.0 110.613 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.528 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 8.8 t -142.34 167.71 21.47 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.867 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.69 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 27.9 p -121.95 18.57 10.93 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.831 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -64.48 139.17 58.74 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.718 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.81 -4.29 45.74 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.1 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.648 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.2 mtp85 -105.49 127.47 53.02 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 117.425 0.612 . . . . 0.0 110.844 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.0 m -96.5 5.95 49.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.784 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.72 -85.81 0.37 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 176.32 -31.58 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.317 -0.944 . . . . 0.0 114.387 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.721 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 8.8 mptt -57.04 115.89 2.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.583 0.692 . . . . 0.0 111.948 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.69 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 70.0 mtm -78.27 142.13 38.04 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.613 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 14.1 p-90 -128.75 -167.37 1.77 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.433 0.635 . . . . 0.0 112.04 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 17.7 p -152.7 141.86 21.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.918 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.573 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -75.99 148.56 38.01 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.178 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.1 p -103.27 11.96 36.13 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.594 0.711 . . . . 0.0 109.712 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.571 HG21 ' HB2' ' A' ' 52' ' ' LYS . 42.3 p -137.62 153.3 49.91 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.762 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.56 -50.09 72.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 110.303 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -105.18 102.83 12.3 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.772 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 71.8 t80 -75.67 -34.31 60.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.936 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.36 -38.91 55.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -85.55 -71.2 0.54 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.519 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 72.9 m-20 -63.54 -26.42 68.7 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 15.4 mtm180 44.2 52.09 7.18 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.571 ' HB2' HG21 ' A' ' 44' ' ' THR . 42.8 mttt -116.35 118.93 34.1 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.772 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.7 p-90 -133.89 176.28 8.71 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.548 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.94 150.07 19.1 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.295 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.657 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.7 m-30 -65.44 162.02 18.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.96 0.88 . . . . 0.0 112.374 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.683 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 5.6 t -66.74 148.81 98.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.683 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 35.7 Cg_endo -58.7 -131.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 123.601 2.867 . . . . 0.0 114.348 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.5 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 8.4 t0 -50.85 109.46 0.32 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.352 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 78.3 mt-30 -123.43 172.16 8.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.366 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.64 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.08 -179.945 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.544 0.212 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -86.61 89.74 8.02 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 75.2 mtm -92.41 133.03 36.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.224 0.535 . . . . 0.0 111.807 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.9 m -128.16 173.07 10.42 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.958 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 p -110.58 172.73 6.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.849 0.833 . . . . 0.0 112.306 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.51 HG23 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -128.08 164.96 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 178.045 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.682 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 61.36 -149.97 44.95 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 118.229 -1.938 . . . . 0.0 111.51 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.558 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 49.79 -145.28 8.66 Favored Glycine 0 C--N 1.33 0.24 0 N-CA-C 114.169 0.428 . . . . 0.0 114.169 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.444 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -143.7 27.84 1.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.242 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.768 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 5.3 m -107.76 -65.47 1.11 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.317 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.77 -67.71 3.61 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.795 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.46 -13.55 58.28 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.305 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.768 ' HB1' ' HB3' ' A' ' 10' ' ' SER . . . -84.99 138.67 37.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 117.092 0.446 . . . . 0.0 111.372 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 85.7 Cg_endo -90.3 169.44 4.11 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.4 2.733 . . . . 0.0 112.038 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.9 m -79.52 142.31 35.89 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.424 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.3 t -116.22 87.99 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.722 0.296 . . . . 0.0 111.318 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.543 ' CE1' ' HE1' ' A' ' 19' ' ' PHE . 8.8 m-85 -90.3 146.11 34.03 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-O 121.443 0.639 . . . . 0.0 111.082 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.67 132.26 18.69 Favored 'Cis proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.4 -1.917 . . . . 0.0 112.197 -0.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.551 ' CB ' ' HB2' ' A' ' 42' ' ' ALA . 0.4 OUTLIER -90.07 -168.19 2.05 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.357 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.454 ' HG1' ' C ' ' A' ' 19' ' ' PHE . 77.2 m -151.13 124.06 8.66 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.983 ' HB2' ' CE2' ' A' ' 26' ' ' TYR 0.471 0.5 OUTLIER -96.5 -173.81 2.87 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 119.068 2.988 . . . . 0.0 119.068 171.698 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.743 HD23 ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -56.29 43.46 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 109.804 -3.362 . . . . 0.0 112.89 -173.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 21' ' ' PHE . . . 122.62 -0.48 10.19 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 114.083 -1.417 . . . . 0.0 113.014 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.824 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 1.8 m-80 -137.9 134.57 35.19 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 118.171 0.986 . . . . 0.0 112.256 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -83.65 127.86 34.09 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.983 ' CE2' ' HB2' ' A' ' 21' ' ' PHE . 6.4 m-85 -107.7 110.89 22.85 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 122.896 1.331 . . . . 0.0 113.249 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.27 -13.6 46.25 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 112.763 -2.017 . . . . 0.0 111.325 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 p -135.57 -177.61 4.75 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.1 m -65.68 153.39 41.82 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.139 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -131.39 175.89 8.76 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.442 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 1.4 p -130.41 17.8 5.38 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.591 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -64.69 154.48 36.46 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.511 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.36 -2.36 15.37 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.877 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.614 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.3 mtp85 -115.89 -61.0 1.8 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.807 0.337 . . . . 0.0 111.094 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.7 m 70.9 13.35 7.06 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.031 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.98 -86.4 0.39 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.146 0.498 . . . . 0.0 110.822 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.79 -33.11 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.42 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.755 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 8.5 mptt -66.48 111.84 3.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.718 0.294 . . . . 0.0 110.291 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.442 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 80.7 mtp -84.89 149.98 25.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.038 0.447 . . . . 0.0 110.828 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.696 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 24.0 p-90 -131.15 -171.94 2.71 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.62 0.724 . . . . 0.0 111.242 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 25.6 p -156.12 137.6 14.03 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.273 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.551 ' HB2' ' CB ' ' A' ' 19' ' ' PHE . . . -76.34 144.67 40.01 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.594 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.3 p -98.17 17.2 19.1 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.669 0.747 . . . . 0.0 110.01 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.9 p -141.67 146.48 36.18 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.75 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -54.4 -32.35 56.99 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.266 0.354 . . . . 0.0 111.886 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -125.66 121.47 33.6 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 1.02 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 30.9 t80 -88.46 -43.53 11.39 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.26 -31.91 1.73 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -93.23 -63.91 1.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -73.19 -20.28 60.92 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.4 mtm-85 41.86 52.34 4.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -118.28 117.81 30.11 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 1.02 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 8.9 p-90 -130.81 174.26 10.14 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -175.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.426 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -169.3 136.84 4.23 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-N 113.673 -1.603 . . . . 0.0 110.578 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.696 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 10.8 m-30 -60.21 158.83 10.76 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.377 0.671 . . . . 0.0 112.189 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.5 m -100.86 162.84 19.37 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.349 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.471 ' HB2' ' H ' ' A' ' 58' ' ' ASP . 93.1 Cg_endo -71.46 -150.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.784 2.323 . . . . 0.0 113.625 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.471 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 42.6 t0 -44.44 110.32 0.21 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.366 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -81.92 -27.29 33.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.262 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.774 0 CA-C-O 118.493 -1.171 . . . . 0.0 112.736 179.938 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.636 ' HB3' ' OG ' ' A' ' 4' ' ' SER . 24.1 m . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.563 0.221 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -83.19 -68.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.0 110.27 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.9 ptp -94.2 90.84 6.5 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.333 0.587 . . . . 0.0 109.719 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.636 ' OG ' ' HB3' ' A' ' 1' ' ' SER . 70.5 m -124.27 -172.31 2.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.587 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -124.58 171.58 9.91 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.885 0.85 . . . . 0.0 111.845 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.663 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.2 OUTLIER -126.39 162.93 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 177.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.731 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 67.03 -144.23 44.53 Favored Glycine 0 C--N 1.309 -0.919 0 C-N-CA 117.747 -2.168 . . . . 0.0 111.077 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.487 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 39.48 -138.08 1.14 Allowed Glycine 0 C--N 1.332 0.309 0 N-CA-C 114.888 0.715 . . . . 0.0 114.888 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.4 -26.7 0.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.465 -0.368 . . . . 0.0 111.664 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.461 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 2.5 m -57.17 -62.46 1.75 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.735 0.302 . . . . 0.0 110.426 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 4' ' ' SER . . . 89.84 -90.06 1.59 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.528 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.85 -11.43 78.19 Favored Glycine 0 CA--C 1.517 0.191 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.759 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.461 ' HB1' ' HB3' ' A' ' 10' ' ' SER . . . -82.34 143.87 49.05 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 117.29 0.545 . . . . 0.0 111.33 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -89.27 161.82 5.64 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.902 2.401 . . . . 0.0 112.664 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 86.6 m -79.99 133.94 36.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.119 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.57 114.4 44.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.724 0.297 . . . . 0.0 111.254 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.46 ' CE2' ' HE1' ' A' ' 19' ' ' PHE . 90.6 m-85 -108.27 146.5 33.71 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-O 120.751 0.31 . . . . 0.0 110.639 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.21 131.63 16.93 Favored 'Cis proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.479 -1.467 . . . . 0.0 111.579 -0.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.618 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 23.9 p90 -101.22 126.65 47.97 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 86.2 m -89.85 124.77 34.97 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.386 0.612 . . . . 0.0 111.739 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.834 ' CE1' HD12 ' A' ' 22' ' ' LEU . 1.8 t80 -124.11 141.53 51.98 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.834 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER 40.64 32.26 0.14 Allowed 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 124.294 1.038 . . . . 0.0 113.03 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.26 -11.15 69.3 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 115.117 0.807 . . . . 0.0 115.117 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.497 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.5 m-80 -105.54 136.1 45.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 118.564 1.182 . . . . 0.0 112.027 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -78.82 120.45 23.46 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.705 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.9 m-30 -103.26 110.61 22.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.044 0.926 . . . . 0.0 111.181 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -88.98 -18.91 26.46 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.73 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -128.36 177.72 6.77 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.1 m -64.57 161.28 17.78 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.688 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.5 t -136.61 171.84 13.89 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.987 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.615 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 29.4 p -124.39 16.73 8.99 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.65 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -61.71 145.46 52.29 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.787 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.62 -16.74 29.19 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.618 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.597 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 3.6 mtp-105 -101.03 -166.75 1.34 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.671 0.735 . . . . 0.0 110.749 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 p -144.7 -24.68 0.51 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.17 -89.32 0.21 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.182 -1.007 . . . . 0.0 113.399 -178.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.45 -14.87 0.12 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 119.187 2.435 . . . . 0.0 119.187 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.597 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 10.5 mptt -69.82 152.42 44.59 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 121.756 2.778 . . . . 0.0 111.8 -178.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.615 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 51.4 mtt -119.55 147.15 44.81 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.659 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 19.9 p-90 -136.96 -168.62 2.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.493 0.663 . . . . 0.0 111.689 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.551 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.6 p -162.18 140.31 8.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.23 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.618 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -69.9 149.11 48.17 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.407 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 81.2 p -95.03 14.63 21.2 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.518 0.675 . . . . 0.0 109.936 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.3 p -137.62 160.79 38.21 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.325 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.593 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -63.3 -32.94 74.48 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.03 0.443 . . . . 0.0 111.16 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -127.04 115.81 19.76 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.764 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 66.0 t80 -81.4 -31.61 33.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -56.89 -34.26 67.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.67 -62.62 1.43 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.35 -24.68 64.84 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 9.0 mtm180 40.51 48.74 2.55 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -120.47 121.72 39.1 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.764 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.8 p-90 -135.44 174.14 10.95 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -175.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.487 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.86 141.84 7.1 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.155 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.731 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.7 m-85 -57.0 154.37 9.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.217 0.532 . . . . 0.0 111.549 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.453 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 4.6 t -58.65 133.09 86.01 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.081 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.11 4.22 3.43 Favored 'Trans proline' 0 CA--C 1.513 -0.575 0 C-N-CA 122.86 2.373 . . . . 0.0 113.558 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -133.59 105.41 6.85 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.085 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -125.31 47.88 2.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.252 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.623 0 CA-C-O 118.443 -1.198 . . . . 0.0 112.23 -179.821 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.0 t . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -64.49 -76.52 0.07 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.955 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 72.6 mtp -128.21 -178.01 4.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.142 0.496 . . . . 0.0 111.443 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 t -127.79 -171.52 2.46 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.852 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.523 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 61.7 p -105.42 162.73 13.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.242 0.544 . . . . 0.0 112.11 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.844 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -96.35 -168.1 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 176.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.663 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 39.06 -124.29 1.72 Allowed Glycine 0 C--O 1.237 0.282 0 O-C-N 123.954 0.784 . . . . 0.0 113.18 177.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.671 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 36.68 -144.57 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 176.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -161.75 33.91 0.13 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.546 -0.827 . . . . 0.0 110.391 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 p -78.22 -54.29 6.39 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.39 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.0 -43.38 1.7 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.609 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.19 40.4 0.2 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.49 145.77 36.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.993 -0.104 . . . . 0.0 110.725 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -91.69 175.6 2.15 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.251 2.634 . . . . 0.0 111.889 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.9 m -78.62 124.55 28.29 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.427 HG13 ' HA ' ' A' ' 45' ' ' ALA . 82.0 t -94.88 106.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.834 0.35 . . . . 0.0 110.102 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -104.46 139.88 20.54 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.514 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -87.32 131.98 12.52 Favored 'Cis proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.748 -1.355 . . . . 0.0 111.932 -0.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.606 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 16.3 p90 -99.42 130.75 45.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.3 m -96.24 123.44 39.87 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.537 0.684 . . . . 0.0 111.681 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.923 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 13.1 t80 -128.36 141.0 51.56 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.33 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.691 HD12 ' CD1' ' A' ' 21' ' ' PHE . 2.8 mp 48.77 31.92 3.36 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 123.794 0.684 . . . . 0.0 112.302 176.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.46 -0.6 87.05 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.683 -0.689 . . . . 0.0 114.289 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.4 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 62.6 m-80 -114.96 137.27 52.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 118.072 0.936 . . . . 0.0 112.676 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -77.43 125.08 28.76 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.336 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.923 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.5 m-30 -112.6 111.16 21.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.982 0.896 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -92.65 -6.69 48.81 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.71 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 p -138.31 -172.66 3.33 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 98.3 m -69.52 163.54 25.16 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.487 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.1 t -140.77 169.05 18.36 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.665 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.625 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 12.3 p -122.89 15.75 10.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.478 ' CB ' ' HD2' ' A' ' 21' ' ' PHE . . . -60.38 138.64 57.95 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.809 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.86 -8.28 23.05 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.051 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.549 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 26.0 mtp85 -110.86 -73.59 0.68 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.088 0.471 . . . . 0.0 110.528 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.2 m 60.95 18.23 8.64 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.303 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -92.92 -54.69 3.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.717 0.77 . . . . 0.0 110.374 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.86 -52.4 0.12 Allowed Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 114.638 -1.165 . . . . 0.0 113.305 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.702 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 1.9 mptt -69.85 116.32 10.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 0.0 111.893 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.625 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 56.4 mtt -83.73 150.8 25.59 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.673 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 14.3 p-90 -130.32 -171.31 2.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.495 0.664 . . . . 0.0 112.505 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.1 p -154.02 140.7 18.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.603 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.561 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -80.05 156.5 27.08 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.129 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.3 p -108.19 17.93 21.7 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.838 0.828 . . . . 0.0 110.209 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.7 p -138.83 146.61 41.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.596 -1.184 . . . . 0.0 108.498 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -53.1 -46.56 68.75 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.131 0.491 . . . . 0.0 110.675 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -116.36 106.82 14.06 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.791 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 77.6 t80 -71.08 -46.2 62.3 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.866 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -44.3 -34.53 1.97 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -86.69 -62.75 1.44 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -80.63 -17.93 49.72 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.637 ' HG3' ' O ' ' A' ' 47' ' ' TYR . 21.6 mtm105 33.35 64.68 0.3 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -125.22 112.93 17.0 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.791 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.7 p-90 -120.42 177.07 5.18 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.673 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -158.59 163.52 33.1 Favored Glycine 0 C--O 1.22 -0.769 0 CA-C-N 113.314 -1.766 . . . . 0.0 108.856 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.844 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 1.9 m-85 -88.22 164.51 15.6 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 118.56 1.18 . . . . 0.0 112.683 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.881 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 3.2 t -84.43 163.12 48.73 Favored Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.881 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 89.0 Cg_endo -69.18 -153.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.964 1.776 . . . . 0.0 113.055 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.416 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 8.5 t70 -75.96 118.47 18.77 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.725 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -113.59 36.29 3.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.375 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.709 0 CA-C-O 118.584 -1.12 . . . . 0.0 112.685 -179.924 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.66 0.266 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 3.2 p-90 -75.38 -40.43 58.03 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 33.3 mtt -118.25 109.12 15.96 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.902 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.9 m -107.2 168.12 9.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.482 -0.781 . . . . 0.0 108.971 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.66 HG22 ' HA3' ' A' ' 54' ' ' GLY . 40.7 p -91.2 155.99 18.17 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 1.1 t -127.74 6.49 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-O 122.934 1.35 . . . . 0.0 110.317 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.434 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . -158.17 -156.05 7.82 Favored Glycine 0 C--N 1.284 -2.338 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.444 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.649 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 75.05 -144.19 31.88 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.297 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.482 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -140.13 29.11 2.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.282 0.563 . . . . 0.0 109.623 179.19 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.422 ' HB2' ' CB ' ' A' ' 13' ' ' ALA . 1.8 p -87.32 -41.0 13.97 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.377 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.19 43.61 7.42 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.883 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.41 35.5 17.08 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.487 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.59 ' O ' HG21 ' A' ' 5' ' ' THR . . . -92.42 148.74 37.02 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.687 0.279 . . . . 0.0 110.492 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.6 Cg_exo -73.14 126.81 11.46 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.696 2.264 . . . . 0.0 112.354 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' A' ' 5' ' ' THR . 88.3 m -65.07 141.65 58.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.366 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.498 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 48.3 t -107.78 132.27 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.708 0.29 . . . . 0.0 111.139 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.479 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 59.8 m-85 -125.39 142.7 42.41 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.308 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.565 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 6.7 Cg_endo -84.91 130.87 14.99 Favored 'Cis proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.324 -1.531 . . . . 0.0 112.014 -0.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.688 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 31.5 p90 -102.72 130.15 49.57 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 62.6 m -93.23 121.54 34.7 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.303 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.805 ' CE2' HD23 ' A' ' 22' ' ' LEU . 56.1 t80 -112.95 129.45 56.47 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.598 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.805 HD23 ' CE2' ' A' ' 21' ' ' PHE . 7.4 mp 42.96 36.83 0.95 Allowed 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 124.349 1.031 . . . . 0.0 112.908 175.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.0 -15.48 56.63 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 20' ' ' THR . 49.8 m-80 -109.65 129.98 55.55 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 119.367 1.583 . . . . 0.0 112.557 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.3 mtmt -77.36 119.59 21.2 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.001 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.798 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.5 m-85 -108.66 114.04 27.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.743 0.782 . . . . 0.0 111.498 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.565 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 35.0 mt-10 -89.98 -8.78 50.85 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.871 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.4 p -136.72 -177.22 4.64 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.0 m -67.05 165.24 16.17 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.064 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.461 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 9.0 t -144.45 170.09 16.7 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.131 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.711 ' HB2' ' HA ' ' A' ' 36' ' ' ASP . 22.9 p -123.78 18.6 9.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.632 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -61.91 136.58 58.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 113.922 -1.49 . . . . 0.0 112.045 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.31 -4.13 9.43 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.775 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.583 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 10.0 mtp85 -106.72 -176.8 3.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.578 0.704 . . . . 0.0 112.177 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.56 ' C ' ' H ' ' A' ' 37' ' ' GLY . 1.5 m -82.36 25.21 0.63 Allowed 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.004 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.711 ' HA ' ' HB2' ' A' ' 31' ' ' SER . 0.0 OUTLIER 64.59 -27.4 0.09 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.856 2.062 . . . . 0.0 113.289 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' A' ' 35' ' ' SER . . . -66.51 -77.39 0.29 Allowed Glycine 0 C--N 1.304 -1.208 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.997 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.695 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 7.9 mptt -72.83 101.71 3.21 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.451 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 50.3 mtt -75.7 153.43 37.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.664 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.7 p-90 -137.46 -165.7 1.81 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.351 0.596 . . . . 0.0 110.977 -178.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.3 p -167.9 141.32 3.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.962 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.611 ' HB3' ' HD2' ' A' ' 47' ' ' TYR . . . -72.3 156.15 39.42 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.025 0.44 . . . . 0.0 111.273 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.8 p -104.58 13.79 31.03 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.796 0.808 . . . . 0.0 109.506 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.0 p -136.89 142.57 42.75 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.819 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.688 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -54.89 -39.89 69.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.979 0.419 . . . . 0.0 110.947 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -119.17 103.11 9.23 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 1.001 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 32.6 t80 -72.59 -32.99 66.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.177 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -51.22 -28.51 11.66 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -95.12 -60.79 1.6 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -82.19 -19.54 39.62 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 8.1 mtm180 44.3 44.67 6.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -109.13 114.96 29.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 1.001 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.6 p-90 -126.84 175.9 7.68 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -175.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.66 ' HA3' HG22 ' A' ' 5' ' ' THR . . . -172.59 154.58 21.41 Favored Glycine 0 C--O 1.217 -0.946 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.558 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 5' ' ' THR . 15.1 m-30 -64.26 164.59 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 31.5 t -89.67 145.05 32.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.342 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.583 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 73.4 Cg_endo -67.7 -146.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 122.772 2.315 . . . . 0.0 114.078 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.453 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 2.5 m-20 -50.06 108.7 0.23 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.56 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -88.86 -34.13 17.11 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.787 0 CA-C-O 118.271 -1.294 . . . . 0.0 111.683 -179.748 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 120.548 0.213 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -109.13 82.49 1.6 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.24 56.36 3.62 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.761 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 26.3 m -71.63 156.94 38.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.505 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.432 HG23 ' SG ' ' A' ' 15' ' ' CYS . 77.5 p -69.8 173.11 6.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.53 0.566 . . . . 0.0 112.53 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.784 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 1.5 t -106.37 -67.96 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 CA-C-O 123.298 1.523 . . . . 0.0 109.88 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.811 ' H ' ' HB2' ' A' ' 55' ' ' PHE . . . -76.61 -156.23 6.83 Favored Glycine 0 C--N 1.284 -2.338 0 CA-C-N 111.167 -2.742 . . . . 0.0 112.599 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.576 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 74.14 -139.56 26.16 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.487 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.407 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -160.76 44.78 0.19 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.092 0.472 . . . . 0.0 110.421 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.473 ' HB2' ' CB ' ' A' ' 13' ' ' ALA . 3.3 p -79.58 -36.1 38.67 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.651 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.81 38.47 23.51 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.132 -1.032 . . . . 0.0 110.983 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.07 53.14 2.1 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.433 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.473 ' CB ' ' HB2' ' A' ' 10' ' ' SER . . . -129.78 144.94 54.98 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.597 0.237 . . . . 0.0 110.608 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 72.0 Cg_endo -83.05 170.69 12.11 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.512 2.142 . . . . 0.0 112.144 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.7 m -85.49 135.14 33.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.573 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 65.5 t -97.14 115.58 37.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -113.53 138.67 22.65 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-O 120.886 0.374 . . . . 0.0 111.246 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -85.45 136.5 21.66 Favored 'Cis proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.466 -1.889 . . . . 0.0 112.654 -0.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.651 ' CG ' ' HB1' ' A' ' 42' ' ' ALA . 28.5 p90 -102.26 136.4 42.16 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 91.3 m -98.48 122.28 41.47 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.614 -0.835 . . . . 0.0 112.618 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.713 ' CE1' HD12 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -123.37 147.34 47.17 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.713 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 37.25 37.06 0.08 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.276 1.03 . . . . 0.0 113.676 178.447 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.15 -1.01 87.66 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.112 0.805 . . . . 0.0 115.112 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 20' ' ' THR . 68.7 m-80 -112.38 144.34 41.98 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 118.617 1.208 . . . . 0.0 111.985 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -87.46 120.44 28.77 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.596 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 16.6 m-85 -102.19 116.41 32.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.645 0.736 . . . . 0.0 111.315 -177.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -89.8 -24.17 21.53 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.616 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.8 p -126.12 -176.76 3.73 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.3 m -65.28 164.82 12.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.512 0.672 . . . . 0.0 109.891 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.48 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 11.5 t -139.61 171.57 14.06 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.272 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.2 p -126.07 19.7 7.66 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.711 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -67.24 138.46 56.93 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 113.503 -1.68 . . . . 0.0 112.009 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.67 -1.08 59.37 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.182 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.597 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 12.8 mtp85 -107.23 129.33 54.88 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.534 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 68.6 m -104.62 8.01 35.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.155 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 1.5 p-10 -93.87 -85.88 0.28 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.951 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.455 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 176.51 -26.61 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.934 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.597 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 62.4 mmtt -64.86 136.69 57.15 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 117.798 0.799 . . . . 0.0 111.664 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 52.1 mtt -92.27 145.2 24.67 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.648 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.5 p-90 -133.23 -167.75 1.97 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.299 0.571 . . . . 0.0 111.881 -177.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 3.4 p -158.34 138.34 12.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.677 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.651 ' HB1' ' CG ' ' A' ' 19' ' ' PHE . . . -71.72 151.18 43.81 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.911 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.9 p -102.44 15.82 28.09 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.564 0.697 . . . . 0.0 110.58 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.7 p -138.39 156.34 47.68 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.32 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.38 -35.01 76.31 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.056 0.455 . . . . 0.0 110.941 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -124.53 113.3 17.91 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.666 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 58.8 t80 -80.58 -33.61 35.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.985 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -56.22 -34.48 66.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -83.9 -62.3 1.6 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.15 -29.6 61.87 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 4.0 mtm180 45.55 45.91 10.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.841 0.829 . . . . 0.0 113.052 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -115.24 119.7 37.23 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.666 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.6 p-90 -131.14 179.97 5.69 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -174.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -170.31 151.32 16.22 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 113.873 -1.512 . . . . 0.0 109.323 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.811 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 11.6 m-85 -65.74 162.77 17.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.625 1.212 . . . . 0.0 112.718 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.435 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.5 t -71.17 126.28 91.95 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.783 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.4 ' HB3' ' O ' ' A' ' 4' ' ' SER . 12.2 Cg_endo -85.06 -161.06 0.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.883 2.389 . . . . 0.0 112.917 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.7 t0 34.35 56.52 0.66 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.307 1.005 . . . . 0.0 112.219 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -99.74 40.67 1.21 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.225 0.536 . . . . 0.0 110.686 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.772 0 CA-C-O 118.891 -0.949 . . . . 0.0 111.343 179.28 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.935 0.398 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -95.12 105.9 17.87 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.249 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.725 ' HG3' ' HB3' ' A' ' 14' ' ' PRO . 19.3 ptm -91.89 36.16 0.97 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.555 0.693 . . . . 0.0 109.637 178.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 12' ' ' GLY . 19.7 m -77.61 162.46 27.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.195 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.552 HG22 ' SG ' ' A' ' 41' ' ' CYS . 76.2 p -106.17 169.98 8.19 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 122.336 1.065 . . . . 0.0 113.844 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.718 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -112.87 -152.89 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 176.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.692 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 28.66 -122.28 0.07 OUTLIER Glycine 0 N--CA 1.463 0.456 0 O-C-N 124.671 1.232 . . . . 0.0 114.099 176.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.687 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 39.59 -144.7 0.34 Allowed Glycine 0 C--N 1.331 0.284 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.19 10.13 0.38 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.49 -0.855 . . . . 0.0 109.94 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -96.88 19.59 12.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.64 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.04 -98.27 0.63 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.999 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 4' ' ' SER . . . -142.08 36.39 1.67 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.77 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -76.96 149.22 79.87 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.311 0.1 . . . . 0.0 110.911 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.725 ' HB3' ' HG3' ' A' ' 3' ' ' MET . 11.9 Cg_exo -70.27 157.15 60.28 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.085 2.523 . . . . 0.0 112.727 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.6 m -79.82 135.51 36.49 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.7 t -100.16 112.43 32.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.669 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 55.0 m-85 -108.39 141.94 24.3 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.852 0.358 . . . . 0.0 111.408 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.495 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.4 Cg_endo -86.87 136.03 17.42 Favored 'Cis proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.531 -1.445 . . . . 0.0 111.981 -0.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.841 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 33.5 p90 -103.29 129.18 50.22 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.7 m -92.43 127.25 37.85 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.233 0.539 . . . . 0.0 112.124 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.852 ' CE1' HD12 ' A' ' 22' ' ' LEU . 1.2 t80 -130.36 144.21 51.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.852 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 40.37 36.86 0.38 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.462 1.105 . . . . 0.0 112.899 178.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.23 -9.84 73.49 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 114.709 0.644 . . . . 0.0 114.709 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -107.6 134.45 50.58 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.453 1.127 . . . . 0.0 111.827 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -79.71 121.14 24.96 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.791 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.821 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.2 m-30 -104.52 110.31 22.54 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.982 0.896 . . . . 0.0 111.086 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 33.2 mt-10 -88.04 -16.69 32.94 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.295 -1.321 . . . . 0.0 110.742 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 p -129.28 -175.24 3.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.9 m -65.43 163.42 15.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.465 0.65 . . . . 0.0 110.177 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.527 HG22 ' CZ ' ' A' ' 19' ' ' PHE . 11.9 t -138.73 -176.78 4.6 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.645 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.436 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 10.1 p -141.07 18.62 2.28 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.766 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -64.84 145.69 55.92 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 113.281 -1.781 . . . . 0.0 112.503 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.09 5.13 32.05 Favored Glycine 0 C--O 1.235 0.198 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.847 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.411 ' NH1' ' HA ' ' A' ' 39' ' ' MET . 0.1 OUTLIER -107.57 -76.12 0.62 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.128 0.464 . . . . 0.0 110.982 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.2 m 75.78 25.8 1.12 Allowed 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -112.14 -88.1 0.54 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.223 0.92 . . . . 0.0 111.3 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.58 -45.08 0.06 OUTLIER Glycine 0 CA--C 1.528 0.859 0 N-CA-C 116.081 1.193 . . . . 0.0 116.081 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.653 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 3.9 mptt -64.63 -158.43 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.436 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 87.8 mtp -158.42 145.55 17.76 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.609 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 23.5 p-90 -135.59 -174.64 3.7 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 5' ' ' THR . 6.5 p -152.76 136.85 16.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.161 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.841 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -73.04 151.14 41.84 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.013 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.3 p -100.61 17.67 21.22 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.733 0.777 . . . . 0.0 109.275 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.489 HG21 ' HB2' ' A' ' 52' ' ' LYS . 71.7 p -135.6 151.7 50.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.213 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.656 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -60.72 -37.67 82.52 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.121 0.486 . . . . 0.0 110.878 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -124.26 107.85 11.62 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.685 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 56.4 t80 -74.75 -32.31 62.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.301 -0.408 . . . . 0.0 112.047 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -55.97 -33.66 65.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -94.96 -56.87 2.6 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -77.54 -20.93 53.4 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 17.5 mtm180 39.63 52.45 2.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.489 ' HB2' HG21 ' A' ' 44' ' ' THR . 88.6 mttt -122.47 117.9 27.05 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.687 ' CE2' ' HA2' ' A' ' 8' ' ' GLY . 9.2 p-90 -125.73 172.73 9.56 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -158.64 154.13 25.23 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.29 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.718 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 1.0 OUTLIER -80.34 156.79 26.58 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -178.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 81.7 m -97.63 124.56 47.97 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -78.43 -159.24 0.1 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.393 2.062 . . . . 0.0 113.771 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.1 t70 40.87 60.2 2.02 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.628 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -113.16 19.61 16.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.038 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.567 0 CA-C-O 118.499 -1.167 . . . . 0.0 111.893 -179.934 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.966 0.413 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -97.44 -137.42 0.27 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.657 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.4 mtt -89.87 67.48 7.21 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 m -70.43 162.39 28.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.946 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.406 HG22 ' SG ' ' A' ' 41' ' ' CYS . 16.1 p -108.11 173.92 6.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.666 0.746 . . . . 0.0 112.47 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -116.78 -168.23 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.072 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.463 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 36.73 -122.7 0.82 Allowed Glycine 0 N--CA 1.462 0.4 0 O-C-N 124.056 0.848 . . . . 0.0 113.076 178.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.699 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 35.15 -141.36 0.13 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 115.616 1.006 . . . . 0.0 115.616 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.89 -0.31 0.82 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.205 -0.497 . . . . 0.0 110.213 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 m -91.39 -63.82 1.21 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.856 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.61 -74.4 2.12 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.098 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.27 -11.83 82.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.233 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.91 140.98 23.65 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.913 0.387 . . . . 0.0 111.165 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -87.04 167.75 8.02 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.927 2.418 . . . . 0.0 112.015 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.7 m -79.73 139.75 37.2 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.312 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.1 t -107.5 112.42 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -114.02 143.7 30.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.723 0.297 . . . . 0.0 111.103 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -85.75 137.25 21.97 Favored 'Cis proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.495 -1.46 . . . . 0.0 111.836 -0.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.523 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 41.3 p90 -102.79 -178.36 3.65 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.453 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.8 m -135.03 126.2 28.02 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.664 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.821 ' CE1' HD12 ' A' ' 22' ' ' LEU . 1.9 t80 -134.24 141.58 47.05 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.821 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER 40.87 38.42 0.65 Allowed 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.746 1.219 . . . . 0.0 113.706 178.607 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.17 -1.65 88.57 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -107.89 154.88 20.94 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 118.439 1.119 . . . . 0.0 111.26 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -94.83 126.36 40.11 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 21.8 m-85 -113.88 111.92 22.51 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.68 0.752 . . . . 0.0 111.784 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -96.03 -8.33 33.88 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.09 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 p -136.57 -172.75 3.23 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.8 m -69.31 168.64 13.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.128 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.445 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 10.2 t -144.48 167.12 23.25 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.594 0.711 . . . . 0.0 110.738 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.493 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 61.3 p -120.54 12.64 11.58 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -56.05 136.74 52.08 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.67 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.37 -10.86 19.99 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.018 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.7 mtp85 -111.21 -71.73 0.75 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.059 0.457 . . . . 0.0 110.272 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.7 m 56.78 27.58 13.02 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.41 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -100.25 -63.41 1.13 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.356 0.598 . . . . 0.0 110.641 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.26 -49.05 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.498 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.617 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -73.24 108.63 6.23 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -179.427 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.493 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 80.9 mtp -80.6 148.37 30.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.651 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 16.5 p-90 -128.31 -165.11 1.45 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.382 0.61 . . . . 0.0 111.627 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.5 p -159.68 146.9 16.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.968 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.523 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -81.0 143.57 32.42 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.473 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.0 p -97.14 13.97 27.43 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.778 0.799 . . . . 0.0 110.113 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.661 HG21 ' HB2' ' A' ' 52' ' ' LYS . 38.1 p -134.09 158.76 42.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.157 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -65.39 -26.54 68.04 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.193 0.52 . . . . 0.0 110.624 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -132.71 117.44 17.85 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.794 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 65.6 t80 -86.18 -34.78 20.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -54.36 -37.06 64.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.967 0.413 . . . . 0.0 111.791 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.76 -66.37 0.93 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.33 -20.37 63.0 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.649 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 26.2 mtt180 38.55 51.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.661 ' HB2' HG21 ' A' ' 44' ' ' THR . 89.8 mttt -113.71 119.22 36.64 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 176.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.794 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 5.3 p-90 -132.25 171.68 13.39 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -174.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.568 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -166.07 143.9 8.76 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 113.3 -1.773 . . . . 0.0 109.838 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.667 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.4 m-30 -60.51 151.51 28.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.399 0.6 . . . . 0.0 111.63 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.483 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 4.5 t -62.56 128.41 91.52 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.66 5.08 2.62 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 C-N-CA 122.856 2.371 . . . . 0.0 114.61 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -154.8 116.51 4.13 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.352 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -100.39 116.35 32.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.713 0.292 . . . . 0.0 110.482 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.714 0 CA-C-O 118.684 -1.064 . . . . 0.0 112.075 179.975 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.442 ' OG ' ' HG2' ' A' ' 3' ' ' MET . 40.4 p . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -91.52 15.39 12.51 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.442 ' HG2' ' OG ' ' A' ' 1' ' ' SER . 19.1 ptp -82.15 129.85 34.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.9 m -96.28 169.55 9.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.26 0.552 . . . . 0.0 111.299 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.0 p -91.14 176.61 6.52 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.605 0.717 . . . . 0.0 111.851 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.771 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -113.77 -166.54 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 176.376 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.632 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 34.7 -126.11 0.58 Allowed Glycine 0 N--CA 1.463 0.47 0 O-C-N 124.069 0.856 . . . . 0.0 114.117 177.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.573 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 40.74 -149.1 0.2 Allowed Glycine 0 C--N 1.337 0.611 0 N-CA-C 115.77 1.068 . . . . 0.0 115.77 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.73 5.22 1.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.826 -0.687 . . . . 0.0 110.435 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.468 ' HG ' HG21 ' A' ' 43' ' ' THR . 13.7 m -84.41 -45.8 12.35 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.175 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.45 -105.28 3.23 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.802 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.69 32.48 3.68 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.674 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' A' ' 10' ' ' SER . . . -105.01 144.24 28.34 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.979 0.39 . . . . 0.0 110.196 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -87.86 167.13 7.12 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.914 2.409 . . . . 0.0 112.136 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.2 m -83.44 129.67 34.99 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.493 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 92.7 t -96.87 112.25 28.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.707 0.289 . . . . 0.0 110.305 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -107.0 138.37 19.8 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.562 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -86.25 132.25 14.48 Favored 'Cis proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.21 -1.579 . . . . 0.0 112.263 -0.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.606 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 17.9 p90 -99.93 126.28 46.06 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.244 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 91.2 m -91.67 122.46 34.25 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.963 0.411 . . . . 0.0 110.565 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.833 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 68.3 t80 -115.2 130.09 56.82 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.604 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.487 HD23 ' H ' ' A' ' 22' ' ' LEU . 3.7 mm? 35.28 45.11 0.19 Allowed 'General case' 0 N--CA 1.428 -1.536 0 O-C-N 124.775 1.297 . . . . 0.0 113.319 175.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.72 -23.07 32.21 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 116.497 1.359 . . . . 0.0 116.497 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -111.26 132.51 54.31 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 120.027 1.914 . . . . 0.0 113.12 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 39.7 mtpt -77.71 126.67 31.22 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.833 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.3 m-85 -110.77 118.67 36.79 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.898 0.856 . . . . 0.0 111.643 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -89.62 -12.44 39.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.76 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.4 p -136.08 -171.21 2.82 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.0 m -70.19 166.24 20.41 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.499 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -143.91 171.22 14.54 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.335 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.464 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 71.3 p -125.41 20.88 7.97 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.453 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -60.45 132.83 55.13 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.971 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.02 -8.04 40.12 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.095 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.0 mtp85 -108.85 -79.16 0.58 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.594 0.235 . . . . 0.0 111.28 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.7 p 52.5 31.31 9.64 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.031 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -105.36 -37.28 6.9 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.728 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.28 -65.35 0.16 Allowed Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.829 -1.078 . . . . 0.0 113.279 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.58 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 2.0 mptt -71.8 135.72 46.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.464 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 58.2 mtt -94.71 153.21 17.9 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.628 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.8 p-90 -133.6 -166.51 1.79 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.216 0.532 . . . . 0.0 111.777 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 8.4 p -160.07 143.99 14.28 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.633 ' HB3' ' HD2' ' A' ' 47' ' ' TYR . . . -78.77 152.57 31.38 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.563 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.468 HG21 ' HG ' ' A' ' 10' ' ' SER . 81.0 p -102.98 9.94 38.44 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.656 0.741 . . . . 0.0 110.553 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.0 p -133.03 153.12 51.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.989 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.44 -42.01 81.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 111.341 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -120.83 111.36 17.46 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 1.033 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 34.3 t80 -77.16 -31.82 55.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.938 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -51.94 -32.8 34.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -90.08 -71.55 0.61 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.25 -27.81 68.24 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 24.0 mtm-85 45.15 51.0 9.31 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -117.04 119.04 34.04 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 1.033 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.8 p-90 -127.42 172.09 10.97 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -175.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.44 147.38 13.8 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 113.292 -1.777 . . . . 0.0 109.466 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.771 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 6.1 m-30 -62.84 158.37 19.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.329 1.065 . . . . 0.0 110.989 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.512 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 25.2 t -64.74 130.74 94.91 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.167 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -78.89 11.46 2.54 Favored 'Trans proline' 0 CA--C 1.515 -0.427 0 C-N-CA 123.178 2.585 . . . . 0.0 112.321 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -121.56 59.48 0.97 Allowed 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.419 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -126.8 -149.12 0.41 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.002 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.91 0 CA-C-O 118.683 -1.065 . . . . 0.0 112.173 179.669 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.8 p . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.883 0.373 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -103.54 76.75 1.43 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.858 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.1 ptm -135.9 133.28 37.53 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.351 0.595 . . . . 0.0 111.086 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.5 t -136.91 -171.37 2.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.701 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.41 166.96 10.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.328 1.061 . . . . 0.0 112.95 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.663 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.2 OUTLIER -129.9 163.45 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 178.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.698 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 62.12 -141.35 47.23 Favored Glycine 0 C--N 1.316 -0.561 0 C-N-CA 118.059 -2.02 . . . . 0.0 111.861 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.61 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 39.67 -139.09 1.03 Allowed Glycine 0 C--N 1.334 0.468 0 N-CA-C 115.676 1.03 . . . . 0.0 115.676 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.16 28.07 0.25 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.273 -0.463 . . . . 0.0 110.569 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.67 -52.24 7.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.311 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.68 -69.33 0.46 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.942 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.58 31.68 2.3 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.351 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.27 139.05 19.76 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.799 0.333 . . . . 0.0 111.168 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -84.25 164.41 13.01 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.726 2.284 . . . . 0.0 111.527 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.9 m -72.33 138.39 47.29 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.444 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 59.7 t -107.88 113.32 43.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.581 0.229 . . . . 0.0 110.681 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -115.82 140.24 25.91 Favored Pre-proline 0 N--CA 1.454 -0.268 0 CA-C-O 120.845 0.355 . . . . 0.0 110.963 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 5.4 Cg_endo -87.0 132.88 13.84 Favored 'Cis proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.292 -1.545 . . . . 0.0 111.754 -0.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.444 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 46.3 p90 -98.48 -175.11 3.0 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.844 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 18.9 m -140.0 119.58 13.19 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.727 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.82 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 68.3 t80 -117.83 133.21 56.15 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.556 ' H ' HD21 ' A' ' 22' ' ' LEU . 3.6 mm? 34.62 47.53 0.24 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.697 1.248 . . . . 0.0 113.797 175.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.99 -9.11 75.79 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 116.402 1.321 . . . . 0.0 116.402 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' THR . 51.5 m-80 -110.12 150.01 29.23 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.821 1.811 . . . . 0.0 112.363 -178.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -91.57 125.74 36.41 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.82 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 88.7 m-85 -115.59 114.3 24.75 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.612 0.72 . . . . 0.0 111.574 -178.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 41.3 mt-10 -93.21 -12.82 29.33 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.234 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.5 p -133.05 -166.47 1.76 Allowed 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.7 m -76.35 170.17 16.86 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.863 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.5 t -147.76 169.5 19.61 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.346 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.9 p -123.59 20.28 9.48 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.85 133.15 55.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 113.523 -1.672 . . . . 0.0 112.101 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.73 -0.22 45.39 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.468 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.442 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 22.3 mtp85 -106.5 -81.99 0.54 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.9 m 62.27 25.91 15.5 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.366 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -98.73 -35.03 10.29 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.644 0.735 . . . . 0.0 110.418 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.95 -41.75 0.76 Allowed Glycine 0 C--N 1.313 -0.716 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.895 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.442 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 21.8 mmmt -84.91 131.71 34.46 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -90.28 147.05 23.76 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.627 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.5 p-90 -128.59 -169.61 2.11 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.303 0.573 . . . . 0.0 111.834 -178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.0 p -154.41 142.2 20.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.761 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.76 143.13 40.09 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.509 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.1 p -99.07 10.35 41.63 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.581 0.705 . . . . 0.0 110.043 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.5 p -136.14 146.85 47.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.729 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.32 -48.24 79.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.768 0.318 . . . . 0.0 111.146 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.412 ' OD1' ' HB2' ' A' ' 48' ' ' ASP . 20.1 t-20 -109.24 99.68 8.92 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.859 ' CE2' ' HB3' ' A' ' 53' ' ' TRP . 47.5 t80 -72.16 -32.91 67.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.559 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.412 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . 54.2 m-20 -45.48 -39.83 7.68 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.8 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -95.97 -55.69 2.9 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -69.23 -35.04 75.76 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.2 mmm180 51.15 37.98 19.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -107.57 118.67 37.33 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.859 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 11.0 p-90 -128.66 174.22 9.61 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.404 -175.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.603 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.08 142.05 7.47 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.751 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.698 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 9.2 m-85 -59.03 154.13 16.23 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.376 0.608 . . . . 0.0 111.639 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.768 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 5.1 t -66.62 153.43 93.46 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.768 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 61.0 Cg_endo -64.18 -143.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.951 2.434 . . . . 0.0 114.055 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.448 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 33.7 t70 -61.21 114.92 3.42 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.867 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.573 ' NE2' ' HB3' ' A' ' 56' ' ' CYS . 38.0 mt-30 -129.47 -55.49 1.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.071 178.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.759 0 CA-C-O 118.253 -1.304 . . . . 0.0 111.3 -179.706 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.441 0.163 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -82.18 124.93 30.33 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.5 mtm -83.92 133.81 34.7 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.493 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.1 m -72.45 160.61 32.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.358 179.399 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.483 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 11.0 p -97.3 162.6 13.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.676 0.75 . . . . 0.0 112.639 -179.43 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.747 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -110.07 -163.44 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.119 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.418 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 34.62 -121.86 0.44 Allowed Glycine 0 N--CA 1.463 0.447 0 O-C-N 124.282 0.988 . . . . 0.0 112.999 177.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.683 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 29.36 -135.28 0.06 OUTLIER Glycine 0 C--N 1.338 0.66 0 N-CA-C 115.986 1.154 . . . . 0.0 115.986 176.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -144.23 -31.89 0.44 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.722 -0.739 . . . . 0.0 109.214 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.0 m -56.76 -66.89 0.37 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.557 179.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.5 -70.77 1.34 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.18 179.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.29 -12.94 69.95 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.917 -0.658 . . . . 0.0 113.213 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -96.15 140.81 22.43 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 117.27 0.535 . . . . 0.0 110.983 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 42.0 Cg_endo -85.78 165.56 10.31 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.941 2.427 . . . . 0.0 112.721 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 5.6 m -71.79 127.7 33.41 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.3 t -102.68 101.83 12.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.033 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.653 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 47.7 m-85 -103.45 143.3 26.34 Favored Pre-proline 0 N--CA 1.45 -0.45 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.751 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.83 136.02 22.55 Favored 'Cis proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.578 -1.843 . . . . 0.0 112.355 -0.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.653 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 29.9 p90 -102.77 -171.97 2.04 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.289 177.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.2 m -145.76 127.43 15.22 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.705 -177.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.817 ' CE1' HD12 ' A' ' 22' ' ' LEU . 1.5 t80 -134.42 143.02 47.33 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.817 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 41.75 35.41 0.5 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 124.416 1.087 . . . . 0.0 112.976 178.953 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.34 -9.46 77.42 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.473 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 70.7 m-80 -107.73 138.13 44.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 118.368 1.084 . . . . 0.0 112.294 -178.426 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -79.5 123.31 27.44 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.758 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 15.3 m-30 -106.01 114.52 28.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.762 0.791 . . . . 0.0 110.821 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -86.81 -24.75 24.89 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.068 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 p -122.75 -173.24 2.65 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.306 179.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.1 m -72.32 166.92 21.52 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.937 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.9 t -141.61 166.03 25.87 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.408 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.9 p -120.8 18.77 11.85 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.772 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -59.91 139.07 57.63 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 113.656 -1.611 . . . . 0.0 111.466 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.01 -1.45 68.99 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.2 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.56 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 24.2 mtp85 -115.87 149.12 39.17 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 p -118.68 2.94 11.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.046 0.45 . . . . 0.0 110.897 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.08 -82.96 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.339 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.06 -14.62 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.569 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.56 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 66.4 mttt -64.27 102.55 0.53 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 122.276 0.23 . . . . 0.0 110.9 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 43.8 mtt -75.01 143.04 43.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.98 0.419 . . . . 0.0 110.271 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.709 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.1 p-90 -131.24 -167.68 1.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.432 -178.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 15.1 p -157.68 149.54 22.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.006 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.456 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -81.9 151.75 27.12 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.66 178.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 34.5 p -116.23 10.08 14.76 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.016 -178.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.593 HG21 ' HB2' ' A' ' 52' ' ' LYS . 73.4 p -123.03 12.08 9.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.346 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . 70.01 -35.99 0.33 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.336 0.655 . . . . 0.0 111.45 -178.449 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 44' ' ' THR . 21.5 t-20 -129.49 110.48 11.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.877 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 49.5 t80 -87.85 -28.68 21.45 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -177.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -58.23 -34.7 70.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -92.94 -53.28 4.21 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.64 -43.98 52.71 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.203 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.583 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER 61.34 39.55 15.25 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.868 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.593 ' HB2' HG21 ' A' ' 44' ' ' THR . 4.6 mppt? -113.76 118.71 35.04 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.877 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.5 p-90 -130.73 174.96 9.42 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -174.246 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.602 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.4 148.04 13.35 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 113.194 -1.821 . . . . 0.0 109.615 178.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.747 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 7.1 m-30 -60.81 157.81 14.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.58 0.705 . . . . 0.0 111.787 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.479 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 29.3 t -70.78 126.13 92.12 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.823 -178.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -80.75 6.04 5.76 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.814 2.342 . . . . 0.0 111.758 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -131.47 68.16 1.5 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.81 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.432 ' OE1' ' HB3' ' A' ' 56' ' ' CYS . 14.8 mm100 -80.67 162.96 23.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.192 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.868 0 CA-C-O 118.432 -1.204 . . . . 0.0 111.661 -179.735 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 120.836 0.35 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -126.35 143.73 51.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -174.39 0.79 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.669 0.271 . . . . 0.0 111.559 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 t 67.51 -169.26 0.19 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.566 -178.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -101.86 158.02 16.43 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.273 1.035 . . . . 0.0 113.222 -179.039 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -137.9 161.33 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 178.188 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.605 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 62.42 -147.78 49.29 Favored Glycine 0 C--N 1.311 -0.816 0 C-N-CA 118.254 -1.927 . . . . 0.0 111.306 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.731 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 49.3 -148.27 5.58 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 121.607 -0.33 . . . . 0.0 113.766 178.127 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.83 -10.53 2.7 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.51 178.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 m -74.68 -55.27 6.06 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.92 69.54 1.24 Allowed Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.228 -0.442 . . . . 0.0 113.758 178.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.45 -32.43 1.96 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.45 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.09 147.06 72.57 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.332 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -81.56 149.78 16.66 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.636 2.224 . . . . 0.0 112.323 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 72.3 m -77.3 126.14 30.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 43.9 t -95.92 121.43 46.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.871 0.367 . . . . 0.0 110.924 -178.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.531 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 52.7 m-85 -115.86 139.43 24.92 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-O 121.248 0.547 . . . . 0.0 111.308 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.628 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 27.7 Cg_endo -86.79 137.53 19.27 Favored 'Cis proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.669 -1.804 . . . . 0.0 112.359 -0.75 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.647 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 42.8 p90 -102.87 129.38 49.55 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.662 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.633 HG21 ' HG3' ' A' ' 25' ' ' LYS . 5.4 m -91.84 127.75 37.41 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.27 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.841 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.1 t80 -129.61 144.81 51.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.783 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 40.36 35.97 0.32 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.15 0.98 . . . . 0.0 113.243 178.381 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.0 -10.06 75.25 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.033 -0.603 . . . . 0.0 114.502 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -111.98 133.62 54.04 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 118.438 1.119 . . . . 0.0 111.794 -179.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.639 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 3.7 mptt -82.07 123.22 28.75 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.548 -179.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.841 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 15.7 m-85 -104.91 110.9 23.46 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.72 0.771 . . . . 0.0 111.031 -178.034 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.628 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 48.7 mt-10 -84.95 -15.76 43.28 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.86 -179.487 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p -130.97 -176.45 4.0 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 68.6 m -67.47 162.62 22.8 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.28 179.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.431 HG22 ' CZ ' ' A' ' 19' ' ' PHE . 11.7 t -139.13 -177.48 4.92 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.7 p -135.88 22.15 3.3 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.71 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -66.72 150.18 49.46 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 113.91 -1.496 . . . . 0.0 113.096 -178.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.97 7.53 50.16 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 114.963 -1.017 . . . . 0.0 114.468 178.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 34' ' ' ARG . 5.4 mtp-105 -101.72 -158.45 0.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.148 0.974 . . . . 0.0 112.557 -179.398 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 p -133.34 -40.67 0.89 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -178.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.557 ' CG ' HH22 ' A' ' 34' ' ' ARG . 1.2 p-10 -98.11 -93.2 0.24 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.237 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.86 21.05 0.17 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 116.426 1.331 . . . . 0.0 116.426 -178.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.647 ' HD3' ' CZ ' ' A' ' 55' ' ' PHE . 45.0 mttp -78.46 137.05 37.77 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 119.159 1.48 . . . . 0.0 108.569 177.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -99.47 144.98 27.94 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.601 -0.839 . . . . 0.0 108.88 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.666 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 18.6 p-90 -139.68 -172.09 3.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.224 0.535 . . . . 0.0 111.519 -178.344 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.6 p -156.94 139.5 14.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.206 178.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.534 ' HB1' ' CG ' ' A' ' 19' ' ' PHE . . . -72.78 152.68 41.46 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 120.989 0.423 . . . . 0.0 110.856 -179.293 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.7 p -100.27 16.39 24.49 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.641 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.402 HG22 ' CB ' ' A' ' 50' ' ' ASP . 70.8 p -135.21 154.83 51.46 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.179 179.271 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -62.18 -35.06 77.69 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.254 0.55 . . . . 0.0 110.399 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -125.77 110.24 13.49 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.693 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 61.9 t80 -76.6 -33.97 58.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.281 -177.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -53.67 -36.23 61.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.27 -63.72 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.402 ' CB ' HG22 ' A' ' 44' ' ' THR . 32.7 m-20 -72.53 -36.51 68.33 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -177.47 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.8 mmm180 54.67 50.77 15.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -120.92 116.61 25.46 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 176.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.693 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.9 p-90 -129.71 172.67 11.38 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -174.012 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.731 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -160.43 146.69 12.9 Favored Glycine 0 C--O 1.221 -0.701 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.969 178.421 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.647 ' CZ ' ' HD3' ' A' ' 38' ' ' LYS . 3.9 m-30 -61.27 163.29 6.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.578 0.704 . . . . 0.0 112.69 -179.427 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.407 ' C ' ' H ' ' A' ' 58' ' ' ASP . 6.6 t -83.44 134.21 45.75 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.417 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.88 10.06 1.18 Allowed 'Trans proline' 0 N--CA 1.481 0.764 0 C-N-CA 123.364 2.709 . . . . 0.0 114.152 -179.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 56' ' ' CYS . 24.8 t70 -90.36 5.71 46.23 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.743 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -104.62 -135.05 0.34 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.922 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.658 -1.079 . . . . 0.0 111.871 -179.915 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 64.64 -86.0 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.596 0.56 . . . . 0.0 111.371 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.91 176.32 9.92 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.847 0.356 . . . . 0.0 111.163 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -93.36 -173.36 3.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.495 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.9 p -86.68 -179.73 6.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.919 0.866 . . . . 0.0 112.589 -179.083 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.761 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -127.48 -171.06 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.153 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.554 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.49 -120.6 0.79 Allowed Glycine 0 CA--C 1.521 0.412 0 O-C-N 123.786 0.679 . . . . 0.0 113.306 177.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.689 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 25.88 -136.12 0.02 OUTLIER Glycine 0 C--N 1.343 0.926 0 N-CA-C 116.383 1.313 . . . . 0.0 116.383 177.53 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.414 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -160.0 41.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.62 -0.79 . . . . 0.0 110.133 179.704 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.21 -42.19 5.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.755 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.12 -79.14 1.94 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.835 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -121.52 32.59 4.61 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.125 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.23 144.73 30.34 Favored Pre-proline 0 C--N 1.328 -0.349 0 O-C-N 122.383 -0.481 . . . . 0.0 110.034 179.161 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -86.22 167.96 9.1 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.54 2.16 . . . . 0.0 112.4 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 74.9 m -87.81 133.23 33.92 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.564 179.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.2 t -95.49 125.9 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.668 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.587 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 49.5 m-85 -122.63 138.97 30.18 Favored Pre-proline 0 N--CA 1.444 -0.727 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.592 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -86.66 133.27 14.87 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.415 -1.494 . . . . 0.0 112.328 -0.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.818 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 27.3 p90 -99.77 130.4 45.97 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.239 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.4 m -91.19 125.39 35.95 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.375 0.607 . . . . 0.0 111.894 -178.031 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.803 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 2.1 t80 -129.7 141.58 50.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.658 HD23 ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER 42.11 36.95 0.76 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.129 0.971 . . . . 0.0 113.078 178.678 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.37 -6.15 83.9 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.83 -0.7 . . . . 0.0 114.751 178.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.53 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.3 m-80 -112.27 136.46 51.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.434 1.117 . . . . 0.0 111.947 -178.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -80.35 122.36 26.83 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.803 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 15.4 m-30 -104.99 111.2 23.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.779 0.799 . . . . 0.0 111.104 -177.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -89.38 -19.55 25.08 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.608 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.9 p -127.33 -179.34 4.84 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.6 m -67.04 156.55 35.76 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.683 178.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.0 t -131.25 173.28 11.21 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.936 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.444 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 24.1 p -127.42 18.34 6.95 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 176.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.616 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . . . -63.4 151.48 40.88 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 113.808 -1.542 . . . . 0.0 111.403 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.69 -1.53 57.66 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.205 178.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.647 ' NH1' ' H ' ' A' ' 38' ' ' LYS . 1.8 mtp-105 -116.23 -173.55 2.38 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 117.17 0.485 . . . . 0.0 111.223 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.6 t -130.64 -28.5 2.03 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -91.48 -92.55 0.14 Allowed 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.627 -0.671 . . . . 0.0 111.323 -179.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.21 25.74 0.09 OUTLIER Glycine 0 CA--C 1.526 0.76 0 C-N-CA 119.109 -1.52 . . . . 0.0 116.753 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.647 ' H ' ' NH1' ' A' ' 34' ' ' ARG . 40.9 mttp -83.58 85.82 7.2 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.169 1.484 . . . . 0.0 109.528 178.368 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.444 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 49.7 mtm -59.32 137.05 58.12 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.142 0.496 . . . . 0.0 110.746 -178.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.661 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.8 p-90 -133.51 -169.4 2.28 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.213 -178.591 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.2 p -160.43 138.12 9.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.006 178.237 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.818 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -69.83 155.11 41.03 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.107 0.479 . . . . 0.0 111.019 -178.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.3 p -102.87 13.65 33.86 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.037 0.922 . . . . 0.0 109.559 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.8 p -133.55 153.5 51.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.969 179.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -59.92 -37.25 78.93 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.057 0.456 . . . . 0.0 110.842 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -123.23 110.45 15.25 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.737 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 64.8 t80 -76.75 -33.14 58.11 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.085 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -57.35 -31.9 66.21 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -88.83 -62.07 1.57 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.13 -27.38 60.84 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.437 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 3.1 mmm180 48.58 49.24 18.78 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -120.59 117.53 27.83 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.737 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.9 p-90 -129.19 177.6 7.03 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -174.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.611 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.44 147.19 11.44 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.638 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.761 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 6.0 m-30 -62.66 157.6 20.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.704 0.752 . . . . 0.0 112.293 -179.056 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.49 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 27.0 t -73.94 135.37 77.28 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.599 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -76.25 6.18 4.1 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.715 2.277 . . . . 0.0 113.73 -179.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -151.09 97.46 2.45 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.12 179.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -113.43 57.95 0.67 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.87 0.367 . . . . 0.0 110.676 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.751 0 CA-C-O 118.67 -1.072 . . . . 0.0 111.653 179.913 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.496 0.189 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -117.49 -176.72 3.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.567 -179.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 ptp -77.84 -167.57 1.02 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.053 0.454 . . . . 0.0 111.26 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.6 m -79.18 -162.82 0.43 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.704 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.477 HG22 ' HA3' ' A' ' 54' ' ' GLY . 68.7 p -65.63 169.51 6.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.594 -178.591 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.18 5.98 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 CA-C-O 122.561 1.172 . . . . 0.0 111.2 -179.3 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.445 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . -154.75 -155.24 7.2 Favored Glycine 0 C--N 1.282 -2.448 0 CA-C-N 113.319 -1.764 . . . . 0.0 111.651 -178.161 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.708 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 72.2 -168.35 52.35 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.846 179.007 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.537 ' H ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -105.69 -1.08 24.94 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.937 0.399 . . . . 0.0 110.542 178.783 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.432 ' HG ' HG21 ' A' ' 43' ' ' THR . 7.9 m -88.08 -61.86 1.62 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.392 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.83 -63.26 4.5 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.913 178.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.26 -18.25 43.34 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.927 -178.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -78.65 139.82 58.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 117.419 0.609 . . . . 0.0 111.614 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 3.4 Cg_exo -76.8 164.91 29.46 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.452 2.768 . . . . 0.0 112.055 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 84.5 m -87.4 142.93 27.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.864 0.364 . . . . 0.0 110.769 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -108.52 120.86 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.952 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.496 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 62.9 m-85 -118.6 143.8 34.12 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-O 121.016 0.436 . . . . 0.0 111.223 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.635 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 28.5 Cg_endo -87.47 140.22 20.72 Favored 'Cis proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.706 -1.789 . . . . 0.0 111.98 -0.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.69 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 35.6 p90 -104.26 -174.06 2.45 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.518 178.064 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.1 m -141.56 127.1 18.91 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.86 -179.033 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.785 ' CD2' ' HB2' ' A' ' 32' ' ' ALA . 0.9 OUTLIER -131.7 144.9 51.33 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.033 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.648 HD12 ' CD1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.17 35.02 0.08 Allowed 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.61 1.164 . . . . 0.0 113.837 178.022 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.12 -3.74 84.45 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 115.026 0.77 . . . . 0.0 115.026 178.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.551 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 59.0 m-80 -110.2 138.7 46.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.371 1.086 . . . . 0.0 111.508 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -79.46 122.0 25.89 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.672 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.4 m-30 -108.35 106.9 17.25 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.836 0.827 . . . . 0.0 110.902 -178.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.635 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 92.1 mt-10 -91.23 -15.55 29.05 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.363 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -129.15 -177.78 4.37 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.5 m -66.19 164.61 15.36 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.684 178.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.428 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 13.0 t -141.99 175.53 9.66 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.772 -179.063 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.412 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 23.3 p -128.64 17.54 6.35 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.785 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -65.26 153.75 40.15 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 114.118 -1.401 . . . . 0.0 112.025 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.28 -0.1 42.4 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.69 -0.686 . . . . 0.0 114.082 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.748 ' NH1' ' H ' ' A' ' 38' ' ' LYS . 2.3 mtp-105 -112.24 -176.47 2.93 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 117.781 0.791 . . . . 0.0 111.428 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 p -130.37 -14.95 3.7 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.451 ' OD2' ' HG3' ' A' ' 38' ' ' LYS . 2.6 p-10 -108.21 -96.17 0.38 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.365 0.53 . . . . 0.0 111.476 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.26 39.99 0.18 Allowed Glycine 0 CA--C 1.523 0.584 0 C-N-CA 119.169 -1.491 . . . . 0.0 116.521 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.748 ' H ' ' NH1' ' A' ' 34' ' ' ARG . 66.0 mttm -99.44 85.23 3.12 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.268 1.034 . . . . 0.0 109.066 177.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.412 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.1 mpt? -56.57 137.42 53.67 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.587 0.708 . . . . 0.0 111.36 -178.048 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.677 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.6 p-90 -134.34 -165.21 1.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.295 -178.149 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.5 p -162.99 145.16 10.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.977 178.419 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.69 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -71.36 149.8 45.68 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.172 -178.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.432 HG21 ' HG ' ' A' ' 10' ' ' SER . 71.3 p -97.95 7.44 46.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.453 0.644 . . . . 0.0 109.869 179.222 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.9 p -129.35 155.7 45.22 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.284 178.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.605 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -61.54 -32.34 72.41 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.978 0.418 . . . . 0.0 110.942 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -127.49 111.36 13.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.826 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 65.2 t80 -78.39 -35.25 47.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.92 -177.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -53.75 -29.74 41.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.134 0.493 . . . . 0.0 112.05 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -85.04 -71.15 0.54 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.518 -179.238 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.98 -29.69 63.24 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 4.4 mtm180 51.61 47.45 24.78 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -114.05 118.22 33.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.826 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.2 p-90 -129.38 177.29 7.29 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.267 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -171.7 150.33 13.21 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.619 179.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 14.5 m-30 -61.42 159.24 13.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -177.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.513 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 8.5 t -68.8 143.73 95.15 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 114.299 -1.318 . . . . 0.0 108.83 178.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.513 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 90.7 Cg_endo -68.6 -148.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.644 2.229 . . . . 0.0 113.412 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.475 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 44.0 t0 -64.0 104.86 0.76 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.199 -179.359 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -79.59 162.67 25.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.235 -179.142 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.783 0 CA-C-O 118.696 -1.058 . . . . 0.0 112.124 179.946 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 71.45 130.15 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.639 0.776 . . . . 0.0 111.953 -179.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.14 51.53 0.82 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.4 t 71.28 -167.36 0.15 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.697 -177.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.431 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 63.7 p -113.26 164.24 13.79 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.298 0.57 . . . . 0.0 111.963 -178.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.789 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -105.05 -166.31 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 176.155 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.625 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 39.57 -123.96 1.93 Allowed Glycine 0 C--N 1.319 -0.404 0 O-C-N 123.903 0.752 . . . . 0.0 113.112 177.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.621 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 37.2 -148.64 0.05 OUTLIER Glycine 0 C--N 1.334 0.464 0 N-CA-C 116.198 1.239 . . . . 0.0 116.198 177.144 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.06 -26.94 0.34 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.502 -0.849 . . . . 0.0 110.795 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -47.96 -59.55 3.27 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 123.548 0.53 . . . . 0.0 111.249 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.67 82.82 0.09 OUTLIER Glycine 0 C--N 1.329 0.194 0 CA-C-N 116.234 -0.439 . . . . 0.0 113.492 178.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.35 -25.36 5.72 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.863 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.26 141.33 30.8 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.749 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -84.33 166.4 12.42 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.764 2.309 . . . . 0.0 111.538 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 2.7 m -74.69 120.83 20.77 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.22 105.28 16.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.092 0.472 . . . . 0.0 110.516 179.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.659 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 46.2 m-85 -100.47 139.23 20.48 Favored Pre-proline 0 N--CA 1.447 -0.588 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.416 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 7.2 Cg_endo -87.68 127.98 9.2 Favored 'Cis proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.377 -1.51 . . . . 0.0 112.711 -0.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.659 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 15.6 p90 -92.26 127.07 37.6 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.279 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 14.8 m -90.65 121.65 32.75 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.428 0.632 . . . . 0.0 112.455 -177.408 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.87 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.9 t80 -127.8 142.94 51.16 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.356 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.842 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 43.5 35.55 0.98 Allowed 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.187 0.995 . . . . 0.0 112.674 178.896 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.71 -6.27 83.69 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.935 -0.575 . . . . 0.0 114.466 179.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.523 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 66.4 m-80 -109.96 132.87 53.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.319 1.06 . . . . 0.0 111.942 -178.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 53.3 mtpt -83.9 118.32 23.9 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.87 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 12.4 m-85 -99.66 112.03 24.3 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.811 0.815 . . . . 0.0 112.191 -177.343 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -83.23 -17.62 42.08 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.615 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 p -131.42 -173.25 3.06 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 70.7 m -64.22 166.2 8.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.595 0.712 . . . . 0.0 110.395 179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.474 HG22 ' CZ ' ' A' ' 19' ' ' PHE . 14.5 t -144.65 171.42 14.41 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.137 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.486 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 15.8 p -129.19 19.02 5.92 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.181 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.782 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -61.7 138.25 58.3 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.122 179.628 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.89 -3.4 44.79 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.935 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.414 ' HD2' ' HE1' ' A' ' 55' ' ' PHE . 17.0 mtp85 -114.35 -81.28 0.6 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.649 0.261 . . . . 0.0 110.763 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.5 m 57.03 32.55 21.87 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.233 -178.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.72 -28.28 8.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.212 -179.052 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 156.78 -66.72 0.3 Allowed Glycine 0 C--N 1.315 -0.611 0 CA-C-N 114.9 -1.045 . . . . 0.0 113.314 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.786 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 3.8 mptt -66.37 135.37 54.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.12 0.486 . . . . 0.0 112.047 -178.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.486 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 47.2 mtt -98.15 154.2 17.92 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.006 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.604 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.3 p-90 -136.46 -172.6 3.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.591 0.71 . . . . 0.0 112.461 -178.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 12.3 p -154.11 143.28 21.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.658 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.546 ' O ' ' HA ' ' A' ' 15' ' ' CYS . . . -81.88 158.34 24.03 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.31 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.1 p -107.74 16.38 23.68 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.542 0.687 . . . . 0.0 110.387 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.7 p -137.2 148.51 46.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.431 178.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -55.91 -42.11 75.56 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.152 0.501 . . . . 0.0 110.821 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -116.31 104.7 11.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.475 178.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.74 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 69.0 t80 -75.96 -29.21 58.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.526 -178.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -57.26 -34.65 68.85 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -96.02 -53.6 3.6 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.068 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -81.13 -19.24 43.97 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -177.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 13.1 mtm180 38.04 55.97 1.65 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -117.89 120.54 38.18 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.74 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.0 p-90 -132.94 177.35 7.72 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -174.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.431 ' HA3' ' HB ' ' A' ' 5' ' ' THR . . . -165.54 146.74 11.44 Favored Glycine 0 C--O 1.22 -0.745 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.959 179.206 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.789 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.1 m-85 -70.17 159.6 33.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.787 0.794 . . . . 0.0 111.919 -179.104 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.692 ' HB3' ' HD2' ' A' ' 57' ' ' PRO . 32.9 m -94.38 172.48 5.59 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.08 178.057 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.692 ' HD2' ' HB3' ' A' ' 56' ' ' CYS . 57.1 Cg_endo -63.92 2.8 0.9 Allowed 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.684 2.256 . . . . 0.0 115.084 -178.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 56' ' ' CYS . 23.4 t70 63.94 150.11 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.593 178.276 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 -74.12 -41.3 61.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.275 -179.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.673 0 CA-C-O 118.515 -1.158 . . . . 0.0 112.366 179.949 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 76.2 p . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.617 0.246 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 30.5 t90 -82.96 -44.98 14.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.033 0.444 . . . . 0.0 110.488 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -86.53 82.15 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.236 0.541 . . . . 0.0 111.235 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.2 m -89.64 171.74 9.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.621 -179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.57 HG21 ' O ' ' A' ' 13' ' ' ALA . 23.2 p -84.3 177.56 8.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 122.156 0.979 . . . . 0.0 113.4 -178.629 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.722 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -136.08 -162.98 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.256 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 44.64 -87.05 0.01 OUTLIER Glycine 0 N--CA 1.465 0.586 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 176.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.607 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . -36.77 161.89 0.01 OUTLIER Glycine 0 N--CA 1.465 0.621 0 N-CA-C 116.77 1.468 . . . . 0.0 116.77 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.434 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -74.23 -7.71 53.67 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -178.918 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m -71.11 -18.83 62.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.2 0.455 . . . . 0.0 111.143 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.92 -105.97 1.99 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.526 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.97 46.72 1.13 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.805 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.57 ' O ' HG21 ' A' ' 5' ' ' THR . . . -93.84 148.54 35.49 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.941 0.37 . . . . 0.0 110.429 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.9 Cg_exo -77.66 143.23 21.15 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.523 2.148 . . . . 0.0 111.84 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 5.2 m -72.32 117.52 14.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.023 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.601 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 73.1 t -83.18 108.89 16.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.57 0.224 . . . . 0.0 110.625 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.402 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 50.8 m-85 -107.4 138.51 19.95 Favored Pre-proline 0 N--CA 1.45 -0.444 0 CA-C-O 120.59 0.233 . . . . 0.0 110.768 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.11 134.1 21.0 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.493 -1.461 . . . . 0.0 111.988 -0.642 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.601 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 23.7 p90 -103.39 136.45 43.12 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.121 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 88.9 m -99.07 121.32 40.83 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.596 -178.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.778 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 77.0 t80 -112.06 131.24 55.55 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.609 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.509 HD21 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 34.25 44.62 0.1 Allowed 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 124.851 1.345 . . . . 0.0 113.727 175.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.48 -19.23 45.83 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 116.96 1.544 . . . . 0.0 116.96 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 20' ' ' THR . 54.0 m-80 -109.16 146.44 34.1 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 120.042 1.921 . . . . 0.0 111.866 -178.522 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 25.3 mtmt -89.07 125.83 35.18 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.653 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.778 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 39.3 m-85 -112.85 116.41 30.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.815 0.816 . . . . 0.0 111.43 -178.316 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -90.85 -22.18 21.09 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.679 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.4 p -123.28 -176.63 3.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.633 179.026 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.6 m -64.37 169.42 4.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.438 0.637 . . . . 0.0 110.562 179.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.5 t -147.6 176.27 10.21 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.315 179.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.1 p -139.14 25.48 2.48 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.133 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.507 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -63.76 139.38 58.76 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 113.063 -1.881 . . . . 0.0 112.558 -179.108 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.15 -5.64 40.74 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.694 -0.685 . . . . 0.0 113.069 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.64 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 14.3 mtp85 -95.81 149.72 21.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.244 0.545 . . . . 0.0 111.478 -179.039 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.1 p -120.77 3.03 10.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.92 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 8.5 p30 -96.51 -78.23 0.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.39 0.614 . . . . 0.0 110.996 179.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.415 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 165.95 -9.02 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.368 -0.833 . . . . 0.0 113.303 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.64 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 33.9 mmtt -67.58 140.55 56.93 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 117.532 0.666 . . . . 0.0 110.087 -179.724 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 68.9 mtm -97.92 144.04 27.88 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.675 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.9 p-90 -138.09 -167.18 2.11 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.396 0.617 . . . . 0.0 111.63 -178.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 22.3 p -159.65 148.94 18.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.115 179.836 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.778 ' HB3' ' HD2' ' A' ' 47' ' ' TYR . . . -81.84 144.13 31.24 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.552 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.8 p -101.69 17.12 23.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.789 0.804 . . . . 0.0 110.69 -178.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.493 HG21 ' HB2' ' A' ' 52' ' ' LYS . 45.4 p -136.14 152.78 51.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.976 178.26 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.63 -39.44 84.34 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.133 0.492 . . . . 0.0 110.823 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -122.5 109.83 14.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.465 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.857 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 46.7 t80 -75.61 -35.1 60.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.206 -178.932 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -48.86 -37.9 20.89 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -86.61 -63.46 1.31 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.492 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 0.9 OUTLIER -77.68 -24.4 49.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -176.98 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.686 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 13.6 mtm180 44.2 50.48 7.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.493 ' HB2' HG21 ' A' ' 44' ' ' THR . 56.6 mttt -108.99 119.34 39.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 177.531 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.857 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 15.3 p-90 -131.82 172.54 12.18 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -175.251 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.607 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -170.78 146.04 9.42 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.804 178.765 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.722 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 14.9 m-30 -62.28 158.68 16.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.339 0.57 . . . . 0.0 111.396 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.1 m -88.25 151.24 48.56 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.311 178.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.3 5.59 2.23 Favored 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.017 2.478 . . . . 0.0 114.322 -178.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -98.12 103.61 15.57 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.766 179.308 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -116.06 39.67 3.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.163 -179.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.868 0 CA-C-O 118.533 -1.148 . . . . 0.0 112.674 179.869 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.811 0.339 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -130.14 83.42 2.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.311 -179.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.4 ' SD ' ' N ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -112.66 169.78 8.65 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.181 -179.108 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 m -85.4 -178.6 6.76 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.029 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -102.13 170.18 8.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.202 1.001 . . . . 0.0 113.654 -178.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -138.08 164.61 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 179.098 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.492 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.19 -149.16 51.35 Favored Glycine 0 C--N 1.315 -0.599 0 C-N-CA 118.23 -1.938 . . . . 0.0 111.853 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.463 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 50.33 -146.61 8.48 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 114.134 0.414 . . . . 0.0 114.134 177.728 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.49 -29.73 1.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.166 -0.517 . . . . 0.0 110.36 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.0 m -53.53 -37.73 63.11 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.986 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.84 -86.52 0.44 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.748 179.116 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.5 31.65 2.22 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.445 -179.623 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.07 141.13 53.98 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.491 0.186 . . . . 0.0 110.955 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.05 137.35 71.18 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.757 2.304 . . . . 0.0 112.148 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.2 m -75.06 126.87 31.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.832 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 75.8 t -87.1 121.68 38.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.702 0.287 . . . . 0.0 111.121 -179.518 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.62 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 51.5 m-85 -116.96 139.2 25.49 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.307 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.8 Cg_endo -86.21 129.89 12.15 Favored 'Cis proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.641 -1.399 . . . . 0.0 112.303 -0.363 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.635 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 19.7 p90 -94.59 128.58 41.31 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.056 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.8 m -92.19 123.66 35.69 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.521 0.677 . . . . 0.0 112.652 -177.63 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.841 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.1 t80 -127.49 143.83 51.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.642 178.012 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.83 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 42.41 31.35 0.27 Allowed 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.168 0.987 . . . . 0.0 113.16 178.636 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.33 -1.33 79.39 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 178.464 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 65.4 m-80 -113.21 135.59 53.66 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.195 0.998 . . . . 0.0 111.675 -179.033 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -77.76 119.36 21.16 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.841 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.2 m-30 -103.56 105.88 16.25 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.88 0.848 . . . . 0.0 110.775 -179.179 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -83.84 -15.35 48.55 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.668 -179.571 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 p -132.96 -175.86 3.92 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.194 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.5 m -66.21 163.73 17.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.532 0.682 . . . . 0.0 109.895 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.565 HG22 ' CZ ' ' A' ' 19' ' ' PHE . 15.3 t -139.83 176.36 8.81 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.158 -179.388 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.439 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 13.0 p -128.52 16.49 6.5 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.429 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.765 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -63.29 139.89 58.82 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.496 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.2 -11.84 21.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.276 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.607 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.3 mtp85 -105.58 -72.02 0.73 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.92 0.39 . . . . 0.0 110.244 179.38 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.8 t 61.74 32.0 18.38 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.469 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 34' ' ' ARG . 27.2 p-10 -112.11 -62.76 1.52 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.39 0.614 . . . . 0.0 110.875 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.75 -53.93 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.27 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.833 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 2.2 mppt? -69.03 110.66 4.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.757 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.439 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 55.6 mtm -77.45 158.44 29.99 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.556 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.645 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 19.5 p-90 -141.98 -169.57 2.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.14 0.495 . . . . 0.0 111.28 -178.784 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.499 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 4.0 p -160.61 144.15 13.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.982 177.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.635 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -76.95 153.91 34.13 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.425 -178.72 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 64.5 p -101.71 9.1 41.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.748 0.785 . . . . 0.0 109.672 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.7 p -130.81 153.94 48.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.253 178.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -59.84 -48.89 79.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 111.452 -179.564 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -111.45 108.77 18.43 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.814 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 71.6 t80 -78.47 -30.36 47.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.031 -178.503 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.61 -32.7 65.54 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -90.59 -57.87 2.68 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -178.649 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -77.73 -30.94 51.93 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 7.9 mmm180 49.49 44.95 24.24 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -110.75 117.77 34.34 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.814 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 10.1 p-90 -133.57 174.92 9.9 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -173.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.463 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.3 144.03 9.31 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 113.219 -1.81 . . . . 0.0 109.907 178.479 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.537 ' HD1' ' HB3' ' A' ' 40' ' ' TRP . 5.3 m-30 -60.0 158.55 10.77 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.516 0.674 . . . . 0.0 112.681 -179.533 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.486 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.6 t -87.55 113.28 53.49 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.451 179.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.438 ' HB3' HG13 ' A' ' 6' ' ' VAL . 51.5 Cg_endo -79.98 3.62 7.44 Favored 'Trans proline' 0 CA--C 1.513 -0.537 0 C-N-CA 122.619 2.213 . . . . 0.0 113.48 -178.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -144.71 75.42 1.45 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.065 -1.425 . . . . 0.0 109.485 179.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -76.86 -37.64 55.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.534 -179.218 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.729 0 CA-C-O 118.388 -1.229 . . . . 0.0 111.997 179.922 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.727 0.299 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -75.78 85.92 2.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.9 ptm -106.73 45.89 0.96 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.844 -179.312 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 57' ' ' PRO . 7.6 m -74.38 -176.51 2.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.136 179.537 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.51 HG21 ' O ' ' A' ' 13' ' ' ALA . 21.3 p -105.48 169.62 8.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.466 1.126 . . . . 0.0 113.688 -178.315 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.662 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -127.49 -166.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.25 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.427 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 36.04 -127.89 0.9 Allowed Glycine 0 N--CA 1.465 0.617 0 O-C-N 123.818 0.698 . . . . 0.0 113.61 177.436 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.587 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 42.61 -148.54 0.54 Allowed Glycine 0 C--N 1.334 0.458 0 N-CA-C 115.796 1.078 . . . . 0.0 115.796 177.127 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.486 HD22 ' HA ' ' A' ' 52' ' ' LYS . 10.9 p30 -133.48 -31.71 1.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.875 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.5 m -59.14 -29.2 67.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.489 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.95 -103.22 2.55 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.073 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -127.42 40.14 1.81 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.133 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.51 ' O ' HG21 ' A' ' 5' ' ' THR . . . -87.35 138.5 32.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.742 0.306 . . . . 0.0 111.122 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -56.84 132.59 52.65 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.888 2.392 . . . . 0.0 112.368 179.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 52.6 m -74.78 130.59 39.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.789 0.328 . . . . 0.0 111.009 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.8 t -83.22 117.89 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -118.28 142.08 30.63 Favored Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-O 120.947 0.403 . . . . 0.0 111.353 -179.406 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -85.63 139.32 25.89 Favored 'Cis proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.038 -1.651 . . . . 0.0 111.763 -0.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.673 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 19.5 p90 -99.83 -166.48 1.34 Allowed 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.79 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.0 m -148.87 126.38 11.64 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.055 0.455 . . . . 0.0 111.115 -178.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.771 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 29.5 t80 -129.4 139.15 51.76 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.652 179.072 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.495 HD21 ' CG ' ' A' ' 21' ' ' PHE . 3.5 mm? 34.08 47.49 0.2 Allowed 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 124.65 1.218 . . . . 0.0 114.24 174.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.18 -12.21 70.17 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 114.345 -1.298 . . . . 0.0 116.022 177.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.433 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 61.1 m-80 -115.19 134.53 55.06 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 119.224 1.512 . . . . 0.0 112.387 -178.525 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -78.98 125.05 28.87 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.359 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.771 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.4 m-30 -109.79 118.81 37.5 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.831 0.824 . . . . 0.0 111.219 -178.816 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -91.7 -8.61 46.51 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.903 -179.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.3 p -140.67 -164.86 1.81 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.159 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.5 m -72.5 168.2 19.03 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.849 178.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.4 t -149.75 166.71 28.61 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.229 -179.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.516 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 29.6 p -120.52 21.6 11.53 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 176.755 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -60.77 140.49 57.56 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 113.826 -1.533 . . . . 0.0 112.167 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.36 -8.03 10.44 Favored Glycine 0 N--CA 1.454 -0.122 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.778 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.624 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 22.8 mtp85 -105.35 -65.74 1.03 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.818 0.342 . . . . 0.0 110.845 -179.375 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.7 m 64.0 15.79 9.46 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.614 -179.553 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.67 -71.34 0.65 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.466 0.65 . . . . 0.0 110.712 179.133 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.34 -33.68 0.06 OUTLIER Glycine 0 C--N 1.308 -1.0 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.524 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.772 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 4.3 mptt -73.66 114.19 11.64 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 -179.726 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.516 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 52.1 mtt -87.9 146.42 25.57 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.618 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.609 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.3 p-90 -134.32 -164.42 1.5 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.142 0.496 . . . . 0.0 111.158 -178.47 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.2 p -169.58 155.85 6.27 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.41 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.673 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -82.86 146.26 29.0 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.113 -179.268 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 71.0 p -97.93 11.84 36.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.743 0.782 . . . . 0.0 109.853 179.339 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.6 p -134.76 158.91 42.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.549 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.81 -44.9 95.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.922 0.392 . . . . 0.0 111.238 -179.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -116.61 106.88 14.04 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.89 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 72.7 t80 -72.0 -39.42 69.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.86 -178.707 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -49.82 -37.39 30.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.559 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -87.65 -58.49 2.55 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.36 -23.77 54.18 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -177.089 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 7.5 mtm180 45.1 49.32 9.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 179.247 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.486 ' HA ' HD22 ' A' ' 9' ' ' ASN . 28.4 mtpp -116.93 117.62 30.18 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.537 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.89 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.3 p-90 -129.15 172.15 11.71 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -175.258 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.587 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.05 144.93 9.73 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 113.58 -1.645 . . . . 0.0 110.578 179.353 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.662 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.6 m-30 -63.39 158.45 20.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.327 0.563 . . . . 0.0 111.879 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.485 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 4.8 t -73.81 142.46 80.15 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.843 178.592 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.485 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 60.4 Cg_endo -74.31 -152.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.778 2.318 . . . . 0.0 113.168 -179.125 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -64.64 108.46 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.441 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -89.09 108.04 19.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.775 -179.579 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.635 -1.091 . . . . 0.0 112.276 -179.98 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 121.135 0.493 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.442 ' HE3' ' HA ' ' A' ' 2' ' ' TRP . 3.8 m95 -95.36 156.53 16.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.831 179.407 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.3 mmt -77.09 160.99 28.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.0 m -67.49 154.85 40.44 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.5 p -83.27 169.61 15.52 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.876 0.846 . . . . 0.0 112.284 -179.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -129.21 163.97 32.91 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 178.226 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.723 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.85 -145.14 46.29 Favored Glycine 0 C--N 1.308 -0.984 0 C-N-CA 117.434 -2.317 . . . . 0.0 111.148 -179.136 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.619 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 43.47 -149.41 0.67 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 116.077 1.191 . . . . 0.0 116.077 176.717 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.61 30.19 0.67 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.836 -0.682 . . . . 0.0 110.073 -179.576 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.03 -59.97 2.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.492 -179.681 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.29 48.28 2.64 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.082 -179.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.55 16.96 40.72 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.146 179.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.29 140.76 21.42 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 117.111 0.456 . . . . 0.0 110.945 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -85.15 171.36 9.14 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.772 2.315 . . . . 0.0 111.404 179.254 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.3 m -75.58 148.24 39.0 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.194 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 98.7 t -114.23 117.43 55.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.241 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.61 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 66.0 m-85 -114.22 139.04 23.28 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.944 0.402 . . . . 0.0 111.117 -179.509 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -86.13 131.82 14.22 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.409 -1.496 . . . . 0.0 112.187 -0.17 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.623 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 27.9 p90 -99.59 128.92 45.71 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.194 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -91.72 123.03 34.81 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.335 -178.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.827 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 62.0 t80 -117.94 129.98 55.94 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.826 178.547 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.462 HD21 ' CG ' ' A' ' 21' ' ' PHE . 3.5 mm? 35.87 49.03 0.54 Allowed 'General case' 0 N--CA 1.424 -1.738 0 O-C-N 125.055 1.472 . . . . 0.0 113.33 175.984 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.09 -19.82 51.46 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 114.354 -1.294 . . . . 0.0 116.298 178.099 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -114.99 133.62 55.87 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 120.075 1.937 . . . . 0.0 113.523 -177.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -77.67 125.67 29.7 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.645 178.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.827 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 17.3 m-30 -111.06 118.64 36.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.794 0.807 . . . . 0.0 112.037 -178.559 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -89.27 -19.33 25.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.938 179.454 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 p -127.7 -178.29 4.43 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.167 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 87.7 m -67.79 170.47 7.93 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.908 179.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.428 HG22 ' CZ ' ' A' ' 19' ' ' PHE . 15.1 t -146.96 173.28 12.58 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.254 0.549 . . . . 0.0 110.615 -178.706 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.599 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 17.4 p -125.4 19.58 8.11 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.057 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.85 135.47 57.71 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.745 -179.668 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.83 -8.34 11.61 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.252 -179.494 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.9 mtp85 -109.73 -92.04 0.45 Allowed 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.038 0.446 . . . . 0.0 111.225 -179.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 t 65.89 33.73 7.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.186 -178.601 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.01 -30.49 10.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.928 -179.722 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 154.84 -48.73 0.5 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.299 -1.319 . . . . 0.0 112.311 -179.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.454 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 27.1 mmtm -79.4 123.58 27.64 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.783 0.291 . . . . 0.0 111.472 -179.532 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.599 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 71.5 mtm -89.55 146.56 24.5 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.235 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.621 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.3 p-90 -129.11 -167.38 1.78 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.4 0.619 . . . . 0.0 112.655 -177.224 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 21.8 p -158.92 143.4 15.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.697 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.411 ' HB1' ' CB ' ' A' ' 19' ' ' PHE . . . -78.44 151.54 32.64 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.424 -0.911 . . . . 0.0 109.605 179.45 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.0 p -103.4 13.22 34.12 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.582 0.706 . . . . 0.0 109.914 -179.573 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.8 p -135.0 149.01 50.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.508 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.78 -37.47 68.61 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.98 0.419 . . . . 0.0 111.498 -179.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -125.04 111.32 15.24 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.52 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.838 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 48.5 t80 -76.26 -34.5 59.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.91 -178.274 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -53.94 -31.17 49.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -89.3 -58.73 2.43 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -179.308 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.27 -19.29 28.5 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.671 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 11.3 mtm180 44.89 49.54 9.1 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 179.558 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -108.63 117.15 33.42 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.32 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.838 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.4 p-90 -126.63 173.31 9.57 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -175.918 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.55 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.77 138.37 5.11 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.587 179.248 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.723 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 12.2 m-85 -56.61 153.67 9.96 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.33 0.586 . . . . 0.0 110.995 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.643 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 9.1 t -68.92 145.7 96.89 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.236 -179.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.643 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 58.4 Cg_endo -74.25 -157.09 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.242 1.961 . . . . 0.0 111.768 179.378 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.3 t70 61.28 12.67 4.35 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 122.179 0.99 . . . . 0.0 110.036 -179.07 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -145.8 -172.42 3.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.846 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.453 -1.193 . . . . 0.0 112.479 179.196 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.884 0.373 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -77.81 109.68 12.04 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.276 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.2 mtp -98.82 175.56 5.91 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -177.608 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.8 m -108.86 -158.41 0.65 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.915 179.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.524 HG21 ' O ' ' A' ' 13' ' ' ALA . 4.5 p -107.5 171.64 7.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 122.008 0.908 . . . . 0.0 113.132 -178.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.533 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.2 OUTLIER -138.04 160.68 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 177.518 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.544 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.38 -154.92 44.41 Favored Glycine 0 C--N 1.313 -0.726 0 C-N-CA 117.804 -2.141 . . . . 0.0 110.637 -178.641 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.695 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 40.52 -141.68 0.84 Allowed Glycine 0 N--CA 1.464 0.558 0 N-CA-C 114.311 0.484 . . . . 0.0 114.311 177.625 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.5 -98.46 0.15 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.859 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m 34.41 31.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.304 1.441 . . . . 0.0 114.878 178.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.04 -87.33 0.04 OUTLIER Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.32 -0.467 . . . . 0.0 112.549 -179.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.31 30.36 0.37 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 178.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.524 ' O ' HG21 ' A' ' 5' ' ' THR . . . -73.6 145.1 84.29 Favored Pre-proline 0 C--O 1.224 -0.245 0 CA-C-N 115.307 -0.446 . . . . 0.0 111.521 -179.06 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.4 Cg_exo -76.02 149.68 32.95 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.019 2.479 . . . . 0.0 111.895 179.181 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 94.9 m -71.85 129.87 39.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.621 0.248 . . . . 0.0 110.372 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.507 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 65.2 t -100.32 128.22 52.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.938 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.0 143.28 35.03 Favored Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.432 179.253 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.0 Cg_endo -84.0 131.96 17.73 Favored 'Cis proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.446 -1.481 . . . . 0.0 111.958 -0.33 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.634 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 48.6 p90 -100.24 131.62 46.07 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.79 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.0 m -92.37 123.79 35.94 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -176.41 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.799 ' CE1' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -125.56 144.17 50.68 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.264 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.799 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.88 35.16 0.11 Allowed 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.456 1.102 . . . . 0.0 113.26 178.896 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.86 -4.65 84.92 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 115.018 0.767 . . . . 0.0 115.018 178.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.571 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 62.4 m-80 -108.69 137.7 46.21 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 118.623 1.211 . . . . 0.0 112.031 -178.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -79.02 118.81 21.35 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.688 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.3 m-30 -103.25 108.44 19.66 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.71 0.767 . . . . 0.0 111.378 -178.482 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -88.77 -17.01 30.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.392 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 p -129.5 175.04 9.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.4 m -62.0 162.9 8.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.534 178.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.444 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 15.3 t -138.91 179.46 6.48 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.083 -178.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 p -133.38 15.93 4.08 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 177.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.783 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -59.98 139.04 57.69 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.384 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.99 -5.94 29.98 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.299 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.531 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 28.5 mtp85 -109.49 -75.97 0.62 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.612 0.206 . . . . 0.0 111.102 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.3 m 60.87 37.66 18.35 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.727 0.642 . . . . 0.0 110.317 -179.242 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -115.16 -32.34 5.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.788 0.804 . . . . 0.0 110.976 -178.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.81 -39.12 1.49 Allowed Glycine 0 C--N 1.309 -0.963 0 CA-C-N 114.282 -1.327 . . . . 0.0 111.849 -179.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.531 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 39.4 mttp -73.62 111.2 8.53 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.413 0.285 . . . . 0.0 110.907 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.6 mtt -85.49 146.61 26.85 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.271 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.676 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 21.4 p-90 -135.68 -169.78 2.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.408 0.623 . . . . 0.0 112.041 -178.466 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.0 p -159.86 145.26 15.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.143 178.823 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.467 ' HB3' ' HD1' ' A' ' 47' ' ' TYR . . . -77.82 151.46 33.94 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.477 -179.363 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 38.4 p -96.7 8.87 43.26 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.495 0.664 . . . . 0.0 110.382 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.4 p -133.07 155.56 49.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.221 179.256 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -62.34 -28.91 70.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.41 . . . . 0.0 111.025 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -125.93 114.42 18.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.412 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.859 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 66.4 t80 -89.03 -29.12 19.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.288 -179.305 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -52.61 -38.8 60.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.859 0.362 . . . . 0.0 111.526 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -92.97 -63.94 1.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.579 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.5 m-20 -64.36 -28.34 69.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -177.408 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.597 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER 42.96 49.46 5.24 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 179.306 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.579 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 9.5 mtpp -114.81 116.85 29.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.859 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.6 p-90 -128.85 176.97 7.42 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -175.278 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.695 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -172.32 145.83 8.84 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 113.107 -1.861 . . . . 0.0 108.94 179.002 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 13.6 m-30 -59.78 160.69 7.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 117.346 0.573 . . . . 0.0 111.853 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.439 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 1.8 t -59.23 134.27 88.02 Favored Pre-proline 0 CA--C 1.527 0.078 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 177.188 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.452 ' HA ' HG13 ' A' ' 6' ' ' VAL . 68.1 Cg_endo -73.03 -163.45 0.16 Allowed 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.024 1.816 . . . . 0.0 115.303 -176.049 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 34.04 63.4 0.41 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.14 -1.846 . . . . 0.0 112.845 -178.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -106.15 144.56 32.68 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.037 179.209 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.72 0 CA-C-O 118.297 -1.279 . . . . 0.0 112.184 179.949 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 120.862 0.363 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -106.16 115.41 30.18 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.022 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.489 ' HG3' ' HE2' ' A' ' 17' ' ' PHE . 0.6 OUTLIER -69.01 136.33 52.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -177.388 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.435 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 70.6 m -107.18 -173.58 2.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.922 177.16 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.419 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 24.2 p -122.96 152.0 41.29 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -178.681 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.735 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -121.72 -164.5 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 175.588 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.425 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 33.85 -123.45 0.39 Allowed Glycine 0 N--CA 1.465 0.61 0 O-C-N 123.903 0.752 . . . . 0.0 113.528 177.654 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.633 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 36.44 -145.38 0.08 OUTLIER Glycine 0 C--N 1.335 0.517 0 N-CA-C 115.744 1.057 . . . . 0.0 115.744 176.945 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.79 -11.18 0.68 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.251 -0.475 . . . . 0.0 111.542 179.963 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.9 m -73.63 -21.18 60.38 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.921 0.391 . . . . 0.0 111.021 -179.7 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.57 -104.88 3.13 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.108 -179.909 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.21 39.94 1.77 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.467 179.875 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.87 140.84 37.63 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.787 0.327 . . . . 0.0 110.691 179.659 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -61.6 131.36 35.36 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.698 2.266 . . . . 0.0 112.14 179.792 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 53.7 m -71.7 120.73 17.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.175 179.462 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 62.3 t -76.65 116.24 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 111.893 -179.301 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.558 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 40.5 m-85 -118.49 139.89 27.54 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.043 179.866 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.421 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.9 Cg_endo -83.4 138.15 31.99 Favored 'Cis proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.311 -1.537 . . . . 0.0 111.99 -0.447 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.558 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 40.4 p90 -102.97 -173.54 2.34 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.182 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.4 m -140.54 123.64 16.61 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.195 -179.508 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.666 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 56.8 t80 -122.46 133.33 54.6 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.99 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.54 HD21 ' CD1' ' A' ' 21' ' ' PHE . 3.8 mm? 32.61 47.76 0.11 Allowed 'General case' 0 N--CA 1.432 -1.357 0 O-C-N 124.915 1.384 . . . . 0.0 114.238 175.685 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.39 -11.92 66.75 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 116.205 1.242 . . . . 0.0 116.205 177.544 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.517 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 59.6 m-80 -109.47 154.94 21.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.417 1.608 . . . . 0.0 112.15 -178.585 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -95.66 126.98 41.31 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.107 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.666 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 37.9 m-85 -119.08 122.42 42.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.542 0.687 . . . . 0.0 112.054 -178.253 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.421 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 82.9 mt-10 -100.02 -18.06 17.21 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.904 178.987 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.3 p -129.04 -173.33 2.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.743 179.423 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.98 167.34 13.99 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 120.297 -0.561 . . . . 0.0 109.586 178.764 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.406 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 13.6 t -145.76 170.09 17.22 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.459 -178.895 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.778 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 56.6 p -122.21 18.66 10.72 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.752 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -58.92 133.69 56.27 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.748 -179.922 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.6 -5.01 54.34 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.315 -179.774 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.0 mtp85 -114.13 -58.17 2.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.083 0.468 . . . . 0.0 110.402 -179.443 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.405 ' HG ' ' C ' ' A' ' 34' ' ' ARG . 75.9 p 54.48 28.32 9.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.334 -179.552 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.13 -88.84 0.47 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.024 0.44 . . . . 0.0 110.824 179.371 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -160.93 -21.16 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.785 179.45 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 89.4 mttt -79.06 76.16 5.56 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 122.328 0.251 . . . . 0.0 110.83 179.778 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.778 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 77.0 mtm -64.15 134.49 54.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 109.934 179.693 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.696 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.1 p-90 -125.12 -161.28 1.01 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.387 -177.518 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 3.5 p -169.53 154.52 5.64 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.594 178.189 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.475 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -78.8 147.81 33.14 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 120.835 0.35 . . . . 0.0 110.998 -179.252 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 66.0 p -100.88 7.06 43.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.636 0.731 . . . . 0.0 109.843 179.545 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.5 p -128.4 157.87 39.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.005 178.402 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.86 99.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.101 0.476 . . . . 0.0 110.759 -179.937 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -119.57 106.07 11.84 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.32 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.973 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 34.2 t80 -71.58 -38.33 70.92 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 -179.078 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -45.59 -36.76 4.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.437 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.79 -63.74 1.23 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -179.28 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.39 -18.64 59.89 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.815 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 34.74 56.3 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -179.868 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -114.32 116.25 28.66 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.492 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.973 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 8.4 p-90 -125.27 169.51 12.21 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -174.859 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.633 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.51 146.68 10.89 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.345 179.339 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.735 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 14.8 m-30 -62.06 163.23 8.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.366 0.603 . . . . 0.0 112.328 -179.21 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.3 t -76.48 139.32 67.48 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.5 179.241 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.643 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 87.6 Cg_endo -71.11 -146.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.366 2.711 . . . . 0.0 112.944 -179.486 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.428 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 9.0 t70 -57.11 112.04 1.24 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.617 179.754 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.643 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 57.0 mt-30 -108.12 -154.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.372 0.606 . . . . 0.0 111.944 -177.958 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.702 0 CA-C-O 118.735 -1.036 . . . . 0.0 111.776 -179.958 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -82.87 129.95 35.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.015 0.436 . . . . 0.0 110.561 -179.766 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.2 mtp -94.69 -121.18 0.1 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.199 0.523 . . . . 0.0 111.238 -179.484 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -49.51 156.99 0.57 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.181 -179.202 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 p -69.78 175.09 4.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.306 1.051 . . . . 0.0 113.762 -178.553 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -132.07 163.52 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 104.945 -2.242 . . . . 0.0 104.945 178.728 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.588 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 64.14 -145.55 49.75 Favored Glycine 0 C--N 1.313 -0.714 0 C-N-CA 118.067 -2.016 . . . . 0.0 110.725 -179.369 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.635 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 44.35 -145.94 1.73 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 114.724 0.65 . . . . 0.0 114.724 177.791 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.21 -4.81 1.13 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.895 0.379 . . . . 0.0 110.686 178.681 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.07 52.28 1.43 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.705 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.12 96.04 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.255 -179.317 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.89 -17.68 3.87 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.358 -179.478 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.85 143.04 26.07 Favored Pre-proline 0 C--O 1.223 -0.294 0 CA-C-N 117.091 0.446 . . . . 0.0 110.584 179.532 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.67 170.86 8.74 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.768 2.312 . . . . 0.0 111.997 179.662 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.2 m -74.81 142.96 44.16 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.954 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 92.6 t -111.63 117.38 54.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 178.767 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.559 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 47.3 m-85 -114.69 142.08 27.73 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.752 -179.778 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.23 136.65 28.62 Favored 'Cis proline' 0 N--CA 1.464 -0.259 0 C-N-CA 123.369 -1.513 . . . . 0.0 112.005 -0.498 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.559 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 32.3 p90 -107.08 132.56 52.84 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.315 178.387 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 68.1 m -94.41 124.46 38.45 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.438 -179.239 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.712 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 41.7 t80 -124.76 137.38 54.33 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.901 178.995 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.472 HD21 ' CG ' ' A' ' 21' ' ' PHE . 3.4 mm? 37.0 49.23 0.78 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 175.293 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.92 -8.97 73.98 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 114.312 -1.313 . . . . 0.0 116.351 177.626 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' THR . 62.7 m-80 -113.69 153.85 28.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 119.515 1.658 . . . . 0.0 112.287 -178.614 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -93.37 122.48 35.83 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.804 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.712 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 15.0 m-85 -110.22 121.81 46.15 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.857 0.837 . . . . 0.0 111.56 -178.272 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -95.44 -21.06 18.57 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.883 179.676 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p -127.26 -174.67 3.22 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.894 179.953 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.6 m -66.64 170.35 6.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.3 0.571 . . . . 0.0 109.558 178.604 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.45 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 12.1 t -148.43 169.18 20.78 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.592 -179.693 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.0 p -121.98 17.72 10.9 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.21 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -62.32 137.07 58.19 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.721 -179.473 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.08 -0.09 63.84 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.718 179.862 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.443 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.0 mtp85 -107.71 -77.28 0.6 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.508 0.154 . . . . 0.0 111.297 -179.581 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.9 m 69.04 31.74 4.0 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.914 0.759 . . . . 0.0 110.663 -179.176 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.63 -84.13 0.59 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.662 179.36 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -158.51 -35.19 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.542 179.414 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.443 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 31.1 mmtm -82.32 143.7 31.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 117.413 0.606 . . . . 0.0 111.801 -179.049 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.8 mtm -102.96 151.17 22.78 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.523 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.638 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 11.3 p-90 -137.09 -170.08 2.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.288 0.566 . . . . 0.0 112.35 -178.082 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 21.4 p -155.85 146.84 22.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.966 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.98 149.42 30.8 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.754 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.1 p -100.22 16.02 25.63 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.77 0.795 . . . . 0.0 110.056 -179.775 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.2 p -143.77 152.88 41.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.059 178.372 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.81 -40.71 80.58 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.963 0.411 . . . . 0.0 111.515 -179.351 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -119.44 107.04 12.85 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.918 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.863 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 58.1 t80 -73.58 -39.8 64.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.68 -178.494 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -49.75 -38.37 33.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.47 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.44 -38.9 12.29 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -178.482 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -93.5 -24.45 17.99 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.524 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 14.4 mtm180 43.17 49.57 5.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 178.977 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -116.91 120.12 37.47 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.014 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.863 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.6 p-90 -130.66 169.33 15.78 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -175.647 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.635 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.16 145.6 11.19 Favored Glycine 0 C--O 1.22 -0.772 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.629 178.732 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.588 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 4.8 m-30 -63.44 159.71 17.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.313 0.578 . . . . 0.0 111.849 179.938 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.751 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 2.7 t -71.43 155.98 92.09 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.272 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.751 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 6.0 Cg_exo -30.37 -111.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.1 1 C-N-CA 125.595 4.197 . . . . 0.0 116.756 -178.942 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -82.4 101.55 10.7 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.074 -177.724 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.42 ' OE1' ' HB3' ' A' ' 56' ' ' CYS . 3.4 mm100 -109.07 -77.8 0.6 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.574 179.604 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.46 -1.189 . . . . 0.0 112.031 -179.764 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -145.2 94.03 2.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.425 -179.788 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.478 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . 16.1 ptm -115.86 42.08 2.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.399 0.618 . . . . 0.0 109.962 179.279 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.625 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 16.7 m -82.07 -174.31 5.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.184 -179.335 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.764 HG22 ' HA3' ' A' ' 54' ' ' GLY . 27.5 p -94.58 159.9 14.88 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.459 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.443 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 1.0 OUTLIER -127.2 6.62 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 CA-C-O 122.799 1.285 . . . . 0.0 109.964 179.922 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.425 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . -156.16 -160.12 9.82 Favored Glycine 0 C--N 1.282 -2.421 0 CA-C-N 112.874 -1.966 . . . . 0.0 111.008 -178.138 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.697 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 74.38 168.33 19.19 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.635 178.572 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.535 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -75.74 -7.64 54.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.55 -0.325 . . . . 0.0 111.527 178.782 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.6 m -80.63 -53.97 6.06 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.997 0.427 . . . . 0.0 109.931 179.419 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.38 78.87 0.11 Allowed Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.689 178.652 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.27 -35.05 2.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.074 179.099 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.527 ' O ' HG21 ' A' ' 5' ' ' THR . . . -68.54 148.88 98.13 Favored Pre-proline 0 CA--C 1.521 -0.167 0 CA-C-N 116.771 0.286 . . . . 0.0 110.915 -179.579 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.625 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 73.6 Cg_endo -82.03 151.01 16.11 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.219 1.946 . . . . 0.0 112.252 -179.967 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.441 ' SG ' HG23 ' A' ' 5' ' ' THR . 72.3 m -78.33 138.55 38.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.218 179.668 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.412 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 47.9 t -104.83 118.08 51.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.578 0.228 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.418 ' CE2' ' HE1' ' A' ' 19' ' ' PHE . 69.6 m-85 -111.27 146.34 34.37 Favored Pre-proline 0 N--CA 1.447 -0.577 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.42 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.504 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -82.64 134.37 24.81 Favored 'Cis proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.431 -1.487 . . . . 0.0 112.106 -0.237 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.627 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 20.8 p90 -108.27 127.79 54.16 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.473 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 91.7 m -91.69 127.09 37.01 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.105 0.479 . . . . 0.0 111.39 -178.81 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.806 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 56.3 t80 -123.32 135.06 54.01 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.789 179.282 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.588 ' H ' HD21 ' A' ' 22' ' ' LEU . 3.6 mm? 35.1 46.92 0.25 Allowed 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 124.491 1.119 . . . . 0.0 113.799 175.197 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.27 -20.7 49.45 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 116.237 1.255 . . . . 0.0 116.237 177.71 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -112.14 134.11 53.88 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 119.545 1.673 . . . . 0.0 112.644 -178.138 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 34.7 mtpt -79.04 125.33 29.24 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.709 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.806 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 17.9 m-85 -109.91 123.15 49.1 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.608 0.718 . . . . 0.0 111.589 -178.588 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.504 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 51.6 mt-10 -100.61 -9.96 21.43 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.817 179.283 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 p -130.88 172.12 12.4 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.3 m -63.72 160.87 16.16 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.616 179.285 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 t -138.74 174.06 10.92 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.159 -178.761 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 p -127.42 21.99 6.55 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 177.039 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.646 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -61.02 138.8 58.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.025 -179.384 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.01 -6.15 28.99 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.047 179.639 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.632 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 13.8 mtp85 -103.39 152.82 21.15 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 117.169 0.484 . . . . 0.0 111.224 -179.678 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.9 t -125.43 3.17 7.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.53 179.831 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.95 -76.81 0.41 Allowed 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.389 0.614 . . . . 0.0 110.758 179.389 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.5 -23.47 0.1 OUTLIER Glycine 0 C--N 1.307 -1.075 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.012 179.437 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.632 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -61.0 125.82 25.11 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 122.378 0.271 . . . . 0.0 110.843 -179.52 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.4 mtt -89.44 143.91 26.46 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.779 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.651 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 12.3 p-90 -132.17 -165.57 1.61 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.49 0.662 . . . . 0.0 111.39 -178.725 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -169.32 150.21 4.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.068 179.447 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.628 ' HB3' ' HD1' ' A' ' 47' ' ' TYR . . . -76.41 149.86 36.85 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.786 -179.23 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.2 p -96.42 9.08 42.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.777 0.798 . . . . 0.0 109.383 179.442 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.0 p -132.67 150.9 52.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.38 178.71 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.627 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.09 -36.48 72.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.07 0.462 . . . . 0.0 111.218 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -123.19 112.03 17.2 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.393 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.893 ' HE1' ' HB3' ' A' ' 53' ' ' TRP . 51.9 t80 -76.11 -39.06 56.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.806 -178.411 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -46.38 -35.96 5.99 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.956 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -82.52 -77.99 0.22 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -179.742 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.644 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 1.4 m-20 -67.83 -20.69 65.19 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -176.84 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 18.9 mtm180 43.24 50.73 5.8 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.943 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.644 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 59.1 mttt -111.69 118.24 35.09 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.113 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.893 ' HB3' ' HE1' ' A' ' 47' ' ' TYR . 7.6 p-90 -128.88 177.31 7.18 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -175.072 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.764 ' HA3' HG22 ' A' ' 5' ' ' THR . . . -176.76 154.63 16.67 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 113.691 -1.595 . . . . 0.0 110.013 179.227 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 15.4 m-30 -66.11 161.12 22.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.106 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.433 ' O ' HG22 ' A' ' 6' ' ' VAL . 18.8 t -76.49 140.49 68.5 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.393 178.729 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.478 ' HG3' ' HA ' ' A' ' 3' ' ' MET . 89.9 Cg_endo -68.78 -149.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 122.965 2.443 . . . . 0.0 114.265 -178.39 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.412 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 44.8 t0 -65.01 111.58 2.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.848 -179.119 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 47.2 mt-30 -108.15 -120.22 0.26 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.09 -179.881 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.846 -0.975 . . . . 0.0 111.596 179.293 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.2 p . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.514 0.197 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -74.99 140.76 43.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.894 0.378 . . . . 0.0 110.548 -179.923 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 81.1 mtp -103.11 -179.29 3.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.414 179.865 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.3 m -128.47 156.46 43.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.005 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 p -109.06 177.99 4.6 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.936 0.874 . . . . 0.0 112.138 -179.128 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.531 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.2 OUTLIER -131.32 165.39 31.7 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.035 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 178.091 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.549 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 61.07 -148.34 46.2 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 118.187 -1.958 . . . . 0.0 111.667 -179.935 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.556 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 51.97 -152.54 6.3 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 114.801 0.68 . . . . 0.0 114.801 177.352 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.416 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -148.14 19.02 1.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.889 0.376 . . . . 0.0 111.025 179.763 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.504 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 3.9 m -81.75 -28.89 33.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.164 -179.172 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.06 -74.66 2.5 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.762 179.307 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.54 60.46 0.65 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.553 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' A' ' 10' ' ' SER . . . -131.25 144.92 55.47 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.677 0.275 . . . . 0.0 111.241 -179.662 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.43 174.4 5.98 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.93 2.42 . . . . 0.0 111.852 179.888 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.8 m -85.02 128.21 34.53 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.817 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 99.3 t -95.45 108.26 20.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.048 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -110.22 142.14 25.36 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.141 -179.081 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -82.55 139.37 38.96 Favored 'Cis proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.821 -1.741 . . . . 0.0 111.276 -0.783 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.483 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 36.3 p90 -105.98 135.76 46.85 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.703 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 41.4 m -96.76 120.32 36.87 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.376 0.608 . . . . 0.0 110.76 -179.139 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.694 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 50.2 t80 -116.34 134.07 55.3 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.741 178.951 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.51 HD21 ' CD1' ' A' ' 21' ' ' PHE . 3.7 mm? 33.36 45.41 0.08 Allowed 'General case' 0 N--CA 1.435 -1.224 0 O-C-N 124.872 1.358 . . . . 0.0 114.224 174.789 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.04 -10.86 62.12 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 116.584 1.394 . . . . 0.0 116.584 177.331 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.491 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 41.0 m-80 -115.35 156.43 25.53 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.87 1.835 . . . . 0.0 112.8 -178.123 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -91.66 122.2 34.01 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.788 179.047 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.694 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 42.8 m-85 -115.22 111.25 20.67 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.725 0.774 . . . . 0.0 111.141 -179.414 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -91.26 -9.21 46.0 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.899 -179.769 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 p -138.91 -166.55 2.04 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.43 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.4 m -71.38 167.28 19.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.416 0.627 . . . . 0.0 110.52 179.018 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.451 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 11.5 t -146.85 173.22 12.6 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.601 179.979 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 p -127.03 19.33 7.07 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.386 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.49 139.6 58.59 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.43 -179.124 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.9 -0.64 44.11 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.036 179.437 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.634 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.8 mtp85 -105.56 142.46 35.26 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.155 0.503 . . . . 0.0 111.741 -179.194 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -109.58 -0.97 18.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.777 179.575 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.67 -85.81 0.24 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.267 0.556 . . . . 0.0 111.551 -179.897 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.95 -8.55 0.04 OUTLIER Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.68 -179.765 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.634 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 44.6 mmtt -73.58 114.13 11.48 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 117.282 0.541 . . . . 0.0 110.0 179.785 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -73.85 149.98 41.24 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.922 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.597 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 13.0 p-90 -137.26 -163.81 1.49 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.152 0.501 . . . . 0.0 111.375 -178.527 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 23.5 p -160.09 153.79 22.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.846 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.476 ' HB3' ' HD1' ' A' ' 47' ' ' TYR . . . -89.38 144.73 25.84 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.318 178.347 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -99.56 13.54 33.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.804 0.812 . . . . 0.0 110.349 -179.353 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.9 p -136.76 147.52 46.71 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.501 178.212 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.16 -48.99 64.64 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.166 0.507 . . . . 0.0 111.053 -179.439 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -113.6 112.09 22.94 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.086 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.848 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 56.7 t80 -73.23 -40.2 64.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.837 -178.432 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -48.22 -36.07 13.1 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.086 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.46 -68.4 0.68 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.716 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.84 -23.16 52.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.87 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 24.7 mtm180 45.4 50.57 10.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -179.617 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -112.51 117.13 31.52 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.019 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.848 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.1 p-90 -127.78 169.7 13.57 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.297 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.48 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -159.2 137.51 5.19 Favored Glycine 0 C--O 1.221 -0.688 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.473 178.647 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.549 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 2.5 m-30 -58.47 158.28 7.76 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.289 0.636 . . . . 0.0 111.738 179.686 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.719 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 10.0 t -90.7 148.5 38.61 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.674 179.983 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.719 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 60.9 Cg_endo -64.48 -113.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.29 2.66 . . . . 0.0 112.626 179.139 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.425 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 29.3 t70 -58.21 104.15 0.19 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.618 179.808 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 68.6 mt-30 -96.98 -9.41 28.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.461 -179.585 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.898 0 CA-C-O 118.701 -1.055 . . . . 0.0 112.11 179.939 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 2' ' ' TRP . 3.1 p . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.317 0.103 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.432 ' HB3' ' O ' ' A' ' 1' ' ' SER . 64.5 t-105 72.55 148.36 0.09 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.778 0.674 . . . . 0.0 110.709 -179.064 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -76.4 59.56 1.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.518 -179.107 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.07 176.36 6.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.187 0.518 . . . . 0.0 111.211 -179.737 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -110.77 172.63 6.76 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.832 -179.715 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.733 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -113.67 -166.93 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 176.8 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 36.99 -125.98 1.08 Allowed Glycine 0 N--CA 1.462 0.419 0 O-C-N 124.038 0.836 . . . . 0.0 113.226 177.592 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.671 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 31.85 -141.42 0.04 OUTLIER Glycine 0 C--N 1.335 0.474 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 176.801 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.512 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -154.51 27.67 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.693 -0.753 . . . . 0.0 109.792 179.894 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.12 -32.87 19.67 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.934 -179.222 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.82 -75.89 2.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.437 -178.628 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -137.16 17.66 3.57 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.78 179.41 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.52 141.81 49.23 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.757 0.313 . . . . 0.0 111.198 179.754 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -84.03 165.74 13.12 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.533 2.155 . . . . 0.0 111.688 179.486 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.5 m -79.93 136.7 36.7 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.829 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.3 t -96.39 107.35 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.688 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.545 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 38.0 m-85 -111.44 138.23 21.34 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-O 121.046 0.45 . . . . 0.0 111.066 -179.59 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.569 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 9.4 Cg_endo -88.5 134.15 12.38 Favored 'Cis proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.239 -1.567 . . . . 0.0 112.415 -0.555 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.747 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 37.3 p90 -97.26 -168.32 1.67 Allowed 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 119.707 -0.797 . . . . 0.0 108.85 178.063 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.4 m -147.36 127.46 13.74 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.421 -179.006 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.817 ' CE1' HD12 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -129.91 144.07 51.13 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.704 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.817 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.06 36.32 0.11 Allowed 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.863 1.265 . . . . 0.0 113.343 178.733 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.4 -12.63 69.24 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 115.19 0.836 . . . . 0.0 115.19 178.667 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -106.0 135.72 46.94 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 118.667 1.234 . . . . 0.0 111.923 -178.932 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 88.8 mttt -78.94 126.15 30.32 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.915 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.789 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.4 m-30 -108.57 114.6 28.56 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.763 0.792 . . . . 0.0 111.199 -179.123 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.569 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 50.8 mt-10 -90.49 -20.34 22.81 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.586 -179.568 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 p -125.61 -175.71 3.41 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.501 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.5 m -67.64 162.54 23.37 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.451 179.039 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.552 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 9.0 t -138.12 171.07 14.94 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.173 -179.349 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.6 p -126.18 21.95 7.3 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.244 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.733 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -66.26 140.61 58.15 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.299 -179.63 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.92 -3.59 50.17 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.553 179.579 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.678 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 16.9 mtp85 -109.47 135.28 50.74 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.155 0.502 . . . . 0.0 110.823 -179.341 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.8 t -102.36 0.91 34.81 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.67 179.876 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.32 -82.85 0.33 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.391 0.615 . . . . 0.0 111.677 179.847 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 168.34 -12.61 0.06 OUTLIER Glycine 0 C--N 1.311 -0.82 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.204 -179.852 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.678 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 81.2 mttt -62.04 98.91 0.11 Allowed 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 122.662 0.385 . . . . 0.0 110.872 179.494 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.7 mtm -69.87 139.04 52.98 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.202 -179.604 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.64 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.1 p-90 -129.08 -165.96 1.58 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.411 -178.899 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.4 p -157.37 150.02 23.12 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.304 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.747 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -84.97 148.05 26.4 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.396 179.596 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 49.7 p -102.98 10.97 37.92 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.841 0.829 . . . . 0.0 109.732 179.805 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.457 HG21 ' HB2' ' A' ' 52' ' ' LYS . 39.5 p -131.0 149.88 52.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.884 178.149 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.38 -43.28 83.46 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.124 0.488 . . . . 0.0 111.036 -179.572 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -117.26 109.05 16.37 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.225 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.822 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 73.7 t80 -77.12 -34.97 56.61 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.866 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -51.12 -35.03 33.43 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.791 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -86.57 -76.8 0.34 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.343 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.74 -19.2 65.81 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -176.824 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 45.2 mtm-85 39.24 54.6 2.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 179.253 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.457 ' HB2' HG21 ' A' ' 44' ' ' THR . 46.4 mttp -112.88 119.21 37.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.525 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.822 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.5 p-90 -129.55 173.13 10.87 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -174.701 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.565 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -164.32 144.61 9.56 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 113.327 -1.76 . . . . 0.0 109.529 178.793 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.733 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.3 m-30 -61.89 156.75 20.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 117.69 0.745 . . . . 0.0 111.843 -179.646 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.466 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 7.6 t -70.65 140.78 87.03 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.404 178.365 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.466 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 65.7 Cg_endo -65.63 -143.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.476 2.784 . . . . 0.0 112.76 -179.544 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.459 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 68.3 m-20 -63.16 85.56 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.451 179.953 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -80.96 -13.8 58.55 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.042 -178.474 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.752 0 CA-C-O 118.596 -1.113 . . . . 0.0 111.601 179.594 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.516 0.198 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -74.83 164.88 26.08 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.886 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.45 ' HB3' ' HG3' ' A' ' 57' ' ' PRO . 1.8 mpt? -50.14 104.89 0.08 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.329 0.393 . . . . 0.0 111.557 -179.141 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.8 m -77.13 159.58 29.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.986 179.968 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 p -93.18 163.57 13.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.605 1.193 . . . . 0.0 114.026 -178.084 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -138.71 162.36 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 177.844 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.579 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.89 -147.47 50.72 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 117.629 -2.224 . . . . 0.0 111.512 -179.46 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.697 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 47.88 -137.87 12.51 Favored Glycine 0 N--CA 1.461 0.309 0 N-CA-C 114.111 0.404 . . . . 0.0 114.111 177.788 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.63 20.67 0.4 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.59 ' HG ' HG21 ' A' ' 43' ' ' THR . 17.3 m -96.15 -12.77 24.23 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.702 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.77 -79.2 1.14 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.57 179.545 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.54 23.09 0.74 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.761 -179.628 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.61 146.37 95.91 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.506 0.193 . . . . 0.0 110.654 179.622 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -77.3 139.67 18.88 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.994 1.796 . . . . 0.0 112.474 -179.831 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 87.9 m -71.14 124.49 24.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.246 179.468 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 64.1 t -89.95 122.13 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.184 -179.57 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.472 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 54.1 m-85 -117.89 140.36 27.65 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.02 179.422 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -86.19 133.21 15.66 Favored 'Cis proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.181 -1.591 . . . . 0.0 112.136 0.152 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.669 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 37.7 p90 -102.4 132.69 48.25 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.63 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 m -95.37 127.31 41.31 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -177.475 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.842 ' CE1' HD12 ' A' ' 22' ' ' LEU . 1.1 t80 -127.16 144.31 51.06 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.182 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.842 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.95 32.62 0.12 Allowed 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 124.298 1.039 . . . . 0.0 113.324 178.505 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.29 -8.43 77.44 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 178.793 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.413 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 67.9 m-80 -107.98 135.81 48.74 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 118.354 1.077 . . . . 0.0 111.859 -179.148 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -78.64 123.12 26.79 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.998 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.797 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.8 m-30 -107.59 110.7 22.66 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.84 0.829 . . . . 0.0 111.183 -178.901 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -86.28 -21.92 27.09 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.108 -1.406 . . . . 0.0 110.37 -179.619 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 p -126.1 -175.2 3.3 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.788 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.9 m -65.9 163.4 17.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.393 0.616 . . . . 0.0 109.758 178.896 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.53 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.7 t -138.22 172.84 12.32 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.269 -179.311 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.4 p -125.39 12.9 8.18 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 177.762 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.769 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -60.9 138.27 58.16 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 113.881 -1.508 . . . . 0.0 111.691 -179.697 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.15 -10.12 43.49 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.779 179.767 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.613 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.6 mtp85 -105.74 139.66 39.98 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 117.424 0.612 . . . . 0.0 110.96 179.567 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.3 m -110.4 3.4 19.7 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.798 179.846 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -93.77 -77.8 0.45 Allowed 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -179.483 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.53 -32.42 0.1 OUTLIER Glycine 0 C--N 1.308 -0.993 0 C-N-CA 120.457 -0.877 . . . . 0.0 114.173 179.745 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.782 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 8.2 mptt -60.08 126.16 26.46 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.405 0.602 . . . . 0.0 111.126 -178.926 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 43.6 mtt -86.11 150.86 24.13 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.459 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.659 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.3 p-90 -137.43 -167.91 2.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.966 0.412 . . . . 0.0 111.184 -178.548 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.7 p -161.76 142.55 10.78 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.556 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.407 ' HB1' ' CD1' ' A' ' 19' ' ' PHE . . . -71.69 154.45 41.35 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.102 0.477 . . . . 0.0 110.737 -179.324 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.59 HG21 ' HG ' ' A' ' 10' ' ' SER . 66.5 p -103.5 10.11 37.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.68 0.752 . . . . 0.0 110.119 179.969 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.1 p -133.46 155.81 48.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.901 178.766 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -59.15 -35.74 74.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.906 0.384 . . . . 0.0 111.432 -179.67 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -124.98 113.09 17.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.493 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.794 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 80.3 t80 -78.06 -31.05 50.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.028 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -58.76 -34.92 71.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.527 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -79.11 -64.43 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.938 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.925 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.3 m-20 -72.86 -36.56 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.466 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 7.9 mmm-85 54.65 45.26 27.19 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.365 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.925 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 12.4 mtpt -116.74 120.4 38.47 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 176.894 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.794 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 10.4 p-90 -132.5 172.15 12.87 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.437 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.697 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -160.89 147.33 13.91 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 112.984 -1.916 . . . . 0.0 109.708 178.209 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.579 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 10.6 m-30 -58.83 163.54 3.34 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.262 0.553 . . . . 0.0 111.719 -179.862 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.565 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.2 t -61.88 134.39 94.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.286 179.753 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.514 ' HB2' ' H ' ' A' ' 58' ' ' ASP . 91.9 Cg_endo -70.02 -146.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.304 2.669 . . . . 0.0 113.537 -179.071 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.514 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 9.0 t70 -56.0 108.24 0.44 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.872 -179.41 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 70.2 mt-30 -102.55 95.21 6.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.754 -179.853 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.738 0 CA-C-O 118.622 -1.099 . . . . 0.0 111.948 179.91 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.358 0.123 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 6.3 m0 64.2 99.54 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.284 0.564 . . . . 0.0 111.424 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.83 68.94 7.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.758 -179.587 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.8 m 42.7 -134.6 0.42 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.296 0.569 . . . . 0.0 112.14 178.134 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.8 p -103.18 177.68 4.77 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 122.07 0.938 . . . . 0.0 111.953 -179.226 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -132.99 159.42 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 177.63 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.809 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 67.2 -147.45 49.1 Favored Glycine 0 C--N 1.308 -1.002 0 C-N-CA 117.587 -2.245 . . . . 0.0 111.078 -179.032 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.607 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 45.25 -144.55 2.83 Favored Glycine 0 C--N 1.328 0.108 0 N-CA-C 115.157 0.823 . . . . 0.0 115.157 177.318 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.82 29.16 0.32 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.19 0.519 . . . . 0.0 110.863 179.95 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.28 -34.44 42.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.913 -179.759 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.38 -64.32 2.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.254 -179.324 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.9 29.7 0.91 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.133 179.573 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.438 ' HB2' ' HB ' ' A' ' 43' ' ' THR . . . -100.64 144.26 28.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.86 -0.17 . . . . 0.0 111.11 179.804 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -87.59 166.17 7.64 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.443 2.095 . . . . 0.0 111.697 179.409 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 71.7 m -81.13 118.77 22.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.581 179.829 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 59.6 t -82.67 117.75 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.854 -179.799 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -114.55 134.52 22.33 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.596 179.875 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.691 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 9.4 Cg_endo -85.97 136.92 20.83 Favored 'Cis proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.246 -1.564 . . . . 0.0 112.901 -0.158 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.685 ' CD2' ' HB1' ' A' ' 42' ' ' ALA . 29.9 p90 -100.96 129.42 46.8 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.778 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.5 m -91.49 127.0 36.76 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.334 0.588 . . . . 0.0 112.552 -177.395 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.812 ' CD2' ' HB2' ' A' ' 32' ' ' ALA . 1.4 t80 -131.3 142.32 50.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.469 178.356 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.751 HD23 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.38 38.96 0.41 Allowed 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.624 1.17 . . . . 0.0 113.665 178.278 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.37 -8.71 79.24 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 115.216 0.846 . . . . 0.0 115.216 178.426 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.539 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 68.3 m-80 -110.39 137.99 47.37 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 118.461 1.13 . . . . 0.0 112.068 -179.082 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -81.5 121.11 25.88 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.498 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.752 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.3 m-30 -104.51 104.7 14.59 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.892 0.854 . . . . 0.0 110.977 -178.129 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.691 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 27.5 mt-10 -84.47 -9.34 58.46 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.159 -1.382 . . . . 0.0 111.259 -179.231 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.0 p -137.58 -167.67 2.17 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.402 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 81.2 m -70.52 170.89 11.17 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.189 -0.605 . . . . 0.0 109.982 178.597 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.587 HG22 ' CZ ' ' A' ' 19' ' ' PHE . 14.3 t -150.11 172.4 15.33 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.279 -179.983 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.6 p -127.11 20.53 6.89 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.07 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.812 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -65.25 142.72 58.19 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 114.067 -1.424 . . . . 0.0 112.234 -179.613 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.58 -4.3 21.47 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.892 179.396 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.673 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 20.6 mtp85 -101.69 133.21 46.76 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.255 0.55 . . . . 0.0 111.688 -179.216 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 p -105.85 1.1 26.55 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.753 178.833 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.523 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 1.2 p-10 -88.08 -83.78 0.21 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.728 179.807 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.64 -30.64 0.11 Allowed Glycine 0 C--N 1.311 -0.832 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.588 179.466 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.673 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.1 OUTLIER -59.19 143.55 48.61 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.875 0.369 . . . . 0.0 111.651 -179.285 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.4 mtt -98.02 149.92 21.94 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.736 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.591 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.4 p-90 -141.11 -171.85 3.36 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.334 0.587 . . . . 0.0 111.434 -178.331 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.7 p -156.7 137.3 13.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.827 177.969 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.698 ' HB3' ' HD1' ' A' ' 47' ' ' TYR . . . -71.09 151.07 44.87 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.436 0.636 . . . . 0.0 111.458 -178.553 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 13' ' ' ALA . 80.1 p -100.75 7.51 43.78 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.915 179.236 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.1 p -127.92 143.83 51.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.754 179.459 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.48 -49.33 70.37 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.916 0.389 . . . . 0.0 110.98 179.958 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -112.46 103.53 11.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.052 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.8 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 56.9 t80 -76.19 -29.25 57.59 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.274 -178.04 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -55.67 -37.77 68.73 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.562 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -86.57 -52.28 5.65 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.298 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.689 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 13.5 m-20 -77.39 -45.98 24.21 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.477 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER 61.46 37.03 16.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.895 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.689 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 5.0 mppt? -105.11 118.09 35.65 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.183 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.8 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.9 p-90 -128.66 174.88 9.03 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -174.067 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.607 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -157.68 145.9 12.62 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 112.789 -2.005 . . . . 0.0 108.733 178.274 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.809 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 6.2 m-85 -66.86 163.93 18.44 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 117.772 0.786 . . . . 0.0 112.106 -179.402 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.881 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 2.2 t -69.41 161.21 75.26 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.592 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.881 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 43.6 Cg_endo -60.45 -143.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.671 2.247 . . . . 0.0 114.636 -178.407 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.487 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 36.0 t0 -60.92 116.99 4.89 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.631 -178.158 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -120.87 162.57 19.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.527 179.669 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.758 0 CA-C-O 118.705 -1.053 . . . . 0.0 111.788 179.897 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.5 t . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.65 0.262 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.561 ' HE3' ' HA ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -74.24 -174.7 2.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.119 0.485 . . . . 0.0 111.505 179.992 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 1.2 pmm? -71.23 145.7 49.46 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.674 179.738 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 m -91.6 163.53 14.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.131 179.872 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 p -109.21 152.65 24.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.788 0.804 . . . . 0.0 112.99 -178.53 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.51 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -133.23 164.01 36.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.979 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.976 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.674 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 77.19 -80.44 1.26 Allowed Glycine 0 N--CA 1.463 0.463 0 C-N-CA 118.194 -1.955 . . . . 0.0 113.928 178.932 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.799 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . -45.98 166.22 0.07 OUTLIER Glycine 0 N--CA 1.468 0.813 0 CA-C-N 114.502 -0.849 . . . . 0.0 115.174 -179.16 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.46 HD21 ' N ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -74.27 -11.67 60.34 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.783 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.46 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.9 OUTLIER -99.55 32.6 2.75 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.551 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -44.87 98.47 0.01 OUTLIER Glycine 0 C--N 1.338 0.642 0 O-C-N 124.002 0.814 . . . . 0.0 113.112 -178.725 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.77 -25.72 4.14 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.039 -179.69 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.76 142.53 34.57 Favored Pre-proline 0 C--O 1.224 -0.274 0 CA-C-N 117.622 0.711 . . . . 0.0 111.213 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.556 ' HB3' ' HB2' ' A' ' 2' ' ' TRP . 13.6 Cg_exo -68.91 147.33 68.07 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.169 2.58 . . . . 0.0 113.018 -179.724 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 86.4 m -82.47 116.5 21.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.336 178.777 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.6 t -77.27 119.32 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -116.09 137.6 23.53 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.057 0.456 . . . . 0.0 111.22 -179.591 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -84.02 142.67 40.96 Favored 'Cis proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.428 -1.905 . . . . 0.0 112.795 -0.172 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.491 ' CZ ' ' HA ' ' A' ' 41' ' ' CYS . 21.6 p90 -104.68 128.77 52.85 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.74 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.3 m -95.6 122.63 38.55 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.433 0.635 . . . . 0.0 111.967 -177.933 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.717 ' CD2' HD23 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -104.44 -140.36 0.36 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.151 178.298 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.717 HD23 ' CD2' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -49.67 52.81 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.825 2.05 . . . . 0.0 114.884 -177.626 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 21' ' ' PHE . . . 86.2 8.4 78.44 Favored Glycine 0 C--N 1.296 -1.654 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.613 179.562 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.464 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 53.0 m-80 -125.89 134.29 51.65 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.34 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -79.6 118.38 21.39 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.381 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.654 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.3 m-85 -105.67 109.58 21.6 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.877 0.846 . . . . 0.0 111.323 -178.522 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.75 -15.91 37.96 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.079 -179.874 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 p -128.23 179.56 5.55 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.168 179.058 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.0 m -66.42 160.45 24.82 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.891 178.963 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.6 t -136.62 170.95 15.23 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.021 -179.509 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.3 p -123.59 15.25 9.52 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 177.023 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.547 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -60.59 140.5 57.37 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.41 -179.893 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.25 -7.55 16.71 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.528 -179.837 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.2 mtp85 -110.2 -68.11 0.95 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.901 0.381 . . . . 0.0 110.842 -179.8 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.7 p 52.99 31.15 10.51 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.74 -179.091 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.13 -79.2 0.55 Allowed 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.631 179.281 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.26 -36.48 0.03 OUTLIER Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.332 179.768 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -88.73 141.01 28.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.226 0.513 . . . . 0.0 112.31 -178.438 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -101.42 148.38 25.24 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 176.616 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.687 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.8 p-90 -135.63 -167.94 2.11 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.193 0.52 . . . . 0.0 111.701 -177.89 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.0 p -162.71 142.39 9.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.253 178.851 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.47 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -73.39 150.78 41.51 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.927 -179.223 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.1 p -100.34 14.76 29.98 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.332 179.373 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.1 p -136.18 154.34 50.98 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.819 179.104 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.94 -41.03 95.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.079 0.466 . . . . 0.0 110.512 -179.814 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -118.31 111.87 19.31 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.58 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.762 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 76.8 t80 -79.62 -28.96 40.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.381 -177.626 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -57.76 -38.26 75.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.053 0.454 . . . . 0.0 112.013 -179.55 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -79.32 -61.05 2.13 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.578 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -81.74 -25.72 35.15 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.763 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.8 mtm180 48.81 45.56 22.07 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -110.97 118.78 37.01 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.277 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.762 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 17.1 p-90 -130.37 174.54 9.76 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -174.645 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.799 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -168.24 142.83 7.71 Favored Glycine 0 C--O 1.222 -0.652 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.04 179.113 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.674 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 13.9 m-30 -59.18 160.31 6.51 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.317 0.579 . . . . 0.0 111.804 -179.396 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.47 ' C ' ' H ' ' A' ' 58' ' ' ASP . 5.9 t -70.45 136.81 86.16 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.933 179.834 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.437 ' HG3' ' HB2' ' A' ' 3' ' ' MET . 94.3 Cg_endo -72.6 5.78 2.69 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.705 2.27 . . . . 0.0 112.168 179.427 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 56' ' ' CYS . 10.7 t70 -138.45 84.6 2.04 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 112.936 -1.938 . . . . 0.0 108.869 179.281 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -94.55 -20.54 19.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.923 -178.817 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.64 0 CA-C-O 118.478 -1.179 . . . . 0.0 111.936 -179.184 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.885 0.374 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -125.63 132.99 52.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.485 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.0 mmt -97.97 77.48 2.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.196 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 t 61.02 -167.67 0.19 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 123.554 0.534 . . . . 0.0 111.513 179.296 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -104.61 -177.93 3.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.999 179.971 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.714 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -117.98 -173.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 177.027 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.425 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 37.27 -129.67 1.23 Allowed Glycine 0 CA--C 1.523 0.578 0 O-C-N 123.932 0.77 . . . . 0.0 113.208 178.158 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.544 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 39.96 -145.47 0.34 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 177.081 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.403 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -156.01 28.72 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.915 -0.642 . . . . 0.0 110.639 179.86 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.22 -53.14 7.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.356 179.915 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.35 -63.83 0.46 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.937 -179.397 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.23 30.92 2.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.441 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.53 139.19 21.32 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 111.4 179.802 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -86.36 174.69 5.9 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.028 2.485 . . . . 0.0 111.987 179.281 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.6 m -79.36 137.8 37.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.619 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.434 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 65.9 t -102.31 113.33 38.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.642 0.258 . . . . 0.0 110.323 179.633 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.611 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 36.6 m-85 -117.53 137.48 24.21 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-O 120.838 0.351 . . . . 0.0 111.237 -179.632 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.65 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 37.7 Cg_endo -87.04 138.88 20.09 Favored 'Cis proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.659 -1.809 . . . . 0.0 112.339 -0.744 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.619 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 34.2 p90 -105.1 -169.03 1.55 Allowed 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.041 178.121 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.454 ' OG1' ' HD2' ' A' ' 25' ' ' LYS . 86.5 m -145.81 124.05 12.25 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.738 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.774 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 66.0 t80 -116.6 129.36 56.12 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.812 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.649 ' H ' HD21 ' A' ' 22' ' ' LEU . 3.8 mm? 33.92 45.18 0.1 Allowed 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 125.114 1.509 . . . . 0.0 113.619 175.583 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.54 -16.94 51.53 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 116.459 1.344 . . . . 0.0 116.459 178.002 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.435 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 54.1 m-80 -110.93 135.64 51.15 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 119.929 1.864 . . . . 0.0 112.73 -177.958 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HD2' ' OG1' ' A' ' 20' ' ' THR . 12.3 mmmm -76.33 120.69 21.92 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.853 178.844 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.774 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.5 m-30 -112.83 118.75 35.81 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.646 0.736 . . . . 0.0 111.275 179.919 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.65 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 38.8 mt-10 -97.9 -12.71 21.78 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.999 179.798 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 p -130.66 -174.28 3.31 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.608 179.086 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.9 m -70.93 165.51 23.2 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.724 179.091 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -146.16 171.18 15.31 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.343 -178.715 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.482 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 66.0 p -123.35 18.68 9.79 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 177.061 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.69 134.62 56.36 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.872 -179.424 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.53 -3.15 60.47 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.377 -179.611 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.563 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.6 mtp85 -116.14 146.76 42.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.026 0.441 . . . . 0.0 111.182 -179.757 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.0 m -128.78 7.71 5.68 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.178 178.195 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.632 ' OD2' ' HG2' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -91.02 -42.42 10.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.066 -178.51 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.75 -35.42 2.05 Favored Glycine 0 C--N 1.315 -0.583 0 C-N-CA 120.145 -1.026 . . . . 0.0 115.131 178.631 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.632 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 14.7 mmtp -60.36 110.64 1.3 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 118.122 0.961 . . . . 0.0 111.83 -178.792 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.482 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 73.7 mtp -76.87 138.03 39.52 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.138 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.642 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.6 p-90 -121.85 -163.6 1.08 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.51 0.672 . . . . 0.0 111.941 -178.006 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 7.4 p -160.79 140.57 10.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.634 -179.722 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.569 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -72.68 149.38 43.87 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.113 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.4 p -104.34 13.51 31.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.465 0.65 . . . . 0.0 110.16 179.728 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.9 p -135.36 154.34 51.53 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.692 178.48 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.26 -43.37 98.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.844 0.354 . . . . 0.0 110.909 -179.809 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -117.97 106.97 13.49 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.693 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.976 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 25.5 t80 -77.17 -31.64 55.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.707 -179.142 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.27 -36.52 14.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.878 0.371 . . . . 0.0 111.799 179.631 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.13 -57.29 2.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -178.25 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.09 -27.4 60.87 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -176.771 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.637 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.5 mtm180 44.33 49.4 8.0 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 179.0 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -114.7 120.89 41.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.608 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.976 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.7 p-90 -128.47 172.85 10.74 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -175.312 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.544 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -163.82 143.96 9.06 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.737 179.751 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.714 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 10.9 m-30 -60.99 155.13 20.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 118.139 0.969 . . . . 0.0 111.864 -179.394 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.49 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 14.8 t -66.92 113.98 15.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.472 179.228 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -83.91 5.42 6.36 Favored 'Trans proline' 0 CA--C 1.513 -0.546 0 C-N-CA 122.957 2.438 . . . . 0.0 114.657 -177.925 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -143.17 93.66 2.52 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.646 179.683 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -123.64 27.49 7.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 -179.686 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.479 -1.178 . . . . 0.0 112.147 -179.956 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.581 0.229 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -84.11 58.7 4.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.729 0.3 . . . . 0.0 111.504 -179.303 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.415 ' HG3' ' HB3' ' A' ' 14' ' ' PRO . 13.9 ptp -144.93 167.53 22.4 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.882 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.0 m -144.9 -177.25 5.43 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.241 179.85 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 p -115.33 178.27 4.35 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.672 0.748 . . . . 0.0 112.175 -179.192 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -130.79 162.81 38.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.998 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 177.652 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.769 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 69.07 -148.13 47.26 Favored Glycine 0 C--N 1.312 -0.766 0 C-N-CA 117.565 -2.255 . . . . 0.0 111.413 -179.251 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.64 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 41.58 -140.49 1.54 Allowed Glycine 0 CA--C 1.52 0.347 0 N-CA-C 115.623 1.009 . . . . 0.0 115.623 177.219 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.464 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -159.23 40.5 0.21 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.79 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.418 ' HB3' HG21 ' A' ' 43' ' ' THR . 0.1 OUTLIER -77.85 -75.46 0.22 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.885 -179.139 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.29 61.11 0.67 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.694 -179.507 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.51 17.81 63.4 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 121.179 -0.534 . . . . 0.0 111.84 -179.343 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 10' ' ' SER . . . -103.31 138.16 19.46 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.341 . . . . 0.0 111.401 -179.637 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HB3' ' HG3' ' A' ' 3' ' ' MET . 67.6 Cg_endo -85.73 164.98 10.48 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.147 2.565 . . . . 0.0 111.718 178.871 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.8 m -72.31 136.75 46.31 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.499 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.85 95.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.743 0.306 . . . . 0.0 111.564 -179.874 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.605 ' CE1' ' HE1' ' A' ' 19' ' ' PHE . 9.2 m-85 -96.61 146.41 31.26 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-O 121.416 0.627 . . . . 0.0 111.412 177.886 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.803 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.1 Cg_endo -83.44 131.3 17.52 Favored 'Cis proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.32 -1.95 . . . . 0.0 111.896 -0.507 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.605 ' HE1' ' CE1' ' A' ' 17' ' ' PHE . 0.6 OUTLIER -85.84 -160.37 0.53 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.056 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.436 ' HG1' ' C ' ' A' ' 19' ' ' PHE . 1.8 m -144.14 120.81 11.15 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -178.706 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.763 ' CD1' HD12 ' A' ' 22' ' ' LEU 0.53 0.5 OUTLIER -127.16 123.66 37.23 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 119.949 3.314 . . . . 0.0 119.949 175.152 . . . . . . . . 4 4 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.763 HD12 ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER 26.26 52.75 0.03 OUTLIER 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 108.912 -3.767 . . . . 0.0 112.92 174.723 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.51 -4.53 56.73 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 114.213 -1.358 . . . . 0.0 115.174 178.333 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.887 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 3.5 m-80 -126.16 141.6 51.87 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 118.572 1.186 . . . . 0.0 112.944 -177.779 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.595 ' HZ1' ' HB3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -81.17 119.27 23.38 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.226 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.887 ' CE1' ' HB2' ' A' ' 24' ' ' ASN . 14.2 m-30 -97.0 95.22 7.66 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.459 1.123 . . . . 0.0 111.779 -177.224 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.803 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 39.7 mt-10 -78.45 -13.12 59.98 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 113.18 -1.827 . . . . 0.0 111.877 -178.466 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p -134.01 178.65 6.79 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.721 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 98.5 m -64.88 163.07 15.05 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 119.496 -0.882 . . . . 0.0 108.8 178.172 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.505 HG22 ' HD2' ' A' ' 26' ' ' TYR . 9.2 t -141.24 177.4 8.12 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.755 -179.609 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 p -126.64 10.56 7.2 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.698 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.693 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -61.04 146.92 45.45 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.504 179.094 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.33 -10.99 7.15 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.229 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.544 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 21.2 mtp85 -111.46 -82.2 0.58 Allowed 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 122.642 -0.328 . . . . 0.0 111.362 -179.86 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.5 m 63.61 29.42 15.15 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.744 -178.657 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.74 -29.7 8.55 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.738 -178.834 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.84 -64.96 0.35 Allowed Glycine 0 C--N 1.316 -0.571 0 CA-C-N 114.877 -1.056 . . . . 0.0 113.156 179.312 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.794 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 3.7 mptt -65.67 125.87 26.61 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.596 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.0 mtm -85.39 153.72 22.33 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.341 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.687 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 17.7 p-90 -132.64 -173.48 3.19 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.399 0.619 . . . . 0.0 110.92 -178.94 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 6.4 p -154.66 134.31 12.79 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.722 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.667 ' HB3' ' HD2' ' A' ' 47' ' ' TYR . . . -73.05 149.22 43.37 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.277 -179.231 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.418 HG21 ' HB3' ' A' ' 10' ' ' SER . 68.3 p -101.07 15.68 27.9 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.608 0.718 . . . . 0.0 109.48 179.774 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.474 HG21 ' HB2' ' A' ' 52' ' ' LYS . 41.6 p -136.77 142.19 42.97 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.236 178.794 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -52.22 -30.77 28.94 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.363 0.414 . . . . 0.0 111.85 -179.639 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -128.18 119.27 24.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.334 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.876 ' CE2' ' HB3' ' A' ' 53' ' ' TRP . 42.8 t80 -86.23 -52.17 5.82 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.936 -178.205 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.52 -32.76 0.59 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 179.647 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.5 -60.83 1.95 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.074 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -84.17 -25.11 29.82 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.027 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 8.4 mtm180 49.81 46.13 24.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 179.553 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.474 ' HB2' HG21 ' A' ' 44' ' ' THR . 39.1 mtpt -113.56 115.34 27.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.149 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.876 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 15.4 p-90 -126.67 177.62 6.43 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.336 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.45 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -166.77 138.99 5.49 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 112.873 -1.967 . . . . 0.0 108.986 178.852 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.769 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 16.1 m-85 -59.2 150.83 24.44 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 117.62 0.71 . . . . 0.0 111.273 -179.967 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.477 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 6.1 t -66.29 119.26 60.73 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.818 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.41 4.35 4.51 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.692 2.262 . . . . 0.0 114.473 -178.093 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -150.44 103.45 3.14 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.189 179.149 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -122.04 99.12 6.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.633 179.833 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.852 0 CA-C-O 118.331 -1.261 . . . . 0.0 112.146 -179.991 . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.74 0.305 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.444 ' CH2' ' HG3' ' A' ' 14' ' ' PRO . 21.9 t90 -71.82 123.12 21.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.319 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 45.8 mtm -59.91 98.25 0.05 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.146 0.498 . . . . 0.0 112.285 -177.962 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -102.71 -174.66 2.61 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.1 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -109.86 157.1 19.56 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.114 0.959 . . . . 0.0 113.145 -179.247 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.598 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.1 OUTLIER -129.95 159.63 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 177.618 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.845 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.4 -154.08 51.99 Favored Glycine 0 C--N 1.307 -1.069 0 C-N-CA 117.126 -2.464 . . . . 0.0 110.664 -178.818 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.625 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 44.43 -139.13 4.56 Favored Glycine 0 C--O 1.236 0.227 0 N-CA-C 114.773 0.669 . . . . 0.0 114.773 177.004 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.479 ' CG ' ' H ' ' A' ' 10' ' ' SER . 11.9 p-10 -141.89 -103.78 0.14 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.475 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.479 ' H ' ' CG ' ' A' ' 9' ' ' ASN . 5.5 m 39.37 15.4 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 176.749 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.23 16.04 47.2 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.986 -179.723 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.15 28.94 26.74 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.829 -179.604 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -73.55 152.76 89.69 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 122.05 0.14 . . . . 0.0 110.945 179.585 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.444 ' HG3' ' CH2' ' A' ' 2' ' ' TRP . 12.6 Cg_exo -67.44 148.71 79.7 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.984 2.456 . . . . 0.0 112.352 179.796 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 90.5 m -79.24 122.35 26.2 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.488 179.458 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.1 t -82.15 119.8 32.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.954 -179.827 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.504 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 57.3 m-85 -119.73 135.81 24.41 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.746 179.755 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.777 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 5.3 Cg_endo -87.95 132.2 11.78 Favored 'Cis proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.273 -1.553 . . . . 0.0 112.251 -0.15 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.64 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 20.8 p90 -91.84 -170.28 2.52 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.651 -0.82 . . . . 0.0 108.908 177.98 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.8 m -144.9 125.64 14.24 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.657 -178.707 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.81 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -132.2 143.65 50.1 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.91 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.802 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.33 38.2 0.33 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.526 1.13 . . . . 0.0 113.457 178.207 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 -6.6 83.39 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 115.311 0.884 . . . . 0.0 115.311 178.296 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.417 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 66.5 m-80 -112.11 136.26 51.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 118.455 1.127 . . . . 0.0 112.013 -178.78 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -79.06 127.86 32.53 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.674 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.81 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.1 m-30 -110.38 111.88 23.45 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 121.709 0.766 . . . . 0.0 111.205 -178.969 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.777 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 36.7 mt-10 -91.17 -11.99 36.74 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.555 -179.768 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 p -133.53 178.87 6.58 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.978 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.3 m -65.92 156.08 34.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.484 179.067 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.3 t -131.88 175.56 9.11 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.11 -179.2 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.2 p -129.15 15.85 6.19 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.35 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.437 ' HB1' ' HD2' ' A' ' 21' ' ' PHE . . . -59.39 141.03 55.54 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.716 -179.74 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.02 -10.99 8.31 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.226 -179.952 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.51 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 25.5 mtp85 -103.2 -69.52 0.79 Allowed 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.722 0.296 . . . . 0.0 110.832 -179.992 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.0 p 52.63 28.99 6.7 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.475 -178.74 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -109.01 -38.52 5.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.544 0.688 . . . . 0.0 110.025 -179.836 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.87 -68.49 0.21 Allowed Glycine 0 C--N 1.313 -0.74 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.466 179.111 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.76 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 4.7 mptt -57.02 130.99 48.49 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.786 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -94.0 156.22 16.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.592 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.656 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 23.4 p-90 -142.98 -169.13 2.95 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.032 0.444 . . . . 0.0 110.986 -178.949 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.6 p -161.37 143.95 12.23 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.162 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.43 153.62 35.49 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.891 0.377 . . . . 0.0 110.888 -178.973 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.5 p -102.83 8.13 39.33 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.58 0.705 . . . . 0.0 109.731 179.644 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.6 p -132.55 153.69 50.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.948 178.928 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.46 94.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.432 179.972 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -113.93 109.48 18.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.765 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.839 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 82.9 t80 -83.06 -31.59 27.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.935 -178.419 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -53.18 -37.12 61.65 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.613 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.8 -66.81 0.86 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -68.05 -29.88 68.96 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.439 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.6 mmm180 47.39 46.67 17.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 179.711 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.434 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 53.9 mtmt -110.46 117.31 33.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.708 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.839 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.0 p-90 -127.4 -177.52 4.11 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -174.853 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.625 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -174.03 139.85 5.19 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 113.625 -1.625 . . . . 0.0 109.885 179.375 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.845 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.7 m-85 -61.15 152.72 27.79 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.407 0.622 . . . . 0.0 112.165 -179.437 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.424 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.4 t -69.67 132.81 88.9 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.441 179.702 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.64 6.77 2.61 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.738 2.292 . . . . 0.0 113.83 -179.293 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -123.59 65.08 1.02 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.916 179.771 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -70.45 162.41 28.76 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.109 -179.572 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.594 0 CA-C-O 118.704 -1.054 . . . . 0.0 111.546 -179.987 . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.463 0.173 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -82.11 178.1 8.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 0.0 110.645 179.28 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -86.07 53.19 2.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.981 178.987 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m -64.47 157.23 27.16 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.556 -179.662 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.7 p -97.26 156.97 16.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 122.331 1.063 . . . . 0.0 113.515 -178.278 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.573 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.2 OUTLIER -128.82 162.98 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 103.456 -2.794 . . . . 0.0 103.456 176.578 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.733 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.24 -142.47 42.9 Favored Glycine 0 C--N 1.308 -0.983 0 C-N-CA 117.392 -2.337 . . . . 0.0 111.45 -179.205 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.619 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 38.08 -143.81 0.23 Allowed Glycine 0 N--CA 1.467 0.733 0 N-CA-C 116.34 1.296 . . . . 0.0 116.34 177.12 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.66 29.95 0.75 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.203 -0.498 . . . . 0.0 111.018 -179.274 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.567 ' HB3' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -82.58 -59.8 2.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.816 -179.624 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.76 45.29 1.22 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.074 -179.481 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.46 32.45 34.31 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.411 -179.85 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.91 149.95 41.12 Favored Pre-proline 0 C--O 1.223 -0.298 0 CA-C-N 116.599 0.2 . . . . 0.0 110.482 179.605 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 3' ' ' MET . 57.9 Cg_endo -81.08 128.14 6.34 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 121.777 1.651 . . . . 0.0 112.212 179.642 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 91.2 m -62.46 126.78 28.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.174 179.8 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 58.2 t -91.86 123.59 44.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.743 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.619 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 59.7 m-85 -118.76 141.03 29.3 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.14 178.925 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.99 134.11 21.28 Favored 'Cis proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.631 -1.404 . . . . 0.0 112.201 -0.492 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.619 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 28.5 p90 -105.06 128.03 53.15 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.281 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.0 m -89.63 123.34 33.6 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.755 -178.892 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.718 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 66.4 t80 -117.11 131.33 56.93 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.402 178.949 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.442 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 3.6 mm? 35.85 46.08 0.32 Allowed 'General case' 0 N--CA 1.427 -1.593 0 O-C-N 124.722 1.263 . . . . 0.0 113.576 175.892 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.02 -15.46 62.52 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 114.489 -1.232 . . . . 0.0 115.872 177.83 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.556 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 61.0 m-80 -111.72 135.17 52.68 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.838 1.819 . . . . 0.0 112.014 -178.376 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -78.9 121.58 25.03 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.411 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.718 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.5 m-30 -108.9 113.97 27.33 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.628 0.728 . . . . 0.0 111.556 -178.2 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -90.13 -17.33 27.85 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.482 179.481 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.2 p -127.75 -174.51 3.21 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.74 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.2 m -68.57 169.53 10.84 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.991 178.82 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.404 HG22 ' CD2' ' A' ' 26' ' ' TYR . 11.6 t -146.47 174.02 11.77 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.016 0.436 . . . . 0.0 110.15 -178.88 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.8 p -129.63 22.57 5.47 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.694 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.555 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . . . -68.9 135.7 51.45 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 113.762 -1.563 . . . . 0.0 112.108 -179.255 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.0 6.52 87.41 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.99 179.563 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.585 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 9.8 mtp85 -107.63 149.06 28.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.325 0.562 . . . . 0.0 111.489 -179.645 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.8 t -106.79 -6.58 17.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.293 -179.701 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.98 -88.0 0.37 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.077 179.689 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.61 -2.91 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.649 179.811 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.585 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 17.7 mmtp -68.36 105.15 2.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.568 0.684 . . . . 0.0 109.171 179.617 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.6 mtm -65.62 144.31 57.03 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.474 -0.49 . . . . 0.0 109.788 -179.664 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.668 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 19.0 p-90 -133.4 -169.05 2.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.394 -178.839 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.5 p -162.53 144.34 10.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.452 178.357 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.456 ' CB ' ' HD2' ' A' ' 47' ' ' TYR . . . -73.91 157.03 37.02 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.261 0.553 . . . . 0.0 110.926 -179.109 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.567 HG21 ' HB3' ' A' ' 10' ' ' SER . 63.7 p -106.28 9.66 31.94 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.863 -179.803 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.2 p -131.88 151.17 51.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.24 178.785 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.42 -37.45 72.79 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.066 0.46 . . . . 0.0 110.891 -179.784 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -123.93 115.12 20.74 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.186 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.946 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 33.6 t80 -80.73 -31.08 36.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.878 -178.116 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -53.16 -35.71 60.09 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.64 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -84.42 -67.15 0.82 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.074 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -73.29 -27.6 61.63 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -177.275 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.6 mtm180 47.56 48.14 17.09 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.971 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -112.32 122.91 49.06 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.44 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.946 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 11.7 p-90 -131.51 174.53 10.0 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -175.778 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.619 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -169.23 141.1 6.49 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.725 178.77 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.733 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.4 m-85 -55.42 151.9 9.49 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.443 0.639 . . . . 0.0 111.632 -179.82 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.619 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 18.0 t -68.54 133.22 90.92 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.632 -179.696 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.94 5.13 4.13 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.508 2.139 . . . . 0.0 112.651 179.709 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -125.77 75.94 1.54 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.914 179.571 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 56' ' ' CYS . 87.8 mt-30 -112.2 -30.69 7.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.721 -179.634 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.45 -1.194 . . . . 0.0 112.139 179.922 . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 120.479 0.181 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 53.5 m95 57.99 -92.93 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.087 0.555 . . . . 0.0 111.659 179.65 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.4 ptt? -78.71 70.19 5.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.622 0.725 . . . . 0.0 110.39 179.167 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 m -137.42 -165.2 1.72 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.722 -179.427 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.547 HG22 ' HA3' ' A' ' 54' ' ' GLY . 50.4 p -68.32 160.59 29.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.649 0.738 . . . . 0.0 112.539 -179.391 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.425 HG11 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -122.6 -53.22 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.966 0 CA-C-O 123.425 1.583 . . . . 0.0 108.545 179.232 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.685 ' H ' ' HB2' ' A' ' 55' ' ' PHE . . . -83.49 -164.25 36.18 Favored Glycine 0 C--N 1.279 -2.627 0 CA-C-N 110.503 -3.044 . . . . 0.0 111.622 178.919 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.604 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 75.94 -175.04 52.55 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.344 -0.932 . . . . 0.0 113.338 178.573 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.83 -8.19 26.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.57 0.224 . . . . 0.0 111.255 179.542 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.8 m -75.61 -61.63 1.85 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.851 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.1 88.39 0.06 OUTLIER Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.333 178.517 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.62 -23.11 22.89 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.087 -1.054 . . . . 0.0 113.548 179.088 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.96 144.82 80.18 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 117.349 0.574 . . . . 0.0 110.27 179.408 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -81.17 148.89 17.06 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.174 1.916 . . . . 0.0 111.957 -179.787 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 88.0 m -80.26 138.78 36.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.746 0.308 . . . . 0.0 110.665 -179.967 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 84.9 t -99.01 125.54 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.119 -179.711 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.419 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 48.5 m-85 -124.81 139.21 32.88 Favored Pre-proline 0 N--CA 1.445 -0.707 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.958 -179.806 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -86.5 135.85 18.13 Favored 'Cis proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.558 -1.851 . . . . 0.0 111.862 -0.458 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.696 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 45.1 p90 -101.47 -171.11 1.93 Allowed 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.476 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 m -146.85 124.77 11.98 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.673 -179.022 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.825 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 63.2 t80 -118.03 130.43 56.16 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.492 179.8 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.46 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . 3.7 mm? 33.74 45.09 0.09 Allowed 'General case' 0 N--CA 1.427 -1.611 0 O-C-N 125.075 1.484 . . . . 0.0 114.108 175.233 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.45 -15.82 49.39 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 115.903 1.121 . . . . 0.0 115.903 177.887 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.523 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 28.3 m-80 -115.82 134.84 54.59 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.789 1.795 . . . . 0.0 112.116 -178.425 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -80.53 126.37 31.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.723 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.825 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.9 m-85 -113.7 123.52 50.1 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.661 0.743 . . . . 0.0 111.531 -178.812 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -93.98 -20.83 19.61 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.181 179.926 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 p -128.38 -173.29 2.91 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.858 179.004 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 70.9 m -65.62 161.97 19.32 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.339 178.726 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -138.63 168.68 19.26 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.322 -178.461 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.2 p -124.76 23.37 7.99 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.056 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.53 136.57 57.65 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 113.912 -1.495 . . . . 0.0 111.591 -179.781 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.69 -6.3 54.37 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.727 -179.126 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.58 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.8 mtp85 -110.17 165.48 11.72 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.682 0.277 . . . . 0.0 110.356 179.809 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.8 p -146.39 15.47 1.29 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.073 179.897 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.79 -81.15 0.44 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.609 0.718 . . . . 0.0 111.396 179.97 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.18 -16.03 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.187 -179.821 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.58 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 37.6 mttp -68.12 122.03 17.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.129 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.9 mtm -98.76 151.35 20.87 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.064 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.681 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 28.6 p-90 -141.4 -170.23 3.04 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.035 0.445 . . . . 0.0 111.102 -178.1 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.56 149.42 11.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.277 178.461 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.557 ' HB1' ' CD1' ' A' ' 19' ' ' PHE . . . -73.25 148.15 43.94 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.787 -179.281 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 69.6 p -100.41 8.06 43.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.663 0.744 . . . . 0.0 109.842 179.382 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.4 p -130.88 157.97 41.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.799 -1.092 . . . . 0.0 109.112 178.542 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.65 -39.54 80.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.912 0.387 . . . . 0.0 111.144 -179.54 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -125.41 114.09 18.39 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.001 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.846 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 58.9 t80 -69.82 -40.62 75.78 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.361 -177.936 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.13 -33.19 51.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.951 0.405 . . . . 0.0 111.933 -179.117 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.29 -68.42 0.53 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.194 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.99 -18.76 29.92 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -176.819 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 24.7 mtm-85 44.4 53.79 6.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 179.434 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -117.75 118.85 33.17 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.549 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.846 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.8 p-90 -127.53 170.47 12.57 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 122.078 0.942 . . . . 0.0 113.365 -175.537 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.604 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.44 147.95 13.2 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.411 179.275 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.685 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 7.0 m-30 -64.0 160.67 17.39 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.519 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.543 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 3.7 t -71.41 144.56 89.32 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.418 179.987 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.543 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 87.5 Cg_endo -70.13 -147.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.475 0.435 0 C-N-CA 123.253 2.635 . . . . 0.0 114.038 -179.165 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.452 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 46.6 t0 -54.78 130.62 41.51 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.166 -179.422 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -103.56 -70.28 0.77 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.766 -179.996 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.74 0 CA-C-O 118.363 -1.243 . . . . 0.0 112.289 179.569 . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.731 0.301 . . . . 0.0 111.418 . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -164.97 177.79 7.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.63 178.837 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.2 mmt -102.66 129.79 49.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.376 179.589 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.504 ' O ' ' HB3' ' A' ' 57' ' ' PRO . 10.4 m -80.76 162.46 24.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.865 0.364 . . . . 0.0 110.509 -179.724 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 p -101.55 164.32 11.81 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 122.234 1.016 . . . . 0.0 113.267 -178.763 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.69 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -118.84 -166.8 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 176.948 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.441 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 35.58 -126.19 0.76 Allowed Glycine 0 N--CA 1.465 0.568 0 O-C-N 124.007 0.817 . . . . 0.0 113.065 177.842 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.615 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 34.05 -139.29 0.14 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 115.248 0.859 . . . . 0.0 115.248 177.384 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.408 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -156.38 30.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.056 0.455 . . . . 0.0 110.827 179.252 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.477 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 19.3 m -101.95 -45.91 5.05 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.983 -179.716 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.48 -102.04 2.23 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.382 -179.68 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.67 32.72 6.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.267 179.917 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 10' ' ' SER . . . -93.61 145.88 30.75 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.799 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -84.94 160.1 11.79 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.434 2.089 . . . . 0.0 112.344 -179.684 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.7 m -89.52 130.9 35.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.619 179.66 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -89.68 120.57 38.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.842 -179.866 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.609 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 65.2 m-85 -116.1 139.0 24.58 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-O 120.772 0.32 . . . . 0.0 110.767 179.908 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -87.05 136.84 17.72 Favored 'Cis proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.615 -1.827 . . . . 0.0 112.636 -0.135 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.609 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 26.3 p90 -101.2 129.05 47.06 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.096 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 98.9 m -92.62 123.71 36.11 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.485 0.659 . . . . 0.0 112.496 -177.972 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.87 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.5 t80 -126.42 145.46 50.46 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.714 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.776 HD23 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.28 36.59 0.2 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.442 1.097 . . . . 0.0 113.384 179.185 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.8 -2.43 87.19 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 114.85 0.7 . . . . 0.0 114.85 178.637 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.559 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 45.2 m-20 -111.33 135.74 51.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.265 1.033 . . . . 0.0 111.95 -179.007 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -81.45 118.05 22.38 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.379 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.87 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.5 m-30 -101.82 113.06 25.92 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.844 0.831 . . . . 0.0 111.492 -178.553 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -86.98 -20.56 27.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.127 179.646 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -126.44 179.66 5.19 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.37 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.1 m -64.77 162.93 15.06 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.779 179.321 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.6 t -137.48 169.34 17.95 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.222 -178.738 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.56 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 41.8 p -121.61 15.76 11.13 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.894 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.828 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -61.09 142.56 56.59 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.936 179.72 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.51 -16.27 6.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.893 -179.482 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -103.51 -74.43 0.64 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 120.753 0.311 . . . . 0.0 110.465 179.681 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m 60.02 23.21 12.36 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.158 -179.83 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -103.4 -35.02 8.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.656 0.741 . . . . 0.0 110.108 -179.548 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.87 -70.18 0.21 Allowed Glycine 0 C--N 1.312 -0.772 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.405 179.634 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.905 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 3.1 mptt -58.55 137.3 57.51 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.704 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.56 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 3.5 mpp? -99.63 153.46 19.05 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.569 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.648 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 22.0 p-90 -138.1 -168.78 2.43 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.084 0.469 . . . . 0.0 110.77 -178.815 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.3 p -163.16 141.1 7.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.39 177.826 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.88 148.53 46.02 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.304 0.573 . . . . 0.0 110.929 -178.662 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 43.9 p -98.31 11.96 36.31 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.092 179.215 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.4 p -131.01 155.19 47.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.974 179.265 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -62.02 -40.06 94.43 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.915 0.388 . . . . 0.0 110.913 -179.995 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -120.11 111.89 18.43 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.802 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.817 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 74.7 t80 -82.18 -31.62 30.33 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.072 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -57.03 -33.29 67.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.127 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -92.35 -56.05 3.18 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.153 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -74.75 -26.89 60.09 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.544 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 12.8 mtm180 43.46 50.67 6.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 179.576 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -119.61 120.35 36.41 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.432 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.817 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.4 p-90 -133.98 177.68 7.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -173.99 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.615 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -169.27 146.24 10.03 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.724 178.82 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.69 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.3 m-30 -60.29 157.78 12.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.606 0.703 . . . . 0.0 111.725 -179.08 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.453 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.5 t -63.2 135.99 96.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.529 -179.844 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.504 ' HB3' ' O ' ' A' ' 4' ' ' SER . 97.3 Cg_endo -73.38 -149.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.166 2.578 . . . . 0.0 112.922 -179.735 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -57.38 120.72 8.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.208 179.879 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 63.1 mt-30 -114.14 14.06 18.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.128 -179.152 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.787 0 CA-C-O 118.472 -1.182 . . . . 0.0 112.045 179.984 . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -101.3 164.95 11.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.846 -179.859 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 73.0 mtm -94.17 42.37 1.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.125 0.488 . . . . 0.0 110.727 179.553 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.1 m -99.66 178.87 4.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.8 179.25 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.654 HG23 ' SG ' ' A' ' 41' ' ' CYS . 50.1 p -97.57 168.09 10.58 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.028 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.828 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -129.18 -160.47 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.668 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 34.4 -123.1 0.46 Allowed Glycine 0 N--CA 1.464 0.51 0 O-C-N 124.105 0.878 . . . . 0.0 113.182 177.679 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.536 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 34.45 -144.68 0.05 OUTLIER Glycine 0 C--N 1.337 0.615 0 N-CA-C 116.097 1.199 . . . . 0.0 116.097 177.062 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.31 -26.76 0.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.844 -0.678 . . . . 0.0 110.093 179.732 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 m -60.85 -20.79 62.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.203 179.581 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.53 -114.81 4.79 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.308 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.91 46.91 1.08 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.022 179.221 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.587 ' O ' HG21 ' A' ' 5' ' ' THR . . . -83.41 148.4 55.45 Favored Pre-proline 0 C--O 1.222 -0.364 0 CA-C-N 116.92 0.36 . . . . 0.0 110.562 179.835 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -65.08 131.82 29.93 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.202 1.935 . . . . 0.0 111.768 179.666 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.8 m -66.04 135.37 54.56 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.811 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 86.8 t -98.83 113.65 34.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.648 0.261 . . . . 0.0 111.109 179.871 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 15' ' ' CYS . 99.4 m-85 -112.84 143.22 28.63 Favored Pre-proline 0 N--CA 1.446 -0.665 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.287 179.172 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -85.45 133.57 17.48 Favored 'Cis proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.38 -1.508 . . . . 0.0 112.034 -0.174 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.671 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 46.7 p90 -105.5 130.77 53.5 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.436 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.9 m -95.75 128.51 42.69 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -176.974 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.87 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.2 t80 -132.53 146.6 52.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.68 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.664 HD12 ' CD1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.51 37.4 0.29 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.557 1.143 . . . . 0.0 113.466 178.535 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.14 -6.06 82.5 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 114.606 0.602 . . . . 0.0 114.606 178.929 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -111.73 133.25 54.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.351 1.075 . . . . 0.0 112.057 -178.721 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -79.03 122.81 26.66 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.889 179.187 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.87 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.5 m-85 -106.15 114.52 28.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.784 0.802 . . . . 0.0 111.504 -178.361 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -93.56 -15.65 25.23 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.288 179.434 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.3 p -130.34 178.58 6.48 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.015 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.5 m -60.9 163.69 5.55 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.566 0.698 . . . . 0.0 110.648 179.274 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.0 t -144.71 169.41 18.07 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.253 179.908 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.56 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 15.7 p -125.7 23.78 7.28 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.066 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.79 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -61.93 140.4 58.31 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 113.969 -1.468 . . . . 0.0 111.015 -179.944 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.02 -8.9 13.42 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.723 -179.452 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.6 mtp85 -108.73 -82.4 0.56 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.972 0.415 . . . . 0.0 110.663 -179.699 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.1 t 62.81 19.07 11.23 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.658 -179.448 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.2 -31.55 12.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.726 0.774 . . . . 0.0 109.946 179.983 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.66 -58.22 0.38 Allowed Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.635 179.78 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.796 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 8.3 mptt -65.54 134.9 54.35 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.79 0.329 . . . . 0.0 111.653 -179.116 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.56 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 61.8 mtt -98.63 160.33 14.35 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.306 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.629 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.1 p-90 -144.08 -173.27 3.96 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.544 0.688 . . . . 0.0 111.974 -178.981 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.654 ' SG ' HG23 ' A' ' 5' ' ' THR . 8.5 p -154.81 138.57 16.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.959 -1.018 . . . . 0.0 108.85 179.769 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.579 ' HB1' ' CG ' ' A' ' 19' ' ' PHE . . . -76.45 153.82 35.28 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.333 179.961 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.4 p -104.55 14.29 30.21 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.851 0.834 . . . . 0.0 110.015 -179.694 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.9 p -137.3 147.5 45.69 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.592 178.89 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.651 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -51.63 -43.77 62.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.929 0.395 . . . . 0.0 111.4 -179.688 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -119.38 107.43 13.35 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.909 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.795 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 79.7 t80 -71.86 -32.04 67.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.364 -178.027 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.689 ' HA ' ' NH1' ' A' ' 51' ' ' ARG . 25.8 m-20 -66.26 -25.45 66.89 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.016 0.436 . . . . 0.0 111.523 -179.764 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -84.4 -58.99 2.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.374 -179.634 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -87.84 -19.4 27.49 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -176.681 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.689 ' NH1' ' HA ' ' A' ' 48' ' ' ASP . 7.8 mtt-85 45.97 51.0 11.1 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 179.978 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -119.84 121.76 39.81 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 176.443 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.795 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.5 p-90 -136.59 176.92 8.26 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -175.597 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.576 ' HA3' ' HB ' ' A' ' 5' ' ' THR . . . -170.07 149.14 12.5 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.289 178.237 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.828 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.6 m-30 -64.72 165.71 9.96 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.859 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.565 ' HB3' ' HD2' ' A' ' 57' ' ' PRO . 37.8 m -101.57 169.05 8.19 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 176.42 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' A' ' 56' ' ' CYS . 94.3 Cg_endo -68.56 -152.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.083 1.855 . . . . 0.0 113.8 -178.541 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.46 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 36.3 t70 -61.97 138.69 58.4 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.029 -178.425 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -99.51 -58.53 1.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.229 179.345 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.847 0 CA-C-O 118.333 -1.259 . . . . 0.0 111.655 -179.62 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 120.863 0.363 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -157.55 106.07 2.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.253 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.402 ' O ' ' HB3' ' A' ' 14' ' ' PRO . 11.8 ptt? -90.21 113.16 24.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.879 0.371 . . . . 0.0 110.796 179.984 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m -90.19 158.51 17.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.655 179.916 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.49 HG22 ' SG ' ' A' ' 41' ' ' CYS . 23.6 p -82.8 170.39 15.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.478 0.656 . . . . 0.0 112.207 -179.674 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.806 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -107.94 -168.13 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 176.793 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.54 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 40.05 -123.23 2.03 Favored Glycine 0 N--CA 1.46 0.288 0 O-C-N 123.827 0.704 . . . . 0.0 113.116 177.829 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.648 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 32.19 -143.13 0.03 OUTLIER Glycine 0 C--N 1.336 0.529 0 N-CA-C 116.836 1.495 . . . . 0.0 116.836 177.065 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.492 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -157.03 24.34 0.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.597 -0.801 . . . . 0.0 110.6 179.961 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.39 -23.32 23.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.316 -179.87 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.2 -76.57 2.14 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.61 -179.75 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -126.96 9.56 7.1 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.436 -179.436 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.7 141.63 56.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 117.341 0.57 . . . . 0.0 111.526 -179.859 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HB3' ' O ' ' A' ' 3' ' ' MET . 60.1 Cg_endo -88.38 178.61 2.9 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.133 2.556 . . . . 0.0 111.812 179.475 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.6 m -81.8 149.03 28.56 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.53 -179.88 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.6 t -115.94 118.41 58.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.516 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.613 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 59.6 m-85 -121.11 143.59 37.47 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-O 121.019 0.437 . . . . 0.0 111.878 -179.084 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.764 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 8.6 Cg_endo -87.5 135.99 15.96 Favored 'Cis proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.029 -1.655 . . . . 0.0 111.6 -0.817 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.662 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 37.6 p90 -103.02 -169.88 1.72 Allowed 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.208 178.647 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.412 ' OG1' ' HD3' ' A' ' 25' ' ' LYS . 63.6 m -147.54 126.89 13.09 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.53 -179.505 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.845 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 59.8 t80 -123.87 133.45 53.76 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.12 179.383 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.446 HD21 ' CG ' ' A' ' 21' ' ' PHE . 3.6 mm? 35.38 48.28 0.39 Allowed 'General case' 0 N--CA 1.427 -1.603 0 O-C-N 124.713 1.258 . . . . 0.0 113.711 175.451 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.73 -11.09 71.75 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 116.334 1.294 . . . . 0.0 116.334 177.763 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -115.61 135.14 54.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 119.555 1.677 . . . . 0.0 112.53 -178.351 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.412 ' HD3' ' OG1' ' A' ' 20' ' ' THR . 65.5 mmtt -76.44 125.15 28.7 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.943 178.875 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.845 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.8 m-85 -115.58 118.37 32.95 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.567 0.698 . . . . 0.0 111.067 -179.985 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.764 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 49.9 mt-10 -96.28 -16.08 21.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.101 179.573 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.9 p -126.19 -177.37 3.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.138 178.233 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.2 m -67.87 165.73 17.0 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.413 178.762 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 t -142.91 173.03 11.91 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.075 -178.704 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.526 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 57.8 p -129.02 22.82 5.7 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.37 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.646 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -62.92 141.05 58.87 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 114.012 -1.449 . . . . 0.0 112.35 -179.069 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.68 -1.71 36.02 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.728 179.56 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.773 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 8.4 mtp85 -101.72 126.75 48.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.829 0.347 . . . . 0.0 110.858 -179.721 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 m -95.09 5.22 52.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.116 -179.83 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.42 -86.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.211 0.529 . . . . 0.0 110.915 179.275 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 179.12 -24.79 0.05 OUTLIER Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.233 179.975 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.773 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 76.7 mttt -49.81 120.49 4.35 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.925 0.49 . . . . 0.0 111.648 179.933 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.526 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.5 mpt? -87.58 141.96 28.21 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.688 179.214 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.637 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 13.0 p-90 -129.99 -162.78 1.24 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.176 -178.856 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.49 ' SG ' HG22 ' A' ' 5' ' ' THR . 26.3 p -163.58 151.09 12.71 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.75 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.506 ' HB1' ' CG ' ' A' ' 19' ' ' PHE . . . -83.11 144.99 29.5 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.294 179.417 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 79.6 p -99.95 13.21 34.7 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.945 0.878 . . . . 0.0 109.704 179.919 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.6 p -137.04 151.08 48.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.94 178.598 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.29 -40.95 78.86 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.891 0.377 . . . . 0.0 111.478 -179.387 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -123.71 109.84 14.2 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.599 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 1.031 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 23.7 t80 -75.83 -34.51 60.11 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.703 -178.492 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -50.75 -34.75 28.43 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.474 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -96.39 -52.69 3.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.464 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.39 -26.2 35.65 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.021 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.637 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 13.5 mtm180 45.36 50.65 9.89 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 179.117 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -114.66 121.82 44.56 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.14 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 1.031 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 12.2 p-90 -128.7 173.35 10.39 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -175.699 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.422 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.94 140.5 6.26 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.543 179.601 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.806 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 8.3 m-30 -60.16 153.29 22.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.783 0.791 . . . . 0.0 111.183 -179.661 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.513 ' HB3' ' HG2' ' A' ' 59' ' ' GLN . 8.7 t -66.29 116.08 30.09 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.706 -179.983 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.01 2.12 8.25 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.713 2.275 . . . . 0.0 113.373 -178.439 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -150.0 77.88 1.33 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.632 179.751 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.513 ' HG2' ' HB3' ' A' ' 56' ' ' CYS . 47.4 mt-30 -81.55 139.95 34.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.988 -179.094 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.719 0 CA-C-O 118.743 -1.031 . . . . 0.0 111.922 -179.846 . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.68 0.276 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -90.11 -15.64 31.23 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.408 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.44 ' SD ' ' HB2' ' A' ' 57' ' ' PRO . 26.2 ptm -69.94 168.31 15.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.3 0.571 . . . . 0.0 112.113 -179.005 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 m -95.94 -175.69 3.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.1 -179.77 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.3 p -86.47 177.91 7.27 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.348 1.071 . . . . 0.0 113.126 -178.974 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -142.58 161.8 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 178.587 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.557 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 65.5 -149.82 51.67 Favored Glycine 0 C--N 1.313 -0.695 0 C-N-CA 117.958 -2.068 . . . . 0.0 111.157 -179.453 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.708 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 50.58 -152.2 4.68 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 114.778 0.671 . . . . 0.0 114.778 177.802 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -125.36 -29.43 3.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.924 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 m -56.29 -42.96 78.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.031 -179.803 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.47 -90.77 1.62 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.888 -0.673 . . . . 0.0 113.322 178.946 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.16 49.44 0.85 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.275 -179.404 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.35 152.73 44.08 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.979 0.39 . . . . 0.0 110.116 179.159 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.35 147.29 18.02 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.01 1.807 . . . . 0.0 112.466 -179.891 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.2 m -78.03 115.69 17.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.504 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 55.3 t -79.83 108.83 13.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.91 0.386 . . . . 0.0 110.616 -179.604 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -109.72 138.51 20.68 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.969 -179.614 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.726 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 58.4 Cg_endo -85.34 138.58 25.6 Favored 'Cis proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.834 -1.736 . . . . 0.0 112.895 -0.327 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.604 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 35.1 p90 -105.55 132.65 51.45 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.184 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 90.3 m -93.78 128.46 40.02 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.412 0.625 . . . . 0.0 112.394 -177.57 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.75 ' CE1' HD12 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -130.69 142.71 50.44 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.596 -1.184 . . . . 0.0 107.83 178.166 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.75 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.37 39.54 0.3 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.757 1.223 . . . . 0.0 113.497 178.17 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.32 -5.67 84.69 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 114.859 0.704 . . . . 0.0 114.859 178.419 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.668 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 50.8 m-20 -110.76 136.39 49.91 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 118.448 1.124 . . . . 0.0 111.511 -178.723 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -82.04 120.03 24.75 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.805 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.718 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.5 m-30 -102.96 110.29 22.15 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.594 0.711 . . . . 0.0 111.38 -177.621 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.726 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 94.5 mt-10 -91.5 -4.86 55.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.131 -179.69 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.3 p -140.96 -171.43 3.25 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.325 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 87.3 m -69.65 166.17 19.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.939 178.882 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -146.38 175.72 10.32 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.665 -179.489 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.3 p -130.94 20.98 4.95 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.382 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.512 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -66.74 143.03 57.18 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 113.918 -1.492 . . . . 0.0 112.215 -179.346 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.33 2.27 47.7 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.659 178.67 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.685 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.5 mtp85 -105.04 121.53 43.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 117.349 0.574 . . . . 0.0 111.412 -179.493 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 m -85.51 -4.34 59.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.17 179.106 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.575 ' OD2' ' HG2' ' A' ' 38' ' ' LYS . 2.3 p-10 -90.64 -84.68 0.24 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.586 179.73 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.469 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 164.08 -14.95 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.853 -0.689 . . . . 0.0 114.589 179.484 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.685 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 24.9 mmtm -65.0 132.12 48.39 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 118.206 1.003 . . . . 0.0 110.278 -179.549 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.422 ' HE1' ' HB2' ' A' ' 39' ' ' MET . 52.1 mtm -85.49 144.08 28.16 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 179.303 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.614 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.2 p-90 -135.78 -168.6 2.24 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.371 0.605 . . . . 0.0 112.121 -177.819 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 23.8 p -153.05 138.95 18.06 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.166 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.97 146.73 35.28 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.795 179.97 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.2 p -101.04 17.64 21.84 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.833 0.825 . . . . 0.0 110.203 -179.695 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.89 152.97 50.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.856 178.643 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -60.19 -39.57 86.98 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.206 0.527 . . . . 0.0 111.188 -179.665 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -122.18 107.84 12.61 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.582 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.767 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 64.2 t80 -74.71 -30.44 61.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.852 -178.149 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -55.19 -37.05 66.57 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.262 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.87 -72.23 0.49 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.823 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.74 -19.49 62.73 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -177.508 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 21.6 mtm180 41.17 53.86 3.44 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 179.886 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.402 ' HG3' ' HZ1' ' A' ' 52' ' ' LYS . 48.2 mttp -112.77 118.28 34.54 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.564 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.767 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 11.9 p-90 -133.03 171.24 14.25 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -174.667 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.708 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.14 142.04 7.78 Favored Glycine 0 C--O 1.221 -0.708 0 CA-C-N 113.122 -1.854 . . . . 0.0 109.313 178.236 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.557 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 7.9 m-30 -56.21 159.34 3.53 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.777 0.789 . . . . 0.0 111.19 179.699 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.518 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 5.5 t -59.68 139.76 89.58 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.572 179.929 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 65.0 Cg_endo -66.38 -0.11 3.95 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.035 2.49 . . . . 0.0 113.88 -179.187 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -136.98 97.27 3.47 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.485 178.434 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -102.37 -175.86 2.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.859 -179.392 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.892 0 CA-C-O 118.618 -1.101 . . . . 0.0 111.925 -179.899 . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.459 0.171 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -75.27 108.26 7.92 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.611 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.484 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 70.2 mtp -66.56 83.27 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.517 -178.506 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.2 m -86.95 163.52 17.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.434 179.957 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -107.31 174.64 5.8 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 122.196 0.998 . . . . 0.0 112.874 -179.178 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.701 HG21 ' N ' ' A' ' 7' ' ' GLY . 0.2 OUTLIER -139.36 164.58 24.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.047 0 N-CA-C 104.667 -2.345 . . . . 0.0 104.667 179.418 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.701 ' N ' HG21 ' A' ' 6' ' ' VAL . . . 64.91 -149.78 51.62 Favored Glycine 0 C--N 1.313 -0.701 0 C-N-CA 118.025 -2.036 . . . . 0.0 111.367 -179.733 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.629 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 51.6 -149.26 8.5 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 114.256 0.463 . . . . 0.0 114.256 177.998 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.97 -4.03 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.685 -0.258 . . . . 0.0 111.147 179.697 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.9 m -86.37 9.51 17.78 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.968 0.413 . . . . 0.0 110.608 179.768 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.9 -106.48 1.97 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.134 -179.804 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.53 36.01 2.46 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.563 179.774 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -75.36 143.51 76.48 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.76 0.28 . . . . 0.0 110.662 179.486 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 3' ' ' MET . 16.3 Cg_exo -65.7 144.49 78.27 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.604 2.203 . . . . 0.0 112.315 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.7 m -72.16 148.43 45.64 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.657 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 64.6 t -108.76 109.67 29.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.627 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.58 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 38.6 m-85 -114.69 143.09 29.33 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-O 121.229 0.538 . . . . 0.0 111.503 -179.312 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.775 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.3 Cg_endo -87.41 136.91 16.97 Favored 'Cis proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.263 -1.557 . . . . 0.0 111.469 -0.97 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.58 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 34.3 p90 -101.4 -170.77 1.88 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.27 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.8 m -148.79 127.44 12.46 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.999 -178.996 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.796 ' CG ' HD23 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -111.11 -143.73 0.39 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 118.342 -0.837 . . . . 0.0 108.915 179.111 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.796 HD23 ' CG ' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -49.11 55.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.916 2.086 . . . . 0.0 114.958 -177.215 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 21' ' ' PHE . . . 86.72 6.87 79.42 Favored Glycine 0 C--N 1.296 -1.651 0 CA-C-N 114.41 -1.268 . . . . 0.0 113.345 178.821 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.522 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 20.7 m-80 -127.56 135.57 50.49 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 117.862 0.831 . . . . 0.0 112.151 -178.76 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -78.75 126.64 31.0 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.26 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.634 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.9 m-85 -112.23 107.65 16.59 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 122.138 0.97 . . . . 0.0 110.91 -179.19 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.775 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 32.0 mt-10 -86.11 -19.95 29.42 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.484 -179.395 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 p -126.53 -172.99 2.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 178.386 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.5 m -68.27 160.06 30.06 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.027 179.077 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.482 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 9.9 t -137.14 168.95 18.61 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.909 -179.587 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.8 p -122.82 24.55 9.02 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 122.042 0.925 . . . . 0.0 108.677 177.857 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.768 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -70.99 148.42 47.66 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.417 -179.667 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.57 -7.14 14.02 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.508 -0.769 . . . . 0.0 114.02 178.526 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.619 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 8.2 mtp-105 -91.88 -171.4 2.85 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.2 1.0 . . . . 0.0 110.793 -179.659 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.6 m -133.59 -23.98 1.8 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.672 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.592 ' CG ' HH22 ' A' ' 34' ' ' ARG . 1.3 p-10 -107.29 -90.81 0.43 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -178.083 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' N ' HH12 ' A' ' 34' ' ' ARG . . . -149.23 -9.68 0.15 Allowed Glycine 0 CA--C 1.53 0.982 0 N-CA-C 119.402 2.521 . . . . 0.0 119.402 -176.593 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.619 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 7.5 mptt -71.99 164.04 26.81 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 121.996 2.898 . . . . 0.0 112.225 -179.751 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -116.91 160.46 20.86 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.995 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.63 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 17.7 p-90 -146.87 -169.1 3.21 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.153 0.501 . . . . 0.0 110.924 -178.774 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 24.5 p -156.23 146.04 21.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.26 179.718 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.555 ' HB1' ' CD2' ' A' ' 19' ' ' PHE . . . -80.68 146.64 31.0 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.054 -0.659 . . . . 0.0 109.565 179.346 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.3 p -100.45 19.43 16.78 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.888 0.851 . . . . 0.0 109.479 179.458 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.4 p -141.15 153.71 45.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.101 179.067 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.86 -31.74 71.19 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.321 0.582 . . . . 0.0 111.252 -179.842 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -129.1 118.58 22.72 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.937 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.835 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 59.5 t80 -82.46 -32.96 28.63 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.856 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -52.32 -39.12 60.18 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.676 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.0 -74.49 0.26 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.82 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.445 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 45.7 m-20 -72.85 -19.74 61.25 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -176.292 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 35.4 mtm-85 40.11 55.69 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 179.709 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 50' ' ' ASP . 49.7 mtmt -114.54 120.42 40.15 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.941 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.835 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.6 p-90 -133.17 170.78 14.91 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.949 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.629 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.82 141.44 7.18 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.46 178.806 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 7.1 m-30 -56.98 162.01 2.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.263 0.554 . . . . 0.0 111.446 179.829 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.575 ' SG ' ' HG2' ' A' ' 59' ' ' GLN . 12.6 t -77.66 130.33 74.05 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.7 -178.46 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -76.05 -147.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.066 2.511 . . . . 0.0 111.676 178.762 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -54.25 105.41 0.15 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.49 0.494 . . . . 0.0 110.36 179.752 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.575 ' HG2' ' SG ' ' A' ' 56' ' ' CYS . 57.1 mt-30 -91.24 159.43 16.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.04 0.448 . . . . 0.0 111.938 -178.736 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.861 0 CA-C-O 118.289 -1.284 . . . . 0.0 111.749 179.228 . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.525 ' HB3' ' SD ' ' A' ' 3' ' ' MET . 14.1 m . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -111.32 55.32 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.728 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.525 ' SD ' ' HB3' ' A' ' 1' ' ' SER . 0.0 OUTLIER -83.8 105.72 14.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.503 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.2 m -75.58 155.38 36.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.934 0.397 . . . . 0.0 111.189 -179.255 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.4 p -87.57 167.02 14.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.378 0.609 . . . . 0.0 111.894 -179.986 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.856 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -107.43 -168.1 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 176.819 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.647 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 38.08 -127.26 1.59 Allowed Glycine 0 C--N 1.318 -0.438 0 O-C-N 123.846 0.716 . . . . 0.0 113.719 177.552 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.586 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 39.49 -149.55 0.11 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 116.115 1.206 . . . . 0.0 116.115 177.127 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.432 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -154.54 12.17 0.39 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.633 -0.784 . . . . 0.0 111.058 -179.755 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.0 m -84.98 0.17 52.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.427 -179.378 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.82 -97.78 2.33 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.267 179.708 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.66 40.27 1.39 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.734 179.899 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.3 148.12 36.98 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.575 0.226 . . . . 0.0 110.874 -179.843 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -72.19 172.23 15.24 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.646 2.231 . . . . 0.0 111.71 179.284 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.7 m -85.36 150.1 24.98 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.562 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.549 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 75.8 t -108.66 110.64 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.251 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -112.34 137.9 21.71 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.969 -178.995 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.7 Cg_endo -86.11 132.15 14.61 Favored 'Cis proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.485 -1.465 . . . . 0.0 112.255 -0.18 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.711 ' HZ ' HG22 ' A' ' 30' ' ' THR . 43.9 p90 -98.57 124.36 43.29 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.569 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 29.9 m -87.61 121.68 30.35 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.502 0.668 . . . . 0.0 112.194 -177.261 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.85 ' CE1' HD12 ' A' ' 22' ' ' LEU . 1.4 t80 -125.7 143.81 50.88 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.527 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.85 HD12 ' CE1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER 39.58 32.88 0.1 Allowed 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.823 1.249 . . . . 0.0 113.582 178.364 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.91 -11.73 64.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.894 -0.67 . . . . 0.0 114.767 178.604 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 20' ' ' THR . 69.6 m-80 -110.01 133.56 53.06 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 118.406 1.103 . . . . 0.0 112.425 -178.759 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 50.6 mttp -79.83 115.31 19.35 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.124 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.846 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.0 m-85 -96.97 111.99 23.95 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.908 0.861 . . . . 0.0 111.562 -177.814 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.47 -14.36 43.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.279 179.692 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.8 p -129.92 -173.54 3.06 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.828 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.5 m -71.03 167.85 18.35 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.823 178.486 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.711 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.7 t -145.55 175.33 10.43 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.13 -179.0 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.513 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 9.8 p -129.52 18.52 5.8 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.189 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.815 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -63.52 144.41 57.01 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 113.978 -1.464 . . . . 0.0 111.879 -179.715 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.3 -1.4 34.82 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.841 179.464 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.721 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 7.7 mtp85 -105.06 127.59 52.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 117.056 0.428 . . . . 0.0 111.58 -179.333 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.4 m -95.37 1.58 54.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.586 179.556 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.12 -85.15 0.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.954 0.407 . . . . 0.0 111.166 179.755 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.03 -23.15 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.433 179.682 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.721 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 1.0 OUTLIER -61.1 130.01 44.2 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 117.255 0.527 . . . . 0.0 111.306 -179.445 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.513 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 59.8 mtm -89.25 149.15 23.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.194 0.521 . . . . 0.0 110.871 -179.531 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.601 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 13.5 p-90 -138.37 -168.33 2.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.518 0.675 . . . . 0.0 112.129 -178.435 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 21.0 p -156.16 136.64 13.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.34 178.742 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.527 ' HB1' ' CG ' ' A' ' 19' ' ' PHE . . . -74.75 151.35 39.17 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.442 -179.599 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 64.2 p -101.51 11.21 39.42 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.712 179.675 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.9 p -135.85 151.43 50.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.459 178.757 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.87 -48.45 79.8 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.915 0.388 . . . . 0.0 111.62 -179.537 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -111.43 104.15 12.56 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.81 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.839 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 70.7 t80 -75.49 -32.27 60.5 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.532 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.78 -36.44 64.88 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.373 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -88.75 -61.7 1.65 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.504 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.89 -34.8 78.58 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.89 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 12.9 mtm-85 48.56 47.87 20.09 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.383 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -115.25 117.8 31.5 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.737 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.839 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 11.8 p-90 -131.59 175.48 9.13 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -174.21 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.4 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -164.34 142.64 7.93 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.616 178.876 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.856 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 8.7 m-85 -59.82 158.49 10.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.065 0.933 . . . . 0.0 111.417 -179.582 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.461 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 5.6 t -64.15 123.8 83.43 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.796 -179.085 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -81.56 5.75 6.08 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.313 2.675 . . . . 0.0 114.618 -178.744 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -131.77 94.71 3.56 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.199 179.626 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -137.14 -86.87 0.3 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.59 -179.844 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.138 -1.368 . . . . 0.0 111.428 -179.671 . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -73.03 116.75 13.93 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 111.224 179.864 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.61 ' HA ' ' HE3' ' A' ' 3' ' ' MET . 3.6 mmt -104.06 149.79 24.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.389 -179.83 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.7 t -89.55 169.83 11.01 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.764 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.465 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 32.8 p -80.81 163.59 23.34 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.432 0.634 . . . . 0.0 112.357 -179.213 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.805 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -106.46 -166.26 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 176.191 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.6 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.15 -127.1 1.19 Allowed Glycine 0 C--N 1.321 -0.281 0 O-C-N 124.072 0.857 . . . . 0.0 112.994 177.774 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.592 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 31.34 -138.66 0.07 OUTLIER Glycine 0 C--N 1.336 0.537 0 N-CA-C 116.083 1.193 . . . . 0.0 116.083 176.997 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.36 37.06 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.857 -0.671 . . . . 0.0 109.782 -179.986 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.55 -65.09 0.73 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.819 -178.748 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 105.1 49.21 1.01 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.085 -179.608 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.83 37.01 10.68 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.926 -179.622 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.0 148.88 49.87 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.536 0.207 . . . . 0.0 111.308 -179.353 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -93.41 175.06 1.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.305 2.67 . . . . 0.0 111.254 179.097 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.8 m -84.17 142.86 30.03 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.458 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.412 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 63.4 t -107.81 121.91 61.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.81 0.338 . . . . 0.0 110.216 178.962 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -121.49 144.29 39.88 Favored Pre-proline 0 N--CA 1.447 -0.616 0 CA-C-O 120.783 0.325 . . . . 0.0 111.277 -179.446 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -85.9 137.03 21.18 Favored 'Cis proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.718 -1.784 . . . . 0.0 111.698 -0.811 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.5 ' CD1' ' HB1' ' A' ' 42' ' ' ALA . 23.3 p90 -104.87 175.35 5.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.055 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 94.7 m -130.26 124.08 31.6 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.833 -179.446 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.694 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 42.5 t80 -126.26 138.78 53.65 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.907 179.029 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.558 ' H ' HD21 ' A' ' 22' ' ' LEU . 3.4 mm? 35.27 46.42 0.25 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 175.318 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.85 -7.01 81.81 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 114.469 -1.241 . . . . 0.0 116.157 177.738 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.511 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 62.0 m-80 -109.14 155.89 20.48 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 119.286 1.543 . . . . 0.0 111.674 -179.023 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -95.84 125.34 40.34 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.405 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.694 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 28.6 m-85 -113.64 119.7 38.35 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.809 0.814 . . . . 0.0 112.072 -177.599 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -96.58 -20.53 18.26 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.385 -1.279 . . . . 0.0 110.318 179.608 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 p -130.09 -174.03 3.21 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.333 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.9 m -68.16 163.46 22.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.605 178.837 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.449 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 11.1 t -142.3 163.76 31.99 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.721 -178.577 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.517 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 26.2 p -116.07 20.66 14.26 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 176.487 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.654 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . . . -59.1 142.14 52.26 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.432 -179.455 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.99 -7.39 9.77 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.246 179.264 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.709 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 22.4 mtp85 -101.37 147.23 26.57 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 117.035 0.417 . . . . 0.0 111.339 -179.17 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 t -109.81 -4.99 15.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.25 179.976 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.65 -81.7 0.24 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.24 0.543 . . . . 0.0 111.223 179.902 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.17 -26.06 0.11 Allowed Glycine 0 C--N 1.308 -1.014 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.733 179.851 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.709 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 2.0 mptp? -53.69 117.84 3.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 122.644 0.378 . . . . 0.0 111.172 179.796 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.517 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 44.0 mtm -83.87 143.55 29.82 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.038 179.743 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.639 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 15.2 p-90 -128.2 -166.98 1.7 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.565 -179.716 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 9.9 p -160.39 146.41 15.26 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.744 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.69 ' HB3' ' HD1' ' A' ' 47' ' ' TYR . . . -78.09 142.59 38.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.115 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 78.7 p -96.17 16.48 18.04 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.436 0.636 . . . . 0.0 110.486 -179.552 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.7 p -139.63 161.11 38.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.741 179.293 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -64.24 -30.33 71.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.002 0.43 . . . . 0.0 111.196 179.946 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -132.69 115.52 15.48 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.908 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.858 ' HE1' ' HB3' ' A' ' 53' ' ' TRP . 44.5 t80 -81.23 -38.3 27.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.196 -178.883 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -47.03 -36.36 7.85 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.536 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -95.11 -56.13 2.84 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.781 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.527 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.5 m-20 -67.22 -43.17 82.68 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -177.73 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 5.3 mmm180 57.59 40.87 26.47 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 179.415 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.527 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 4.2 mppt? -114.28 122.32 46.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.586 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.858 ' HB3' ' HE1' ' A' ' 47' ' ' TYR . 11.4 p-90 -132.67 170.8 14.7 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -175.022 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.494 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.24 143.26 8.33 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.863 179.254 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.805 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.2 m-30 -61.35 156.61 18.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.969 0.885 . . . . 0.0 111.499 -179.641 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.4 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 4.3 t -67.53 126.78 93.04 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.992 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -81.31 -160.68 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.007 1.804 . . . . 0.0 113.63 -177.696 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 t70 36.88 63.14 0.71 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.627 179.982 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -109.27 117.83 35.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.366 179.576 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.73 0 CA-C-O 118.778 -1.012 . . . . 0.0 112.029 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 13' ' ' ALA . 11.6 p . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 122.429 1.109 . . . . 0.0 113.494 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -127.75 164.48 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 177.43 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.45 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.27 -146.6 50.46 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 117.728 -2.177 . . . . 0.0 111.1 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.645 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 46.29 -140.23 6.38 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 114.327 0.491 . . . . 0.0 114.327 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.4 p30 . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.848 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--O 1.223 -0.297 0 CA-C-O 120.474 0.178 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 37.9 Cg_exo -59.44 136.22 70.2 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.762 2.308 . . . . 0.0 112.777 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 7.2 m -67.95 128.2 35.65 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 90.1 t -95.25 112.94 28.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.643 0.259 . . . . 0.0 110.654 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.533 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 70.0 m-85 -111.51 139.96 22.61 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.264 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.2 134.51 21.51 Favored 'Cis proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.321 -1.533 . . . . 0.0 111.93 -0.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.548 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 45.8 p90 -103.59 133.57 48.4 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.93 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 76.3 m -96.53 121.32 38.21 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.349 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.755 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 45.4 t80 -115.64 130.33 56.82 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.12 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.662 HD13 ' CD1' ' A' ' 21' ' ' PHE . 6.7 mp 44.64 33.44 0.94 Allowed 'General case' 0 N--CA 1.436 -1.133 0 O-C-N 124.363 1.039 . . . . 0.0 113.685 175.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.77 -15.9 40.55 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 115.696 1.038 . . . . 0.0 115.696 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 20' ' ' THR . 62.8 m-80 -110.68 146.72 35.74 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 119.267 1.533 . . . . 0.0 112.299 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -86.76 122.17 30.27 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.755 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 28.6 m-85 -107.21 116.77 32.52 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.69 0.757 . . . . 0.0 110.63 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -92.88 -17.04 24.53 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.275 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 p -129.6 -178.12 4.55 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.28 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 81.8 m -66.6 165.23 15.11 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.706 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.421 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 9.2 t -140.4 167.64 21.66 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.314 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.485 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 12.6 p -122.03 19.65 10.8 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.86 139.66 58.34 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 113.661 -1.609 . . . . 0.0 111.263 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.95 -2.83 54.01 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.369 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.63 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.9 mtp85 . . . . . 0 N--CA 1.446 -0.662 0 CA-C-N 117.105 0.452 . . . . 0.0 110.667 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.63 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.371 0 CA-C-O 120.691 0.281 . . . . 0.0 111.385 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.485 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 54.4 mtt -87.91 149.66 23.95 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.633 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.4 p-90 -131.87 -166.36 1.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.13 0.49 . . . . 0.0 111.577 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 28.1 p -156.9 148.99 22.91 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.492 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -84.98 148.91 25.95 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 119.455 -0.898 . . . . 0.0 108.939 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.8 p -102.2 12.9 36.0 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.448 0.642 . . . . 0.0 110.433 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.425 HG21 ' CB ' ' A' ' 50' ' ' ASP . 76.3 p -135.89 153.97 51.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.982 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.5 85.27 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.189 0.518 . . . . 0.0 110.942 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -114.49 108.32 16.71 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 1.019 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 27.4 t80 -73.89 -35.65 64.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.009 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -48.47 -33.99 10.35 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -90.88 -64.18 1.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.709 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 19.8 m-20 -69.01 -34.27 74.98 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 9.3 mtm180 50.26 45.21 26.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.709 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 34.3 mttt -111.45 119.8 40.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 1.019 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 6.9 p-90 -132.17 173.17 11.52 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -175.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.645 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.26 144.11 8.77 Favored Glycine 0 C--O 1.22 -0.731 0 CA-C-N 113.732 -1.576 . . . . 0.0 110.284 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 14.8 m-30 -57.03 155.19 8.55 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.414 0.626 . . . . 0.0 112.099 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.513 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 16.6 t . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.295 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.446 -0.629 0 CA-C-O 121.727 0.775 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.738 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -113.15 -168.04 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.04 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.451 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.45 -126.28 1.28 Allowed Glycine 0 N--CA 1.46 0.274 0 O-C-N 123.955 0.784 . . . . 0.0 113.04 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.7 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 38.59 -142.94 0.33 Allowed Glycine 0 C--N 1.331 0.3 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 114.784 -0.708 . . . . 0.0 110.333 179.147 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.98 0.419 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -88.55 170.17 5.57 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.183 2.589 . . . . 0.0 112.188 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.4 m -76.07 140.54 41.93 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 84.1 t -106.65 108.6 25.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.532 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 50.9 m-85 -109.66 141.32 23.41 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-O 120.831 0.348 . . . . 0.0 111.411 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.615 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 3.8 Cg_endo -85.7 134.05 17.64 Favored 'Cis proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.254 -1.561 . . . . 0.0 111.718 -0.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.532 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 43.9 p90 -102.81 -171.17 1.91 Allowed 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.356 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 96.6 m -145.56 119.17 9.13 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.242 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.623 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 72.4 t80 -109.46 131.16 55.33 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.615 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.8 mm? 35.63 44.06 0.19 Allowed 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 124.511 1.132 . . . . 0.0 113.859 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.2 -10.81 63.69 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 114.581 -1.191 . . . . 0.0 116.038 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.504 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 52.5 m-80 -113.23 134.01 54.8 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.887 1.843 . . . . 0.0 111.951 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -78.1 122.93 26.25 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.368 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.623 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 17.3 m-30 -110.89 118.23 35.54 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.749 0.785 . . . . 0.0 110.912 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 47.9 mt-10 -96.93 -12.81 22.93 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.356 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 p -132.69 -175.12 3.66 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 89.5 m -64.66 171.72 3.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.248 0.547 . . . . 0.0 110.052 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.4 t -151.11 173.13 14.74 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.849 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 p -133.24 24.65 4.17 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.407 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -60.53 137.48 58.16 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 113.172 -1.831 . . . . 0.0 111.786 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.87 -2.68 31.98 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.234 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.606 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.4 mtp85 . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 120.762 0.315 . . . . 0.0 111.417 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.606 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 44.2 mttp . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.503 0.192 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.3 mtm -83.93 146.77 27.86 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.636 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 21.3 p-90 -136.97 -168.1 2.21 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.336 0.589 . . . . 0.0 111.675 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 24.5 p -160.17 156.09 26.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.075 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -84.17 145.81 28.18 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.556 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.8 p -102.07 11.12 38.9 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.494 0.664 . . . . 0.0 110.291 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 p -133.33 152.0 51.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.389 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.91 82.24 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.828 0.347 . . . . 0.0 111.415 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -120.58 109.77 15.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.999 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 28.6 t80 -70.81 -37.25 73.23 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.737 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.42 -35.48 60.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.418 . . . . 0.0 111.609 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -76.12 -69.39 0.5 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -85.74 -18.05 34.13 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 23.0 mtm180 44.57 52.34 7.65 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -113.95 122.18 46.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.999 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 7.8 p-90 -129.76 173.13 10.93 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.486 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.4 140.72 6.43 Favored Glycine 0 C--O 1.223 -0.583 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.871 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.738 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.2 m-30 -63.09 158.13 20.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.364 0.582 . . . . 0.0 111.852 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 68.5 m . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.003 177.581 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.448 -0.573 0 CA-C-O 121.395 0.617 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -114.21 -165.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 176.852 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.57 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.27 -125.49 1.16 Allowed Glycine 0 C--N 1.319 -0.385 0 O-C-N 124.173 0.92 . . . . 0.0 113.569 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.703 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 38.15 -141.19 0.42 Allowed Glycine 0 C--N 1.333 0.387 0 N-CA-C 115.754 1.062 . . . . 0.0 115.754 177.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 114.74 -0.73 . . . . 0.0 109.781 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.543 0.211 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 61.2 Cg_endo -84.72 170.41 10.15 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.951 2.434 . . . . 0.0 111.942 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.5 m -79.9 138.57 37.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.509 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.0 t -100.68 109.79 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 19.2 m-30 -112.9 139.59 23.08 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.607 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.632 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.1 Cg_endo -86.72 136.79 18.58 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.097 -1.626 . . . . 0.0 112.373 -0.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 40.7 p90 -99.27 -171.58 2.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.172 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 32.2 m -142.94 127.94 18.46 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.156 0.503 . . . . 0.0 111.515 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.672 ' CE2' ' HZ2' ' A' ' 40' ' ' TRP . 1.4 t80 -133.87 140.7 47.01 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.335 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.674 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 39.46 33.92 0.12 Allowed 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 125.12 1.368 . . . . 0.0 114.103 178.023 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.94 -11.43 60.66 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.625 -0.798 . . . . 0.0 114.975 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' THR . 68.3 m-80 -109.47 154.81 22.13 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 118.513 1.156 . . . . 0.0 111.976 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.545 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -94.31 126.04 39.32 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.614 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 20.9 m-85 -110.88 110.67 21.37 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.724 0.773 . . . . 0.0 111.213 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.632 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 54.1 mt-10 -90.43 -10.26 44.44 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.824 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 p -136.84 -170.8 2.78 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.5 m -70.2 167.12 18.56 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.802 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.44 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 9.4 t -144.35 169.03 18.7 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.768 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.417 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 19.6 p -124.41 17.12 8.98 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.603 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -60.23 142.4 54.57 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 113.736 -1.574 . . . . 0.0 111.588 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.0 -5.73 12.32 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.642 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.477 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 25.2 mtp85 . . . . . 0 N--CA 1.443 -0.812 0 O-C-N 122.654 -0.321 . . . . 0.0 110.987 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 121.113 0.482 . . . . 0.0 112.043 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.417 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 71.3 mtp -100.15 150.72 22.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.672 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.0 p-90 -135.3 -170.28 2.56 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.913 0.387 . . . . 0.0 111.303 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 20.5 p -155.68 141.58 18.13 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.439 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -76.42 145.81 39.08 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.976 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.9 p -99.33 10.47 41.35 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.377 0.608 . . . . 0.0 109.91 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.468 HG21 ' HB2' ' A' ' 50' ' ' ASP . 32.6 p -128.13 153.51 46.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.053 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.24 -38.66 77.31 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.089 0.471 . . . . 0.0 110.452 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -123.99 111.35 15.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.766 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 59.4 t80 -70.13 -40.67 74.71 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.71 -30.64 70.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.089 0.471 . . . . 0.0 111.768 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -61.13 1.9 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.751 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HB2' HG21 ' A' ' 44' ' ' THR . 68.0 m-20 -95.81 -23.85 16.74 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 5.7 mtm180 53.7 52.05 13.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -117.84 119.09 33.81 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.766 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.2 p-90 -129.84 174.28 9.88 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -175.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.405 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.38 141.41 7.19 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 113.93 -1.487 . . . . 0.0 110.024 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.726 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 4.7 m-30 -60.28 157.8 12.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.898 0.849 . . . . 0.0 111.668 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.408 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 2.1 t . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.451 -0.396 0 CA-C-O 121.722 0.772 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.717 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -117.89 -167.26 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.044 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.45 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 36.78 -121.7 0.75 Allowed Glycine 0 N--CA 1.46 0.289 0 O-C-N 124.13 0.894 . . . . 0.0 113.248 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.666 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 30.21 -135.11 0.08 OUTLIER Glycine 0 C--N 1.337 0.632 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.0 p30 . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 114.815 -0.692 . . . . 0.0 110.422 179.935 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.166 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -86.53 171.74 7.21 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.898 2.399 . . . . 0.0 112.416 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 78.7 m -95.67 112.24 24.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 46.1 t -73.59 115.34 14.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.87 0.367 . . . . 0.0 111.544 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -113.03 141.18 25.16 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 120.91 0.386 . . . . 0.0 110.572 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -85.68 139.87 26.72 Favored 'Cis proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.386 -1.922 . . . . 0.0 111.707 -0.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 40.3 p90 -103.81 -174.32 2.52 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.147 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 94.3 m -142.67 120.03 11.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.865 0.364 . . . . 0.0 110.286 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.875 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 66.3 t80 -115.97 135.09 54.3 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.587 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 34.68 47.18 0.22 Allowed 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 124.589 1.18 . . . . 0.0 114.01 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.32 -7.74 80.03 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 116.546 1.378 . . . . 0.0 116.546 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' THR . 54.4 m-80 -112.79 143.14 44.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.567 1.684 . . . . 0.0 111.823 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -86.81 129.38 34.9 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.875 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 88.0 m-85 -116.75 118.22 31.93 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.394 0.616 . . . . 0.0 111.089 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -94.28 -16.62 23.42 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.845 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.7 p -130.67 -177.59 4.42 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.485 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 77.8 m -66.91 161.93 22.96 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -138.28 167.83 21.03 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.12 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.671 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 11.0 p -121.22 20.16 11.4 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -60.88 134.47 57.12 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 113.751 -1.568 . . . . 0.0 111.779 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.83 -5.71 37.77 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.136 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 20.4 mtp85 . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 120.797 0.332 . . . . 0.0 111.282 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.433 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.445 -0.678 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.671 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.2 mpt? -95.69 154.65 17.11 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.652 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.6 p-90 -139.88 -163.21 1.46 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.1 0.476 . . . . 0.0 111.144 -178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p -169.45 155.98 6.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.264 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 15' ' ' CYS . . . -79.61 152.86 29.8 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 120.911 0.386 . . . . 0.0 111.464 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.1 p -102.12 6.87 41.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.95 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.7 p -130.73 150.66 51.81 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.295 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.02 -35.44 71.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.969 0.414 . . . . 0.0 110.986 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -124.47 109.99 13.95 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 1.007 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 30.6 t80 -75.38 -34.84 61.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.345 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -52.26 -32.87 39.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.885 0.374 . . . . 0.0 111.324 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -83.17 -58.54 2.8 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.837 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 56.2 m-20 -91.31 -19.8 22.57 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 3.2 mtm105 46.57 43.72 12.69 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.837 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 22.2 mtpt -110.57 124.0 51.02 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 1.007 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 7.8 p-90 -131.58 172.66 11.97 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.566 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.65 145.78 11.3 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 113.646 -1.616 . . . . 0.0 110.255 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.717 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 7.0 m-30 -66.62 160.56 25.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.465 0.65 . . . . 0.0 112.318 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.867 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.723 0.773 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -132.0 161.73 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 177.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.768 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.73 -154.33 46.15 Favored Glycine 0 C--N 1.309 -0.921 0 C-N-CA 118.068 -2.015 . . . . 0.0 111.544 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.614 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 48.94 -150.42 3.82 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 115.45 0.94 . . . . 0.0 115.45 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 114.835 -0.682 . . . . 0.0 109.625 179.858 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 120.433 0.159 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -85.61 -177.21 2.53 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.834 2.356 . . . . 0.0 111.308 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.9 m -87.75 122.42 31.39 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.241 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 74.6 t -85.06 110.16 18.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.733 0.301 . . . . 0.0 110.329 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -116.26 138.55 24.36 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-O 120.95 0.405 . . . . 0.0 111.013 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.652 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 6.4 Cg_endo -86.47 137.85 20.67 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.136 -1.61 . . . . 0.0 112.002 -0.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.55 ' CG ' ' HB3' ' A' ' 42' ' ' ALA . 47.1 p90 -103.09 -169.66 1.68 Allowed 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.9 m -144.31 128.93 18.15 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.947 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.738 ' CG ' HD22 ' A' ' 22' ' ' LEU . 1.1 t80 -132.49 142.3 49.16 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.738 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 41.12 35.81 0.41 Allowed 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 124.557 1.143 . . . . 0.0 112.812 178.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.13 -6.6 83.31 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 115.01 0.764 . . . . 0.0 115.01 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.518 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.1 m-80 -107.07 136.87 46.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.508 1.154 . . . . 0.0 111.638 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -78.03 123.09 26.42 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.723 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 14.8 m-30 -107.03 112.17 24.99 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.805 0.812 . . . . 0.0 110.884 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.652 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 45.6 mt-10 -91.54 -18.0 24.78 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.366 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 p -129.89 -174.17 3.24 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 80.8 m -62.92 166.66 5.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.54 0.686 . . . . 0.0 110.36 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -147.65 169.5 19.52 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.32 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.586 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 55.1 p -128.55 17.7 6.39 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.644 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -59.79 138.25 57.83 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 113.96 -1.473 . . . . 0.0 111.086 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.06 -9.31 26.15 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.289 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.605 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.7 mtp85 . . . . . 0 N--CA 1.445 -0.69 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.718 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 24.7 mmmt . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.586 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 60.8 mtt -81.8 149.5 28.34 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.616 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 21.6 p-90 -136.61 -172.76 3.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.563 0.697 . . . . 0.0 112.297 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 25.0 p -151.05 140.46 21.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.739 -1.118 . . . . 0.0 108.693 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.55 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -75.61 151.24 37.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.347 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 65.1 p -108.04 14.81 24.86 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.798 0.808 . . . . 0.0 110.199 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.0 p -137.23 150.05 47.58 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.94 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.23 -42.25 76.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.879 0.371 . . . . 0.0 111.205 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -118.09 106.24 12.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.744 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 75.8 t80 -74.44 -35.28 63.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.231 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -54.44 -39.51 67.44 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -84.08 -49.78 8.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -83.02 -34.09 26.36 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 4.3 mmm-85 55.19 44.46 27.69 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -111.53 118.36 35.53 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.744 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 11.5 p-90 -129.45 174.88 9.23 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -175.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.17 141.22 7.08 Favored Glycine 0 C--O 1.221 -0.683 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.107 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.768 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 6.1 m-85 -65.75 163.38 16.74 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 117.344 0.572 . . . . 0.0 111.989 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 63.1 m . . . . . 0 N--CA 1.453 -0.284 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.755 178.351 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.442 -0.853 0 CA-C-O 121.665 0.745 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -126.74 160.76 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 177.486 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.831 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 68.53 -144.78 42.87 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 117.887 -2.102 . . . . 0.0 111.612 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.633 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 43.12 -145.86 1.04 Allowed Glycine 0 C--N 1.331 0.275 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 114.878 -0.661 . . . . 0.0 109.506 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.079 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -84.63 160.99 12.47 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.744 2.296 . . . . 0.0 112.43 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 91.8 m -83.37 123.12 29.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.469 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.8 t -90.31 120.02 38.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.715 0.293 . . . . 0.0 110.922 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.599 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 58.6 m-85 -114.74 141.88 27.44 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.483 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.462 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.3 Cg_endo -86.49 132.75 14.61 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.308 -1.538 . . . . 0.0 112.14 -0.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.599 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 22.5 p90 -98.56 128.03 44.73 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.525 ' OG1' ' HD2' ' A' ' 25' ' ' LYS . 13.9 m -91.38 125.64 36.21 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.432 0.634 . . . . 0.0 112.148 -177.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.871 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -130.36 145.97 51.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.41 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.728 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.24 36.88 0.21 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.461 1.104 . . . . 0.0 113.099 178.66 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.27 -5.52 84.96 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.441 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 68.6 m-80 -110.29 135.7 50.63 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.587 1.194 . . . . 0.0 112.202 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HD2' ' OG1' ' A' ' 20' ' ' THR . 25.1 mmmt -77.42 117.13 18.6 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.871 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.5 m-30 -101.77 104.4 15.19 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.02 0.914 . . . . 0.0 111.361 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 15.5 mt-10 -84.46 -17.42 39.2 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.215 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 p -129.06 -178.45 4.64 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.639 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.9 m -66.64 159.52 27.45 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.725 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.488 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.5 t -137.74 178.48 7.08 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.703 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.7 p -128.77 17.44 6.29 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.513 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -60.87 142.96 55.78 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.107 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.06 -5.26 19.79 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.536 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.625 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 12.2 mtp85 . . . . . 0 N--CA 1.449 -0.504 0 CA-C-N 117.33 0.565 . . . . 0.0 111.565 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.625 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 5.7 mptt . . . . . 0 CA--C 1.515 -0.367 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.0 mtp -89.86 156.82 18.21 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.632 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 18.6 p-90 -143.85 -172.06 3.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.417 0.627 . . . . 0.0 111.332 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.549 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.4 p -159.3 139.26 11.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.044 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . . . -72.01 155.48 40.28 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.372 0.606 . . . . 0.0 111.511 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.4 p -101.93 11.24 38.88 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.767 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.9 p -133.08 151.82 52.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.912 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.96 -32.57 67.97 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.163 0.506 . . . . 0.0 111.358 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -126.69 120.2 28.84 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.861 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 64.5 t80 -86.17 -31.42 21.8 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.325 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -61.13 -30.94 70.68 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.05 -45.23 8.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -100.32 -18.51 16.76 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.1 mtm105 43.5 51.28 6.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -114.82 119.39 36.45 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.861 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.2 p-90 -132.99 176.48 8.45 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -174.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -167.28 142.55 7.63 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 112.95 -1.932 . . . . 0.0 109.222 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.831 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 12.9 m-85 -60.76 157.37 14.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.407 0.622 . . . . 0.0 112.081 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.501 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.9 t . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.055 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.448 -0.545 0 CA-C-O 121.987 0.899 . . . . 0.0 112.742 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -132.75 163.91 36.58 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.032 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 178.398 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.533 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 65.16 -149.94 51.7 Favored Glycine 0 C--N 1.312 -0.782 0 C-N-CA 117.716 -2.183 . . . . 0.0 111.014 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.638 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 48.47 -150.51 3.34 Favored Glycine 0 C--N 1.332 0.326 0 N-CA-C 114.641 0.616 . . . . 0.0 114.641 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 . . . . . 0 C--N 1.329 -0.323 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.418 178.872 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 CA--C 1.521 -0.163 0 CA-C-O 120.809 0.338 . . . . 0.0 111.513 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 14.2 Cg_exo -65.51 154.31 74.29 Favored 'Trans proline' 0 C--N 1.334 -0.219 0 C-N-CA 122.896 2.397 . . . . 0.0 111.472 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.2 m -73.78 134.58 43.44 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.0 t -95.06 113.87 30.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.834 0.35 . . . . 0.0 110.426 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.614 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 47.4 m-85 -118.64 139.94 27.72 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.538 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.754 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 35.9 Cg_endo -87.06 136.12 17.05 Favored 'Cis proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.51 -1.871 . . . . 0.0 112.379 -0.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.614 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 34.3 p90 -101.93 -168.02 1.49 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 76.0 m -149.47 126.28 11.12 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.433 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.822 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 36.8 t80 -123.03 131.64 53.79 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.988 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.683 HD22 ' CE2' ' A' ' 21' ' ' PHE . 6.7 mp 41.76 33.56 0.34 Allowed 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 124.531 1.144 . . . . 0.0 113.502 174.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.68 -18.16 32.41 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 115.422 0.929 . . . . 0.0 115.422 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.475 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 43.8 m-80 -112.6 132.01 55.34 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.888 1.344 . . . . 0.0 112.181 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 46.5 mtpt -78.17 127.03 31.67 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.822 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.4 m-85 -111.91 121.2 44.38 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.683 0.754 . . . . 0.0 111.223 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.754 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 99.1 mt-10 -94.87 -14.67 24.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.224 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.3 p -130.08 -175.37 3.6 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.63 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.7 m -67.1 166.29 14.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.774 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.3 t -146.15 165.36 29.38 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.098 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 p -121.53 23.8 10.13 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -66.04 139.73 58.22 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.022 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.65 -6.45 17.79 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.612 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.482 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.9 mtp85 . . . . . 0 N--CA 1.449 -0.48 0 CA-C-N 117.401 0.601 . . . . 0.0 111.211 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 1.5 mppt? . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.0 mtm -104.61 159.07 16.05 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.722 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.584 ' HA ' ' N ' ' A' ' 56' ' ' CYS . 13.9 p-90 -142.5 -165.7 2.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.369 0.604 . . . . 0.0 111.94 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.3 p -161.04 152.79 19.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.672 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.401 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -86.85 148.53 25.33 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.401 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.3 p -103.12 8.02 38.71 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.536 0.684 . . . . 0.0 109.877 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.9 p -130.07 152.63 49.31 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.663 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.73 -47.74 81.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.756 0.313 . . . . 0.0 111.518 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -115.4 104.61 11.94 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.96 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 43.4 t80 -69.28 -37.6 77.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.792 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -53.0 -28.82 25.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.96 0.41 . . . . 0.0 111.762 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -87.48 -70.6 0.61 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.59 -21.18 55.94 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.63 ' HB3' ' NH1' ' A' ' 51' ' ' ARG . 0.9 OUTLIER 46.98 50.77 13.53 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 179.166 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -114.13 118.37 33.83 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.96 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.8 p-90 -129.85 171.21 12.96 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -174.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.638 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.61 142.64 7.83 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 113.122 -1.854 . . . . 0.0 109.502 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 13.7 m-30 -55.15 155.65 4.63 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 117.043 0.422 . . . . 0.0 111.249 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.584 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.7 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.577 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 121.466 0.651 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.71 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -116.5 -164.96 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 177.059 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.545 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.64 -125.51 1.31 Allowed Glycine 0 N--CA 1.463 0.47 0 O-C-N 123.814 0.696 . . . . 0.0 113.307 177.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.649 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 30.55 -136.4 0.07 OUTLIER Glycine 0 C--N 1.338 0.693 0 N-CA-C 116.049 1.179 . . . . 0.0 116.049 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 33.7 p30 . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 114.729 -0.736 . . . . 0.0 110.083 179.859 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.563 0.22 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -86.12 166.52 9.62 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.62 2.213 . . . . 0.0 112.254 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.7 m -81.08 133.92 35.56 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.531 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 82.9 t -96.48 115.76 36.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.742 0.306 . . . . 0.0 110.29 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -118.15 139.54 26.81 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.314 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.683 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 6.0 Cg_endo -85.64 136.12 20.61 Favored 'Cis proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.288 -1.547 . . . . 0.0 111.571 -0.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.649 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 43.8 p90 -104.1 -170.04 1.71 Allowed 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.364 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.7 m -148.18 126.86 12.53 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.094 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.831 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 67.9 t80 -117.95 132.73 56.37 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.599 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.614 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.8 mm? 33.28 45.45 0.08 Allowed 'General case' 0 N--CA 1.432 -1.332 0 O-C-N 124.792 1.308 . . . . 0.0 114.034 174.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.77 -19.01 51.61 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.452 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 32.4 m-80 -111.86 133.67 53.91 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.787 1.794 . . . . 0.0 112.418 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 11.4 mtmt -75.59 127.11 32.37 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.361 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.831 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.9 m-85 -115.97 109.7 17.93 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 122.244 1.021 . . . . 0.0 110.384 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.683 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 24.4 mt-10 -87.81 -10.47 50.8 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.498 -1.683 . . . . 0.0 110.648 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.5 p -133.15 -168.2 2.05 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.6 m -74.52 167.63 21.34 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.4 t -146.71 169.97 17.94 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.309 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.427 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 11.8 p -122.32 20.15 10.52 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.12 140.55 56.83 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.233 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.4 -1.07 45.16 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.51 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.659 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.6 mtp85 . . . . . 0 N--CA 1.447 -0.58 0 CA-C-N 116.944 0.372 . . . . 0.0 111.076 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.659 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 2.9 mppt? . . . . . 0 N--CA 1.446 -0.645 0 CA-C-O 120.939 0.399 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.427 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 47.1 mtt -91.18 151.06 21.1 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.651 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.6 p-90 -130.08 -167.07 1.76 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.187 0.518 . . . . 0.0 111.533 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 10.6 p -159.72 143.97 14.81 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.505 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -76.11 149.72 37.35 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 59.8 p -104.74 13.86 30.67 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.677 0.751 . . . . 0.0 109.788 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.8 p -139.33 154.98 47.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.835 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.85 -48.01 83.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.772 0.32 . . . . 0.0 111.325 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -114.49 106.68 14.57 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 1.063 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 20.3 t80 -75.81 -34.39 60.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.196 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.13 -39.81 21.68 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.92 -35.71 11.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -89.82 -30.86 17.66 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.534 ' HB3' HH11 ' A' ' 51' ' ' ARG . 0.3 OUTLIER 48.62 47.09 20.99 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -117.77 118.07 31.06 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 1.063 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 10.2 p-90 -132.57 173.7 11.05 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -175.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.56 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.7 147.22 11.39 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 113.437 -1.711 . . . . 0.0 109.571 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.71 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 11.5 m-30 -61.04 155.71 19.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.752 0.776 . . . . 0.0 111.592 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.559 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 11.3 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.639 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 121.492 0.663 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.535 HG13 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -124.57 -50.1 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-O 123.194 1.473 . . . . 0.0 109.716 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.759 ' H ' ' HB2' ' A' ' 55' ' ' PHE . . . -83.38 -162.29 32.75 Favored Glycine 0 C--N 1.278 -2.692 0 CA-C-N 111.054 -2.794 . . . . 0.0 111.85 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 53' ' ' TRP . . . 75.62 -157.89 49.67 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.693 -0.765 . . . . 0.0 114.419 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 C--N 1.33 -0.273 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.922 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.487 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.857 0.361 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 3.1 Cg_exo -78.45 154.54 27.86 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.894 2.396 . . . . 0.0 112.008 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.8 m -76.99 141.75 40.26 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.0 t -109.39 92.11 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.726 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.696 ' CE1' ' HE1' ' A' ' 19' ' ' PHE . 6.5 m-85 -94.32 143.98 27.25 Favored Pre-proline 0 N--CA 1.447 -0.624 0 CA-C-O 121.657 0.741 . . . . 0.0 111.331 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.3 Cg_endo -84.14 129.91 14.73 Favored 'Cis proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.402 -1.916 . . . . 0.0 111.964 -0.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.696 ' HE1' ' CE1' ' A' ' 17' ' ' PHE . 2.0 p90 -86.7 -163.68 0.94 Allowed 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.5 m -149.19 121.75 8.56 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.992 ' HB3' HD22 ' A' ' 22' ' ' LEU 0.494 0.5 OUTLIER -104.09 -171.38 1.92 Allowed 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 119.264 3.061 . . . . 0.0 119.264 171.964 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.992 HD22 ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -52.93 45.6 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 110.086 -3.234 . . . . 0.0 113.684 -173.544 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.19 1.46 16.34 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.318 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.894 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 1.9 m-80 -138.67 136.57 36.0 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 118.572 1.186 . . . . 0.0 113.016 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.53 122.34 26.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 175.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.989 ' CE2' ' HB2' ' A' ' 21' ' ' PHE . 22.1 m-30 -95.42 98.35 10.49 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 122.39 1.09 . . . . 0.0 112.824 -175.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 16.4 mt-10 -78.21 -12.66 60.01 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.778 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.6 p -138.57 -179.84 6.04 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.4 m -64.6 163.28 13.97 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.503 -0.879 . . . . 0.0 109.209 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -143.92 170.27 16.22 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.599 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 61.2 p -122.77 15.63 10.16 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.439 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -64.52 147.89 51.85 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.001 -1.454 . . . . 0.0 111.336 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.94 -4.59 37.4 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.158 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.596 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 28.3 mtp85 . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 120.751 0.31 . . . . 0.0 111.242 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.596 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 7.1 mptt . . . . . 0 N--CA 1.448 -0.542 0 CA-C-O 120.732 0.301 . . . . 0.0 110.762 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.599 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 56.2 mtt -91.34 142.88 27.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.765 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 18.3 p-90 -122.93 -170.82 2.17 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.504 0.668 . . . . 0.0 110.979 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 8.3 p -157.56 134.49 10.08 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.0 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.516 ' HB3' ' CB ' ' A' ' 19' ' ' PHE . . . -72.49 149.43 44.14 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.011 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.5 p -101.99 13.74 33.93 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.538 0.685 . . . . 0.0 110.335 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.8 p -135.69 148.28 48.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.014 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -55.81 -36.64 67.66 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.894 0.378 . . . . 0.0 110.978 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -119.58 116.9 26.99 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.722 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 60.9 t80 -87.56 -43.78 11.75 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.343 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -42.94 -37.89 2.03 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -91.29 -67.88 0.83 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.451 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 2.2 m-20 -63.97 -26.13 68.44 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.9 mtm-85 44.33 52.62 7.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.451 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 25.7 mttm -116.94 115.64 25.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.722 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 16.6 p-90 -129.73 175.09 9.11 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.978 0.894 . . . . 0.0 112.758 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.488 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -164.8 142.6 7.87 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 113.617 -1.629 . . . . 0.0 109.191 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.759 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 4.3 m-30 -60.66 147.39 42.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.688 0.744 . . . . 0.0 111.0 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.442 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.6 t . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.192 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 122.019 0.914 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -134.62 160.94 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.012 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.88 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 68.63 -147.54 47.02 Favored Glycine 0 C--N 1.309 -0.956 0 C-N-CA 117.487 -2.292 . . . . 0.0 111.612 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.649 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 47.25 -147.18 3.68 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 114.441 0.537 . . . . 0.0 114.441 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.8 p30 . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 120.823 0.344 . . . . 0.0 110.733 179.577 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 120.434 0.159 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -88.87 167.33 5.78 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.805 2.337 . . . . 0.0 111.932 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.7 m -76.56 141.08 41.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 88.1 t -111.4 115.1 48.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -116.43 144.16 32.58 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.935 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.629 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.7 Cg_endo -84.21 133.49 19.73 Favored 'Cis proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.485 -1.465 . . . . 0.0 111.285 -0.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.567 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 17.5 p90 -103.37 162.6 12.88 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.2 m -118.84 122.44 42.36 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.943 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.808 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 60.6 t80 -119.9 133.71 55.48 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.521 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.5 mm? 36.19 46.76 0.41 Allowed 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.5 -4.05 86.49 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 114.225 -1.352 . . . . 0.0 116.318 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 26' ' ' TYR . 40.2 m-80 -110.14 155.71 21.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.673 1.737 . . . . 0.0 111.571 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -94.65 131.33 40.56 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.157 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.808 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 88.9 m-85 -123.77 107.56 11.57 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.697 0.761 . . . . 0.0 112.041 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.629 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 93.6 mt-10 -93.39 -14.32 26.96 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.591 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.6 p -128.14 -177.06 3.99 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.605 -1.179 . . . . 0.0 108.158 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.6 m -67.08 168.91 9.28 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.284 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.6 t -143.99 169.17 18.33 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.184 0.516 . . . . 0.0 110.787 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.461 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 32.4 p -123.52 15.51 9.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.473 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -55.9 136.86 51.38 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.405 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.26 -18.59 3.36 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.147 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.7 mtp85 . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 120.795 0.331 . . . . 0.0 110.519 179.715 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.413 ' N ' ' HD2' ' A' ' 38' ' ' LYS . 7.0 mptt . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.461 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.5 mpt? -96.41 152.62 18.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.6 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.6 p-90 -133.4 -166.08 1.72 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.326 0.584 . . . . 0.0 111.531 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 29.3 p -158.58 149.69 20.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.008 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.546 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -84.27 148.33 26.75 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.2 p -102.41 10.61 38.91 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.665 0.745 . . . . 0.0 110.32 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.2 p -133.56 151.31 51.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.924 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -55.78 -37.66 68.86 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.971 0.415 . . . . 0.0 111.077 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -125.51 112.44 16.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 1.033 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 30.6 t80 -73.95 -36.93 64.67 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.538 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -54.22 -35.08 62.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.148 0.499 . . . . 0.0 111.103 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.57 -71.42 0.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -81.47 -18.85 43.78 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 11.1 mtm180 45.2 55.65 6.17 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -119.49 120.86 38.03 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 1.033 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.7 p-90 -128.35 169.8 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.57 140.72 6.71 Favored Glycine 0 C--O 1.22 -0.78 0 CA-C-N 113.377 -1.738 . . . . 0.0 109.819 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.88 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.2 m-85 -58.93 154.41 15.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 117.59 0.695 . . . . 0.0 111.233 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.436 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.5 t . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.955 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.776 0.798 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -127.8 -168.24 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 177.263 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.479 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 35.84 -131.22 0.78 Allowed Glycine 0 CA--C 1.522 0.511 0 O-C-N 124.079 0.862 . . . . 0.0 113.496 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.676 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 40.31 -144.59 0.46 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 114.983 0.753 . . . . 0.0 114.983 177.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.177 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.27 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -81.74 154.36 17.76 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.118 1.879 . . . . 0.0 111.513 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.7 m -74.17 131.4 41.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.2 t -86.55 109.39 18.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.519 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 35.4 m-85 -116.59 139.31 25.33 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-O 120.749 0.309 . . . . 0.0 111.684 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.716 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 3.8 Cg_endo -86.22 134.78 17.5 Favored 'Cis proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.312 -1.537 . . . . 0.0 111.211 -1.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.519 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 43.5 p90 -96.95 -168.66 1.74 Allowed 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.437 178.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 73.9 m -144.43 122.98 12.45 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.002 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.741 ' CG ' HD22 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -125.0 142.94 51.16 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.684 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.741 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 40.91 27.94 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.758 1.223 . . . . 0.0 113.562 178.655 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.02 -7.02 62.35 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 114.819 0.688 . . . . 0.0 114.819 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 20' ' ' THR . 60.7 m-80 -105.5 149.33 26.31 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.512 1.156 . . . . 0.0 111.921 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -88.46 119.07 28.56 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.603 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 28.1 m-85 -104.64 112.52 25.63 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.72 0.772 . . . . 0.0 110.587 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.716 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 46.6 mt-10 -92.04 -17.75 24.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.475 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 p -129.62 -175.67 3.67 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 78.2 m -65.77 164.17 15.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.474 0.654 . . . . 0.0 110.613 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -142.34 167.71 21.47 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.867 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.706 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 27.9 p -121.95 18.57 10.93 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.554 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -64.48 139.17 58.74 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.718 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.81 -4.29 45.74 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.1 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.654 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.2 mtp85 . . . . . 0 N--CA 1.451 -0.391 0 CA-C-N 117.425 0.612 . . . . 0.0 110.844 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.654 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 8.8 mptt . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.885 0.374 . . . . 0.0 111.948 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.706 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 70.0 mtm -78.27 142.13 38.04 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.626 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.1 p-90 -128.75 -167.37 1.77 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.433 0.635 . . . . 0.0 112.04 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 17.7 p -152.7 141.86 21.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.918 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.99 148.56 38.01 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.178 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.1 p -103.27 11.96 36.13 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.594 0.711 . . . . 0.0 109.712 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.3 p -137.62 153.3 49.91 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.762 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.56 -50.09 72.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 110.303 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -105.18 102.83 12.3 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.793 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 71.8 t80 -75.67 -34.31 60.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.936 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.36 -38.91 55.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -85.55 -71.2 0.54 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.525 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 72.9 m-20 -63.54 -26.42 68.7 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 15.4 mtm180 44.2 52.09 7.18 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.525 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 42.8 mttt -116.35 118.93 34.1 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.793 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.7 p-90 -133.89 176.28 8.71 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.543 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.94 150.07 19.1 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.295 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.687 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.7 m-30 -65.44 162.02 18.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.96 0.88 . . . . 0.0 112.374 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.455 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 5.6 t . . . . . 0 C--N 1.33 -0.254 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.849 0.833 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.534 HG22 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -128.08 164.96 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 178.045 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.715 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 61.36 -149.97 44.95 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 118.229 -1.938 . . . . 0.0 111.51 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.573 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 49.79 -145.28 8.66 Favored Glycine 0 C--N 1.33 0.24 0 N-CA-C 114.169 0.428 . . . . 0.0 114.169 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 p30 . . . . . 0 C--N 1.326 -0.445 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.242 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 CA--C 1.522 -0.134 0 CA-C-O 120.859 0.361 . . . . 0.0 111.372 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 85.7 Cg_endo -90.3 169.44 4.11 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.4 2.733 . . . . 0.0 112.038 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.9 m -79.52 142.31 35.89 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.424 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.3 t -116.22 87.99 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.722 0.296 . . . . 0.0 111.318 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.543 ' CE1' ' HE1' ' A' ' 19' ' ' PHE . 8.8 m-85 -90.3 146.11 34.03 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-O 121.443 0.639 . . . . 0.0 111.082 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.67 132.26 18.69 Favored 'Cis proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.4 -1.917 . . . . 0.0 112.197 -0.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.591 ' CB ' ' HB3' ' A' ' 42' ' ' ALA . 0.4 OUTLIER -90.07 -168.19 2.05 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.357 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.2 m -151.13 124.06 8.66 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.983 ' HB2' ' CE2' ' A' ' 26' ' ' TYR 0.471 0.5 OUTLIER -96.5 -173.81 2.87 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 119.068 2.988 . . . . 0.0 119.068 171.698 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.964 HD22 ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -56.29 43.46 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 109.804 -3.362 . . . . 0.0 112.89 -173.599 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 21' ' ' PHE . . . 122.62 -0.48 10.19 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 114.083 -1.417 . . . . 0.0 113.014 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.849 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 1.8 m-80 -137.9 134.57 35.19 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 118.171 0.986 . . . . 0.0 112.256 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -83.65 127.86 34.09 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.983 ' CE2' ' HB2' ' A' ' 21' ' ' PHE . 6.4 m-85 -107.7 110.89 22.85 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 122.896 1.331 . . . . 0.0 113.249 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -86.27 -13.6 46.25 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 112.763 -2.017 . . . . 0.0 111.325 -178.758 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 p -135.57 -177.61 4.75 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.1 m -65.68 153.39 41.82 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.139 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -131.39 175.89 8.76 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.439 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 1.4 p -130.41 17.8 5.38 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.69 154.48 36.46 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.511 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.36 -2.36 15.37 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.877 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.622 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.3 mtp85 . . . . . 0 N--CA 1.451 -0.419 0 CA-C-O 120.807 0.337 . . . . 0.0 111.094 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.622 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 8.5 mptt . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 120.718 0.294 . . . . 0.0 110.291 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.439 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 80.7 mtp -84.89 149.98 25.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.038 0.447 . . . . 0.0 110.828 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.736 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 24.0 p-90 -131.15 -171.94 2.71 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.62 0.724 . . . . 0.0 111.242 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.491 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 25.6 p -156.12 137.6 14.03 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.273 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.591 ' HB3' ' CB ' ' A' ' 19' ' ' PHE . . . -76.34 144.67 40.01 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.594 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.3 p -98.17 17.2 19.1 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.669 0.747 . . . . 0.0 110.01 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.9 p -141.67 146.48 36.18 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.75 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -54.4 -32.35 56.99 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.266 0.354 . . . . 0.0 111.886 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -125.66 121.47 33.6 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 1.034 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 30.9 t80 -88.46 -43.53 11.39 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.26 -31.91 1.73 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -93.23 -63.91 1.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -73.19 -20.28 60.92 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.4 mtm-85 41.86 52.34 4.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -118.28 117.81 30.11 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 1.034 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 8.9 p-90 -130.81 174.26 10.14 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -175.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.438 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -169.3 136.84 4.23 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-N 113.673 -1.603 . . . . 0.0 110.578 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.736 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 10.8 m-30 -60.21 158.83 10.76 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.377 0.671 . . . . 0.0 112.189 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.349 178.452 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.44 -0.955 0 CA-C-O 121.885 0.85 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -126.39 162.93 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 177.853 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.763 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 67.03 -144.23 44.53 Favored Glycine 0 C--N 1.309 -0.919 0 C-N-CA 117.747 -2.168 . . . . 0.0 111.077 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.497 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 39.48 -138.08 1.14 Allowed Glycine 0 C--N 1.332 0.309 0 N-CA-C 114.888 0.715 . . . . 0.0 114.888 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.465 -0.368 . . . . 0.0 111.664 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.699 0.285 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -89.27 161.82 5.64 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.902 2.401 . . . . 0.0 112.664 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 86.6 m -79.99 133.94 36.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.119 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.57 114.4 44.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.724 0.297 . . . . 0.0 111.254 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.458 ' CE2' ' HE1' ' A' ' 19' ' ' PHE . 90.6 m-85 -108.27 146.5 33.71 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-O 120.751 0.31 . . . . 0.0 110.639 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.21 131.63 16.93 Favored 'Cis proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.479 -1.467 . . . . 0.0 111.579 -0.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 23.9 p90 -101.22 126.65 47.97 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 86.2 m -89.85 124.77 34.97 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.386 0.612 . . . . 0.0 111.739 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.733 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.8 t80 -124.11 141.53 51.98 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.677 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.1 OUTLIER 40.64 32.26 0.14 Allowed 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 124.294 1.038 . . . . 0.0 113.03 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.26 -11.15 69.3 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 115.117 0.807 . . . . 0.0 115.117 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.528 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.5 m-80 -105.54 136.1 45.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 118.564 1.182 . . . . 0.0 112.027 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -78.82 120.45 23.46 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.733 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.9 m-30 -103.26 110.61 22.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.044 0.926 . . . . 0.0 111.181 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -88.98 -18.91 26.46 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.73 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -128.36 177.72 6.77 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.1 m -64.57 161.28 17.78 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.688 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.5 t -136.61 171.84 13.89 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.987 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.622 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 29.4 p -124.39 16.73 8.99 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.499 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.71 145.46 52.29 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.787 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.62 -16.74 29.19 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.618 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.608 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 3.6 mtp-105 . . . . . 0 N--CA 1.453 -0.318 0 CA-C-N 117.671 0.735 . . . . 0.0 110.749 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.608 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 10.5 mptt . . . . . 0 N--CA 1.441 -0.88 0 CA-C-O 121.252 0.549 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.622 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 51.4 mtt -119.55 147.15 44.81 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.661 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 19.9 p-90 -136.96 -168.62 2.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.493 0.663 . . . . 0.0 111.689 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.6 p -162.18 140.31 8.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.23 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -69.9 149.11 48.17 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.407 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 81.2 p -95.03 14.63 21.2 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.518 0.675 . . . . 0.0 109.936 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.3 p -137.62 160.79 38.21 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.325 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.598 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -63.3 -32.94 74.48 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.03 0.443 . . . . 0.0 111.16 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -127.04 115.81 19.76 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.783 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 66.0 t80 -81.4 -31.61 33.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -56.89 -34.26 67.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.67 -62.62 1.43 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.35 -24.68 64.84 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 9.0 mtm180 40.51 48.74 2.55 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -120.47 121.72 39.1 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.783 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.8 p-90 -135.44 174.14 10.95 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -175.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.497 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.86 141.84 7.1 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.155 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.763 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.7 m-85 -57.0 154.37 9.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.217 0.532 . . . . 0.0 111.549 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.473 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 4.6 t . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.081 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.466 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 61.7 p . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 121.242 0.544 . . . . 0.0 112.11 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.88 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -96.35 -168.1 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 176.505 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.691 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 39.06 -124.29 1.72 Allowed Glycine 0 C--O 1.237 0.282 0 O-C-N 123.954 0.784 . . . . 0.0 113.18 177.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.681 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 36.68 -144.57 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 176.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 . . . . . 0 C--O 1.234 0.283 0 CA-C-N 114.546 -0.827 . . . . 0.0 110.391 -179.803 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 110.725 -0.102 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -91.69 175.6 2.15 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.251 2.634 . . . . 0.0 111.889 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.9 m -78.62 124.55 28.29 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 82.0 t -94.88 106.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.834 0.35 . . . . 0.0 110.102 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -104.46 139.88 20.54 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.514 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -87.32 131.98 12.52 Favored 'Cis proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.748 -1.355 . . . . 0.0 111.932 -0.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.607 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 16.3 p90 -99.42 130.75 45.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.3 m -96.24 123.44 39.87 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.537 0.684 . . . . 0.0 111.681 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.963 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 13.1 t80 -128.36 141.0 51.56 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.33 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.704 HD13 ' CD1' ' A' ' 21' ' ' PHE . 2.8 mp 48.77 31.92 3.36 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 123.794 0.684 . . . . 0.0 112.302 176.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.46 -0.6 87.05 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.683 -0.689 . . . . 0.0 114.289 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.426 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 62.6 m-80 -114.96 137.27 52.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 118.072 0.936 . . . . 0.0 112.676 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -77.43 125.08 28.76 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.336 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.963 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.5 m-30 -112.6 111.16 21.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.982 0.896 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -92.65 -6.69 48.81 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.71 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 p -138.31 -172.66 3.33 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 98.3 m -69.52 163.54 25.16 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 t -140.77 169.05 18.36 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.665 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.632 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 12.3 p -122.89 15.75 10.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.474 ' CB ' ' HD2' ' A' ' 21' ' ' PHE . . . -60.38 138.64 57.95 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.809 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.86 -8.28 23.05 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.051 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.553 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 26.0 mtp85 . . . . . 0 N--CA 1.446 -0.669 0 CA-C-O 121.088 0.471 . . . . 0.0 110.528 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.553 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 1.9 mptt . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.807 0.337 . . . . 0.0 111.893 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.632 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 56.4 mtt -83.73 150.8 25.59 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.694 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 14.3 p-90 -130.32 -171.31 2.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.495 0.664 . . . . 0.0 112.505 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.1 p -154.02 140.7 18.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.603 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.05 156.5 27.08 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.129 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.3 p -108.19 17.93 21.7 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.838 0.828 . . . . 0.0 110.209 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.7 p -138.83 146.61 41.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.596 -1.184 . . . . 0.0 108.498 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -53.1 -46.56 68.75 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.131 0.491 . . . . 0.0 110.675 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -116.36 106.82 14.06 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.814 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 77.6 t80 -71.08 -46.2 62.3 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.866 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -44.3 -34.53 1.97 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -86.69 -62.75 1.44 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -80.63 -17.93 49.72 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.652 ' HG3' ' O ' ' A' ' 47' ' ' TYR . 21.6 mtm105 33.35 64.68 0.3 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -125.22 112.93 17.0 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.814 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.7 p-90 -120.42 177.07 5.18 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.694 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -158.59 163.52 33.1 Favored Glycine 0 C--O 1.22 -0.769 0 CA-C-N 113.314 -1.766 . . . . 0.0 108.856 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.88 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 1.9 m-85 -88.22 164.51 15.6 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 118.56 1.18 . . . . 0.0 112.683 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.237 0.424 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.166 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 55' ' ' PHE . 40.7 p . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 1.1 t -127.74 6.49 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-O 122.934 1.35 . . . . 0.0 110.317 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.422 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . -158.17 -156.05 7.82 Favored Glycine 0 C--N 1.284 -2.338 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.444 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.662 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 75.05 -144.19 31.88 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.297 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 . . . . . 0 C--N 1.321 -0.663 0 CA-C-O 121.282 0.563 . . . . 0.0 109.623 179.19 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.515 ' O ' HG23 ' A' ' 5' ' ' THR . . . . . . . . 0 C--O 1.225 -0.231 0 CA-C-O 120.687 0.279 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.6 Cg_exo -73.14 126.81 11.46 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.696 2.264 . . . . 0.0 112.354 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 88.3 m -65.07 141.65 58.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.366 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 48.3 t -107.78 132.27 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.708 0.29 . . . . 0.0 111.139 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.48 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 59.8 m-85 -125.39 142.7 42.41 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.308 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.598 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 6.7 Cg_endo -84.91 130.87 14.99 Favored 'Cis proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.324 -1.531 . . . . 0.0 112.014 -0.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.696 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 31.5 p90 -102.72 130.15 49.57 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 62.6 m -93.23 121.54 34.7 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.303 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.836 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 56.1 t80 -112.95 129.45 56.47 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.598 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.733 HD22 ' CE2' ' A' ' 21' ' ' PHE . 7.4 mp 42.96 36.83 0.95 Allowed 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 124.349 1.031 . . . . 0.0 112.908 175.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.0 -15.48 56.63 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 20' ' ' THR . 49.8 m-80 -109.65 129.98 55.55 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 119.367 1.583 . . . . 0.0 112.557 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.3 mtmt -77.36 119.59 21.2 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.001 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.836 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.5 m-85 -108.66 114.04 27.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.743 0.782 . . . . 0.0 111.498 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.598 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 35.0 mt-10 -89.98 -8.78 50.85 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.871 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.4 p -136.72 -177.22 4.64 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.0 m -67.05 165.24 16.17 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.064 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.555 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 9.0 t -144.45 170.09 16.7 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.131 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.464 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 22.9 p -123.78 18.6 9.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.91 136.58 58.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 113.922 -1.49 . . . . 0.0 112.045 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.31 -4.13 9.43 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.775 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.579 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 10.0 mtp85 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 121.578 0.704 . . . . 0.0 112.177 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.621 ' N ' ' HD2' ' A' ' 38' ' ' LYS . 7.9 mptt . . . . . 0 N--CA 1.443 -0.777 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.464 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 50.3 mtt -75.7 153.43 37.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.689 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.7 p-90 -137.46 -165.7 1.81 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.351 0.596 . . . . 0.0 110.977 -178.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.496 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.3 p -167.9 141.32 3.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.962 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.432 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -72.3 156.15 39.42 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.025 0.44 . . . . 0.0 111.273 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.8 p -104.58 13.79 31.03 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.796 0.808 . . . . 0.0 109.506 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.0 p -136.89 142.57 42.75 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.819 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.696 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -54.89 -39.89 69.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.979 0.419 . . . . 0.0 110.947 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -119.17 103.11 9.23 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 1.032 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 32.6 t80 -72.59 -32.99 66.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.177 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -51.22 -28.51 11.66 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -95.12 -60.79 1.6 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -82.19 -19.54 39.62 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 8.1 mtm180 44.3 44.67 6.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -109.13 114.96 29.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 1.032 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.6 p-90 -126.84 175.9 7.68 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -175.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.606 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -172.59 154.58 21.41 Favored Glycine 0 C--O 1.217 -0.946 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.558 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 5' ' ' THR . 15.1 m-30 -64.26 164.59 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.508 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 31.5 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.342 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.512 HG22 ' SG ' ' A' ' 41' ' ' CYS . 77.5 p . . . . . 0 C--O 1.234 0.26 0 N-CA-C 112.53 0.566 . . . . 0.0 112.53 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.82 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 1.5 t -106.37 -67.96 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 CA-C-O 123.298 1.523 . . . . 0.0 109.88 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.86 ' H ' ' HB2' ' A' ' 55' ' ' PHE . . . -76.61 -156.23 6.83 Favored Glycine 0 C--N 1.284 -2.338 0 CA-C-N 111.167 -2.742 . . . . 0.0 112.599 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.592 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 74.14 -139.56 26.16 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.487 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 33.7 p30 . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.092 0.472 . . . . 0.0 110.421 -179.988 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 120.597 0.237 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.05 170.69 12.11 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.512 2.142 . . . . 0.0 112.144 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.7 m -85.49 135.14 33.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.578 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 65.5 t -97.14 115.58 37.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.401 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 61.9 m-85 -113.53 138.67 22.65 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-O 120.886 0.374 . . . . 0.0 111.246 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -85.45 136.5 21.66 Favored 'Cis proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.466 -1.889 . . . . 0.0 112.654 -0.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.578 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 28.5 p90 -102.26 136.4 42.16 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 91.3 m -98.48 122.28 41.47 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.614 -0.835 . . . . 0.0 112.618 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.753 ' CG ' HD22 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -123.37 147.34 47.17 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.615 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.753 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 37.25 37.06 0.08 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.276 1.03 . . . . 0.0 113.676 178.447 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.15 -1.01 87.66 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.112 0.805 . . . . 0.0 115.112 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 20' ' ' THR . 68.7 m-80 -112.38 144.34 41.98 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 118.617 1.208 . . . . 0.0 111.985 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -87.46 120.44 28.77 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.628 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 16.6 m-85 -102.19 116.41 32.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.645 0.736 . . . . 0.0 111.315 -177.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -89.8 -24.17 21.53 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.616 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.8 p -126.12 -176.76 3.73 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.3 m -65.28 164.82 12.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.512 0.672 . . . . 0.0 109.891 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.524 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.5 t -139.61 171.57 14.06 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.272 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.2 p -126.07 19.7 7.66 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.49 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -67.24 138.46 56.93 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 113.503 -1.68 . . . . 0.0 112.009 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.67 -1.08 59.37 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.182 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 12.8 mtp85 . . . . . 0 N--CA 1.448 -0.565 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.534 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 62.4 mmtt . . . . . 0 N--CA 1.462 0.128 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 52.1 mtt -92.27 145.2 24.67 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.672 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.5 p-90 -133.23 -167.75 1.97 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.299 0.571 . . . . 0.0 111.881 -177.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.512 ' SG ' HG22 ' A' ' 5' ' ' THR . 3.4 p -158.34 138.34 12.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.677 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.478 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -71.72 151.18 43.81 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.911 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.9 p -102.44 15.82 28.09 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.564 0.697 . . . . 0.0 110.58 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.7 p -138.39 156.34 47.68 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.32 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.38 -35.01 76.31 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.056 0.455 . . . . 0.0 110.941 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -124.53 113.3 17.91 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.687 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 58.8 t80 -80.58 -33.61 35.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.985 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -56.22 -34.48 66.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -83.9 -62.3 1.6 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.15 -29.6 61.87 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 4.0 mtm180 45.55 45.91 10.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.841 0.829 . . . . 0.0 113.052 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -115.24 119.7 37.23 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.687 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.6 p-90 -131.14 179.97 5.69 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -174.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -170.31 151.32 16.22 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 113.873 -1.512 . . . . 0.0 109.323 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.86 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 11.6 m-85 -65.74 162.77 17.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.625 1.212 . . . . 0.0 112.718 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.456 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.5 t . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.783 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.507 HG22 ' SG ' ' A' ' 41' ' ' CYS . 76.2 p . . . . . 0 N--CA 1.444 -0.757 0 CA-C-O 122.336 1.065 . . . . 0.0 113.844 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.753 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -112.87 -152.89 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 176.569 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.712 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 28.66 -122.28 0.07 OUTLIER Glycine 0 N--CA 1.463 0.456 0 O-C-N 124.671 1.232 . . . . 0.0 114.099 176.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.695 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 39.59 -144.7 0.34 Allowed Glycine 0 C--N 1.331 0.284 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.8 p30 . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 114.49 -0.855 . . . . 0.0 109.94 179.87 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--O 1.226 -0.137 0 CA-C-O 120.311 0.1 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 11.9 Cg_exo -70.27 157.15 60.28 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.085 2.523 . . . . 0.0 112.727 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.6 m -79.82 135.51 36.49 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.7 t -100.16 112.43 32.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.673 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 55.0 m-85 -108.39 141.94 24.3 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.852 0.358 . . . . 0.0 111.408 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.4 Cg_endo -86.87 136.03 17.42 Favored 'Cis proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.531 -1.445 . . . . 0.0 111.981 -0.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.673 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 33.5 p90 -103.29 129.18 50.22 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.7 m -92.43 127.25 37.85 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.233 0.539 . . . . 0.0 112.124 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.85 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.2 t80 -130.36 144.21 51.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.761 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 40.37 36.86 0.38 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.462 1.105 . . . . 0.0 112.899 178.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.23 -9.84 73.49 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 114.709 0.644 . . . . 0.0 114.709 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.412 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 72.9 m-80 -107.6 134.45 50.58 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.453 1.127 . . . . 0.0 111.827 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -79.71 121.14 24.96 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.791 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.85 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.2 m-30 -104.52 110.31 22.54 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.982 0.896 . . . . 0.0 111.086 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 33.2 mt-10 -88.04 -16.69 32.94 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.295 -1.321 . . . . 0.0 110.742 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 p -129.28 -175.24 3.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.9 m -65.43 163.42 15.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.465 0.65 . . . . 0.0 110.177 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.422 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.9 t -138.73 -176.78 4.6 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.645 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.45 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 10.1 p -141.07 18.62 2.28 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -64.84 145.69 55.92 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 113.281 -1.781 . . . . 0.0 112.503 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.09 5.13 32.05 Favored Glycine 0 C--O 1.235 0.198 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.847 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 34' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 117.128 0.464 . . . . 0.0 110.982 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mptt . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.45 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 87.8 mtp -158.42 145.55 17.76 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.63 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 23.5 p-90 -135.59 -174.64 3.7 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.507 ' SG ' HG22 ' A' ' 5' ' ' THR . 6.5 p -152.76 136.85 16.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.161 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . . . -73.04 151.14 41.84 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.013 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.3 p -100.61 17.67 21.22 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.733 0.777 . . . . 0.0 109.275 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.7 p -135.6 151.7 50.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.213 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.666 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -60.72 -37.67 82.52 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.121 0.486 . . . . 0.0 110.878 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -124.26 107.85 11.62 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.708 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 56.4 t80 -74.75 -32.31 62.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.301 -0.408 . . . . 0.0 112.047 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -55.97 -33.66 65.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -94.96 -56.87 2.6 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -77.54 -20.93 53.4 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.588 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 17.5 mtm180 39.63 52.45 2.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -122.47 117.9 27.05 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.708 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.2 p-90 -125.73 172.73 9.56 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.561 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -158.64 154.13 25.23 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.29 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.753 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 1.0 OUTLIER -80.34 156.79 26.58 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -178.636 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 C--N 1.328 -0.368 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.74 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 p . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 121.666 0.746 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -116.78 -168.23 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.072 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.455 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 36.73 -122.7 0.82 Allowed Glycine 0 N--CA 1.462 0.4 0 O-C-N 124.056 0.848 . . . . 0.0 113.076 178.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.712 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 35.15 -141.36 0.13 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 115.616 1.006 . . . . 0.0 115.616 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.0 p30 . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.205 -0.497 . . . . 0.0 110.213 179.074 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.913 0.387 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 73.1 Cg_endo -87.04 167.75 8.02 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.927 2.418 . . . . 0.0 112.015 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.7 m -79.73 139.75 37.2 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.312 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.1 t -107.5 112.42 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -114.02 143.7 30.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.723 0.297 . . . . 0.0 111.103 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -85.75 137.25 21.97 Favored 'Cis proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.495 -1.46 . . . . 0.0 111.836 -0.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 41.3 p90 -102.79 -178.36 3.65 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.453 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.8 m -135.03 126.2 28.02 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.664 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.645 ' CE2' ' HZ2' ' A' ' 40' ' ' TRP . 1.9 t80 -134.24 141.58 47.05 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.655 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 40.87 38.42 0.65 Allowed 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.746 1.219 . . . . 0.0 113.706 178.607 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.17 -1.65 88.57 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -107.89 154.88 20.94 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 118.439 1.119 . . . . 0.0 111.26 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -94.83 126.36 40.11 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.606 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 21.8 m-85 -113.88 111.92 22.51 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.68 0.752 . . . . 0.0 111.784 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -96.03 -8.33 33.88 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.09 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 p -136.57 -172.75 3.23 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.8 m -69.31 168.64 13.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.128 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.511 ' HG1' ' HE2' ' A' ' 26' ' ' TYR . 10.2 t -144.48 167.12 23.25 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.594 0.711 . . . . 0.0 110.738 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.512 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 61.3 p -120.54 12.64 11.58 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.586 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -56.05 136.74 52.08 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.67 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.37 -10.86 19.99 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.018 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.7 mtp85 . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.059 0.457 . . . . 0.0 110.272 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.488 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.512 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 80.9 mtp -80.6 148.37 30.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.665 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.5 p-90 -128.31 -165.11 1.45 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.382 0.61 . . . . 0.0 111.627 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.5 p -159.68 146.9 16.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.968 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -81.0 143.57 32.42 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.473 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.0 p -97.14 13.97 27.43 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.778 0.799 . . . . 0.0 110.113 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.411 HG23 ' HB2' ' A' ' 52' ' ' LYS . 38.1 p -134.09 158.76 42.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.157 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -65.39 -26.54 68.04 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.193 0.52 . . . . 0.0 110.624 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -132.71 117.44 17.85 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.814 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 65.6 t80 -86.18 -34.78 20.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -54.36 -37.06 64.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.967 0.413 . . . . 0.0 111.791 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.76 -66.37 0.93 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.33 -20.37 63.0 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 26.2 mtt180 38.55 51.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.411 ' HB2' HG23 ' A' ' 44' ' ' THR . 89.8 mttt -113.71 119.22 36.64 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 176.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.814 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 5.3 p-90 -132.25 171.68 13.39 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -174.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.562 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -166.07 143.9 8.76 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 113.3 -1.773 . . . . 0.0 109.838 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.684 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.4 m-30 -60.51 151.51 28.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.399 0.6 . . . . 0.0 111.63 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.497 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 4.5 t . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.0 p . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 121.605 0.717 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.792 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -113.77 -166.54 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 176.376 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.646 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 34.7 -126.11 0.58 Allowed Glycine 0 N--CA 1.463 0.47 0 O-C-N 124.069 0.856 . . . . 0.0 114.117 177.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.579 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 40.74 -149.1 0.2 Allowed Glycine 0 C--N 1.337 0.611 0 N-CA-C 115.77 1.068 . . . . 0.0 115.77 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.0 p30 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 114.826 -0.687 . . . . 0.0 110.435 179.66 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -87.86 167.13 7.12 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.914 2.409 . . . . 0.0 112.136 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.2 m -83.44 129.67 34.99 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 92.7 t -96.87 112.25 28.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.707 0.289 . . . . 0.0 110.305 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -107.0 138.37 19.8 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.562 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -86.25 132.25 14.48 Favored 'Cis proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.21 -1.579 . . . . 0.0 112.263 -0.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.605 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 17.9 p90 -99.93 126.28 46.06 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.244 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 91.2 m -91.67 122.46 34.25 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.963 0.411 . . . . 0.0 110.565 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.867 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 68.3 t80 -115.2 130.09 56.82 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.604 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.552 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.7 mm? 35.28 45.11 0.19 Allowed 'General case' 0 N--CA 1.428 -1.536 0 O-C-N 124.775 1.297 . . . . 0.0 113.319 175.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.72 -23.07 32.21 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 116.497 1.359 . . . . 0.0 116.497 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -111.26 132.51 54.31 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 120.027 1.914 . . . . 0.0 113.12 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 39.7 mtpt -77.71 126.67 31.22 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.867 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.3 m-85 -110.77 118.67 36.79 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.898 0.856 . . . . 0.0 111.643 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -89.62 -12.44 39.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.76 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.4 p -136.08 -171.21 2.82 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.0 m -70.19 166.24 20.41 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.499 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -143.91 171.22 14.54 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.335 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.478 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 71.3 p -125.41 20.88 7.97 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.45 132.83 55.13 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.971 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.02 -8.04 40.12 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.095 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.0 mtp85 . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 120.594 0.235 . . . . 0.0 111.28 179.993 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 mptt . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.478 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 58.2 mtt -94.71 153.21 17.9 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.651 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.8 p-90 -133.6 -166.51 1.79 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.216 0.532 . . . . 0.0 111.777 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 8.4 p -160.07 143.99 14.28 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 19' ' ' PHE . . . -78.77 152.57 31.38 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.563 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.0 p -102.98 9.94 38.44 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.656 0.741 . . . . 0.0 110.553 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.0 p -133.03 153.12 51.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.989 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.44 -42.01 81.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 111.341 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -120.83 111.36 17.46 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 1.051 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 34.3 t80 -77.16 -31.82 55.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.938 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -51.94 -32.8 34.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -90.08 -71.55 0.61 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.25 -27.81 68.24 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.692 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 24.0 mtm-85 45.15 51.0 9.31 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -117.04 119.04 34.04 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 1.051 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.8 p-90 -127.42 172.09 10.97 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -175.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.576 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.44 147.38 13.8 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 113.292 -1.777 . . . . 0.0 109.466 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.792 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 6.1 m-30 -62.84 158.37 19.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.329 1.065 . . . . 0.0 110.989 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.529 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 25.2 t . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.167 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 122.328 1.061 . . . . 0.0 112.95 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.613 HG22 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -129.9 163.45 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 178.934 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.725 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 62.12 -141.35 47.23 Favored Glycine 0 C--N 1.316 -0.561 0 C-N-CA 118.059 -2.02 . . . . 0.0 111.861 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.625 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 39.67 -139.09 1.03 Allowed Glycine 0 C--N 1.334 0.468 0 N-CA-C 115.676 1.03 . . . . 0.0 115.676 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.273 -0.463 . . . . 0.0 110.569 -179.962 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.319 0 CA-C-O 120.799 0.333 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -84.25 164.41 13.01 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.726 2.284 . . . . 0.0 111.527 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.459 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.9 m -72.33 138.39 47.29 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 59.7 t -107.88 113.32 43.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.581 0.229 . . . . 0.0 110.681 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -115.82 140.24 25.91 Favored Pre-proline 0 N--CA 1.454 -0.268 0 CA-C-O 120.845 0.355 . . . . 0.0 110.963 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.453 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 5.4 Cg_endo -87.0 132.88 13.84 Favored 'Cis proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.292 -1.545 . . . . 0.0 111.754 -0.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.457 ' CG ' ' HB3' ' A' ' 42' ' ' ALA . 46.3 p90 -98.48 -175.11 3.0 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.844 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 18.9 m -140.0 119.58 13.19 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.727 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.85 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 68.3 t80 -117.83 133.21 56.15 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.504 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.6 mm? 34.62 47.53 0.24 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.697 1.248 . . . . 0.0 113.797 175.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.99 -9.11 75.79 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 116.402 1.321 . . . . 0.0 116.402 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 20' ' ' THR . 51.5 m-80 -110.12 150.01 29.23 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.821 1.811 . . . . 0.0 112.363 -178.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -91.57 125.74 36.41 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.85 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 88.7 m-85 -115.59 114.3 24.75 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.612 0.72 . . . . 0.0 111.574 -178.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.453 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 41.3 mt-10 -93.21 -12.82 29.33 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.234 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.5 p -133.05 -166.47 1.76 Allowed 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.7 m -76.35 170.17 16.86 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.863 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.5 t -147.76 169.5 19.61 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.346 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.9 p -123.59 20.28 9.48 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.411 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -59.85 133.15 55.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 113.523 -1.672 . . . . 0.0 112.101 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.73 -0.22 45.39 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.468 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 22.3 mtp85 . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.439 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 21.8 mmmt . . . . . 0 CA--C 1.516 -0.357 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -90.28 147.05 23.76 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.645 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.5 p-90 -128.59 -169.61 2.11 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.303 0.573 . . . . 0.0 111.834 -178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.0 p -154.41 142.2 20.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.761 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -76.76 143.13 40.09 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.509 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.1 p -99.07 10.35 41.63 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.581 0.705 . . . . 0.0 110.043 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.5 p -136.14 146.85 47.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.729 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.32 -48.24 79.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.768 0.318 . . . . 0.0 111.146 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 48' ' ' ASP . 20.1 t-20 -109.24 99.68 8.92 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.884 ' CE2' ' HB3' ' A' ' 53' ' ' TRP . 47.5 t80 -72.16 -32.91 67.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.559 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.413 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . 54.2 m-20 -45.48 -39.83 7.68 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.8 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -95.97 -55.69 2.9 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -69.23 -35.04 75.76 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.2 mmm180 51.15 37.98 19.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -107.57 118.67 37.33 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.884 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 11.0 p-90 -128.66 174.22 9.61 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.404 -175.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.612 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.08 142.05 7.47 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.751 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.725 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 9.2 m-85 -59.03 154.13 16.23 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.376 0.608 . . . . 0.0 111.639 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.475 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 5.1 t . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.439 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 11.0 p . . . . . 0 N--CA 1.448 -0.558 0 CA-C-O 121.676 0.75 . . . . 0.0 112.639 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.771 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -110.07 -163.44 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.119 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.427 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 34.62 -121.86 0.44 Allowed Glycine 0 N--CA 1.463 0.447 0 O-C-N 124.282 0.988 . . . . 0.0 112.999 177.515 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.698 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 29.36 -135.28 0.06 OUTLIER Glycine 0 C--N 1.338 0.66 0 N-CA-C 115.986 1.154 . . . . 0.0 115.986 176.773 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 114.722 -0.739 . . . . 0.0 109.214 179.568 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.64 0.257 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 42.0 Cg_endo -85.78 165.56 10.31 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.941 2.427 . . . . 0.0 112.721 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 5.6 m -71.79 127.7 33.41 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.3 t -102.68 101.83 12.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.033 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.655 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 47.7 m-85 -103.45 143.3 26.34 Favored Pre-proline 0 N--CA 1.45 -0.45 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.751 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.83 136.02 22.55 Favored 'Cis proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.578 -1.843 . . . . 0.0 112.355 -0.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.655 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 29.9 p90 -102.77 -171.97 2.04 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.289 177.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.2 m -145.76 127.43 15.22 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.705 -177.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.791 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.5 t80 -134.42 143.02 47.33 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.874 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.69 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 41.75 35.41 0.5 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 124.416 1.087 . . . . 0.0 112.976 178.953 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.34 -9.46 77.42 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.506 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 70.7 m-80 -107.73 138.13 44.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 118.368 1.084 . . . . 0.0 112.294 -178.426 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -79.5 123.31 27.44 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.791 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 15.3 m-30 -106.01 114.52 28.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.762 0.791 . . . . 0.0 110.821 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -86.81 -24.75 24.89 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.068 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 p -122.75 -173.24 2.65 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.306 179.07 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.1 m -72.32 166.92 21.52 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.937 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.9 t -141.61 166.03 25.87 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.408 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.405 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 12.9 p -120.8 18.77 11.85 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.459 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.618 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -59.91 139.07 57.63 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 113.656 -1.611 . . . . 0.0 111.466 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.01 -1.45 68.99 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.2 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.572 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 24.2 mtp85 . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.572 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 66.4 mttt . . . . . 0 C--O 1.226 -0.164 0 CA-C-O 120.286 0.089 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.405 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 43.8 mtt -75.01 143.04 43.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.98 0.419 . . . . 0.0 110.271 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.704 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.1 p-90 -131.24 -167.68 1.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.432 -178.695 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 15.1 p -157.68 149.54 22.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.006 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.9 151.75 27.12 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.66 178.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 34.5 p -116.23 10.08 14.76 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.016 -178.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.565 HG21 ' HE2' ' A' ' 52' ' ' LYS . 73.4 p -123.03 12.08 9.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.346 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . 70.01 -35.99 0.33 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.336 0.655 . . . . 0.0 111.45 -178.449 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 44' ' ' THR . 21.5 t-20 -129.49 110.48 11.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.697 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.898 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 49.5 t80 -87.85 -28.68 21.45 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -177.501 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -58.23 -34.7 70.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -92.94 -53.28 4.21 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.0 OUTLIER -74.64 -43.98 52.71 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.203 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER 61.34 39.55 15.25 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.868 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.565 ' HE2' HG21 ' A' ' 44' ' ' THR . 4.6 mppt? -113.76 118.71 35.04 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.898 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.5 p-90 -130.73 174.96 9.42 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -174.246 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.602 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.4 148.04 13.35 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 113.194 -1.821 . . . . 0.0 109.615 178.831 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.771 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 7.1 m-30 -60.81 157.81 14.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.58 0.705 . . . . 0.0 111.787 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.494 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 29.3 t . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.823 -178.804 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 122.273 1.035 . . . . 0.0 113.222 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.501 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -137.9 161.33 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 178.188 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.638 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 62.42 -147.78 49.29 Favored Glycine 0 C--N 1.311 -0.816 0 C-N-CA 118.254 -1.927 . . . . 0.0 111.306 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.745 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 49.3 -148.27 5.58 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 121.607 -0.33 . . . . 0.0 113.766 178.127 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 . . . . . 0 C--N 1.331 -0.214 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.51 178.8 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.1 Cg_endo -81.56 149.78 16.66 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.636 2.224 . . . . 0.0 112.323 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 72.3 m -77.3 126.14 30.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.847 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 43.9 t -95.92 121.43 46.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.871 0.367 . . . . 0.0 110.924 -178.791 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.535 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 52.7 m-85 -115.86 139.43 24.92 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-O 121.248 0.547 . . . . 0.0 111.308 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.664 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 27.7 Cg_endo -86.79 137.53 19.27 Favored 'Cis proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.669 -1.804 . . . . 0.0 112.359 -0.75 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.643 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 42.8 p90 -102.87 129.38 49.55 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.662 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 5.4 m -91.84 127.75 37.41 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.27 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.874 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.1 t80 -129.61 144.81 51.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.433 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.769 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 40.36 35.97 0.32 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.15 0.98 . . . . 0.0 113.243 178.381 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.0 -10.06 75.25 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.033 -0.603 . . . . 0.0 114.502 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -111.98 133.62 54.04 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 118.438 1.119 . . . . 0.0 111.794 -179.041 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.689 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 3.7 mptt -82.07 123.22 28.75 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.548 -179.652 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.874 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 15.7 m-85 -104.91 110.9 23.46 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.72 0.771 . . . . 0.0 111.031 -178.034 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.664 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 48.7 mt-10 -84.95 -15.76 43.28 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.86 -179.487 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p -130.97 -176.45 4.0 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 68.6 m -67.47 162.62 22.8 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.28 179.294 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.542 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.7 t -139.13 -177.48 4.92 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.7 p -135.88 22.15 3.3 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.61 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.493 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -66.72 150.18 49.46 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 113.91 -1.496 . . . . 0.0 113.096 -178.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.97 7.53 50.16 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 114.963 -1.017 . . . . 0.0 114.468 178.065 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.601 ' HB3' ' CZ ' ' A' ' 34' ' ' ARG . 5.4 mtp-105 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 118.148 0.974 . . . . 0.0 112.557 -179.398 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.667 ' HD3' ' CZ ' ' A' ' 55' ' ' PHE . 45.0 mttp . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -99.47 144.98 27.94 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.601 -0.839 . . . . 0.0 108.88 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.691 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 18.6 p-90 -139.68 -172.09 3.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.224 0.535 . . . . 0.0 111.519 -178.344 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.6 p -156.94 139.5 14.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.206 178.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -72.78 152.68 41.46 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 120.989 0.423 . . . . 0.0 110.856 -179.293 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.7 p -100.27 16.39 24.49 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.641 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.448 HG21 ' CB ' ' A' ' 50' ' ' ASP . 70.8 p -135.21 154.83 51.46 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.179 179.271 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -62.18 -35.06 77.69 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.254 0.55 . . . . 0.0 110.399 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -125.77 110.24 13.49 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.717 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 61.9 t80 -76.6 -33.97 58.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.281 -177.711 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -53.67 -36.23 61.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.046 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.27 -63.72 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.711 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.448 ' CB ' HG21 ' A' ' 44' ' ' THR . 32.7 m-20 -72.53 -36.51 68.33 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -177.47 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.8 mmm180 54.67 50.77 15.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -120.92 116.61 25.46 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 176.112 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.717 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.9 p-90 -129.71 172.67 11.38 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -174.012 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.745 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -160.43 146.69 12.9 Favored Glycine 0 C--O 1.221 -0.701 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.969 178.421 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.667 ' CZ ' ' HD3' ' A' ' 38' ' ' LYS . 3.9 m-30 -61.27 163.29 6.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.578 0.704 . . . . 0.0 112.69 -179.427 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.413 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 6.6 t . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.417 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.9 p . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 121.919 0.866 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.79 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -127.48 -171.06 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.153 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.567 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.49 -120.6 0.79 Allowed Glycine 0 CA--C 1.521 0.412 0 O-C-N 123.786 0.679 . . . . 0.0 113.306 177.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.705 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 25.88 -136.12 0.02 OUTLIER Glycine 0 C--N 1.343 0.926 0 N-CA-C 116.383 1.313 . . . . 0.0 116.383 177.53 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 114.62 -0.79 . . . . 0.0 110.133 179.704 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.141 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -86.22 167.96 9.1 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.54 2.16 . . . . 0.0 112.4 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 74.9 m -87.81 133.23 33.92 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.564 179.354 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.2 t -95.49 125.9 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.668 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.588 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 49.5 m-85 -122.63 138.97 30.18 Favored Pre-proline 0 N--CA 1.444 -0.727 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.592 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -86.66 133.27 14.87 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.415 -1.494 . . . . 0.0 112.328 -0.331 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.588 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 27.3 p90 -99.77 130.4 45.97 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.239 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.4 m -91.19 125.39 35.95 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.375 0.607 . . . . 0.0 111.894 -178.031 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.828 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 2.1 t80 -129.7 141.58 50.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.845 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.642 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 42.11 36.95 0.76 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.129 0.971 . . . . 0.0 113.078 178.678 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.37 -6.15 83.9 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.83 -0.7 . . . . 0.0 114.751 178.748 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.553 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.3 m-80 -112.27 136.46 51.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.434 1.117 . . . . 0.0 111.947 -178.928 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -80.35 122.36 26.83 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.828 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 15.4 m-30 -104.99 111.2 23.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.779 0.799 . . . . 0.0 111.104 -177.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -89.38 -19.55 25.08 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.608 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.9 p -127.33 -179.34 4.84 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.6 m -67.04 156.55 35.76 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.683 178.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.451 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 14.0 t -131.25 173.28 11.21 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.936 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.453 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 24.1 p -127.42 18.34 6.95 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 176.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.457 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -63.4 151.48 40.88 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 113.808 -1.542 . . . . 0.0 111.403 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.69 -1.53 57.66 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.205 178.879 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 34' ' ' ARG . 1.8 mtp-105 . . . . . 0 N--CA 1.444 -0.751 0 CA-C-N 117.17 0.485 . . . . 0.0 111.223 -179.308 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 34' ' ' ARG . 40.9 mttp . . . . . 0 CA--C 1.514 -0.42 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.453 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 49.7 mtm -59.32 137.05 58.12 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.142 0.496 . . . . 0.0 110.746 -178.609 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.682 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.8 p-90 -133.51 -169.4 2.28 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.213 -178.591 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.2 p -160.43 138.12 9.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.006 178.237 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.83 155.11 41.03 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.107 0.479 . . . . 0.0 111.019 -178.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.3 p -102.87 13.65 33.86 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.037 0.922 . . . . 0.0 109.559 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.41 HG21 ' CB ' ' A' ' 50' ' ' ASP . 65.8 p -133.55 153.5 51.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.969 179.118 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -59.92 -37.25 78.93 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.057 0.456 . . . . 0.0 110.842 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -123.23 110.45 15.25 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.323 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.758 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 64.8 t80 -76.75 -33.14 58.11 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.085 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -57.35 -31.9 66.21 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.219 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -88.83 -62.07 1.57 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.41 ' CB ' HG21 ' A' ' 44' ' ' THR . 2.4 m-20 -74.13 -27.38 60.84 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.437 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 3.1 mmm180 48.58 49.24 18.78 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -120.59 117.53 27.83 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.263 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.758 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.9 p-90 -129.19 177.6 7.03 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -174.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.608 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.44 147.19 11.44 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.638 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.79 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 6.0 m-30 -62.66 157.6 20.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.704 0.752 . . . . 0.0 112.293 -179.056 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.509 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 27.0 t . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.599 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.404 HG21 ' HA3' ' A' ' 54' ' ' GLY . 68.7 p . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.18 5.98 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 CA-C-O 122.561 1.172 . . . . 0.0 111.2 -179.3 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.439 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . -154.75 -155.24 7.2 Favored Glycine 0 C--N 1.282 -2.448 0 CA-C-N 113.319 -1.764 . . . . 0.0 111.651 -178.161 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.724 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 72.2 -168.35 52.35 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.846 179.007 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.2 p30 . . . . . 0 C--N 1.319 -0.738 0 CA-C-O 120.937 0.399 . . . . 0.0 110.542 178.783 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.996 0.427 . . . . 0.0 111.614 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 3.4 Cg_exo -76.8 164.91 29.46 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.452 2.768 . . . . 0.0 112.055 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 84.5 m -87.4 142.93 27.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.864 0.364 . . . . 0.0 110.769 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -108.52 120.86 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.952 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.502 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 62.9 m-85 -118.6 143.8 34.12 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-O 121.016 0.436 . . . . 0.0 111.223 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.679 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 28.5 Cg_endo -87.47 140.22 20.72 Favored 'Cis proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.706 -1.789 . . . . 0.0 111.98 -0.481 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.633 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 35.6 p90 -104.26 -174.06 2.45 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.518 178.064 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.1 m -141.56 127.1 18.91 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.86 -179.033 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.757 ' CG ' HD22 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -131.7 144.9 51.33 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.033 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.757 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.17 35.02 0.08 Allowed 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.61 1.164 . . . . 0.0 113.837 178.022 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.12 -3.74 84.45 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 115.026 0.77 . . . . 0.0 115.026 178.528 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.579 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 59.0 m-80 -110.2 138.7 46.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.371 1.086 . . . . 0.0 111.508 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -79.46 122.0 25.89 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.709 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.4 m-30 -108.35 106.9 17.25 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.836 0.827 . . . . 0.0 110.902 -178.7 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.679 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 92.1 mt-10 -91.23 -15.55 29.05 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.363 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -129.15 -177.78 4.37 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.499 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.5 m -66.19 164.61 15.36 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.684 178.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.0 t -141.99 175.53 9.66 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.772 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.428 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 23.3 p -128.64 17.54 6.35 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.54 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.522 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -65.26 153.75 40.15 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 114.118 -1.401 . . . . 0.0 112.025 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.28 -0.1 42.4 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.69 -0.686 . . . . 0.0 114.082 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 34' ' ' ARG . 2.3 mtp-105 . . . . . 0 N--CA 1.451 -0.39 0 CA-C-N 117.781 0.791 . . . . 0.0 111.428 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 34' ' ' ARG . 66.0 mttm . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.428 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.1 mpt? -56.57 137.42 53.67 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.587 0.708 . . . . 0.0 111.36 -178.048 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.699 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.6 p-90 -134.34 -165.21 1.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.295 -178.149 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.5 p -162.99 145.16 10.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.977 178.419 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.36 149.8 45.68 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.172 -178.534 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.3 p -97.95 7.44 46.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.453 0.644 . . . . 0.0 109.869 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.9 p -129.35 155.7 45.22 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.284 178.792 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.633 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -61.54 -32.34 72.41 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.978 0.418 . . . . 0.0 110.942 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -127.49 111.36 13.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.184 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.846 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 65.2 t80 -78.39 -35.25 47.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.92 -177.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -53.75 -29.74 41.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.134 0.493 . . . . 0.0 112.05 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -85.04 -71.15 0.54 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.518 -179.238 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.98 -29.69 63.24 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.036 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 4.4 mtm180 51.61 47.45 24.78 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -114.05 118.22 33.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.412 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.846 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.2 p-90 -129.38 177.29 7.29 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.267 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -171.7 150.33 13.21 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.619 179.042 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 14.5 m-30 -61.42 159.24 13.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -177.935 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.45 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.5 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 114.299 -1.318 . . . . 0.0 108.83 178.63 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.7 p . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 121.298 0.57 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.809 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -105.05 -166.31 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 176.155 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.645 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 39.57 -123.96 1.93 Allowed Glycine 0 C--N 1.319 -0.404 0 O-C-N 123.903 0.752 . . . . 0.0 113.112 177.676 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.633 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 37.2 -148.64 0.05 OUTLIER Glycine 0 C--N 1.334 0.464 0 N-CA-C 116.198 1.239 . . . . 0.0 116.198 177.144 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 114.502 -0.849 . . . . 0.0 110.795 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.678 0.275 . . . . 0.0 110.749 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 56.8 Cg_endo -84.33 166.4 12.42 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.764 2.309 . . . . 0.0 111.538 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 2.7 m -74.69 120.83 20.77 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.22 105.28 16.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.092 0.472 . . . . 0.0 110.516 179.623 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.659 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 46.2 m-85 -100.47 139.23 20.48 Favored Pre-proline 0 N--CA 1.447 -0.588 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.416 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 7.2 Cg_endo -87.68 127.98 9.2 Favored 'Cis proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.377 -1.51 . . . . 0.0 112.711 -0.371 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.659 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 15.6 p90 -92.26 127.07 37.6 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.279 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 14.8 m -90.65 121.65 32.75 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.428 0.632 . . . . 0.0 112.455 -177.408 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.903 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.9 t80 -127.8 142.94 51.16 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.356 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.681 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 43.5 35.55 0.98 Allowed 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.187 0.995 . . . . 0.0 112.674 178.896 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.71 -6.27 83.69 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.935 -0.575 . . . . 0.0 114.466 179.244 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.55 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 66.4 m-80 -109.96 132.87 53.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.319 1.06 . . . . 0.0 111.942 -178.887 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -83.9 118.32 23.9 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.903 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 12.4 m-85 -99.66 112.03 24.3 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.811 0.815 . . . . 0.0 112.191 -177.343 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -83.23 -17.62 42.08 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.615 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 p -131.42 -173.25 3.06 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.827 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 70.7 m -64.22 166.2 8.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.595 0.712 . . . . 0.0 110.395 179.279 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.535 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 14.5 t -144.65 171.42 14.41 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.137 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 15.8 p -129.19 19.02 5.92 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.181 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.562 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.7 138.25 58.3 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.122 179.628 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.89 -3.4 44.79 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.935 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.427 ' HD2' ' HE1' ' A' ' 55' ' ' PHE . 17.0 mtp85 . . . . . 0 N--CA 1.448 -0.552 0 CA-C-O 120.649 0.261 . . . . 0.0 110.763 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 38' ' ' LYS . 3.8 mptt . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.12 0.486 . . . . 0.0 112.047 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.492 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 47.2 mtt -98.15 154.2 17.92 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.006 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.605 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 20.3 p-90 -136.46 -172.6 3.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.591 0.71 . . . . 0.0 112.461 -178.325 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 12.3 p -154.11 143.28 21.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.658 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 15' ' ' CYS . . . -81.88 158.34 24.03 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.31 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.1 p -107.74 16.38 23.68 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.542 0.687 . . . . 0.0 110.387 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.7 p -137.2 148.51 46.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.431 178.516 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -55.91 -42.11 75.56 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.152 0.501 . . . . 0.0 110.821 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -116.31 104.7 11.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.475 178.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.76 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 69.0 t80 -75.96 -29.21 58.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.526 -178.789 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -57.26 -34.65 68.85 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -96.02 -53.6 3.6 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.068 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -81.13 -19.24 43.97 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -177.179 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 13.1 mtm180 38.04 55.97 1.65 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -117.89 120.54 38.18 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.247 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.76 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.0 p-90 -132.94 177.35 7.72 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -174.686 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.54 146.74 11.44 Favored Glycine 0 C--O 1.22 -0.745 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.959 179.206 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.809 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.1 m-85 -70.17 159.6 33.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.787 0.794 . . . . 0.0 111.919 -179.104 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 32.9 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.08 178.057 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.436 HG22 ' SG ' ' A' ' 41' ' ' CYS . 23.2 p . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 122.156 0.979 . . . . 0.0 113.4 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.758 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -136.08 -162.98 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.256 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 44.64 -87.05 0.01 OUTLIER Glycine 0 N--CA 1.465 0.586 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 176.482 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.612 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . -36.77 161.89 0.01 OUTLIER Glycine 0 N--CA 1.465 0.621 0 N-CA-C 116.77 1.468 . . . . 0.0 116.77 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -178.918 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.436 ' O ' HG23 ' A' ' 5' ' ' THR . . . . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.707 0.289 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.9 Cg_exo -77.66 143.23 21.15 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.523 2.148 . . . . 0.0 111.84 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 5.2 m -72.32 117.52 14.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.023 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.61 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 73.1 t -83.18 108.89 16.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.57 0.224 . . . . 0.0 110.625 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.405 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 50.8 m-85 -107.4 138.51 19.95 Favored Pre-proline 0 N--CA 1.45 -0.444 0 CA-C-O 120.59 0.233 . . . . 0.0 110.768 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.11 134.1 21.0 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.493 -1.461 . . . . 0.0 111.988 -0.642 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.61 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 23.7 p90 -103.39 136.45 43.12 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.121 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 88.9 m -99.07 121.32 40.83 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.596 -178.96 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.808 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 77.0 t80 -112.06 131.24 55.55 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.609 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.532 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 34.25 44.62 0.1 Allowed 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 124.851 1.345 . . . . 0.0 113.727 175.879 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.48 -19.23 45.83 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 116.96 1.544 . . . . 0.0 116.96 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.534 ' O ' ' HA ' ' A' ' 20' ' ' THR . 54.0 m-80 -109.16 146.44 34.1 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 120.042 1.921 . . . . 0.0 111.866 -178.522 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 25.3 mtmt -89.07 125.83 35.18 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.653 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.808 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 39.3 m-85 -112.85 116.41 30.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.815 0.816 . . . . 0.0 111.43 -178.316 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -90.85 -22.18 21.09 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.679 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.4 p -123.28 -176.63 3.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.633 179.026 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.6 m -64.37 169.42 4.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.438 0.637 . . . . 0.0 110.562 179.57 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.488 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.5 t -147.6 176.27 10.21 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.315 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.1 p -139.14 25.48 2.48 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.133 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.76 139.38 58.76 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 113.063 -1.881 . . . . 0.0 112.558 -179.108 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.15 -5.64 40.74 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.694 -0.685 . . . . 0.0 113.069 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.647 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 14.3 mtp85 . . . . . 0 N--CA 1.449 -0.498 0 CA-C-O 121.244 0.545 . . . . 0.0 111.478 -179.039 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.647 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 33.9 mmtt . . . . . 0 CA--C 1.518 -0.278 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 68.9 mtm -97.92 144.04 27.88 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.897 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.699 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.9 p-90 -138.09 -167.18 2.11 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.396 0.617 . . . . 0.0 111.63 -178.455 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 22.3 p -159.65 148.94 18.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.115 179.836 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.547 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -81.84 144.13 31.24 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.552 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.8 p -101.69 17.12 23.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.789 0.804 . . . . 0.0 110.69 -178.857 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.4 p -136.14 152.78 51.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.976 178.26 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.63 -39.44 84.34 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.133 0.492 . . . . 0.0 110.823 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -122.5 109.83 14.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.465 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.87 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 46.7 t80 -75.61 -35.1 60.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.206 -178.932 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -48.86 -37.9 20.89 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.921 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -86.61 -63.46 1.31 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.717 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.488 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 0.9 OUTLIER -77.68 -24.4 49.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -176.98 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.705 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 13.6 mtm180 44.2 50.48 7.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 56.6 mttt -108.99 119.34 39.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 177.531 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.87 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 15.3 p-90 -131.82 172.54 12.18 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -175.251 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.612 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -170.78 146.04 9.42 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.804 178.765 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.758 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 14.9 m-30 -62.28 158.68 16.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.339 0.57 . . . . 0.0 111.396 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.1 m . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.311 178.95 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.232 0.153 0 CA-C-O 122.202 1.001 . . . . 0.0 113.654 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -138.08 164.61 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 179.098 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.526 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.19 -149.16 51.35 Favored Glycine 0 C--N 1.315 -0.599 0 C-N-CA 118.23 -1.938 . . . . 0.0 111.853 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.479 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 50.33 -146.61 8.48 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 114.134 0.414 . . . . 0.0 114.134 177.728 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.166 -0.517 . . . . 0.0 110.36 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.491 0.186 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 24.2 Cg_exo -61.05 137.35 71.18 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.757 2.304 . . . . 0.0 112.148 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.2 m -75.06 126.87 31.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.832 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 75.8 t -87.1 121.68 38.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.702 0.287 . . . . 0.0 111.121 -179.518 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.62 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 51.5 m-85 -116.96 139.2 25.49 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.307 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.8 Cg_endo -86.21 129.89 12.15 Favored 'Cis proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.641 -1.399 . . . . 0.0 112.303 -0.363 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.62 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 19.7 p90 -94.59 128.58 41.31 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.056 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 28.8 m -92.19 123.66 35.69 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.521 0.677 . . . . 0.0 112.652 -177.63 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.869 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.1 t80 -127.49 143.83 51.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.642 178.012 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.747 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 42.41 31.35 0.27 Allowed 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.168 0.987 . . . . 0.0 113.16 178.636 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.33 -1.33 79.39 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 178.464 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.5 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 65.4 m-80 -113.21 135.59 53.66 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.195 0.998 . . . . 0.0 111.675 -179.033 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -77.76 119.36 21.16 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.929 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.869 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.2 m-30 -103.56 105.88 16.25 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.88 0.848 . . . . 0.0 110.775 -179.179 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -83.84 -15.35 48.55 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.668 -179.571 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 p -132.96 -175.86 3.92 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.194 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.5 m -66.21 163.73 17.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.532 0.682 . . . . 0.0 109.895 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.467 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 15.3 t -139.83 176.36 8.81 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.158 -179.388 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.445 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 13.0 p -128.52 16.49 6.5 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.429 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.541 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -63.29 139.89 58.82 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.496 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.2 -11.84 21.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.276 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.612 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.3 mtp85 . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.92 0.39 . . . . 0.0 110.244 179.38 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.612 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 2.2 mppt? . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.445 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 55.6 mtm -77.45 158.44 29.99 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.556 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.665 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 19.5 p-90 -141.98 -169.57 2.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.14 0.495 . . . . 0.0 111.28 -178.784 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.521 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 4.0 p -160.61 144.15 13.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.982 177.742 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.95 153.91 34.13 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.425 -178.72 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 64.5 p -101.71 9.1 41.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.748 0.785 . . . . 0.0 109.672 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.7 p -130.81 153.94 48.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.253 178.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -59.84 -48.89 79.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 111.452 -179.564 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -111.45 108.77 18.43 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.514 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.832 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 71.6 t80 -78.47 -30.36 47.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.031 -178.503 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.61 -32.7 65.54 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -90.59 -57.87 2.68 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -178.649 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -77.73 -30.94 51.93 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.244 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 7.9 mmm180 49.49 44.95 24.24 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -110.75 117.77 34.34 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.891 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.832 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 10.1 p-90 -133.57 174.92 9.9 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -173.871 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.479 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.3 144.03 9.31 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 113.219 -1.81 . . . . 0.0 109.907 178.479 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.548 ' HD1' ' HB3' ' A' ' 40' ' ' TRP . 5.3 m-30 -60.0 158.55 10.77 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.516 0.674 . . . . 0.0 112.681 -179.533 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.5 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.6 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.451 179.386 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.449 -0.508 0 CA-C-O 122.466 1.126 . . . . 0.0 113.688 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.681 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -127.49 -166.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.25 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.417 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 36.04 -127.89 0.9 Allowed Glycine 0 N--CA 1.465 0.617 0 O-C-N 123.818 0.698 . . . . 0.0 113.61 177.436 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.592 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 42.61 -148.54 0.54 Allowed Glycine 0 C--N 1.334 0.458 0 N-CA-C 115.796 1.078 . . . . 0.0 115.796 177.127 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.529 HD21 ' HA ' ' A' ' 52' ' ' LYS . 10.9 p30 . . . . . 0 C--N 1.327 -0.376 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 120.742 0.306 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -56.84 132.59 52.65 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.888 2.392 . . . . 0.0 112.368 179.777 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 52.6 m -74.78 130.59 39.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.789 0.328 . . . . 0.0 111.009 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.8 t -83.22 117.89 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -118.28 142.08 30.63 Favored Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-O 120.947 0.403 . . . . 0.0 111.353 -179.406 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.6 Cg_endo -85.63 139.32 25.89 Favored 'Cis proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.038 -1.651 . . . . 0.0 111.763 -0.594 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.548 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 19.5 p90 -99.83 -166.48 1.34 Allowed 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.79 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.0 m -148.87 126.38 11.64 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.055 0.455 . . . . 0.0 111.115 -178.777 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.801 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 29.5 t80 -129.4 139.15 51.76 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.652 179.072 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.541 HD23 ' CG ' ' A' ' 21' ' ' PHE . 3.5 mm? 34.08 47.49 0.2 Allowed 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 124.65 1.218 . . . . 0.0 114.24 174.999 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.18 -12.21 70.17 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 114.345 -1.298 . . . . 0.0 116.022 177.454 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.455 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 61.1 m-80 -115.19 134.53 55.06 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 119.224 1.512 . . . . 0.0 112.387 -178.525 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -78.98 125.05 28.87 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.359 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.801 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.4 m-30 -109.79 118.81 37.5 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.831 0.824 . . . . 0.0 111.219 -178.816 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 28.3 mt-10 -91.7 -8.61 46.51 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.903 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.3 p -140.67 -164.86 1.81 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.159 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.5 m -72.5 168.2 19.03 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.849 178.531 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.4 t -149.75 166.71 28.61 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.229 -179.147 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.523 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 29.6 p -120.52 21.6 11.53 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 176.755 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.474 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -60.77 140.49 57.56 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 113.826 -1.533 . . . . 0.0 112.167 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.36 -8.03 10.44 Favored Glycine 0 N--CA 1.454 -0.122 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.778 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.634 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 22.8 mtp85 . . . . . 0 N--CA 1.443 -0.805 0 CA-C-O 120.818 0.342 . . . . 0.0 110.845 -179.375 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.634 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 4.3 mptt . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.523 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 52.1 mtt -87.9 146.42 25.57 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.618 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.624 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.3 p-90 -134.32 -164.42 1.5 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.142 0.496 . . . . 0.0 111.158 -178.47 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.2 p -169.58 155.85 6.27 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.41 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.86 146.26 29.0 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.113 -179.268 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 71.0 p -97.93 11.84 36.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.743 0.782 . . . . 0.0 109.853 179.339 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.6 p -134.76 158.91 42.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.549 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -61.81 -44.9 95.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.922 0.392 . . . . 0.0 111.238 -179.615 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -116.61 106.88 14.04 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.907 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 72.7 t80 -72.0 -39.42 69.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.86 -178.707 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -49.82 -37.39 30.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.559 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -87.65 -58.49 2.55 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.36 -23.77 54.18 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -177.089 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 7.5 mtm180 45.1 49.32 9.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 179.247 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.529 ' HA ' HD21 ' A' ' 9' ' ' ASN . 28.4 mtpp -116.93 117.62 30.18 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.537 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.907 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.3 p-90 -129.15 172.15 11.71 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -175.258 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.591 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.05 144.93 9.73 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 113.58 -1.645 . . . . 0.0 110.578 179.353 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.681 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.6 m-30 -63.39 158.45 20.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.327 0.563 . . . . 0.0 111.879 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.843 178.592 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.5 p . . . . . 0 N--CA 1.446 -0.639 0 CA-C-O 121.876 0.846 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -129.21 163.97 32.91 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 178.226 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.755 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.85 -145.14 46.29 Favored Glycine 0 C--N 1.308 -0.984 0 C-N-CA 117.434 -2.317 . . . . 0.0 111.148 -179.136 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.628 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 43.47 -149.41 0.67 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 116.077 1.191 . . . . 0.0 116.077 176.717 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.5 p30 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 114.836 -0.682 . . . . 0.0 110.073 -179.576 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.157 0 CA-C-O 120.71 0.29 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -85.15 171.36 9.14 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.772 2.315 . . . . 0.0 111.404 179.254 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.3 m -75.58 148.24 39.0 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.194 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 98.7 t -114.23 117.43 55.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.241 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.612 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 66.0 m-85 -114.22 139.04 23.28 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.944 0.402 . . . . 0.0 111.117 -179.509 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -86.13 131.82 14.22 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.409 -1.496 . . . . 0.0 112.187 -0.17 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.623 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 27.9 p90 -99.59 128.92 45.71 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.194 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -91.72 123.03 34.81 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.335 -178.648 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.863 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 62.0 t80 -117.94 129.98 55.94 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.826 178.547 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.533 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.5 mm? 35.87 49.03 0.54 Allowed 'General case' 0 N--CA 1.424 -1.738 0 O-C-N 125.055 1.472 . . . . 0.0 113.33 175.984 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.09 -19.82 51.46 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 114.354 -1.294 . . . . 0.0 116.298 178.099 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -114.99 133.62 55.87 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 120.075 1.937 . . . . 0.0 113.523 -177.632 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -77.67 125.67 29.7 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.645 178.912 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.863 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 17.3 m-30 -111.06 118.64 36.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.794 0.807 . . . . 0.0 112.037 -178.559 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -89.27 -19.33 25.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.938 179.454 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 p -127.7 -178.29 4.43 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.167 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 87.7 m -67.79 170.47 7.93 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.908 179.181 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -146.96 173.28 12.58 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.254 0.549 . . . . 0.0 110.615 -178.706 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.611 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 17.4 p -125.4 19.58 8.11 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.057 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -59.85 135.47 57.71 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.745 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.83 -8.34 11.61 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.252 -179.494 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.9 mtp85 . . . . . 0 N--CA 1.446 -0.633 0 CA-C-O 121.038 0.446 . . . . 0.0 111.225 -179.513 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 27.1 mmtm . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.611 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 71.5 mtm -89.55 146.56 24.5 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.235 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.644 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.3 p-90 -129.11 -167.38 1.78 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.4 0.619 . . . . 0.0 112.655 -177.224 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 21.8 p -158.92 143.4 15.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.697 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 19' ' ' PHE . . . -78.44 151.54 32.64 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.424 -0.911 . . . . 0.0 109.605 179.45 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.0 p -103.4 13.22 34.12 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.582 0.706 . . . . 0.0 109.914 -179.573 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.8 p -135.0 149.01 50.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.508 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.78 -37.47 68.61 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.98 0.419 . . . . 0.0 111.498 -179.595 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -125.04 111.32 15.24 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.52 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.864 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 48.5 t80 -76.26 -34.5 59.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.91 -178.274 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -53.94 -31.17 49.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.714 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -89.3 -58.73 2.43 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -179.308 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.27 -19.29 28.5 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.671 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 11.3 mtm180 44.89 49.54 9.1 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 179.558 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -108.63 117.15 33.42 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.32 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.864 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.4 p-90 -126.63 173.31 9.57 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -175.918 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.566 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.77 138.37 5.11 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.587 179.248 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.755 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 12.2 m-85 -56.61 153.67 9.96 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.33 0.586 . . . . 0.0 110.995 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.512 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 9.1 t . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.236 -179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 122.008 0.908 . . . . 0.0 113.132 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -138.04 160.68 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 177.518 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.573 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.38 -154.92 44.41 Favored Glycine 0 C--N 1.313 -0.726 0 C-N-CA 117.804 -2.141 . . . . 0.0 110.637 -178.641 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.693 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 40.52 -141.68 0.84 Allowed Glycine 0 N--CA 1.464 0.558 0 N-CA-C 114.311 0.484 . . . . 0.0 114.311 177.625 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.859 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--O 1.224 -0.245 0 CA-C-O 120.656 0.265 . . . . 0.0 111.521 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.4 Cg_exo -76.02 149.68 32.95 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.019 2.479 . . . . 0.0 111.895 179.181 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 94.9 m -71.85 129.87 39.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.621 0.248 . . . . 0.0 110.372 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 65.2 t -100.32 128.22 52.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.938 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.0 143.28 35.03 Favored Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.432 179.253 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.0 Cg_endo -84.0 131.96 17.73 Favored 'Cis proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.446 -1.481 . . . . 0.0 111.958 -0.33 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.632 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 48.6 p90 -100.24 131.62 46.07 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.79 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.0 m -92.37 123.79 35.94 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -176.41 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.757 ' CG ' HD22 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -125.56 144.17 50.68 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.264 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.757 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.88 35.16 0.11 Allowed 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.456 1.102 . . . . 0.0 113.26 178.896 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.86 -4.65 84.92 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 115.018 0.767 . . . . 0.0 115.018 178.757 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.601 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 62.4 m-80 -108.69 137.7 46.21 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 118.623 1.211 . . . . 0.0 112.031 -178.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -79.02 118.81 21.35 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.673 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.722 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.3 m-30 -103.25 108.44 19.66 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.71 0.767 . . . . 0.0 111.378 -178.482 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -88.77 -17.01 30.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.392 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 p -129.5 175.04 9.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.693 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.4 m -62.0 162.9 8.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.534 178.994 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -138.91 179.46 6.48 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.083 -178.948 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 p -133.38 15.93 4.08 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 177.434 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.641 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -59.98 139.04 57.69 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.384 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.99 -5.94 29.98 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.299 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 28.5 mtp85 . . . . . 0 N--CA 1.45 -0.462 0 CA-C-N 116.612 0.206 . . . . 0.0 111.102 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.527 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 39.4 mttp . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.605 0.241 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.6 mtt -85.49 146.61 26.85 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.271 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.689 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 21.4 p-90 -135.68 -169.78 2.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.408 0.623 . . . . 0.0 112.041 -178.466 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.0 p -159.86 145.26 15.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.143 178.823 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -77.82 151.46 33.94 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.477 -179.363 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 38.4 p -96.7 8.87 43.26 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.495 0.664 . . . . 0.0 110.382 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.4 p -133.07 155.56 49.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.221 179.256 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -62.34 -28.91 70.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.41 . . . . 0.0 111.025 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -125.93 114.42 18.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.412 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.879 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 66.4 t80 -89.03 -29.12 19.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.288 -179.305 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -52.61 -38.8 60.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.859 0.362 . . . . 0.0 111.526 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -92.97 -63.94 1.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.845 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.605 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.5 m-20 -64.36 -28.34 69.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -177.408 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER 42.96 49.46 5.24 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 179.306 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.605 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 9.5 mtpp -114.81 116.85 29.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.879 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.6 p-90 -128.85 176.97 7.42 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -175.278 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.693 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -172.32 145.83 8.84 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 113.107 -1.861 . . . . 0.0 108.94 179.002 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 13.6 m-30 -59.78 160.69 7.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 117.346 0.573 . . . . 0.0 111.853 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.457 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 1.8 t . . . . . 0 CA--C 1.527 0.078 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 177.188 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.421 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 24.2 p . . . . . 0 N--CA 1.446 -0.669 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.76 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -121.72 -164.5 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 175.588 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.433 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 33.85 -123.45 0.39 Allowed Glycine 0 N--CA 1.465 0.61 0 O-C-N 123.903 0.752 . . . . 0.0 113.528 177.654 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.635 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 36.44 -145.38 0.08 OUTLIER Glycine 0 C--N 1.335 0.517 0 N-CA-C 115.744 1.057 . . . . 0.0 115.744 176.945 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 . . . . . 0 N--CA 1.463 0.221 0 CA-C-N 115.251 -0.475 . . . . 0.0 111.542 179.963 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--O 1.225 -0.191 0 CA-C-O 120.787 0.327 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 23.4 Cg_exo -61.6 131.36 35.36 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.698 2.266 . . . . 0.0 112.14 179.792 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 53.7 m -71.7 120.73 17.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.175 179.462 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 62.3 t -76.65 116.24 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 111.893 -179.301 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.559 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 40.5 m-85 -118.49 139.89 27.54 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.043 179.866 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.442 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.9 Cg_endo -83.4 138.15 31.99 Favored 'Cis proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.311 -1.537 . . . . 0.0 111.99 -0.447 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.559 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 40.4 p90 -102.97 -173.54 2.34 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.182 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.4 m -140.54 123.64 16.61 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.195 -179.508 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.693 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 56.8 t80 -122.46 133.33 54.6 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.99 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.56 HD23 ' CE1' ' A' ' 21' ' ' PHE . 3.8 mm? 32.61 47.76 0.11 Allowed 'General case' 0 N--CA 1.432 -1.357 0 O-C-N 124.915 1.384 . . . . 0.0 114.238 175.685 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.39 -11.92 66.75 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 116.205 1.242 . . . . 0.0 116.205 177.544 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.531 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 59.6 m-80 -109.47 154.94 21.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.417 1.608 . . . . 0.0 112.15 -178.585 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -95.66 126.98 41.31 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.107 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.693 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 37.9 m-85 -119.08 122.42 42.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.542 0.687 . . . . 0.0 112.054 -178.253 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.442 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 82.9 mt-10 -100.02 -18.06 17.21 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.904 178.987 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.3 p -129.04 -173.33 2.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.743 179.423 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.98 167.34 13.99 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 120.297 -0.561 . . . . 0.0 109.586 178.764 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.451 ' HG1' ' HE2' ' A' ' 26' ' ' TYR . 13.6 t -145.76 170.09 17.22 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.459 -178.895 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.793 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 56.6 p -122.21 18.66 10.72 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.752 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -58.92 133.69 56.27 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.748 -179.922 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.6 -5.01 54.34 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.315 -179.774 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.0 mtp85 . . . . . 0 N--CA 1.45 -0.43 0 CA-C-O 121.083 0.468 . . . . 0.0 110.402 -179.443 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.5 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 89.4 mttt . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.531 0.205 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.793 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 77.0 mtm -64.15 134.49 54.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 109.934 179.693 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.72 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.1 p-90 -125.12 -161.28 1.01 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.387 -177.518 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 3.5 p -169.53 154.52 5.64 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.594 178.189 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.412 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -78.8 147.81 33.14 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 120.835 0.35 . . . . 0.0 110.998 -179.252 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 66.0 p -100.88 7.06 43.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.636 0.731 . . . . 0.0 109.843 179.545 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.5 p -128.4 157.87 39.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.005 178.402 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.86 99.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.101 0.476 . . . . 0.0 110.759 -179.937 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -119.57 106.07 11.84 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.32 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.989 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 34.2 t80 -71.58 -38.33 70.92 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 -179.078 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -45.59 -36.76 4.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.437 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.79 -63.74 1.23 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -179.28 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.39 -18.64 59.89 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.815 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 34.74 56.3 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -179.868 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -114.32 116.25 28.66 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.492 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.989 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 8.4 p-90 -125.27 169.51 12.21 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -174.859 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.635 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.51 146.68 10.89 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.345 179.339 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.76 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 14.8 m-30 -62.06 163.23 8.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.366 0.603 . . . . 0.0 112.328 -179.21 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.5 179.241 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 p . . . . . 0 C--O 1.233 0.199 0 CA-C-O 122.306 1.051 . . . . 0.0 113.762 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -132.07 163.52 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 104.945 -2.242 . . . . 0.0 104.945 178.728 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.62 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 64.14 -145.55 49.75 Favored Glycine 0 C--N 1.313 -0.714 0 C-N-CA 118.067 -2.016 . . . . 0.0 110.725 -179.369 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.643 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 44.35 -145.94 1.73 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 114.724 0.65 . . . . 0.0 114.724 177.791 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 . . . . . 0 C--N 1.325 -0.462 0 CA-C-O 120.895 0.379 . . . . 0.0 110.686 178.681 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.294 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.67 170.86 8.74 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.768 2.312 . . . . 0.0 111.997 179.662 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.2 m -74.81 142.96 44.16 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.954 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 92.6 t -111.63 117.38 54.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 178.767 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.563 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 47.3 m-85 -114.69 142.08 27.73 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.752 -179.778 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.23 136.65 28.62 Favored 'Cis proline' 0 N--CA 1.464 -0.259 0 C-N-CA 123.369 -1.513 . . . . 0.0 112.005 -0.498 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.563 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 32.3 p90 -107.08 132.56 52.84 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.315 178.387 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 68.1 m -94.41 124.46 38.45 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.438 -179.239 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.743 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 41.7 t80 -124.76 137.38 54.33 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.901 178.995 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.545 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.4 mm? 37.0 49.23 0.78 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 175.293 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.92 -8.97 73.98 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 114.312 -1.313 . . . . 0.0 116.351 177.626 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 20' ' ' THR . 62.7 m-80 -113.69 153.85 28.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 119.515 1.658 . . . . 0.0 112.287 -178.614 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -93.37 122.48 35.83 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.804 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.743 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 15.0 m-85 -110.22 121.81 46.15 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.857 0.837 . . . . 0.0 111.56 -178.272 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -95.44 -21.06 18.57 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.883 179.676 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p -127.26 -174.67 3.22 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.894 179.953 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.6 m -66.64 170.35 6.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.3 0.571 . . . . 0.0 109.558 178.604 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.537 ' HG1' ' HE2' ' A' ' 26' ' ' TYR . 12.1 t -148.43 169.18 20.78 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.592 -179.693 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.0 p -121.98 17.72 10.9 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.21 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.32 137.07 58.19 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.721 -179.473 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.08 -0.09 63.84 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.718 179.862 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.448 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.0 mtp85 . . . . . 0 N--CA 1.448 -0.55 0 CA-C-N 116.508 0.154 . . . . 0.0 111.297 -179.581 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 31.1 mmtm . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 120.989 0.423 . . . . 0.0 111.801 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.8 mtm -102.96 151.17 22.78 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.523 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.657 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 11.3 p-90 -137.09 -170.08 2.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.288 0.566 . . . . 0.0 112.35 -178.082 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 21.4 p -155.85 146.84 22.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.966 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.98 149.42 30.8 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.754 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.1 p -100.22 16.02 25.63 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.77 0.795 . . . . 0.0 110.056 -179.775 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.2 p -143.77 152.88 41.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.059 178.372 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.81 -40.71 80.58 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.963 0.411 . . . . 0.0 111.515 -179.351 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -119.44 107.04 12.85 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.918 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.89 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 58.1 t80 -73.58 -39.8 64.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.68 -178.494 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -49.75 -38.37 33.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.47 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.44 -38.9 12.29 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -178.482 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -93.5 -24.45 17.99 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.524 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 14.4 mtm180 43.17 49.57 5.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 178.977 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -116.91 120.12 37.47 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.014 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.89 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.6 p-90 -130.66 169.33 15.78 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -175.647 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.643 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.16 145.6 11.19 Favored Glycine 0 C--O 1.22 -0.772 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.629 178.732 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.62 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 4.8 m-30 -63.44 159.71 17.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.313 0.578 . . . . 0.0 111.849 179.938 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.272 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 55' ' ' PHE . 27.5 p . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 1.0 OUTLIER -127.2 6.62 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 CA-C-O 122.799 1.285 . . . . 0.0 109.964 179.922 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.42 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . -156.16 -160.12 9.82 Favored Glycine 0 C--N 1.282 -2.421 0 CA-C-N 112.874 -1.966 . . . . 0.0 111.008 -178.138 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.713 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 74.38 168.33 19.19 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.635 178.572 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.6 p30 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.55 -0.325 . . . . 0.0 111.527 178.782 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 120.392 0.139 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.03 151.01 16.11 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.219 1.946 . . . . 0.0 112.252 -179.967 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 72.3 m -78.33 138.55 38.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.218 179.668 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 47.9 t -104.83 118.08 51.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.578 0.228 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.418 ' CE2' ' HE1' ' A' ' 19' ' ' PHE . 69.6 m-85 -111.27 146.34 34.37 Favored Pre-proline 0 N--CA 1.447 -0.577 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.42 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -82.64 134.37 24.81 Favored 'Cis proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.431 -1.487 . . . . 0.0 112.106 -0.237 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.64 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 20.8 p90 -108.27 127.79 54.16 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.473 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 91.7 m -91.69 127.09 37.01 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.105 0.479 . . . . 0.0 111.39 -178.81 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.844 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 56.3 t80 -123.32 135.06 54.01 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.789 179.282 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.555 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 35.1 46.92 0.25 Allowed 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 124.491 1.119 . . . . 0.0 113.799 175.197 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.27 -20.7 49.45 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 116.237 1.255 . . . . 0.0 116.237 177.71 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -112.14 134.11 53.88 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 119.545 1.673 . . . . 0.0 112.644 -178.138 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 34.7 mtpt -79.04 125.33 29.24 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.709 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.844 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 17.9 m-85 -109.91 123.15 49.1 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.608 0.718 . . . . 0.0 111.589 -178.588 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 51.6 mt-10 -100.61 -9.96 21.43 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.817 179.283 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 p -130.88 172.12 12.4 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.976 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.3 m -63.72 160.87 16.16 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.616 179.285 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 t -138.74 174.06 10.92 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.159 -178.761 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 p -127.42 21.99 6.55 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 177.039 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.02 138.8 58.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.025 -179.384 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.01 -6.15 28.99 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.047 179.639 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.642 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 13.8 mtp85 . . . . . 0 N--CA 1.45 -0.434 0 CA-C-N 117.169 0.484 . . . . 0.0 111.224 -179.678 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.642 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.543 0 CA-C-O 120.593 0.235 . . . . 0.0 110.843 . . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.4 mtt -89.44 143.91 26.46 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.779 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.666 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 12.3 p-90 -132.17 -165.57 1.61 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.49 0.662 . . . . 0.0 111.39 -178.725 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -169.32 150.21 4.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.068 179.447 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.41 149.86 36.85 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.786 -179.23 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.2 p -96.42 9.08 42.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.777 0.798 . . . . 0.0 109.383 179.442 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.0 p -132.67 150.9 52.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.38 178.71 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.64 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.09 -36.48 72.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.07 0.462 . . . . 0.0 111.218 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -123.19 112.03 17.2 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.393 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.908 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 51.9 t80 -76.11 -39.06 56.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.806 -178.411 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -46.38 -35.96 5.99 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.956 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -82.52 -77.99 0.22 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -179.742 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.638 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 1.4 m-20 -67.83 -20.69 65.19 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -176.84 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 18.9 mtm180 43.24 50.73 5.8 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.943 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.638 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 59.1 mttt -111.69 118.24 35.09 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.113 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.908 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.6 p-90 -128.88 177.31 7.18 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -175.072 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.52 ' HA3' ' CG2' ' A' ' 5' ' ' THR . . . -176.76 154.63 16.67 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 113.691 -1.595 . . . . 0.0 110.013 179.227 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 15.4 m-30 -66.11 161.12 22.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.106 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.8 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.393 178.729 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.446 -0.671 0 CA-C-O 121.936 0.874 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -131.32 165.39 31.7 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.035 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 178.091 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.581 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 61.07 -148.34 46.2 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 118.187 -1.958 . . . . 0.0 111.667 -179.935 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.57 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 51.97 -152.54 6.3 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 114.801 0.68 . . . . 0.0 114.801 177.352 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 50.2 p-10 . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.889 0.376 . . . . 0.0 111.025 179.763 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.677 0.275 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.43 174.4 5.98 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.93 2.42 . . . . 0.0 111.852 179.888 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.8 m -85.02 128.21 34.53 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.817 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 99.3 t -95.45 108.26 20.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.048 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -110.22 142.14 25.36 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.141 -179.081 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -82.55 139.37 38.96 Favored 'Cis proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.821 -1.741 . . . . 0.0 111.276 -0.783 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.54 ' HZ ' HG22 ' A' ' 30' ' ' THR . 36.3 p90 -105.98 135.76 46.85 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.703 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 41.4 m -96.76 120.32 36.87 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.376 0.608 . . . . 0.0 110.76 -179.139 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.723 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 50.2 t80 -116.34 134.07 55.3 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.741 178.951 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.538 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.7 mm? 33.36 45.41 0.08 Allowed 'General case' 0 N--CA 1.435 -1.224 0 O-C-N 124.872 1.358 . . . . 0.0 114.224 174.789 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.04 -10.86 62.12 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 116.584 1.394 . . . . 0.0 116.584 177.331 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.502 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 41.0 m-80 -115.35 156.43 25.53 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.87 1.835 . . . . 0.0 112.8 -178.123 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -91.66 122.2 34.01 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.788 179.047 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.723 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 42.8 m-85 -115.22 111.25 20.67 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.725 0.774 . . . . 0.0 111.141 -179.414 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -91.26 -9.21 46.0 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.899 -179.769 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 p -138.91 -166.55 2.04 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.43 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.4 m -71.38 167.28 19.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.416 0.627 . . . . 0.0 110.52 179.018 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.54 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.5 t -146.85 173.22 12.6 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.601 179.979 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 p -127.03 19.33 7.07 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.386 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -62.49 139.6 58.59 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.43 -179.124 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.9 -0.64 44.11 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.036 179.437 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.641 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.8 mtp85 . . . . . 0 N--CA 1.45 -0.46 0 CA-C-O 121.155 0.503 . . . . 0.0 111.741 -179.194 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.641 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 44.6 mmtt . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -73.85 149.98 41.24 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.922 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.618 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 13.0 p-90 -137.26 -163.81 1.49 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.152 0.501 . . . . 0.0 111.375 -178.527 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 23.5 p -160.09 153.79 22.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.846 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.38 144.73 25.84 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.318 178.347 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -99.56 13.54 33.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.804 0.812 . . . . 0.0 110.349 -179.353 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.9 p -136.76 147.52 46.71 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.501 178.212 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.16 -48.99 64.64 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.166 0.507 . . . . 0.0 111.053 -179.439 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -113.6 112.09 22.94 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.086 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.875 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 56.7 t80 -73.23 -40.2 64.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.837 -178.432 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -48.22 -36.07 13.1 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.086 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.46 -68.4 0.68 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.716 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.84 -23.16 52.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.87 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 24.7 mtm180 45.4 50.57 10.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -179.617 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -112.51 117.13 31.52 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.019 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.875 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.1 p-90 -127.78 169.7 13.57 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.297 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.493 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -159.2 137.51 5.19 Favored Glycine 0 C--O 1.221 -0.688 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.473 178.647 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.581 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 2.5 m-30 -58.47 158.28 7.76 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.289 0.636 . . . . 0.0 111.738 179.686 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.418 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.0 t . . . . . 0 C--N 1.319 -0.737 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.674 179.983 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 121.372 0.606 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.758 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -113.67 -166.93 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 176.8 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 36.99 -125.98 1.08 Allowed Glycine 0 N--CA 1.462 0.419 0 O-C-N 124.038 0.836 . . . . 0.0 113.226 177.592 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.683 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 31.85 -141.42 0.04 OUTLIER Glycine 0 C--N 1.335 0.474 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 176.801 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 114.693 -0.753 . . . . 0.0 109.792 179.894 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.757 0.313 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -84.03 165.74 13.12 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.533 2.155 . . . . 0.0 111.688 179.486 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.5 m -79.93 136.7 36.7 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.829 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.3 t -96.39 107.35 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.688 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.552 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 38.0 m-85 -111.44 138.23 21.34 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-O 121.046 0.45 . . . . 0.0 111.066 -179.59 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.606 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 9.4 Cg_endo -88.5 134.15 12.38 Favored 'Cis proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.239 -1.567 . . . . 0.0 112.415 -0.555 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.594 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 37.3 p90 -97.26 -168.32 1.67 Allowed 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 119.707 -0.797 . . . . 0.0 108.85 178.063 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.4 m -147.36 127.46 13.74 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.421 -179.006 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.818 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -129.91 144.07 51.13 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.704 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.758 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.06 36.32 0.11 Allowed 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.863 1.265 . . . . 0.0 113.343 178.733 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.4 -12.63 69.24 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 115.19 0.836 . . . . 0.0 115.19 178.667 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -106.0 135.72 46.94 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 118.667 1.234 . . . . 0.0 111.923 -178.932 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 88.8 mttt -78.94 126.15 30.32 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.915 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.818 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.4 m-30 -108.57 114.6 28.56 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.763 0.792 . . . . 0.0 111.199 -179.123 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.606 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 50.8 mt-10 -90.49 -20.34 22.81 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.586 -179.568 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 p -125.61 -175.71 3.41 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.501 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.5 m -67.64 162.54 23.37 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.451 179.039 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -138.12 171.07 14.94 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.173 -179.349 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.6 p -126.18 21.95 7.3 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.244 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.634 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -66.26 140.61 58.15 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.299 -179.63 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.92 -3.59 50.17 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.553 179.579 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.687 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 16.9 mtp85 . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 121.155 0.502 . . . . 0.0 110.823 -179.341 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.687 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 81.2 mttt . . . . . 0 CA--C 1.518 -0.259 0 CA-C-O 120.69 0.281 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.7 mtm -69.87 139.04 52.98 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.202 -179.604 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.659 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.1 p-90 -129.08 -165.96 1.58 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.411 -178.899 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.4 p -157.37 150.02 23.12 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.304 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.461 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -84.97 148.05 26.4 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.396 179.596 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 49.7 p -102.98 10.97 37.92 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.841 0.829 . . . . 0.0 109.732 179.805 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.5 p -131.0 149.88 52.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.884 178.149 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.38 -43.28 83.46 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.124 0.488 . . . . 0.0 111.036 -179.572 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -117.26 109.05 16.37 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.225 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.843 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 73.7 t80 -77.12 -34.97 56.61 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.866 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -51.12 -35.03 33.43 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.791 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -86.57 -76.8 0.34 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.343 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.74 -19.2 65.81 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -176.824 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 45.2 mtm-85 39.24 54.6 2.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 179.253 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -112.88 119.21 37.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.525 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.843 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.5 p-90 -129.55 173.13 10.87 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -174.701 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.562 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -164.32 144.61 9.56 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 113.327 -1.76 . . . . 0.0 109.529 178.793 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.758 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.3 m-30 -61.89 156.75 20.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 117.69 0.745 . . . . 0.0 111.843 -179.646 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.453 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 7.6 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.404 178.365 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 122.605 1.193 . . . . 0.0 114.026 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -138.71 162.36 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 177.844 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.607 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.89 -147.47 50.72 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 117.629 -2.224 . . . . 0.0 111.512 -179.46 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.696 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 47.88 -137.87 12.51 Favored Glycine 0 N--CA 1.461 0.309 0 N-CA-C 114.111 0.404 . . . . 0.0 114.111 177.788 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.966 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.189 0 CA-C-O 120.506 0.193 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -77.3 139.67 18.88 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.994 1.796 . . . . 0.0 112.474 -179.831 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 87.9 m -71.14 124.49 24.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.246 179.468 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.502 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 64.1 t -89.95 122.13 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.184 -179.57 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.477 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 54.1 m-85 -117.89 140.36 27.65 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.02 179.422 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -86.19 133.21 15.66 Favored 'Cis proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.181 -1.591 . . . . 0.0 112.136 0.152 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.665 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 37.7 p90 -102.4 132.69 48.25 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.63 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 m -95.37 127.31 41.31 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -177.475 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.832 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.1 t80 -127.16 144.31 51.06 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.182 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.759 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.95 32.62 0.12 Allowed 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 124.298 1.039 . . . . 0.0 113.324 178.505 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.29 -8.43 77.44 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 178.793 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.439 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 67.9 m-80 -107.98 135.81 48.74 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 118.354 1.077 . . . . 0.0 111.859 -179.148 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -78.64 123.12 26.79 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.998 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.832 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.8 m-30 -107.59 110.7 22.66 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.84 0.829 . . . . 0.0 111.183 -178.901 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -86.28 -21.92 27.09 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.108 -1.406 . . . . 0.0 110.37 -179.619 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 p -126.1 -175.2 3.3 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.788 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.9 m -65.9 163.4 17.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.393 0.616 . . . . 0.0 109.758 178.896 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.488 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.7 t -138.22 172.84 12.32 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.269 -179.311 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.4 p -125.39 12.9 8.18 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 177.762 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.551 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -60.9 138.27 58.16 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 113.881 -1.508 . . . . 0.0 111.691 -179.697 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.15 -10.12 43.49 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.779 179.767 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.613 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.6 mtp85 . . . . . 0 C--O 1.236 0.361 0 CA-C-N 117.424 0.612 . . . . 0.0 110.96 179.567 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.613 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 8.2 mptt . . . . . 0 N--CA 1.455 -0.221 0 CA-C-O 120.722 0.296 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 43.6 mtt -86.11 150.86 24.13 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.459 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.686 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.3 p-90 -137.43 -167.91 2.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.966 0.412 . . . . 0.0 111.184 -178.548 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.7 p -161.76 142.55 10.78 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.556 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -71.69 154.45 41.35 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.102 0.477 . . . . 0.0 110.737 -179.324 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.5 p -103.5 10.11 37.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.68 0.752 . . . . 0.0 110.119 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.1 p -133.46 155.81 48.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.901 178.766 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -59.15 -35.74 74.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.906 0.384 . . . . 0.0 111.432 -179.67 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -124.98 113.09 17.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.493 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.819 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 80.3 t80 -78.06 -31.05 50.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.028 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -58.76 -34.92 71.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.527 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -79.11 -64.43 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.938 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.955 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.3 m-20 -72.86 -36.56 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.466 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 7.9 mmm-85 54.65 45.26 27.19 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.365 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.955 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 12.4 mtpt -116.74 120.4 38.47 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 176.894 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.819 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 10.4 p-90 -132.5 172.15 12.87 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.437 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.696 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -160.89 147.33 13.91 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 112.984 -1.916 . . . . 0.0 109.708 178.209 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.607 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 10.6 m-30 -58.83 163.54 3.34 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.262 0.553 . . . . 0.0 111.719 -179.862 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.581 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.2 t . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.286 179.753 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 122.07 0.938 . . . . 0.0 111.953 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -132.99 159.42 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 177.63 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.862 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 67.2 -147.45 49.1 Favored Glycine 0 C--N 1.308 -1.002 0 C-N-CA 117.587 -2.245 . . . . 0.0 111.078 -179.032 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.617 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 45.25 -144.55 2.83 Favored Glycine 0 C--N 1.328 0.108 0 N-CA-C 115.157 0.823 . . . . 0.0 115.157 177.318 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.0 p30 . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 121.19 0.519 . . . . 0.0 110.863 179.95 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.188 0 CA-C-O 120.301 0.096 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -87.59 166.17 7.64 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.443 2.095 . . . . 0.0 111.697 179.409 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 71.7 m -81.13 118.77 22.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.581 179.829 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 59.6 t -82.67 117.75 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.854 -179.799 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -114.55 134.52 22.33 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.596 179.875 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.724 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 9.4 Cg_endo -85.97 136.92 20.83 Favored 'Cis proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.246 -1.564 . . . . 0.0 112.901 -0.158 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.562 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 29.9 p90 -100.96 129.42 46.8 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.778 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.5 m -91.49 127.0 36.76 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.334 0.588 . . . . 0.0 112.552 -177.395 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.784 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.4 t80 -131.3 142.32 50.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.469 178.356 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.727 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.38 38.96 0.41 Allowed 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.624 1.17 . . . . 0.0 113.665 178.278 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.37 -8.71 79.24 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 115.216 0.846 . . . . 0.0 115.216 178.426 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.566 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 68.3 m-80 -110.39 137.99 47.37 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 118.461 1.13 . . . . 0.0 112.068 -179.082 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -81.5 121.11 25.88 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.498 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.784 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.3 m-30 -104.51 104.7 14.59 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.892 0.854 . . . . 0.0 110.977 -178.129 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.724 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 27.5 mt-10 -84.47 -9.34 58.46 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.159 -1.382 . . . . 0.0 111.259 -179.231 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.0 p -137.58 -167.67 2.17 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.402 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 81.2 m -70.52 170.89 11.17 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.189 -0.605 . . . . 0.0 109.982 178.597 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.542 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 14.3 t -150.11 172.4 15.33 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.279 -179.983 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.6 p -127.11 20.53 6.89 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.07 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.527 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -65.25 142.72 58.19 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 114.067 -1.424 . . . . 0.0 112.234 -179.613 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.58 -4.3 21.47 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.892 179.396 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.678 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 20.6 mtp85 . . . . . 0 N--CA 1.449 -0.525 0 CA-C-O 121.255 0.55 . . . . 0.0 111.688 -179.216 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.678 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.875 0.369 . . . . 0.0 111.651 . . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.4 mtt -98.02 149.92 21.94 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.736 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.611 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.4 p-90 -141.11 -171.85 3.36 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.334 0.587 . . . . 0.0 111.434 -178.331 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.7 p -156.7 137.3 13.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.827 177.969 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.09 151.07 44.87 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.436 0.636 . . . . 0.0 111.458 -178.553 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.1 p -100.75 7.51 43.78 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.915 179.236 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.1 p -127.92 143.83 51.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.754 179.459 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.48 -49.33 70.37 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.916 0.389 . . . . 0.0 110.98 179.958 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -112.46 103.53 11.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.052 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.822 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 56.9 t80 -76.19 -29.25 57.59 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.274 -178.04 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -55.67 -37.77 68.73 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.562 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -86.57 -52.28 5.65 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.298 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.69 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 13.5 m-20 -77.39 -45.98 24.21 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.477 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.675 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER 61.46 37.03 16.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.895 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.69 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 5.0 mppt? -105.11 118.09 35.65 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.183 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.822 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.9 p-90 -128.66 174.88 9.03 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -174.067 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.617 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -157.68 145.9 12.62 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 112.789 -2.005 . . . . 0.0 108.733 178.274 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.862 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 6.2 m-85 -66.86 163.93 18.44 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 117.772 0.786 . . . . 0.0 112.106 -179.402 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.497 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 2.2 t . . . . . 0 C--N 1.329 -0.286 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.592 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.449 -0.519 0 CA-C-O 121.788 0.804 . . . . 0.0 112.99 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -133.23 164.01 36.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.979 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.976 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.699 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 77.19 -80.44 1.26 Allowed Glycine 0 N--CA 1.463 0.463 0 C-N-CA 118.194 -1.955 . . . . 0.0 113.928 178.932 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.8 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . -45.98 166.22 0.07 OUTLIER Glycine 0 N--CA 1.468 0.813 0 CA-C-N 114.502 -0.849 . . . . 0.0 115.174 -179.16 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 50.7 p30 . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.783 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.274 0 CA-C-O 120.867 0.365 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.91 147.33 68.07 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.169 2.58 . . . . 0.0 113.018 -179.724 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 86.4 m -82.47 116.5 21.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.336 178.777 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.6 t -77.27 119.32 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -116.09 137.6 23.53 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.057 0.456 . . . . 0.0 111.22 -179.591 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 87.4 Cg_endo -84.02 142.67 40.96 Favored 'Cis proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.428 -1.905 . . . . 0.0 112.795 -0.172 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.605 ' HZ ' HG22 ' A' ' 30' ' ' THR . 21.6 p90 -104.68 128.77 52.85 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.74 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.3 m -95.6 122.63 38.55 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.433 0.635 . . . . 0.0 111.967 -177.933 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.684 ' CE2' ' HZ2' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -104.44 -140.36 0.36 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.151 178.298 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.703 ' H ' HD22 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -49.67 52.81 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.825 2.05 . . . . 0.0 114.884 -177.626 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 21' ' ' PHE . . . 86.2 8.4 78.44 Favored Glycine 0 C--N 1.296 -1.654 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.613 179.562 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.487 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 53.0 m-80 -125.89 134.29 51.65 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.34 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -79.6 118.38 21.39 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.381 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.643 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.3 m-85 -105.67 109.58 21.6 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.877 0.846 . . . . 0.0 111.323 -178.522 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.416 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 31.6 mt-10 -86.75 -15.91 37.96 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.079 -179.874 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 p -128.23 179.56 5.55 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.168 179.058 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.0 m -66.42 160.45 24.82 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.891 178.963 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.605 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 10.6 t -136.62 170.95 15.23 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.021 -179.509 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.3 p -123.59 15.25 9.52 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 177.023 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.486 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -60.59 140.5 57.37 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.41 -179.893 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.25 -7.55 16.71 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.528 -179.837 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.2 mtp85 . . . . . 0 N--CA 1.449 -0.476 0 CA-C-O 120.901 0.381 . . . . 0.0 110.842 -179.8 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt . . . . . 0 CA--C 1.521 -0.166 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -101.42 148.38 25.24 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 176.616 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.684 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.8 p-90 -135.63 -167.94 2.11 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.193 0.52 . . . . 0.0 111.701 -177.89 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.0 p -162.71 142.39 9.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.253 178.851 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' A' ' 19' ' ' PHE . . . -73.39 150.78 41.51 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.927 -179.223 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.1 p -100.34 14.76 29.98 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.332 179.373 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.1 p -136.18 154.34 50.98 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.819 179.104 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.94 -41.03 95.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.079 0.466 . . . . 0.0 110.512 -179.814 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -118.31 111.87 19.31 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.58 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.783 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 76.8 t80 -79.62 -28.96 40.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.381 -177.626 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -57.76 -38.26 75.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.053 0.454 . . . . 0.0 112.013 -179.55 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -79.32 -61.05 2.13 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.578 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -81.74 -25.72 35.15 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.763 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.8 mtm180 48.81 45.56 22.07 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -110.97 118.78 37.01 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.277 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.783 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 17.1 p-90 -130.37 174.54 9.76 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -174.645 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.8 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -168.24 142.83 7.71 Favored Glycine 0 C--O 1.222 -0.652 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.04 179.113 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.699 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 13.9 m-30 -59.18 160.31 6.51 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.317 0.579 . . . . 0.0 111.804 -179.396 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.9 t . . . . . 0 C--N 1.32 -0.702 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.933 179.834 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.347 0.594 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.745 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -117.98 -173.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 177.027 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.42 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 37.27 -129.67 1.23 Allowed Glycine 0 CA--C 1.523 0.578 0 O-C-N 123.932 0.77 . . . . 0.0 113.208 178.158 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.553 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 39.96 -145.47 0.34 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 177.081 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 114.915 -0.642 . . . . 0.0 110.639 179.86 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.188 0 CA-C-O 120.929 0.395 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -86.36 174.69 5.9 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.028 2.485 . . . . 0.0 111.987 179.281 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.6 m -79.36 137.8 37.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.619 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 65.9 t -102.31 113.33 38.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.642 0.258 . . . . 0.0 110.323 179.633 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.616 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 36.6 m-85 -117.53 137.48 24.21 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-O 120.838 0.351 . . . . 0.0 111.237 -179.632 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.687 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 37.7 Cg_endo -87.04 138.88 20.09 Favored 'Cis proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.659 -1.809 . . . . 0.0 112.339 -0.744 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.616 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 34.2 p90 -105.1 -169.03 1.55 Allowed 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.041 178.121 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.464 ' OG1' ' HD2' ' A' ' 25' ' ' LYS . 86.5 m -145.81 124.05 12.25 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.738 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.811 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 66.0 t80 -116.6 129.36 56.12 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.812 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.555 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.8 mm? 33.92 45.18 0.1 Allowed 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 125.114 1.509 . . . . 0.0 113.619 175.583 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.54 -16.94 51.53 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 116.459 1.344 . . . . 0.0 116.459 178.002 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.46 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 54.1 m-80 -110.93 135.64 51.15 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 119.929 1.864 . . . . 0.0 112.73 -177.958 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.464 ' HD2' ' OG1' ' A' ' 20' ' ' THR . 12.3 mmmm -76.33 120.69 21.92 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.853 178.844 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.811 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.5 m-30 -112.83 118.75 35.81 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.646 0.736 . . . . 0.0 111.275 179.919 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.687 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 38.8 mt-10 -97.9 -12.71 21.78 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.999 179.798 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 p -130.66 -174.28 3.31 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.608 179.086 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.9 m -70.93 165.51 23.2 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.724 179.091 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -146.16 171.18 15.31 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.343 -178.715 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.494 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 66.0 p -123.35 18.68 9.79 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 177.061 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.69 134.62 56.36 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.872 -179.424 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.53 -3.15 60.47 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.377 -179.611 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.569 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.6 mtp85 . . . . . 0 N--CA 1.446 -0.66 0 CA-C-O 121.026 0.441 . . . . 0.0 111.182 -179.757 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.569 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 14.7 mmtp . . . . . 0 CA--C 1.518 -0.252 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.494 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 73.7 mtp -76.87 138.03 39.52 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.138 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.661 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.6 p-90 -121.85 -163.6 1.08 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.51 0.672 . . . . 0.0 111.941 -178.006 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 7.4 p -160.79 140.57 10.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.634 -179.722 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -72.68 149.38 43.87 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.113 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.4 p -104.34 13.51 31.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.465 0.65 . . . . 0.0 110.16 179.728 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.9 p -135.36 154.34 51.53 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.692 178.48 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.26 -43.37 98.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.844 0.354 . . . . 0.0 110.909 -179.809 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -117.97 106.97 13.49 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.693 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 1.003 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 25.5 t80 -77.17 -31.64 55.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.707 -179.142 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.27 -36.52 14.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.878 0.371 . . . . 0.0 111.799 179.631 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.13 -57.29 2.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -178.25 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.09 -27.4 60.87 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -176.771 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.5 mtm180 44.33 49.4 8.0 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 179.0 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -114.7 120.89 41.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.608 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 1.003 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.7 p-90 -128.47 172.85 10.74 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -175.312 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.553 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -163.82 143.96 9.06 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.737 179.751 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.745 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 10.9 m-30 -60.99 155.13 20.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 118.139 0.969 . . . . 0.0 111.864 -179.394 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.508 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 14.8 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.472 179.228 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.449 -0.508 0 CA-C-O 121.672 0.748 . . . . 0.0 112.175 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -130.79 162.81 38.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.998 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 177.652 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.809 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 69.07 -148.13 47.26 Favored Glycine 0 C--N 1.312 -0.766 0 C-N-CA 117.565 -2.255 . . . . 0.0 111.413 -179.251 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.654 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 41.58 -140.49 1.54 Allowed Glycine 0 CA--C 1.52 0.347 0 N-CA-C 115.623 1.009 . . . . 0.0 115.623 177.219 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 p30 . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.79 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.817 0.341 . . . . 0.0 111.401 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -85.73 164.98 10.48 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.147 2.565 . . . . 0.0 111.718 178.871 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.8 m -72.31 136.75 46.31 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.499 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.85 95.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.743 0.306 . . . . 0.0 111.564 -179.874 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.606 ' CE1' ' HE1' ' A' ' 19' ' ' PHE . 9.2 m-85 -96.61 146.41 31.26 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-O 121.416 0.627 . . . . 0.0 111.412 177.886 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.842 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.1 Cg_endo -83.44 131.3 17.52 Favored 'Cis proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.32 -1.95 . . . . 0.0 111.896 -0.507 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.606 ' HE1' ' CE1' ' A' ' 17' ' ' PHE . 0.6 OUTLIER -85.84 -160.37 0.53 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.056 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 47' ' ' TYR . 1.8 m -144.14 120.81 11.15 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -178.706 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.942 ' HB3' HD22 ' A' ' 22' ' ' LEU 0.53 0.5 OUTLIER -127.16 123.66 37.23 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 119.949 3.314 . . . . 0.0 119.949 175.152 . . . . . . . . 4 4 . 1 . 040 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.942 HD22 ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER 26.26 52.75 0.03 OUTLIER 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 108.912 -3.767 . . . . 0.0 112.92 174.723 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.51 -4.53 56.73 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 114.213 -1.358 . . . . 0.0 115.174 178.333 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.907 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 3.5 m-80 -126.16 141.6 51.87 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 118.572 1.186 . . . . 0.0 112.944 -177.779 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.409 ' HB3' ' NZ ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -81.17 119.27 23.38 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.226 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.907 ' CE1' ' HB2' ' A' ' 24' ' ' ASN . 14.2 m-30 -97.0 95.22 7.66 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.459 1.123 . . . . 0.0 111.779 -177.224 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.842 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 39.7 mt-10 -78.45 -13.12 59.98 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 113.18 -1.827 . . . . 0.0 111.877 -178.466 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p -134.01 178.65 6.79 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.721 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 98.5 m -64.88 163.07 15.05 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 119.496 -0.882 . . . . 0.0 108.8 178.172 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.2 t -141.24 177.4 8.12 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.755 -179.609 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 p -126.64 10.56 7.2 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.698 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.83 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.04 146.92 45.45 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.504 179.094 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.33 -10.99 7.15 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.229 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.546 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 21.2 mtp85 . . . . . 0 N--CA 1.451 -0.389 0 O-C-N 122.642 -0.328 . . . . 0.0 111.362 -179.86 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.546 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 3.7 mptt . . . . . 0 CA--C 1.518 -0.279 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.0 mtm -85.39 153.72 22.33 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.341 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.681 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 17.7 p-90 -132.64 -173.48 3.19 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.399 0.619 . . . . 0.0 110.92 -178.94 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.55 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 6.4 p -154.66 134.31 12.79 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.722 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.575 ' HB3' ' CB ' ' A' ' 19' ' ' PHE . . . -73.05 149.22 43.37 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.277 -179.231 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.3 p -101.07 15.68 27.9 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.608 0.718 . . . . 0.0 109.48 179.774 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 p -136.77 142.19 42.97 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.236 178.794 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -52.22 -30.77 28.94 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.363 0.414 . . . . 0.0 111.85 -179.639 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -128.18 119.27 24.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.334 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.901 ' CE2' ' HB3' ' A' ' 53' ' ' TRP . 42.8 t80 -86.23 -52.17 5.82 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.936 -178.205 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.52 -32.76 0.59 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 179.647 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.5 -60.83 1.95 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.074 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.411 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 24.3 m-20 -84.17 -25.11 29.82 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.027 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 8.4 mtm180 49.81 46.13 24.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 179.553 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.411 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 39.1 mtpt -113.56 115.34 27.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.149 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.901 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 15.4 p-90 -126.67 177.62 6.43 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.336 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.451 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -166.77 138.99 5.49 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 112.873 -1.967 . . . . 0.0 108.986 178.852 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.809 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 16.1 m-85 -59.2 150.83 24.44 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 117.62 0.71 . . . . 0.0 111.273 -179.967 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.492 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 6.1 t . . . . . 0 C--N 1.33 -0.279 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.818 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.447 -0.621 0 CA-C-O 122.114 0.959 . . . . 0.0 113.145 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -129.95 159.63 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 177.618 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.899 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.4 -154.08 51.99 Favored Glycine 0 C--N 1.307 -1.069 0 C-N-CA 117.126 -2.464 . . . . 0.0 110.664 -178.818 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.615 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 44.43 -139.13 4.56 Favored Glycine 0 C--O 1.236 0.227 0 N-CA-C 114.773 0.669 . . . . 0.0 114.773 177.004 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.475 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 CA--C 1.531 0.226 0 CA-C-O 120.355 0.121 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 12.6 Cg_exo -67.44 148.71 79.7 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.984 2.456 . . . . 0.0 112.352 179.796 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 90.5 m -79.24 122.35 26.2 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.488 179.458 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.1 t -82.15 119.8 32.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.954 -179.827 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.5 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 57.3 m-85 -119.73 135.81 24.41 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.746 179.755 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.811 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 5.3 Cg_endo -87.95 132.2 11.78 Favored 'Cis proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.273 -1.553 . . . . 0.0 112.251 -0.15 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.639 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 20.8 p90 -91.84 -170.28 2.52 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.651 -0.82 . . . . 0.0 108.908 177.98 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.8 m -144.9 125.64 14.24 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.657 -178.707 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.841 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -132.2 143.65 50.1 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.91 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.76 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.33 38.2 0.33 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.526 1.13 . . . . 0.0 113.457 178.207 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 -6.6 83.39 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 115.311 0.884 . . . . 0.0 115.311 178.296 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.45 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 66.5 m-80 -112.11 136.26 51.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 118.455 1.127 . . . . 0.0 112.013 -178.78 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -79.06 127.86 32.53 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.674 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.841 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.1 m-30 -110.38 111.88 23.45 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 121.709 0.766 . . . . 0.0 111.205 -178.969 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.811 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 36.7 mt-10 -91.17 -11.99 36.74 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.555 -179.768 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 p -133.53 178.87 6.58 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.978 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.3 m -65.92 156.08 34.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.484 179.067 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.3 t -131.88 175.56 9.11 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.11 -179.2 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.2 p -129.15 15.85 6.19 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.35 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.617 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -59.39 141.03 55.54 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.716 -179.74 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.02 -10.99 8.31 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.226 -179.952 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.512 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 25.5 mtp85 . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 120.722 0.296 . . . . 0.0 110.832 -179.992 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.512 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 4.7 mptt . . . . . 0 C--O 1.233 0.185 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -94.0 156.22 16.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.592 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.65 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 23.4 p-90 -142.98 -169.13 2.95 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.032 0.444 . . . . 0.0 110.986 -178.949 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.6 p -161.37 143.95 12.23 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.162 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.43 153.62 35.49 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.891 0.377 . . . . 0.0 110.888 -178.973 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.5 p -102.83 8.13 39.33 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.58 0.705 . . . . 0.0 109.731 179.644 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.6 p -132.55 153.69 50.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.948 178.928 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.46 94.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.432 179.972 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -113.93 109.48 18.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.765 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.859 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 82.9 t80 -83.06 -31.59 27.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.935 -178.419 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -53.18 -37.12 61.65 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.613 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.8 -66.81 0.86 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -68.05 -29.88 68.96 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.439 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.6 mmm180 47.39 46.67 17.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 179.711 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -110.46 117.31 33.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.708 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.859 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.0 p-90 -127.4 -177.52 4.11 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -174.853 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.615 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -174.03 139.85 5.19 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 113.625 -1.625 . . . . 0.0 109.885 179.375 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.899 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.7 m-85 -61.15 152.72 27.79 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.407 0.622 . . . . 0.0 112.165 -179.437 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.438 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.4 t . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.441 179.702 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 13' ' ' ALA . 20.7 p . . . . . 0 N--CA 1.442 -0.854 0 CA-C-O 122.331 1.063 . . . . 0.0 113.515 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -128.82 162.98 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 103.456 -2.794 . . . . 0.0 103.456 176.578 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.767 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.24 -142.47 42.9 Favored Glycine 0 C--N 1.308 -0.983 0 C-N-CA 117.392 -2.337 . . . . 0.0 111.45 -179.205 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.626 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 38.08 -143.81 0.23 Allowed Glycine 0 N--CA 1.467 0.733 0 N-CA-C 116.34 1.296 . . . . 0.0 116.34 177.12 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 . . . . . 0 N--CA 1.465 0.319 0 CA-C-N 115.203 -0.498 . . . . 0.0 111.018 -179.274 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 5' ' ' THR . . . . . . . . 0 C--O 1.223 -0.298 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -81.08 128.14 6.34 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 121.777 1.651 . . . . 0.0 112.212 179.642 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 91.2 m -62.46 126.78 28.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.174 179.8 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 58.2 t -91.86 123.59 44.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.743 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.619 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 59.7 m-85 -118.76 141.03 29.3 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.14 178.925 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.99 134.11 21.28 Favored 'Cis proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.631 -1.404 . . . . 0.0 112.201 -0.492 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.619 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 28.5 p90 -105.06 128.03 53.15 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.281 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.0 m -89.63 123.34 33.6 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.755 -178.892 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.754 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 66.4 t80 -117.11 131.33 56.93 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.402 178.949 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.516 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.6 mm? 35.85 46.08 0.32 Allowed 'General case' 0 N--CA 1.427 -1.593 0 O-C-N 124.722 1.263 . . . . 0.0 113.576 175.892 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.02 -15.46 62.52 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 114.489 -1.232 . . . . 0.0 115.872 177.83 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.581 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 61.0 m-80 -111.72 135.17 52.68 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.838 1.819 . . . . 0.0 112.014 -178.376 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -78.9 121.58 25.03 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.411 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.754 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.5 m-30 -108.9 113.97 27.33 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.628 0.728 . . . . 0.0 111.556 -178.2 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -90.13 -17.33 27.85 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.482 179.481 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.2 p -127.75 -174.51 3.21 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.74 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.2 m -68.57 169.53 10.84 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.991 178.82 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.405 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.6 t -146.47 174.02 11.77 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.016 0.436 . . . . 0.0 110.15 -178.88 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.8 p -129.63 22.57 5.47 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.694 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.9 135.7 51.45 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 113.762 -1.563 . . . . 0.0 112.108 -179.255 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.0 6.52 87.41 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.99 179.563 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.596 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 9.8 mtp85 . . . . . 0 N--CA 1.452 -0.361 0 CA-C-N 117.325 0.562 . . . . 0.0 111.489 -179.645 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.596 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 17.7 mmtp . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.6 mtm -65.62 144.31 57.03 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.474 -0.49 . . . . 0.0 109.788 -179.664 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.688 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 19.0 p-90 -133.4 -169.05 2.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.394 -178.839 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.5 p -162.53 144.34 10.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.452 178.357 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.456 ' CB ' ' HD2' ' A' ' 47' ' ' TYR . . . -73.91 157.03 37.02 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.261 0.553 . . . . 0.0 110.926 -179.109 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.7 p -106.28 9.66 31.94 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.863 -179.803 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.2 p -131.88 151.17 51.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.24 178.785 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.42 -37.45 72.79 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.066 0.46 . . . . 0.0 110.891 -179.784 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -123.93 115.12 20.74 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.186 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.953 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 33.6 t80 -80.73 -31.08 36.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.878 -178.116 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -53.16 -35.71 60.09 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.64 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -84.42 -67.15 0.82 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.074 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -73.29 -27.6 61.63 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -177.275 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.661 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.6 mtm180 47.56 48.14 17.09 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.971 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -112.32 122.91 49.06 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.44 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.953 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 11.7 p-90 -131.51 174.53 10.0 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -175.778 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.626 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -169.23 141.1 6.49 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.725 178.77 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.767 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.4 m-85 -55.42 151.9 9.49 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.443 0.639 . . . . 0.0 111.632 -179.82 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.632 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 18.0 t . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.632 -179.696 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.461 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 50.4 p . . . . . 0 C--O 1.236 0.358 0 CA-C-O 121.649 0.738 . . . . 0.0 112.539 . . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.483 HG13 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -122.6 -53.22 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.966 0 CA-C-O 123.425 1.583 . . . . 0.0 108.545 179.232 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.816 ' H ' ' HB2' ' A' ' 55' ' ' PHE . . . -83.49 -164.25 36.18 Favored Glycine 0 C--N 1.279 -2.627 0 CA-C-N 110.503 -3.044 . . . . 0.0 111.622 178.919 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.609 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 75.94 -175.04 52.55 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.344 -0.932 . . . . 0.0 113.338 178.573 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 120.57 0.224 . . . . 0.0 111.255 179.542 . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -81.17 148.89 17.06 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.174 1.916 . . . . 0.0 111.957 -179.787 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 88.0 m -80.26 138.78 36.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.746 0.308 . . . . 0.0 110.665 -179.967 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.436 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 84.9 t -99.01 125.54 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.119 -179.711 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.425 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 48.5 m-85 -124.81 139.21 32.88 Favored Pre-proline 0 N--CA 1.445 -0.707 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.958 -179.806 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -86.5 135.85 18.13 Favored 'Cis proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.558 -1.851 . . . . 0.0 111.862 -0.458 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.691 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 45.1 p90 -101.47 -171.11 1.93 Allowed 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.476 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 m -146.85 124.77 11.98 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.673 -179.022 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.861 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 63.2 t80 -118.03 130.43 56.16 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.492 179.8 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.561 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.7 mm? 33.74 45.09 0.09 Allowed 'General case' 0 N--CA 1.427 -1.611 0 O-C-N 125.075 1.484 . . . . 0.0 114.108 175.233 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.45 -15.82 49.39 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 115.903 1.121 . . . . 0.0 115.903 177.887 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.543 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 28.3 m-80 -115.82 134.84 54.59 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.789 1.795 . . . . 0.0 112.116 -178.425 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -80.53 126.37 31.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.723 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.861 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.9 m-85 -113.7 123.52 50.1 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.661 0.743 . . . . 0.0 111.531 -178.812 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -93.98 -20.83 19.61 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.181 179.926 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 p -128.38 -173.29 2.91 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.858 179.004 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 70.9 m -65.62 161.97 19.32 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.339 178.726 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -138.63 168.68 19.26 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.322 -178.461 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.2 p -124.76 23.37 7.99 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.056 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.53 136.57 57.65 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 113.912 -1.495 . . . . 0.0 111.591 -179.781 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.69 -6.3 54.37 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.727 -179.126 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.589 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.8 mtp85 . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 120.682 0.277 . . . . 0.0 110.356 179.809 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.589 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 37.6 mttp . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.9 mtm -98.76 151.35 20.87 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.064 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.7 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 28.6 p-90 -141.4 -170.23 3.04 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.035 0.445 . . . . 0.0 111.102 -178.1 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.56 149.42 11.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.277 178.461 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.468 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -73.25 148.15 43.94 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.787 -179.281 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 69.6 p -100.41 8.06 43.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.663 0.744 . . . . 0.0 109.842 179.382 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.4 p -130.88 157.97 41.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.799 -1.092 . . . . 0.0 109.112 178.542 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.65 -39.54 80.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.912 0.387 . . . . 0.0 111.144 -179.54 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -125.41 114.09 18.39 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.001 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.874 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 58.9 t80 -69.82 -40.62 75.78 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.361 -177.936 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.13 -33.19 51.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.951 0.405 . . . . 0.0 111.933 -179.117 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.29 -68.42 0.53 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.194 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.99 -18.76 29.92 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -176.819 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 24.7 mtm-85 44.4 53.79 6.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 179.434 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -117.75 118.85 33.17 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.549 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.874 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.8 p-90 -127.53 170.47 12.57 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 122.078 0.942 . . . . 0.0 113.365 -175.537 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.609 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.44 147.95 13.2 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.411 179.275 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.816 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 7.0 m-30 -64.0 160.67 17.39 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.519 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.418 179.987 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.444 -0.757 0 CA-C-O 122.234 1.016 . . . . 0.0 113.267 . . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.712 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -118.84 -166.8 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 176.948 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 35.58 -126.19 0.76 Allowed Glycine 0 N--CA 1.465 0.568 0 O-C-N 124.007 0.817 . . . . 0.0 113.065 177.842 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.613 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 34.05 -139.29 0.14 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 115.248 0.859 . . . . 0.0 115.248 177.384 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.056 0.455 . . . . 0.0 110.827 179.252 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.22 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -84.94 160.1 11.79 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.434 2.089 . . . . 0.0 112.344 -179.684 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.7 m -89.52 130.9 35.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.619 179.66 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -89.68 120.57 38.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.842 -179.866 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.611 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 65.2 m-85 -116.1 139.0 24.58 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-O 120.772 0.32 . . . . 0.0 110.767 179.908 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -87.05 136.84 17.72 Favored 'Cis proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.615 -1.827 . . . . 0.0 112.636 -0.135 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.611 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 26.3 p90 -101.2 129.05 47.06 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.096 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 98.9 m -92.62 123.71 36.11 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.485 0.659 . . . . 0.0 112.496 -177.972 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.904 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.5 t80 -126.42 145.46 50.46 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.714 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.694 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.28 36.59 0.2 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.442 1.097 . . . . 0.0 113.384 179.185 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.8 -2.43 87.19 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 114.85 0.7 . . . . 0.0 114.85 178.637 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.59 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 45.2 m-20 -111.33 135.74 51.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.265 1.033 . . . . 0.0 111.95 -179.007 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -81.45 118.05 22.38 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.379 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.904 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.5 m-30 -101.82 113.06 25.92 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.844 0.831 . . . . 0.0 111.492 -178.553 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -86.98 -20.56 27.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.127 179.646 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -126.44 179.66 5.19 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.37 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.1 m -64.77 162.93 15.06 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.779 179.321 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.6 t -137.48 169.34 17.95 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.222 -178.738 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.584 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 41.8 p -121.61 15.76 11.13 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.894 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.567 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.09 142.56 56.59 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.936 179.72 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.51 -16.27 6.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.893 -179.482 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 . . . . . 0 N--CA 1.445 -0.686 0 CA-C-O 120.753 0.311 . . . . 0.0 110.465 179.681 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 38' ' ' LYS . 3.1 mptt . . . . . 0 C--O 1.234 0.265 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 . . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.584 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 3.5 mpp? -99.63 153.46 19.05 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.569 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.668 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 22.0 p-90 -138.1 -168.78 2.43 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.084 0.469 . . . . 0.0 110.77 -178.815 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.3 p -163.16 141.1 7.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.39 177.826 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.88 148.53 46.02 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.304 0.573 . . . . 0.0 110.929 -178.662 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 43.9 p -98.31 11.96 36.31 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.092 179.215 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.4 p -131.01 155.19 47.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.974 179.265 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -62.02 -40.06 94.43 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.915 0.388 . . . . 0.0 110.913 -179.995 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -120.11 111.89 18.43 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.802 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.833 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 74.7 t80 -82.18 -31.62 30.33 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.072 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -57.03 -33.29 67.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.127 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -92.35 -56.05 3.18 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.153 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -74.75 -26.89 60.09 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.544 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 12.8 mtm180 43.46 50.67 6.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 179.576 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -119.61 120.35 36.41 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.432 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.833 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.4 p-90 -133.98 177.68 7.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -173.99 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.607 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -169.27 146.24 10.03 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.724 178.82 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.712 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.3 m-30 -60.29 157.78 12.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.606 0.703 . . . . 0.0 111.725 -179.08 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.468 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.5 t . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.529 -179.844 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.711 HG22 ' SG ' ' A' ' 41' ' ' CYS . 50.1 p . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 . . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.861 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -129.18 -160.47 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.668 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 34.4 -123.1 0.46 Allowed Glycine 0 N--CA 1.464 0.51 0 O-C-N 124.105 0.878 . . . . 0.0 113.182 177.679 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.551 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 34.45 -144.68 0.05 OUTLIER Glycine 0 C--N 1.337 0.615 0 N-CA-C 116.097 1.199 . . . . 0.0 116.097 177.062 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 114.844 -0.678 . . . . 0.0 110.093 179.732 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 5' ' ' THR . . . . . . . . 0 C--O 1.222 -0.364 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 . . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -65.08 131.82 29.93 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.202 1.935 . . . . 0.0 111.768 179.666 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.8 m -66.04 135.37 54.56 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.811 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 86.8 t -98.83 113.65 34.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.648 0.261 . . . . 0.0 111.109 179.871 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.502 ' CE2' ' HB2' ' A' ' 15' ' ' CYS . 99.4 m-85 -112.84 143.22 28.63 Favored Pre-proline 0 N--CA 1.446 -0.665 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.287 179.172 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -85.45 133.57 17.48 Favored 'Cis proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.38 -1.508 . . . . 0.0 112.034 -0.174 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.672 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 46.7 p90 -105.5 130.77 53.5 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.436 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.9 m -95.75 128.51 42.69 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -176.974 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.897 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.2 t80 -132.53 146.6 52.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.68 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.745 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.51 37.4 0.29 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.557 1.143 . . . . 0.0 113.466 178.535 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.14 -6.06 82.5 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 114.606 0.602 . . . . 0.0 114.606 178.929 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -111.73 133.25 54.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.351 1.075 . . . . 0.0 112.057 -178.721 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -79.03 122.81 26.66 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.889 179.187 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.897 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.5 m-85 -106.15 114.52 28.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.784 0.802 . . . . 0.0 111.504 -178.361 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -93.56 -15.65 25.23 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.288 179.434 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.3 p -130.34 178.58 6.48 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.015 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.5 m -60.9 163.69 5.55 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.566 0.698 . . . . 0.0 110.648 179.274 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.0 t -144.71 169.41 18.07 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.253 179.908 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.562 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 15.7 p -125.7 23.78 7.28 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.066 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.93 140.4 58.31 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 113.969 -1.468 . . . . 0.0 111.015 -179.944 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.02 -8.9 13.42 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.723 -179.452 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.6 mtp85 . . . . . 0 N--CA 1.448 -0.571 0 CA-C-O 120.972 0.415 . . . . 0.0 110.663 -179.699 . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.596 ' N ' ' HD2' ' A' ' 38' ' ' LYS . 8.3 mptt . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 120.79 0.329 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.562 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 61.8 mtt -98.63 160.33 14.35 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.306 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.652 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 20.1 p-90 -144.08 -173.27 3.96 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.544 0.688 . . . . 0.0 111.974 -178.981 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.711 ' SG ' HG22 ' A' ' 5' ' ' THR . 8.5 p -154.81 138.57 16.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.959 -1.018 . . . . 0.0 108.85 179.769 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.466 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -76.45 153.82 35.28 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.333 179.961 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.4 p -104.55 14.29 30.21 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.851 0.834 . . . . 0.0 110.015 -179.694 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.9 p -137.3 147.5 45.69 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.592 178.89 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.668 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -51.63 -43.77 62.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.929 0.395 . . . . 0.0 111.4 -179.688 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -119.38 107.43 13.35 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.909 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.818 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 79.7 t80 -71.86 -32.04 67.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.364 -178.027 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.704 ' HA ' ' NH1' ' A' ' 51' ' ' ARG . 25.8 m-20 -66.26 -25.45 66.89 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.016 0.436 . . . . 0.0 111.523 -179.764 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -84.4 -58.99 2.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.374 -179.634 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -87.84 -19.4 27.49 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -176.681 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.704 ' NH1' ' HA ' ' A' ' 48' ' ' ASP . 7.8 mtt-85 45.97 51.0 11.1 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 179.978 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -119.84 121.76 39.81 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 176.443 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.818 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.5 p-90 -136.59 176.92 8.26 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -175.597 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.529 ' HA3' ' HB ' ' A' ' 5' ' ' THR . . . -170.07 149.14 12.5 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.289 178.237 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.861 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.6 m-30 -64.72 165.71 9.96 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.859 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 37.8 m . . . . . 0 C--N 1.325 -0.491 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 176.42 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.478 0.656 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.824 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -107.94 -168.13 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 176.793 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.56 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 40.05 -123.23 2.03 Favored Glycine 0 N--CA 1.46 0.288 0 O-C-N 123.827 0.704 . . . . 0.0 113.116 177.829 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.659 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 32.19 -143.13 0.03 OUTLIER Glycine 0 C--N 1.336 0.529 0 N-CA-C 116.836 1.495 . . . . 0.0 116.836 177.065 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 114.597 -0.801 . . . . 0.0 110.6 179.961 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 CA--C 1.521 -0.147 0 CA-C-O 120.768 0.318 . . . . 0.0 111.526 . . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 60.1 Cg_endo -88.38 178.61 2.9 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.133 2.556 . . . . 0.0 111.812 179.475 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.6 m -81.8 149.03 28.56 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.53 -179.88 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.6 t -115.94 118.41 58.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.516 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.615 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 59.6 m-85 -121.11 143.59 37.47 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-O 121.019 0.437 . . . . 0.0 111.878 -179.084 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.804 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 8.6 Cg_endo -87.5 135.99 15.96 Favored 'Cis proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.029 -1.655 . . . . 0.0 111.6 -0.817 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.66 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 37.6 p90 -103.02 -169.88 1.72 Allowed 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.208 178.647 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.434 ' OG1' ' HD3' ' A' ' 25' ' ' LYS . 63.6 m -147.54 126.89 13.09 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.53 -179.505 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.88 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 59.8 t80 -123.87 133.45 53.76 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.12 179.383 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.549 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 35.38 48.28 0.39 Allowed 'General case' 0 N--CA 1.427 -1.603 0 O-C-N 124.713 1.258 . . . . 0.0 113.711 175.451 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.73 -11.09 71.75 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 116.334 1.294 . . . . 0.0 116.334 177.763 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.409 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 53.7 m-80 -115.61 135.14 54.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 119.555 1.677 . . . . 0.0 112.53 -178.351 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HD3' ' OG1' ' A' ' 20' ' ' THR . 65.5 mmtt -76.44 125.15 28.7 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.943 178.875 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.88 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.8 m-85 -115.58 118.37 32.95 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.567 0.698 . . . . 0.0 111.067 -179.985 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.804 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 49.9 mt-10 -96.28 -16.08 21.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.101 179.573 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.9 p -126.19 -177.37 3.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.138 178.233 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.2 m -67.87 165.73 17.0 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.413 178.762 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 t -142.91 173.03 11.91 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.075 -178.704 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.535 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 57.8 p -129.02 22.82 5.7 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.37 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.464 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -62.92 141.05 58.87 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 114.012 -1.449 . . . . 0.0 112.35 -179.069 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.68 -1.71 36.02 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.728 179.56 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.778 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 8.4 mtp85 . . . . . 0 N--CA 1.448 -0.543 0 CA-C-O 120.829 0.347 . . . . 0.0 110.858 -179.721 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.778 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 76.7 mttt . . . . . 0 N--CA 1.461 0.123 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 . . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.535 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.5 mpt? -87.58 141.96 28.21 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.688 179.214 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 13.0 p-90 -129.99 -162.78 1.24 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.176 -178.856 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.3 p -163.58 151.09 12.71 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.75 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.445 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -83.11 144.99 29.5 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.294 179.417 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 79.6 p -99.95 13.21 34.7 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.945 0.878 . . . . 0.0 109.704 179.919 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.6 p -137.04 151.08 48.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.94 178.598 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.29 -40.95 78.86 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.891 0.377 . . . . 0.0 111.478 -179.387 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -123.71 109.84 14.2 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.599 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 1.07 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 23.7 t80 -75.83 -34.51 60.11 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.703 -178.492 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -50.75 -34.75 28.43 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.474 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -96.39 -52.69 3.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.464 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.39 -26.2 35.65 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.021 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 13.5 mtm180 45.36 50.65 9.89 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 179.117 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -114.66 121.82 44.56 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.14 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 1.07 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 12.2 p-90 -128.7 173.35 10.39 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -175.699 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.431 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.94 140.5 6.26 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.543 179.601 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.824 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 8.3 m-30 -60.16 153.29 22.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.783 0.791 . . . . 0.0 111.183 -179.661 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.46 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.7 t . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.706 -179.983 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.3 p . . . . . 0 C--O 1.236 0.348 0 CA-C-O 122.348 1.071 . . . . 0.0 113.126 . . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.531 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -142.58 161.8 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 178.587 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.589 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 65.5 -149.82 51.67 Favored Glycine 0 C--N 1.313 -0.695 0 C-N-CA 117.958 -2.068 . . . . 0.0 111.157 -179.453 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.713 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 50.58 -152.2 4.68 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 114.778 0.671 . . . . 0.0 114.778 177.802 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.0 p30 . . . . . 0 C--N 1.328 -0.369 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.924 . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.261 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.35 147.29 18.02 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.01 1.807 . . . . 0.0 112.466 -179.891 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.2 m -78.03 115.69 17.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.504 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 55.3 t -79.83 108.83 13.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.91 0.386 . . . . 0.0 110.616 -179.604 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -109.72 138.51 20.68 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.969 -179.614 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.762 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 58.4 Cg_endo -85.34 138.58 25.6 Favored 'Cis proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.834 -1.736 . . . . 0.0 112.895 -0.327 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.605 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 35.1 p90 -105.55 132.65 51.45 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.184 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 90.3 m -93.78 128.46 40.02 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.412 0.625 . . . . 0.0 112.394 -177.57 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.748 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -130.69 142.71 50.44 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.596 -1.184 . . . . 0.0 107.83 178.166 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.747 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.37 39.54 0.3 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.757 1.223 . . . . 0.0 113.497 178.17 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.32 -5.67 84.69 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 114.859 0.704 . . . . 0.0 114.859 178.419 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.691 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 50.8 m-20 -110.76 136.39 49.91 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 118.448 1.124 . . . . 0.0 111.511 -178.723 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -82.04 120.03 24.75 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.805 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.748 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.5 m-30 -102.96 110.29 22.15 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.594 0.711 . . . . 0.0 111.38 -177.621 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.762 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 94.5 mt-10 -91.5 -4.86 55.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.131 -179.69 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.3 p -140.96 -171.43 3.25 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.325 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 87.3 m -69.65 166.17 19.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.939 178.882 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.513 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 14.1 t -146.38 175.72 10.32 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.665 -179.489 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.3 p -130.94 20.98 4.95 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.382 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.601 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -66.74 143.03 57.18 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 113.918 -1.492 . . . . 0.0 112.215 -179.346 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.33 2.27 47.7 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.659 178.67 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.691 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.5 mtp85 . . . . . 0 N--CA 1.448 -0.546 0 CA-C-N 117.349 0.574 . . . . 0.0 111.412 -179.493 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.691 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 24.9 mmtm . . . . . 0 CA--C 1.521 -0.148 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 52.1 mtm -85.49 144.08 28.16 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 179.303 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.637 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.2 p-90 -135.78 -168.6 2.24 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.371 0.605 . . . . 0.0 112.121 -177.819 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 23.8 p -153.05 138.95 18.06 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.166 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.536 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -77.97 146.73 35.28 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.795 179.97 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.2 p -101.04 17.64 21.84 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.833 0.825 . . . . 0.0 110.203 -179.695 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.89 152.97 50.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.856 178.643 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -60.19 -39.57 86.98 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.206 0.527 . . . . 0.0 111.188 -179.665 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -122.18 107.84 12.61 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.582 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.791 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 64.2 t80 -74.71 -30.44 61.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.852 -178.149 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -55.19 -37.05 66.57 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.262 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.87 -72.23 0.49 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.823 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.74 -19.49 62.73 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -177.508 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.631 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 21.6 mtm180 41.17 53.86 3.44 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 179.886 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.408 ' HG3' ' HZ2' ' A' ' 52' ' ' LYS . 48.2 mttp -112.77 118.28 34.54 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.564 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.791 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 11.9 p-90 -133.03 171.24 14.25 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -174.667 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.713 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.14 142.04 7.78 Favored Glycine 0 C--O 1.221 -0.708 0 CA-C-N 113.122 -1.854 . . . . 0.0 109.313 178.236 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.589 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 7.9 m-30 -56.21 159.34 3.53 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.777 0.789 . . . . 0.0 111.19 179.699 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.545 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 5.5 t . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.572 179.929 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 122.196 0.998 . . . . 0.0 112.874 . . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -139.36 164.58 24.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.047 0 N-CA-C 104.667 -2.345 . . . . 0.0 104.667 179.418 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.499 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 64.91 -149.78 51.62 Favored Glycine 0 C--N 1.313 -0.701 0 C-N-CA 118.025 -2.036 . . . . 0.0 111.367 -179.733 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.632 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 51.6 -149.26 8.5 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 114.256 0.463 . . . . 0.0 114.256 177.998 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.685 -0.258 . . . . 0.0 111.147 179.697 . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 120.592 0.234 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 16.3 Cg_exo -65.7 144.49 78.27 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.604 2.203 . . . . 0.0 112.315 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.7 m -72.16 148.43 45.64 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.657 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 64.6 t -108.76 109.67 29.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.627 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.585 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 38.6 m-85 -114.69 143.09 29.33 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-O 121.229 0.538 . . . . 0.0 111.503 -179.312 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.8 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.3 Cg_endo -87.41 136.91 16.97 Favored 'Cis proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.263 -1.557 . . . . 0.0 111.469 -0.97 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.585 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 34.3 p90 -101.4 -170.77 1.88 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.27 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.8 m -148.79 127.44 12.46 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.999 -178.996 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.677 ' CG ' HD22 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -111.11 -143.73 0.39 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 118.342 -0.837 . . . . 0.0 108.915 179.111 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.677 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -49.11 55.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.916 2.086 . . . . 0.0 114.958 -177.215 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 21' ' ' PHE . . . 86.72 6.87 79.42 Favored Glycine 0 C--N 1.296 -1.651 0 CA-C-N 114.41 -1.268 . . . . 0.0 113.345 178.821 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.539 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 20.7 m-80 -127.56 135.57 50.49 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 117.862 0.831 . . . . 0.0 112.151 -178.76 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -78.75 126.64 31.0 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.26 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.626 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.9 m-85 -112.23 107.65 16.59 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 122.138 0.97 . . . . 0.0 110.91 -179.19 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.8 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 32.0 mt-10 -86.11 -19.95 29.42 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.484 -179.395 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 p -126.53 -172.99 2.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 178.386 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.5 m -68.27 160.06 30.06 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.027 179.077 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t -137.14 168.95 18.61 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.909 -179.587 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.8 p -122.82 24.55 9.02 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 122.042 0.925 . . . . 0.0 108.677 177.857 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.502 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -70.99 148.42 47.66 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.417 -179.667 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.57 -7.14 14.02 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.508 -0.769 . . . . 0.0 114.02 178.526 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.621 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 8.2 mtp-105 . . . . . 0 N--CA 1.453 -0.294 0 CA-C-N 118.2 1.0 . . . . 0.0 110.793 -179.659 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.621 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 7.5 mptt . . . . . 0 N--CA 1.447 -0.584 0 CA-C-O 121.349 0.595 . . . . 0.0 112.225 . . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -116.91 160.46 20.86 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.995 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.651 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.7 p-90 -146.87 -169.1 3.21 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.153 0.501 . . . . 0.0 110.924 -178.774 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 24.5 p -156.23 146.04 21.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.26 179.718 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.401 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -80.68 146.64 31.0 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.054 -0.659 . . . . 0.0 109.565 179.346 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.3 p -100.45 19.43 16.78 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.888 0.851 . . . . 0.0 109.479 179.458 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.4 p -141.15 153.71 45.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.101 179.067 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.86 -31.74 71.19 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.321 0.582 . . . . 0.0 111.252 -179.842 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -129.1 118.58 22.72 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.937 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.858 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 59.5 t80 -82.46 -32.96 28.63 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.856 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -52.32 -39.12 60.18 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.676 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.0 -74.49 0.26 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.82 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.474 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 45.7 m-20 -72.85 -19.74 61.25 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -176.292 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 35.4 mtm-85 40.11 55.69 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 179.709 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 50' ' ' ASP . 49.7 mtmt -114.54 120.42 40.15 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.941 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.858 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.6 p-90 -133.17 170.78 14.91 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.949 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.632 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.82 141.44 7.18 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.46 178.806 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.508 ' HD1' ' HB3' ' A' ' 40' ' ' TRP . 7.1 m-30 -56.98 162.01 2.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.263 0.554 . . . . 0.0 111.446 179.829 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.468 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 12.6 t . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.7 -178.46 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.378 0.609 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.885 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -107.43 -168.1 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 176.819 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.671 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 38.08 -127.26 1.59 Allowed Glycine 0 C--N 1.318 -0.438 0 O-C-N 123.846 0.716 . . . . 0.0 113.719 177.552 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.595 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 39.49 -149.55 0.11 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 116.115 1.206 . . . . 0.0 116.115 177.127 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 114.633 -0.784 . . . . 0.0 111.058 -179.755 . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--O 1.223 -0.294 0 CA-C-O 120.575 0.226 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 6.2 Cg_exo -72.19 172.23 15.24 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.646 2.231 . . . . 0.0 111.71 179.284 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.7 m -85.36 150.1 24.98 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.562 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.558 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 75.8 t -108.66 110.64 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.251 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -112.34 137.9 21.71 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.969 -178.995 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.7 Cg_endo -86.11 132.15 14.61 Favored 'Cis proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.485 -1.465 . . . . 0.0 112.255 -0.18 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.644 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 43.9 p90 -98.57 124.36 43.29 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.569 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 29.9 m -87.61 121.68 30.35 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.502 0.668 . . . . 0.0 112.194 -177.261 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.879 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.4 t80 -125.7 143.81 50.88 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.527 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.698 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 39.58 32.88 0.1 Allowed 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.823 1.249 . . . . 0.0 113.582 178.364 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.91 -11.73 64.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.894 -0.67 . . . . 0.0 114.767 178.604 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.6 m-80 -110.01 133.56 53.06 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 118.406 1.103 . . . . 0.0 112.425 -178.759 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -79.83 115.31 19.35 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.124 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.879 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.0 m-85 -96.97 111.99 23.95 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.908 0.861 . . . . 0.0 111.562 -177.814 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.47 -14.36 43.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.279 179.692 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.8 p -129.92 -173.54 3.06 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.828 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.5 m -71.03 167.85 18.35 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.823 178.486 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.594 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.7 t -145.55 175.33 10.43 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.13 -179.0 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.524 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 9.8 p -129.52 18.52 5.8 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.189 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.571 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -63.52 144.41 57.01 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 113.978 -1.464 . . . . 0.0 111.879 -179.715 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.3 -1.4 34.82 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.841 179.464 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.728 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 7.7 mtp85 . . . . . 0 N--CA 1.448 -0.537 0 CA-C-N 117.056 0.428 . . . . 0.0 111.58 -179.333 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.728 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 111.306 . . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.524 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 59.8 mtm -89.25 149.15 23.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.194 0.521 . . . . 0.0 110.871 -179.531 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.613 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 13.5 p-90 -138.37 -168.33 2.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.518 0.675 . . . . 0.0 112.129 -178.435 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 21.0 p -156.16 136.64 13.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.34 178.742 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -74.75 151.35 39.17 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.442 -179.599 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 64.2 p -101.51 11.21 39.42 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.712 179.675 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.9 p -135.85 151.43 50.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.459 178.757 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.87 -48.45 79.8 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.915 0.388 . . . . 0.0 111.62 -179.537 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -111.43 104.15 12.56 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.81 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.855 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 70.7 t80 -75.49 -32.27 60.5 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.532 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.78 -36.44 64.88 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.373 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -88.75 -61.7 1.65 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.504 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.89 -34.8 78.58 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.89 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 12.9 mtm-85 48.56 47.87 20.09 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.383 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -115.25 117.8 31.5 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.737 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.855 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 11.8 p-90 -131.59 175.48 9.13 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -174.21 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.403 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -164.34 142.64 7.93 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.616 178.876 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.885 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 8.7 m-85 -59.82 158.49 10.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.065 0.933 . . . . 0.0 111.417 -179.582 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.481 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 5.6 t . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.796 -179.085 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.406 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 32.8 p . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.432 0.634 . . . . 0.0 112.357 . . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.831 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -106.46 -166.26 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 176.191 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.616 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.15 -127.1 1.19 Allowed Glycine 0 C--N 1.321 -0.281 0 O-C-N 124.072 0.857 . . . . 0.0 112.994 177.774 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.605 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 31.34 -138.66 0.07 OUTLIER Glycine 0 C--N 1.336 0.537 0 N-CA-C 116.083 1.193 . . . . 0.0 116.083 176.997 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.8 p30 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 114.857 -0.671 . . . . 0.0 109.782 -179.986 . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.536 0.207 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 98.7 Cg_endo -93.41 175.06 1.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.305 2.67 . . . . 0.0 111.254 179.097 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.8 m -84.17 142.86 30.03 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.458 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 63.4 t -107.81 121.91 61.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.81 0.338 . . . . 0.0 110.216 178.962 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -121.49 144.29 39.88 Favored Pre-proline 0 N--CA 1.447 -0.616 0 CA-C-O 120.783 0.325 . . . . 0.0 111.277 -179.446 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -85.9 137.03 21.18 Favored 'Cis proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.718 -1.784 . . . . 0.0 111.698 -0.811 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.498 ' CG ' ' HB3' ' A' ' 42' ' ' ALA . 23.3 p90 -104.87 175.35 5.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.055 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 94.7 m -130.26 124.08 31.6 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.833 -179.446 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.716 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 42.5 t80 -126.26 138.78 53.65 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.907 179.029 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.545 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.4 mm? 35.27 46.42 0.25 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 175.318 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.85 -7.01 81.81 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 114.469 -1.241 . . . . 0.0 116.157 177.738 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.531 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 62.0 m-80 -109.14 155.89 20.48 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 119.286 1.543 . . . . 0.0 111.674 -179.023 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -95.84 125.34 40.34 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.405 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.716 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 28.6 m-85 -113.64 119.7 38.35 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.809 0.814 . . . . 0.0 112.072 -177.599 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -96.58 -20.53 18.26 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.385 -1.279 . . . . 0.0 110.318 179.608 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 p -130.09 -174.03 3.21 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.333 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.9 m -68.16 163.46 22.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.605 178.837 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.1 t -142.3 163.76 31.99 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.721 -178.577 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.526 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 26.2 p -116.07 20.66 14.26 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 176.487 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.1 142.14 52.26 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.432 -179.455 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.99 -7.39 9.77 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.246 179.264 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.72 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 22.4 mtp85 . . . . . 0 N--CA 1.447 -0.619 0 CA-C-N 117.035 0.417 . . . . 0.0 111.339 -179.17 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.72 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 2.0 mptp? . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 120.781 0.324 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.526 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 44.0 mtm -83.87 143.55 29.82 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.038 179.743 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.648 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.2 p-90 -128.2 -166.98 1.7 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.565 -179.716 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 9.9 p -160.39 146.41 15.26 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.744 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.498 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -78.09 142.59 38.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.115 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 78.7 p -96.17 16.48 18.04 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.436 0.636 . . . . 0.0 110.486 -179.552 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.7 p -139.63 161.11 38.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.741 179.293 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -64.24 -30.33 71.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.002 0.43 . . . . 0.0 111.196 179.946 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -132.69 115.52 15.48 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.908 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.88 ' HE1' ' HB3' ' A' ' 53' ' ' TRP . 44.5 t80 -81.23 -38.3 27.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.196 -178.883 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -47.03 -36.36 7.85 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.536 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -95.11 -56.13 2.84 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.781 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.546 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.5 m-20 -67.22 -43.17 82.68 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -177.73 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 5.3 mmm180 57.59 40.87 26.47 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 179.415 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.546 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 4.2 mppt? -114.28 122.32 46.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.586 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.88 ' HB3' ' HE1' ' A' ' 47' ' ' TYR . 11.4 p-90 -132.67 170.8 14.7 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -175.022 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.5 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.24 143.26 8.33 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.863 179.254 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.831 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.2 m-30 -61.35 156.61 18.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.969 0.885 . . . . 0.0 111.499 -179.641 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.411 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 4.3 t . . . . . 0 C--N 1.327 -0.372 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.434 ' O ' ' HG3' ' A' ' 3' ' ' MET . 58.5 p . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 120.46 0.171 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 60.05 39.22 20.08 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.358 0.599 . . . . 0.0 109.595 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 66.3 mtt -128.29 127.44 42.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.252 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.4 m -83.24 159.69 21.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 13' ' ' ALA . 11.6 p -94.99 164.66 12.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.429 1.109 . . . . 0.0 113.494 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -127.75 164.48 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 177.43 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.45 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.27 -146.6 50.46 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 117.728 -2.177 . . . . 0.0 111.1 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.645 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 46.29 -140.23 6.38 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 114.327 0.491 . . . . 0.0 114.327 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -156.22 17.24 0.35 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p -77.4 -37.66 51.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.13 0.491 . . . . 0.0 111.099 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.31 16.43 34.87 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.519 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.2 47.19 1.17 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.182 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -101.34 140.32 21.17 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.474 0.178 . . . . 0.0 110.722 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 3' ' ' MET . 37.9 Cg_exo -59.44 136.22 70.2 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.762 2.308 . . . . 0.0 112.777 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 7.2 m -67.95 128.2 35.65 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 90.1 t -95.25 112.94 28.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.643 0.259 . . . . 0.0 110.654 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.533 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 70.0 m-85 -111.51 139.96 22.61 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.264 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.2 134.51 21.51 Favored 'Cis proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.321 -1.533 . . . . 0.0 111.93 -0.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.548 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 45.8 p90 -103.59 133.57 48.4 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.93 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 76.3 m -96.53 121.32 38.21 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.349 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.755 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 45.4 t80 -115.64 130.33 56.82 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.12 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.662 HD13 ' CD1' ' A' ' 21' ' ' PHE . 6.7 mp 44.64 33.44 0.94 Allowed 'General case' 0 N--CA 1.436 -1.133 0 O-C-N 124.363 1.039 . . . . 0.0 113.685 175.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.77 -15.9 40.55 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 115.696 1.038 . . . . 0.0 115.696 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 20' ' ' THR . 62.8 m-80 -110.68 146.72 35.74 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 119.267 1.533 . . . . 0.0 112.299 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -86.76 122.17 30.27 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.755 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 28.6 m-85 -107.21 116.77 32.52 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.69 0.757 . . . . 0.0 110.63 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -92.88 -17.04 24.53 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.275 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 p -129.6 -178.12 4.55 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.28 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 81.8 m -66.6 165.23 15.11 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.706 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.421 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 9.2 t -140.4 167.64 21.66 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.314 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.485 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 12.6 p -122.03 19.65 10.8 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.86 139.66 58.34 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 113.661 -1.609 . . . . 0.0 111.263 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.95 -2.83 54.01 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.369 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.63 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.9 mtp85 -116.36 139.73 50.1 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 117.105 0.452 . . . . 0.0 110.667 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.4 m -120.12 22.35 11.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.351 0.596 . . . . 0.0 110.537 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.32 -79.84 0.53 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.006 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.5 -29.16 0.08 OUTLIER Glycine 0 C--N 1.314 -0.694 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.765 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.636 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -62.81 119.69 9.83 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.691 0.281 . . . . 0.0 111.385 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.485 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 54.4 mtt -87.91 149.66 23.95 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.633 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.4 p-90 -131.87 -166.36 1.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.13 0.49 . . . . 0.0 111.577 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 28.1 p -156.9 148.99 22.91 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.492 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -84.98 148.91 25.95 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 119.455 -0.898 . . . . 0.0 108.939 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.8 p -102.2 12.9 36.0 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.448 0.642 . . . . 0.0 110.433 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.425 HG21 ' CB ' ' A' ' 50' ' ' ASP . 76.3 p -135.89 153.97 51.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.982 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.5 85.27 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.189 0.518 . . . . 0.0 110.942 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -114.49 108.32 16.71 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 1.019 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 27.4 t80 -73.89 -35.65 64.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.009 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -48.47 -33.99 10.35 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -90.88 -64.18 1.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.709 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 19.8 m-20 -69.01 -34.27 74.98 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 9.3 mtm180 50.26 45.21 26.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.709 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 34.3 mttt -111.45 119.8 40.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 1.019 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 6.9 p-90 -132.17 173.17 11.52 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -175.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.645 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.26 144.11 8.77 Favored Glycine 0 C--O 1.22 -0.731 0 CA-C-N 113.732 -1.576 . . . . 0.0 110.284 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 14.8 m-30 -57.03 155.19 8.55 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.414 0.626 . . . . 0.0 112.099 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.572 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 16.6 t -69.65 143.7 92.98 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.295 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.572 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 87.3 Cg_endo -71.88 -149.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.938 2.425 . . . . 0.0 112.58 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -61.53 116.31 4.61 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.612 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -98.3 29.25 3.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.01 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.845 0 CA-C-O 118.339 -1.256 . . . . 0.0 112.019 179.728 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.487 0.184 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -86.71 130.68 34.38 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.1 ptp -81.91 72.49 8.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.181 0.515 . . . . 0.0 111.097 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.3 m -72.22 161.34 31.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.81 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.0 p -101.73 172.07 7.17 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.727 0.775 . . . . 0.0 112.244 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.738 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -113.15 -168.04 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.04 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.451 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.45 -126.28 1.28 Allowed Glycine 0 N--CA 1.46 0.274 0 O-C-N 123.955 0.784 . . . . 0.0 113.04 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.7 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 38.59 -142.94 0.33 Allowed Glycine 0 C--N 1.331 0.3 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -147.22 4.98 0.83 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.784 -0.708 . . . . 0.0 110.333 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.562 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 4.6 m -94.88 -58.12 2.25 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.801 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.16 -81.84 1.4 Allowed Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.613 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.43 -19.35 76.09 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.175 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -80.86 138.77 49.98 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.98 0.419 . . . . 0.0 110.903 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -88.55 170.17 5.57 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.183 2.589 . . . . 0.0 112.188 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.4 m -76.07 140.54 41.93 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 84.1 t -106.65 108.6 25.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.532 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 50.9 m-85 -109.66 141.32 23.41 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-O 120.831 0.348 . . . . 0.0 111.411 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.615 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 3.8 Cg_endo -85.7 134.05 17.64 Favored 'Cis proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.254 -1.561 . . . . 0.0 111.718 -0.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.532 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 43.9 p90 -102.81 -171.17 1.91 Allowed 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.356 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 96.6 m -145.56 119.17 9.13 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.242 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.623 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 72.4 t80 -109.46 131.16 55.33 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.615 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.8 mm? 35.63 44.06 0.19 Allowed 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 124.511 1.132 . . . . 0.0 113.859 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.2 -10.81 63.69 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 114.581 -1.191 . . . . 0.0 116.038 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.504 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 52.5 m-80 -113.23 134.01 54.8 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.887 1.843 . . . . 0.0 111.951 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -78.1 122.93 26.25 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.368 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.623 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 17.3 m-30 -110.89 118.23 35.54 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.749 0.785 . . . . 0.0 110.912 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 47.9 mt-10 -96.93 -12.81 22.93 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.356 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 p -132.69 -175.12 3.66 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 89.5 m -64.66 171.72 3.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.248 0.547 . . . . 0.0 110.052 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.4 t -151.11 173.13 14.74 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.849 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 p -133.24 24.65 4.17 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.407 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -60.53 137.48 58.16 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 113.172 -1.831 . . . . 0.0 111.786 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.87 -2.68 31.98 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.234 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.606 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.4 mtp85 -112.04 -78.59 0.58 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.762 0.315 . . . . 0.0 111.417 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.2 m 65.54 22.05 11.77 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.966 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.49 -35.54 9.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.49 0.662 . . . . 0.0 110.22 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.9 -42.41 0.92 Allowed Glycine 0 C--N 1.313 -0.741 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.771 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.606 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 44.2 mttp -65.54 106.75 1.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.503 0.192 . . . . 0.0 110.688 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.3 mtm -83.93 146.77 27.86 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.636 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 21.3 p-90 -136.97 -168.1 2.21 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.336 0.589 . . . . 0.0 111.675 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 24.5 p -160.17 156.09 26.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.075 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -84.17 145.81 28.18 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.556 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.8 p -102.07 11.12 38.9 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.494 0.664 . . . . 0.0 110.291 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 p -133.33 152.0 51.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.389 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.91 82.24 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.828 0.347 . . . . 0.0 111.415 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -120.58 109.77 15.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.999 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 28.6 t80 -70.81 -37.25 73.23 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.737 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.42 -35.48 60.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.418 . . . . 0.0 111.609 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -76.12 -69.39 0.5 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -85.74 -18.05 34.13 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 23.0 mtm180 44.57 52.34 7.65 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -113.95 122.18 46.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.999 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 7.8 p-90 -129.76 173.13 10.93 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.486 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.4 140.72 6.43 Favored Glycine 0 C--O 1.223 -0.583 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.871 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.738 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.2 m-30 -63.09 158.13 20.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.364 0.582 . . . . 0.0 111.852 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 68.5 m -95.49 130.94 30.67 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.003 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -78.52 9.37 3.21 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 C-N-CA 123.089 2.526 . . . . 0.0 114.975 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -124.78 85.41 2.41 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.394 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -79.37 157.42 27.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.077 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.578 -1.123 . . . . 0.0 112.441 179.886 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.77 0.319 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -121.97 -15.04 7.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.357 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -123.07 20.57 9.89 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.9 t 46.36 -150.64 0.09 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.509 0.671 . . . . 0.0 111.763 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.8 p -114.53 170.41 8.33 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.039 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -114.21 -165.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 176.852 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.57 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.27 -125.49 1.16 Allowed Glycine 0 C--N 1.319 -0.385 0 O-C-N 124.173 0.92 . . . . 0.0 113.569 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.703 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 38.15 -141.19 0.42 Allowed Glycine 0 C--N 1.333 0.387 0 N-CA-C 115.754 1.062 . . . . 0.0 115.754 177.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.24 -21.22 0.34 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.74 -0.73 . . . . 0.0 109.781 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 5.8 m -57.48 -43.69 84.3 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.805 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.73 -80.72 1.3 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.968 -0.634 . . . . 0.0 114.028 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.21 40.98 2.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.369 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -128.83 139.54 35.94 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 117.224 0.512 . . . . 0.0 110.805 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 61.2 Cg_endo -84.72 170.41 10.15 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.951 2.434 . . . . 0.0 111.942 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.5 m -79.9 138.57 37.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.509 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.0 t -100.68 109.79 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 19.2 m-30 -112.9 139.59 23.08 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.607 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.632 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.1 Cg_endo -86.72 136.79 18.58 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.097 -1.626 . . . . 0.0 112.373 -0.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 40.7 p90 -99.27 -171.58 2.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.172 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 32.2 m -142.94 127.94 18.46 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.156 0.503 . . . . 0.0 111.515 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.672 ' CE2' ' HZ2' ' A' ' 40' ' ' TRP . 1.4 t80 -133.87 140.7 47.01 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.335 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.674 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 39.46 33.92 0.12 Allowed 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 125.12 1.368 . . . . 0.0 114.103 178.023 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.94 -11.43 60.66 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.625 -0.798 . . . . 0.0 114.975 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' THR . 68.3 m-80 -109.47 154.81 22.13 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 118.513 1.156 . . . . 0.0 111.976 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.545 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -94.31 126.04 39.32 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.614 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 20.9 m-85 -110.88 110.67 21.37 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.724 0.773 . . . . 0.0 111.213 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.632 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 54.1 mt-10 -90.43 -10.26 44.44 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.824 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 p -136.84 -170.8 2.78 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.5 m -70.2 167.12 18.56 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.802 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.44 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 9.4 t -144.35 169.03 18.7 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.768 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.417 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 19.6 p -124.41 17.12 8.98 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.603 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -60.23 142.4 54.57 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 113.736 -1.574 . . . . 0.0 111.588 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.0 -5.73 12.32 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.642 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.477 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 25.2 mtp85 -106.7 -72.92 0.7 Allowed 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 122.654 -0.321 . . . . 0.0 110.987 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m 60.87 24.59 14.57 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.313 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.54 -33.5 8.08 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.164 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.23 -61.45 0.4 Allowed Glycine 0 C--N 1.313 -0.712 0 CA-C-N 115.028 -0.987 . . . . 0.0 113.04 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.565 ' H ' ' CD ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -58.84 134.66 57.09 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.113 0.482 . . . . 0.0 112.043 -179.369 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.417 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 71.3 mtp -100.15 150.72 22.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.672 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.0 p-90 -135.3 -170.28 2.56 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.913 0.387 . . . . 0.0 111.303 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 20.5 p -155.68 141.58 18.13 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.439 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -76.42 145.81 39.08 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.976 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.9 p -99.33 10.47 41.35 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.377 0.608 . . . . 0.0 109.91 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.468 HG21 ' HB2' ' A' ' 50' ' ' ASP . 32.6 p -128.13 153.51 46.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.053 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.24 -38.66 77.31 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.089 0.471 . . . . 0.0 110.452 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -123.99 111.35 15.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.766 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 59.4 t80 -70.13 -40.67 74.71 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.71 -30.64 70.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.089 0.471 . . . . 0.0 111.768 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -61.13 1.9 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.751 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HB2' HG21 ' A' ' 44' ' ' THR . 68.0 m-20 -95.81 -23.85 16.74 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 5.7 mtm180 53.7 52.05 13.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -117.84 119.09 33.81 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.766 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.2 p-90 -129.84 174.28 9.88 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -175.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.405 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.38 141.41 7.19 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 113.93 -1.487 . . . . 0.0 110.024 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.726 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 4.7 m-30 -60.28 157.8 12.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.898 0.849 . . . . 0.0 111.668 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.661 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 2.1 t -64.75 150.55 94.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.661 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 60.8 Cg_endo -63.65 -146.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.476 0.468 0 C-N-CA 122.932 2.421 . . . . 0.0 114.218 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.504 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 5.7 t0 -48.64 110.9 0.39 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.921 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 74.8 mt-30 -124.19 158.91 31.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.236 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.746 0 CA-C-O 118.368 -1.24 . . . . 0.0 111.513 179.598 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.788 0.328 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -106.39 60.14 0.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.058 0.456 . . . . 0.0 110.4 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.405 ' O ' ' HB3' ' A' ' 14' ' ' PRO . 22.6 ptp -83.23 -164.54 0.9 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.246 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -107.63 164.37 12.28 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.412 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 p -111.86 171.98 7.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.722 0.772 . . . . 0.0 112.661 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.717 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -117.89 -167.26 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.044 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.45 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 36.78 -121.7 0.75 Allowed Glycine 0 N--CA 1.46 0.289 0 O-C-N 124.13 0.894 . . . . 0.0 113.248 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.666 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 30.21 -135.11 0.08 OUTLIER Glycine 0 C--N 1.337 0.632 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -161.8 34.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.815 -0.692 . . . . 0.0 110.422 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.511 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -99.36 -36.81 9.47 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.353 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.55 -68.69 2.6 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.13 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -137.02 5.43 3.62 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.827 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 10' ' ' SER . . . -73.09 147.6 88.33 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.707 0.253 . . . . 0.0 110.574 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.405 ' HB3' ' O ' ' A' ' 3' ' ' MET . 83.7 Cg_endo -86.53 171.74 7.21 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.898 2.399 . . . . 0.0 112.416 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 78.7 m -95.67 112.24 24.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 46.1 t -73.59 115.34 14.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.87 0.367 . . . . 0.0 111.544 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -113.03 141.18 25.16 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 120.91 0.386 . . . . 0.0 110.572 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -85.68 139.87 26.72 Favored 'Cis proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.386 -1.922 . . . . 0.0 111.707 -0.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 40.3 p90 -103.81 -174.32 2.52 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.147 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 94.3 m -142.67 120.03 11.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.865 0.364 . . . . 0.0 110.286 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.875 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 66.3 t80 -115.97 135.09 54.3 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.587 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 34.68 47.18 0.22 Allowed 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 124.589 1.18 . . . . 0.0 114.01 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.32 -7.74 80.03 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 116.546 1.378 . . . . 0.0 116.546 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' THR . 54.4 m-80 -112.79 143.14 44.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.567 1.684 . . . . 0.0 111.823 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -86.81 129.38 34.9 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.875 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 88.0 m-85 -116.75 118.22 31.93 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.394 0.616 . . . . 0.0 111.089 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -94.28 -16.62 23.42 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.845 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.7 p -130.67 -177.59 4.42 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.485 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 77.8 m -66.91 161.93 22.96 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -138.28 167.83 21.03 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.12 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.671 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 11.0 p -121.22 20.16 11.4 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -60.88 134.47 57.12 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 113.751 -1.568 . . . . 0.0 111.779 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.83 -5.71 37.77 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.136 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 20.4 mtp85 -110.44 -81.33 0.58 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.797 0.332 . . . . 0.0 111.282 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 68.6 m 57.84 29.44 17.51 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.829 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -103.05 -42.78 5.68 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.901 0.858 . . . . 0.0 109.732 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 168.95 -55.57 0.21 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 114.167 -1.379 . . . . 0.0 112.337 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.487 ' H ' ' CD ' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -71.79 130.69 41.71 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.147 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.671 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.2 mpt? -95.69 154.65 17.11 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.652 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.6 p-90 -139.88 -163.21 1.46 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.1 0.476 . . . . 0.0 111.144 -178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p -169.45 155.98 6.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.264 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 15' ' ' CYS . . . -79.61 152.86 29.8 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 120.911 0.386 . . . . 0.0 111.464 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.1 p -102.12 6.87 41.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.95 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.7 p -130.73 150.66 51.81 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.295 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.02 -35.44 71.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.969 0.414 . . . . 0.0 110.986 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -124.47 109.99 13.95 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 1.007 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 30.6 t80 -75.38 -34.84 61.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.345 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -52.26 -32.87 39.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.885 0.374 . . . . 0.0 111.324 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -83.17 -58.54 2.8 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.837 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 56.2 m-20 -91.31 -19.8 22.57 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 3.2 mtm105 46.57 43.72 12.69 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.837 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 22.2 mtpt -110.57 124.0 51.02 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 1.007 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 7.8 p-90 -131.58 172.66 11.97 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.566 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.65 145.78 11.3 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 113.646 -1.616 . . . . 0.0 110.255 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.717 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 7.0 m-30 -66.62 160.56 25.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.465 0.65 . . . . 0.0 112.318 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.68 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 8.8 t -84.59 149.88 55.39 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.68 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 89.9 Cg_endo -70.4 -150.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.282 1.988 . . . . 0.0 113.418 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.417 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 2.1 m-20 -56.65 134.94 55.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.073 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -80.38 95.5 6.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.484 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.616 0 CA-C-O 118.746 -1.03 . . . . 0.0 111.953 179.639 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.752 0.311 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -82.46 87.09 6.66 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.4 mtp -104.56 96.74 6.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.337 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 t 63.71 -159.88 0.3 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.05 0.453 . . . . 0.0 110.057 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -109.6 -176.64 3.07 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.723 0.773 . . . . 0.0 111.832 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -132.0 161.73 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 177.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.768 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.73 -154.33 46.15 Favored Glycine 0 C--N 1.309 -0.921 0 C-N-CA 118.068 -2.015 . . . . 0.0 111.544 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.614 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 48.94 -150.42 3.82 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 115.45 0.94 . . . . 0.0 115.45 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -153.16 31.93 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.835 -0.682 . . . . 0.0 109.625 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.837 ' HB3' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -55.69 -51.23 67.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.005 -178.649 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.02 45.24 6.37 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.46 62.54 1.7 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.14 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.4 144.38 17.39 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.824 0.312 . . . . 0.0 110.933 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -85.61 -177.21 2.53 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.834 2.356 . . . . 0.0 111.308 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.9 m -87.75 122.42 31.39 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.241 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 74.6 t -85.06 110.16 18.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.733 0.301 . . . . 0.0 110.329 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -116.26 138.55 24.36 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-O 120.95 0.405 . . . . 0.0 111.013 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.652 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 6.4 Cg_endo -86.47 137.85 20.67 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.136 -1.61 . . . . 0.0 112.002 -0.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.55 ' CG ' ' HB3' ' A' ' 42' ' ' ALA . 47.1 p90 -103.09 -169.66 1.68 Allowed 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.9 m -144.31 128.93 18.15 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.947 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.738 ' CG ' HD22 ' A' ' 22' ' ' LEU . 1.1 t80 -132.49 142.3 49.16 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.738 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 41.12 35.81 0.41 Allowed 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 124.557 1.143 . . . . 0.0 112.812 178.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.13 -6.6 83.31 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 115.01 0.764 . . . . 0.0 115.01 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.518 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.1 m-80 -107.07 136.87 46.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.508 1.154 . . . . 0.0 111.638 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -78.03 123.09 26.42 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.723 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 14.8 m-30 -107.03 112.17 24.99 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.805 0.812 . . . . 0.0 110.884 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.652 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 45.6 mt-10 -91.54 -18.0 24.78 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.366 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 p -129.89 -174.17 3.24 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 80.8 m -62.92 166.66 5.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.54 0.686 . . . . 0.0 110.36 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -147.65 169.5 19.52 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.32 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.586 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 55.1 p -128.55 17.7 6.39 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.644 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -59.79 138.25 57.83 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 113.96 -1.473 . . . . 0.0 111.086 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.06 -9.31 26.15 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.289 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.605 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.7 mtp85 -111.2 -39.91 4.6 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 51.1 m 78.53 -59.5 0.42 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -175.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.0 -106.13 0.32 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 175.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.501 ' O ' ' NE ' ' A' ' 34' ' ' ARG . . . 27.54 47.09 0.05 OUTLIER Glycine 0 C--O 1.209 -1.426 0 O-C-N 124.43 1.081 . . . . 0.0 114.646 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.718 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 24.7 mmmt 66.67 145.64 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 125.402 1.481 . . . . 0.0 113.728 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.586 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 60.8 mtt -81.8 149.5 28.34 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.616 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 21.6 p-90 -136.61 -172.76 3.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.563 0.697 . . . . 0.0 112.297 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 25.0 p -151.05 140.46 21.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.739 -1.118 . . . . 0.0 108.693 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.55 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -75.61 151.24 37.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.347 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.837 HG21 ' HB3' ' A' ' 10' ' ' SER . 65.1 p -108.04 14.81 24.86 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.798 0.808 . . . . 0.0 110.199 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.0 p -137.23 150.05 47.58 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.94 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.23 -42.25 76.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.879 0.371 . . . . 0.0 111.205 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -118.09 106.24 12.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.744 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 75.8 t80 -74.44 -35.28 63.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.231 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -54.44 -39.51 67.44 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -84.08 -49.78 8.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -83.02 -34.09 26.36 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 4.3 mmm-85 55.19 44.46 27.69 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -111.53 118.36 35.53 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.744 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 11.5 p-90 -129.45 174.88 9.23 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -175.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.17 141.22 7.08 Favored Glycine 0 C--O 1.221 -0.683 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.107 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.768 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 6.1 m-85 -65.75 163.38 16.74 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 117.344 0.572 . . . . 0.0 111.989 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 63.1 m -101.3 153.99 37.48 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.755 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.458 ' HB2' ' H ' ' A' ' 58' ' ' ASP . 93.5 Cg_endo -71.12 -146.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.439 2.76 . . . . 0.0 113.767 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.458 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 38.2 t70 -49.25 121.51 5.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.118 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -63.98 108.82 1.6 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.032 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.531 -1.15 . . . . 0.0 111.873 179.852 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 62.48 -145.68 0.38 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -81.74 89.56 6.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.287 0.565 . . . . 0.0 109.887 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.606 ' HB3' ' O ' ' A' ' 11' ' ' GLY . 69.1 m -127.1 -170.32 2.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.147 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -122.59 177.79 5.28 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 121.665 0.745 . . . . 0.0 111.805 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -126.74 160.76 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 177.486 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.831 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 68.53 -144.78 42.87 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 117.887 -2.102 . . . . 0.0 111.612 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.633 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 43.12 -145.86 1.04 Allowed Glycine 0 C--N 1.331 0.275 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.73 -30.87 1.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.878 -0.661 . . . . 0.0 109.506 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 3.4 m -58.88 -58.7 7.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.579 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' A' ' 4' ' ' SER . . . 76.08 -74.87 1.59 Allowed Glycine 0 C--O 1.225 -0.447 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.519 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.42 27.93 6.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.055 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.495 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -122.96 144.62 43.54 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -84.63 160.99 12.47 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.744 2.296 . . . . 0.0 112.43 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 91.8 m -83.37 123.12 29.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.469 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.8 t -90.31 120.02 38.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.715 0.293 . . . . 0.0 110.922 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.599 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 58.6 m-85 -114.74 141.88 27.44 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.483 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.462 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.3 Cg_endo -86.49 132.75 14.61 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.308 -1.538 . . . . 0.0 112.14 -0.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.599 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 22.5 p90 -98.56 128.03 44.73 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.525 ' OG1' ' HD2' ' A' ' 25' ' ' LYS . 13.9 m -91.38 125.64 36.21 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.432 0.634 . . . . 0.0 112.148 -177.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.871 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -130.36 145.97 51.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.41 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.728 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.24 36.88 0.21 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.461 1.104 . . . . 0.0 113.099 178.66 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.27 -5.52 84.96 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.441 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 68.6 m-80 -110.29 135.7 50.63 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.587 1.194 . . . . 0.0 112.202 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HD2' ' OG1' ' A' ' 20' ' ' THR . 25.1 mmmt -77.42 117.13 18.6 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.871 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.5 m-30 -101.77 104.4 15.19 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.02 0.914 . . . . 0.0 111.361 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 15.5 mt-10 -84.46 -17.42 39.2 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.215 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 p -129.06 -178.45 4.64 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.639 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.9 m -66.64 159.52 27.45 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.725 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.488 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.5 t -137.74 178.48 7.08 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.703 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.7 p -128.77 17.44 6.29 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.513 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -60.87 142.96 55.78 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.107 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.06 -5.26 19.79 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.536 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.625 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 12.2 mtp85 -100.66 155.67 17.75 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 117.33 0.565 . . . . 0.0 111.565 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 p -132.17 13.06 4.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.805 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -104.92 -79.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.178 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 176.81 -31.74 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.411 -0.9 . . . . 0.0 114.418 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.643 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 5.7 mptt -63.22 135.14 56.93 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 117.633 0.716 . . . . 0.0 112.344 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.0 mtp -89.86 156.82 18.21 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.632 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 18.6 p-90 -143.85 -172.06 3.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.417 0.627 . . . . 0.0 111.332 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.549 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.4 p -159.3 139.26 11.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.044 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . . . -72.01 155.48 40.28 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.372 0.606 . . . . 0.0 111.511 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.4 p -101.93 11.24 38.88 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.767 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.9 p -133.08 151.82 52.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.912 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.96 -32.57 67.97 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.163 0.506 . . . . 0.0 111.358 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -126.69 120.2 28.84 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.861 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 64.5 t80 -86.17 -31.42 21.8 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.325 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -61.13 -30.94 70.68 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.05 -45.23 8.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -100.32 -18.51 16.76 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.1 mtm105 43.5 51.28 6.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -114.82 119.39 36.45 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.861 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.2 p-90 -132.99 176.48 8.45 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -174.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -167.28 142.55 7.63 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 112.95 -1.932 . . . . 0.0 109.222 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.831 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 12.9 m-85 -60.76 157.37 14.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.407 0.622 . . . . 0.0 112.081 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.501 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.9 t -75.25 117.03 59.99 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.055 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.422 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 6.4 Cg_endo -87.62 -162.36 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.718 2.279 . . . . 0.0 112.406 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 t0 29.18 66.71 0.1 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.061 1.345 . . . . 0.0 113.405 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 54.2 mt-30 -122.88 -68.82 0.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.051 0.453 . . . . 0.0 110.058 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.762 0 CA-C-O 118.599 -1.112 . . . . 0.0 111.401 -179.722 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.66 0.266 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.457 ' HA ' ' CE3' ' A' ' 2' ' ' TRP . 3.9 t-105 -76.54 -88.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.116 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.9 mmt -102.77 164.1 11.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.728 0.299 . . . . 0.0 110.934 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.6 m -101.5 -171.14 1.93 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -82.08 154.74 25.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.987 0.899 . . . . 0.0 112.742 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -132.75 163.91 36.58 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.032 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 178.398 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.533 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 65.16 -149.94 51.7 Favored Glycine 0 C--N 1.312 -0.782 0 C-N-CA 117.716 -2.183 . . . . 0.0 111.014 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.638 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 48.47 -150.51 3.34 Favored Glycine 0 C--N 1.332 0.326 0 N-CA-C 114.641 0.616 . . . . 0.0 114.641 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -130.36 -6.64 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.418 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 m -78.79 -51.49 9.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.44 72.03 0.64 Allowed Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.774 -0.648 . . . . 0.0 114.23 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.02 -42.69 1.29 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.835 -1.174 . . . . 0.0 113.196 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -66.11 135.3 95.06 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.809 0.338 . . . . 0.0 111.513 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 14.2 Cg_exo -65.51 154.31 74.29 Favored 'Trans proline' 0 C--N 1.334 -0.219 0 C-N-CA 122.896 2.397 . . . . 0.0 111.472 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.412 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 5.2 m -73.78 134.58 43.44 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.0 t -95.06 113.87 30.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.834 0.35 . . . . 0.0 110.426 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.614 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 47.4 m-85 -118.64 139.94 27.72 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.538 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.754 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 35.9 Cg_endo -87.06 136.12 17.05 Favored 'Cis proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.51 -1.871 . . . . 0.0 112.379 -0.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.614 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 34.3 p90 -101.93 -168.02 1.49 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 76.0 m -149.47 126.28 11.12 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.433 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.822 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 36.8 t80 -123.03 131.64 53.79 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.988 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.683 HD22 ' CE2' ' A' ' 21' ' ' PHE . 6.7 mp 41.76 33.56 0.34 Allowed 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 124.531 1.144 . . . . 0.0 113.502 174.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.68 -18.16 32.41 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 115.422 0.929 . . . . 0.0 115.422 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.475 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 43.8 m-80 -112.6 132.01 55.34 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.888 1.344 . . . . 0.0 112.181 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 46.5 mtpt -78.17 127.03 31.67 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.822 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.4 m-85 -111.91 121.2 44.38 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.683 0.754 . . . . 0.0 111.223 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.754 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 99.1 mt-10 -94.87 -14.67 24.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.224 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.3 p -130.08 -175.37 3.6 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.63 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.7 m -67.1 166.29 14.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.774 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.3 t -146.15 165.36 29.38 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.098 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 p -121.53 23.8 10.13 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -66.04 139.73 58.22 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.022 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.65 -6.45 17.79 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.612 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.482 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.9 mtp85 -100.84 -78.67 0.52 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 117.401 0.601 . . . . 0.0 111.211 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 m 66.13 14.81 9.82 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.718 0.636 . . . . 0.0 109.957 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.48 -34.03 12.22 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.196 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.65 -65.73 0.31 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.224 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.836 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 1.5 mppt? -61.92 149.7 39.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.0 mtm -104.61 159.07 16.05 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.722 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.584 ' HA ' ' N ' ' A' ' 56' ' ' CYS . 13.9 p-90 -142.5 -165.7 2.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.369 0.604 . . . . 0.0 111.94 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.3 p -161.04 152.79 19.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.672 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.401 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -86.85 148.53 25.33 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.401 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.3 p -103.12 8.02 38.71 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.536 0.684 . . . . 0.0 109.877 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.9 p -130.07 152.63 49.31 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.663 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.73 -47.74 81.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.756 0.313 . . . . 0.0 111.518 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -115.4 104.61 11.94 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.96 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 43.4 t80 -69.28 -37.6 77.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.792 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -53.0 -28.82 25.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.96 0.41 . . . . 0.0 111.762 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -87.48 -70.6 0.61 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.59 -21.18 55.94 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.63 ' HB3' ' NH1' ' A' ' 51' ' ' ARG . 0.9 OUTLIER 46.98 50.77 13.53 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 179.166 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -114.13 118.37 33.83 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.96 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.8 p-90 -129.85 171.21 12.96 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -174.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.638 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.61 142.64 7.83 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 113.122 -1.854 . . . . 0.0 109.502 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 13.7 m-30 -55.15 155.65 4.63 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 117.043 0.422 . . . . 0.0 111.249 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.584 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.7 t -53.87 137.71 54.77 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.577 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' SG ' ' A' ' 15' ' ' CYS . 74.8 Cg_endo -69.77 4.97 1.89 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.029 2.486 . . . . 0.0 113.384 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -141.52 78.3 1.63 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.024 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 56' ' ' CYS . 15.6 mm100 -94.2 -44.86 7.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.956 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.293 -1.282 . . . . 0.0 111.379 -179.899 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.2 m . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 121.041 0.448 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.485 ' HE3' ' HG3' ' A' ' 14' ' ' PRO . 7.5 m0 -114.59 -109.51 0.36 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.6 mtt -90.23 163.27 14.85 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.9 m -123.92 162.04 24.16 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.995 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -120.77 161.64 21.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.35 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.71 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -116.5 -164.96 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 177.059 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.545 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.64 -125.51 1.31 Allowed Glycine 0 N--CA 1.463 0.47 0 O-C-N 123.814 0.696 . . . . 0.0 113.307 177.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.649 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 30.55 -136.4 0.07 OUTLIER Glycine 0 C--N 1.338 0.693 0 N-CA-C 116.049 1.179 . . . . 0.0 116.049 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -158.75 31.61 0.22 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.729 -0.736 . . . . 0.0 110.083 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.38 -45.66 9.31 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.516 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.19 -75.92 1.17 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.676 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.39 18.84 4.36 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.782 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.17 143.13 36.59 Favored Pre-proline 0 C--N 1.328 -0.339 0 O-C-N 122.665 -0.315 . . . . 0.0 110.598 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.485 ' HG3' ' HE3' ' A' ' 2' ' ' TRP . 71.8 Cg_endo -86.12 166.52 9.62 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.62 2.213 . . . . 0.0 112.254 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.7 m -81.08 133.92 35.56 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.531 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 82.9 t -96.48 115.76 36.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.742 0.306 . . . . 0.0 110.29 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -118.15 139.54 26.81 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.314 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.683 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 6.0 Cg_endo -85.64 136.12 20.61 Favored 'Cis proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.288 -1.547 . . . . 0.0 111.571 -0.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.649 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 43.8 p90 -104.1 -170.04 1.71 Allowed 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.364 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.7 m -148.18 126.86 12.53 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.094 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.831 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 67.9 t80 -117.95 132.73 56.37 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.599 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.614 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.8 mm? 33.28 45.45 0.08 Allowed 'General case' 0 N--CA 1.432 -1.332 0 O-C-N 124.792 1.308 . . . . 0.0 114.034 174.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.77 -19.01 51.61 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.452 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 32.4 m-80 -111.86 133.67 53.91 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.787 1.794 . . . . 0.0 112.418 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 11.4 mtmt -75.59 127.11 32.37 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.361 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.831 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.9 m-85 -115.97 109.7 17.93 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 122.244 1.021 . . . . 0.0 110.384 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.683 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 24.4 mt-10 -87.81 -10.47 50.8 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.498 -1.683 . . . . 0.0 110.648 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.5 p -133.15 -168.2 2.05 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.6 m -74.52 167.63 21.34 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.4 t -146.71 169.97 17.94 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.309 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.427 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 11.8 p -122.32 20.15 10.52 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.12 140.55 56.83 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.233 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.4 -1.07 45.16 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.51 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.659 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.6 mtp85 -108.04 -64.71 1.19 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.944 0.372 . . . . 0.0 111.076 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.4 t 66.67 15.78 10.21 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.357 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.72 -84.32 0.45 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.036 0.446 . . . . 0.0 110.548 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.62 -46.83 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.244 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.75 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 2.9 mppt? -63.56 122.18 15.68 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 120.939 0.399 . . . . 0.0 111.259 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.427 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 47.1 mtt -91.18 151.06 21.1 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.651 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.6 p-90 -130.08 -167.07 1.76 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.187 0.518 . . . . 0.0 111.533 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 10.6 p -159.72 143.97 14.81 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.505 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -76.11 149.72 37.35 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 59.8 p -104.74 13.86 30.67 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.677 0.751 . . . . 0.0 109.788 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.8 p -139.33 154.98 47.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.835 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.85 -48.01 83.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.772 0.32 . . . . 0.0 111.325 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -114.49 106.68 14.57 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 1.063 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 20.3 t80 -75.81 -34.39 60.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.196 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.13 -39.81 21.68 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.92 -35.71 11.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -89.82 -30.86 17.66 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.534 ' HB3' HH11 ' A' ' 51' ' ' ARG . 0.3 OUTLIER 48.62 47.09 20.99 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -117.77 118.07 31.06 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 1.063 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 10.2 p-90 -132.57 173.7 11.05 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -175.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.56 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.7 147.22 11.39 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 113.437 -1.711 . . . . 0.0 109.571 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.71 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 11.5 m-30 -61.04 155.71 19.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.752 0.776 . . . . 0.0 111.592 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.585 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 11.3 t -63.66 144.88 97.77 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.639 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.585 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 62.0 Cg_endo -65.63 2.59 1.52 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.164 2.576 . . . . 0.0 114.413 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -121.22 97.01 5.32 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.275 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -99.68 47.63 0.95 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.237 0.541 . . . . 0.0 110.611 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.92 0 CA-C-O 118.543 -1.143 . . . . 0.0 112.146 179.755 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.0 m . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.98 0.419 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -97.55 125.43 42.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.855 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.0 tpt -67.76 115.26 7.12 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.5 m -82.0 -161.94 0.5 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.762 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p -68.79 170.3 9.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.843 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.535 HG13 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -124.57 -50.1 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-O 123.194 1.473 . . . . 0.0 109.716 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.759 ' H ' ' HB2' ' A' ' 55' ' ' PHE . . . -83.38 -162.29 32.75 Favored Glycine 0 C--N 1.278 -2.692 0 CA-C-N 111.054 -2.794 . . . . 0.0 111.85 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 53' ' ' TRP . . . 75.62 -157.89 49.67 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.693 -0.765 . . . . 0.0 114.419 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -115.03 -29.84 6.55 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 m -52.15 -47.26 65.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.761 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.68 -86.83 1.52 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.493 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.06 43.55 1.68 Allowed Glycine 0 C--N 1.329 0.158 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.913 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.487 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -113.33 145.13 32.61 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 120.857 0.361 . . . . 0.0 110.807 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 3.1 Cg_exo -78.45 154.54 27.86 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.894 2.396 . . . . 0.0 112.008 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.8 m -76.99 141.75 40.26 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.0 t -109.39 92.11 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.726 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.696 ' CE1' ' HE1' ' A' ' 19' ' ' PHE . 6.5 m-85 -94.32 143.98 27.25 Favored Pre-proline 0 N--CA 1.447 -0.624 0 CA-C-O 121.657 0.741 . . . . 0.0 111.331 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.3 Cg_endo -84.14 129.91 14.73 Favored 'Cis proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.402 -1.916 . . . . 0.0 111.964 -0.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.696 ' HE1' ' CE1' ' A' ' 17' ' ' PHE . 2.0 p90 -86.7 -163.68 0.94 Allowed 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.5 m -149.19 121.75 8.56 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.992 ' HB3' HD22 ' A' ' 22' ' ' LEU 0.494 0.5 OUTLIER -104.09 -171.38 1.92 Allowed 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 119.264 3.061 . . . . 0.0 119.264 171.964 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.992 HD22 ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -52.93 45.6 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 110.086 -3.234 . . . . 0.0 113.684 -173.544 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.19 1.46 16.34 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.318 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.894 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 1.9 m-80 -138.67 136.57 36.0 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 118.572 1.186 . . . . 0.0 113.016 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.53 122.34 26.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 175.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.989 ' CE2' ' HB2' ' A' ' 21' ' ' PHE . 22.1 m-30 -95.42 98.35 10.49 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 122.39 1.09 . . . . 0.0 112.824 -175.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 16.4 mt-10 -78.21 -12.66 60.01 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.778 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.6 p -138.57 -179.84 6.04 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.4 m -64.6 163.28 13.97 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.503 -0.879 . . . . 0.0 109.209 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -143.92 170.27 16.22 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.599 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 61.2 p -122.77 15.63 10.16 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.439 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -64.52 147.89 51.85 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.001 -1.454 . . . . 0.0 111.336 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.94 -4.59 37.4 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.158 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.596 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 28.3 mtp85 -112.1 -64.7 1.26 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.751 0.31 . . . . 0.0 111.242 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.6 m 69.83 13.83 8.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.803 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.6 -83.75 0.34 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.145 0.498 . . . . 0.0 110.609 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.48 -35.27 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.394 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.773 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 7.1 mptt -69.8 119.96 14.82 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.732 0.301 . . . . 0.0 110.762 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.599 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 56.2 mtt -91.34 142.88 27.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.765 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 18.3 p-90 -122.93 -170.82 2.17 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.504 0.668 . . . . 0.0 110.979 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 8.3 p -157.56 134.49 10.08 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.0 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.516 ' HB3' ' CB ' ' A' ' 19' ' ' PHE . . . -72.49 149.43 44.14 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.011 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.5 p -101.99 13.74 33.93 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.538 0.685 . . . . 0.0 110.335 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.8 p -135.69 148.28 48.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.014 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -55.81 -36.64 67.66 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.894 0.378 . . . . 0.0 110.978 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -119.58 116.9 26.99 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.722 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 60.9 t80 -87.56 -43.78 11.75 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.343 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -42.94 -37.89 2.03 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -91.29 -67.88 0.83 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.451 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 2.2 m-20 -63.97 -26.13 68.44 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.9 mtm-85 44.33 52.62 7.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.451 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 25.7 mttm -116.94 115.64 25.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.722 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 16.6 p-90 -129.73 175.09 9.11 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.978 0.894 . . . . 0.0 112.758 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.488 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -164.8 142.6 7.87 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 113.617 -1.629 . . . . 0.0 109.191 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.759 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 4.3 m-30 -60.66 147.39 42.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.688 0.744 . . . . 0.0 111.0 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.442 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.6 t -57.62 133.7 82.42 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.192 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.413 ' HB2' ' H ' ' A' ' 58' ' ' ASP . 83.1 Cg_endo -73.61 -142.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.187 2.591 . . . . 0.0 112.571 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.413 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 50.6 t0 -63.1 104.59 0.59 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.057 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -79.97 101.52 8.69 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.77 0.319 . . . . 0.0 110.592 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.711 0 CA-C-O 118.619 -1.1 . . . . 0.0 111.761 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 120.677 0.275 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -83.99 153.26 23.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.161 0.505 . . . . 0.0 111.43 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 58.5 mtt -87.36 -177.21 5.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.724 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 t -77.49 175.59 9.68 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.263 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.3 p -100.64 173.27 6.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.019 0.914 . . . . 0.0 112.669 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -134.62 160.94 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.012 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.88 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 68.63 -147.54 47.02 Favored Glycine 0 C--N 1.309 -0.956 0 C-N-CA 117.487 -2.292 . . . . 0.0 111.612 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.649 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 47.25 -147.18 3.68 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 114.441 0.537 . . . . 0.0 114.441 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -141.82 17.61 2.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.823 0.344 . . . . 0.0 110.733 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 p -75.38 -67.45 0.66 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.56 -60.36 0.33 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.941 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.75 26.54 2.51 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.571 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.8 143.75 27.33 Favored Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 122.656 -0.32 . . . . 0.0 111.253 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -88.87 167.33 5.78 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.805 2.337 . . . . 0.0 111.932 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.7 m -76.56 141.08 41.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 88.1 t -111.4 115.1 48.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -116.43 144.16 32.58 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.935 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.629 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.7 Cg_endo -84.21 133.49 19.73 Favored 'Cis proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.485 -1.465 . . . . 0.0 111.285 -0.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.567 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 17.5 p90 -103.37 162.6 12.88 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.2 m -118.84 122.44 42.36 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.943 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.808 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 60.6 t80 -119.9 133.71 55.48 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.521 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.5 mm? 36.19 46.76 0.41 Allowed 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.5 -4.05 86.49 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 114.225 -1.352 . . . . 0.0 116.318 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 26' ' ' TYR . 40.2 m-80 -110.14 155.71 21.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.673 1.737 . . . . 0.0 111.571 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -94.65 131.33 40.56 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.157 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.808 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 88.9 m-85 -123.77 107.56 11.57 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.697 0.761 . . . . 0.0 112.041 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.629 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 93.6 mt-10 -93.39 -14.32 26.96 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.591 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.6 p -128.14 -177.06 3.99 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.605 -1.179 . . . . 0.0 108.158 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.6 m -67.08 168.91 9.28 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.284 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.6 t -143.99 169.17 18.33 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.184 0.516 . . . . 0.0 110.787 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.461 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 32.4 p -123.52 15.51 9.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.473 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -55.9 136.86 51.38 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.405 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.26 -18.59 3.36 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.147 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.7 mtp85 -96.25 -80.76 0.42 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.795 0.331 . . . . 0.0 110.519 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.7 m 62.42 16.16 8.38 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.943 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.37 -35.26 13.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.639 0.733 . . . . 0.0 109.569 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.52 -65.86 0.23 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.59 -1.186 . . . . 0.0 113.359 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.819 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 7.0 mptt -63.0 134.37 56.06 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.461 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.5 mpt? -96.41 152.62 18.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.6 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.6 p-90 -133.4 -166.08 1.72 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.326 0.584 . . . . 0.0 111.531 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 29.3 p -158.58 149.69 20.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.008 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.546 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -84.27 148.33 26.75 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.2 p -102.41 10.61 38.91 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.665 0.745 . . . . 0.0 110.32 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.2 p -133.56 151.31 51.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.924 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -55.78 -37.66 68.86 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.971 0.415 . . . . 0.0 111.077 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -125.51 112.44 16.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 1.033 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 30.6 t80 -73.95 -36.93 64.67 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.538 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -54.22 -35.08 62.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.148 0.499 . . . . 0.0 111.103 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.57 -71.42 0.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -81.47 -18.85 43.78 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 11.1 mtm180 45.2 55.65 6.17 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -119.49 120.86 38.03 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 1.033 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.7 p-90 -128.35 169.8 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.57 140.72 6.71 Favored Glycine 0 C--O 1.22 -0.78 0 CA-C-N 113.377 -1.738 . . . . 0.0 109.819 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.88 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.2 m-85 -58.93 154.41 15.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 117.59 0.695 . . . . 0.0 111.233 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.606 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 8.5 t -67.46 143.41 97.13 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.955 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.606 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 73.9 Cg_endo -67.39 -144.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.379 2.719 . . . . 0.0 113.313 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.489 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 39.0 t70 -48.03 106.62 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.871 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -83.85 135.13 34.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.503 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.76 0 CA-C-O 118.007 -1.44 . . . . 0.0 111.439 179.807 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.8 p . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.47 0.176 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 37.1 t90 65.01 105.63 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.792 0.682 . . . . 0.0 112.786 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.0 ptp -103.56 136.38 43.39 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -85.4 -178.46 6.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.191 0.52 . . . . 0.0 111.777 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -111.07 -178.53 3.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.776 0.798 . . . . 0.0 112.5 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -127.8 -168.24 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 177.263 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.479 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 35.84 -131.22 0.78 Allowed Glycine 0 CA--C 1.522 0.511 0 O-C-N 124.079 0.862 . . . . 0.0 113.496 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.676 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 40.31 -144.59 0.46 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 114.983 0.753 . . . . 0.0 114.983 177.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -139.37 -13.6 1.15 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.56 ' HB2' HG21 ' A' ' 43' ' ' THR . 0.9 OUTLIER -95.98 44.82 1.07 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.29 178.493 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -53.37 99.76 0.05 OUTLIER Glycine 0 C--N 1.333 0.381 0 O-C-N 123.668 0.605 . . . . 0.0 112.365 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.37 -29.6 3.62 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.312 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.36 145.91 69.24 Favored Pre-proline 0 CA--C 1.518 -0.27 0 CA-C-N 116.785 0.292 . . . . 0.0 110.25 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -81.74 154.36 17.76 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.118 1.879 . . . . 0.0 111.513 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.7 m -74.17 131.4 41.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.2 t -86.55 109.39 18.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.519 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 35.4 m-85 -116.59 139.31 25.33 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-O 120.749 0.309 . . . . 0.0 111.684 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.716 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 3.8 Cg_endo -86.22 134.78 17.5 Favored 'Cis proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.312 -1.537 . . . . 0.0 111.211 -1.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.519 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 43.5 p90 -96.95 -168.66 1.74 Allowed 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.437 178.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 73.9 m -144.43 122.98 12.45 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.002 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.741 ' CG ' HD22 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -125.0 142.94 51.16 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.684 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.741 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 40.91 27.94 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.758 1.223 . . . . 0.0 113.562 178.655 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.02 -7.02 62.35 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 114.819 0.688 . . . . 0.0 114.819 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 20' ' ' THR . 60.7 m-80 -105.5 149.33 26.31 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.512 1.156 . . . . 0.0 111.921 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -88.46 119.07 28.56 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.603 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 28.1 m-85 -104.64 112.52 25.63 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.72 0.772 . . . . 0.0 110.587 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.716 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 46.6 mt-10 -92.04 -17.75 24.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.475 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 p -129.62 -175.67 3.67 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 78.2 m -65.77 164.17 15.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.474 0.654 . . . . 0.0 110.613 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -142.34 167.71 21.47 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.867 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.706 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 27.9 p -121.95 18.57 10.93 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.554 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -64.48 139.17 58.74 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.718 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.81 -4.29 45.74 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.1 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.654 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.2 mtp85 -105.49 127.47 53.02 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 117.425 0.612 . . . . 0.0 110.844 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.0 m -96.5 5.95 49.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.784 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.72 -85.81 0.37 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 176.32 -31.58 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.317 -0.944 . . . . 0.0 114.387 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.782 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 8.8 mptt -57.04 115.89 2.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.583 0.692 . . . . 0.0 111.948 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.706 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 70.0 mtm -78.27 142.13 38.04 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.626 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.1 p-90 -128.75 -167.37 1.77 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.433 0.635 . . . . 0.0 112.04 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 17.7 p -152.7 141.86 21.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.918 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.99 148.56 38.01 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.178 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.56 HG21 ' HB2' ' A' ' 10' ' ' SER . 63.1 p -103.27 11.96 36.13 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.594 0.711 . . . . 0.0 109.712 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.3 p -137.62 153.3 49.91 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.762 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.56 -50.09 72.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 110.303 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -105.18 102.83 12.3 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.793 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 71.8 t80 -75.67 -34.31 60.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.936 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.36 -38.91 55.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -85.55 -71.2 0.54 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.525 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 72.9 m-20 -63.54 -26.42 68.7 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 15.4 mtm180 44.2 52.09 7.18 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.525 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 42.8 mttt -116.35 118.93 34.1 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.793 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.7 p-90 -133.89 176.28 8.71 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.543 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.94 150.07 19.1 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.295 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.687 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.7 m-30 -65.44 162.02 18.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.96 0.88 . . . . 0.0 112.374 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.677 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 5.6 t -66.74 148.81 98.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.677 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 35.7 Cg_endo -58.7 -131.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 123.601 2.867 . . . . 0.0 114.348 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 8.4 t0 -50.85 109.46 0.32 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.352 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 78.3 mt-30 -123.43 172.16 8.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.366 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.64 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.08 -179.945 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.544 0.212 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -86.61 89.74 8.02 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 75.2 mtm -92.41 133.03 36.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.224 0.535 . . . . 0.0 111.807 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.9 m -128.16 173.07 10.42 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.958 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 p -110.58 172.73 6.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.849 0.833 . . . . 0.0 112.306 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.534 HG22 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -128.08 164.96 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 178.045 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.715 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 61.36 -149.97 44.95 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 118.229 -1.938 . . . . 0.0 111.51 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.573 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 49.79 -145.28 8.66 Favored Glycine 0 C--N 1.33 0.24 0 N-CA-C 114.169 0.428 . . . . 0.0 114.169 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -143.7 27.84 1.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.762 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 5.3 m -107.76 -65.47 1.11 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.317 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.77 -67.71 3.61 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.795 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.46 -13.55 58.28 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.305 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.762 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -84.99 138.67 37.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 117.092 0.446 . . . . 0.0 111.372 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 85.7 Cg_endo -90.3 169.44 4.11 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.4 2.733 . . . . 0.0 112.038 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.9 m -79.52 142.31 35.89 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.424 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.3 t -116.22 87.99 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.722 0.296 . . . . 0.0 111.318 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.543 ' CE1' ' HE1' ' A' ' 19' ' ' PHE . 8.8 m-85 -90.3 146.11 34.03 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-O 121.443 0.639 . . . . 0.0 111.082 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.67 132.26 18.69 Favored 'Cis proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.4 -1.917 . . . . 0.0 112.197 -0.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.591 ' CB ' ' HB3' ' A' ' 42' ' ' ALA . 0.4 OUTLIER -90.07 -168.19 2.05 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.357 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.2 m -151.13 124.06 8.66 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.983 ' HB2' ' CE2' ' A' ' 26' ' ' TYR 0.471 0.5 OUTLIER -96.5 -173.81 2.87 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 119.068 2.988 . . . . 0.0 119.068 171.698 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.964 HD22 ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -56.29 43.46 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 109.804 -3.362 . . . . 0.0 112.89 -173.599 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 21' ' ' PHE . . . 122.62 -0.48 10.19 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 114.083 -1.417 . . . . 0.0 113.014 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.849 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 1.8 m-80 -137.9 134.57 35.19 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 118.171 0.986 . . . . 0.0 112.256 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -83.65 127.86 34.09 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.983 ' CE2' ' HB2' ' A' ' 21' ' ' PHE . 6.4 m-85 -107.7 110.89 22.85 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 122.896 1.331 . . . . 0.0 113.249 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -86.27 -13.6 46.25 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 112.763 -2.017 . . . . 0.0 111.325 -178.758 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 p -135.57 -177.61 4.75 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.1 m -65.68 153.39 41.82 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.139 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -131.39 175.89 8.76 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.439 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 1.4 p -130.41 17.8 5.38 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.69 154.48 36.46 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.511 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.36 -2.36 15.37 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.877 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.622 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.3 mtp85 -115.89 -61.0 1.8 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.807 0.337 . . . . 0.0 111.094 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.7 m 70.9 13.35 7.06 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.031 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.98 -86.4 0.39 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.146 0.498 . . . . 0.0 110.822 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.79 -33.11 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.42 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.777 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 8.5 mptt -66.48 111.84 3.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.718 0.294 . . . . 0.0 110.291 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.439 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 80.7 mtp -84.89 149.98 25.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.038 0.447 . . . . 0.0 110.828 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.736 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 24.0 p-90 -131.15 -171.94 2.71 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.62 0.724 . . . . 0.0 111.242 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.491 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 25.6 p -156.12 137.6 14.03 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.273 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.591 ' HB3' ' CB ' ' A' ' 19' ' ' PHE . . . -76.34 144.67 40.01 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.594 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.3 p -98.17 17.2 19.1 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.669 0.747 . . . . 0.0 110.01 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.9 p -141.67 146.48 36.18 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.75 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -54.4 -32.35 56.99 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.266 0.354 . . . . 0.0 111.886 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -125.66 121.47 33.6 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 1.034 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 30.9 t80 -88.46 -43.53 11.39 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.26 -31.91 1.73 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -93.23 -63.91 1.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -73.19 -20.28 60.92 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.4 mtm-85 41.86 52.34 4.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -118.28 117.81 30.11 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 1.034 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 8.9 p-90 -130.81 174.26 10.14 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -175.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.438 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -169.3 136.84 4.23 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-N 113.673 -1.603 . . . . 0.0 110.578 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.736 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 10.8 m-30 -60.21 158.83 10.76 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.377 0.671 . . . . 0.0 112.189 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.5 m -100.86 162.84 19.37 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.349 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.44 ' HB2' ' H ' ' A' ' 58' ' ' ASP . 93.1 Cg_endo -71.46 -150.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.784 2.323 . . . . 0.0 113.625 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 42.6 t0 -44.44 110.32 0.21 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.366 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -81.92 -27.29 33.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.262 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.774 0 CA-C-O 118.493 -1.171 . . . . 0.0 112.736 179.938 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.651 ' HB3' ' OG ' ' A' ' 4' ' ' SER . 24.1 m . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.563 0.221 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -83.19 -68.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.0 110.27 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.9 ptp -94.2 90.84 6.5 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.333 0.587 . . . . 0.0 109.719 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.651 ' OG ' ' HB3' ' A' ' 1' ' ' SER . 70.5 m -124.27 -172.31 2.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.587 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -124.58 171.58 9.91 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.885 0.85 . . . . 0.0 111.845 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -126.39 162.93 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 177.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.763 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 67.03 -144.23 44.53 Favored Glycine 0 C--N 1.309 -0.919 0 C-N-CA 117.747 -2.168 . . . . 0.0 111.077 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.497 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 39.48 -138.08 1.14 Allowed Glycine 0 C--N 1.332 0.309 0 N-CA-C 114.888 0.715 . . . . 0.0 114.888 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.4 -26.7 0.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.465 -0.368 . . . . 0.0 111.664 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.482 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 2.5 m -57.17 -62.46 1.75 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.735 0.302 . . . . 0.0 110.426 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 4' ' ' SER . . . 89.84 -90.06 1.59 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.528 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.85 -11.43 78.19 Favored Glycine 0 CA--C 1.517 0.191 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.759 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -82.34 143.87 49.05 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 117.29 0.545 . . . . 0.0 111.33 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -89.27 161.82 5.64 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.902 2.401 . . . . 0.0 112.664 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 86.6 m -79.99 133.94 36.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.119 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.57 114.4 44.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.724 0.297 . . . . 0.0 111.254 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.458 ' CE2' ' HE1' ' A' ' 19' ' ' PHE . 90.6 m-85 -108.27 146.5 33.71 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-O 120.751 0.31 . . . . 0.0 110.639 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.21 131.63 16.93 Favored 'Cis proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.479 -1.467 . . . . 0.0 111.579 -0.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 23.9 p90 -101.22 126.65 47.97 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 86.2 m -89.85 124.77 34.97 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.386 0.612 . . . . 0.0 111.739 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.733 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.8 t80 -124.11 141.53 51.98 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.677 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.1 OUTLIER 40.64 32.26 0.14 Allowed 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 124.294 1.038 . . . . 0.0 113.03 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.26 -11.15 69.3 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 115.117 0.807 . . . . 0.0 115.117 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.528 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.5 m-80 -105.54 136.1 45.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 118.564 1.182 . . . . 0.0 112.027 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -78.82 120.45 23.46 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.733 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.9 m-30 -103.26 110.61 22.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.044 0.926 . . . . 0.0 111.181 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -88.98 -18.91 26.46 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.73 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -128.36 177.72 6.77 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.1 m -64.57 161.28 17.78 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.688 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.5 t -136.61 171.84 13.89 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.987 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.622 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 29.4 p -124.39 16.73 8.99 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.499 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.71 145.46 52.29 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.787 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.62 -16.74 29.19 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.618 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.608 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 3.6 mtp-105 -101.03 -166.75 1.34 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.671 0.735 . . . . 0.0 110.749 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 p -144.7 -24.68 0.51 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.17 -89.32 0.21 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.182 -1.007 . . . . 0.0 113.399 -178.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.45 -14.87 0.12 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 119.187 2.435 . . . . 0.0 119.187 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.608 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 10.5 mptt -69.82 152.42 44.59 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 121.756 2.778 . . . . 0.0 111.8 -178.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.622 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 51.4 mtt -119.55 147.15 44.81 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.661 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 19.9 p-90 -136.96 -168.62 2.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.493 0.663 . . . . 0.0 111.689 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.6 p -162.18 140.31 8.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.23 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -69.9 149.11 48.17 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.407 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 81.2 p -95.03 14.63 21.2 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.518 0.675 . . . . 0.0 109.936 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.3 p -137.62 160.79 38.21 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.325 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.598 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -63.3 -32.94 74.48 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.03 0.443 . . . . 0.0 111.16 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -127.04 115.81 19.76 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.783 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 66.0 t80 -81.4 -31.61 33.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -56.89 -34.26 67.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.67 -62.62 1.43 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.35 -24.68 64.84 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 9.0 mtm180 40.51 48.74 2.55 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -120.47 121.72 39.1 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.783 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.8 p-90 -135.44 174.14 10.95 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -175.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.497 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.86 141.84 7.1 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.155 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.763 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.7 m-85 -57.0 154.37 9.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.217 0.532 . . . . 0.0 111.549 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.473 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 4.6 t -58.65 133.09 86.01 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.081 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.11 4.22 3.43 Favored 'Trans proline' 0 CA--C 1.513 -0.575 0 C-N-CA 122.86 2.373 . . . . 0.0 113.558 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -133.59 105.41 6.85 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.085 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -125.31 47.88 2.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.252 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.623 0 CA-C-O 118.443 -1.198 . . . . 0.0 112.23 -179.821 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.0 t . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -64.49 -76.52 0.07 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.955 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 72.6 mtp -128.21 -178.01 4.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.142 0.496 . . . . 0.0 111.443 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 t -127.79 -171.52 2.46 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.852 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.466 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 61.7 p -105.42 162.73 13.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.242 0.544 . . . . 0.0 112.11 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.88 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -96.35 -168.1 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 176.505 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.691 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 39.06 -124.29 1.72 Allowed Glycine 0 C--O 1.237 0.282 0 O-C-N 123.954 0.784 . . . . 0.0 113.18 177.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.681 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 36.68 -144.57 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 176.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -161.75 33.91 0.13 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.546 -0.827 . . . . 0.0 110.391 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 2.6 p -78.22 -54.29 6.39 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.39 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.0 -43.38 1.7 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.609 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.19 40.4 0.2 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 10' ' ' SER . . . -117.49 145.77 36.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.993 -0.104 . . . . 0.0 110.725 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -91.69 175.6 2.15 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.251 2.634 . . . . 0.0 111.889 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.9 m -78.62 124.55 28.29 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 82.0 t -94.88 106.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.834 0.35 . . . . 0.0 110.102 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -104.46 139.88 20.54 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.514 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -87.32 131.98 12.52 Favored 'Cis proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.748 -1.355 . . . . 0.0 111.932 -0.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.607 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 16.3 p90 -99.42 130.75 45.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.3 m -96.24 123.44 39.87 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.537 0.684 . . . . 0.0 111.681 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.963 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 13.1 t80 -128.36 141.0 51.56 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.33 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.704 HD13 ' CD1' ' A' ' 21' ' ' PHE . 2.8 mp 48.77 31.92 3.36 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 123.794 0.684 . . . . 0.0 112.302 176.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.46 -0.6 87.05 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.683 -0.689 . . . . 0.0 114.289 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.426 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 62.6 m-80 -114.96 137.27 52.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 118.072 0.936 . . . . 0.0 112.676 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -77.43 125.08 28.76 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.336 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.963 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.5 m-30 -112.6 111.16 21.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.982 0.896 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -92.65 -6.69 48.81 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.71 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 p -138.31 -172.66 3.33 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 98.3 m -69.52 163.54 25.16 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 t -140.77 169.05 18.36 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.665 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.632 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 12.3 p -122.89 15.75 10.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.474 ' CB ' ' HD2' ' A' ' 21' ' ' PHE . . . -60.38 138.64 57.95 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.809 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.86 -8.28 23.05 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.051 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.553 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 26.0 mtp85 -110.86 -73.59 0.68 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.088 0.471 . . . . 0.0 110.528 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.2 m 60.95 18.23 8.64 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.303 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.404 ' OD1' ' HB3' ' A' ' 34' ' ' ARG . 31.7 p-10 -92.92 -54.69 3.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.717 0.77 . . . . 0.0 110.374 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.86 -52.4 0.12 Allowed Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 114.638 -1.165 . . . . 0.0 113.305 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.764 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 1.9 mptt -69.85 116.32 10.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 0.0 111.893 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.632 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 56.4 mtt -83.73 150.8 25.59 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.694 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 14.3 p-90 -130.32 -171.31 2.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.495 0.664 . . . . 0.0 112.505 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.1 p -154.02 140.7 18.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.603 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.05 156.5 27.08 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.129 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.3 p -108.19 17.93 21.7 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.838 0.828 . . . . 0.0 110.209 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.7 p -138.83 146.61 41.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.596 -1.184 . . . . 0.0 108.498 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -53.1 -46.56 68.75 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.131 0.491 . . . . 0.0 110.675 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -116.36 106.82 14.06 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.814 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 77.6 t80 -71.08 -46.2 62.3 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.866 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -44.3 -34.53 1.97 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -86.69 -62.75 1.44 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -80.63 -17.93 49.72 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.652 ' HG3' ' O ' ' A' ' 47' ' ' TYR . 21.6 mtm105 33.35 64.68 0.3 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -125.22 112.93 17.0 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.814 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.7 p-90 -120.42 177.07 5.18 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.694 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -158.59 163.52 33.1 Favored Glycine 0 C--O 1.22 -0.769 0 CA-C-N 113.314 -1.766 . . . . 0.0 108.856 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.88 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 1.9 m-85 -88.22 164.51 15.6 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 118.56 1.18 . . . . 0.0 112.683 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.891 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 3.2 t -84.43 163.12 48.73 Favored Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.891 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 89.0 Cg_endo -69.18 -153.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.964 1.776 . . . . 0.0 113.055 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -75.96 118.47 18.77 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.725 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -113.59 36.29 3.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.375 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.709 0 CA-C-O 118.584 -1.12 . . . . 0.0 112.685 -179.924 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.66 0.266 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 3.2 p-90 -75.38 -40.43 58.03 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 33.3 mtt -118.25 109.12 15.96 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.902 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.9 m -107.2 168.12 9.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.482 -0.781 . . . . 0.0 108.971 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 55' ' ' PHE . 40.7 p -91.2 155.99 18.17 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 1.1 t -127.74 6.49 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-O 122.934 1.35 . . . . 0.0 110.317 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.422 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . -158.17 -156.05 7.82 Favored Glycine 0 C--N 1.284 -2.338 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.444 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.662 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 75.05 -144.19 31.88 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.297 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -140.13 29.11 2.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.282 0.563 . . . . 0.0 109.623 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.656 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 1.8 p -87.32 -41.0 13.97 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.377 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.19 43.61 7.42 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.883 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.41 35.5 17.08 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.487 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.656 ' HB3' ' HB2' ' A' ' 10' ' ' SER . . . -92.42 148.74 37.02 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.687 0.279 . . . . 0.0 110.492 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.6 Cg_exo -73.14 126.81 11.46 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.696 2.264 . . . . 0.0 112.354 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 88.3 m -65.07 141.65 58.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.366 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 48.3 t -107.78 132.27 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.708 0.29 . . . . 0.0 111.139 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.48 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 59.8 m-85 -125.39 142.7 42.41 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.308 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.598 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 6.7 Cg_endo -84.91 130.87 14.99 Favored 'Cis proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.324 -1.531 . . . . 0.0 112.014 -0.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.696 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 31.5 p90 -102.72 130.15 49.57 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 62.6 m -93.23 121.54 34.7 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.303 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.836 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 56.1 t80 -112.95 129.45 56.47 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.598 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.733 HD22 ' CE2' ' A' ' 21' ' ' PHE . 7.4 mp 42.96 36.83 0.95 Allowed 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 124.349 1.031 . . . . 0.0 112.908 175.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.0 -15.48 56.63 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 20' ' ' THR . 49.8 m-80 -109.65 129.98 55.55 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 119.367 1.583 . . . . 0.0 112.557 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.3 mtmt -77.36 119.59 21.2 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.001 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.836 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.5 m-85 -108.66 114.04 27.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.743 0.782 . . . . 0.0 111.498 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.598 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 35.0 mt-10 -89.98 -8.78 50.85 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.871 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.4 p -136.72 -177.22 4.64 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.0 m -67.05 165.24 16.17 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.064 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.555 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 9.0 t -144.45 170.09 16.7 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.131 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.735 ' HB2' ' HA ' ' A' ' 36' ' ' ASP . 22.9 p -123.78 18.6 9.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.91 136.58 58.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 113.922 -1.49 . . . . 0.0 112.045 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.31 -4.13 9.43 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.775 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.579 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 10.0 mtp85 -106.72 -176.8 3.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.578 0.704 . . . . 0.0 112.177 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 37' ' ' GLY . 1.5 m -82.36 25.21 0.63 Allowed 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.004 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.735 ' HA ' ' HB2' ' A' ' 31' ' ' SER . 0.0 OUTLIER 64.59 -27.4 0.09 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.856 2.062 . . . . 0.0 113.289 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 35' ' ' SER . . . -66.51 -77.39 0.29 Allowed Glycine 0 C--N 1.304 -1.208 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.997 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.718 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 7.9 mptt -72.83 101.71 3.21 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.464 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 50.3 mtt -75.7 153.43 37.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.689 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.7 p-90 -137.46 -165.7 1.81 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.351 0.596 . . . . 0.0 110.977 -178.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.496 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.3 p -167.9 141.32 3.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.962 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.432 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -72.3 156.15 39.42 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.025 0.44 . . . . 0.0 111.273 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.634 HG21 ' HB3' ' A' ' 10' ' ' SER . 45.8 p -104.58 13.79 31.03 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.796 0.808 . . . . 0.0 109.506 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.0 p -136.89 142.57 42.75 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.819 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.696 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -54.89 -39.89 69.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.979 0.419 . . . . 0.0 110.947 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -119.17 103.11 9.23 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 1.032 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 32.6 t80 -72.59 -32.99 66.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.177 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -51.22 -28.51 11.66 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -95.12 -60.79 1.6 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -82.19 -19.54 39.62 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 8.1 mtm180 44.3 44.67 6.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -109.13 114.96 29.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 1.032 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.6 p-90 -126.84 175.9 7.68 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -175.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.606 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -172.59 154.58 21.41 Favored Glycine 0 C--O 1.217 -0.946 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.558 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 5' ' ' THR . 15.1 m-30 -64.26 164.59 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.576 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 31.5 t -89.67 145.05 32.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.342 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.576 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 73.4 Cg_endo -67.7 -146.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 122.772 2.315 . . . . 0.0 114.078 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.468 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 2.5 m-20 -50.06 108.7 0.23 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.56 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -88.86 -34.13 17.11 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.787 0 CA-C-O 118.271 -1.294 . . . . 0.0 111.683 -179.748 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 120.548 0.213 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -109.13 82.49 1.6 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.24 56.36 3.62 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.761 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 26.3 m -71.63 156.94 38.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.505 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.512 HG22 ' SG ' ' A' ' 41' ' ' CYS . 77.5 p -69.8 173.11 6.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.53 0.566 . . . . 0.0 112.53 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.82 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 1.5 t -106.37 -67.96 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 CA-C-O 123.298 1.523 . . . . 0.0 109.88 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.86 ' H ' ' HB2' ' A' ' 55' ' ' PHE . . . -76.61 -156.23 6.83 Favored Glycine 0 C--N 1.284 -2.338 0 CA-C-N 111.167 -2.742 . . . . 0.0 112.599 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.592 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 74.14 -139.56 26.16 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.487 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -160.76 44.78 0.19 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.092 0.472 . . . . 0.0 110.421 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.861 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 3.3 p -79.58 -36.1 38.67 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.651 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.81 38.47 23.51 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.132 -1.032 . . . . 0.0 110.983 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.07 53.14 2.1 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.433 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.861 ' HB3' ' HB2' ' A' ' 10' ' ' SER . . . -129.78 144.94 54.98 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.597 0.237 . . . . 0.0 110.608 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 72.0 Cg_endo -83.05 170.69 12.11 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.512 2.142 . . . . 0.0 112.144 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.7 m -85.49 135.14 33.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.578 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 65.5 t -97.14 115.58 37.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.401 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 61.9 m-85 -113.53 138.67 22.65 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-O 120.886 0.374 . . . . 0.0 111.246 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -85.45 136.5 21.66 Favored 'Cis proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.466 -1.889 . . . . 0.0 112.654 -0.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.578 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 28.5 p90 -102.26 136.4 42.16 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 91.3 m -98.48 122.28 41.47 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.614 -0.835 . . . . 0.0 112.618 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.753 ' CG ' HD22 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -123.37 147.34 47.17 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.615 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.753 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 37.25 37.06 0.08 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.276 1.03 . . . . 0.0 113.676 178.447 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.15 -1.01 87.66 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.112 0.805 . . . . 0.0 115.112 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 20' ' ' THR . 68.7 m-80 -112.38 144.34 41.98 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 118.617 1.208 . . . . 0.0 111.985 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -87.46 120.44 28.77 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.628 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 16.6 m-85 -102.19 116.41 32.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.645 0.736 . . . . 0.0 111.315 -177.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -89.8 -24.17 21.53 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.616 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.8 p -126.12 -176.76 3.73 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.3 m -65.28 164.82 12.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.512 0.672 . . . . 0.0 109.891 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.524 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.5 t -139.61 171.57 14.06 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.272 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.2 p -126.07 19.7 7.66 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.49 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -67.24 138.46 56.93 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 113.503 -1.68 . . . . 0.0 112.009 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.67 -1.08 59.37 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.182 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 12.8 mtp85 -107.23 129.33 54.88 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.534 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 68.6 m -104.62 8.01 35.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.155 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 1.5 p-10 -93.87 -85.88 0.28 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.951 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.415 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 176.51 -26.61 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.934 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 62.4 mmtt -64.86 136.69 57.15 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 117.798 0.799 . . . . 0.0 111.664 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 52.1 mtt -92.27 145.2 24.67 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.672 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.5 p-90 -133.23 -167.75 1.97 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.299 0.571 . . . . 0.0 111.881 -177.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.512 ' SG ' HG22 ' A' ' 5' ' ' THR . 3.4 p -158.34 138.34 12.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.677 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.478 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -71.72 151.18 43.81 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.911 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.63 HG21 ' HB3' ' A' ' 10' ' ' SER . 67.9 p -102.44 15.82 28.09 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.564 0.697 . . . . 0.0 110.58 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.7 p -138.39 156.34 47.68 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.32 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.38 -35.01 76.31 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.056 0.455 . . . . 0.0 110.941 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -124.53 113.3 17.91 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.687 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 58.8 t80 -80.58 -33.61 35.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.985 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -56.22 -34.48 66.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -83.9 -62.3 1.6 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.15 -29.6 61.87 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 4.0 mtm180 45.55 45.91 10.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.841 0.829 . . . . 0.0 113.052 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -115.24 119.7 37.23 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.687 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.6 p-90 -131.14 179.97 5.69 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -174.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -170.31 151.32 16.22 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 113.873 -1.512 . . . . 0.0 109.323 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.86 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 11.6 m-85 -65.74 162.77 17.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.625 1.212 . . . . 0.0 112.718 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.456 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.5 t -71.17 126.28 91.95 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.783 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.433 ' HB3' ' O ' ' A' ' 4' ' ' SER . 12.2 Cg_endo -85.06 -161.06 0.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.883 2.389 . . . . 0.0 112.917 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.7 t0 34.35 56.52 0.66 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.307 1.005 . . . . 0.0 112.219 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -99.74 40.67 1.21 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.225 0.536 . . . . 0.0 110.686 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.772 0 CA-C-O 118.891 -0.949 . . . . 0.0 111.343 179.28 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.935 0.398 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -95.12 105.9 17.87 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.249 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.737 ' HG3' ' HB3' ' A' ' 14' ' ' PRO . 19.3 ptm -91.89 36.16 0.97 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.555 0.693 . . . . 0.0 109.637 178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -77.61 162.46 27.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.195 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.507 HG22 ' SG ' ' A' ' 41' ' ' CYS . 76.2 p -106.17 169.98 8.19 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 122.336 1.065 . . . . 0.0 113.844 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.753 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -112.87 -152.89 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 176.569 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.712 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 28.66 -122.28 0.07 OUTLIER Glycine 0 N--CA 1.463 0.456 0 O-C-N 124.671 1.232 . . . . 0.0 114.099 176.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.695 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 39.59 -144.7 0.34 Allowed Glycine 0 C--N 1.331 0.284 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -154.19 10.13 0.38 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.49 -0.855 . . . . 0.0 109.94 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -96.88 19.59 12.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.64 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.04 -98.27 0.63 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.999 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.08 36.39 1.67 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.77 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -76.96 149.22 79.87 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.311 0.1 . . . . 0.0 110.911 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.737 ' HB3' ' HG3' ' A' ' 3' ' ' MET . 11.9 Cg_exo -70.27 157.15 60.28 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.085 2.523 . . . . 0.0 112.727 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.6 m -79.82 135.51 36.49 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.7 t -100.16 112.43 32.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.673 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 55.0 m-85 -108.39 141.94 24.3 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.852 0.358 . . . . 0.0 111.408 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.4 Cg_endo -86.87 136.03 17.42 Favored 'Cis proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.531 -1.445 . . . . 0.0 111.981 -0.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.673 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 33.5 p90 -103.29 129.18 50.22 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.7 m -92.43 127.25 37.85 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.233 0.539 . . . . 0.0 112.124 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.85 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.2 t80 -130.36 144.21 51.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.761 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 40.37 36.86 0.38 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.462 1.105 . . . . 0.0 112.899 178.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.23 -9.84 73.49 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 114.709 0.644 . . . . 0.0 114.709 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.412 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 72.9 m-80 -107.6 134.45 50.58 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.453 1.127 . . . . 0.0 111.827 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -79.71 121.14 24.96 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.791 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.85 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.2 m-30 -104.52 110.31 22.54 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.982 0.896 . . . . 0.0 111.086 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 33.2 mt-10 -88.04 -16.69 32.94 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.295 -1.321 . . . . 0.0 110.742 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 p -129.28 -175.24 3.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.9 m -65.43 163.42 15.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.465 0.65 . . . . 0.0 110.177 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.422 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.9 t -138.73 -176.78 4.6 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.645 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.45 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 10.1 p -141.07 18.62 2.28 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -64.84 145.69 55.92 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 113.281 -1.781 . . . . 0.0 112.503 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.09 5.13 32.05 Favored Glycine 0 C--O 1.235 0.198 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.847 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 34' ' ' ARG . 0.1 OUTLIER -107.57 -76.12 0.62 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.128 0.464 . . . . 0.0 110.982 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.2 m 75.78 25.8 1.12 Allowed 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -112.14 -88.1 0.54 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.223 0.92 . . . . 0.0 111.3 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.58 -45.08 0.06 OUTLIER Glycine 0 CA--C 1.528 0.859 0 N-CA-C 116.081 1.193 . . . . 0.0 116.081 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.71 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 3.9 mptt -64.63 -158.43 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.45 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 87.8 mtp -158.42 145.55 17.76 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.63 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 23.5 p-90 -135.59 -174.64 3.7 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.507 ' SG ' HG22 ' A' ' 5' ' ' THR . 6.5 p -152.76 136.85 16.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.161 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . . . -73.04 151.14 41.84 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.013 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.3 p -100.61 17.67 21.22 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.733 0.777 . . . . 0.0 109.275 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.7 p -135.6 151.7 50.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.213 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.666 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -60.72 -37.67 82.52 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.121 0.486 . . . . 0.0 110.878 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -124.26 107.85 11.62 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.708 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 56.4 t80 -74.75 -32.31 62.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.301 -0.408 . . . . 0.0 112.047 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -55.97 -33.66 65.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -94.96 -56.87 2.6 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -77.54 -20.93 53.4 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.588 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 17.5 mtm180 39.63 52.45 2.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -122.47 117.9 27.05 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.708 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.2 p-90 -125.73 172.73 9.56 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.561 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -158.64 154.13 25.23 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.29 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.753 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 1.0 OUTLIER -80.34 156.79 26.58 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -178.636 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 81.7 m -97.63 124.56 47.97 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -78.43 -159.24 0.1 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.393 2.062 . . . . 0.0 113.771 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.1 t70 40.87 60.2 2.02 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.628 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -113.16 19.61 16.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.038 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.567 0 CA-C-O 118.499 -1.167 . . . . 0.0 111.893 -179.934 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.966 0.413 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -97.44 -137.42 0.27 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.657 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.4 mtt -89.87 67.48 7.21 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 m -70.43 162.39 28.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.946 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 p -108.11 173.92 6.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.666 0.746 . . . . 0.0 112.47 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -116.78 -168.23 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.072 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.455 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 36.73 -122.7 0.82 Allowed Glycine 0 N--CA 1.462 0.4 0 O-C-N 124.056 0.848 . . . . 0.0 113.076 178.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.712 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 35.15 -141.36 0.13 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 115.616 1.006 . . . . 0.0 115.616 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.0 p30 -145.89 -0.31 0.82 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.205 -0.497 . . . . 0.0 110.213 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.586 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 5.3 m -91.39 -63.82 1.21 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.856 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.61 -74.4 2.12 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.098 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.27 -11.83 82.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.233 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -92.91 140.98 23.65 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.913 0.387 . . . . 0.0 111.165 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 73.1 Cg_endo -87.04 167.75 8.02 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.927 2.418 . . . . 0.0 112.015 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.7 m -79.73 139.75 37.2 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.312 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.1 t -107.5 112.42 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -114.02 143.7 30.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.723 0.297 . . . . 0.0 111.103 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -85.75 137.25 21.97 Favored 'Cis proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.495 -1.46 . . . . 0.0 111.836 -0.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 41.3 p90 -102.79 -178.36 3.65 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.453 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.8 m -135.03 126.2 28.02 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.664 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.645 ' CE2' ' HZ2' ' A' ' 40' ' ' TRP . 1.9 t80 -134.24 141.58 47.05 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.655 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 40.87 38.42 0.65 Allowed 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.746 1.219 . . . . 0.0 113.706 178.607 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.17 -1.65 88.57 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -107.89 154.88 20.94 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 118.439 1.119 . . . . 0.0 111.26 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -94.83 126.36 40.11 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.606 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 21.8 m-85 -113.88 111.92 22.51 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.68 0.752 . . . . 0.0 111.784 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -96.03 -8.33 33.88 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.09 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 p -136.57 -172.75 3.23 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.8 m -69.31 168.64 13.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.128 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.511 ' HG1' ' HE2' ' A' ' 26' ' ' TYR . 10.2 t -144.48 167.12 23.25 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.594 0.711 . . . . 0.0 110.738 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.512 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 61.3 p -120.54 12.64 11.58 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.586 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -56.05 136.74 52.08 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.67 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.37 -10.86 19.99 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.018 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.7 mtp85 -111.21 -71.73 0.75 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.059 0.457 . . . . 0.0 110.272 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.7 m 56.78 27.58 13.02 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.41 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -100.25 -63.41 1.13 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.356 0.598 . . . . 0.0 110.641 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.26 -49.05 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.498 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.677 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -73.24 108.63 6.23 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -179.427 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.512 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 80.9 mtp -80.6 148.37 30.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.665 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.5 p-90 -128.31 -165.11 1.45 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.382 0.61 . . . . 0.0 111.627 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.5 p -159.68 146.9 16.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.968 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -81.0 143.57 32.42 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.473 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.0 p -97.14 13.97 27.43 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.778 0.799 . . . . 0.0 110.113 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.411 HG23 ' HB2' ' A' ' 52' ' ' LYS . 38.1 p -134.09 158.76 42.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.157 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -65.39 -26.54 68.04 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.193 0.52 . . . . 0.0 110.624 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -132.71 117.44 17.85 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.814 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 65.6 t80 -86.18 -34.78 20.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -54.36 -37.06 64.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.967 0.413 . . . . 0.0 111.791 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.76 -66.37 0.93 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.33 -20.37 63.0 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 26.2 mtt180 38.55 51.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.411 ' HB2' HG23 ' A' ' 44' ' ' THR . 89.8 mttt -113.71 119.22 36.64 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 176.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.814 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 5.3 p-90 -132.25 171.68 13.39 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -174.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.562 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -166.07 143.9 8.76 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 113.3 -1.773 . . . . 0.0 109.838 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.684 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.4 m-30 -60.51 151.51 28.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.399 0.6 . . . . 0.0 111.63 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.497 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 4.5 t -62.56 128.41 91.52 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.66 5.08 2.62 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 C-N-CA 122.856 2.371 . . . . 0.0 114.61 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -154.8 116.51 4.13 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.352 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -100.39 116.35 32.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.713 0.292 . . . . 0.0 110.482 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.714 0 CA-C-O 118.684 -1.064 . . . . 0.0 112.075 179.975 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.442 ' OG ' ' HG2' ' A' ' 3' ' ' MET . 40.4 p . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -91.52 15.39 12.51 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.442 ' HG2' ' OG ' ' A' ' 1' ' ' SER . 19.1 ptp -82.15 129.85 34.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.9 m -96.28 169.55 9.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.26 0.552 . . . . 0.0 111.299 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.0 p -91.14 176.61 6.52 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.605 0.717 . . . . 0.0 111.851 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.792 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -113.77 -166.54 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 176.376 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.646 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 34.7 -126.11 0.58 Allowed Glycine 0 N--CA 1.463 0.47 0 O-C-N 124.069 0.856 . . . . 0.0 114.117 177.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.579 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 40.74 -149.1 0.2 Allowed Glycine 0 C--N 1.337 0.611 0 N-CA-C 115.77 1.068 . . . . 0.0 115.77 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -143.73 5.22 1.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.826 -0.687 . . . . 0.0 110.435 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -84.41 -45.8 12.35 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.175 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.45 -105.28 3.23 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.802 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.69 32.48 3.68 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.674 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.01 144.24 28.34 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.979 0.39 . . . . 0.0 110.196 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -87.86 167.13 7.12 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.914 2.409 . . . . 0.0 112.136 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.2 m -83.44 129.67 34.99 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 92.7 t -96.87 112.25 28.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.707 0.289 . . . . 0.0 110.305 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -107.0 138.37 19.8 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.562 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -86.25 132.25 14.48 Favored 'Cis proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.21 -1.579 . . . . 0.0 112.263 -0.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.605 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 17.9 p90 -99.93 126.28 46.06 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.244 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 91.2 m -91.67 122.46 34.25 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.963 0.411 . . . . 0.0 110.565 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.867 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 68.3 t80 -115.2 130.09 56.82 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.604 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.552 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.7 mm? 35.28 45.11 0.19 Allowed 'General case' 0 N--CA 1.428 -1.536 0 O-C-N 124.775 1.297 . . . . 0.0 113.319 175.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.72 -23.07 32.21 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 116.497 1.359 . . . . 0.0 116.497 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -111.26 132.51 54.31 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 120.027 1.914 . . . . 0.0 113.12 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 39.7 mtpt -77.71 126.67 31.22 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.867 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.3 m-85 -110.77 118.67 36.79 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.898 0.856 . . . . 0.0 111.643 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -89.62 -12.44 39.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.76 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.4 p -136.08 -171.21 2.82 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.0 m -70.19 166.24 20.41 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.499 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -143.91 171.22 14.54 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.335 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.478 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 71.3 p -125.41 20.88 7.97 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.45 132.83 55.13 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.971 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.02 -8.04 40.12 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.095 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.0 mtp85 -108.85 -79.16 0.58 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.594 0.235 . . . . 0.0 111.28 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.7 p 52.5 31.31 9.64 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.031 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -105.36 -37.28 6.9 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.728 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.28 -65.35 0.16 Allowed Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.829 -1.078 . . . . 0.0 113.279 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.647 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 2.0 mptt -71.8 135.72 46.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.478 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 58.2 mtt -94.71 153.21 17.9 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.651 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.8 p-90 -133.6 -166.51 1.79 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.216 0.532 . . . . 0.0 111.777 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 8.4 p -160.07 143.99 14.28 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 19' ' ' PHE . . . -78.77 152.57 31.38 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.563 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.0 p -102.98 9.94 38.44 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.656 0.741 . . . . 0.0 110.553 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.0 p -133.03 153.12 51.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.989 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.44 -42.01 81.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 111.341 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -120.83 111.36 17.46 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 1.051 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 34.3 t80 -77.16 -31.82 55.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.938 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -51.94 -32.8 34.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -90.08 -71.55 0.61 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.25 -27.81 68.24 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.692 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 24.0 mtm-85 45.15 51.0 9.31 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -117.04 119.04 34.04 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 1.051 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.8 p-90 -127.42 172.09 10.97 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -175.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.576 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.44 147.38 13.8 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 113.292 -1.777 . . . . 0.0 109.466 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.792 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 6.1 m-30 -62.84 158.37 19.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.329 1.065 . . . . 0.0 110.989 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.529 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 25.2 t -64.74 130.74 94.91 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.167 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -78.89 11.46 2.54 Favored 'Trans proline' 0 CA--C 1.515 -0.427 0 C-N-CA 123.178 2.585 . . . . 0.0 112.321 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -121.56 59.48 0.97 Allowed 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.419 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -126.8 -149.12 0.41 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.002 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.91 0 CA-C-O 118.683 -1.065 . . . . 0.0 112.173 179.669 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.8 p . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.883 0.373 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -103.54 76.75 1.43 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.858 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.1 ptm -135.9 133.28 37.53 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.351 0.595 . . . . 0.0 111.086 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.5 t -136.91 -171.37 2.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.701 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.41 166.96 10.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.328 1.061 . . . . 0.0 112.95 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.613 HG22 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -129.9 163.45 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 178.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.725 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 62.12 -141.35 47.23 Favored Glycine 0 C--N 1.316 -0.561 0 C-N-CA 118.059 -2.02 . . . . 0.0 111.861 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.625 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 39.67 -139.09 1.03 Allowed Glycine 0 C--N 1.334 0.468 0 N-CA-C 115.676 1.03 . . . . 0.0 115.676 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -158.16 28.07 0.25 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.273 -0.463 . . . . 0.0 110.569 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.67 -52.24 7.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.311 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.68 -69.33 0.46 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.942 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.58 31.68 2.3 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.351 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.27 139.05 19.76 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.799 0.333 . . . . 0.0 111.168 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -84.25 164.41 13.01 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.726 2.284 . . . . 0.0 111.527 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.459 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.9 m -72.33 138.39 47.29 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 59.7 t -107.88 113.32 43.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.581 0.229 . . . . 0.0 110.681 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -115.82 140.24 25.91 Favored Pre-proline 0 N--CA 1.454 -0.268 0 CA-C-O 120.845 0.355 . . . . 0.0 110.963 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.453 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 5.4 Cg_endo -87.0 132.88 13.84 Favored 'Cis proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.292 -1.545 . . . . 0.0 111.754 -0.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.457 ' CG ' ' HB3' ' A' ' 42' ' ' ALA . 46.3 p90 -98.48 -175.11 3.0 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.844 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 18.9 m -140.0 119.58 13.19 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.727 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.85 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 68.3 t80 -117.83 133.21 56.15 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.504 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.6 mm? 34.62 47.53 0.24 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.697 1.248 . . . . 0.0 113.797 175.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.99 -9.11 75.79 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 116.402 1.321 . . . . 0.0 116.402 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 20' ' ' THR . 51.5 m-80 -110.12 150.01 29.23 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.821 1.811 . . . . 0.0 112.363 -178.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -91.57 125.74 36.41 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.85 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 88.7 m-85 -115.59 114.3 24.75 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.612 0.72 . . . . 0.0 111.574 -178.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.453 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 41.3 mt-10 -93.21 -12.82 29.33 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.234 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.5 p -133.05 -166.47 1.76 Allowed 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.7 m -76.35 170.17 16.86 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.863 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.5 t -147.76 169.5 19.61 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.346 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.9 p -123.59 20.28 9.48 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.411 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -59.85 133.15 55.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 113.523 -1.672 . . . . 0.0 112.101 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.73 -0.22 45.39 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.468 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 22.3 mtp85 -106.5 -81.99 0.54 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.9 m 62.27 25.91 15.5 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.366 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -98.73 -35.03 10.29 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.644 0.735 . . . . 0.0 110.418 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.95 -41.75 0.76 Allowed Glycine 0 C--N 1.313 -0.716 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.895 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.439 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 21.8 mmmt -84.91 131.71 34.46 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -90.28 147.05 23.76 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.645 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.5 p-90 -128.59 -169.61 2.11 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.303 0.573 . . . . 0.0 111.834 -178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.0 p -154.41 142.2 20.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.761 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -76.76 143.13 40.09 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.509 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.1 p -99.07 10.35 41.63 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.581 0.705 . . . . 0.0 110.043 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.5 p -136.14 146.85 47.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.729 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.32 -48.24 79.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.768 0.318 . . . . 0.0 111.146 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 48' ' ' ASP . 20.1 t-20 -109.24 99.68 8.92 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.884 ' CE2' ' HB3' ' A' ' 53' ' ' TRP . 47.5 t80 -72.16 -32.91 67.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.559 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.413 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . 54.2 m-20 -45.48 -39.83 7.68 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.8 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -95.97 -55.69 2.9 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -69.23 -35.04 75.76 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.2 mmm180 51.15 37.98 19.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -107.57 118.67 37.33 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.884 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 11.0 p-90 -128.66 174.22 9.61 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.404 -175.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.612 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.08 142.05 7.47 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.751 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.725 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 9.2 m-85 -59.03 154.13 16.23 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.376 0.608 . . . . 0.0 111.639 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.771 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 5.1 t -66.62 153.43 93.46 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.771 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 61.0 Cg_endo -64.18 -143.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.951 2.434 . . . . 0.0 114.055 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 33.7 t70 -61.21 114.92 3.42 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.867 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.591 ' NE2' ' HB3' ' A' ' 56' ' ' CYS . 38.0 mt-30 -129.47 -55.49 1.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.071 178.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.759 0 CA-C-O 118.253 -1.304 . . . . 0.0 111.3 -179.706 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.441 0.163 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -82.18 124.93 30.33 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.5 mtm -83.92 133.81 34.7 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.493 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.1 m -72.45 160.61 32.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.358 179.399 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.439 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 11.0 p -97.3 162.6 13.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.676 0.75 . . . . 0.0 112.639 -179.43 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.771 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -110.07 -163.44 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.119 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.427 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 34.62 -121.86 0.44 Allowed Glycine 0 N--CA 1.463 0.447 0 O-C-N 124.282 0.988 . . . . 0.0 112.999 177.515 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.698 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 29.36 -135.28 0.06 OUTLIER Glycine 0 C--N 1.338 0.66 0 N-CA-C 115.986 1.154 . . . . 0.0 115.986 176.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -144.23 -31.89 0.44 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.722 -0.739 . . . . 0.0 109.214 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.427 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 5.0 m -56.76 -66.89 0.37 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.557 179.291 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.5 -70.77 1.34 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.18 179.526 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.29 -12.94 69.95 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.917 -0.658 . . . . 0.0 113.213 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -96.15 140.81 22.43 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 117.27 0.535 . . . . 0.0 110.983 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 42.0 Cg_endo -85.78 165.56 10.31 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.941 2.427 . . . . 0.0 112.721 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 5.6 m -71.79 127.7 33.41 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.3 t -102.68 101.83 12.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.033 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.655 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 47.7 m-85 -103.45 143.3 26.34 Favored Pre-proline 0 N--CA 1.45 -0.45 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.751 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.83 136.02 22.55 Favored 'Cis proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.578 -1.843 . . . . 0.0 112.355 -0.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.655 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 29.9 p90 -102.77 -171.97 2.04 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.289 177.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.2 m -145.76 127.43 15.22 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.705 -177.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.791 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.5 t80 -134.42 143.02 47.33 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.69 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 41.75 35.41 0.5 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 124.416 1.087 . . . . 0.0 112.976 178.953 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.34 -9.46 77.42 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.506 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 70.7 m-80 -107.73 138.13 44.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 118.368 1.084 . . . . 0.0 112.294 -178.426 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -79.5 123.31 27.44 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.791 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 15.3 m-30 -106.01 114.52 28.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.762 0.791 . . . . 0.0 110.821 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -86.81 -24.75 24.89 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.068 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 p -122.75 -173.24 2.65 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.306 179.07 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.1 m -72.32 166.92 21.52 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.937 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.9 t -141.61 166.03 25.87 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.408 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.405 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 12.9 p -120.8 18.77 11.85 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.459 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.618 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -59.91 139.07 57.63 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 113.656 -1.611 . . . . 0.0 111.466 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.01 -1.45 68.99 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.2 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.572 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 24.2 mtp85 -115.87 149.12 39.17 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.669 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 p -118.68 2.94 11.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.046 0.45 . . . . 0.0 110.897 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.08 -82.96 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.339 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.06 -14.62 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.569 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.572 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 66.4 mttt -64.27 102.55 0.53 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 122.276 0.23 . . . . 0.0 110.9 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.405 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 43.8 mtt -75.01 143.04 43.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.98 0.419 . . . . 0.0 110.271 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.704 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.1 p-90 -131.24 -167.68 1.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.432 -178.695 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 15.1 p -157.68 149.54 22.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.006 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.9 151.75 27.12 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.66 178.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 34.5 p -116.23 10.08 14.76 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.016 -178.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.565 HG21 ' HE2' ' A' ' 52' ' ' LYS . 73.4 p -123.03 12.08 9.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.346 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . 70.01 -35.99 0.33 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.336 0.655 . . . . 0.0 111.45 -178.449 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 44' ' ' THR . 21.5 t-20 -129.49 110.48 11.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.697 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.898 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 49.5 t80 -87.85 -28.68 21.45 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -177.501 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -58.23 -34.7 70.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -92.94 -53.28 4.21 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.0 OUTLIER -74.64 -43.98 52.71 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.203 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER 61.34 39.55 15.25 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.868 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.565 ' HE2' HG21 ' A' ' 44' ' ' THR . 4.6 mppt? -113.76 118.71 35.04 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.898 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.5 p-90 -130.73 174.96 9.42 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -174.246 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.602 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.4 148.04 13.35 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 113.194 -1.821 . . . . 0.0 109.615 178.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.771 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 7.1 m-30 -60.81 157.81 14.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.58 0.705 . . . . 0.0 111.787 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.494 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 29.3 t -70.78 126.13 92.12 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.823 -178.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -80.75 6.04 5.76 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.814 2.342 . . . . 0.0 111.758 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -131.47 68.16 1.5 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.81 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.442 ' OE1' ' HB3' ' A' ' 56' ' ' CYS . 14.8 mm100 -80.67 162.96 23.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.192 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.868 0 CA-C-O 118.432 -1.204 . . . . 0.0 111.661 -179.735 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 120.836 0.35 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -126.35 143.73 51.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -174.39 0.79 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.669 0.271 . . . . 0.0 111.559 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 t 67.51 -169.26 0.19 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.566 -178.683 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -101.86 158.02 16.43 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.273 1.035 . . . . 0.0 113.222 -179.039 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.501 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -137.9 161.33 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 178.188 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.638 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 62.42 -147.78 49.29 Favored Glycine 0 C--N 1.311 -0.816 0 C-N-CA 118.254 -1.927 . . . . 0.0 111.306 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.745 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 49.3 -148.27 5.58 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 121.607 -0.33 . . . . 0.0 113.766 178.127 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -133.83 -10.53 2.7 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.51 178.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 m -74.68 -55.27 6.06 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.92 69.54 1.24 Allowed Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.228 -0.442 . . . . 0.0 113.758 178.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.45 -32.43 1.96 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.45 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -78.09 147.06 72.57 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.1 Cg_endo -81.56 149.78 16.66 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.636 2.224 . . . . 0.0 112.323 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 72.3 m -77.3 126.14 30.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.847 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 43.9 t -95.92 121.43 46.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.871 0.367 . . . . 0.0 110.924 -178.791 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.535 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 52.7 m-85 -115.86 139.43 24.92 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-O 121.248 0.547 . . . . 0.0 111.308 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.664 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 27.7 Cg_endo -86.79 137.53 19.27 Favored 'Cis proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.669 -1.804 . . . . 0.0 112.359 -0.75 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.643 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 42.8 p90 -102.87 129.38 49.55 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.662 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 5.4 m -91.84 127.75 37.41 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.27 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.874 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.1 t80 -129.61 144.81 51.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.433 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.769 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 40.36 35.97 0.32 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.15 0.98 . . . . 0.0 113.243 178.381 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.0 -10.06 75.25 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.033 -0.603 . . . . 0.0 114.502 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -111.98 133.62 54.04 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 118.438 1.119 . . . . 0.0 111.794 -179.041 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.689 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 3.7 mptt -82.07 123.22 28.75 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.548 -179.652 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.874 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 15.7 m-85 -104.91 110.9 23.46 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.72 0.771 . . . . 0.0 111.031 -178.034 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.664 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 48.7 mt-10 -84.95 -15.76 43.28 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.86 -179.487 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p -130.97 -176.45 4.0 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 68.6 m -67.47 162.62 22.8 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.28 179.294 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.542 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.7 t -139.13 -177.48 4.92 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.7 p -135.88 22.15 3.3 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.61 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.493 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -66.72 150.18 49.46 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 113.91 -1.496 . . . . 0.0 113.096 -178.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.97 7.53 50.16 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 114.963 -1.017 . . . . 0.0 114.468 178.065 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.601 ' HB3' ' CZ ' ' A' ' 34' ' ' ARG . 5.4 mtp-105 -101.72 -158.45 0.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.148 0.974 . . . . 0.0 112.557 -179.398 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 p -133.34 -40.67 0.89 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -178.205 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.578 ' CG ' HH22 ' A' ' 34' ' ' ARG . 1.2 p-10 -98.11 -93.2 0.24 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.237 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' N ' HH12 ' A' ' 34' ' ' ARG . . . -162.86 21.05 0.17 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 116.426 1.331 . . . . 0.0 116.426 -178.597 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.667 ' HD3' ' CZ ' ' A' ' 55' ' ' PHE . 45.0 mttp -78.46 137.05 37.77 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 119.159 1.48 . . . . 0.0 108.569 177.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -99.47 144.98 27.94 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.601 -0.839 . . . . 0.0 108.88 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.691 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 18.6 p-90 -139.68 -172.09 3.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.224 0.535 . . . . 0.0 111.519 -178.344 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.6 p -156.94 139.5 14.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.206 178.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -72.78 152.68 41.46 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 120.989 0.423 . . . . 0.0 110.856 -179.293 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.7 p -100.27 16.39 24.49 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.641 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.448 HG21 ' CB ' ' A' ' 50' ' ' ASP . 70.8 p -135.21 154.83 51.46 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.179 179.271 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -62.18 -35.06 77.69 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.254 0.55 . . . . 0.0 110.399 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -125.77 110.24 13.49 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.717 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 61.9 t80 -76.6 -33.97 58.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.281 -177.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -53.67 -36.23 61.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.046 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.27 -63.72 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.448 ' CB ' HG21 ' A' ' 44' ' ' THR . 32.7 m-20 -72.53 -36.51 68.33 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -177.47 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.8 mmm180 54.67 50.77 15.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -120.92 116.61 25.46 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 176.112 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.717 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.9 p-90 -129.71 172.67 11.38 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -174.012 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.745 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -160.43 146.69 12.9 Favored Glycine 0 C--O 1.221 -0.701 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.969 178.421 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.667 ' CZ ' ' HD3' ' A' ' 38' ' ' LYS . 3.9 m-30 -61.27 163.29 6.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.578 0.704 . . . . 0.0 112.69 -179.427 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.413 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 6.6 t -83.44 134.21 45.75 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.417 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.88 10.06 1.18 Allowed 'Trans proline' 0 N--CA 1.481 0.764 0 C-N-CA 123.364 2.709 . . . . 0.0 114.152 -179.085 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.36 5.71 46.23 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.743 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -104.62 -135.05 0.34 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.922 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.658 -1.079 . . . . 0.0 111.871 -179.915 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 64.64 -86.0 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.596 0.56 . . . . 0.0 111.371 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.91 176.32 9.92 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.847 0.356 . . . . 0.0 111.163 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -93.36 -173.36 3.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.495 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.9 p -86.68 -179.73 6.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.919 0.866 . . . . 0.0 112.589 -179.083 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.79 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -127.48 -171.06 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.153 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.567 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.49 -120.6 0.79 Allowed Glycine 0 CA--C 1.521 0.412 0 O-C-N 123.786 0.679 . . . . 0.0 113.306 177.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.705 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 25.88 -136.12 0.02 OUTLIER Glycine 0 C--N 1.343 0.926 0 N-CA-C 116.383 1.313 . . . . 0.0 116.383 177.53 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -160.0 41.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.62 -0.79 . . . . 0.0 110.133 179.704 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.21 -42.19 5.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.755 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.12 -79.14 1.94 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.835 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -121.52 32.59 4.61 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.125 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.23 144.73 30.34 Favored Pre-proline 0 C--N 1.328 -0.349 0 O-C-N 122.383 -0.481 . . . . 0.0 110.034 179.161 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -86.22 167.96 9.1 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.54 2.16 . . . . 0.0 112.4 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 74.9 m -87.81 133.23 33.92 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.564 179.354 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.2 t -95.49 125.9 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.668 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.588 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 49.5 m-85 -122.63 138.97 30.18 Favored Pre-proline 0 N--CA 1.444 -0.727 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.592 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -86.66 133.27 14.87 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.415 -1.494 . . . . 0.0 112.328 -0.331 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.588 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 27.3 p90 -99.77 130.4 45.97 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.239 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.4 m -91.19 125.39 35.95 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.375 0.607 . . . . 0.0 111.894 -178.031 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.828 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 2.1 t80 -129.7 141.58 50.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.845 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.642 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 42.11 36.95 0.76 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.129 0.971 . . . . 0.0 113.078 178.678 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.37 -6.15 83.9 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.83 -0.7 . . . . 0.0 114.751 178.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.553 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.3 m-80 -112.27 136.46 51.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.434 1.117 . . . . 0.0 111.947 -178.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -80.35 122.36 26.83 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.828 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 15.4 m-30 -104.99 111.2 23.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.779 0.799 . . . . 0.0 111.104 -177.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -89.38 -19.55 25.08 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.608 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.9 p -127.33 -179.34 4.84 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.6 m -67.04 156.55 35.76 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.683 178.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.451 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 14.0 t -131.25 173.28 11.21 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.936 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.453 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 24.1 p -127.42 18.34 6.95 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 176.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.457 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -63.4 151.48 40.88 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 113.808 -1.542 . . . . 0.0 111.403 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.69 -1.53 57.66 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.205 178.879 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.666 ' NH1' ' H ' ' A' ' 38' ' ' LYS . 1.8 mtp-105 -116.23 -173.55 2.38 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 117.17 0.485 . . . . 0.0 111.223 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.6 t -130.64 -28.5 2.03 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.471 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.42 ' CG ' HH12 ' A' ' 34' ' ' ARG . 1.4 p-10 -91.48 -92.55 0.14 Allowed 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.627 -0.671 . . . . 0.0 111.323 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.21 25.74 0.09 OUTLIER Glycine 0 CA--C 1.526 0.76 0 C-N-CA 119.109 -1.52 . . . . 0.0 116.753 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.666 ' H ' ' NH1' ' A' ' 34' ' ' ARG . 40.9 mttp -83.58 85.82 7.2 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.169 1.484 . . . . 0.0 109.528 178.368 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.453 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 49.7 mtm -59.32 137.05 58.12 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.142 0.496 . . . . 0.0 110.746 -178.609 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.682 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.8 p-90 -133.51 -169.4 2.28 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.213 -178.591 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.2 p -160.43 138.12 9.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.006 178.237 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.83 155.11 41.03 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.107 0.479 . . . . 0.0 111.019 -178.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.3 p -102.87 13.65 33.86 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.037 0.922 . . . . 0.0 109.559 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.41 HG21 ' CB ' ' A' ' 50' ' ' ASP . 65.8 p -133.55 153.5 51.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.969 179.118 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -59.92 -37.25 78.93 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.057 0.456 . . . . 0.0 110.842 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -123.23 110.45 15.25 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.323 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.758 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 64.8 t80 -76.75 -33.14 58.11 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.085 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -57.35 -31.9 66.21 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.219 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -88.83 -62.07 1.57 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.41 ' CB ' HG21 ' A' ' 44' ' ' THR . 2.4 m-20 -74.13 -27.38 60.84 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.437 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 3.1 mmm180 48.58 49.24 18.78 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -120.59 117.53 27.83 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.263 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.758 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.9 p-90 -129.19 177.6 7.03 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -174.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.608 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.44 147.19 11.44 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.638 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.79 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 6.0 m-30 -62.66 157.6 20.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.704 0.752 . . . . 0.0 112.293 -179.056 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.509 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 27.0 t -73.94 135.37 77.28 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.599 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -76.25 6.18 4.1 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.715 2.277 . . . . 0.0 113.73 -179.323 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -151.09 97.46 2.45 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.12 179.555 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -113.43 57.95 0.67 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.87 0.367 . . . . 0.0 110.676 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.751 0 CA-C-O 118.67 -1.072 . . . . 0.0 111.653 179.913 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.496 0.189 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.415 ' CD1' ' HB3' ' A' ' 58' ' ' ASP . 5.6 m-90 -117.49 -176.72 3.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.567 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 ptp -77.84 -167.57 1.02 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.053 0.454 . . . . 0.0 111.26 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.6 m -79.18 -162.82 0.43 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.704 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.404 HG21 ' HA3' ' A' ' 54' ' ' GLY . 68.7 p -65.63 169.51 6.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.594 -178.591 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.18 5.98 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 CA-C-O 122.561 1.172 . . . . 0.0 111.2 -179.3 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.439 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . -154.75 -155.24 7.2 Favored Glycine 0 C--N 1.282 -2.448 0 CA-C-N 113.319 -1.764 . . . . 0.0 111.651 -178.161 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.724 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 72.2 -168.35 52.35 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.846 179.007 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -105.69 -1.08 24.94 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.937 0.399 . . . . 0.0 110.542 178.783 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.9 m -88.08 -61.86 1.62 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.392 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.83 -63.26 4.5 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.913 178.305 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.26 -18.25 43.34 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.927 -178.348 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -78.65 139.82 58.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 117.419 0.609 . . . . 0.0 111.614 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 3.4 Cg_exo -76.8 164.91 29.46 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.452 2.768 . . . . 0.0 112.055 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 84.5 m -87.4 142.93 27.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.864 0.364 . . . . 0.0 110.769 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -108.52 120.86 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.952 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.502 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 62.9 m-85 -118.6 143.8 34.12 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-O 121.016 0.436 . . . . 0.0 111.223 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.679 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 28.5 Cg_endo -87.47 140.22 20.72 Favored 'Cis proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.706 -1.789 . . . . 0.0 111.98 -0.481 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.633 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 35.6 p90 -104.26 -174.06 2.45 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.518 178.064 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.1 m -141.56 127.1 18.91 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.86 -179.033 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.757 ' CG ' HD22 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -131.7 144.9 51.33 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.033 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.757 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.17 35.02 0.08 Allowed 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.61 1.164 . . . . 0.0 113.837 178.022 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.12 -3.74 84.45 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 115.026 0.77 . . . . 0.0 115.026 178.528 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.579 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 59.0 m-80 -110.2 138.7 46.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.371 1.086 . . . . 0.0 111.508 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -79.46 122.0 25.89 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.709 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.4 m-30 -108.35 106.9 17.25 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.836 0.827 . . . . 0.0 110.902 -178.7 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.679 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 92.1 mt-10 -91.23 -15.55 29.05 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.363 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -129.15 -177.78 4.37 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.499 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.5 m -66.19 164.61 15.36 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.684 178.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.0 t -141.99 175.53 9.66 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.772 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.428 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 23.3 p -128.64 17.54 6.35 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.54 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.522 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -65.26 153.75 40.15 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 114.118 -1.401 . . . . 0.0 112.025 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.28 -0.1 42.4 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.69 -0.686 . . . . 0.0 114.082 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.772 ' NH1' ' H ' ' A' ' 38' ' ' LYS . 2.3 mtp-105 -112.24 -176.47 2.93 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 117.781 0.791 . . . . 0.0 111.428 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 p -130.37 -14.95 3.7 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.462 ' OD2' ' HG3' ' A' ' 38' ' ' LYS . 2.6 p-10 -108.21 -96.17 0.38 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.365 0.53 . . . . 0.0 111.476 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.26 39.99 0.18 Allowed Glycine 0 CA--C 1.523 0.584 0 C-N-CA 119.169 -1.491 . . . . 0.0 116.521 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.772 ' H ' ' NH1' ' A' ' 34' ' ' ARG . 66.0 mttm -99.44 85.23 3.12 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.268 1.034 . . . . 0.0 109.066 177.722 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.428 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.1 mpt? -56.57 137.42 53.67 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.587 0.708 . . . . 0.0 111.36 -178.048 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.699 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.6 p-90 -134.34 -165.21 1.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.295 -178.149 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.5 p -162.99 145.16 10.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.977 178.419 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.36 149.8 45.68 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.172 -178.534 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.3 p -97.95 7.44 46.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.453 0.644 . . . . 0.0 109.869 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.9 p -129.35 155.7 45.22 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.284 178.792 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.633 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -61.54 -32.34 72.41 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.978 0.418 . . . . 0.0 110.942 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -127.49 111.36 13.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.184 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.846 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 65.2 t80 -78.39 -35.25 47.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.92 -177.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -53.75 -29.74 41.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.134 0.493 . . . . 0.0 112.05 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -85.04 -71.15 0.54 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.518 -179.238 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.98 -29.69 63.24 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.036 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 4.4 mtm180 51.61 47.45 24.78 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -114.05 118.22 33.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.412 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.846 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.2 p-90 -129.38 177.29 7.29 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.267 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -171.7 150.33 13.21 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.619 179.042 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 14.5 m-30 -61.42 159.24 13.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -177.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.512 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 8.5 t -68.8 143.73 95.15 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 114.299 -1.318 . . . . 0.0 108.83 178.63 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.512 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 90.7 Cg_endo -68.6 -148.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.644 2.229 . . . . 0.0 113.412 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.415 ' HB3' ' CD1' ' A' ' 2' ' ' TRP . 44.0 t0 -64.0 104.86 0.76 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.199 -179.359 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -79.59 162.67 25.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.235 -179.142 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.783 0 CA-C-O 118.696 -1.058 . . . . 0.0 112.124 179.946 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 71.45 130.15 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.639 0.776 . . . . 0.0 111.953 -179.783 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.14 51.53 0.82 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.4 t 71.28 -167.36 0.15 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.697 -177.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.7 p -113.26 164.24 13.79 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.298 0.57 . . . . 0.0 111.963 -178.847 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.809 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -105.05 -166.31 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 176.155 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.645 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 39.57 -123.96 1.93 Allowed Glycine 0 C--N 1.319 -0.404 0 O-C-N 123.903 0.752 . . . . 0.0 113.112 177.676 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.633 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 37.2 -148.64 0.05 OUTLIER Glycine 0 C--N 1.334 0.464 0 N-CA-C 116.198 1.239 . . . . 0.0 116.198 177.144 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.06 -26.94 0.34 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.502 -0.849 . . . . 0.0 110.795 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -47.96 -59.55 3.27 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 123.548 0.53 . . . . 0.0 111.249 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.67 82.82 0.09 OUTLIER Glycine 0 C--N 1.329 0.194 0 CA-C-N 116.234 -0.439 . . . . 0.0 113.492 178.806 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.35 -25.36 5.72 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.863 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -88.26 141.33 30.8 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.749 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 56.8 Cg_endo -84.33 166.4 12.42 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.764 2.309 . . . . 0.0 111.538 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 2.7 m -74.69 120.83 20.77 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.22 105.28 16.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.092 0.472 . . . . 0.0 110.516 179.623 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.659 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 46.2 m-85 -100.47 139.23 20.48 Favored Pre-proline 0 N--CA 1.447 -0.588 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.416 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 7.2 Cg_endo -87.68 127.98 9.2 Favored 'Cis proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.377 -1.51 . . . . 0.0 112.711 -0.371 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.659 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 15.6 p90 -92.26 127.07 37.6 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.279 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 14.8 m -90.65 121.65 32.75 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.428 0.632 . . . . 0.0 112.455 -177.408 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.903 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.9 t80 -127.8 142.94 51.16 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.356 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.681 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 43.5 35.55 0.98 Allowed 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.187 0.995 . . . . 0.0 112.674 178.896 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.71 -6.27 83.69 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.935 -0.575 . . . . 0.0 114.466 179.244 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.55 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 66.4 m-80 -109.96 132.87 53.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.319 1.06 . . . . 0.0 111.942 -178.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -83.9 118.32 23.9 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.903 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 12.4 m-85 -99.66 112.03 24.3 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.811 0.815 . . . . 0.0 112.191 -177.343 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -83.23 -17.62 42.08 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.615 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 p -131.42 -173.25 3.06 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.827 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 70.7 m -64.22 166.2 8.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.595 0.712 . . . . 0.0 110.395 179.279 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.535 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 14.5 t -144.65 171.42 14.41 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.137 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 15.8 p -129.19 19.02 5.92 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.181 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.562 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.7 138.25 58.3 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.122 179.628 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.89 -3.4 44.79 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.935 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.427 ' HD2' ' HE1' ' A' ' 55' ' ' PHE . 17.0 mtp85 -114.35 -81.28 0.6 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.649 0.261 . . . . 0.0 110.763 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.5 m 57.03 32.55 21.87 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.233 -178.823 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.72 -28.28 8.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.212 -179.052 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 156.78 -66.72 0.3 Allowed Glycine 0 C--N 1.315 -0.611 0 CA-C-N 114.9 -1.045 . . . . 0.0 113.314 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.825 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 3.8 mptt -66.37 135.37 54.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.12 0.486 . . . . 0.0 112.047 -178.82 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.492 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 47.2 mtt -98.15 154.2 17.92 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.006 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.605 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 20.3 p-90 -136.46 -172.6 3.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.591 0.71 . . . . 0.0 112.461 -178.325 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 12.3 p -154.11 143.28 21.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.658 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 15' ' ' CYS . . . -81.88 158.34 24.03 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.31 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.1 p -107.74 16.38 23.68 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.542 0.687 . . . . 0.0 110.387 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.7 p -137.2 148.51 46.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.431 178.516 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -55.91 -42.11 75.56 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.152 0.501 . . . . 0.0 110.821 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -116.31 104.7 11.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.475 178.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.76 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 69.0 t80 -75.96 -29.21 58.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.526 -178.789 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -57.26 -34.65 68.85 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -96.02 -53.6 3.6 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.068 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -81.13 -19.24 43.97 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -177.179 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 13.1 mtm180 38.04 55.97 1.65 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -117.89 120.54 38.18 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.247 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.76 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.0 p-90 -132.94 177.35 7.72 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -174.686 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.54 146.74 11.44 Favored Glycine 0 C--O 1.22 -0.745 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.959 179.206 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.809 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.1 m-85 -70.17 159.6 33.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.787 0.794 . . . . 0.0 111.919 -179.104 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.682 ' HB3' ' HD2' ' A' ' 57' ' ' PRO . 32.9 m -94.38 172.48 5.59 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.08 178.057 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.682 ' HD2' ' HB3' ' A' ' 56' ' ' CYS . 57.1 Cg_endo -63.92 2.8 0.9 Allowed 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.684 2.256 . . . . 0.0 115.084 -178.622 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 63.94 150.11 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.593 178.276 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 -74.12 -41.3 61.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.275 -179.029 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.673 0 CA-C-O 118.515 -1.158 . . . . 0.0 112.366 179.949 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 76.2 p . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.617 0.246 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 30.5 t90 -82.96 -44.98 14.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.033 0.444 . . . . 0.0 110.488 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -86.53 82.15 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.236 0.541 . . . . 0.0 111.235 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.2 m -89.64 171.74 9.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.621 -179.959 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.436 HG22 ' SG ' ' A' ' 41' ' ' CYS . 23.2 p -84.3 177.56 8.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 122.156 0.979 . . . . 0.0 113.4 -178.629 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.758 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -136.08 -162.98 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.256 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 44.64 -87.05 0.01 OUTLIER Glycine 0 N--CA 1.465 0.586 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 176.482 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.612 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . -36.77 161.89 0.01 OUTLIER Glycine 0 N--CA 1.465 0.621 0 N-CA-C 116.77 1.468 . . . . 0.0 116.77 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -74.23 -7.71 53.67 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -178.918 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m -71.11 -18.83 62.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.2 0.455 . . . . 0.0 111.143 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.92 -105.97 1.99 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.526 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.97 46.72 1.13 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.805 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.436 ' O ' HG23 ' A' ' 5' ' ' THR . . . -93.84 148.54 35.49 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.941 0.37 . . . . 0.0 110.429 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.9 Cg_exo -77.66 143.23 21.15 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.523 2.148 . . . . 0.0 111.84 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 5.2 m -72.32 117.52 14.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.023 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.61 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 73.1 t -83.18 108.89 16.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.57 0.224 . . . . 0.0 110.625 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.405 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 50.8 m-85 -107.4 138.51 19.95 Favored Pre-proline 0 N--CA 1.45 -0.444 0 CA-C-O 120.59 0.233 . . . . 0.0 110.768 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.11 134.1 21.0 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.493 -1.461 . . . . 0.0 111.988 -0.642 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.61 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 23.7 p90 -103.39 136.45 43.12 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.121 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 88.9 m -99.07 121.32 40.83 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.596 -178.96 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.808 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 77.0 t80 -112.06 131.24 55.55 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.609 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.532 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 34.25 44.62 0.1 Allowed 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 124.851 1.345 . . . . 0.0 113.727 175.879 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.48 -19.23 45.83 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 116.96 1.544 . . . . 0.0 116.96 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.534 ' O ' ' HA ' ' A' ' 20' ' ' THR . 54.0 m-80 -109.16 146.44 34.1 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 120.042 1.921 . . . . 0.0 111.866 -178.522 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 25.3 mtmt -89.07 125.83 35.18 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.653 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.808 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 39.3 m-85 -112.85 116.41 30.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.815 0.816 . . . . 0.0 111.43 -178.316 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -90.85 -22.18 21.09 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.679 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.4 p -123.28 -176.63 3.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.633 179.026 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.6 m -64.37 169.42 4.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.438 0.637 . . . . 0.0 110.562 179.57 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.488 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.5 t -147.6 176.27 10.21 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.315 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.1 p -139.14 25.48 2.48 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.133 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.76 139.38 58.76 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 113.063 -1.881 . . . . 0.0 112.558 -179.108 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.15 -5.64 40.74 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.694 -0.685 . . . . 0.0 113.069 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.647 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 14.3 mtp85 -95.81 149.72 21.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.244 0.545 . . . . 0.0 111.478 -179.039 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.1 p -120.77 3.03 10.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.92 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 p30 -96.51 -78.23 0.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.39 0.614 . . . . 0.0 110.996 179.761 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.95 -9.02 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.368 -0.833 . . . . 0.0 113.303 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.647 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 33.9 mmtt -67.58 140.55 56.93 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 117.532 0.666 . . . . 0.0 110.087 -179.724 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 68.9 mtm -97.92 144.04 27.88 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.897 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.699 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.9 p-90 -138.09 -167.18 2.11 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.396 0.617 . . . . 0.0 111.63 -178.455 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 22.3 p -159.65 148.94 18.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.115 179.836 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.547 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -81.84 144.13 31.24 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.552 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.8 p -101.69 17.12 23.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.789 0.804 . . . . 0.0 110.69 -178.857 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.4 p -136.14 152.78 51.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.976 178.26 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.63 -39.44 84.34 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.133 0.492 . . . . 0.0 110.823 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -122.5 109.83 14.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.465 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.87 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 46.7 t80 -75.61 -35.1 60.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.206 -178.932 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -48.86 -37.9 20.89 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.921 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -86.61 -63.46 1.31 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.717 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.488 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 0.9 OUTLIER -77.68 -24.4 49.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -176.98 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.705 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 13.6 mtm180 44.2 50.48 7.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 56.6 mttt -108.99 119.34 39.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 177.531 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.87 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 15.3 p-90 -131.82 172.54 12.18 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -175.251 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.612 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -170.78 146.04 9.42 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.804 178.765 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.758 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 14.9 m-30 -62.28 158.68 16.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.339 0.57 . . . . 0.0 111.396 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.1 m -88.25 151.24 48.56 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.311 178.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.3 5.59 2.23 Favored 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.017 2.478 . . . . 0.0 114.322 -178.746 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -98.12 103.61 15.57 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.766 179.308 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -116.06 39.67 3.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.163 -179.425 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.868 0 CA-C-O 118.533 -1.148 . . . . 0.0 112.674 179.869 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.811 0.339 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -130.14 83.42 2.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.311 -179.672 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.4 ' SD ' ' N ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -112.66 169.78 8.65 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.181 -179.108 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 m -85.4 -178.6 6.76 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.029 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -102.13 170.18 8.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.202 1.001 . . . . 0.0 113.654 -178.952 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -138.08 164.61 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 179.098 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.526 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.19 -149.16 51.35 Favored Glycine 0 C--N 1.315 -0.599 0 C-N-CA 118.23 -1.938 . . . . 0.0 111.853 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.479 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 50.33 -146.61 8.48 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 114.134 0.414 . . . . 0.0 114.134 177.728 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.49 -29.73 1.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.166 -0.517 . . . . 0.0 110.36 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.0 m -53.53 -37.73 63.11 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.986 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.84 -86.52 0.44 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.748 179.116 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.5 31.65 2.22 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.445 -179.623 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -80.07 141.13 53.98 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.491 0.186 . . . . 0.0 110.955 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 24.2 Cg_exo -61.05 137.35 71.18 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.757 2.304 . . . . 0.0 112.148 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.2 m -75.06 126.87 31.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.832 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 75.8 t -87.1 121.68 38.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.702 0.287 . . . . 0.0 111.121 -179.518 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.62 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 51.5 m-85 -116.96 139.2 25.49 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.307 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.8 Cg_endo -86.21 129.89 12.15 Favored 'Cis proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.641 -1.399 . . . . 0.0 112.303 -0.363 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.62 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 19.7 p90 -94.59 128.58 41.31 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.056 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 28.8 m -92.19 123.66 35.69 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.521 0.677 . . . . 0.0 112.652 -177.63 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.869 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.1 t80 -127.49 143.83 51.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.642 178.012 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.747 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 42.41 31.35 0.27 Allowed 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.168 0.987 . . . . 0.0 113.16 178.636 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.33 -1.33 79.39 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 178.464 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.5 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 65.4 m-80 -113.21 135.59 53.66 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.195 0.998 . . . . 0.0 111.675 -179.033 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -77.76 119.36 21.16 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.929 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.869 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.2 m-30 -103.56 105.88 16.25 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.88 0.848 . . . . 0.0 110.775 -179.179 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -83.84 -15.35 48.55 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.668 -179.571 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 p -132.96 -175.86 3.92 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.194 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.5 m -66.21 163.73 17.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.532 0.682 . . . . 0.0 109.895 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.467 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 15.3 t -139.83 176.36 8.81 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.158 -179.388 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.445 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 13.0 p -128.52 16.49 6.5 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.429 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.541 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -63.29 139.89 58.82 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.496 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.2 -11.84 21.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.276 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.612 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.3 mtp85 -105.58 -72.02 0.73 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.92 0.39 . . . . 0.0 110.244 179.38 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.8 t 61.74 32.0 18.38 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.469 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' OD1' ' HB3' ' A' ' 34' ' ' ARG . 27.2 p-10 -112.11 -62.76 1.52 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.39 0.614 . . . . 0.0 110.875 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.75 -53.93 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.27 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.872 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 2.2 mppt? -69.03 110.66 4.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.757 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.445 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 55.6 mtm -77.45 158.44 29.99 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.556 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.665 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 19.5 p-90 -141.98 -169.57 2.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.14 0.495 . . . . 0.0 111.28 -178.784 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.521 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 4.0 p -160.61 144.15 13.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.982 177.742 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.95 153.91 34.13 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.425 -178.72 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 64.5 p -101.71 9.1 41.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.748 0.785 . . . . 0.0 109.672 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.7 p -130.81 153.94 48.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.253 178.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -59.84 -48.89 79.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 111.452 -179.564 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -111.45 108.77 18.43 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.514 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.832 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 71.6 t80 -78.47 -30.36 47.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.031 -178.503 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.61 -32.7 65.54 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -90.59 -57.87 2.68 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -178.649 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -77.73 -30.94 51.93 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.244 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 7.9 mmm180 49.49 44.95 24.24 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -110.75 117.77 34.34 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.832 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 10.1 p-90 -133.57 174.92 9.9 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -173.871 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.479 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.3 144.03 9.31 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 113.219 -1.81 . . . . 0.0 109.907 178.479 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.548 ' HD1' ' HB3' ' A' ' 40' ' ' TRP . 5.3 m-30 -60.0 158.55 10.77 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.516 0.674 . . . . 0.0 112.681 -179.533 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.5 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.6 t -87.55 113.28 53.49 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.451 179.386 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -79.98 3.62 7.44 Favored 'Trans proline' 0 CA--C 1.513 -0.537 0 C-N-CA 122.619 2.213 . . . . 0.0 113.48 -178.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -144.71 75.42 1.45 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.065 -1.425 . . . . 0.0 109.485 179.228 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -76.86 -37.64 55.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.534 -179.218 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.729 0 CA-C-O 118.388 -1.229 . . . . 0.0 111.997 179.922 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.727 0.299 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -75.78 85.92 2.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.504 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.9 ptm -106.73 45.89 0.96 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.844 -179.312 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.419 ' O ' ' HB3' ' A' ' 57' ' ' PRO . 7.6 m -74.38 -176.51 2.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.136 179.537 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.3 p -105.48 169.62 8.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.466 1.126 . . . . 0.0 113.688 -178.315 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.681 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -127.49 -166.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.25 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.417 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 36.04 -127.89 0.9 Allowed Glycine 0 N--CA 1.465 0.617 0 O-C-N 123.818 0.698 . . . . 0.0 113.61 177.436 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.592 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 42.61 -148.54 0.54 Allowed Glycine 0 C--N 1.334 0.458 0 N-CA-C 115.796 1.078 . . . . 0.0 115.796 177.127 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.529 HD21 ' HA ' ' A' ' 52' ' ' LYS . 10.9 p30 -133.48 -31.71 1.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.875 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.5 m -59.14 -29.2 67.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.489 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.95 -103.22 2.55 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.073 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -127.42 40.14 1.81 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.133 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.35 138.5 32.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.742 0.306 . . . . 0.0 111.122 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -56.84 132.59 52.65 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.888 2.392 . . . . 0.0 112.368 179.777 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 52.6 m -74.78 130.59 39.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.789 0.328 . . . . 0.0 111.009 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.8 t -83.22 117.89 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -118.28 142.08 30.63 Favored Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-O 120.947 0.403 . . . . 0.0 111.353 -179.406 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.6 Cg_endo -85.63 139.32 25.89 Favored 'Cis proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.038 -1.651 . . . . 0.0 111.763 -0.594 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.548 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 19.5 p90 -99.83 -166.48 1.34 Allowed 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.79 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.0 m -148.87 126.38 11.64 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.055 0.455 . . . . 0.0 111.115 -178.777 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.801 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 29.5 t80 -129.4 139.15 51.76 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.652 179.072 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.541 HD23 ' CG ' ' A' ' 21' ' ' PHE . 3.5 mm? 34.08 47.49 0.2 Allowed 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 124.65 1.218 . . . . 0.0 114.24 174.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.18 -12.21 70.17 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 114.345 -1.298 . . . . 0.0 116.022 177.454 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.455 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 61.1 m-80 -115.19 134.53 55.06 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 119.224 1.512 . . . . 0.0 112.387 -178.525 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -78.98 125.05 28.87 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.359 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.801 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.4 m-30 -109.79 118.81 37.5 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.831 0.824 . . . . 0.0 111.219 -178.816 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 28.3 mt-10 -91.7 -8.61 46.51 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.903 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.3 p -140.67 -164.86 1.81 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.159 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.5 m -72.5 168.2 19.03 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.849 178.531 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.4 t -149.75 166.71 28.61 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.229 -179.147 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.523 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 29.6 p -120.52 21.6 11.53 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 176.755 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.474 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -60.77 140.49 57.56 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 113.826 -1.533 . . . . 0.0 112.167 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.36 -8.03 10.44 Favored Glycine 0 N--CA 1.454 -0.122 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.778 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.634 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 22.8 mtp85 -105.35 -65.74 1.03 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.818 0.342 . . . . 0.0 110.845 -179.375 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.7 m 64.0 15.79 9.46 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.614 -179.553 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.67 -71.34 0.65 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.466 0.65 . . . . 0.0 110.712 179.133 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.34 -33.68 0.06 OUTLIER Glycine 0 C--N 1.308 -1.0 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.524 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.814 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 4.3 mptt -73.66 114.19 11.64 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 -179.726 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.523 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 52.1 mtt -87.9 146.42 25.57 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.618 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.624 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.3 p-90 -134.32 -164.42 1.5 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.142 0.496 . . . . 0.0 111.158 -178.47 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.2 p -169.58 155.85 6.27 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.41 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.86 146.26 29.0 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.113 -179.268 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 71.0 p -97.93 11.84 36.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.743 0.782 . . . . 0.0 109.853 179.339 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.6 p -134.76 158.91 42.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.549 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -61.81 -44.9 95.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.922 0.392 . . . . 0.0 111.238 -179.615 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -116.61 106.88 14.04 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.907 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 72.7 t80 -72.0 -39.42 69.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.86 -178.707 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -49.82 -37.39 30.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.559 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -87.65 -58.49 2.55 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.36 -23.77 54.18 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -177.089 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 7.5 mtm180 45.1 49.32 9.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 179.247 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.529 ' HA ' HD21 ' A' ' 9' ' ' ASN . 28.4 mtpp -116.93 117.62 30.18 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.537 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.907 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.3 p-90 -129.15 172.15 11.71 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -175.258 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.591 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.05 144.93 9.73 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 113.58 -1.645 . . . . 0.0 110.578 179.353 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.681 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.6 m-30 -63.39 158.45 20.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.327 0.563 . . . . 0.0 111.879 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.491 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 4.8 t -73.81 142.46 80.15 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.843 178.592 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.491 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 60.4 Cg_endo -74.31 -152.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.778 2.318 . . . . 0.0 113.168 -179.125 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -64.64 108.46 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.441 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -89.09 108.04 19.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.775 -179.579 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.635 -1.091 . . . . 0.0 112.276 -179.98 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 121.135 0.493 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.457 ' HE3' ' HA ' ' A' ' 2' ' ' TRP . 3.8 m95 -95.36 156.53 16.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.831 179.407 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.3 mmt -77.09 160.99 28.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.0 m -67.49 154.85 40.44 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.405 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.5 p -83.27 169.61 15.52 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.876 0.846 . . . . 0.0 112.284 -179.194 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -129.21 163.97 32.91 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 178.226 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.755 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.85 -145.14 46.29 Favored Glycine 0 C--N 1.308 -0.984 0 C-N-CA 117.434 -2.317 . . . . 0.0 111.148 -179.136 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.628 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 43.47 -149.41 0.67 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 116.077 1.191 . . . . 0.0 116.077 176.717 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.5 p30 -150.61 30.19 0.67 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.836 -0.682 . . . . 0.0 110.073 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.726 ' HB3' HG21 ' A' ' 43' ' ' THR . 0.1 OUTLIER -69.03 -59.97 2.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.492 -179.681 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.29 48.28 2.64 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.082 -179.752 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.55 16.96 40.72 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.146 179.743 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.402 ' HB3' ' HB2' ' A' ' 10' ' ' SER . . . -102.29 140.76 21.42 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 117.111 0.456 . . . . 0.0 110.945 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -85.15 171.36 9.14 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.772 2.315 . . . . 0.0 111.404 179.254 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.3 m -75.58 148.24 39.0 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.194 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 98.7 t -114.23 117.43 55.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.241 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.612 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 66.0 m-85 -114.22 139.04 23.28 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.944 0.402 . . . . 0.0 111.117 -179.509 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -86.13 131.82 14.22 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.409 -1.496 . . . . 0.0 112.187 -0.17 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.623 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 27.9 p90 -99.59 128.92 45.71 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.194 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -91.72 123.03 34.81 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.335 -178.648 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.863 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 62.0 t80 -117.94 129.98 55.94 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.826 178.547 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.533 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.5 mm? 35.87 49.03 0.54 Allowed 'General case' 0 N--CA 1.424 -1.738 0 O-C-N 125.055 1.472 . . . . 0.0 113.33 175.984 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.09 -19.82 51.46 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 114.354 -1.294 . . . . 0.0 116.298 178.099 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -114.99 133.62 55.87 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 120.075 1.937 . . . . 0.0 113.523 -177.632 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -77.67 125.67 29.7 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.645 178.912 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.863 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 17.3 m-30 -111.06 118.64 36.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.794 0.807 . . . . 0.0 112.037 -178.559 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -89.27 -19.33 25.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.938 179.454 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 p -127.7 -178.29 4.43 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.167 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 87.7 m -67.79 170.47 7.93 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.908 179.181 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -146.96 173.28 12.58 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.254 0.549 . . . . 0.0 110.615 -178.706 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.611 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 17.4 p -125.4 19.58 8.11 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.057 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -59.85 135.47 57.71 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.745 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.83 -8.34 11.61 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.252 -179.494 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.9 mtp85 -109.73 -92.04 0.45 Allowed 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.038 0.446 . . . . 0.0 111.225 -179.513 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 t 65.89 33.73 7.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.186 -178.601 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.01 -30.49 10.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.928 -179.722 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 154.84 -48.73 0.5 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.299 -1.319 . . . . 0.0 112.311 -179.429 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 27.1 mmtm -79.4 123.58 27.64 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.783 0.291 . . . . 0.0 111.472 -179.532 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.611 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 71.5 mtm -89.55 146.56 24.5 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.235 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.644 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.3 p-90 -129.11 -167.38 1.78 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.4 0.619 . . . . 0.0 112.655 -177.224 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 21.8 p -158.92 143.4 15.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.697 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 19' ' ' PHE . . . -78.44 151.54 32.64 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.424 -0.911 . . . . 0.0 109.605 179.45 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.726 HG21 ' HB3' ' A' ' 10' ' ' SER . 70.0 p -103.4 13.22 34.12 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.582 0.706 . . . . 0.0 109.914 -179.573 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.8 p -135.0 149.01 50.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.508 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.78 -37.47 68.61 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.98 0.419 . . . . 0.0 111.498 -179.595 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -125.04 111.32 15.24 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.52 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.864 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 48.5 t80 -76.26 -34.5 59.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.91 -178.274 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -53.94 -31.17 49.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.714 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -89.3 -58.73 2.43 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -179.308 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.27 -19.29 28.5 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.671 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 11.3 mtm180 44.89 49.54 9.1 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 179.558 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -108.63 117.15 33.42 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.32 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.864 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.4 p-90 -126.63 173.31 9.57 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -175.918 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.566 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.77 138.37 5.11 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.587 179.248 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.755 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 12.2 m-85 -56.61 153.67 9.96 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.33 0.586 . . . . 0.0 110.995 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.639 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 9.1 t -68.92 145.7 96.89 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.236 -179.846 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.639 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 58.4 Cg_endo -74.25 -157.09 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.242 1.961 . . . . 0.0 111.768 179.378 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.3 t70 61.28 12.67 4.35 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 122.179 0.99 . . . . 0.0 110.036 -179.07 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -145.8 -172.42 3.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.846 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.453 -1.193 . . . . 0.0 112.479 179.196 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.884 0.373 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -77.81 109.68 12.04 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.276 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.2 mtp -98.82 175.56 5.91 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -177.608 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.8 m -108.86 -158.41 0.65 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.915 179.245 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.5 p -107.5 171.64 7.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 122.008 0.908 . . . . 0.0 113.132 -178.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.474 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -138.04 160.68 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 177.518 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.573 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.38 -154.92 44.41 Favored Glycine 0 C--N 1.313 -0.726 0 C-N-CA 117.804 -2.141 . . . . 0.0 110.637 -178.641 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.693 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 40.52 -141.68 0.84 Allowed Glycine 0 N--CA 1.464 0.558 0 N-CA-C 114.311 0.484 . . . . 0.0 114.311 177.625 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.5 -98.46 0.15 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.859 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m 34.41 31.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.304 1.441 . . . . 0.0 114.878 178.263 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.04 -87.33 0.04 OUTLIER Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.32 -0.467 . . . . 0.0 112.549 -179.653 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.31 30.36 0.37 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 178.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -73.6 145.1 84.29 Favored Pre-proline 0 C--O 1.224 -0.245 0 CA-C-N 115.307 -0.446 . . . . 0.0 111.521 -179.06 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.4 Cg_exo -76.02 149.68 32.95 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.019 2.479 . . . . 0.0 111.895 179.181 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 94.9 m -71.85 129.87 39.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.621 0.248 . . . . 0.0 110.372 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 65.2 t -100.32 128.22 52.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.938 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.0 143.28 35.03 Favored Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.432 179.253 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.0 Cg_endo -84.0 131.96 17.73 Favored 'Cis proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.446 -1.481 . . . . 0.0 111.958 -0.33 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.632 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 48.6 p90 -100.24 131.62 46.07 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.79 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.0 m -92.37 123.79 35.94 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -176.41 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.757 ' CG ' HD22 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -125.56 144.17 50.68 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.264 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.757 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.88 35.16 0.11 Allowed 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.456 1.102 . . . . 0.0 113.26 178.896 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.86 -4.65 84.92 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 115.018 0.767 . . . . 0.0 115.018 178.757 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.601 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 62.4 m-80 -108.69 137.7 46.21 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 118.623 1.211 . . . . 0.0 112.031 -178.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -79.02 118.81 21.35 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.673 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.722 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.3 m-30 -103.25 108.44 19.66 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.71 0.767 . . . . 0.0 111.378 -178.482 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -88.77 -17.01 30.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.392 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 p -129.5 175.04 9.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.693 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.4 m -62.0 162.9 8.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.534 178.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -138.91 179.46 6.48 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.083 -178.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 p -133.38 15.93 4.08 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 177.434 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.641 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -59.98 139.04 57.69 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.384 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.99 -5.94 29.98 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.299 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 28.5 mtp85 -109.49 -75.97 0.62 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.612 0.206 . . . . 0.0 111.102 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.3 m 60.87 37.66 18.35 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.727 0.642 . . . . 0.0 110.317 -179.242 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -115.16 -32.34 5.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.788 0.804 . . . . 0.0 110.976 -178.804 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.81 -39.12 1.49 Allowed Glycine 0 C--N 1.309 -0.963 0 CA-C-N 114.282 -1.327 . . . . 0.0 111.849 -179.434 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.527 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 39.4 mttp -73.62 111.2 8.53 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.413 0.285 . . . . 0.0 110.907 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.6 mtt -85.49 146.61 26.85 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.271 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.689 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 21.4 p-90 -135.68 -169.78 2.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.408 0.623 . . . . 0.0 112.041 -178.466 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.0 p -159.86 145.26 15.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.143 178.823 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -77.82 151.46 33.94 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.477 -179.363 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 38.4 p -96.7 8.87 43.26 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.495 0.664 . . . . 0.0 110.382 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.4 p -133.07 155.56 49.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.221 179.256 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -62.34 -28.91 70.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.41 . . . . 0.0 111.025 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -125.93 114.42 18.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.412 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.879 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 66.4 t80 -89.03 -29.12 19.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.288 -179.305 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -52.61 -38.8 60.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.859 0.362 . . . . 0.0 111.526 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -92.97 -63.94 1.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.845 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.605 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.5 m-20 -64.36 -28.34 69.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -177.408 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER 42.96 49.46 5.24 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 179.306 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.605 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 9.5 mtpp -114.81 116.85 29.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.879 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.6 p-90 -128.85 176.97 7.42 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -175.278 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.693 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -172.32 145.83 8.84 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 113.107 -1.861 . . . . 0.0 108.94 179.002 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 13.6 m-30 -59.78 160.69 7.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 117.346 0.573 . . . . 0.0 111.853 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.457 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 1.8 t -59.23 134.27 88.02 Favored Pre-proline 0 CA--C 1.527 0.078 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 177.188 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.474 ' HA ' ' CG1' ' A' ' 6' ' ' VAL . 68.1 Cg_endo -73.03 -163.45 0.16 Allowed 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.024 1.816 . . . . 0.0 115.303 -176.049 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 34.04 63.4 0.41 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.14 -1.846 . . . . 0.0 112.845 -178.702 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -106.15 144.56 32.68 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.037 179.209 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.72 0 CA-C-O 118.297 -1.279 . . . . 0.0 112.184 179.949 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 120.862 0.363 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -106.16 115.41 30.18 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.022 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.497 ' HG3' ' HE2' ' A' ' 17' ' ' PHE . 0.6 OUTLIER -69.01 136.33 52.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -177.388 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.422 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 70.6 m -107.18 -173.58 2.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.922 177.16 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.421 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 24.2 p -122.96 152.0 41.29 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -178.681 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.76 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -121.72 -164.5 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 175.588 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.433 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 33.85 -123.45 0.39 Allowed Glycine 0 N--CA 1.465 0.61 0 O-C-N 123.903 0.752 . . . . 0.0 113.528 177.654 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.635 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 36.44 -145.38 0.08 OUTLIER Glycine 0 C--N 1.335 0.517 0 N-CA-C 115.744 1.057 . . . . 0.0 115.744 176.945 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -143.79 -11.18 0.68 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.251 -0.475 . . . . 0.0 111.542 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.9 m -73.63 -21.18 60.38 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.921 0.391 . . . . 0.0 111.021 -179.7 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.57 -104.88 3.13 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.108 -179.909 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.21 39.94 1.77 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.467 179.875 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -84.87 140.84 37.63 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.787 0.327 . . . . 0.0 110.691 179.659 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 23.4 Cg_exo -61.6 131.36 35.36 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.698 2.266 . . . . 0.0 112.14 179.792 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 53.7 m -71.7 120.73 17.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.175 179.462 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 62.3 t -76.65 116.24 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 111.893 -179.301 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.559 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 40.5 m-85 -118.49 139.89 27.54 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.043 179.866 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.442 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.9 Cg_endo -83.4 138.15 31.99 Favored 'Cis proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.311 -1.537 . . . . 0.0 111.99 -0.447 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.559 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 40.4 p90 -102.97 -173.54 2.34 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.182 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.4 m -140.54 123.64 16.61 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.195 -179.508 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.693 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 56.8 t80 -122.46 133.33 54.6 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.99 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.56 HD23 ' CE1' ' A' ' 21' ' ' PHE . 3.8 mm? 32.61 47.76 0.11 Allowed 'General case' 0 N--CA 1.432 -1.357 0 O-C-N 124.915 1.384 . . . . 0.0 114.238 175.685 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.39 -11.92 66.75 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 116.205 1.242 . . . . 0.0 116.205 177.544 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.531 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 59.6 m-80 -109.47 154.94 21.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.417 1.608 . . . . 0.0 112.15 -178.585 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -95.66 126.98 41.31 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.107 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.693 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 37.9 m-85 -119.08 122.42 42.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.542 0.687 . . . . 0.0 112.054 -178.253 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.442 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 82.9 mt-10 -100.02 -18.06 17.21 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.904 178.987 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.3 p -129.04 -173.33 2.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.743 179.423 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.98 167.34 13.99 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 120.297 -0.561 . . . . 0.0 109.586 178.764 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.451 ' HG1' ' HE2' ' A' ' 26' ' ' TYR . 13.6 t -145.76 170.09 17.22 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.459 -178.895 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.793 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 56.6 p -122.21 18.66 10.72 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.752 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -58.92 133.69 56.27 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.748 -179.922 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.6 -5.01 54.34 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.315 -179.774 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.0 mtp85 -114.13 -58.17 2.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.083 0.468 . . . . 0.0 110.402 -179.443 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.9 p 54.48 28.32 9.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.334 -179.552 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.13 -88.84 0.47 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.024 0.44 . . . . 0.0 110.824 179.371 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -160.93 -21.16 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.785 179.45 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.5 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 89.4 mttt -79.06 76.16 5.56 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 122.328 0.251 . . . . 0.0 110.83 179.778 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.793 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 77.0 mtm -64.15 134.49 54.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 109.934 179.693 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.72 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.1 p-90 -125.12 -161.28 1.01 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.387 -177.518 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 3.5 p -169.53 154.52 5.64 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.594 178.189 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.412 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -78.8 147.81 33.14 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 120.835 0.35 . . . . 0.0 110.998 -179.252 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 66.0 p -100.88 7.06 43.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.636 0.731 . . . . 0.0 109.843 179.545 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.5 p -128.4 157.87 39.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.005 178.402 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.86 99.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.101 0.476 . . . . 0.0 110.759 -179.937 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -119.57 106.07 11.84 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.32 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.989 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 34.2 t80 -71.58 -38.33 70.92 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 -179.078 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -45.59 -36.76 4.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.437 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.79 -63.74 1.23 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -179.28 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.39 -18.64 59.89 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.815 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 34.74 56.3 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -179.868 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -114.32 116.25 28.66 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.492 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.989 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 8.4 p-90 -125.27 169.51 12.21 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -174.859 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.635 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.51 146.68 10.89 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.345 179.339 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.76 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 14.8 m-30 -62.06 163.23 8.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.366 0.603 . . . . 0.0 112.328 -179.21 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.3 t -76.48 139.32 67.48 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.5 179.241 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.653 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 87.6 Cg_endo -71.11 -146.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.366 2.711 . . . . 0.0 112.944 -179.486 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.421 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 9.0 t70 -57.11 112.04 1.24 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.617 179.754 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.653 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 57.0 mt-30 -108.12 -154.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.372 0.606 . . . . 0.0 111.944 -177.958 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.702 0 CA-C-O 118.735 -1.036 . . . . 0.0 111.776 -179.958 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -82.87 129.95 35.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.015 0.436 . . . . 0.0 110.561 -179.766 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.2 mtp -94.69 -121.18 0.1 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.199 0.523 . . . . 0.0 111.238 -179.484 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -49.51 156.99 0.57 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.181 -179.202 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 p -69.78 175.09 4.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.306 1.051 . . . . 0.0 113.762 -178.553 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -132.07 163.52 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 104.945 -2.242 . . . . 0.0 104.945 178.728 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.62 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 64.14 -145.55 49.75 Favored Glycine 0 C--N 1.313 -0.714 0 C-N-CA 118.067 -2.016 . . . . 0.0 110.725 -179.369 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.643 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 44.35 -145.94 1.73 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 114.724 0.65 . . . . 0.0 114.724 177.791 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -141.21 -4.81 1.13 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.895 0.379 . . . . 0.0 110.686 178.681 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.497 ' HB2' HG21 ' A' ' 43' ' ' THR . 1.0 OUTLIER -95.07 52.28 1.43 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.705 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.12 96.04 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.255 -179.317 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.89 -17.68 3.87 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.358 -179.478 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.85 143.04 26.07 Favored Pre-proline 0 C--O 1.223 -0.294 0 CA-C-N 117.091 0.446 . . . . 0.0 110.584 179.532 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.67 170.86 8.74 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.768 2.312 . . . . 0.0 111.997 179.662 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.2 m -74.81 142.96 44.16 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.954 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 92.6 t -111.63 117.38 54.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 178.767 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.563 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 47.3 m-85 -114.69 142.08 27.73 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.752 -179.778 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.23 136.65 28.62 Favored 'Cis proline' 0 N--CA 1.464 -0.259 0 C-N-CA 123.369 -1.513 . . . . 0.0 112.005 -0.498 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.563 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 32.3 p90 -107.08 132.56 52.84 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.315 178.387 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 68.1 m -94.41 124.46 38.45 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.438 -179.239 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.743 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 41.7 t80 -124.76 137.38 54.33 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.901 178.995 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.545 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.4 mm? 37.0 49.23 0.78 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 175.293 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.92 -8.97 73.98 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 114.312 -1.313 . . . . 0.0 116.351 177.626 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 20' ' ' THR . 62.7 m-80 -113.69 153.85 28.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 119.515 1.658 . . . . 0.0 112.287 -178.614 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -93.37 122.48 35.83 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.804 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.743 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 15.0 m-85 -110.22 121.81 46.15 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.857 0.837 . . . . 0.0 111.56 -178.272 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -95.44 -21.06 18.57 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.883 179.676 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p -127.26 -174.67 3.22 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.894 179.953 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.6 m -66.64 170.35 6.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.3 0.571 . . . . 0.0 109.558 178.604 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.537 ' HG1' ' HE2' ' A' ' 26' ' ' TYR . 12.1 t -148.43 169.18 20.78 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.592 -179.693 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.0 p -121.98 17.72 10.9 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.21 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.32 137.07 58.19 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.721 -179.473 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.08 -0.09 63.84 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.718 179.862 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.448 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.0 mtp85 -107.71 -77.28 0.6 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.508 0.154 . . . . 0.0 111.297 -179.581 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.9 m 69.04 31.74 4.0 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.914 0.759 . . . . 0.0 110.663 -179.176 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.63 -84.13 0.59 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.662 179.36 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -158.51 -35.19 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.542 179.414 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 31.1 mmtm -82.32 143.7 31.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 117.413 0.606 . . . . 0.0 111.801 -179.049 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.8 mtm -102.96 151.17 22.78 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.523 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.657 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 11.3 p-90 -137.09 -170.08 2.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.288 0.566 . . . . 0.0 112.35 -178.082 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 21.4 p -155.85 146.84 22.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.966 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.98 149.42 30.8 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.754 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.497 HG21 ' HB2' ' A' ' 10' ' ' SER . 81.1 p -100.22 16.02 25.63 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.77 0.795 . . . . 0.0 110.056 -179.775 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.2 p -143.77 152.88 41.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.059 178.372 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.81 -40.71 80.58 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.963 0.411 . . . . 0.0 111.515 -179.351 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -119.44 107.04 12.85 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.918 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.89 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 58.1 t80 -73.58 -39.8 64.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.68 -178.494 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -49.75 -38.37 33.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.47 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.44 -38.9 12.29 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -178.482 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -93.5 -24.45 17.99 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.524 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 14.4 mtm180 43.17 49.57 5.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 178.977 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -116.91 120.12 37.47 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.014 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.89 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.6 p-90 -130.66 169.33 15.78 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -175.647 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.643 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.16 145.6 11.19 Favored Glycine 0 C--O 1.22 -0.772 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.629 178.732 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.62 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 4.8 m-30 -63.44 159.71 17.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.313 0.578 . . . . 0.0 111.849 179.938 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.742 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 2.7 t -71.43 155.98 92.09 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.272 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.742 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 6.0 Cg_exo -30.37 -111.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.1 1 C-N-CA 125.595 4.197 . . . . 0.0 116.756 -178.942 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.541 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 6.4 t70 -82.4 101.55 10.7 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.074 -177.724 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.439 ' OE1' ' HB3' ' A' ' 56' ' ' CYS . 3.4 mm100 -109.07 -77.8 0.6 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.574 179.604 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.46 -1.189 . . . . 0.0 112.031 -179.764 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -145.2 94.03 2.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.425 -179.788 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.508 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . 16.1 ptm -115.86 42.08 2.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.399 0.618 . . . . 0.0 109.962 179.279 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 16.7 m -82.07 -174.31 5.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.184 -179.335 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 55' ' ' PHE . 27.5 p -94.58 159.9 14.88 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.459 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 1.0 OUTLIER -127.2 6.62 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 CA-C-O 122.799 1.285 . . . . 0.0 109.964 179.922 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.42 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . -156.16 -160.12 9.82 Favored Glycine 0 C--N 1.282 -2.421 0 CA-C-N 112.874 -1.966 . . . . 0.0 111.008 -178.138 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.713 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 74.38 168.33 19.19 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.635 178.572 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -75.74 -7.64 54.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.55 -0.325 . . . . 0.0 111.527 178.782 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.6 m -80.63 -53.97 6.06 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.997 0.427 . . . . 0.0 109.931 179.419 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.38 78.87 0.11 Allowed Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.689 178.652 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.27 -35.05 2.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.074 179.099 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.54 148.88 98.13 Favored Pre-proline 0 CA--C 1.521 -0.167 0 CA-C-N 116.771 0.286 . . . . 0.0 110.915 -179.579 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 73.6 Cg_endo -82.03 151.01 16.11 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.219 1.946 . . . . 0.0 112.252 -179.967 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 72.3 m -78.33 138.55 38.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.218 179.668 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 47.9 t -104.83 118.08 51.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.578 0.228 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.418 ' CE2' ' HE1' ' A' ' 19' ' ' PHE . 69.6 m-85 -111.27 146.34 34.37 Favored Pre-proline 0 N--CA 1.447 -0.577 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.42 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -82.64 134.37 24.81 Favored 'Cis proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.431 -1.487 . . . . 0.0 112.106 -0.237 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.64 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 20.8 p90 -108.27 127.79 54.16 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.473 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 91.7 m -91.69 127.09 37.01 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.105 0.479 . . . . 0.0 111.39 -178.81 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.844 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 56.3 t80 -123.32 135.06 54.01 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.789 179.282 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.555 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 35.1 46.92 0.25 Allowed 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 124.491 1.119 . . . . 0.0 113.799 175.197 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.27 -20.7 49.45 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 116.237 1.255 . . . . 0.0 116.237 177.71 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -112.14 134.11 53.88 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 119.545 1.673 . . . . 0.0 112.644 -178.138 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 34.7 mtpt -79.04 125.33 29.24 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.709 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.844 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 17.9 m-85 -109.91 123.15 49.1 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.608 0.718 . . . . 0.0 111.589 -178.588 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 51.6 mt-10 -100.61 -9.96 21.43 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.817 179.283 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 p -130.88 172.12 12.4 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.976 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.3 m -63.72 160.87 16.16 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.616 179.285 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 t -138.74 174.06 10.92 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.159 -178.761 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 p -127.42 21.99 6.55 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 177.039 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.02 138.8 58.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.025 -179.384 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.01 -6.15 28.99 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.047 179.639 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.642 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 13.8 mtp85 -103.39 152.82 21.15 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 117.169 0.484 . . . . 0.0 111.224 -179.678 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.9 t -125.43 3.17 7.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.53 179.831 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.95 -76.81 0.41 Allowed 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.389 0.614 . . . . 0.0 110.758 179.389 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.5 -23.47 0.1 OUTLIER Glycine 0 C--N 1.307 -1.075 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.012 179.437 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.649 ' H ' ' CD ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -61.0 125.82 25.11 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 122.378 0.271 . . . . 0.0 110.843 -179.52 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.4 mtt -89.44 143.91 26.46 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.779 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.666 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 12.3 p-90 -132.17 -165.57 1.61 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.49 0.662 . . . . 0.0 111.39 -178.725 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -169.32 150.21 4.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.068 179.447 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.41 149.86 36.85 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.786 -179.23 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.2 p -96.42 9.08 42.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.777 0.798 . . . . 0.0 109.383 179.442 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.0 p -132.67 150.9 52.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.38 178.71 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.64 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.09 -36.48 72.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.07 0.462 . . . . 0.0 111.218 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -123.19 112.03 17.2 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.393 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.908 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 51.9 t80 -76.11 -39.06 56.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.806 -178.411 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -46.38 -35.96 5.99 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.956 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -82.52 -77.99 0.22 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -179.742 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.638 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 1.4 m-20 -67.83 -20.69 65.19 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -176.84 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 18.9 mtm180 43.24 50.73 5.8 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.943 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.638 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 59.1 mttt -111.69 118.24 35.09 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.113 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.908 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.6 p-90 -128.88 177.31 7.18 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -175.072 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.52 ' HA3' ' CG2' ' A' ' 5' ' ' THR . . . -176.76 154.63 16.67 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 113.691 -1.595 . . . . 0.0 110.013 179.227 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 15.4 m-30 -66.11 161.12 22.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.106 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.424 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 18.8 t -76.49 140.49 68.5 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.393 178.729 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.508 ' HG3' ' HA ' ' A' ' 3' ' ' MET . 89.9 Cg_endo -68.78 -149.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 122.965 2.443 . . . . 0.0 114.265 -178.39 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.427 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 44.8 t0 -65.01 111.58 2.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.848 -179.119 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 30.7 mt-30 -108.15 -120.22 0.26 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.09 -179.881 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.846 -0.975 . . . . 0.0 111.596 179.293 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.2 p . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.514 0.197 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -74.99 140.76 43.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.894 0.378 . . . . 0.0 110.548 -179.923 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 81.1 mtp -103.11 -179.29 3.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.414 179.865 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.3 m -128.47 156.46 43.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.005 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 p -109.06 177.99 4.6 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.936 0.874 . . . . 0.0 112.138 -179.128 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -131.32 165.39 31.7 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.035 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 178.091 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.581 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 61.07 -148.34 46.2 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 118.187 -1.958 . . . . 0.0 111.667 -179.935 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.57 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 51.97 -152.54 6.3 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 114.801 0.68 . . . . 0.0 114.801 177.352 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 50.2 p-10 -148.14 19.02 1.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.889 0.376 . . . . 0.0 111.025 179.763 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 3.9 m -81.75 -28.89 33.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.164 -179.172 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.06 -74.66 2.5 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.762 179.307 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.54 60.46 0.65 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.553 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -131.25 144.92 55.47 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.677 0.275 . . . . 0.0 111.241 -179.662 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.43 174.4 5.98 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.93 2.42 . . . . 0.0 111.852 179.888 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.8 m -85.02 128.21 34.53 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.817 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 99.3 t -95.45 108.26 20.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.048 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -110.22 142.14 25.36 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.141 -179.081 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -82.55 139.37 38.96 Favored 'Cis proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.821 -1.741 . . . . 0.0 111.276 -0.783 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.54 ' HZ ' HG22 ' A' ' 30' ' ' THR . 36.3 p90 -105.98 135.76 46.85 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.703 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 41.4 m -96.76 120.32 36.87 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.376 0.608 . . . . 0.0 110.76 -179.139 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.723 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 50.2 t80 -116.34 134.07 55.3 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.741 178.951 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.538 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.7 mm? 33.36 45.41 0.08 Allowed 'General case' 0 N--CA 1.435 -1.224 0 O-C-N 124.872 1.358 . . . . 0.0 114.224 174.789 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.04 -10.86 62.12 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 116.584 1.394 . . . . 0.0 116.584 177.331 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.502 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 41.0 m-80 -115.35 156.43 25.53 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.87 1.835 . . . . 0.0 112.8 -178.123 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -91.66 122.2 34.01 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.788 179.047 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.723 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 42.8 m-85 -115.22 111.25 20.67 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.725 0.774 . . . . 0.0 111.141 -179.414 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -91.26 -9.21 46.0 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.899 -179.769 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 p -138.91 -166.55 2.04 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.43 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.4 m -71.38 167.28 19.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.416 0.627 . . . . 0.0 110.52 179.018 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.54 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.5 t -146.85 173.22 12.6 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.601 179.979 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 p -127.03 19.33 7.07 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.386 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -62.49 139.6 58.59 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.43 -179.124 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.9 -0.64 44.11 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.036 179.437 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.641 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.8 mtp85 -105.56 142.46 35.26 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.155 0.503 . . . . 0.0 111.741 -179.194 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -109.58 -0.97 18.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.777 179.575 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.67 -85.81 0.24 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.267 0.556 . . . . 0.0 111.551 -179.897 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.95 -8.55 0.04 OUTLIER Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.68 -179.765 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.641 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 44.6 mmtt -73.58 114.13 11.48 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 117.282 0.541 . . . . 0.0 110.0 179.785 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -73.85 149.98 41.24 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.922 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.618 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 13.0 p-90 -137.26 -163.81 1.49 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.152 0.501 . . . . 0.0 111.375 -178.527 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 23.5 p -160.09 153.79 22.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.846 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.38 144.73 25.84 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.318 178.347 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -99.56 13.54 33.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.804 0.812 . . . . 0.0 110.349 -179.353 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.9 p -136.76 147.52 46.71 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.501 178.212 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.16 -48.99 64.64 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.166 0.507 . . . . 0.0 111.053 -179.439 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -113.6 112.09 22.94 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.086 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.875 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 56.7 t80 -73.23 -40.2 64.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.837 -178.432 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -48.22 -36.07 13.1 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.086 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.46 -68.4 0.68 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.716 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.84 -23.16 52.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.87 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 24.7 mtm180 45.4 50.57 10.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -179.617 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -112.51 117.13 31.52 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.019 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.875 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.1 p-90 -127.78 169.7 13.57 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.297 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.493 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -159.2 137.51 5.19 Favored Glycine 0 C--O 1.221 -0.688 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.473 178.647 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.581 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 2.5 m-30 -58.47 158.28 7.76 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.289 0.636 . . . . 0.0 111.738 179.686 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.712 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 10.0 t -90.7 148.5 38.61 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.674 179.983 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.712 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 60.9 Cg_endo -64.48 -113.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.29 2.66 . . . . 0.0 112.626 179.139 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.406 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 29.3 t70 -58.21 104.15 0.19 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.618 179.808 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 68.6 mt-30 -96.98 -9.41 28.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.461 -179.585 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.898 0 CA-C-O 118.701 -1.055 . . . . 0.0 112.11 179.939 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 2' ' ' TRP . 3.1 p . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.317 0.103 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.443 ' HB3' ' O ' ' A' ' 1' ' ' SER . 64.5 t-105 72.55 148.36 0.09 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.778 0.674 . . . . 0.0 110.709 -179.064 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -76.4 59.56 1.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.518 -179.107 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.07 176.36 6.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.187 0.518 . . . . 0.0 111.211 -179.737 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -110.77 172.63 6.76 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.832 -179.715 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.758 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -113.67 -166.93 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 176.8 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 36.99 -125.98 1.08 Allowed Glycine 0 N--CA 1.462 0.419 0 O-C-N 124.038 0.836 . . . . 0.0 113.226 177.592 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.683 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 31.85 -141.42 0.04 OUTLIER Glycine 0 C--N 1.335 0.474 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 176.801 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -154.51 27.67 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.693 -0.753 . . . . 0.0 109.792 179.894 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.46 ' HB3' HG21 ' A' ' 43' ' ' THR . 0.3 OUTLIER -87.12 -32.87 19.67 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.934 -179.222 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.82 -75.89 2.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.437 -178.628 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -137.16 17.66 3.57 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.78 179.41 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 10' ' ' SER . . . -81.52 141.81 49.23 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.757 0.313 . . . . 0.0 111.198 179.754 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -84.03 165.74 13.12 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.533 2.155 . . . . 0.0 111.688 179.486 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.5 m -79.93 136.7 36.7 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.829 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.3 t -96.39 107.35 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.688 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.552 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 38.0 m-85 -111.44 138.23 21.34 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-O 121.046 0.45 . . . . 0.0 111.066 -179.59 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.606 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 9.4 Cg_endo -88.5 134.15 12.38 Favored 'Cis proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.239 -1.567 . . . . 0.0 112.415 -0.555 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.594 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 37.3 p90 -97.26 -168.32 1.67 Allowed 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 119.707 -0.797 . . . . 0.0 108.85 178.063 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.4 m -147.36 127.46 13.74 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.421 -179.006 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.818 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -129.91 144.07 51.13 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.704 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.758 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.06 36.32 0.11 Allowed 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.863 1.265 . . . . 0.0 113.343 178.733 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.4 -12.63 69.24 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 115.19 0.836 . . . . 0.0 115.19 178.667 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -106.0 135.72 46.94 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 118.667 1.234 . . . . 0.0 111.923 -178.932 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 88.8 mttt -78.94 126.15 30.32 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.915 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.818 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.4 m-30 -108.57 114.6 28.56 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.763 0.792 . . . . 0.0 111.199 -179.123 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.606 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 50.8 mt-10 -90.49 -20.34 22.81 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.586 -179.568 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 p -125.61 -175.71 3.41 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.501 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.5 m -67.64 162.54 23.37 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.451 179.039 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -138.12 171.07 14.94 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.173 -179.349 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.6 p -126.18 21.95 7.3 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.244 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.634 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -66.26 140.61 58.15 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.299 -179.63 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.92 -3.59 50.17 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.553 179.579 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.687 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 16.9 mtp85 -109.47 135.28 50.74 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.155 0.502 . . . . 0.0 110.823 -179.341 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.8 t -102.36 0.91 34.81 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.67 179.876 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.32 -82.85 0.33 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.391 0.615 . . . . 0.0 111.677 179.847 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 168.34 -12.61 0.06 OUTLIER Glycine 0 C--N 1.311 -0.82 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.204 -179.852 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.687 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 81.2 mttt -62.04 98.91 0.11 Allowed 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 122.662 0.385 . . . . 0.0 110.872 179.494 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.7 mtm -69.87 139.04 52.98 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.202 -179.604 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.659 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.1 p-90 -129.08 -165.96 1.58 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.411 -178.899 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.4 p -157.37 150.02 23.12 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.304 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.461 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -84.97 148.05 26.4 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.396 179.596 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.46 HG21 ' HB3' ' A' ' 10' ' ' SER . 49.7 p -102.98 10.97 37.92 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.841 0.829 . . . . 0.0 109.732 179.805 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.5 p -131.0 149.88 52.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.884 178.149 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.38 -43.28 83.46 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.124 0.488 . . . . 0.0 111.036 -179.572 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -117.26 109.05 16.37 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.225 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.843 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 73.7 t80 -77.12 -34.97 56.61 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.866 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -51.12 -35.03 33.43 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.791 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -86.57 -76.8 0.34 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.343 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.74 -19.2 65.81 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -176.824 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 45.2 mtm-85 39.24 54.6 2.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 179.253 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -112.88 119.21 37.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.525 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.843 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.5 p-90 -129.55 173.13 10.87 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -174.701 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.562 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -164.32 144.61 9.56 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 113.327 -1.76 . . . . 0.0 109.529 178.793 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.758 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.3 m-30 -61.89 156.75 20.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 117.69 0.745 . . . . 0.0 111.843 -179.646 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.456 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 7.6 t -70.65 140.78 87.03 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.404 178.365 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.456 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 65.7 Cg_endo -65.63 -143.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.476 2.784 . . . . 0.0 112.76 -179.544 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.416 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 68.3 m-20 -63.16 85.56 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.451 179.953 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.451 ' HG2' ' H ' ' A' ' 59' ' ' GLN . 2.6 pt20 -80.96 -13.8 58.55 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.042 -178.474 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.752 0 CA-C-O 118.596 -1.113 . . . . 0.0 111.601 179.594 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.516 0.198 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -74.83 164.88 26.08 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.886 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.472 ' HB3' ' HG3' ' A' ' 57' ' ' PRO . 1.8 mpt? -50.14 104.89 0.08 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.329 0.393 . . . . 0.0 111.557 -179.141 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.8 m -77.13 159.58 29.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.986 179.968 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 p -93.18 163.57 13.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.605 1.193 . . . . 0.0 114.026 -178.084 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -138.71 162.36 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 177.844 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.607 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.89 -147.47 50.72 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 117.629 -2.224 . . . . 0.0 111.512 -179.46 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.696 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 47.88 -137.87 12.51 Favored Glycine 0 N--CA 1.461 0.309 0 N-CA-C 114.111 0.404 . . . . 0.0 114.111 177.788 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -155.63 20.67 0.4 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.966 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.3 m -96.15 -12.77 24.23 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.702 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.77 -79.2 1.14 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.57 179.545 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.54 23.09 0.74 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.761 -179.628 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.61 146.37 95.91 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.506 0.193 . . . . 0.0 110.654 179.622 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -77.3 139.67 18.88 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.994 1.796 . . . . 0.0 112.474 -179.831 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 87.9 m -71.14 124.49 24.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.246 179.468 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.502 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 64.1 t -89.95 122.13 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.184 -179.57 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.477 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 54.1 m-85 -117.89 140.36 27.65 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.02 179.422 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -86.19 133.21 15.66 Favored 'Cis proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.181 -1.591 . . . . 0.0 112.136 0.152 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.665 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 37.7 p90 -102.4 132.69 48.25 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.63 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 m -95.37 127.31 41.31 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -177.475 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.832 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.1 t80 -127.16 144.31 51.06 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.182 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.759 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.95 32.62 0.12 Allowed 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 124.298 1.039 . . . . 0.0 113.324 178.505 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.29 -8.43 77.44 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 178.793 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.439 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 67.9 m-80 -107.98 135.81 48.74 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 118.354 1.077 . . . . 0.0 111.859 -179.148 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -78.64 123.12 26.79 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.998 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.832 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.8 m-30 -107.59 110.7 22.66 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.84 0.829 . . . . 0.0 111.183 -178.901 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -86.28 -21.92 27.09 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.108 -1.406 . . . . 0.0 110.37 -179.619 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 p -126.1 -175.2 3.3 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.788 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.9 m -65.9 163.4 17.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.393 0.616 . . . . 0.0 109.758 178.896 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.488 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.7 t -138.22 172.84 12.32 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.269 -179.311 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.4 p -125.39 12.9 8.18 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 177.762 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.551 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -60.9 138.27 58.16 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 113.881 -1.508 . . . . 0.0 111.691 -179.697 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.15 -10.12 43.49 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.779 179.767 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.613 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.6 mtp85 -105.74 139.66 39.98 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 117.424 0.612 . . . . 0.0 110.96 179.567 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.3 m -110.4 3.4 19.7 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.798 179.846 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -93.77 -77.8 0.45 Allowed 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -179.483 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.53 -32.42 0.1 OUTLIER Glycine 0 C--N 1.308 -0.993 0 C-N-CA 120.457 -0.877 . . . . 0.0 114.173 179.745 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.836 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 8.2 mptt -60.08 126.16 26.46 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.405 0.602 . . . . 0.0 111.126 -178.926 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 43.6 mtt -86.11 150.86 24.13 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.459 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.686 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.3 p-90 -137.43 -167.91 2.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.966 0.412 . . . . 0.0 111.184 -178.548 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.7 p -161.76 142.55 10.78 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.556 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -71.69 154.45 41.35 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.102 0.477 . . . . 0.0 110.737 -179.324 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.5 p -103.5 10.11 37.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.68 0.752 . . . . 0.0 110.119 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.1 p -133.46 155.81 48.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.901 178.766 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -59.15 -35.74 74.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.906 0.384 . . . . 0.0 111.432 -179.67 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -124.98 113.09 17.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.493 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.819 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 80.3 t80 -78.06 -31.05 50.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.028 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -58.76 -34.92 71.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.527 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -79.11 -64.43 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.938 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.955 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.3 m-20 -72.86 -36.56 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.466 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 7.9 mmm-85 54.65 45.26 27.19 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.365 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.955 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 12.4 mtpt -116.74 120.4 38.47 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 176.894 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.819 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 10.4 p-90 -132.5 172.15 12.87 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.437 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.696 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -160.89 147.33 13.91 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 112.984 -1.916 . . . . 0.0 109.708 178.209 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.607 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 10.6 m-30 -58.83 163.54 3.34 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.262 0.553 . . . . 0.0 111.719 -179.862 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.581 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.2 t -61.88 134.39 94.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.286 179.753 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.472 ' HG3' ' HB3' ' A' ' 3' ' ' MET . 91.9 Cg_endo -70.02 -146.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.304 2.669 . . . . 0.0 113.537 -179.071 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.426 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 9.0 t70 -56.0 108.24 0.44 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.872 -179.41 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 70.2 mt-30 -102.55 95.21 6.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.754 -179.853 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.738 0 CA-C-O 118.622 -1.099 . . . . 0.0 111.948 179.91 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.358 0.123 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 6.3 m0 64.2 99.54 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.284 0.564 . . . . 0.0 111.424 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.83 68.94 7.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.758 -179.587 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.8 m 42.7 -134.6 0.42 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.296 0.569 . . . . 0.0 112.14 178.134 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.8 p -103.18 177.68 4.77 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 122.07 0.938 . . . . 0.0 111.953 -179.226 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -132.99 159.42 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 177.63 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.862 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 67.2 -147.45 49.1 Favored Glycine 0 C--N 1.308 -1.002 0 C-N-CA 117.587 -2.245 . . . . 0.0 111.078 -179.032 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.617 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 45.25 -144.55 2.83 Favored Glycine 0 C--N 1.328 0.108 0 N-CA-C 115.157 0.823 . . . . 0.0 115.157 177.318 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.0 p30 -156.82 29.16 0.32 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.19 0.519 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -79.28 -34.44 42.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.913 -179.759 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.38 -64.32 2.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.254 -179.324 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.9 29.7 0.91 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.133 179.573 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 10' ' ' SER . . . -100.64 144.26 28.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.86 -0.17 . . . . 0.0 111.11 179.804 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -87.59 166.17 7.64 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.443 2.095 . . . . 0.0 111.697 179.409 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 71.7 m -81.13 118.77 22.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.581 179.829 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 59.6 t -82.67 117.75 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.854 -179.799 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -114.55 134.52 22.33 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.596 179.875 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.724 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 9.4 Cg_endo -85.97 136.92 20.83 Favored 'Cis proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.246 -1.564 . . . . 0.0 112.901 -0.158 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.562 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 29.9 p90 -100.96 129.42 46.8 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.778 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.5 m -91.49 127.0 36.76 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.334 0.588 . . . . 0.0 112.552 -177.395 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.784 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.4 t80 -131.3 142.32 50.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.469 178.356 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.727 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.38 38.96 0.41 Allowed 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.624 1.17 . . . . 0.0 113.665 178.278 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.37 -8.71 79.24 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 115.216 0.846 . . . . 0.0 115.216 178.426 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.566 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 68.3 m-80 -110.39 137.99 47.37 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 118.461 1.13 . . . . 0.0 112.068 -179.082 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -81.5 121.11 25.88 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.498 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.784 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.3 m-30 -104.51 104.7 14.59 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.892 0.854 . . . . 0.0 110.977 -178.129 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.724 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 27.5 mt-10 -84.47 -9.34 58.46 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.159 -1.382 . . . . 0.0 111.259 -179.231 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.0 p -137.58 -167.67 2.17 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.402 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 81.2 m -70.52 170.89 11.17 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.189 -0.605 . . . . 0.0 109.982 178.597 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.542 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 14.3 t -150.11 172.4 15.33 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.279 -179.983 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.6 p -127.11 20.53 6.89 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.07 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.527 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -65.25 142.72 58.19 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 114.067 -1.424 . . . . 0.0 112.234 -179.613 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.58 -4.3 21.47 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.892 179.396 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.678 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 20.6 mtp85 -101.69 133.21 46.76 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.255 0.55 . . . . 0.0 111.688 -179.216 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 p -105.85 1.1 26.55 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.753 178.833 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.539 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 1.2 p-10 -88.08 -83.78 0.21 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.728 179.807 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.64 -30.64 0.11 Allowed Glycine 0 C--N 1.311 -0.832 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.588 179.466 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.678 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.1 OUTLIER -59.19 143.55 48.61 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.875 0.369 . . . . 0.0 111.651 -179.285 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.4 mtt -98.02 149.92 21.94 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.736 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.611 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.4 p-90 -141.11 -171.85 3.36 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.334 0.587 . . . . 0.0 111.434 -178.331 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.7 p -156.7 137.3 13.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.827 177.969 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.09 151.07 44.87 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.436 0.636 . . . . 0.0 111.458 -178.553 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.1 p -100.75 7.51 43.78 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.915 179.236 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.1 p -127.92 143.83 51.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.754 179.459 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.48 -49.33 70.37 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.916 0.389 . . . . 0.0 110.98 179.958 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -112.46 103.53 11.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.052 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.822 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 56.9 t80 -76.19 -29.25 57.59 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.274 -178.04 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -55.67 -37.77 68.73 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.562 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -86.57 -52.28 5.65 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.298 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.69 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 13.5 m-20 -77.39 -45.98 24.21 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.477 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.675 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER 61.46 37.03 16.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.895 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.69 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 5.0 mppt? -105.11 118.09 35.65 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.183 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.822 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.9 p-90 -128.66 174.88 9.03 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -174.067 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.617 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -157.68 145.9 12.62 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 112.789 -2.005 . . . . 0.0 108.733 178.274 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.862 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 6.2 m-85 -66.86 163.93 18.44 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 117.772 0.786 . . . . 0.0 112.106 -179.402 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.889 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 2.2 t -69.41 161.21 75.26 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.592 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.889 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 43.6 Cg_endo -60.45 -143.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.671 2.247 . . . . 0.0 114.636 -178.407 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.49 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 36.0 t0 -60.92 116.99 4.89 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.631 -178.158 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -120.87 162.57 19.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.527 179.669 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.758 0 CA-C-O 118.705 -1.053 . . . . 0.0 111.788 179.897 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.5 t . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.65 0.262 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.609 ' HB2' ' HB3' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -74.24 -174.7 2.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.119 0.485 . . . . 0.0 111.505 179.992 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 1.2 pmm? -71.23 145.7 49.46 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.674 179.738 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 m -91.6 163.53 14.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.131 179.872 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 p -109.21 152.65 24.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.788 0.804 . . . . 0.0 112.99 -178.53 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -133.23 164.01 36.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.979 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.976 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.699 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 77.19 -80.44 1.26 Allowed Glycine 0 N--CA 1.463 0.463 0 C-N-CA 118.194 -1.955 . . . . 0.0 113.928 178.932 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.8 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . -45.98 166.22 0.07 OUTLIER Glycine 0 N--CA 1.468 0.813 0 CA-C-N 114.502 -0.849 . . . . 0.0 115.174 -179.16 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 50.7 p30 -74.27 -11.67 60.34 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.783 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.536 ' HB2' HG21 ' A' ' 43' ' ' THR . 0.9 OUTLIER -99.55 32.6 2.75 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.551 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -44.87 98.47 0.01 OUTLIER Glycine 0 C--N 1.338 0.642 0 O-C-N 124.002 0.814 . . . . 0.0 113.112 -178.725 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.77 -25.72 4.14 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.039 -179.69 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.76 142.53 34.57 Favored Pre-proline 0 C--O 1.224 -0.274 0 CA-C-N 117.622 0.711 . . . . 0.0 111.213 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.609 ' HB3' ' HB2' ' A' ' 2' ' ' TRP . 13.6 Cg_exo -68.91 147.33 68.07 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.169 2.58 . . . . 0.0 113.018 -179.724 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 86.4 m -82.47 116.5 21.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.336 178.777 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.6 t -77.27 119.32 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -116.09 137.6 23.53 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.057 0.456 . . . . 0.0 111.22 -179.591 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 87.4 Cg_endo -84.02 142.67 40.96 Favored 'Cis proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.428 -1.905 . . . . 0.0 112.795 -0.172 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.605 ' HZ ' HG22 ' A' ' 30' ' ' THR . 21.6 p90 -104.68 128.77 52.85 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.74 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.3 m -95.6 122.63 38.55 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.433 0.635 . . . . 0.0 111.967 -177.933 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.684 ' CE2' ' HZ2' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -104.44 -140.36 0.36 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.151 178.298 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.703 ' H ' HD22 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -49.67 52.81 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.825 2.05 . . . . 0.0 114.884 -177.626 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 21' ' ' PHE . . . 86.2 8.4 78.44 Favored Glycine 0 C--N 1.296 -1.654 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.613 179.562 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.487 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 53.0 m-80 -125.89 134.29 51.65 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.34 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -79.6 118.38 21.39 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.381 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.643 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.3 m-85 -105.67 109.58 21.6 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.877 0.846 . . . . 0.0 111.323 -178.522 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.416 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 31.6 mt-10 -86.75 -15.91 37.96 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.079 -179.874 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 p -128.23 179.56 5.55 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.168 179.058 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.0 m -66.42 160.45 24.82 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.891 178.963 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.605 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 10.6 t -136.62 170.95 15.23 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.021 -179.509 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.3 p -123.59 15.25 9.52 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 177.023 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.486 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -60.59 140.5 57.37 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.41 -179.893 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.25 -7.55 16.71 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.528 -179.837 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.2 mtp85 -110.2 -68.11 0.95 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.901 0.381 . . . . 0.0 110.842 -179.8 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.7 p 52.99 31.15 10.51 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.74 -179.091 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.13 -79.2 0.55 Allowed 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.631 179.281 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.26 -36.48 0.03 OUTLIER Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.332 179.768 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -88.73 141.01 28.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.226 0.513 . . . . 0.0 112.31 -178.438 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -101.42 148.38 25.24 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 176.616 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.684 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.8 p-90 -135.63 -167.94 2.11 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.193 0.52 . . . . 0.0 111.701 -177.89 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.0 p -162.71 142.39 9.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.253 178.851 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' A' ' 19' ' ' PHE . . . -73.39 150.78 41.51 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.927 -179.223 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.536 HG21 ' HB2' ' A' ' 10' ' ' SER . 70.1 p -100.34 14.76 29.98 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.332 179.373 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.1 p -136.18 154.34 50.98 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.819 179.104 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.94 -41.03 95.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.079 0.466 . . . . 0.0 110.512 -179.814 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -118.31 111.87 19.31 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.58 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.783 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 76.8 t80 -79.62 -28.96 40.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.381 -177.626 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -57.76 -38.26 75.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.053 0.454 . . . . 0.0 112.013 -179.55 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -79.32 -61.05 2.13 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.578 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -81.74 -25.72 35.15 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.763 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.8 mtm180 48.81 45.56 22.07 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -110.97 118.78 37.01 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.277 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.783 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 17.1 p-90 -130.37 174.54 9.76 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -174.645 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.8 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -168.24 142.83 7.71 Favored Glycine 0 C--O 1.222 -0.652 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.04 179.113 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.699 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 13.9 m-30 -59.18 160.31 6.51 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.317 0.579 . . . . 0.0 111.804 -179.396 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.437 ' C ' ' H ' ' A' ' 58' ' ' ASP . 5.9 t -70.45 136.81 86.16 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.933 179.834 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HG3' ' HB2' ' A' ' 3' ' ' MET . 94.3 Cg_endo -72.6 5.78 2.69 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.705 2.27 . . . . 0.0 112.168 179.427 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 56' ' ' CYS . 10.7 t70 -138.45 84.6 2.04 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 112.936 -1.938 . . . . 0.0 108.869 179.281 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -94.55 -20.54 19.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.923 -178.817 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.64 0 CA-C-O 118.478 -1.179 . . . . 0.0 111.936 -179.184 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.885 0.374 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -125.63 132.99 52.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.485 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.0 mmt -97.97 77.48 2.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.196 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 t 61.02 -167.67 0.19 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 123.554 0.534 . . . . 0.0 111.513 179.296 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -104.61 -177.93 3.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.999 179.971 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.745 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -117.98 -173.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 177.027 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.42 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 37.27 -129.67 1.23 Allowed Glycine 0 CA--C 1.523 0.578 0 O-C-N 123.932 0.77 . . . . 0.0 113.208 178.158 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.553 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 39.96 -145.47 0.34 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 177.081 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -156.01 28.72 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.915 -0.642 . . . . 0.0 110.639 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.22 -53.14 7.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.356 179.915 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.35 -63.83 0.46 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.937 -179.397 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.23 30.92 2.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.441 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.53 139.19 21.32 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 111.4 179.802 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -86.36 174.69 5.9 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.028 2.485 . . . . 0.0 111.987 179.281 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.6 m -79.36 137.8 37.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.619 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 65.9 t -102.31 113.33 38.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.642 0.258 . . . . 0.0 110.323 179.633 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.616 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 36.6 m-85 -117.53 137.48 24.21 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-O 120.838 0.351 . . . . 0.0 111.237 -179.632 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.687 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 37.7 Cg_endo -87.04 138.88 20.09 Favored 'Cis proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.659 -1.809 . . . . 0.0 112.339 -0.744 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.616 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 34.2 p90 -105.1 -169.03 1.55 Allowed 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.041 178.121 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.464 ' OG1' ' HD2' ' A' ' 25' ' ' LYS . 86.5 m -145.81 124.05 12.25 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.738 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.811 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 66.0 t80 -116.6 129.36 56.12 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.812 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.555 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.8 mm? 33.92 45.18 0.1 Allowed 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 125.114 1.509 . . . . 0.0 113.619 175.583 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.54 -16.94 51.53 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 116.459 1.344 . . . . 0.0 116.459 178.002 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.46 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 54.1 m-80 -110.93 135.64 51.15 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 119.929 1.864 . . . . 0.0 112.73 -177.958 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.464 ' HD2' ' OG1' ' A' ' 20' ' ' THR . 12.3 mmmm -76.33 120.69 21.92 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.853 178.844 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.811 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.5 m-30 -112.83 118.75 35.81 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.646 0.736 . . . . 0.0 111.275 179.919 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.687 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 38.8 mt-10 -97.9 -12.71 21.78 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.999 179.798 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 p -130.66 -174.28 3.31 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.608 179.086 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.9 m -70.93 165.51 23.2 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.724 179.091 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -146.16 171.18 15.31 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.343 -178.715 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.494 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 66.0 p -123.35 18.68 9.79 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 177.061 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.69 134.62 56.36 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.872 -179.424 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.53 -3.15 60.47 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.377 -179.611 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.569 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.6 mtp85 -116.14 146.76 42.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.026 0.441 . . . . 0.0 111.182 -179.757 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.0 m -128.78 7.71 5.68 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.178 178.195 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.65 ' OD2' ' HG2' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -91.02 -42.42 10.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.066 -178.51 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.75 -35.42 2.05 Favored Glycine 0 C--N 1.315 -0.583 0 C-N-CA 120.145 -1.026 . . . . 0.0 115.131 178.631 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 14.7 mmtp -60.36 110.64 1.3 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 118.122 0.961 . . . . 0.0 111.83 -178.792 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.494 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 73.7 mtp -76.87 138.03 39.52 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.138 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.661 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.6 p-90 -121.85 -163.6 1.08 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.51 0.672 . . . . 0.0 111.941 -178.006 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 7.4 p -160.79 140.57 10.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.634 -179.722 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -72.68 149.38 43.87 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.113 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.4 p -104.34 13.51 31.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.465 0.65 . . . . 0.0 110.16 179.728 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.9 p -135.36 154.34 51.53 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.692 178.48 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.26 -43.37 98.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.844 0.354 . . . . 0.0 110.909 -179.809 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -117.97 106.97 13.49 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.693 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 1.003 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 25.5 t80 -77.17 -31.64 55.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.707 -179.142 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.27 -36.52 14.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.878 0.371 . . . . 0.0 111.799 179.631 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.13 -57.29 2.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -178.25 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.09 -27.4 60.87 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -176.771 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.5 mtm180 44.33 49.4 8.0 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 179.0 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -114.7 120.89 41.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.608 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 1.003 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.7 p-90 -128.47 172.85 10.74 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -175.312 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.553 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -163.82 143.96 9.06 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.737 179.751 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.745 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 10.9 m-30 -60.99 155.13 20.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 118.139 0.969 . . . . 0.0 111.864 -179.394 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.508 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 14.8 t -66.92 113.98 15.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.472 179.228 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -83.91 5.42 6.36 Favored 'Trans proline' 0 CA--C 1.513 -0.546 0 C-N-CA 122.957 2.438 . . . . 0.0 114.657 -177.925 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -143.17 93.66 2.52 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.646 179.683 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -123.64 27.49 7.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 -179.686 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.479 -1.178 . . . . 0.0 112.147 -179.956 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.581 0.229 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -84.11 58.7 4.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.729 0.3 . . . . 0.0 111.504 -179.303 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.457 ' HG3' ' HB3' ' A' ' 14' ' ' PRO . 13.9 ptp -144.93 167.53 22.4 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.882 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.0 m -144.9 -177.25 5.43 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.241 179.85 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 p -115.33 178.27 4.35 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.672 0.748 . . . . 0.0 112.175 -179.192 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -130.79 162.81 38.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.998 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 177.652 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.809 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 69.07 -148.13 47.26 Favored Glycine 0 C--N 1.312 -0.766 0 C-N-CA 117.565 -2.255 . . . . 0.0 111.413 -179.251 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.654 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 41.58 -140.49 1.54 Allowed Glycine 0 CA--C 1.52 0.347 0 N-CA-C 115.623 1.009 . . . . 0.0 115.623 177.219 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -159.23 40.5 0.21 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.79 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.683 ' HB3' HG21 ' A' ' 43' ' ' THR . 0.1 OUTLIER -77.85 -75.46 0.22 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.885 -179.139 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.29 61.11 0.67 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.694 -179.507 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.51 17.81 63.4 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 121.179 -0.534 . . . . 0.0 111.84 -179.343 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.487 ' HB3' ' HB2' ' A' ' 10' ' ' SER . . . -103.31 138.16 19.46 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.341 . . . . 0.0 111.401 -179.637 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.457 ' HB3' ' HG3' ' A' ' 3' ' ' MET . 67.6 Cg_endo -85.73 164.98 10.48 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.147 2.565 . . . . 0.0 111.718 178.871 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.8 m -72.31 136.75 46.31 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.499 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.85 95.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.743 0.306 . . . . 0.0 111.564 -179.874 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.606 ' CE1' ' HE1' ' A' ' 19' ' ' PHE . 9.2 m-85 -96.61 146.41 31.26 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-O 121.416 0.627 . . . . 0.0 111.412 177.886 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.842 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.1 Cg_endo -83.44 131.3 17.52 Favored 'Cis proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.32 -1.95 . . . . 0.0 111.896 -0.507 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.606 ' HE1' ' CE1' ' A' ' 17' ' ' PHE . 0.6 OUTLIER -85.84 -160.37 0.53 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.056 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 47' ' ' TYR . 1.8 m -144.14 120.81 11.15 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -178.706 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.942 ' HB3' HD22 ' A' ' 22' ' ' LEU 0.53 0.5 OUTLIER -127.16 123.66 37.23 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 119.949 3.314 . . . . 0.0 119.949 175.152 . . . . . . . . 4 4 . 1 . 040 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.942 HD22 ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER 26.26 52.75 0.03 OUTLIER 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 108.912 -3.767 . . . . 0.0 112.92 174.723 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.51 -4.53 56.73 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 114.213 -1.358 . . . . 0.0 115.174 178.333 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.907 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 3.5 m-80 -126.16 141.6 51.87 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 118.572 1.186 . . . . 0.0 112.944 -177.779 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.409 ' HB3' ' NZ ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -81.17 119.27 23.38 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.226 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.907 ' CE1' ' HB2' ' A' ' 24' ' ' ASN . 14.2 m-30 -97.0 95.22 7.66 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.459 1.123 . . . . 0.0 111.779 -177.224 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.842 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 39.7 mt-10 -78.45 -13.12 59.98 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 113.18 -1.827 . . . . 0.0 111.877 -178.466 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p -134.01 178.65 6.79 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.721 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 98.5 m -64.88 163.07 15.05 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 119.496 -0.882 . . . . 0.0 108.8 178.172 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.2 t -141.24 177.4 8.12 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.755 -179.609 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 p -126.64 10.56 7.2 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.698 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.83 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.04 146.92 45.45 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.504 179.094 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.33 -10.99 7.15 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.229 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.546 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 21.2 mtp85 -111.46 -82.2 0.58 Allowed 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 122.642 -0.328 . . . . 0.0 111.362 -179.86 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.5 m 63.61 29.42 15.15 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.744 -178.657 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.74 -29.7 8.55 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.738 -178.834 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.84 -64.96 0.35 Allowed Glycine 0 C--N 1.316 -0.571 0 CA-C-N 114.877 -1.056 . . . . 0.0 113.156 179.312 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.837 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 3.7 mptt -65.67 125.87 26.61 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.596 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.0 mtm -85.39 153.72 22.33 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.341 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.681 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 17.7 p-90 -132.64 -173.48 3.19 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.399 0.619 . . . . 0.0 110.92 -178.94 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.55 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 6.4 p -154.66 134.31 12.79 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.722 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.575 ' HB3' ' CB ' ' A' ' 19' ' ' PHE . . . -73.05 149.22 43.37 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.277 -179.231 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.683 HG21 ' HB3' ' A' ' 10' ' ' SER . 68.3 p -101.07 15.68 27.9 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.608 0.718 . . . . 0.0 109.48 179.774 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 p -136.77 142.19 42.97 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.236 178.794 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -52.22 -30.77 28.94 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.363 0.414 . . . . 0.0 111.85 -179.639 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -128.18 119.27 24.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.334 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.901 ' CE2' ' HB3' ' A' ' 53' ' ' TRP . 42.8 t80 -86.23 -52.17 5.82 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.936 -178.205 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.52 -32.76 0.59 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 179.647 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.5 -60.83 1.95 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.074 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.411 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 24.3 m-20 -84.17 -25.11 29.82 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.027 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 8.4 mtm180 49.81 46.13 24.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 179.553 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.411 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 39.1 mtpt -113.56 115.34 27.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.149 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.901 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 15.4 p-90 -126.67 177.62 6.43 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.336 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.451 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -166.77 138.99 5.49 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 112.873 -1.967 . . . . 0.0 108.986 178.852 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.809 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 16.1 m-85 -59.2 150.83 24.44 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 117.62 0.71 . . . . 0.0 111.273 -179.967 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.492 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 6.1 t -66.29 119.26 60.73 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.818 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.41 4.35 4.51 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.692 2.262 . . . . 0.0 114.473 -178.093 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -150.44 103.45 3.14 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.189 179.149 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -122.04 99.12 6.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.633 179.833 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.852 0 CA-C-O 118.331 -1.261 . . . . 0.0 112.146 -179.991 . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.74 0.305 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.466 ' CH2' ' HG3' ' A' ' 14' ' ' PRO . 21.9 t90 -71.82 123.12 21.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.319 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 45.8 mtm -59.91 98.25 0.05 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.146 0.498 . . . . 0.0 112.285 -177.962 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -102.71 -174.66 2.61 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.1 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -109.86 157.1 19.56 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.114 0.959 . . . . 0.0 113.145 -179.247 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -129.95 159.63 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 177.618 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.899 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.4 -154.08 51.99 Favored Glycine 0 C--N 1.307 -1.069 0 C-N-CA 117.126 -2.464 . . . . 0.0 110.664 -178.818 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.615 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 44.43 -139.13 4.56 Favored Glycine 0 C--O 1.236 0.227 0 N-CA-C 114.773 0.669 . . . . 0.0 114.773 177.004 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.449 ' CG ' ' H ' ' A' ' 10' ' ' SER . 11.9 p-10 -141.89 -103.78 0.14 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.475 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.449 ' H ' ' CG ' ' A' ' 9' ' ' ASN . 5.5 m 39.37 15.4 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 176.749 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.23 16.04 47.2 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.986 -179.723 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.15 28.94 26.74 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.829 -179.604 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -73.55 152.76 89.69 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 122.05 0.14 . . . . 0.0 110.945 179.585 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.466 ' HG3' ' CH2' ' A' ' 2' ' ' TRP . 12.6 Cg_exo -67.44 148.71 79.7 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.984 2.456 . . . . 0.0 112.352 179.796 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 90.5 m -79.24 122.35 26.2 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.488 179.458 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.1 t -82.15 119.8 32.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.954 -179.827 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.5 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 57.3 m-85 -119.73 135.81 24.41 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.746 179.755 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.811 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 5.3 Cg_endo -87.95 132.2 11.78 Favored 'Cis proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.273 -1.553 . . . . 0.0 112.251 -0.15 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.639 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 20.8 p90 -91.84 -170.28 2.52 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.651 -0.82 . . . . 0.0 108.908 177.98 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.8 m -144.9 125.64 14.24 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.657 -178.707 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.841 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -132.2 143.65 50.1 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.91 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.76 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.33 38.2 0.33 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.526 1.13 . . . . 0.0 113.457 178.207 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 -6.6 83.39 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 115.311 0.884 . . . . 0.0 115.311 178.296 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.45 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 66.5 m-80 -112.11 136.26 51.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 118.455 1.127 . . . . 0.0 112.013 -178.78 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -79.06 127.86 32.53 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.674 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.841 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.1 m-30 -110.38 111.88 23.45 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 121.709 0.766 . . . . 0.0 111.205 -178.969 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.811 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 36.7 mt-10 -91.17 -11.99 36.74 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.555 -179.768 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 p -133.53 178.87 6.58 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.978 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.3 m -65.92 156.08 34.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.484 179.067 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.3 t -131.88 175.56 9.11 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.11 -179.2 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.2 p -129.15 15.85 6.19 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.35 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.617 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -59.39 141.03 55.54 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.716 -179.74 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.02 -10.99 8.31 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.226 -179.952 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.512 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 25.5 mtp85 -103.2 -69.52 0.79 Allowed 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.722 0.296 . . . . 0.0 110.832 -179.992 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.0 p 52.63 28.99 6.7 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.475 -178.74 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -109.01 -38.52 5.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.544 0.688 . . . . 0.0 110.025 -179.836 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.87 -68.49 0.21 Allowed Glycine 0 C--N 1.313 -0.74 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.466 179.111 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.8 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 4.7 mptt -57.02 130.99 48.49 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.786 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -94.0 156.22 16.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.592 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.65 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 23.4 p-90 -142.98 -169.13 2.95 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.032 0.444 . . . . 0.0 110.986 -178.949 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.6 p -161.37 143.95 12.23 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.162 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.43 153.62 35.49 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.891 0.377 . . . . 0.0 110.888 -178.973 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.5 p -102.83 8.13 39.33 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.58 0.705 . . . . 0.0 109.731 179.644 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.6 p -132.55 153.69 50.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.948 178.928 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.46 94.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.432 179.972 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -113.93 109.48 18.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.765 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.859 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 82.9 t80 -83.06 -31.59 27.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.935 -178.419 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -53.18 -37.12 61.65 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.613 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.8 -66.81 0.86 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -68.05 -29.88 68.96 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.439 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.6 mmm180 47.39 46.67 17.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 179.711 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 53.9 mtmt -110.46 117.31 33.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.708 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.859 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.0 p-90 -127.4 -177.52 4.11 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -174.853 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.615 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -174.03 139.85 5.19 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 113.625 -1.625 . . . . 0.0 109.885 179.375 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.899 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.7 m-85 -61.15 152.72 27.79 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.407 0.622 . . . . 0.0 112.165 -179.437 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.438 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.4 t -69.67 132.81 88.9 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.441 179.702 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.64 6.77 2.61 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.738 2.292 . . . . 0.0 113.83 -179.293 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -123.59 65.08 1.02 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.916 179.771 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -70.45 162.41 28.76 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.109 -179.572 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.594 0 CA-C-O 118.704 -1.054 . . . . 0.0 111.546 -179.987 . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.463 0.173 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -82.11 178.1 8.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 0.0 110.645 179.28 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -86.07 53.19 2.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.981 178.987 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m -64.47 157.23 27.16 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.556 -179.662 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 13' ' ' ALA . 20.7 p -97.26 156.97 16.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 122.331 1.063 . . . . 0.0 113.515 -178.278 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -128.82 162.98 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 103.456 -2.794 . . . . 0.0 103.456 176.578 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.767 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.24 -142.47 42.9 Favored Glycine 0 C--N 1.308 -0.983 0 C-N-CA 117.392 -2.337 . . . . 0.0 111.45 -179.205 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.626 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 38.08 -143.81 0.23 Allowed Glycine 0 N--CA 1.467 0.733 0 N-CA-C 116.34 1.296 . . . . 0.0 116.34 177.12 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -149.66 29.95 0.75 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.203 -0.498 . . . . 0.0 111.018 -179.274 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.566 ' HB3' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -82.58 -59.8 2.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.816 -179.624 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.76 45.29 1.22 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.074 -179.481 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.46 32.45 34.31 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.411 -179.85 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 5' ' ' THR . . . -90.91 149.95 41.12 Favored Pre-proline 0 C--O 1.223 -0.298 0 CA-C-N 116.599 0.2 . . . . 0.0 110.482 179.605 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 3' ' ' MET . 57.9 Cg_endo -81.08 128.14 6.34 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 121.777 1.651 . . . . 0.0 112.212 179.642 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 91.2 m -62.46 126.78 28.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.174 179.8 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 58.2 t -91.86 123.59 44.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.743 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.619 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 59.7 m-85 -118.76 141.03 29.3 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.14 178.925 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.99 134.11 21.28 Favored 'Cis proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.631 -1.404 . . . . 0.0 112.201 -0.492 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.619 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 28.5 p90 -105.06 128.03 53.15 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.281 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.0 m -89.63 123.34 33.6 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.755 -178.892 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.754 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 66.4 t80 -117.11 131.33 56.93 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.402 178.949 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.516 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.6 mm? 35.85 46.08 0.32 Allowed 'General case' 0 N--CA 1.427 -1.593 0 O-C-N 124.722 1.263 . . . . 0.0 113.576 175.892 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.02 -15.46 62.52 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 114.489 -1.232 . . . . 0.0 115.872 177.83 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.581 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 61.0 m-80 -111.72 135.17 52.68 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.838 1.819 . . . . 0.0 112.014 -178.376 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -78.9 121.58 25.03 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.411 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.754 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.5 m-30 -108.9 113.97 27.33 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.628 0.728 . . . . 0.0 111.556 -178.2 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -90.13 -17.33 27.85 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.482 179.481 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.2 p -127.75 -174.51 3.21 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.74 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.2 m -68.57 169.53 10.84 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.991 178.82 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.405 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.6 t -146.47 174.02 11.77 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.016 0.436 . . . . 0.0 110.15 -178.88 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.8 p -129.63 22.57 5.47 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.694 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.9 135.7 51.45 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 113.762 -1.563 . . . . 0.0 112.108 -179.255 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.0 6.52 87.41 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.99 179.563 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.596 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 9.8 mtp85 -107.63 149.06 28.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.325 0.562 . . . . 0.0 111.489 -179.645 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.8 t -106.79 -6.58 17.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.293 -179.701 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.98 -88.0 0.37 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.077 179.689 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.61 -2.91 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.649 179.811 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.596 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 17.7 mmtp -68.36 105.15 2.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.568 0.684 . . . . 0.0 109.171 179.617 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.6 mtm -65.62 144.31 57.03 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.474 -0.49 . . . . 0.0 109.788 -179.664 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.688 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 19.0 p-90 -133.4 -169.05 2.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.394 -178.839 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.5 p -162.53 144.34 10.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.452 178.357 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.456 ' CB ' ' HD2' ' A' ' 47' ' ' TYR . . . -73.91 157.03 37.02 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.261 0.553 . . . . 0.0 110.926 -179.109 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.566 HG21 ' HB3' ' A' ' 10' ' ' SER . 63.7 p -106.28 9.66 31.94 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.863 -179.803 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.2 p -131.88 151.17 51.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.24 178.785 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.42 -37.45 72.79 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.066 0.46 . . . . 0.0 110.891 -179.784 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -123.93 115.12 20.74 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.186 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.953 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 33.6 t80 -80.73 -31.08 36.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.878 -178.116 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -53.16 -35.71 60.09 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.64 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -84.42 -67.15 0.82 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.074 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -73.29 -27.6 61.63 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -177.275 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.661 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.6 mtm180 47.56 48.14 17.09 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.971 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -112.32 122.91 49.06 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.44 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.953 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 11.7 p-90 -131.51 174.53 10.0 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -175.778 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.626 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -169.23 141.1 6.49 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.725 178.77 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.767 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.4 m-85 -55.42 151.9 9.49 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.443 0.639 . . . . 0.0 111.632 -179.82 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.632 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 18.0 t -68.54 133.22 90.92 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.632 -179.696 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.94 5.13 4.13 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.508 2.139 . . . . 0.0 112.651 179.709 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -125.77 75.94 1.54 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.914 179.571 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.515 ' HG3' ' O ' ' A' ' 56' ' ' CYS . 31.9 mt-30 -112.2 -30.69 7.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.721 -179.634 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.45 -1.194 . . . . 0.0 112.139 179.922 . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 120.479 0.181 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 53.5 m95 57.99 -92.93 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.087 0.555 . . . . 0.0 111.659 179.65 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.4 ptt? -78.71 70.19 5.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.622 0.725 . . . . 0.0 110.39 179.167 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 m -137.42 -165.2 1.72 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.722 -179.427 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.461 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 50.4 p -68.32 160.59 29.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.649 0.738 . . . . 0.0 112.539 -179.391 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.483 HG13 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -122.6 -53.22 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.966 0 CA-C-O 123.425 1.583 . . . . 0.0 108.545 179.232 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.816 ' H ' ' HB2' ' A' ' 55' ' ' PHE . . . -83.49 -164.25 36.18 Favored Glycine 0 C--N 1.279 -2.627 0 CA-C-N 110.503 -3.044 . . . . 0.0 111.622 178.919 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.609 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 75.94 -175.04 52.55 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.344 -0.932 . . . . 0.0 113.338 178.573 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 -98.83 -8.19 26.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.57 0.224 . . . . 0.0 111.255 179.542 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.8 m -75.61 -61.63 1.85 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.851 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.1 88.39 0.06 OUTLIER Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.333 178.517 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.62 -23.11 22.89 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.087 -1.054 . . . . 0.0 113.548 179.088 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.96 144.82 80.18 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 117.349 0.574 . . . . 0.0 110.27 179.408 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -81.17 148.89 17.06 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.174 1.916 . . . . 0.0 111.957 -179.787 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 88.0 m -80.26 138.78 36.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.746 0.308 . . . . 0.0 110.665 -179.967 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.436 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 84.9 t -99.01 125.54 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.119 -179.711 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.425 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 48.5 m-85 -124.81 139.21 32.88 Favored Pre-proline 0 N--CA 1.445 -0.707 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.958 -179.806 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -86.5 135.85 18.13 Favored 'Cis proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.558 -1.851 . . . . 0.0 111.862 -0.458 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.691 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 45.1 p90 -101.47 -171.11 1.93 Allowed 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.476 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 m -146.85 124.77 11.98 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.673 -179.022 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.861 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 63.2 t80 -118.03 130.43 56.16 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.492 179.8 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.561 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.7 mm? 33.74 45.09 0.09 Allowed 'General case' 0 N--CA 1.427 -1.611 0 O-C-N 125.075 1.484 . . . . 0.0 114.108 175.233 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.45 -15.82 49.39 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 115.903 1.121 . . . . 0.0 115.903 177.887 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.543 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 28.3 m-80 -115.82 134.84 54.59 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.789 1.795 . . . . 0.0 112.116 -178.425 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -80.53 126.37 31.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.723 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.861 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.9 m-85 -113.7 123.52 50.1 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.661 0.743 . . . . 0.0 111.531 -178.812 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -93.98 -20.83 19.61 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.181 179.926 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 p -128.38 -173.29 2.91 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.858 179.004 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 70.9 m -65.62 161.97 19.32 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.339 178.726 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -138.63 168.68 19.26 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.322 -178.461 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.2 p -124.76 23.37 7.99 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.056 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.53 136.57 57.65 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 113.912 -1.495 . . . . 0.0 111.591 -179.781 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.69 -6.3 54.37 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.727 -179.126 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.589 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.8 mtp85 -110.17 165.48 11.72 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.682 0.277 . . . . 0.0 110.356 179.809 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.8 p -146.39 15.47 1.29 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.073 179.897 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.79 -81.15 0.44 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.609 0.718 . . . . 0.0 111.396 179.97 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.18 -16.03 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.187 -179.821 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.589 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 37.6 mttp -68.12 122.03 17.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.129 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.9 mtm -98.76 151.35 20.87 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.064 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.7 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 28.6 p-90 -141.4 -170.23 3.04 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.035 0.445 . . . . 0.0 111.102 -178.1 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.56 149.42 11.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.277 178.461 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.468 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -73.25 148.15 43.94 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.787 -179.281 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 69.6 p -100.41 8.06 43.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.663 0.744 . . . . 0.0 109.842 179.382 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.4 p -130.88 157.97 41.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.799 -1.092 . . . . 0.0 109.112 178.542 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.65 -39.54 80.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.912 0.387 . . . . 0.0 111.144 -179.54 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -125.41 114.09 18.39 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.001 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.874 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 58.9 t80 -69.82 -40.62 75.78 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.361 -177.936 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.13 -33.19 51.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.951 0.405 . . . . 0.0 111.933 -179.117 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.29 -68.42 0.53 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.194 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.99 -18.76 29.92 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -176.819 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 24.7 mtm-85 44.4 53.79 6.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 179.434 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -117.75 118.85 33.17 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.549 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.874 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.8 p-90 -127.53 170.47 12.57 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 122.078 0.942 . . . . 0.0 113.365 -175.537 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.609 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.44 147.95 13.2 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.411 179.275 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.816 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 7.0 m-30 -64.0 160.67 17.39 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.519 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.542 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 3.7 t -71.41 144.56 89.32 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.418 179.987 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.542 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 87.5 Cg_endo -70.13 -147.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.475 0.435 0 C-N-CA 123.253 2.635 . . . . 0.0 114.038 -179.165 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.439 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 46.6 t0 -54.78 130.62 41.51 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.166 -179.422 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -103.56 -70.28 0.77 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.766 -179.996 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.74 0 CA-C-O 118.363 -1.243 . . . . 0.0 112.289 179.569 . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.731 0.301 . . . . 0.0 111.418 . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -164.97 177.79 7.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.63 178.837 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.2 mmt -102.66 129.79 49.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.376 179.589 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' ' 57' ' ' PRO . 10.4 m -80.76 162.46 24.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.865 0.364 . . . . 0.0 110.509 -179.724 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 p -101.55 164.32 11.81 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 122.234 1.016 . . . . 0.0 113.267 -178.763 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.712 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -118.84 -166.8 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 176.948 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 35.58 -126.19 0.76 Allowed Glycine 0 N--CA 1.465 0.568 0 O-C-N 124.007 0.817 . . . . 0.0 113.065 177.842 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.613 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 34.05 -139.29 0.14 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 115.248 0.859 . . . . 0.0 115.248 177.384 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -156.38 30.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.056 0.455 . . . . 0.0 110.827 179.252 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 19.3 m -101.95 -45.91 5.05 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.983 -179.716 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.48 -102.04 2.23 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.382 -179.68 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.67 32.72 6.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.267 179.917 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -93.61 145.88 30.75 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.799 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -84.94 160.1 11.79 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.434 2.089 . . . . 0.0 112.344 -179.684 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.7 m -89.52 130.9 35.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.619 179.66 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -89.68 120.57 38.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.842 -179.866 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.611 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 65.2 m-85 -116.1 139.0 24.58 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-O 120.772 0.32 . . . . 0.0 110.767 179.908 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -87.05 136.84 17.72 Favored 'Cis proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.615 -1.827 . . . . 0.0 112.636 -0.135 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.611 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 26.3 p90 -101.2 129.05 47.06 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.096 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 98.9 m -92.62 123.71 36.11 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.485 0.659 . . . . 0.0 112.496 -177.972 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.904 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.5 t80 -126.42 145.46 50.46 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.714 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.694 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.28 36.59 0.2 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.442 1.097 . . . . 0.0 113.384 179.185 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.8 -2.43 87.19 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 114.85 0.7 . . . . 0.0 114.85 178.637 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.59 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 45.2 m-20 -111.33 135.74 51.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.265 1.033 . . . . 0.0 111.95 -179.007 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -81.45 118.05 22.38 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.379 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.904 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.5 m-30 -101.82 113.06 25.92 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.844 0.831 . . . . 0.0 111.492 -178.553 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -86.98 -20.56 27.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.127 179.646 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -126.44 179.66 5.19 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.37 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.1 m -64.77 162.93 15.06 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.779 179.321 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.6 t -137.48 169.34 17.95 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.222 -178.738 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.584 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 41.8 p -121.61 15.76 11.13 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.894 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.567 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.09 142.56 56.59 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.936 179.72 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.51 -16.27 6.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.893 -179.482 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -103.51 -74.43 0.64 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 120.753 0.311 . . . . 0.0 110.465 179.681 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m 60.02 23.21 12.36 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.158 -179.83 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -103.4 -35.02 8.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.656 0.741 . . . . 0.0 110.108 -179.548 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.87 -70.18 0.21 Allowed Glycine 0 C--N 1.312 -0.772 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.405 179.634 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.936 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 3.1 mptt -58.55 137.3 57.51 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.704 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.584 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 3.5 mpp? -99.63 153.46 19.05 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.569 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.668 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 22.0 p-90 -138.1 -168.78 2.43 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.084 0.469 . . . . 0.0 110.77 -178.815 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.3 p -163.16 141.1 7.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.39 177.826 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.88 148.53 46.02 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.304 0.573 . . . . 0.0 110.929 -178.662 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 43.9 p -98.31 11.96 36.31 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.092 179.215 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.4 p -131.01 155.19 47.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.974 179.265 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -62.02 -40.06 94.43 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.915 0.388 . . . . 0.0 110.913 -179.995 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -120.11 111.89 18.43 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.802 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.833 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 74.7 t80 -82.18 -31.62 30.33 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.072 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -57.03 -33.29 67.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.127 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -92.35 -56.05 3.18 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.153 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -74.75 -26.89 60.09 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.544 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 12.8 mtm180 43.46 50.67 6.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 179.576 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -119.61 120.35 36.41 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.432 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.833 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.4 p-90 -133.98 177.68 7.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -173.99 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.607 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -169.27 146.24 10.03 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.724 178.82 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.712 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.3 m-30 -60.29 157.78 12.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.606 0.703 . . . . 0.0 111.725 -179.08 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.468 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.5 t -63.2 135.99 96.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.529 -179.844 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 4' ' ' SER . 97.3 Cg_endo -73.38 -149.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.166 2.578 . . . . 0.0 112.922 -179.735 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 9.7 t70 -57.38 120.72 8.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.208 179.879 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 63.1 mt-30 -114.14 14.06 18.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.128 -179.152 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.787 0 CA-C-O 118.472 -1.182 . . . . 0.0 112.045 179.984 . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -101.3 164.95 11.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.846 -179.859 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 73.0 mtm -94.17 42.37 1.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.125 0.488 . . . . 0.0 110.727 179.553 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.1 m -99.66 178.87 4.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.8 179.25 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.711 HG22 ' SG ' ' A' ' 41' ' ' CYS . 50.1 p -97.57 168.09 10.58 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.028 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.861 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -129.18 -160.47 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.668 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 34.4 -123.1 0.46 Allowed Glycine 0 N--CA 1.464 0.51 0 O-C-N 124.105 0.878 . . . . 0.0 113.182 177.679 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.551 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 34.45 -144.68 0.05 OUTLIER Glycine 0 C--N 1.337 0.615 0 N-CA-C 116.097 1.199 . . . . 0.0 116.097 177.062 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.31 -26.76 0.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.844 -0.678 . . . . 0.0 110.093 179.732 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 m -60.85 -20.79 62.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.203 179.581 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.53 -114.81 4.79 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.308 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.91 46.91 1.08 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.022 179.221 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 5' ' ' THR . . . -83.41 148.4 55.45 Favored Pre-proline 0 C--O 1.222 -0.364 0 CA-C-N 116.92 0.36 . . . . 0.0 110.562 179.835 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -65.08 131.82 29.93 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.202 1.935 . . . . 0.0 111.768 179.666 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.8 m -66.04 135.37 54.56 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.811 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 86.8 t -98.83 113.65 34.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.648 0.261 . . . . 0.0 111.109 179.871 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.502 ' CE2' ' HB2' ' A' ' 15' ' ' CYS . 99.4 m-85 -112.84 143.22 28.63 Favored Pre-proline 0 N--CA 1.446 -0.665 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.287 179.172 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -85.45 133.57 17.48 Favored 'Cis proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.38 -1.508 . . . . 0.0 112.034 -0.174 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.672 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 46.7 p90 -105.5 130.77 53.5 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.436 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.9 m -95.75 128.51 42.69 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -176.974 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.897 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.2 t80 -132.53 146.6 52.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.68 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.745 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.51 37.4 0.29 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.557 1.143 . . . . 0.0 113.466 178.535 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.14 -6.06 82.5 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 114.606 0.602 . . . . 0.0 114.606 178.929 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -111.73 133.25 54.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.351 1.075 . . . . 0.0 112.057 -178.721 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -79.03 122.81 26.66 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.889 179.187 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.897 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.5 m-85 -106.15 114.52 28.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.784 0.802 . . . . 0.0 111.504 -178.361 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -93.56 -15.65 25.23 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.288 179.434 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.3 p -130.34 178.58 6.48 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.015 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.5 m -60.9 163.69 5.55 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.566 0.698 . . . . 0.0 110.648 179.274 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.0 t -144.71 169.41 18.07 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.253 179.908 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.562 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 15.7 p -125.7 23.78 7.28 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.066 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.93 140.4 58.31 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 113.969 -1.468 . . . . 0.0 111.015 -179.944 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.02 -8.9 13.42 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.723 -179.452 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.6 mtp85 -108.73 -82.4 0.56 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.972 0.415 . . . . 0.0 110.663 -179.699 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.1 t 62.81 19.07 11.23 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.658 -179.448 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.2 -31.55 12.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.726 0.774 . . . . 0.0 109.946 179.983 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.66 -58.22 0.38 Allowed Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.635 179.78 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.827 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 8.3 mptt -65.54 134.9 54.35 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.79 0.329 . . . . 0.0 111.653 -179.116 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.562 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 61.8 mtt -98.63 160.33 14.35 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.306 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.652 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 20.1 p-90 -144.08 -173.27 3.96 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.544 0.688 . . . . 0.0 111.974 -178.981 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.711 ' SG ' HG22 ' A' ' 5' ' ' THR . 8.5 p -154.81 138.57 16.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.959 -1.018 . . . . 0.0 108.85 179.769 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.466 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -76.45 153.82 35.28 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.333 179.961 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.4 p -104.55 14.29 30.21 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.851 0.834 . . . . 0.0 110.015 -179.694 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.9 p -137.3 147.5 45.69 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.592 178.89 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.668 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -51.63 -43.77 62.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.929 0.395 . . . . 0.0 111.4 -179.688 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -119.38 107.43 13.35 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.909 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.818 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 79.7 t80 -71.86 -32.04 67.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.364 -178.027 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.704 ' HA ' ' NH1' ' A' ' 51' ' ' ARG . 25.8 m-20 -66.26 -25.45 66.89 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.016 0.436 . . . . 0.0 111.523 -179.764 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -84.4 -58.99 2.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.374 -179.634 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -87.84 -19.4 27.49 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -176.681 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.704 ' NH1' ' HA ' ' A' ' 48' ' ' ASP . 7.8 mtt-85 45.97 51.0 11.1 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 179.978 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -119.84 121.76 39.81 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 176.443 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.818 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.5 p-90 -136.59 176.92 8.26 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -175.597 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.529 ' HA3' ' HB ' ' A' ' 5' ' ' THR . . . -170.07 149.14 12.5 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.289 178.237 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.861 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.6 m-30 -64.72 165.71 9.96 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.859 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.564 ' HB3' ' HD2' ' A' ' 57' ' ' PRO . 37.8 m -101.57 169.05 8.19 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 176.42 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.564 ' HD2' ' HB3' ' A' ' 56' ' ' CYS . 94.3 Cg_endo -68.56 -152.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.083 1.855 . . . . 0.0 113.8 -178.541 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.97 138.69 58.4 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.029 -178.425 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -99.51 -58.53 1.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.229 179.345 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.847 0 CA-C-O 118.333 -1.259 . . . . 0.0 111.655 -179.62 . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 120.863 0.363 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -157.55 106.07 2.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.253 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -90.21 113.16 24.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.879 0.371 . . . . 0.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m -90.19 158.51 17.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.655 179.916 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p -82.8 170.39 15.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.478 0.656 . . . . 0.0 112.207 -179.674 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.824 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -107.94 -168.13 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 176.793 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.56 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 40.05 -123.23 2.03 Favored Glycine 0 N--CA 1.46 0.288 0 O-C-N 123.827 0.704 . . . . 0.0 113.116 177.829 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.659 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 32.19 -143.13 0.03 OUTLIER Glycine 0 C--N 1.336 0.529 0 N-CA-C 116.836 1.495 . . . . 0.0 116.836 177.065 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -157.03 24.34 0.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.597 -0.801 . . . . 0.0 110.6 179.961 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.631 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -88.39 -23.32 23.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.316 -179.87 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.2 -76.57 2.14 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.61 -179.75 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -126.96 9.56 7.1 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.436 -179.436 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 10' ' ' SER . . . -79.7 141.63 56.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 117.341 0.57 . . . . 0.0 111.526 -179.859 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 60.1 Cg_endo -88.38 178.61 2.9 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.133 2.556 . . . . 0.0 111.812 179.475 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.6 m -81.8 149.03 28.56 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.53 -179.88 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.6 t -115.94 118.41 58.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.516 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.615 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 59.6 m-85 -121.11 143.59 37.47 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-O 121.019 0.437 . . . . 0.0 111.878 -179.084 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.804 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 8.6 Cg_endo -87.5 135.99 15.96 Favored 'Cis proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.029 -1.655 . . . . 0.0 111.6 -0.817 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.66 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 37.6 p90 -103.02 -169.88 1.72 Allowed 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.208 178.647 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.434 ' OG1' ' HD3' ' A' ' 25' ' ' LYS . 63.6 m -147.54 126.89 13.09 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.53 -179.505 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.88 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 59.8 t80 -123.87 133.45 53.76 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.12 179.383 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.549 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 35.38 48.28 0.39 Allowed 'General case' 0 N--CA 1.427 -1.603 0 O-C-N 124.713 1.258 . . . . 0.0 113.711 175.451 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.73 -11.09 71.75 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 116.334 1.294 . . . . 0.0 116.334 177.763 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.409 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 53.7 m-80 -115.61 135.14 54.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 119.555 1.677 . . . . 0.0 112.53 -178.351 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HD3' ' OG1' ' A' ' 20' ' ' THR . 65.5 mmtt -76.44 125.15 28.7 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.943 178.875 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.88 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.8 m-85 -115.58 118.37 32.95 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.567 0.698 . . . . 0.0 111.067 -179.985 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.804 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 49.9 mt-10 -96.28 -16.08 21.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.101 179.573 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.9 p -126.19 -177.37 3.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.138 178.233 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.2 m -67.87 165.73 17.0 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.413 178.762 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 t -142.91 173.03 11.91 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.075 -178.704 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.535 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 57.8 p -129.02 22.82 5.7 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.37 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.464 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -62.92 141.05 58.87 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 114.012 -1.449 . . . . 0.0 112.35 -179.069 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.68 -1.71 36.02 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.728 179.56 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.778 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 8.4 mtp85 -101.72 126.75 48.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.829 0.347 . . . . 0.0 110.858 -179.721 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 m -95.09 5.22 52.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.116 -179.83 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.42 -86.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.211 0.529 . . . . 0.0 110.915 179.275 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 179.12 -24.79 0.05 OUTLIER Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.233 179.975 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.778 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 76.7 mttt -49.81 120.49 4.35 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.925 0.49 . . . . 0.0 111.648 179.933 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.535 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.5 mpt? -87.58 141.96 28.21 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.688 179.214 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 13.0 p-90 -129.99 -162.78 1.24 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.176 -178.856 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.3 p -163.58 151.09 12.71 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.75 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.445 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -83.11 144.99 29.5 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.294 179.417 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 79.6 p -99.95 13.21 34.7 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.945 0.878 . . . . 0.0 109.704 179.919 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.6 p -137.04 151.08 48.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.94 178.598 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.29 -40.95 78.86 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.891 0.377 . . . . 0.0 111.478 -179.387 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -123.71 109.84 14.2 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.599 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 1.07 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 23.7 t80 -75.83 -34.51 60.11 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.703 -178.492 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -50.75 -34.75 28.43 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.474 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -96.39 -52.69 3.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.464 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.39 -26.2 35.65 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.021 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 13.5 mtm180 45.36 50.65 9.89 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 179.117 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -114.66 121.82 44.56 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.14 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 1.07 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 12.2 p-90 -128.7 173.35 10.39 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -175.699 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.431 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.94 140.5 6.26 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.543 179.601 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.824 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 8.3 m-30 -60.16 153.29 22.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.783 0.791 . . . . 0.0 111.183 -179.661 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.541 ' HB3' ' HG2' ' A' ' 59' ' ' GLN . 8.7 t -66.29 116.08 30.09 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.706 -179.983 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.01 2.12 8.25 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.713 2.275 . . . . 0.0 113.373 -178.439 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -150.0 77.88 1.33 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.632 179.751 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.541 ' HG2' ' HB3' ' A' ' 56' ' ' CYS . 47.4 mt-30 -81.55 139.95 34.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.988 -179.094 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.719 0 CA-C-O 118.743 -1.031 . . . . 0.0 111.922 -179.846 . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.68 0.276 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -90.11 -15.64 31.23 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.408 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.454 ' SD ' ' HB2' ' A' ' 57' ' ' PRO . 26.2 ptm -69.94 168.31 15.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.3 0.571 . . . . 0.0 112.113 -179.005 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 m -95.94 -175.69 3.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.1 -179.77 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.3 p -86.47 177.91 7.27 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.348 1.071 . . . . 0.0 113.126 -178.974 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.531 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -142.58 161.8 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 178.587 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.589 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 65.5 -149.82 51.67 Favored Glycine 0 C--N 1.313 -0.695 0 C-N-CA 117.958 -2.068 . . . . 0.0 111.157 -179.453 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.713 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 50.58 -152.2 4.68 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 114.778 0.671 . . . . 0.0 114.778 177.802 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -125.36 -29.43 3.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.924 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 m -56.29 -42.96 78.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.031 -179.803 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.47 -90.77 1.62 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.888 -0.673 . . . . 0.0 113.322 178.946 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.16 49.44 0.85 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.275 -179.404 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.35 152.73 44.08 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.979 0.39 . . . . 0.0 110.116 179.159 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.35 147.29 18.02 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.01 1.807 . . . . 0.0 112.466 -179.891 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.2 m -78.03 115.69 17.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.504 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 55.3 t -79.83 108.83 13.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.91 0.386 . . . . 0.0 110.616 -179.604 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -109.72 138.51 20.68 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.969 -179.614 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.762 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 58.4 Cg_endo -85.34 138.58 25.6 Favored 'Cis proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.834 -1.736 . . . . 0.0 112.895 -0.327 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.605 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 35.1 p90 -105.55 132.65 51.45 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.184 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 90.3 m -93.78 128.46 40.02 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.412 0.625 . . . . 0.0 112.394 -177.57 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.748 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -130.69 142.71 50.44 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.596 -1.184 . . . . 0.0 107.83 178.166 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.747 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.37 39.54 0.3 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.757 1.223 . . . . 0.0 113.497 178.17 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.32 -5.67 84.69 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 114.859 0.704 . . . . 0.0 114.859 178.419 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.691 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 50.8 m-20 -110.76 136.39 49.91 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 118.448 1.124 . . . . 0.0 111.511 -178.723 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -82.04 120.03 24.75 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.805 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.748 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.5 m-30 -102.96 110.29 22.15 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.594 0.711 . . . . 0.0 111.38 -177.621 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.762 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 94.5 mt-10 -91.5 -4.86 55.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.131 -179.69 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.3 p -140.96 -171.43 3.25 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.325 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 87.3 m -69.65 166.17 19.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.939 178.882 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.513 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 14.1 t -146.38 175.72 10.32 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.665 -179.489 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.3 p -130.94 20.98 4.95 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.382 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.601 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -66.74 143.03 57.18 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 113.918 -1.492 . . . . 0.0 112.215 -179.346 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.33 2.27 47.7 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.659 178.67 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.691 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.5 mtp85 -105.04 121.53 43.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 117.349 0.574 . . . . 0.0 111.412 -179.493 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 m -85.51 -4.34 59.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.17 179.106 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.588 ' OD2' ' HG2' ' A' ' 38' ' ' LYS . 2.3 p-10 -90.64 -84.68 0.24 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.586 179.73 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.444 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 164.08 -14.95 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.853 -0.689 . . . . 0.0 114.589 179.484 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.691 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 24.9 mmtm -65.0 132.12 48.39 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 118.206 1.003 . . . . 0.0 110.278 -179.549 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 52.1 mtm -85.49 144.08 28.16 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 179.303 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.637 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.2 p-90 -135.78 -168.6 2.24 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.371 0.605 . . . . 0.0 112.121 -177.819 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 23.8 p -153.05 138.95 18.06 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.166 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.536 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -77.97 146.73 35.28 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.795 179.97 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.2 p -101.04 17.64 21.84 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.833 0.825 . . . . 0.0 110.203 -179.695 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.89 152.97 50.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.856 178.643 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -60.19 -39.57 86.98 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.206 0.527 . . . . 0.0 111.188 -179.665 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -122.18 107.84 12.61 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.582 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.791 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 64.2 t80 -74.71 -30.44 61.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.852 -178.149 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -55.19 -37.05 66.57 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.262 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.87 -72.23 0.49 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.823 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.74 -19.49 62.73 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -177.508 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.631 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 21.6 mtm180 41.17 53.86 3.44 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 179.886 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.408 ' HG3' ' HZ2' ' A' ' 52' ' ' LYS . 48.2 mttp -112.77 118.28 34.54 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.564 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.791 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 11.9 p-90 -133.03 171.24 14.25 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -174.667 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.713 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.14 142.04 7.78 Favored Glycine 0 C--O 1.221 -0.708 0 CA-C-N 113.122 -1.854 . . . . 0.0 109.313 178.236 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.589 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 7.9 m-30 -56.21 159.34 3.53 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.777 0.789 . . . . 0.0 111.19 179.699 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.545 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 5.5 t -59.68 139.76 89.58 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.572 179.929 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.457 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 65.0 Cg_endo -66.38 -0.11 3.95 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.035 2.49 . . . . 0.0 113.88 -179.187 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -136.98 97.27 3.47 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.485 178.434 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -102.37 -175.86 2.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.859 -179.392 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.892 0 CA-C-O 118.618 -1.101 . . . . 0.0 111.925 -179.899 . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.459 0.171 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -75.27 108.26 7.92 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.611 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.434 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 70.2 mtp -66.56 83.27 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.517 -178.506 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.2 m -86.95 163.52 17.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.434 179.957 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -107.31 174.64 5.8 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 122.196 0.998 . . . . 0.0 112.874 -179.178 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -139.36 164.58 24.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.047 0 N-CA-C 104.667 -2.345 . . . . 0.0 104.667 179.418 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.499 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 64.91 -149.78 51.62 Favored Glycine 0 C--N 1.313 -0.701 0 C-N-CA 118.025 -2.036 . . . . 0.0 111.367 -179.733 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.632 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 51.6 -149.26 8.5 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 114.256 0.463 . . . . 0.0 114.256 177.998 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -141.97 -4.03 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.685 -0.258 . . . . 0.0 111.147 179.697 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.9 m -86.37 9.51 17.78 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.968 0.413 . . . . 0.0 110.608 179.768 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.9 -106.48 1.97 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.134 -179.804 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.53 36.01 2.46 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.563 179.774 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -75.36 143.51 76.48 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.76 0.28 . . . . 0.0 110.662 179.486 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 3' ' ' MET . 16.3 Cg_exo -65.7 144.49 78.27 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.604 2.203 . . . . 0.0 112.315 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.7 m -72.16 148.43 45.64 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.657 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 64.6 t -108.76 109.67 29.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.627 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.585 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 38.6 m-85 -114.69 143.09 29.33 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-O 121.229 0.538 . . . . 0.0 111.503 -179.312 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.8 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.3 Cg_endo -87.41 136.91 16.97 Favored 'Cis proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.263 -1.557 . . . . 0.0 111.469 -0.97 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.585 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 34.3 p90 -101.4 -170.77 1.88 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.27 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.8 m -148.79 127.44 12.46 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.999 -178.996 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.677 ' CG ' HD22 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -111.11 -143.73 0.39 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 118.342 -0.837 . . . . 0.0 108.915 179.111 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.677 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -49.11 55.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.916 2.086 . . . . 0.0 114.958 -177.215 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 21' ' ' PHE . . . 86.72 6.87 79.42 Favored Glycine 0 C--N 1.296 -1.651 0 CA-C-N 114.41 -1.268 . . . . 0.0 113.345 178.821 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.539 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 20.7 m-80 -127.56 135.57 50.49 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 117.862 0.831 . . . . 0.0 112.151 -178.76 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -78.75 126.64 31.0 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.26 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.626 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.9 m-85 -112.23 107.65 16.59 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 122.138 0.97 . . . . 0.0 110.91 -179.19 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.8 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 32.0 mt-10 -86.11 -19.95 29.42 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.484 -179.395 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 p -126.53 -172.99 2.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 178.386 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.5 m -68.27 160.06 30.06 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.027 179.077 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t -137.14 168.95 18.61 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.909 -179.587 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.8 p -122.82 24.55 9.02 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 122.042 0.925 . . . . 0.0 108.677 177.857 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.502 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -70.99 148.42 47.66 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.417 -179.667 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.57 -7.14 14.02 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.508 -0.769 . . . . 0.0 114.02 178.526 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.621 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 8.2 mtp-105 -91.88 -171.4 2.85 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.2 1.0 . . . . 0.0 110.793 -179.659 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.6 m -133.59 -23.98 1.8 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.672 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.603 ' CG ' HH22 ' A' ' 34' ' ' ARG . 1.3 p-10 -107.29 -90.81 0.43 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -178.083 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.488 ' N ' HH12 ' A' ' 34' ' ' ARG . . . -149.23 -9.68 0.15 Allowed Glycine 0 CA--C 1.53 0.982 0 N-CA-C 119.402 2.521 . . . . 0.0 119.402 -176.593 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.621 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 7.5 mptt -71.99 164.04 26.81 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 121.996 2.898 . . . . 0.0 112.225 -179.751 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -116.91 160.46 20.86 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.995 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.651 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.7 p-90 -146.87 -169.1 3.21 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.153 0.501 . . . . 0.0 110.924 -178.774 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 24.5 p -156.23 146.04 21.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.26 179.718 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.401 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -80.68 146.64 31.0 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.054 -0.659 . . . . 0.0 109.565 179.346 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.3 p -100.45 19.43 16.78 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.888 0.851 . . . . 0.0 109.479 179.458 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.4 p -141.15 153.71 45.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.101 179.067 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.86 -31.74 71.19 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.321 0.582 . . . . 0.0 111.252 -179.842 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -129.1 118.58 22.72 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.937 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.858 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 59.5 t80 -82.46 -32.96 28.63 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.856 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -52.32 -39.12 60.18 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.676 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.0 -74.49 0.26 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.82 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.474 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 45.7 m-20 -72.85 -19.74 61.25 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -176.292 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 35.4 mtm-85 40.11 55.69 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 179.709 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 50' ' ' ASP . 49.7 mtmt -114.54 120.42 40.15 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.941 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.858 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.6 p-90 -133.17 170.78 14.91 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.949 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.632 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.82 141.44 7.18 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.46 178.806 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.508 ' HD1' ' HB3' ' A' ' 40' ' ' TRP . 7.1 m-30 -56.98 162.01 2.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.263 0.554 . . . . 0.0 111.446 179.829 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.588 ' SG ' ' HG2' ' A' ' 59' ' ' GLN . 12.6 t -77.66 130.33 74.05 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.7 -178.46 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -76.05 -147.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.066 2.511 . . . . 0.0 111.676 178.762 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -54.25 105.41 0.15 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.49 0.494 . . . . 0.0 110.36 179.752 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.588 ' HG2' ' SG ' ' A' ' 56' ' ' CYS . 57.1 mt-30 -91.24 159.43 16.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.04 0.448 . . . . 0.0 111.938 -178.736 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.861 0 CA-C-O 118.289 -1.284 . . . . 0.0 111.749 179.228 . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.543 ' HB3' ' SD ' ' A' ' 3' ' ' MET . 14.1 m . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -111.32 55.32 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.728 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.543 ' SD ' ' HB3' ' A' ' 1' ' ' SER . 0.0 OUTLIER -83.8 105.72 14.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.503 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.2 m -75.58 155.38 36.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.934 0.397 . . . . 0.0 111.189 -179.255 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.4 p -87.57 167.02 14.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.378 0.609 . . . . 0.0 111.894 -179.986 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.885 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -107.43 -168.1 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 176.819 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.671 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 38.08 -127.26 1.59 Allowed Glycine 0 C--N 1.318 -0.438 0 O-C-N 123.846 0.716 . . . . 0.0 113.719 177.552 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.595 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 39.49 -149.55 0.11 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 116.115 1.206 . . . . 0.0 116.115 177.127 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -154.54 12.17 0.39 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.633 -0.784 . . . . 0.0 111.058 -179.755 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.0 m -84.98 0.17 52.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.427 -179.378 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.82 -97.78 2.33 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.267 179.708 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.66 40.27 1.39 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.734 179.899 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -91.3 148.12 36.98 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.575 0.226 . . . . 0.0 110.874 -179.843 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 6.2 Cg_exo -72.19 172.23 15.24 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.646 2.231 . . . . 0.0 111.71 179.284 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.7 m -85.36 150.1 24.98 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.562 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.558 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 75.8 t -108.66 110.64 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.251 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -112.34 137.9 21.71 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.969 -178.995 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.7 Cg_endo -86.11 132.15 14.61 Favored 'Cis proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.485 -1.465 . . . . 0.0 112.255 -0.18 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.644 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 43.9 p90 -98.57 124.36 43.29 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.569 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 29.9 m -87.61 121.68 30.35 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.502 0.668 . . . . 0.0 112.194 -177.261 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.879 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.4 t80 -125.7 143.81 50.88 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.527 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.698 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 39.58 32.88 0.1 Allowed 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.823 1.249 . . . . 0.0 113.582 178.364 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.91 -11.73 64.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.894 -0.67 . . . . 0.0 114.767 178.604 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.6 m-80 -110.01 133.56 53.06 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 118.406 1.103 . . . . 0.0 112.425 -178.759 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -79.83 115.31 19.35 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.124 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.879 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.0 m-85 -96.97 111.99 23.95 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.908 0.861 . . . . 0.0 111.562 -177.814 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.47 -14.36 43.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.279 179.692 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.8 p -129.92 -173.54 3.06 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.828 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.5 m -71.03 167.85 18.35 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.823 178.486 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.594 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.7 t -145.55 175.33 10.43 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.13 -179.0 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.524 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 9.8 p -129.52 18.52 5.8 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.189 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.571 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -63.52 144.41 57.01 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 113.978 -1.464 . . . . 0.0 111.879 -179.715 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.3 -1.4 34.82 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.841 179.464 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.728 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 7.7 mtp85 -105.06 127.59 52.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 117.056 0.428 . . . . 0.0 111.58 -179.333 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.4 m -95.37 1.58 54.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.586 179.556 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.12 -85.15 0.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.954 0.407 . . . . 0.0 111.166 179.755 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.03 -23.15 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.433 179.682 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.728 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 1.0 OUTLIER -61.1 130.01 44.2 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 117.255 0.527 . . . . 0.0 111.306 -179.445 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.524 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 59.8 mtm -89.25 149.15 23.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.194 0.521 . . . . 0.0 110.871 -179.531 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.613 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 13.5 p-90 -138.37 -168.33 2.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.518 0.675 . . . . 0.0 112.129 -178.435 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 21.0 p -156.16 136.64 13.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.34 178.742 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -74.75 151.35 39.17 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.442 -179.599 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 64.2 p -101.51 11.21 39.42 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.712 179.675 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.9 p -135.85 151.43 50.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.459 178.757 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.87 -48.45 79.8 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.915 0.388 . . . . 0.0 111.62 -179.537 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -111.43 104.15 12.56 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.81 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.855 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 70.7 t80 -75.49 -32.27 60.5 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.532 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.78 -36.44 64.88 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.373 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -88.75 -61.7 1.65 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.504 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.89 -34.8 78.58 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.89 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 12.9 mtm-85 48.56 47.87 20.09 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.383 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -115.25 117.8 31.5 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.737 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.855 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 11.8 p-90 -131.59 175.48 9.13 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -174.21 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.403 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -164.34 142.64 7.93 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.616 178.876 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.885 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 8.7 m-85 -59.82 158.49 10.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.065 0.933 . . . . 0.0 111.417 -179.582 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.481 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 5.6 t -64.15 123.8 83.43 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.796 -179.085 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -81.56 5.75 6.08 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.313 2.675 . . . . 0.0 114.618 -178.744 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -131.77 94.71 3.56 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.199 179.626 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -137.14 -86.87 0.3 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.59 -179.844 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.138 -1.368 . . . . 0.0 111.428 -179.671 . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -73.03 116.75 13.93 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 111.224 179.864 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 mmt -104.06 149.79 24.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.389 -179.83 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.7 t -89.55 169.83 11.01 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.764 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.406 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 32.8 p -80.81 163.59 23.34 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.432 0.634 . . . . 0.0 112.357 -179.213 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.831 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -106.46 -166.26 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 176.191 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.616 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.15 -127.1 1.19 Allowed Glycine 0 C--N 1.321 -0.281 0 O-C-N 124.072 0.857 . . . . 0.0 112.994 177.774 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.605 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 31.34 -138.66 0.07 OUTLIER Glycine 0 C--N 1.336 0.537 0 N-CA-C 116.083 1.193 . . . . 0.0 116.083 176.997 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.8 p30 -168.36 37.06 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.857 -0.671 . . . . 0.0 109.782 -179.986 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.548 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -63.55 -65.09 0.73 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.819 -178.748 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 105.1 49.21 1.01 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.085 -179.608 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.83 37.01 10.68 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.926 -179.622 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -121.0 148.88 49.87 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.536 0.207 . . . . 0.0 111.308 -179.353 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 98.7 Cg_endo -93.41 175.06 1.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.305 2.67 . . . . 0.0 111.254 179.097 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.8 m -84.17 142.86 30.03 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.458 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 63.4 t -107.81 121.91 61.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.81 0.338 . . . . 0.0 110.216 178.962 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -121.49 144.29 39.88 Favored Pre-proline 0 N--CA 1.447 -0.616 0 CA-C-O 120.783 0.325 . . . . 0.0 111.277 -179.446 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -85.9 137.03 21.18 Favored 'Cis proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.718 -1.784 . . . . 0.0 111.698 -0.811 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.498 ' CG ' ' HB3' ' A' ' 42' ' ' ALA . 23.3 p90 -104.87 175.35 5.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.055 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 94.7 m -130.26 124.08 31.6 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.833 -179.446 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.716 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 42.5 t80 -126.26 138.78 53.65 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.907 179.029 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.545 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.4 mm? 35.27 46.42 0.25 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 175.318 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.85 -7.01 81.81 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 114.469 -1.241 . . . . 0.0 116.157 177.738 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.531 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 62.0 m-80 -109.14 155.89 20.48 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 119.286 1.543 . . . . 0.0 111.674 -179.023 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -95.84 125.34 40.34 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.405 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.716 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 28.6 m-85 -113.64 119.7 38.35 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.809 0.814 . . . . 0.0 112.072 -177.599 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -96.58 -20.53 18.26 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.385 -1.279 . . . . 0.0 110.318 179.608 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 p -130.09 -174.03 3.21 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.333 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.9 m -68.16 163.46 22.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.605 178.837 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.1 t -142.3 163.76 31.99 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.721 -178.577 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.526 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 26.2 p -116.07 20.66 14.26 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 176.487 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.1 142.14 52.26 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.432 -179.455 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.99 -7.39 9.77 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.246 179.264 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.72 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 22.4 mtp85 -101.37 147.23 26.57 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 117.035 0.417 . . . . 0.0 111.339 -179.17 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 t -109.81 -4.99 15.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.25 179.976 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.65 -81.7 0.24 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.24 0.543 . . . . 0.0 111.223 179.902 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.17 -26.06 0.11 Allowed Glycine 0 C--N 1.308 -1.014 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.733 179.851 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.72 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 2.0 mptp? -53.69 117.84 3.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 122.644 0.378 . . . . 0.0 111.172 179.796 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.526 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 44.0 mtm -83.87 143.55 29.82 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.038 179.743 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.648 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.2 p-90 -128.2 -166.98 1.7 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.565 -179.716 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 9.9 p -160.39 146.41 15.26 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.744 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.498 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -78.09 142.59 38.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.115 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 78.7 p -96.17 16.48 18.04 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.436 0.636 . . . . 0.0 110.486 -179.552 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.7 p -139.63 161.11 38.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.741 179.293 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -64.24 -30.33 71.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.002 0.43 . . . . 0.0 111.196 179.946 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -132.69 115.52 15.48 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.908 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.88 ' HE1' ' HB3' ' A' ' 53' ' ' TRP . 44.5 t80 -81.23 -38.3 27.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.196 -178.883 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -47.03 -36.36 7.85 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.536 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -95.11 -56.13 2.84 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.781 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.546 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.5 m-20 -67.22 -43.17 82.68 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -177.73 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 5.3 mmm180 57.59 40.87 26.47 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 179.415 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.546 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 4.2 mppt? -114.28 122.32 46.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.586 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.88 ' HB3' ' HE1' ' A' ' 47' ' ' TYR . 11.4 p-90 -132.67 170.8 14.7 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -175.022 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.5 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.24 143.26 8.33 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.863 179.254 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.831 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.2 m-30 -61.35 156.61 18.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.969 0.885 . . . . 0.0 111.499 -179.641 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.411 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 4.3 t -67.53 126.78 93.04 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.992 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -81.31 -160.68 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.007 1.804 . . . . 0.0 113.63 -177.696 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 t70 36.88 63.14 0.71 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.627 179.982 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -109.27 117.83 35.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.366 179.576 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.73 0 CA-C-O 118.778 -1.012 . . . . 0.0 112.029 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 13' ' ' ALA . 11.6 p . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 122.429 1.109 . . . . 0.0 113.494 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -127.75 164.48 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 177.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.45 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.27 -146.6 50.46 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 117.728 -2.177 . . . . 0.0 111.1 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.645 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 46.29 -140.23 6.38 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 114.327 0.491 . . . . 0.0 114.327 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--O 1.223 -0.297 0 CA-C-O 120.474 0.178 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 37.9 Cg_exo -59.44 136.22 70.2 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.762 2.308 . . . . 0.0 112.777 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 7.2 m -67.95 128.2 35.65 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 90.1 t -95.25 112.94 28.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.643 0.259 . . . . 0.0 110.654 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.533 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 70.0 m-85 -111.51 139.96 22.61 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.264 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.2 134.51 21.51 Favored 'Cis proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.321 -1.533 . . . . 0.0 111.93 -0.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.548 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 45.8 p90 -103.59 133.57 48.4 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.93 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 76.3 m -96.53 121.32 38.21 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.349 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.755 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 45.4 t80 -115.64 130.33 56.82 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.12 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.662 HD13 ' CD1' ' A' ' 21' ' ' PHE . 6.7 mp 44.64 33.44 0.94 Allowed 'General case' 0 N--CA 1.436 -1.133 0 O-C-N 124.363 1.039 . . . . 0.0 113.685 175.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.77 -15.9 40.55 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 115.696 1.038 . . . . 0.0 115.696 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 20' ' ' THR . 62.8 m-80 -110.68 146.72 35.74 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 119.267 1.533 . . . . 0.0 112.299 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -86.76 122.17 30.27 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.755 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 28.6 m-85 -107.21 116.77 32.52 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.69 0.757 . . . . 0.0 110.63 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -92.88 -17.04 24.53 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.275 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 p -129.6 -178.12 4.55 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.28 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 81.8 m -66.6 165.23 15.11 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.706 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.421 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 9.2 t -140.4 167.64 21.66 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.314 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.485 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 12.6 p -122.03 19.65 10.8 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.86 139.66 58.34 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 113.661 -1.609 . . . . 0.0 111.263 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.95 -2.83 54.01 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.369 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.63 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.9 mtp85 . . . . . 0 N--CA 1.446 -0.662 0 CA-C-N 117.105 0.452 . . . . 0.0 110.667 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.63 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.371 0 CA-C-O 120.691 0.281 . . . . 0.0 111.385 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.485 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 54.4 mtt -87.91 149.66 23.95 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.633 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.4 p-90 -131.87 -166.36 1.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.13 0.49 . . . . 0.0 111.577 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 28.1 p -156.9 148.99 22.91 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.492 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -84.98 148.91 25.95 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 119.455 -0.898 . . . . 0.0 108.939 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.8 p -102.2 12.9 36.0 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.448 0.642 . . . . 0.0 110.433 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.425 HG21 ' CB ' ' A' ' 50' ' ' ASP . 76.3 p -135.89 153.97 51.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.982 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.5 85.27 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.189 0.518 . . . . 0.0 110.942 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -114.49 108.32 16.71 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 1.019 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 27.4 t80 -73.89 -35.65 64.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.009 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -48.47 -33.99 10.35 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -90.88 -64.18 1.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.709 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 19.8 m-20 -69.01 -34.27 74.98 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 9.3 mtm180 50.26 45.21 26.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.709 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 34.3 mttt -111.45 119.8 40.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 1.019 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 6.9 p-90 -132.17 173.17 11.52 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -175.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.645 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.26 144.11 8.77 Favored Glycine 0 C--O 1.22 -0.731 0 CA-C-N 113.732 -1.576 . . . . 0.0 110.284 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 14.8 m-30 -57.03 155.19 8.55 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.414 0.626 . . . . 0.0 112.099 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.513 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 16.6 t . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.295 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.446 -0.629 0 CA-C-O 121.727 0.775 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.738 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -113.15 -168.04 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.04 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.451 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.45 -126.28 1.28 Allowed Glycine 0 N--CA 1.46 0.274 0 O-C-N 123.955 0.784 . . . . 0.0 113.04 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.7 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 38.59 -142.94 0.33 Allowed Glycine 0 C--N 1.331 0.3 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.464 ' H ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 114.784 -0.708 . . . . 0.0 110.333 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.98 0.419 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -88.55 170.17 5.57 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.183 2.589 . . . . 0.0 112.188 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.4 m -76.07 140.54 41.93 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 84.1 t -106.65 108.6 25.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.532 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 50.9 m-85 -109.66 141.32 23.41 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-O 120.831 0.348 . . . . 0.0 111.411 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.615 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 3.8 Cg_endo -85.7 134.05 17.64 Favored 'Cis proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.254 -1.561 . . . . 0.0 111.718 -0.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.532 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 43.9 p90 -102.81 -171.17 1.91 Allowed 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.356 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 96.6 m -145.56 119.17 9.13 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.242 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.623 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 72.4 t80 -109.46 131.16 55.33 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.615 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.8 mm? 35.63 44.06 0.19 Allowed 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 124.511 1.132 . . . . 0.0 113.859 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.2 -10.81 63.69 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 114.581 -1.191 . . . . 0.0 116.038 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.504 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 52.5 m-80 -113.23 134.01 54.8 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.887 1.843 . . . . 0.0 111.951 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -78.1 122.93 26.25 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.368 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.623 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 17.3 m-30 -110.89 118.23 35.54 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.749 0.785 . . . . 0.0 110.912 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 47.9 mt-10 -96.93 -12.81 22.93 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.356 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 p -132.69 -175.12 3.66 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 89.5 m -64.66 171.72 3.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.248 0.547 . . . . 0.0 110.052 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.4 t -151.11 173.13 14.74 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.849 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 p -133.24 24.65 4.17 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.407 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -60.53 137.48 58.16 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 113.172 -1.831 . . . . 0.0 111.786 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.87 -2.68 31.98 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.234 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.606 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.4 mtp85 . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 120.762 0.315 . . . . 0.0 111.417 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.606 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 44.2 mttp . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.503 0.192 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.3 mtm -83.93 146.77 27.86 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.636 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 21.3 p-90 -136.97 -168.1 2.21 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.336 0.589 . . . . 0.0 111.675 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 24.5 p -160.17 156.09 26.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.075 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -84.17 145.81 28.18 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.556 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.8 p -102.07 11.12 38.9 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.494 0.664 . . . . 0.0 110.291 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 p -133.33 152.0 51.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.389 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.91 82.24 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.828 0.347 . . . . 0.0 111.415 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -120.58 109.77 15.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.999 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 28.6 t80 -70.81 -37.25 73.23 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.737 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.42 -35.48 60.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.418 . . . . 0.0 111.609 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -76.12 -69.39 0.5 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -85.74 -18.05 34.13 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 23.0 mtm180 44.57 52.34 7.65 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -113.95 122.18 46.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.999 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 7.8 p-90 -129.76 173.13 10.93 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.486 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.4 140.72 6.43 Favored Glycine 0 C--O 1.223 -0.583 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.871 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.738 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.2 m-30 -63.09 158.13 20.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.364 0.582 . . . . 0.0 111.852 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 68.5 m . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.003 177.581 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.448 -0.573 0 CA-C-O 121.395 0.617 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -114.21 -165.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 176.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.57 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.27 -125.49 1.16 Allowed Glycine 0 C--N 1.319 -0.385 0 O-C-N 124.173 0.92 . . . . 0.0 113.569 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.703 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 38.15 -141.19 0.42 Allowed Glycine 0 C--N 1.333 0.387 0 N-CA-C 115.754 1.062 . . . . 0.0 115.754 177.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 114.74 -0.73 . . . . 0.0 109.781 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.543 0.211 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 61.2 Cg_endo -84.72 170.41 10.15 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.951 2.434 . . . . 0.0 111.942 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.5 m -79.9 138.57 37.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.509 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.0 t -100.68 109.79 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 19.2 m-30 -112.9 139.59 23.08 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.607 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.632 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.1 Cg_endo -86.72 136.79 18.58 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.097 -1.626 . . . . 0.0 112.373 -0.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 40.7 p90 -99.27 -171.58 2.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.172 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 32.2 m -142.94 127.94 18.46 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.156 0.503 . . . . 0.0 111.515 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.672 ' CE2' ' HZ2' ' A' ' 40' ' ' TRP . 1.4 t80 -133.87 140.7 47.01 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.335 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.674 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 39.46 33.92 0.12 Allowed 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 125.12 1.368 . . . . 0.0 114.103 178.023 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.94 -11.43 60.66 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.625 -0.798 . . . . 0.0 114.975 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' THR . 68.3 m-80 -109.47 154.81 22.13 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 118.513 1.156 . . . . 0.0 111.976 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.545 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -94.31 126.04 39.32 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.614 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 20.9 m-85 -110.88 110.67 21.37 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.724 0.773 . . . . 0.0 111.213 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.632 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 54.1 mt-10 -90.43 -10.26 44.44 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.824 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 p -136.84 -170.8 2.78 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.5 m -70.2 167.12 18.56 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.802 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.44 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 9.4 t -144.35 169.03 18.7 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.768 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.417 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 19.6 p -124.41 17.12 8.98 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.603 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -60.23 142.4 54.57 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 113.736 -1.574 . . . . 0.0 111.588 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.0 -5.73 12.32 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.642 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.477 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 25.2 mtp85 . . . . . 0 N--CA 1.443 -0.812 0 O-C-N 122.654 -0.321 . . . . 0.0 110.987 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 121.113 0.482 . . . . 0.0 112.043 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.417 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 71.3 mtp -100.15 150.72 22.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.672 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.0 p-90 -135.3 -170.28 2.56 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.913 0.387 . . . . 0.0 111.303 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 20.5 p -155.68 141.58 18.13 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.439 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -76.42 145.81 39.08 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.976 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.9 p -99.33 10.47 41.35 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.377 0.608 . . . . 0.0 109.91 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.468 HG21 ' HB2' ' A' ' 50' ' ' ASP . 32.6 p -128.13 153.51 46.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.053 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.24 -38.66 77.31 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.089 0.471 . . . . 0.0 110.452 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -123.99 111.35 15.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.766 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 59.4 t80 -70.13 -40.67 74.71 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.71 -30.64 70.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.089 0.471 . . . . 0.0 111.768 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -61.13 1.9 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.751 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HB2' HG21 ' A' ' 44' ' ' THR . 68.0 m-20 -95.81 -23.85 16.74 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 5.7 mtm180 53.7 52.05 13.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -117.84 119.09 33.81 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.766 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.2 p-90 -129.84 174.28 9.88 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -175.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.405 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.38 141.41 7.19 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 113.93 -1.487 . . . . 0.0 110.024 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.726 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 4.7 m-30 -60.28 157.8 12.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.898 0.849 . . . . 0.0 111.668 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.408 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 2.1 t . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.451 -0.396 0 CA-C-O 121.722 0.772 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.717 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -117.89 -167.26 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.044 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.45 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 36.78 -121.7 0.75 Allowed Glycine 0 N--CA 1.46 0.289 0 O-C-N 124.13 0.894 . . . . 0.0 113.248 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.666 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 30.21 -135.11 0.08 OUTLIER Glycine 0 C--N 1.337 0.632 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 114.815 -0.692 . . . . 0.0 110.422 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.166 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -86.53 171.74 7.21 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.898 2.399 . . . . 0.0 112.416 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 78.7 m -95.67 112.24 24.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 46.1 t -73.59 115.34 14.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.87 0.367 . . . . 0.0 111.544 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -113.03 141.18 25.16 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 120.91 0.386 . . . . 0.0 110.572 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -85.68 139.87 26.72 Favored 'Cis proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.386 -1.922 . . . . 0.0 111.707 -0.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 40.3 p90 -103.81 -174.32 2.52 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.147 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 94.3 m -142.67 120.03 11.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.865 0.364 . . . . 0.0 110.286 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.875 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 66.3 t80 -115.97 135.09 54.3 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.587 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 34.68 47.18 0.22 Allowed 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 124.589 1.18 . . . . 0.0 114.01 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.32 -7.74 80.03 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 116.546 1.378 . . . . 0.0 116.546 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' THR . 54.4 m-80 -112.79 143.14 44.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.567 1.684 . . . . 0.0 111.823 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -86.81 129.38 34.9 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.875 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 88.0 m-85 -116.75 118.22 31.93 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.394 0.616 . . . . 0.0 111.089 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -94.28 -16.62 23.42 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.845 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.7 p -130.67 -177.59 4.42 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.485 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 77.8 m -66.91 161.93 22.96 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -138.28 167.83 21.03 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.12 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.671 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 11.0 p -121.22 20.16 11.4 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -60.88 134.47 57.12 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 113.751 -1.568 . . . . 0.0 111.779 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.83 -5.71 37.77 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.136 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 20.4 mtp85 . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 120.797 0.332 . . . . 0.0 111.282 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.433 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.445 -0.678 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.671 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.2 mpt? -95.69 154.65 17.11 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.652 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.6 p-90 -139.88 -163.21 1.46 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.1 0.476 . . . . 0.0 111.144 -178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p -169.45 155.98 6.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.264 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 15' ' ' CYS . . . -79.61 152.86 29.8 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 120.911 0.386 . . . . 0.0 111.464 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.1 p -102.12 6.87 41.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.95 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.7 p -130.73 150.66 51.81 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.295 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.02 -35.44 71.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.969 0.414 . . . . 0.0 110.986 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -124.47 109.99 13.95 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 1.007 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 30.6 t80 -75.38 -34.84 61.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.345 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -52.26 -32.87 39.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.885 0.374 . . . . 0.0 111.324 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -83.17 -58.54 2.8 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.837 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 56.2 m-20 -91.31 -19.8 22.57 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 3.2 mtm105 46.57 43.72 12.69 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.837 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 22.2 mtpt -110.57 124.0 51.02 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 1.007 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 7.8 p-90 -131.58 172.66 11.97 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.566 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.65 145.78 11.3 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 113.646 -1.616 . . . . 0.0 110.255 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.717 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 7.0 m-30 -66.62 160.56 25.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.465 0.65 . . . . 0.0 112.318 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.867 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.723 0.773 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -132.0 161.73 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 177.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.768 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.73 -154.33 46.15 Favored Glycine 0 C--N 1.309 -0.921 0 C-N-CA 118.068 -2.015 . . . . 0.0 111.544 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.614 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 48.94 -150.42 3.82 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 115.45 0.94 . . . . 0.0 115.45 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 114.835 -0.682 . . . . 0.0 109.625 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 120.433 0.159 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -85.61 -177.21 2.53 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.834 2.356 . . . . 0.0 111.308 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.9 m -87.75 122.42 31.39 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.241 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 74.6 t -85.06 110.16 18.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.733 0.301 . . . . 0.0 110.329 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -116.26 138.55 24.36 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-O 120.95 0.405 . . . . 0.0 111.013 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.652 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 6.4 Cg_endo -86.47 137.85 20.67 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.136 -1.61 . . . . 0.0 112.002 -0.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.55 ' CG ' ' HB3' ' A' ' 42' ' ' ALA . 47.1 p90 -103.09 -169.66 1.68 Allowed 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.9 m -144.31 128.93 18.15 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.947 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.738 ' CG ' HD22 ' A' ' 22' ' ' LEU . 1.1 t80 -132.49 142.3 49.16 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.738 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 41.12 35.81 0.41 Allowed 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 124.557 1.143 . . . . 0.0 112.812 178.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.13 -6.6 83.31 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 115.01 0.764 . . . . 0.0 115.01 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.518 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.1 m-80 -107.07 136.87 46.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.508 1.154 . . . . 0.0 111.638 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -78.03 123.09 26.42 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.723 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 14.8 m-30 -107.03 112.17 24.99 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.805 0.812 . . . . 0.0 110.884 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.652 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 45.6 mt-10 -91.54 -18.0 24.78 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.366 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 p -129.89 -174.17 3.24 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 80.8 m -62.92 166.66 5.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.54 0.686 . . . . 0.0 110.36 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -147.65 169.5 19.52 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.32 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.586 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 55.1 p -128.55 17.7 6.39 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.644 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -59.79 138.25 57.83 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 113.96 -1.473 . . . . 0.0 111.086 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.06 -9.31 26.15 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.289 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.605 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.7 mtp85 . . . . . 0 N--CA 1.445 -0.69 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.718 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 24.7 mmmt . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.586 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 60.8 mtt -81.8 149.5 28.34 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.616 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 21.6 p-90 -136.61 -172.76 3.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.563 0.697 . . . . 0.0 112.297 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 25.0 p -151.05 140.46 21.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.739 -1.118 . . . . 0.0 108.693 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.55 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -75.61 151.24 37.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.347 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 65.1 p -108.04 14.81 24.86 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.798 0.808 . . . . 0.0 110.199 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.0 p -137.23 150.05 47.58 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.94 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.23 -42.25 76.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.879 0.371 . . . . 0.0 111.205 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -118.09 106.24 12.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.744 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 75.8 t80 -74.44 -35.28 63.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.231 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -54.44 -39.51 67.44 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -84.08 -49.78 8.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -83.02 -34.09 26.36 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 4.3 mmm-85 55.19 44.46 27.69 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -111.53 118.36 35.53 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.744 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 11.5 p-90 -129.45 174.88 9.23 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -175.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.17 141.22 7.08 Favored Glycine 0 C--O 1.221 -0.683 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.107 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.768 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 6.1 m-85 -65.75 163.38 16.74 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 117.344 0.572 . . . . 0.0 111.989 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 63.1 m . . . . . 0 N--CA 1.453 -0.284 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.755 178.351 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.442 -0.853 0 CA-C-O 121.665 0.745 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -126.74 160.76 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 177.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.831 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 68.53 -144.78 42.87 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 117.887 -2.102 . . . . 0.0 111.612 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.633 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 43.12 -145.86 1.04 Allowed Glycine 0 C--N 1.331 0.275 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 114.878 -0.661 . . . . 0.0 109.506 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.079 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -84.63 160.99 12.47 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.744 2.296 . . . . 0.0 112.43 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 91.8 m -83.37 123.12 29.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.469 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.8 t -90.31 120.02 38.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.715 0.293 . . . . 0.0 110.922 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.599 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 58.6 m-85 -114.74 141.88 27.44 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.483 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.462 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.3 Cg_endo -86.49 132.75 14.61 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.308 -1.538 . . . . 0.0 112.14 -0.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.599 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 22.5 p90 -98.56 128.03 44.73 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.525 ' OG1' ' HD2' ' A' ' 25' ' ' LYS . 13.9 m -91.38 125.64 36.21 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.432 0.634 . . . . 0.0 112.148 -177.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.871 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -130.36 145.97 51.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.41 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.728 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.24 36.88 0.21 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.461 1.104 . . . . 0.0 113.099 178.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.27 -5.52 84.96 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.441 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 68.6 m-80 -110.29 135.7 50.63 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.587 1.194 . . . . 0.0 112.202 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HD2' ' OG1' ' A' ' 20' ' ' THR . 25.1 mmmt -77.42 117.13 18.6 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.871 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.5 m-30 -101.77 104.4 15.19 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.02 0.914 . . . . 0.0 111.361 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 15.5 mt-10 -84.46 -17.42 39.2 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.215 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 p -129.06 -178.45 4.64 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.639 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.9 m -66.64 159.52 27.45 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.725 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.488 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.5 t -137.74 178.48 7.08 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.703 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.7 p -128.77 17.44 6.29 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.513 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -60.87 142.96 55.78 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.107 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.06 -5.26 19.79 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.536 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.625 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 12.2 mtp85 . . . . . 0 N--CA 1.449 -0.504 0 CA-C-N 117.33 0.565 . . . . 0.0 111.565 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.625 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 5.7 mptt . . . . . 0 CA--C 1.515 -0.367 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.0 mtp -89.86 156.82 18.21 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.632 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 18.6 p-90 -143.85 -172.06 3.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.417 0.627 . . . . 0.0 111.332 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.549 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.4 p -159.3 139.26 11.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.044 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . . . -72.01 155.48 40.28 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.372 0.606 . . . . 0.0 111.511 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.4 p -101.93 11.24 38.88 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.767 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.9 p -133.08 151.82 52.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.912 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.96 -32.57 67.97 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.163 0.506 . . . . 0.0 111.358 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -126.69 120.2 28.84 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.861 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 64.5 t80 -86.17 -31.42 21.8 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.325 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -61.13 -30.94 70.68 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.05 -45.23 8.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -100.32 -18.51 16.76 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.1 mtm105 43.5 51.28 6.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -114.82 119.39 36.45 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.861 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.2 p-90 -132.99 176.48 8.45 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -174.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -167.28 142.55 7.63 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 112.95 -1.932 . . . . 0.0 109.222 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.831 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 12.9 m-85 -60.76 157.37 14.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.407 0.622 . . . . 0.0 112.081 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.501 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.9 t . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.055 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.448 -0.545 0 CA-C-O 121.987 0.899 . . . . 0.0 112.742 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -132.75 163.91 36.58 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.032 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 178.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.533 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 65.16 -149.94 51.7 Favored Glycine 0 C--N 1.312 -0.782 0 C-N-CA 117.716 -2.183 . . . . 0.0 111.014 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.638 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 48.47 -150.51 3.34 Favored Glycine 0 C--N 1.332 0.326 0 N-CA-C 114.641 0.616 . . . . 0.0 114.641 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.491 ' H ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.418 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 CA--C 1.521 -0.163 0 CA-C-O 120.809 0.338 . . . . 0.0 111.513 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 14.2 Cg_exo -65.51 154.31 74.29 Favored 'Trans proline' 0 C--N 1.334 -0.219 0 C-N-CA 122.896 2.397 . . . . 0.0 111.472 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.2 m -73.78 134.58 43.44 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.0 t -95.06 113.87 30.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.834 0.35 . . . . 0.0 110.426 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.614 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 47.4 m-85 -118.64 139.94 27.72 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.538 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.754 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 35.9 Cg_endo -87.06 136.12 17.05 Favored 'Cis proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.51 -1.871 . . . . 0.0 112.379 -0.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.614 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 34.3 p90 -101.93 -168.02 1.49 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 76.0 m -149.47 126.28 11.12 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.433 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.822 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 36.8 t80 -123.03 131.64 53.79 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.988 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.683 HD22 ' CE2' ' A' ' 21' ' ' PHE . 6.7 mp 41.76 33.56 0.34 Allowed 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 124.531 1.144 . . . . 0.0 113.502 174.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.68 -18.16 32.41 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 115.422 0.929 . . . . 0.0 115.422 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.475 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 43.8 m-80 -112.6 132.01 55.34 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.888 1.344 . . . . 0.0 112.181 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 46.5 mtpt -78.17 127.03 31.67 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.822 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.4 m-85 -111.91 121.2 44.38 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.683 0.754 . . . . 0.0 111.223 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.754 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 99.1 mt-10 -94.87 -14.67 24.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.224 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.3 p -130.08 -175.37 3.6 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.63 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.7 m -67.1 166.29 14.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.774 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.3 t -146.15 165.36 29.38 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.098 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 p -121.53 23.8 10.13 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -66.04 139.73 58.22 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.022 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.65 -6.45 17.79 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.612 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.482 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.9 mtp85 . . . . . 0 N--CA 1.449 -0.48 0 CA-C-N 117.401 0.601 . . . . 0.0 111.211 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 1.5 mppt? . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.0 mtm -104.61 159.07 16.05 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.722 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.584 ' HA ' ' N ' ' A' ' 56' ' ' CYS . 13.9 p-90 -142.5 -165.7 2.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.369 0.604 . . . . 0.0 111.94 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.3 p -161.04 152.79 19.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.672 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.401 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -86.85 148.53 25.33 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.401 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.3 p -103.12 8.02 38.71 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.536 0.684 . . . . 0.0 109.877 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.9 p -130.07 152.63 49.31 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.663 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.73 -47.74 81.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.756 0.313 . . . . 0.0 111.518 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -115.4 104.61 11.94 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.96 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 43.4 t80 -69.28 -37.6 77.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.792 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -53.0 -28.82 25.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.96 0.41 . . . . 0.0 111.762 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -87.48 -70.6 0.61 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.59 -21.18 55.94 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.63 ' HB3' ' NH1' ' A' ' 51' ' ' ARG . 0.9 OUTLIER 46.98 50.77 13.53 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 179.166 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -114.13 118.37 33.83 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.96 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.8 p-90 -129.85 171.21 12.96 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -174.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.638 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.61 142.64 7.83 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 113.122 -1.854 . . . . 0.0 109.502 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 13.7 m-30 -55.15 155.65 4.63 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 117.043 0.422 . . . . 0.0 111.249 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.584 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.7 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.577 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 121.466 0.651 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.71 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -116.5 -164.96 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 177.059 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.545 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.64 -125.51 1.31 Allowed Glycine 0 N--CA 1.463 0.47 0 O-C-N 123.814 0.696 . . . . 0.0 113.307 177.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.649 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 30.55 -136.4 0.07 OUTLIER Glycine 0 C--N 1.338 0.693 0 N-CA-C 116.049 1.179 . . . . 0.0 116.049 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.464 HD22 ' N ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 114.729 -0.736 . . . . 0.0 110.083 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.563 0.22 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -86.12 166.52 9.62 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.62 2.213 . . . . 0.0 112.254 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.7 m -81.08 133.92 35.56 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.531 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 82.9 t -96.48 115.76 36.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.742 0.306 . . . . 0.0 110.29 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -118.15 139.54 26.81 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.314 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.683 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 6.0 Cg_endo -85.64 136.12 20.61 Favored 'Cis proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.288 -1.547 . . . . 0.0 111.571 -0.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.649 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 43.8 p90 -104.1 -170.04 1.71 Allowed 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.364 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.7 m -148.18 126.86 12.53 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.094 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.831 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 67.9 t80 -117.95 132.73 56.37 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.599 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.614 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.8 mm? 33.28 45.45 0.08 Allowed 'General case' 0 N--CA 1.432 -1.332 0 O-C-N 124.792 1.308 . . . . 0.0 114.034 174.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.77 -19.01 51.61 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.452 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 32.4 m-80 -111.86 133.67 53.91 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.787 1.794 . . . . 0.0 112.418 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 11.4 mtmt -75.59 127.11 32.37 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.361 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.831 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.9 m-85 -115.97 109.7 17.93 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 122.244 1.021 . . . . 0.0 110.384 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.683 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 24.4 mt-10 -87.81 -10.47 50.8 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.498 -1.683 . . . . 0.0 110.648 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.5 p -133.15 -168.2 2.05 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.6 m -74.52 167.63 21.34 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.4 t -146.71 169.97 17.94 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.309 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.427 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 11.8 p -122.32 20.15 10.52 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.12 140.55 56.83 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.233 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.4 -1.07 45.16 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.51 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.659 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.6 mtp85 . . . . . 0 N--CA 1.447 -0.58 0 CA-C-N 116.944 0.372 . . . . 0.0 111.076 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.659 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 2.9 mppt? . . . . . 0 N--CA 1.446 -0.645 0 CA-C-O 120.939 0.399 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.427 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 47.1 mtt -91.18 151.06 21.1 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.651 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.6 p-90 -130.08 -167.07 1.76 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.187 0.518 . . . . 0.0 111.533 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 10.6 p -159.72 143.97 14.81 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.505 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -76.11 149.72 37.35 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 59.8 p -104.74 13.86 30.67 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.677 0.751 . . . . 0.0 109.788 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.8 p -139.33 154.98 47.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.835 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.85 -48.01 83.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.772 0.32 . . . . 0.0 111.325 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -114.49 106.68 14.57 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 1.063 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 20.3 t80 -75.81 -34.39 60.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.196 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.13 -39.81 21.68 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.92 -35.71 11.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -89.82 -30.86 17.66 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.534 ' HB3' HH11 ' A' ' 51' ' ' ARG . 0.3 OUTLIER 48.62 47.09 20.99 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -117.77 118.07 31.06 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 1.063 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 10.2 p-90 -132.57 173.7 11.05 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -175.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.56 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.7 147.22 11.39 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 113.437 -1.711 . . . . 0.0 109.571 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.71 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 11.5 m-30 -61.04 155.71 19.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.752 0.776 . . . . 0.0 111.592 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.559 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 11.3 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.639 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 121.492 0.663 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.535 HG13 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -124.57 -50.1 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-O 123.194 1.473 . . . . 0.0 109.716 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.759 ' H ' ' HB2' ' A' ' 55' ' ' PHE . . . -83.38 -162.29 32.75 Favored Glycine 0 C--N 1.278 -2.692 0 CA-C-N 111.054 -2.794 . . . . 0.0 111.85 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 53' ' ' TRP . . . 75.62 -157.89 49.67 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.693 -0.765 . . . . 0.0 114.419 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.487 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.857 0.361 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 3.1 Cg_exo -78.45 154.54 27.86 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.894 2.396 . . . . 0.0 112.008 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.8 m -76.99 141.75 40.26 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.0 t -109.39 92.11 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.726 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.696 ' CE1' ' HE1' ' A' ' 19' ' ' PHE . 6.5 m-85 -94.32 143.98 27.25 Favored Pre-proline 0 N--CA 1.447 -0.624 0 CA-C-O 121.657 0.741 . . . . 0.0 111.331 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.3 Cg_endo -84.14 129.91 14.73 Favored 'Cis proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.402 -1.916 . . . . 0.0 111.964 -0.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.696 ' HE1' ' CE1' ' A' ' 17' ' ' PHE . 2.0 p90 -86.7 -163.68 0.94 Allowed 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.5 m -149.19 121.75 8.56 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.992 ' HB3' HD22 ' A' ' 22' ' ' LEU 0.494 0.5 OUTLIER -104.09 -171.38 1.92 Allowed 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 119.264 3.061 . . . . 0.0 119.264 171.964 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.992 HD22 ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -52.93 45.6 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 110.086 -3.234 . . . . 0.0 113.684 -173.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.19 1.46 16.34 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.318 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.894 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 1.9 m-80 -138.67 136.57 36.0 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 118.572 1.186 . . . . 0.0 113.016 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.53 122.34 26.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 175.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.989 ' CE2' ' HB2' ' A' ' 21' ' ' PHE . 22.1 m-30 -95.42 98.35 10.49 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 122.39 1.09 . . . . 0.0 112.824 -175.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 16.4 mt-10 -78.21 -12.66 60.01 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.778 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.6 p -138.57 -179.84 6.04 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.4 m -64.6 163.28 13.97 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.503 -0.879 . . . . 0.0 109.209 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -143.92 170.27 16.22 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.599 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 61.2 p -122.77 15.63 10.16 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.439 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -64.52 147.89 51.85 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.001 -1.454 . . . . 0.0 111.336 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.94 -4.59 37.4 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.158 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.596 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 28.3 mtp85 . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 120.751 0.31 . . . . 0.0 111.242 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.596 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 7.1 mptt . . . . . 0 N--CA 1.448 -0.542 0 CA-C-O 120.732 0.301 . . . . 0.0 110.762 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.599 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 56.2 mtt -91.34 142.88 27.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.765 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 18.3 p-90 -122.93 -170.82 2.17 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.504 0.668 . . . . 0.0 110.979 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 8.3 p -157.56 134.49 10.08 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.0 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.516 ' HB3' ' CB ' ' A' ' 19' ' ' PHE . . . -72.49 149.43 44.14 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.011 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.5 p -101.99 13.74 33.93 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.538 0.685 . . . . 0.0 110.335 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.8 p -135.69 148.28 48.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.014 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -55.81 -36.64 67.66 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.894 0.378 . . . . 0.0 110.978 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -119.58 116.9 26.99 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.722 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 60.9 t80 -87.56 -43.78 11.75 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.343 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -42.94 -37.89 2.03 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -91.29 -67.88 0.83 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.451 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 2.2 m-20 -63.97 -26.13 68.44 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.9 mtm-85 44.33 52.62 7.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.451 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 25.7 mttm -116.94 115.64 25.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.722 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 16.6 p-90 -129.73 175.09 9.11 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.978 0.894 . . . . 0.0 112.758 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.488 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -164.8 142.6 7.87 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 113.617 -1.629 . . . . 0.0 109.191 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.759 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 4.3 m-30 -60.66 147.39 42.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.688 0.744 . . . . 0.0 111.0 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.442 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.6 t . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.192 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 122.019 0.914 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -134.62 160.94 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.012 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.88 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 68.63 -147.54 47.02 Favored Glycine 0 C--N 1.309 -0.956 0 C-N-CA 117.487 -2.292 . . . . 0.0 111.612 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.649 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 47.25 -147.18 3.68 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 114.441 0.537 . . . . 0.0 114.441 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 120.823 0.344 . . . . 0.0 110.733 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 120.434 0.159 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -88.87 167.33 5.78 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.805 2.337 . . . . 0.0 111.932 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.7 m -76.56 141.08 41.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 88.1 t -111.4 115.1 48.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -116.43 144.16 32.58 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.935 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.629 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.7 Cg_endo -84.21 133.49 19.73 Favored 'Cis proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.485 -1.465 . . . . 0.0 111.285 -0.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.567 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 17.5 p90 -103.37 162.6 12.88 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.2 m -118.84 122.44 42.36 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.943 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.808 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 60.6 t80 -119.9 133.71 55.48 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.521 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.5 mm? 36.19 46.76 0.41 Allowed 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.5 -4.05 86.49 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 114.225 -1.352 . . . . 0.0 116.318 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 26' ' ' TYR . 40.2 m-80 -110.14 155.71 21.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.673 1.737 . . . . 0.0 111.571 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -94.65 131.33 40.56 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.157 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.808 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 88.9 m-85 -123.77 107.56 11.57 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.697 0.761 . . . . 0.0 112.041 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.629 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 93.6 mt-10 -93.39 -14.32 26.96 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.591 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.6 p -128.14 -177.06 3.99 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.605 -1.179 . . . . 0.0 108.158 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.6 m -67.08 168.91 9.28 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.284 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.6 t -143.99 169.17 18.33 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.184 0.516 . . . . 0.0 110.787 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.461 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 32.4 p -123.52 15.51 9.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.473 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -55.9 136.86 51.38 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.405 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.26 -18.59 3.36 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.147 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.7 mtp85 . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 120.795 0.331 . . . . 0.0 110.519 179.715 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.413 ' N ' ' HD2' ' A' ' 38' ' ' LYS . 7.0 mptt . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.461 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.5 mpt? -96.41 152.62 18.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.6 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.6 p-90 -133.4 -166.08 1.72 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.326 0.584 . . . . 0.0 111.531 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 29.3 p -158.58 149.69 20.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.008 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.546 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -84.27 148.33 26.75 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.2 p -102.41 10.61 38.91 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.665 0.745 . . . . 0.0 110.32 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.2 p -133.56 151.31 51.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.924 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -55.78 -37.66 68.86 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.971 0.415 . . . . 0.0 111.077 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -125.51 112.44 16.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 1.033 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 30.6 t80 -73.95 -36.93 64.67 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.538 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -54.22 -35.08 62.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.148 0.499 . . . . 0.0 111.103 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.57 -71.42 0.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -81.47 -18.85 43.78 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 11.1 mtm180 45.2 55.65 6.17 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -119.49 120.86 38.03 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 1.033 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.7 p-90 -128.35 169.8 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.57 140.72 6.71 Favored Glycine 0 C--O 1.22 -0.78 0 CA-C-N 113.377 -1.738 . . . . 0.0 109.819 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.88 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.2 m-85 -58.93 154.41 15.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 117.59 0.695 . . . . 0.0 111.233 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.436 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.5 t . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.955 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.776 0.798 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -127.8 -168.24 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 177.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.479 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 35.84 -131.22 0.78 Allowed Glycine 0 CA--C 1.522 0.511 0 O-C-N 124.079 0.862 . . . . 0.0 113.496 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.676 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 40.31 -144.59 0.46 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 114.983 0.753 . . . . 0.0 114.983 177.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.27 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -81.74 154.36 17.76 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.118 1.879 . . . . 0.0 111.513 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.7 m -74.17 131.4 41.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.2 t -86.55 109.39 18.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.519 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 35.4 m-85 -116.59 139.31 25.33 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-O 120.749 0.309 . . . . 0.0 111.684 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.716 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 3.8 Cg_endo -86.22 134.78 17.5 Favored 'Cis proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.312 -1.537 . . . . 0.0 111.211 -1.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.519 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 43.5 p90 -96.95 -168.66 1.74 Allowed 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.437 178.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 73.9 m -144.43 122.98 12.45 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.002 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.741 ' CG ' HD22 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -125.0 142.94 51.16 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.741 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 40.91 27.94 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.758 1.223 . . . . 0.0 113.562 178.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.02 -7.02 62.35 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 114.819 0.688 . . . . 0.0 114.819 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 20' ' ' THR . 60.7 m-80 -105.5 149.33 26.31 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.512 1.156 . . . . 0.0 111.921 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -88.46 119.07 28.56 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.603 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 28.1 m-85 -104.64 112.52 25.63 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.72 0.772 . . . . 0.0 110.587 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.716 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 46.6 mt-10 -92.04 -17.75 24.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.475 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 p -129.62 -175.67 3.67 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 78.2 m -65.77 164.17 15.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.474 0.654 . . . . 0.0 110.613 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -142.34 167.71 21.47 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.867 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.706 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 27.9 p -121.95 18.57 10.93 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.554 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -64.48 139.17 58.74 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.718 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.81 -4.29 45.74 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.1 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.654 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.2 mtp85 . . . . . 0 N--CA 1.451 -0.391 0 CA-C-N 117.425 0.612 . . . . 0.0 110.844 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.654 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 8.8 mptt . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.885 0.374 . . . . 0.0 111.948 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.706 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 70.0 mtm -78.27 142.13 38.04 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.626 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.1 p-90 -128.75 -167.37 1.77 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.433 0.635 . . . . 0.0 112.04 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 17.7 p -152.7 141.86 21.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.918 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.99 148.56 38.01 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.178 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.1 p -103.27 11.96 36.13 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.594 0.711 . . . . 0.0 109.712 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.3 p -137.62 153.3 49.91 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.762 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.56 -50.09 72.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 110.303 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -105.18 102.83 12.3 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.793 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 71.8 t80 -75.67 -34.31 60.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.936 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.36 -38.91 55.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -85.55 -71.2 0.54 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.525 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 72.9 m-20 -63.54 -26.42 68.7 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 15.4 mtm180 44.2 52.09 7.18 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.525 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 42.8 mttt -116.35 118.93 34.1 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.793 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.7 p-90 -133.89 176.28 8.71 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.543 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.94 150.07 19.1 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.295 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.687 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.7 m-30 -65.44 162.02 18.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.96 0.88 . . . . 0.0 112.374 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.455 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 5.6 t . . . . . 0 C--N 1.33 -0.254 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.849 0.833 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.534 HG22 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -128.08 164.96 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 178.045 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.715 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 61.36 -149.97 44.95 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 118.229 -1.938 . . . . 0.0 111.51 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.573 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 49.79 -145.28 8.66 Favored Glycine 0 C--N 1.33 0.24 0 N-CA-C 114.169 0.428 . . . . 0.0 114.169 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.521 ' H ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.445 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 CA--C 1.522 -0.134 0 CA-C-O 120.859 0.361 . . . . 0.0 111.372 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 85.7 Cg_endo -90.3 169.44 4.11 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.4 2.733 . . . . 0.0 112.038 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.9 m -79.52 142.31 35.89 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.424 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.3 t -116.22 87.99 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.722 0.296 . . . . 0.0 111.318 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.543 ' CE1' ' HE1' ' A' ' 19' ' ' PHE . 8.8 m-85 -90.3 146.11 34.03 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-O 121.443 0.639 . . . . 0.0 111.082 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.67 132.26 18.69 Favored 'Cis proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.4 -1.917 . . . . 0.0 112.197 -0.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.591 ' CB ' ' HB3' ' A' ' 42' ' ' ALA . 0.4 OUTLIER -90.07 -168.19 2.05 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.2 m -151.13 124.06 8.66 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.983 ' HB2' ' CE2' ' A' ' 26' ' ' TYR 0.471 0.5 OUTLIER -96.5 -173.81 2.87 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 119.068 2.988 . . . . 0.0 119.068 171.698 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.964 HD22 ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -56.29 43.46 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 109.804 -3.362 . . . . 0.0 112.89 -173.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 21' ' ' PHE . . . 122.62 -0.48 10.19 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 114.083 -1.417 . . . . 0.0 113.014 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.849 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 1.8 m-80 -137.9 134.57 35.19 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 118.171 0.986 . . . . 0.0 112.256 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -83.65 127.86 34.09 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.983 ' CE2' ' HB2' ' A' ' 21' ' ' PHE . 6.4 m-85 -107.7 110.89 22.85 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 122.896 1.331 . . . . 0.0 113.249 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -86.27 -13.6 46.25 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 112.763 -2.017 . . . . 0.0 111.325 -178.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 p -135.57 -177.61 4.75 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.1 m -65.68 153.39 41.82 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.139 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -131.39 175.89 8.76 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.439 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 1.4 p -130.41 17.8 5.38 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.69 154.48 36.46 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.511 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.36 -2.36 15.37 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.877 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.622 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.3 mtp85 . . . . . 0 N--CA 1.451 -0.419 0 CA-C-O 120.807 0.337 . . . . 0.0 111.094 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.622 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 8.5 mptt . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 120.718 0.294 . . . . 0.0 110.291 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.439 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 80.7 mtp -84.89 149.98 25.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.038 0.447 . . . . 0.0 110.828 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.736 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 24.0 p-90 -131.15 -171.94 2.71 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.62 0.724 . . . . 0.0 111.242 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.491 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 25.6 p -156.12 137.6 14.03 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.273 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.591 ' HB3' ' CB ' ' A' ' 19' ' ' PHE . . . -76.34 144.67 40.01 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.594 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.3 p -98.17 17.2 19.1 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.669 0.747 . . . . 0.0 110.01 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.9 p -141.67 146.48 36.18 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.75 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -54.4 -32.35 56.99 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.266 0.354 . . . . 0.0 111.886 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -125.66 121.47 33.6 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 1.034 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 30.9 t80 -88.46 -43.53 11.39 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.26 -31.91 1.73 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -93.23 -63.91 1.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -73.19 -20.28 60.92 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.4 mtm-85 41.86 52.34 4.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -118.28 117.81 30.11 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 1.034 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 8.9 p-90 -130.81 174.26 10.14 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -175.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.438 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -169.3 136.84 4.23 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-N 113.673 -1.603 . . . . 0.0 110.578 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.736 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 10.8 m-30 -60.21 158.83 10.76 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.377 0.671 . . . . 0.0 112.189 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.349 178.452 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.44 -0.955 0 CA-C-O 121.885 0.85 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -126.39 162.93 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 177.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.763 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 67.03 -144.23 44.53 Favored Glycine 0 C--N 1.309 -0.919 0 C-N-CA 117.747 -2.168 . . . . 0.0 111.077 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.497 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 39.48 -138.08 1.14 Allowed Glycine 0 C--N 1.332 0.309 0 N-CA-C 114.888 0.715 . . . . 0.0 114.888 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.465 -0.368 . . . . 0.0 111.664 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.699 0.285 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -89.27 161.82 5.64 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.902 2.401 . . . . 0.0 112.664 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 86.6 m -79.99 133.94 36.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.119 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.57 114.4 44.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.724 0.297 . . . . 0.0 111.254 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.458 ' CE2' ' HE1' ' A' ' 19' ' ' PHE . 90.6 m-85 -108.27 146.5 33.71 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-O 120.751 0.31 . . . . 0.0 110.639 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.21 131.63 16.93 Favored 'Cis proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.479 -1.467 . . . . 0.0 111.579 -0.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 23.9 p90 -101.22 126.65 47.97 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 86.2 m -89.85 124.77 34.97 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.386 0.612 . . . . 0.0 111.739 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.733 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.8 t80 -124.11 141.53 51.98 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.677 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.1 OUTLIER 40.64 32.26 0.14 Allowed 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 124.294 1.038 . . . . 0.0 113.03 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.26 -11.15 69.3 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 115.117 0.807 . . . . 0.0 115.117 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.528 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.5 m-80 -105.54 136.1 45.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 118.564 1.182 . . . . 0.0 112.027 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -78.82 120.45 23.46 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.733 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.9 m-30 -103.26 110.61 22.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.044 0.926 . . . . 0.0 111.181 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -88.98 -18.91 26.46 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.73 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -128.36 177.72 6.77 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.1 m -64.57 161.28 17.78 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.688 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.5 t -136.61 171.84 13.89 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.987 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.622 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 29.4 p -124.39 16.73 8.99 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.499 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.71 145.46 52.29 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.787 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.62 -16.74 29.19 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.618 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.608 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 3.6 mtp-105 . . . . . 0 N--CA 1.453 -0.318 0 CA-C-N 117.671 0.735 . . . . 0.0 110.749 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.608 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 10.5 mptt . . . . . 0 N--CA 1.441 -0.88 0 CA-C-O 121.252 0.549 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.622 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 51.4 mtt -119.55 147.15 44.81 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.661 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 19.9 p-90 -136.96 -168.62 2.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.493 0.663 . . . . 0.0 111.689 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.6 p -162.18 140.31 8.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.23 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -69.9 149.11 48.17 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.407 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 81.2 p -95.03 14.63 21.2 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.518 0.675 . . . . 0.0 109.936 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.3 p -137.62 160.79 38.21 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.325 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.598 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -63.3 -32.94 74.48 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.03 0.443 . . . . 0.0 111.16 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -127.04 115.81 19.76 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.783 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 66.0 t80 -81.4 -31.61 33.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -56.89 -34.26 67.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.67 -62.62 1.43 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.35 -24.68 64.84 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 9.0 mtm180 40.51 48.74 2.55 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -120.47 121.72 39.1 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.783 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.8 p-90 -135.44 174.14 10.95 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -175.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.497 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.86 141.84 7.1 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.155 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.763 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.7 m-85 -57.0 154.37 9.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.217 0.532 . . . . 0.0 111.549 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.473 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 4.6 t . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.081 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.466 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 61.7 p . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 121.242 0.544 . . . . 0.0 112.11 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.88 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -96.35 -168.1 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 176.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.691 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 39.06 -124.29 1.72 Allowed Glycine 0 C--O 1.237 0.282 0 O-C-N 123.954 0.784 . . . . 0.0 113.18 177.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.681 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 36.68 -144.57 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 176.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.283 0 CA-C-N 114.546 -0.827 . . . . 0.0 110.391 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 110.725 -0.102 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -91.69 175.6 2.15 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.251 2.634 . . . . 0.0 111.889 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.9 m -78.62 124.55 28.29 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 82.0 t -94.88 106.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.834 0.35 . . . . 0.0 110.102 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -104.46 139.88 20.54 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.514 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -87.32 131.98 12.52 Favored 'Cis proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.748 -1.355 . . . . 0.0 111.932 -0.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.607 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 16.3 p90 -99.42 130.75 45.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.3 m -96.24 123.44 39.87 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.537 0.684 . . . . 0.0 111.681 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.963 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 13.1 t80 -128.36 141.0 51.56 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.33 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.704 HD13 ' CD1' ' A' ' 21' ' ' PHE . 2.8 mp 48.77 31.92 3.36 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 123.794 0.684 . . . . 0.0 112.302 176.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.46 -0.6 87.05 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.683 -0.689 . . . . 0.0 114.289 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.426 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 62.6 m-80 -114.96 137.27 52.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 118.072 0.936 . . . . 0.0 112.676 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -77.43 125.08 28.76 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.336 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.963 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.5 m-30 -112.6 111.16 21.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.982 0.896 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -92.65 -6.69 48.81 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.71 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 p -138.31 -172.66 3.33 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 98.3 m -69.52 163.54 25.16 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 t -140.77 169.05 18.36 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.665 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.632 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 12.3 p -122.89 15.75 10.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.474 ' CB ' ' HD2' ' A' ' 21' ' ' PHE . . . -60.38 138.64 57.95 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.809 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.86 -8.28 23.05 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.051 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.553 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 26.0 mtp85 . . . . . 0 N--CA 1.446 -0.669 0 CA-C-O 121.088 0.471 . . . . 0.0 110.528 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.553 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 1.9 mptt . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.807 0.337 . . . . 0.0 111.893 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.632 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 56.4 mtt -83.73 150.8 25.59 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.694 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 14.3 p-90 -130.32 -171.31 2.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.495 0.664 . . . . 0.0 112.505 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.1 p -154.02 140.7 18.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.603 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.05 156.5 27.08 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.129 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.3 p -108.19 17.93 21.7 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.838 0.828 . . . . 0.0 110.209 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.7 p -138.83 146.61 41.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.596 -1.184 . . . . 0.0 108.498 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -53.1 -46.56 68.75 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.131 0.491 . . . . 0.0 110.675 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -116.36 106.82 14.06 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.814 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 77.6 t80 -71.08 -46.2 62.3 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.866 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -44.3 -34.53 1.97 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -86.69 -62.75 1.44 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -80.63 -17.93 49.72 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.652 ' HG3' ' O ' ' A' ' 47' ' ' TYR . 21.6 mtm105 33.35 64.68 0.3 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -125.22 112.93 17.0 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.814 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.7 p-90 -120.42 177.07 5.18 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.694 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -158.59 163.52 33.1 Favored Glycine 0 C--O 1.22 -0.769 0 CA-C-N 113.314 -1.766 . . . . 0.0 108.856 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.88 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 1.9 m-85 -88.22 164.51 15.6 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 118.56 1.18 . . . . 0.0 112.683 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.237 0.424 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.166 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 55' ' ' PHE . 40.7 p . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 1.1 t -127.74 6.49 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-O 122.934 1.35 . . . . 0.0 110.317 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.422 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . -158.17 -156.05 7.82 Favored Glycine 0 C--N 1.284 -2.338 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.444 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.662 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 75.05 -144.19 31.88 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.297 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.574 ' H ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.663 0 CA-C-O 121.282 0.563 . . . . 0.0 109.623 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.515 ' O ' HG23 ' A' ' 5' ' ' THR . . . . . . . . 0 C--O 1.225 -0.231 0 CA-C-O 120.687 0.279 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.6 Cg_exo -73.14 126.81 11.46 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.696 2.264 . . . . 0.0 112.354 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 88.3 m -65.07 141.65 58.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.366 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 48.3 t -107.78 132.27 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.708 0.29 . . . . 0.0 111.139 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.48 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 59.8 m-85 -125.39 142.7 42.41 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.308 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.598 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 6.7 Cg_endo -84.91 130.87 14.99 Favored 'Cis proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.324 -1.531 . . . . 0.0 112.014 -0.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.696 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 31.5 p90 -102.72 130.15 49.57 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 62.6 m -93.23 121.54 34.7 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.303 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.836 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 56.1 t80 -112.95 129.45 56.47 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.598 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.733 HD22 ' CE2' ' A' ' 21' ' ' PHE . 7.4 mp 42.96 36.83 0.95 Allowed 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 124.349 1.031 . . . . 0.0 112.908 175.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.0 -15.48 56.63 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 20' ' ' THR . 49.8 m-80 -109.65 129.98 55.55 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 119.367 1.583 . . . . 0.0 112.557 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.3 mtmt -77.36 119.59 21.2 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.001 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.836 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.5 m-85 -108.66 114.04 27.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.743 0.782 . . . . 0.0 111.498 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.598 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 35.0 mt-10 -89.98 -8.78 50.85 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.871 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.4 p -136.72 -177.22 4.64 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.0 m -67.05 165.24 16.17 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.064 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.555 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 9.0 t -144.45 170.09 16.7 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.131 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.464 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 22.9 p -123.78 18.6 9.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.91 136.58 58.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 113.922 -1.49 . . . . 0.0 112.045 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.31 -4.13 9.43 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.775 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.579 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 10.0 mtp85 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 121.578 0.704 . . . . 0.0 112.177 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.621 ' N ' ' HD2' ' A' ' 38' ' ' LYS . 7.9 mptt . . . . . 0 N--CA 1.443 -0.777 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.464 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 50.3 mtt -75.7 153.43 37.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.689 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.7 p-90 -137.46 -165.7 1.81 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.351 0.596 . . . . 0.0 110.977 -178.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.496 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.3 p -167.9 141.32 3.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.962 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.432 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -72.3 156.15 39.42 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.025 0.44 . . . . 0.0 111.273 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.8 p -104.58 13.79 31.03 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.796 0.808 . . . . 0.0 109.506 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.0 p -136.89 142.57 42.75 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.819 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.696 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -54.89 -39.89 69.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.979 0.419 . . . . 0.0 110.947 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -119.17 103.11 9.23 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 1.032 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 32.6 t80 -72.59 -32.99 66.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.177 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -51.22 -28.51 11.66 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -95.12 -60.79 1.6 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -82.19 -19.54 39.62 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 8.1 mtm180 44.3 44.67 6.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -109.13 114.96 29.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 1.032 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.6 p-90 -126.84 175.9 7.68 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -175.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.606 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -172.59 154.58 21.41 Favored Glycine 0 C--O 1.217 -0.946 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.558 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 5' ' ' THR . 15.1 m-30 -64.26 164.59 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.508 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 31.5 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.342 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.512 HG22 ' SG ' ' A' ' 41' ' ' CYS . 77.5 p . . . . . 0 C--O 1.234 0.26 0 N-CA-C 112.53 0.566 . . . . 0.0 112.53 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.82 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 1.5 t -106.37 -67.96 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 CA-C-O 123.298 1.523 . . . . 0.0 109.88 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.86 ' H ' ' HB2' ' A' ' 55' ' ' PHE . . . -76.61 -156.23 6.83 Favored Glycine 0 C--N 1.284 -2.338 0 CA-C-N 111.167 -2.742 . . . . 0.0 112.599 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.592 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 74.14 -139.56 26.16 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.487 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.408 ' N ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.092 0.472 . . . . 0.0 110.421 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 120.597 0.237 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.05 170.69 12.11 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.512 2.142 . . . . 0.0 112.144 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.7 m -85.49 135.14 33.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.578 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 65.5 t -97.14 115.58 37.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.401 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 61.9 m-85 -113.53 138.67 22.65 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-O 120.886 0.374 . . . . 0.0 111.246 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -85.45 136.5 21.66 Favored 'Cis proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.466 -1.889 . . . . 0.0 112.654 -0.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.578 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 28.5 p90 -102.26 136.4 42.16 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 91.3 m -98.48 122.28 41.47 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.614 -0.835 . . . . 0.0 112.618 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.753 ' CG ' HD22 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -123.37 147.34 47.17 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.753 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 37.25 37.06 0.08 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.276 1.03 . . . . 0.0 113.676 178.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.15 -1.01 87.66 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.112 0.805 . . . . 0.0 115.112 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 20' ' ' THR . 68.7 m-80 -112.38 144.34 41.98 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 118.617 1.208 . . . . 0.0 111.985 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -87.46 120.44 28.77 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.628 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 16.6 m-85 -102.19 116.41 32.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.645 0.736 . . . . 0.0 111.315 -177.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -89.8 -24.17 21.53 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.616 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.8 p -126.12 -176.76 3.73 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.3 m -65.28 164.82 12.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.512 0.672 . . . . 0.0 109.891 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.524 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.5 t -139.61 171.57 14.06 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.272 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.2 p -126.07 19.7 7.66 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.49 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -67.24 138.46 56.93 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 113.503 -1.68 . . . . 0.0 112.009 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.67 -1.08 59.37 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.182 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 12.8 mtp85 . . . . . 0 N--CA 1.448 -0.565 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.534 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 62.4 mmtt . . . . . 0 N--CA 1.462 0.128 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 52.1 mtt -92.27 145.2 24.67 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.672 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.5 p-90 -133.23 -167.75 1.97 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.299 0.571 . . . . 0.0 111.881 -177.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.512 ' SG ' HG22 ' A' ' 5' ' ' THR . 3.4 p -158.34 138.34 12.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.677 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.478 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -71.72 151.18 43.81 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.911 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.9 p -102.44 15.82 28.09 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.564 0.697 . . . . 0.0 110.58 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.7 p -138.39 156.34 47.68 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.32 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.38 -35.01 76.31 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.056 0.455 . . . . 0.0 110.941 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -124.53 113.3 17.91 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.687 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 58.8 t80 -80.58 -33.61 35.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.985 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -56.22 -34.48 66.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -83.9 -62.3 1.6 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.15 -29.6 61.87 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 4.0 mtm180 45.55 45.91 10.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.841 0.829 . . . . 0.0 113.052 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -115.24 119.7 37.23 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.687 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.6 p-90 -131.14 179.97 5.69 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -174.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -170.31 151.32 16.22 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 113.873 -1.512 . . . . 0.0 109.323 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.86 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 11.6 m-85 -65.74 162.77 17.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.625 1.212 . . . . 0.0 112.718 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.456 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.5 t . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.783 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.507 HG22 ' SG ' ' A' ' 41' ' ' CYS . 76.2 p . . . . . 0 N--CA 1.444 -0.757 0 CA-C-O 122.336 1.065 . . . . 0.0 113.844 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.753 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -112.87 -152.89 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 176.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.712 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 28.66 -122.28 0.07 OUTLIER Glycine 0 N--CA 1.463 0.456 0 O-C-N 124.671 1.232 . . . . 0.0 114.099 176.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.695 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 39.59 -144.7 0.34 Allowed Glycine 0 C--N 1.331 0.284 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 114.49 -0.855 . . . . 0.0 109.94 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--O 1.226 -0.137 0 CA-C-O 120.311 0.1 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 11.9 Cg_exo -70.27 157.15 60.28 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.085 2.523 . . . . 0.0 112.727 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.6 m -79.82 135.51 36.49 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.7 t -100.16 112.43 32.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.673 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 55.0 m-85 -108.39 141.94 24.3 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.852 0.358 . . . . 0.0 111.408 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.4 Cg_endo -86.87 136.03 17.42 Favored 'Cis proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.531 -1.445 . . . . 0.0 111.981 -0.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.673 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 33.5 p90 -103.29 129.18 50.22 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.7 m -92.43 127.25 37.85 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.233 0.539 . . . . 0.0 112.124 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.85 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.2 t80 -130.36 144.21 51.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.761 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 40.37 36.86 0.38 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.462 1.105 . . . . 0.0 112.899 178.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.23 -9.84 73.49 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 114.709 0.644 . . . . 0.0 114.709 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.412 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 72.9 m-80 -107.6 134.45 50.58 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.453 1.127 . . . . 0.0 111.827 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -79.71 121.14 24.96 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.791 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.85 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.2 m-30 -104.52 110.31 22.54 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.982 0.896 . . . . 0.0 111.086 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 33.2 mt-10 -88.04 -16.69 32.94 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.295 -1.321 . . . . 0.0 110.742 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 p -129.28 -175.24 3.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.9 m -65.43 163.42 15.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.465 0.65 . . . . 0.0 110.177 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.422 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.9 t -138.73 -176.78 4.6 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.645 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.45 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 10.1 p -141.07 18.62 2.28 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -64.84 145.69 55.92 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 113.281 -1.781 . . . . 0.0 112.503 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.09 5.13 32.05 Favored Glycine 0 C--O 1.235 0.198 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.847 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 34' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 117.128 0.464 . . . . 0.0 110.982 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mptt . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.45 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 87.8 mtp -158.42 145.55 17.76 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.63 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 23.5 p-90 -135.59 -174.64 3.7 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.507 ' SG ' HG22 ' A' ' 5' ' ' THR . 6.5 p -152.76 136.85 16.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.161 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . . . -73.04 151.14 41.84 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.013 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.3 p -100.61 17.67 21.22 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.733 0.777 . . . . 0.0 109.275 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.7 p -135.6 151.7 50.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.213 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.666 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -60.72 -37.67 82.52 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.121 0.486 . . . . 0.0 110.878 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -124.26 107.85 11.62 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.708 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 56.4 t80 -74.75 -32.31 62.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.301 -0.408 . . . . 0.0 112.047 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -55.97 -33.66 65.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -94.96 -56.87 2.6 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -77.54 -20.93 53.4 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.588 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 17.5 mtm180 39.63 52.45 2.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -122.47 117.9 27.05 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.708 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.2 p-90 -125.73 172.73 9.56 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.561 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -158.64 154.13 25.23 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.29 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.753 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 1.0 OUTLIER -80.34 156.79 26.58 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -178.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 C--N 1.328 -0.368 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.74 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 p . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 121.666 0.746 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -116.78 -168.23 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.072 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.455 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 36.73 -122.7 0.82 Allowed Glycine 0 N--CA 1.462 0.4 0 O-C-N 124.056 0.848 . . . . 0.0 113.076 178.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.712 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 35.15 -141.36 0.13 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 115.616 1.006 . . . . 0.0 115.616 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.205 -0.497 . . . . 0.0 110.213 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.913 0.387 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 73.1 Cg_endo -87.04 167.75 8.02 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.927 2.418 . . . . 0.0 112.015 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.7 m -79.73 139.75 37.2 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.312 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.1 t -107.5 112.42 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -114.02 143.7 30.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.723 0.297 . . . . 0.0 111.103 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -85.75 137.25 21.97 Favored 'Cis proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.495 -1.46 . . . . 0.0 111.836 -0.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 41.3 p90 -102.79 -178.36 3.65 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.453 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.8 m -135.03 126.2 28.02 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.664 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.645 ' CE2' ' HZ2' ' A' ' 40' ' ' TRP . 1.9 t80 -134.24 141.58 47.05 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.655 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 40.87 38.42 0.65 Allowed 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.746 1.219 . . . . 0.0 113.706 178.607 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.17 -1.65 88.57 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -107.89 154.88 20.94 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 118.439 1.119 . . . . 0.0 111.26 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -94.83 126.36 40.11 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.606 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 21.8 m-85 -113.88 111.92 22.51 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.68 0.752 . . . . 0.0 111.784 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -96.03 -8.33 33.88 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.09 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 p -136.57 -172.75 3.23 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.8 m -69.31 168.64 13.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.128 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.511 ' HG1' ' HE2' ' A' ' 26' ' ' TYR . 10.2 t -144.48 167.12 23.25 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.594 0.711 . . . . 0.0 110.738 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.512 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 61.3 p -120.54 12.64 11.58 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.586 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -56.05 136.74 52.08 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.67 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.37 -10.86 19.99 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.018 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.7 mtp85 . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.059 0.457 . . . . 0.0 110.272 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.488 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.512 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 80.9 mtp -80.6 148.37 30.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.665 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.5 p-90 -128.31 -165.11 1.45 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.382 0.61 . . . . 0.0 111.627 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.5 p -159.68 146.9 16.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.968 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -81.0 143.57 32.42 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.473 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.0 p -97.14 13.97 27.43 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.778 0.799 . . . . 0.0 110.113 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.411 HG23 ' HB2' ' A' ' 52' ' ' LYS . 38.1 p -134.09 158.76 42.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.157 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -65.39 -26.54 68.04 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.193 0.52 . . . . 0.0 110.624 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -132.71 117.44 17.85 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.814 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 65.6 t80 -86.18 -34.78 20.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -54.36 -37.06 64.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.967 0.413 . . . . 0.0 111.791 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.76 -66.37 0.93 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.33 -20.37 63.0 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 26.2 mtt180 38.55 51.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.411 ' HB2' HG23 ' A' ' 44' ' ' THR . 89.8 mttt -113.71 119.22 36.64 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 176.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.814 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 5.3 p-90 -132.25 171.68 13.39 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -174.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.562 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -166.07 143.9 8.76 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 113.3 -1.773 . . . . 0.0 109.838 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.684 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.4 m-30 -60.51 151.51 28.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.399 0.6 . . . . 0.0 111.63 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.497 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 4.5 t . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.0 p . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 121.605 0.717 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.792 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -113.77 -166.54 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 176.376 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.646 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 34.7 -126.11 0.58 Allowed Glycine 0 N--CA 1.463 0.47 0 O-C-N 124.069 0.856 . . . . 0.0 114.117 177.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.579 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 40.74 -149.1 0.2 Allowed Glycine 0 C--N 1.337 0.611 0 N-CA-C 115.77 1.068 . . . . 0.0 115.77 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.422 ' H ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 114.826 -0.687 . . . . 0.0 110.435 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -87.86 167.13 7.12 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.914 2.409 . . . . 0.0 112.136 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.2 m -83.44 129.67 34.99 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 92.7 t -96.87 112.25 28.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.707 0.289 . . . . 0.0 110.305 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -107.0 138.37 19.8 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.562 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -86.25 132.25 14.48 Favored 'Cis proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.21 -1.579 . . . . 0.0 112.263 -0.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.605 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 17.9 p90 -99.93 126.28 46.06 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.244 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 91.2 m -91.67 122.46 34.25 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.963 0.411 . . . . 0.0 110.565 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.867 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 68.3 t80 -115.2 130.09 56.82 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.604 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.552 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.7 mm? 35.28 45.11 0.19 Allowed 'General case' 0 N--CA 1.428 -1.536 0 O-C-N 124.775 1.297 . . . . 0.0 113.319 175.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.72 -23.07 32.21 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 116.497 1.359 . . . . 0.0 116.497 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -111.26 132.51 54.31 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 120.027 1.914 . . . . 0.0 113.12 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 39.7 mtpt -77.71 126.67 31.22 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.867 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.3 m-85 -110.77 118.67 36.79 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.898 0.856 . . . . 0.0 111.643 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -89.62 -12.44 39.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.76 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.4 p -136.08 -171.21 2.82 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.0 m -70.19 166.24 20.41 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.499 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -143.91 171.22 14.54 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.335 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.478 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 71.3 p -125.41 20.88 7.97 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.45 132.83 55.13 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.971 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.02 -8.04 40.12 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.095 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.0 mtp85 . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 120.594 0.235 . . . . 0.0 111.28 179.993 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 mptt . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.478 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 58.2 mtt -94.71 153.21 17.9 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.651 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.8 p-90 -133.6 -166.51 1.79 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.216 0.532 . . . . 0.0 111.777 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 8.4 p -160.07 143.99 14.28 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 19' ' ' PHE . . . -78.77 152.57 31.38 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.563 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.0 p -102.98 9.94 38.44 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.656 0.741 . . . . 0.0 110.553 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.0 p -133.03 153.12 51.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.989 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.44 -42.01 81.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 111.341 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -120.83 111.36 17.46 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 1.051 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 34.3 t80 -77.16 -31.82 55.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.938 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -51.94 -32.8 34.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -90.08 -71.55 0.61 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.25 -27.81 68.24 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.692 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 24.0 mtm-85 45.15 51.0 9.31 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -117.04 119.04 34.04 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 1.051 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.8 p-90 -127.42 172.09 10.97 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -175.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.576 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.44 147.38 13.8 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 113.292 -1.777 . . . . 0.0 109.466 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.792 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 6.1 m-30 -62.84 158.37 19.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.329 1.065 . . . . 0.0 110.989 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.529 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 25.2 t . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.167 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 122.328 1.061 . . . . 0.0 112.95 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.613 HG22 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -129.9 163.45 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 178.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.725 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 62.12 -141.35 47.23 Favored Glycine 0 C--N 1.316 -0.561 0 C-N-CA 118.059 -2.02 . . . . 0.0 111.861 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.625 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 39.67 -139.09 1.03 Allowed Glycine 0 C--N 1.334 0.468 0 N-CA-C 115.676 1.03 . . . . 0.0 115.676 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.273 -0.463 . . . . 0.0 110.569 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.319 0 CA-C-O 120.799 0.333 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -84.25 164.41 13.01 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.726 2.284 . . . . 0.0 111.527 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.459 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.9 m -72.33 138.39 47.29 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 59.7 t -107.88 113.32 43.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.581 0.229 . . . . 0.0 110.681 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -115.82 140.24 25.91 Favored Pre-proline 0 N--CA 1.454 -0.268 0 CA-C-O 120.845 0.355 . . . . 0.0 110.963 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.453 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 5.4 Cg_endo -87.0 132.88 13.84 Favored 'Cis proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.292 -1.545 . . . . 0.0 111.754 -0.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.457 ' CG ' ' HB3' ' A' ' 42' ' ' ALA . 46.3 p90 -98.48 -175.11 3.0 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.844 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 18.9 m -140.0 119.58 13.19 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.727 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.85 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 68.3 t80 -117.83 133.21 56.15 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.504 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.6 mm? 34.62 47.53 0.24 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.697 1.248 . . . . 0.0 113.797 175.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.99 -9.11 75.79 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 116.402 1.321 . . . . 0.0 116.402 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 20' ' ' THR . 51.5 m-80 -110.12 150.01 29.23 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.821 1.811 . . . . 0.0 112.363 -178.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -91.57 125.74 36.41 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.85 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 88.7 m-85 -115.59 114.3 24.75 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.612 0.72 . . . . 0.0 111.574 -178.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.453 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 41.3 mt-10 -93.21 -12.82 29.33 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.234 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.5 p -133.05 -166.47 1.76 Allowed 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.7 m -76.35 170.17 16.86 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.863 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.5 t -147.76 169.5 19.61 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.346 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.9 p -123.59 20.28 9.48 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.411 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -59.85 133.15 55.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 113.523 -1.672 . . . . 0.0 112.101 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.73 -0.22 45.39 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.468 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 22.3 mtp85 . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.439 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 21.8 mmmt . . . . . 0 CA--C 1.516 -0.357 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -90.28 147.05 23.76 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.645 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.5 p-90 -128.59 -169.61 2.11 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.303 0.573 . . . . 0.0 111.834 -178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.0 p -154.41 142.2 20.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.761 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -76.76 143.13 40.09 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.509 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.1 p -99.07 10.35 41.63 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.581 0.705 . . . . 0.0 110.043 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.5 p -136.14 146.85 47.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.729 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.32 -48.24 79.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.768 0.318 . . . . 0.0 111.146 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 48' ' ' ASP . 20.1 t-20 -109.24 99.68 8.92 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.884 ' CE2' ' HB3' ' A' ' 53' ' ' TRP . 47.5 t80 -72.16 -32.91 67.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.559 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.413 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . 54.2 m-20 -45.48 -39.83 7.68 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.8 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -95.97 -55.69 2.9 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -69.23 -35.04 75.76 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.2 mmm180 51.15 37.98 19.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -107.57 118.67 37.33 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.884 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 11.0 p-90 -128.66 174.22 9.61 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.404 -175.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.612 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.08 142.05 7.47 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.751 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.725 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 9.2 m-85 -59.03 154.13 16.23 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.376 0.608 . . . . 0.0 111.639 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.475 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 5.1 t . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.439 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 11.0 p . . . . . 0 N--CA 1.448 -0.558 0 CA-C-O 121.676 0.75 . . . . 0.0 112.639 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.771 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -110.07 -163.44 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.119 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.427 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 34.62 -121.86 0.44 Allowed Glycine 0 N--CA 1.463 0.447 0 O-C-N 124.282 0.988 . . . . 0.0 112.999 177.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.698 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 29.36 -135.28 0.06 OUTLIER Glycine 0 C--N 1.338 0.66 0 N-CA-C 115.986 1.154 . . . . 0.0 115.986 176.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.2 p30 . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 114.722 -0.739 . . . . 0.0 109.214 179.568 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.64 0.257 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 42.0 Cg_endo -85.78 165.56 10.31 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.941 2.427 . . . . 0.0 112.721 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 5.6 m -71.79 127.7 33.41 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.3 t -102.68 101.83 12.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.033 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.655 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 47.7 m-85 -103.45 143.3 26.34 Favored Pre-proline 0 N--CA 1.45 -0.45 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.751 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.83 136.02 22.55 Favored 'Cis proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.578 -1.843 . . . . 0.0 112.355 -0.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.655 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 29.9 p90 -102.77 -171.97 2.04 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.289 177.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.2 m -145.76 127.43 15.22 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.705 -177.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.791 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.5 t80 -134.42 143.02 47.33 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.69 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 41.75 35.41 0.5 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 124.416 1.087 . . . . 0.0 112.976 178.953 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.34 -9.46 77.42 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.506 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 70.7 m-80 -107.73 138.13 44.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 118.368 1.084 . . . . 0.0 112.294 -178.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -79.5 123.31 27.44 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.791 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 15.3 m-30 -106.01 114.52 28.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.762 0.791 . . . . 0.0 110.821 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -86.81 -24.75 24.89 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.068 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 p -122.75 -173.24 2.65 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.306 179.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.1 m -72.32 166.92 21.52 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.937 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.9 t -141.61 166.03 25.87 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.408 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.405 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 12.9 p -120.8 18.77 11.85 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.618 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -59.91 139.07 57.63 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 113.656 -1.611 . . . . 0.0 111.466 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.01 -1.45 68.99 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.2 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.572 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 24.2 mtp85 . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.572 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 66.4 mttt . . . . . 0 C--O 1.226 -0.164 0 CA-C-O 120.286 0.089 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.405 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 43.8 mtt -75.01 143.04 43.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.98 0.419 . . . . 0.0 110.271 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.704 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.1 p-90 -131.24 -167.68 1.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.432 -178.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 15.1 p -157.68 149.54 22.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.006 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.9 151.75 27.12 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.66 178.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 34.5 p -116.23 10.08 14.76 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.016 -178.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.565 HG21 ' HE2' ' A' ' 52' ' ' LYS . 73.4 p -123.03 12.08 9.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . 70.01 -35.99 0.33 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.336 0.655 . . . . 0.0 111.45 -178.449 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 44' ' ' THR . 21.5 t-20 -129.49 110.48 11.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.898 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 49.5 t80 -87.85 -28.68 21.45 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -177.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -58.23 -34.7 70.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -92.94 -53.28 4.21 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.0 OUTLIER -74.64 -43.98 52.71 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.203 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER 61.34 39.55 15.25 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.868 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.565 ' HE2' HG21 ' A' ' 44' ' ' THR . 4.6 mppt? -113.76 118.71 35.04 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.898 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.5 p-90 -130.73 174.96 9.42 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -174.246 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.602 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.4 148.04 13.35 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 113.194 -1.821 . . . . 0.0 109.615 178.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.771 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 7.1 m-30 -60.81 157.81 14.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.58 0.705 . . . . 0.0 111.787 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.494 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 29.3 t . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.823 -178.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 122.273 1.035 . . . . 0.0 113.222 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.501 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -137.9 161.33 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 178.188 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.638 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 62.42 -147.78 49.29 Favored Glycine 0 C--N 1.311 -0.816 0 C-N-CA 118.254 -1.927 . . . . 0.0 111.306 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.745 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 49.3 -148.27 5.58 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 121.607 -0.33 . . . . 0.0 113.766 178.127 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.214 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.51 178.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.1 Cg_endo -81.56 149.78 16.66 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.636 2.224 . . . . 0.0 112.323 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 72.3 m -77.3 126.14 30.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 43.9 t -95.92 121.43 46.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.871 0.367 . . . . 0.0 110.924 -178.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.535 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 52.7 m-85 -115.86 139.43 24.92 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-O 121.248 0.547 . . . . 0.0 111.308 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.664 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 27.7 Cg_endo -86.79 137.53 19.27 Favored 'Cis proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.669 -1.804 . . . . 0.0 112.359 -0.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.643 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 42.8 p90 -102.87 129.38 49.55 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.662 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 5.4 m -91.84 127.75 37.41 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.27 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.874 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.1 t80 -129.61 144.81 51.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.769 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 40.36 35.97 0.32 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.15 0.98 . . . . 0.0 113.243 178.381 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.0 -10.06 75.25 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.033 -0.603 . . . . 0.0 114.502 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -111.98 133.62 54.04 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 118.438 1.119 . . . . 0.0 111.794 -179.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.689 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 3.7 mptt -82.07 123.22 28.75 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.548 -179.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.874 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 15.7 m-85 -104.91 110.9 23.46 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.72 0.771 . . . . 0.0 111.031 -178.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.664 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 48.7 mt-10 -84.95 -15.76 43.28 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.86 -179.487 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p -130.97 -176.45 4.0 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 68.6 m -67.47 162.62 22.8 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.28 179.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.542 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.7 t -139.13 -177.48 4.92 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.7 p -135.88 22.15 3.3 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.61 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.493 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -66.72 150.18 49.46 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 113.91 -1.496 . . . . 0.0 113.096 -178.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.97 7.53 50.16 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 114.963 -1.017 . . . . 0.0 114.468 178.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.601 ' HB3' ' CZ ' ' A' ' 34' ' ' ARG . 5.4 mtp-105 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 118.148 0.974 . . . . 0.0 112.557 -179.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.667 ' HD3' ' CZ ' ' A' ' 55' ' ' PHE . 45.0 mttp . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -99.47 144.98 27.94 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.601 -0.839 . . . . 0.0 108.88 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.691 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 18.6 p-90 -139.68 -172.09 3.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.224 0.535 . . . . 0.0 111.519 -178.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.6 p -156.94 139.5 14.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.206 178.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -72.78 152.68 41.46 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 120.989 0.423 . . . . 0.0 110.856 -179.293 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.7 p -100.27 16.39 24.49 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.641 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.448 HG21 ' CB ' ' A' ' 50' ' ' ASP . 70.8 p -135.21 154.83 51.46 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.179 179.271 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -62.18 -35.06 77.69 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.254 0.55 . . . . 0.0 110.399 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -125.77 110.24 13.49 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.717 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 61.9 t80 -76.6 -33.97 58.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.281 -177.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -53.67 -36.23 61.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.27 -63.72 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.448 ' CB ' HG21 ' A' ' 44' ' ' THR . 32.7 m-20 -72.53 -36.51 68.33 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -177.47 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.8 mmm180 54.67 50.77 15.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -120.92 116.61 25.46 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 176.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.717 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.9 p-90 -129.71 172.67 11.38 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -174.012 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.745 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -160.43 146.69 12.9 Favored Glycine 0 C--O 1.221 -0.701 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.969 178.421 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.667 ' CZ ' ' HD3' ' A' ' 38' ' ' LYS . 3.9 m-30 -61.27 163.29 6.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.578 0.704 . . . . 0.0 112.69 -179.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.413 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 6.6 t . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.417 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.9 p . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 121.919 0.866 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.79 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -127.48 -171.06 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.153 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.567 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.49 -120.6 0.79 Allowed Glycine 0 CA--C 1.521 0.412 0 O-C-N 123.786 0.679 . . . . 0.0 113.306 177.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.705 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 25.88 -136.12 0.02 OUTLIER Glycine 0 C--N 1.343 0.926 0 N-CA-C 116.383 1.313 . . . . 0.0 116.383 177.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.406 HD22 ' N ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 114.62 -0.79 . . . . 0.0 110.133 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.141 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -86.22 167.96 9.1 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.54 2.16 . . . . 0.0 112.4 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 74.9 m -87.81 133.23 33.92 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.564 179.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.2 t -95.49 125.9 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.668 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.588 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 49.5 m-85 -122.63 138.97 30.18 Favored Pre-proline 0 N--CA 1.444 -0.727 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.592 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -86.66 133.27 14.87 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.415 -1.494 . . . . 0.0 112.328 -0.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.588 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 27.3 p90 -99.77 130.4 45.97 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.239 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.4 m -91.19 125.39 35.95 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.375 0.607 . . . . 0.0 111.894 -178.031 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.828 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 2.1 t80 -129.7 141.58 50.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.642 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 42.11 36.95 0.76 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.129 0.971 . . . . 0.0 113.078 178.678 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.37 -6.15 83.9 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.83 -0.7 . . . . 0.0 114.751 178.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.553 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.3 m-80 -112.27 136.46 51.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.434 1.117 . . . . 0.0 111.947 -178.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -80.35 122.36 26.83 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.828 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 15.4 m-30 -104.99 111.2 23.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.779 0.799 . . . . 0.0 111.104 -177.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -89.38 -19.55 25.08 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.608 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.9 p -127.33 -179.34 4.84 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.6 m -67.04 156.55 35.76 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.683 178.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.451 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 14.0 t -131.25 173.28 11.21 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.936 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.453 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 24.1 p -127.42 18.34 6.95 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 176.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.457 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -63.4 151.48 40.88 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 113.808 -1.542 . . . . 0.0 111.403 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.69 -1.53 57.66 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.205 178.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 34' ' ' ARG . 1.8 mtp-105 . . . . . 0 N--CA 1.444 -0.751 0 CA-C-N 117.17 0.485 . . . . 0.0 111.223 -179.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 34' ' ' ARG . 40.9 mttp . . . . . 0 CA--C 1.514 -0.42 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.453 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 49.7 mtm -59.32 137.05 58.12 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.142 0.496 . . . . 0.0 110.746 -178.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.682 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.8 p-90 -133.51 -169.4 2.28 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.213 -178.591 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.2 p -160.43 138.12 9.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.006 178.237 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.83 155.11 41.03 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.107 0.479 . . . . 0.0 111.019 -178.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.3 p -102.87 13.65 33.86 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.037 0.922 . . . . 0.0 109.559 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.41 HG21 ' CB ' ' A' ' 50' ' ' ASP . 65.8 p -133.55 153.5 51.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.969 179.118 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -59.92 -37.25 78.93 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.057 0.456 . . . . 0.0 110.842 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -123.23 110.45 15.25 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.758 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 64.8 t80 -76.75 -33.14 58.11 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.085 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -57.35 -31.9 66.21 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -88.83 -62.07 1.57 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.41 ' CB ' HG21 ' A' ' 44' ' ' THR . 2.4 m-20 -74.13 -27.38 60.84 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 3.1 mmm180 48.58 49.24 18.78 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -120.59 117.53 27.83 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.758 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.9 p-90 -129.19 177.6 7.03 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -174.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.608 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.44 147.19 11.44 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.638 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.79 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 6.0 m-30 -62.66 157.6 20.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.704 0.752 . . . . 0.0 112.293 -179.056 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.509 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 27.0 t . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.599 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.404 HG21 ' HA3' ' A' ' 54' ' ' GLY . 68.7 p . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.18 5.98 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 CA-C-O 122.561 1.172 . . . . 0.0 111.2 -179.3 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.439 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . -154.75 -155.24 7.2 Favored Glycine 0 C--N 1.282 -2.448 0 CA-C-N 113.319 -1.764 . . . . 0.0 111.651 -178.161 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.724 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 72.2 -168.35 52.35 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.846 179.007 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.62 ' H ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.738 0 CA-C-O 120.937 0.399 . . . . 0.0 110.542 178.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.996 0.427 . . . . 0.0 111.614 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 3.4 Cg_exo -76.8 164.91 29.46 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.452 2.768 . . . . 0.0 112.055 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 84.5 m -87.4 142.93 27.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.864 0.364 . . . . 0.0 110.769 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -108.52 120.86 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.952 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.502 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 62.9 m-85 -118.6 143.8 34.12 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-O 121.016 0.436 . . . . 0.0 111.223 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.679 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 28.5 Cg_endo -87.47 140.22 20.72 Favored 'Cis proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.706 -1.789 . . . . 0.0 111.98 -0.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.633 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 35.6 p90 -104.26 -174.06 2.45 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.518 178.064 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.1 m -141.56 127.1 18.91 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.86 -179.033 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.757 ' CG ' HD22 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -131.7 144.9 51.33 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.033 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.757 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.17 35.02 0.08 Allowed 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.61 1.164 . . . . 0.0 113.837 178.022 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.12 -3.74 84.45 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 115.026 0.77 . . . . 0.0 115.026 178.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.579 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 59.0 m-80 -110.2 138.7 46.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.371 1.086 . . . . 0.0 111.508 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -79.46 122.0 25.89 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.709 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.4 m-30 -108.35 106.9 17.25 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.836 0.827 . . . . 0.0 110.902 -178.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.679 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 92.1 mt-10 -91.23 -15.55 29.05 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.363 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -129.15 -177.78 4.37 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.5 m -66.19 164.61 15.36 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.684 178.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.0 t -141.99 175.53 9.66 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.772 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.428 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 23.3 p -128.64 17.54 6.35 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.522 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -65.26 153.75 40.15 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 114.118 -1.401 . . . . 0.0 112.025 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.28 -0.1 42.4 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.69 -0.686 . . . . 0.0 114.082 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 34' ' ' ARG . 2.3 mtp-105 . . . . . 0 N--CA 1.451 -0.39 0 CA-C-N 117.781 0.791 . . . . 0.0 111.428 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 34' ' ' ARG . 66.0 mttm . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.428 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.1 mpt? -56.57 137.42 53.67 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.587 0.708 . . . . 0.0 111.36 -178.048 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.699 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.6 p-90 -134.34 -165.21 1.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.295 -178.149 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.5 p -162.99 145.16 10.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.977 178.419 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.36 149.8 45.68 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.172 -178.534 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.3 p -97.95 7.44 46.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.453 0.644 . . . . 0.0 109.869 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.9 p -129.35 155.7 45.22 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.284 178.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.633 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -61.54 -32.34 72.41 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.978 0.418 . . . . 0.0 110.942 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -127.49 111.36 13.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.846 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 65.2 t80 -78.39 -35.25 47.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.92 -177.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -53.75 -29.74 41.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.134 0.493 . . . . 0.0 112.05 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -85.04 -71.15 0.54 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.518 -179.238 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.98 -29.69 63.24 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 4.4 mtm180 51.61 47.45 24.78 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -114.05 118.22 33.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.846 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.2 p-90 -129.38 177.29 7.29 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -171.7 150.33 13.21 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.619 179.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 14.5 m-30 -61.42 159.24 13.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -177.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.45 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.5 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 114.299 -1.318 . . . . 0.0 108.83 178.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.7 p . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 121.298 0.57 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.809 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -105.05 -166.31 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 176.155 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.645 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 39.57 -123.96 1.93 Allowed Glycine 0 C--N 1.319 -0.404 0 O-C-N 123.903 0.752 . . . . 0.0 113.112 177.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.633 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 37.2 -148.64 0.05 OUTLIER Glycine 0 C--N 1.334 0.464 0 N-CA-C 116.198 1.239 . . . . 0.0 116.198 177.144 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 114.502 -0.849 . . . . 0.0 110.795 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.678 0.275 . . . . 0.0 110.749 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 56.8 Cg_endo -84.33 166.4 12.42 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.764 2.309 . . . . 0.0 111.538 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 2.7 m -74.69 120.83 20.77 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.22 105.28 16.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.092 0.472 . . . . 0.0 110.516 179.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.659 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 46.2 m-85 -100.47 139.23 20.48 Favored Pre-proline 0 N--CA 1.447 -0.588 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.416 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 7.2 Cg_endo -87.68 127.98 9.2 Favored 'Cis proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.377 -1.51 . . . . 0.0 112.711 -0.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.659 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 15.6 p90 -92.26 127.07 37.6 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.279 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 14.8 m -90.65 121.65 32.75 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.428 0.632 . . . . 0.0 112.455 -177.408 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.903 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.9 t80 -127.8 142.94 51.16 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.681 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 43.5 35.55 0.98 Allowed 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.187 0.995 . . . . 0.0 112.674 178.896 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.71 -6.27 83.69 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.935 -0.575 . . . . 0.0 114.466 179.244 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.55 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 66.4 m-80 -109.96 132.87 53.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.319 1.06 . . . . 0.0 111.942 -178.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -83.9 118.32 23.9 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.903 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 12.4 m-85 -99.66 112.03 24.3 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.811 0.815 . . . . 0.0 112.191 -177.343 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -83.23 -17.62 42.08 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.615 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 p -131.42 -173.25 3.06 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 70.7 m -64.22 166.2 8.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.595 0.712 . . . . 0.0 110.395 179.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.535 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 14.5 t -144.65 171.42 14.41 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.137 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 15.8 p -129.19 19.02 5.92 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.181 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.562 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.7 138.25 58.3 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.122 179.628 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.89 -3.4 44.79 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.935 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.427 ' HD2' ' HE1' ' A' ' 55' ' ' PHE . 17.0 mtp85 . . . . . 0 N--CA 1.448 -0.552 0 CA-C-O 120.649 0.261 . . . . 0.0 110.763 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 38' ' ' LYS . 3.8 mptt . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.12 0.486 . . . . 0.0 112.047 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.492 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 47.2 mtt -98.15 154.2 17.92 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.006 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.605 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 20.3 p-90 -136.46 -172.6 3.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.591 0.71 . . . . 0.0 112.461 -178.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 12.3 p -154.11 143.28 21.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.658 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 15' ' ' CYS . . . -81.88 158.34 24.03 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.31 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.1 p -107.74 16.38 23.68 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.542 0.687 . . . . 0.0 110.387 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.7 p -137.2 148.51 46.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.431 178.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -55.91 -42.11 75.56 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.152 0.501 . . . . 0.0 110.821 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -116.31 104.7 11.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.475 178.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.76 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 69.0 t80 -75.96 -29.21 58.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.526 -178.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -57.26 -34.65 68.85 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -96.02 -53.6 3.6 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.068 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -81.13 -19.24 43.97 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -177.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 13.1 mtm180 38.04 55.97 1.65 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -117.89 120.54 38.18 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.76 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.0 p-90 -132.94 177.35 7.72 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -174.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.54 146.74 11.44 Favored Glycine 0 C--O 1.22 -0.745 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.959 179.206 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.809 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.1 m-85 -70.17 159.6 33.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.787 0.794 . . . . 0.0 111.919 -179.104 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 32.9 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.08 178.057 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.436 HG22 ' SG ' ' A' ' 41' ' ' CYS . 23.2 p . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 122.156 0.979 . . . . 0.0 113.4 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.758 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -136.08 -162.98 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.256 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 44.64 -87.05 0.01 OUTLIER Glycine 0 N--CA 1.465 0.586 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 176.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.612 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . -36.77 161.89 0.01 OUTLIER Glycine 0 N--CA 1.465 0.621 0 N-CA-C 116.77 1.468 . . . . 0.0 116.77 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.43 HD22 ' N ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -178.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.436 ' O ' HG23 ' A' ' 5' ' ' THR . . . . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.707 0.289 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.9 Cg_exo -77.66 143.23 21.15 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.523 2.148 . . . . 0.0 111.84 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 5.2 m -72.32 117.52 14.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.023 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.61 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 73.1 t -83.18 108.89 16.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.57 0.224 . . . . 0.0 110.625 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.405 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 50.8 m-85 -107.4 138.51 19.95 Favored Pre-proline 0 N--CA 1.45 -0.444 0 CA-C-O 120.59 0.233 . . . . 0.0 110.768 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.11 134.1 21.0 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.493 -1.461 . . . . 0.0 111.988 -0.642 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.61 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 23.7 p90 -103.39 136.45 43.12 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.121 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 88.9 m -99.07 121.32 40.83 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.596 -178.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.808 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 77.0 t80 -112.06 131.24 55.55 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.609 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.532 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 34.25 44.62 0.1 Allowed 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 124.851 1.345 . . . . 0.0 113.727 175.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.48 -19.23 45.83 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 116.96 1.544 . . . . 0.0 116.96 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.534 ' O ' ' HA ' ' A' ' 20' ' ' THR . 54.0 m-80 -109.16 146.44 34.1 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 120.042 1.921 . . . . 0.0 111.866 -178.522 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 25.3 mtmt -89.07 125.83 35.18 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.653 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.808 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 39.3 m-85 -112.85 116.41 30.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.815 0.816 . . . . 0.0 111.43 -178.316 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -90.85 -22.18 21.09 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.679 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.4 p -123.28 -176.63 3.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.633 179.026 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.6 m -64.37 169.42 4.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.438 0.637 . . . . 0.0 110.562 179.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.488 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.5 t -147.6 176.27 10.21 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.315 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.1 p -139.14 25.48 2.48 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.133 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.76 139.38 58.76 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 113.063 -1.881 . . . . 0.0 112.558 -179.108 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.15 -5.64 40.74 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.694 -0.685 . . . . 0.0 113.069 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.647 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 14.3 mtp85 . . . . . 0 N--CA 1.449 -0.498 0 CA-C-O 121.244 0.545 . . . . 0.0 111.478 -179.039 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.647 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 33.9 mmtt . . . . . 0 CA--C 1.518 -0.278 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 68.9 mtm -97.92 144.04 27.88 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.699 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.9 p-90 -138.09 -167.18 2.11 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.396 0.617 . . . . 0.0 111.63 -178.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 22.3 p -159.65 148.94 18.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.115 179.836 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.547 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -81.84 144.13 31.24 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.552 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.8 p -101.69 17.12 23.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.789 0.804 . . . . 0.0 110.69 -178.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.4 p -136.14 152.78 51.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.976 178.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.63 -39.44 84.34 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.133 0.492 . . . . 0.0 110.823 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -122.5 109.83 14.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.465 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.87 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 46.7 t80 -75.61 -35.1 60.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.206 -178.932 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -48.86 -37.9 20.89 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -86.61 -63.46 1.31 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.488 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 0.9 OUTLIER -77.68 -24.4 49.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -176.98 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.705 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 13.6 mtm180 44.2 50.48 7.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 56.6 mttt -108.99 119.34 39.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 177.531 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.87 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 15.3 p-90 -131.82 172.54 12.18 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -175.251 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.612 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -170.78 146.04 9.42 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.804 178.765 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.758 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 14.9 m-30 -62.28 158.68 16.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.339 0.57 . . . . 0.0 111.396 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.1 m . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.311 178.95 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.232 0.153 0 CA-C-O 122.202 1.001 . . . . 0.0 113.654 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -138.08 164.61 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 179.098 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.526 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.19 -149.16 51.35 Favored Glycine 0 C--N 1.315 -0.599 0 C-N-CA 118.23 -1.938 . . . . 0.0 111.853 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.479 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 50.33 -146.61 8.48 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 114.134 0.414 . . . . 0.0 114.134 177.728 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.166 -0.517 . . . . 0.0 110.36 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.491 0.186 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 24.2 Cg_exo -61.05 137.35 71.18 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.757 2.304 . . . . 0.0 112.148 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.2 m -75.06 126.87 31.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.832 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 75.8 t -87.1 121.68 38.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.702 0.287 . . . . 0.0 111.121 -179.518 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.62 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 51.5 m-85 -116.96 139.2 25.49 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.307 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.8 Cg_endo -86.21 129.89 12.15 Favored 'Cis proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.641 -1.399 . . . . 0.0 112.303 -0.363 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.62 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 19.7 p90 -94.59 128.58 41.31 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.056 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 28.8 m -92.19 123.66 35.69 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.521 0.677 . . . . 0.0 112.652 -177.63 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.869 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.1 t80 -127.49 143.83 51.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.642 178.012 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.747 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 42.41 31.35 0.27 Allowed 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.168 0.987 . . . . 0.0 113.16 178.636 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.33 -1.33 79.39 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 178.464 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.5 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 65.4 m-80 -113.21 135.59 53.66 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.195 0.998 . . . . 0.0 111.675 -179.033 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -77.76 119.36 21.16 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.869 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.2 m-30 -103.56 105.88 16.25 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.88 0.848 . . . . 0.0 110.775 -179.179 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -83.84 -15.35 48.55 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.668 -179.571 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 p -132.96 -175.86 3.92 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.194 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.5 m -66.21 163.73 17.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.532 0.682 . . . . 0.0 109.895 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.467 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 15.3 t -139.83 176.36 8.81 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.158 -179.388 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.445 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 13.0 p -128.52 16.49 6.5 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.429 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.541 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -63.29 139.89 58.82 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.496 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.2 -11.84 21.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.276 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.612 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.3 mtp85 . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.92 0.39 . . . . 0.0 110.244 179.38 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.612 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 2.2 mppt? . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.445 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 55.6 mtm -77.45 158.44 29.99 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.556 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.665 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 19.5 p-90 -141.98 -169.57 2.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.14 0.495 . . . . 0.0 111.28 -178.784 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.521 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 4.0 p -160.61 144.15 13.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.982 177.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.95 153.91 34.13 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.425 -178.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 64.5 p -101.71 9.1 41.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.748 0.785 . . . . 0.0 109.672 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.7 p -130.81 153.94 48.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.253 178.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -59.84 -48.89 79.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 111.452 -179.564 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -111.45 108.77 18.43 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.832 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 71.6 t80 -78.47 -30.36 47.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.031 -178.503 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.61 -32.7 65.54 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -90.59 -57.87 2.68 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -178.649 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -77.73 -30.94 51.93 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 7.9 mmm180 49.49 44.95 24.24 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -110.75 117.77 34.34 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.832 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 10.1 p-90 -133.57 174.92 9.9 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -173.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.479 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.3 144.03 9.31 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 113.219 -1.81 . . . . 0.0 109.907 178.479 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.548 ' HD1' ' HB3' ' A' ' 40' ' ' TRP . 5.3 m-30 -60.0 158.55 10.77 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.516 0.674 . . . . 0.0 112.681 -179.533 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.5 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.6 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.451 179.386 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.449 -0.508 0 CA-C-O 122.466 1.126 . . . . 0.0 113.688 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.681 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -127.49 -166.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.25 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.417 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 36.04 -127.89 0.9 Allowed Glycine 0 N--CA 1.465 0.617 0 O-C-N 123.818 0.698 . . . . 0.0 113.61 177.436 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.592 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 42.61 -148.54 0.54 Allowed Glycine 0 C--N 1.334 0.458 0 N-CA-C 115.796 1.078 . . . . 0.0 115.796 177.127 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.529 HD21 ' HA ' ' A' ' 52' ' ' LYS . 10.9 p30 . . . . . 0 C--N 1.327 -0.376 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 120.742 0.306 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -56.84 132.59 52.65 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.888 2.392 . . . . 0.0 112.368 179.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 52.6 m -74.78 130.59 39.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.789 0.328 . . . . 0.0 111.009 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.8 t -83.22 117.89 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -118.28 142.08 30.63 Favored Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-O 120.947 0.403 . . . . 0.0 111.353 -179.406 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.6 Cg_endo -85.63 139.32 25.89 Favored 'Cis proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.038 -1.651 . . . . 0.0 111.763 -0.594 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.548 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 19.5 p90 -99.83 -166.48 1.34 Allowed 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.79 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.0 m -148.87 126.38 11.64 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.055 0.455 . . . . 0.0 111.115 -178.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.801 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 29.5 t80 -129.4 139.15 51.76 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.652 179.072 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.541 HD23 ' CG ' ' A' ' 21' ' ' PHE . 3.5 mm? 34.08 47.49 0.2 Allowed 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 124.65 1.218 . . . . 0.0 114.24 174.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.18 -12.21 70.17 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 114.345 -1.298 . . . . 0.0 116.022 177.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.455 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 61.1 m-80 -115.19 134.53 55.06 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 119.224 1.512 . . . . 0.0 112.387 -178.525 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -78.98 125.05 28.87 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.359 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.801 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.4 m-30 -109.79 118.81 37.5 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.831 0.824 . . . . 0.0 111.219 -178.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 28.3 mt-10 -91.7 -8.61 46.51 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.903 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.3 p -140.67 -164.86 1.81 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.159 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.5 m -72.5 168.2 19.03 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.849 178.531 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.4 t -149.75 166.71 28.61 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.229 -179.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.523 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 29.6 p -120.52 21.6 11.53 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 176.755 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.474 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -60.77 140.49 57.56 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 113.826 -1.533 . . . . 0.0 112.167 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.36 -8.03 10.44 Favored Glycine 0 N--CA 1.454 -0.122 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.778 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.634 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 22.8 mtp85 . . . . . 0 N--CA 1.443 -0.805 0 CA-C-O 120.818 0.342 . . . . 0.0 110.845 -179.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.634 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 4.3 mptt . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.523 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 52.1 mtt -87.9 146.42 25.57 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.618 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.624 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.3 p-90 -134.32 -164.42 1.5 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.142 0.496 . . . . 0.0 111.158 -178.47 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.2 p -169.58 155.85 6.27 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.41 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.86 146.26 29.0 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.113 -179.268 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 71.0 p -97.93 11.84 36.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.743 0.782 . . . . 0.0 109.853 179.339 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.6 p -134.76 158.91 42.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.549 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -61.81 -44.9 95.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.922 0.392 . . . . 0.0 111.238 -179.615 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -116.61 106.88 14.04 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.907 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 72.7 t80 -72.0 -39.42 69.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.86 -178.707 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -49.82 -37.39 30.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.559 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -87.65 -58.49 2.55 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.36 -23.77 54.18 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -177.089 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 7.5 mtm180 45.1 49.32 9.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 179.247 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.529 ' HA ' HD21 ' A' ' 9' ' ' ASN . 28.4 mtpp -116.93 117.62 30.18 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.537 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.907 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.3 p-90 -129.15 172.15 11.71 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -175.258 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.591 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.05 144.93 9.73 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 113.58 -1.645 . . . . 0.0 110.578 179.353 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.681 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.6 m-30 -63.39 158.45 20.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.327 0.563 . . . . 0.0 111.879 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.843 178.592 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.5 p . . . . . 0 N--CA 1.446 -0.639 0 CA-C-O 121.876 0.846 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -129.21 163.97 32.91 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 178.226 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.755 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.85 -145.14 46.29 Favored Glycine 0 C--N 1.308 -0.984 0 C-N-CA 117.434 -2.317 . . . . 0.0 111.148 -179.136 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.628 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 43.47 -149.41 0.67 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 116.077 1.191 . . . . 0.0 116.077 176.717 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 114.836 -0.682 . . . . 0.0 110.073 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.157 0 CA-C-O 120.71 0.29 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -85.15 171.36 9.14 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.772 2.315 . . . . 0.0 111.404 179.254 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.3 m -75.58 148.24 39.0 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.194 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 98.7 t -114.23 117.43 55.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.241 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.612 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 66.0 m-85 -114.22 139.04 23.28 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.944 0.402 . . . . 0.0 111.117 -179.509 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -86.13 131.82 14.22 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.409 -1.496 . . . . 0.0 112.187 -0.17 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.623 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 27.9 p90 -99.59 128.92 45.71 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.194 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -91.72 123.03 34.81 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.335 -178.648 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.863 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 62.0 t80 -117.94 129.98 55.94 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.826 178.547 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.533 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.5 mm? 35.87 49.03 0.54 Allowed 'General case' 0 N--CA 1.424 -1.738 0 O-C-N 125.055 1.472 . . . . 0.0 113.33 175.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.09 -19.82 51.46 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 114.354 -1.294 . . . . 0.0 116.298 178.099 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -114.99 133.62 55.87 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 120.075 1.937 . . . . 0.0 113.523 -177.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -77.67 125.67 29.7 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.645 178.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.863 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 17.3 m-30 -111.06 118.64 36.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.794 0.807 . . . . 0.0 112.037 -178.559 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -89.27 -19.33 25.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.938 179.454 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 p -127.7 -178.29 4.43 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.167 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 87.7 m -67.79 170.47 7.93 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.908 179.181 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -146.96 173.28 12.58 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.254 0.549 . . . . 0.0 110.615 -178.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.611 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 17.4 p -125.4 19.58 8.11 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.057 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -59.85 135.47 57.71 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.745 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.83 -8.34 11.61 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.252 -179.494 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.9 mtp85 . . . . . 0 N--CA 1.446 -0.633 0 CA-C-O 121.038 0.446 . . . . 0.0 111.225 -179.513 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 27.1 mmtm . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.611 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 71.5 mtm -89.55 146.56 24.5 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.235 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.644 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.3 p-90 -129.11 -167.38 1.78 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.4 0.619 . . . . 0.0 112.655 -177.224 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 21.8 p -158.92 143.4 15.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.697 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 19' ' ' PHE . . . -78.44 151.54 32.64 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.424 -0.911 . . . . 0.0 109.605 179.45 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.0 p -103.4 13.22 34.12 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.582 0.706 . . . . 0.0 109.914 -179.573 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.8 p -135.0 149.01 50.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.508 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.78 -37.47 68.61 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.98 0.419 . . . . 0.0 111.498 -179.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -125.04 111.32 15.24 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.52 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.864 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 48.5 t80 -76.26 -34.5 59.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.91 -178.274 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -53.94 -31.17 49.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.714 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -89.3 -58.73 2.43 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -179.308 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.27 -19.29 28.5 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.671 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 11.3 mtm180 44.89 49.54 9.1 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 179.558 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -108.63 117.15 33.42 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.32 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.864 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.4 p-90 -126.63 173.31 9.57 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -175.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.566 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.77 138.37 5.11 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.587 179.248 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.755 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 12.2 m-85 -56.61 153.67 9.96 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.33 0.586 . . . . 0.0 110.995 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.512 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 9.1 t . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.236 -179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 122.008 0.908 . . . . 0.0 113.132 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -138.04 160.68 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 177.518 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.573 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.38 -154.92 44.41 Favored Glycine 0 C--N 1.313 -0.726 0 C-N-CA 117.804 -2.141 . . . . 0.0 110.637 -178.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.693 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 40.52 -141.68 0.84 Allowed Glycine 0 N--CA 1.464 0.558 0 N-CA-C 114.311 0.484 . . . . 0.0 114.311 177.625 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--O 1.224 -0.245 0 CA-C-O 120.656 0.265 . . . . 0.0 111.521 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.4 Cg_exo -76.02 149.68 32.95 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.019 2.479 . . . . 0.0 111.895 179.181 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 94.9 m -71.85 129.87 39.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.621 0.248 . . . . 0.0 110.372 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 65.2 t -100.32 128.22 52.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.938 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.0 143.28 35.03 Favored Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.432 179.253 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.0 Cg_endo -84.0 131.96 17.73 Favored 'Cis proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.446 -1.481 . . . . 0.0 111.958 -0.33 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.632 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 48.6 p90 -100.24 131.62 46.07 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.79 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.0 m -92.37 123.79 35.94 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -176.41 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.757 ' CG ' HD22 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -125.56 144.17 50.68 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.264 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.757 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.88 35.16 0.11 Allowed 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.456 1.102 . . . . 0.0 113.26 178.896 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.86 -4.65 84.92 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 115.018 0.767 . . . . 0.0 115.018 178.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.601 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 62.4 m-80 -108.69 137.7 46.21 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 118.623 1.211 . . . . 0.0 112.031 -178.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -79.02 118.81 21.35 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.673 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.722 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.3 m-30 -103.25 108.44 19.66 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.71 0.767 . . . . 0.0 111.378 -178.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -88.77 -17.01 30.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.392 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 p -129.5 175.04 9.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.4 m -62.0 162.9 8.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.534 178.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -138.91 179.46 6.48 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.083 -178.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 p -133.38 15.93 4.08 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 177.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.641 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -59.98 139.04 57.69 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.384 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.99 -5.94 29.98 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.299 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 28.5 mtp85 . . . . . 0 N--CA 1.45 -0.462 0 CA-C-N 116.612 0.206 . . . . 0.0 111.102 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.527 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 39.4 mttp . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.605 0.241 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.6 mtt -85.49 146.61 26.85 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.271 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.689 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 21.4 p-90 -135.68 -169.78 2.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.408 0.623 . . . . 0.0 112.041 -178.466 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.0 p -159.86 145.26 15.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.143 178.823 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -77.82 151.46 33.94 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.477 -179.363 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 38.4 p -96.7 8.87 43.26 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.495 0.664 . . . . 0.0 110.382 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.4 p -133.07 155.56 49.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.221 179.256 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -62.34 -28.91 70.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.41 . . . . 0.0 111.025 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -125.93 114.42 18.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.412 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.879 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 66.4 t80 -89.03 -29.12 19.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.288 -179.305 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -52.61 -38.8 60.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.859 0.362 . . . . 0.0 111.526 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -92.97 -63.94 1.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.605 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.5 m-20 -64.36 -28.34 69.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -177.408 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER 42.96 49.46 5.24 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 179.306 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.605 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 9.5 mtpp -114.81 116.85 29.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.879 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.6 p-90 -128.85 176.97 7.42 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -175.278 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.693 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -172.32 145.83 8.84 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 113.107 -1.861 . . . . 0.0 108.94 179.002 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 13.6 m-30 -59.78 160.69 7.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 117.346 0.573 . . . . 0.0 111.853 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.457 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 1.8 t . . . . . 0 CA--C 1.527 0.078 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 177.188 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.421 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 24.2 p . . . . . 0 N--CA 1.446 -0.669 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.76 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -121.72 -164.5 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 175.588 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.433 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 33.85 -123.45 0.39 Allowed Glycine 0 N--CA 1.465 0.61 0 O-C-N 123.903 0.752 . . . . 0.0 113.528 177.654 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.635 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 36.44 -145.38 0.08 OUTLIER Glycine 0 C--N 1.335 0.517 0 N-CA-C 115.744 1.057 . . . . 0.0 115.744 176.945 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.424 ' H ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.221 0 CA-C-N 115.251 -0.475 . . . . 0.0 111.542 179.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--O 1.225 -0.191 0 CA-C-O 120.787 0.327 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 23.4 Cg_exo -61.6 131.36 35.36 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.698 2.266 . . . . 0.0 112.14 179.792 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 53.7 m -71.7 120.73 17.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.175 179.462 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 62.3 t -76.65 116.24 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 111.893 -179.301 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.559 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 40.5 m-85 -118.49 139.89 27.54 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.043 179.866 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.442 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.9 Cg_endo -83.4 138.15 31.99 Favored 'Cis proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.311 -1.537 . . . . 0.0 111.99 -0.447 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.559 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 40.4 p90 -102.97 -173.54 2.34 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.182 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.4 m -140.54 123.64 16.61 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.195 -179.508 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.693 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 56.8 t80 -122.46 133.33 54.6 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.99 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.56 HD23 ' CE1' ' A' ' 21' ' ' PHE . 3.8 mm? 32.61 47.76 0.11 Allowed 'General case' 0 N--CA 1.432 -1.357 0 O-C-N 124.915 1.384 . . . . 0.0 114.238 175.685 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.39 -11.92 66.75 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 116.205 1.242 . . . . 0.0 116.205 177.544 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.531 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 59.6 m-80 -109.47 154.94 21.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.417 1.608 . . . . 0.0 112.15 -178.585 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -95.66 126.98 41.31 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.107 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.693 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 37.9 m-85 -119.08 122.42 42.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.542 0.687 . . . . 0.0 112.054 -178.253 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.442 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 82.9 mt-10 -100.02 -18.06 17.21 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.904 178.987 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.3 p -129.04 -173.33 2.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.743 179.423 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.98 167.34 13.99 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 120.297 -0.561 . . . . 0.0 109.586 178.764 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.451 ' HG1' ' HE2' ' A' ' 26' ' ' TYR . 13.6 t -145.76 170.09 17.22 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.459 -178.895 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.793 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 56.6 p -122.21 18.66 10.72 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.752 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -58.92 133.69 56.27 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.748 -179.922 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.6 -5.01 54.34 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.315 -179.774 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.0 mtp85 . . . . . 0 N--CA 1.45 -0.43 0 CA-C-O 121.083 0.468 . . . . 0.0 110.402 -179.443 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.5 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 89.4 mttt . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.531 0.205 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.793 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 77.0 mtm -64.15 134.49 54.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 109.934 179.693 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.72 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.1 p-90 -125.12 -161.28 1.01 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.387 -177.518 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 3.5 p -169.53 154.52 5.64 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.594 178.189 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.412 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -78.8 147.81 33.14 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 120.835 0.35 . . . . 0.0 110.998 -179.252 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 66.0 p -100.88 7.06 43.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.636 0.731 . . . . 0.0 109.843 179.545 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.5 p -128.4 157.87 39.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.005 178.402 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.86 99.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.101 0.476 . . . . 0.0 110.759 -179.937 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -119.57 106.07 11.84 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.32 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.989 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 34.2 t80 -71.58 -38.33 70.92 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 -179.078 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -45.59 -36.76 4.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.437 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.79 -63.74 1.23 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -179.28 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.39 -18.64 59.89 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.815 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 34.74 56.3 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -179.868 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -114.32 116.25 28.66 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.492 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.989 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 8.4 p-90 -125.27 169.51 12.21 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -174.859 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.635 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.51 146.68 10.89 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.345 179.339 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.76 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 14.8 m-30 -62.06 163.23 8.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.366 0.603 . . . . 0.0 112.328 -179.21 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.5 179.241 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 p . . . . . 0 C--O 1.233 0.199 0 CA-C-O 122.306 1.051 . . . . 0.0 113.762 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -132.07 163.52 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 104.945 -2.242 . . . . 0.0 104.945 178.728 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.62 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 64.14 -145.55 49.75 Favored Glycine 0 C--N 1.313 -0.714 0 C-N-CA 118.067 -2.016 . . . . 0.0 110.725 -179.369 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.643 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 44.35 -145.94 1.73 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 114.724 0.65 . . . . 0.0 114.724 177.791 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.462 0 CA-C-O 120.895 0.379 . . . . 0.0 110.686 178.681 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.294 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.67 170.86 8.74 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.768 2.312 . . . . 0.0 111.997 179.662 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.2 m -74.81 142.96 44.16 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.954 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 92.6 t -111.63 117.38 54.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 178.767 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.563 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 47.3 m-85 -114.69 142.08 27.73 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.752 -179.778 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.23 136.65 28.62 Favored 'Cis proline' 0 N--CA 1.464 -0.259 0 C-N-CA 123.369 -1.513 . . . . 0.0 112.005 -0.498 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.563 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 32.3 p90 -107.08 132.56 52.84 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.315 178.387 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 68.1 m -94.41 124.46 38.45 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.438 -179.239 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.743 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 41.7 t80 -124.76 137.38 54.33 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.901 178.995 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.545 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.4 mm? 37.0 49.23 0.78 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 175.293 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.92 -8.97 73.98 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 114.312 -1.313 . . . . 0.0 116.351 177.626 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 20' ' ' THR . 62.7 m-80 -113.69 153.85 28.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 119.515 1.658 . . . . 0.0 112.287 -178.614 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -93.37 122.48 35.83 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.804 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.743 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 15.0 m-85 -110.22 121.81 46.15 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.857 0.837 . . . . 0.0 111.56 -178.272 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -95.44 -21.06 18.57 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.883 179.676 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p -127.26 -174.67 3.22 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.894 179.953 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.6 m -66.64 170.35 6.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.3 0.571 . . . . 0.0 109.558 178.604 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.537 ' HG1' ' HE2' ' A' ' 26' ' ' TYR . 12.1 t -148.43 169.18 20.78 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.592 -179.693 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.0 p -121.98 17.72 10.9 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.21 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.32 137.07 58.19 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.721 -179.473 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.08 -0.09 63.84 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.718 179.862 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.448 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.0 mtp85 . . . . . 0 N--CA 1.448 -0.55 0 CA-C-N 116.508 0.154 . . . . 0.0 111.297 -179.581 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 31.1 mmtm . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 120.989 0.423 . . . . 0.0 111.801 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.8 mtm -102.96 151.17 22.78 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.523 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.657 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 11.3 p-90 -137.09 -170.08 2.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.288 0.566 . . . . 0.0 112.35 -178.082 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 21.4 p -155.85 146.84 22.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.966 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.98 149.42 30.8 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.754 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.1 p -100.22 16.02 25.63 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.77 0.795 . . . . 0.0 110.056 -179.775 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.2 p -143.77 152.88 41.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.059 178.372 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.81 -40.71 80.58 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.963 0.411 . . . . 0.0 111.515 -179.351 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -119.44 107.04 12.85 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.918 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.89 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 58.1 t80 -73.58 -39.8 64.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.68 -178.494 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -49.75 -38.37 33.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.47 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.44 -38.9 12.29 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -178.482 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -93.5 -24.45 17.99 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.524 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 14.4 mtm180 43.17 49.57 5.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 178.977 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -116.91 120.12 37.47 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.014 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.89 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.6 p-90 -130.66 169.33 15.78 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -175.647 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.643 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.16 145.6 11.19 Favored Glycine 0 C--O 1.22 -0.772 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.629 178.732 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.62 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 4.8 m-30 -63.44 159.71 17.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.313 0.578 . . . . 0.0 111.849 179.938 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.272 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 55' ' ' PHE . 27.5 p . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 1.0 OUTLIER -127.2 6.62 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 CA-C-O 122.799 1.285 . . . . 0.0 109.964 179.922 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.42 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . -156.16 -160.12 9.82 Favored Glycine 0 C--N 1.282 -2.421 0 CA-C-N 112.874 -1.966 . . . . 0.0 111.008 -178.138 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.713 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 74.38 168.33 19.19 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.635 178.572 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.538 HD22 ' N ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.55 -0.325 . . . . 0.0 111.527 178.782 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 120.392 0.139 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.03 151.01 16.11 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.219 1.946 . . . . 0.0 112.252 -179.967 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 72.3 m -78.33 138.55 38.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.218 179.668 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 47.9 t -104.83 118.08 51.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.578 0.228 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.418 ' CE2' ' HE1' ' A' ' 19' ' ' PHE . 69.6 m-85 -111.27 146.34 34.37 Favored Pre-proline 0 N--CA 1.447 -0.577 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.42 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -82.64 134.37 24.81 Favored 'Cis proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.431 -1.487 . . . . 0.0 112.106 -0.237 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.64 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 20.8 p90 -108.27 127.79 54.16 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.473 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 91.7 m -91.69 127.09 37.01 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.105 0.479 . . . . 0.0 111.39 -178.81 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.844 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 56.3 t80 -123.32 135.06 54.01 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.789 179.282 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.555 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 35.1 46.92 0.25 Allowed 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 124.491 1.119 . . . . 0.0 113.799 175.197 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.27 -20.7 49.45 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 116.237 1.255 . . . . 0.0 116.237 177.71 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -112.14 134.11 53.88 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 119.545 1.673 . . . . 0.0 112.644 -178.138 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 34.7 mtpt -79.04 125.33 29.24 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.709 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.844 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 17.9 m-85 -109.91 123.15 49.1 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.608 0.718 . . . . 0.0 111.589 -178.588 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 51.6 mt-10 -100.61 -9.96 21.43 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.817 179.283 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 p -130.88 172.12 12.4 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.3 m -63.72 160.87 16.16 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.616 179.285 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 t -138.74 174.06 10.92 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.159 -178.761 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 p -127.42 21.99 6.55 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 177.039 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.02 138.8 58.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.025 -179.384 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.01 -6.15 28.99 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.047 179.639 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.642 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 13.8 mtp85 . . . . . 0 N--CA 1.45 -0.434 0 CA-C-N 117.169 0.484 . . . . 0.0 111.224 -179.678 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.642 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.543 0 CA-C-O 120.593 0.235 . . . . 0.0 110.843 . . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.4 mtt -89.44 143.91 26.46 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.779 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.666 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 12.3 p-90 -132.17 -165.57 1.61 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.49 0.662 . . . . 0.0 111.39 -178.725 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -169.32 150.21 4.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.068 179.447 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.41 149.86 36.85 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.786 -179.23 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.2 p -96.42 9.08 42.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.777 0.798 . . . . 0.0 109.383 179.442 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.0 p -132.67 150.9 52.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.38 178.71 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.64 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.09 -36.48 72.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.07 0.462 . . . . 0.0 111.218 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -123.19 112.03 17.2 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.393 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.908 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 51.9 t80 -76.11 -39.06 56.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.806 -178.411 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -46.38 -35.96 5.99 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.956 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -82.52 -77.99 0.22 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -179.742 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.638 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 1.4 m-20 -67.83 -20.69 65.19 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -176.84 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 18.9 mtm180 43.24 50.73 5.8 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.943 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.638 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 59.1 mttt -111.69 118.24 35.09 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.113 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.908 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.6 p-90 -128.88 177.31 7.18 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -175.072 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.52 ' HA3' ' CG2' ' A' ' 5' ' ' THR . . . -176.76 154.63 16.67 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 113.691 -1.595 . . . . 0.0 110.013 179.227 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 15.4 m-30 -66.11 161.12 22.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.106 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.8 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.393 178.729 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.446 -0.671 0 CA-C-O 121.936 0.874 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -131.32 165.39 31.7 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.035 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 178.091 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.581 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 61.07 -148.34 46.2 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 118.187 -1.958 . . . . 0.0 111.667 -179.935 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.57 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 51.97 -152.54 6.3 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 114.801 0.68 . . . . 0.0 114.801 177.352 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.449 ' H ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.889 0.376 . . . . 0.0 111.025 179.763 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.677 0.275 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.43 174.4 5.98 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.93 2.42 . . . . 0.0 111.852 179.888 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.8 m -85.02 128.21 34.53 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.817 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 99.3 t -95.45 108.26 20.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.048 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -110.22 142.14 25.36 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.141 -179.081 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -82.55 139.37 38.96 Favored 'Cis proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.821 -1.741 . . . . 0.0 111.276 -0.783 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.54 ' HZ ' HG22 ' A' ' 30' ' ' THR . 36.3 p90 -105.98 135.76 46.85 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.703 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 41.4 m -96.76 120.32 36.87 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.376 0.608 . . . . 0.0 110.76 -179.139 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.723 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 50.2 t80 -116.34 134.07 55.3 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.741 178.951 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.538 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.7 mm? 33.36 45.41 0.08 Allowed 'General case' 0 N--CA 1.435 -1.224 0 O-C-N 124.872 1.358 . . . . 0.0 114.224 174.789 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.04 -10.86 62.12 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 116.584 1.394 . . . . 0.0 116.584 177.331 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.502 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 41.0 m-80 -115.35 156.43 25.53 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.87 1.835 . . . . 0.0 112.8 -178.123 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -91.66 122.2 34.01 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.788 179.047 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.723 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 42.8 m-85 -115.22 111.25 20.67 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.725 0.774 . . . . 0.0 111.141 -179.414 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -91.26 -9.21 46.0 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.899 -179.769 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 p -138.91 -166.55 2.04 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.43 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.4 m -71.38 167.28 19.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.416 0.627 . . . . 0.0 110.52 179.018 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.54 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.5 t -146.85 173.22 12.6 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.601 179.979 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 p -127.03 19.33 7.07 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.386 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -62.49 139.6 58.59 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.43 -179.124 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.9 -0.64 44.11 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.036 179.437 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.641 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.8 mtp85 . . . . . 0 N--CA 1.45 -0.46 0 CA-C-O 121.155 0.503 . . . . 0.0 111.741 -179.194 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.641 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 44.6 mmtt . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -73.85 149.98 41.24 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.922 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.618 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 13.0 p-90 -137.26 -163.81 1.49 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.152 0.501 . . . . 0.0 111.375 -178.527 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 23.5 p -160.09 153.79 22.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.846 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.38 144.73 25.84 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.318 178.347 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -99.56 13.54 33.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.804 0.812 . . . . 0.0 110.349 -179.353 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.9 p -136.76 147.52 46.71 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.501 178.212 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.16 -48.99 64.64 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.166 0.507 . . . . 0.0 111.053 -179.439 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -113.6 112.09 22.94 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.086 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.875 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 56.7 t80 -73.23 -40.2 64.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.837 -178.432 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -48.22 -36.07 13.1 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.086 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.46 -68.4 0.68 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.716 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.84 -23.16 52.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.87 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 24.7 mtm180 45.4 50.57 10.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -179.617 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -112.51 117.13 31.52 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.019 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.875 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.1 p-90 -127.78 169.7 13.57 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.297 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.493 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -159.2 137.51 5.19 Favored Glycine 0 C--O 1.221 -0.688 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.473 178.647 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.581 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 2.5 m-30 -58.47 158.28 7.76 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.289 0.636 . . . . 0.0 111.738 179.686 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.418 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.0 t . . . . . 0 C--N 1.319 -0.737 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.674 179.983 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 121.372 0.606 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.758 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -113.67 -166.93 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 176.8 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 36.99 -125.98 1.08 Allowed Glycine 0 N--CA 1.462 0.419 0 O-C-N 124.038 0.836 . . . . 0.0 113.226 177.592 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.683 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 31.85 -141.42 0.04 OUTLIER Glycine 0 C--N 1.335 0.474 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 176.801 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.516 HD22 ' N ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 114.693 -0.753 . . . . 0.0 109.792 179.894 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.757 0.313 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -84.03 165.74 13.12 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.533 2.155 . . . . 0.0 111.688 179.486 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.5 m -79.93 136.7 36.7 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.829 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.3 t -96.39 107.35 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.688 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.552 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 38.0 m-85 -111.44 138.23 21.34 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-O 121.046 0.45 . . . . 0.0 111.066 -179.59 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.606 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 9.4 Cg_endo -88.5 134.15 12.38 Favored 'Cis proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.239 -1.567 . . . . 0.0 112.415 -0.555 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.594 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 37.3 p90 -97.26 -168.32 1.67 Allowed 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 119.707 -0.797 . . . . 0.0 108.85 178.063 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.4 m -147.36 127.46 13.74 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.421 -179.006 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.818 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -129.91 144.07 51.13 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.704 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.758 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.06 36.32 0.11 Allowed 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.863 1.265 . . . . 0.0 113.343 178.733 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.4 -12.63 69.24 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 115.19 0.836 . . . . 0.0 115.19 178.667 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -106.0 135.72 46.94 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 118.667 1.234 . . . . 0.0 111.923 -178.932 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 88.8 mttt -78.94 126.15 30.32 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.915 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.818 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.4 m-30 -108.57 114.6 28.56 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.763 0.792 . . . . 0.0 111.199 -179.123 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.606 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 50.8 mt-10 -90.49 -20.34 22.81 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.586 -179.568 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 p -125.61 -175.71 3.41 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.501 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.5 m -67.64 162.54 23.37 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.451 179.039 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -138.12 171.07 14.94 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.173 -179.349 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.6 p -126.18 21.95 7.3 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.244 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.634 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -66.26 140.61 58.15 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.299 -179.63 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.92 -3.59 50.17 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.553 179.579 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.687 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 16.9 mtp85 . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 121.155 0.502 . . . . 0.0 110.823 -179.341 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.687 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 81.2 mttt . . . . . 0 CA--C 1.518 -0.259 0 CA-C-O 120.69 0.281 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.7 mtm -69.87 139.04 52.98 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.202 -179.604 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.659 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.1 p-90 -129.08 -165.96 1.58 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.411 -178.899 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.4 p -157.37 150.02 23.12 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.304 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.461 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -84.97 148.05 26.4 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.396 179.596 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 49.7 p -102.98 10.97 37.92 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.841 0.829 . . . . 0.0 109.732 179.805 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.5 p -131.0 149.88 52.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.884 178.149 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.38 -43.28 83.46 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.124 0.488 . . . . 0.0 111.036 -179.572 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -117.26 109.05 16.37 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.225 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.843 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 73.7 t80 -77.12 -34.97 56.61 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.866 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -51.12 -35.03 33.43 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.791 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -86.57 -76.8 0.34 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.343 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.74 -19.2 65.81 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -176.824 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 45.2 mtm-85 39.24 54.6 2.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 179.253 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -112.88 119.21 37.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.525 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.843 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.5 p-90 -129.55 173.13 10.87 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -174.701 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.562 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -164.32 144.61 9.56 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 113.327 -1.76 . . . . 0.0 109.529 178.793 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.758 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.3 m-30 -61.89 156.75 20.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 117.69 0.745 . . . . 0.0 111.843 -179.646 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.453 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 7.6 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.404 178.365 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 122.605 1.193 . . . . 0.0 114.026 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -138.71 162.36 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 177.844 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.607 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.89 -147.47 50.72 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 117.629 -2.224 . . . . 0.0 111.512 -179.46 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.696 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 47.88 -137.87 12.51 Favored Glycine 0 N--CA 1.461 0.309 0 N-CA-C 114.111 0.404 . . . . 0.0 114.111 177.788 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.966 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.189 0 CA-C-O 120.506 0.193 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -77.3 139.67 18.88 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.994 1.796 . . . . 0.0 112.474 -179.831 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 87.9 m -71.14 124.49 24.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.246 179.468 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.502 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 64.1 t -89.95 122.13 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.184 -179.57 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.477 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 54.1 m-85 -117.89 140.36 27.65 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.02 179.422 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -86.19 133.21 15.66 Favored 'Cis proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.181 -1.591 . . . . 0.0 112.136 0.152 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.665 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 37.7 p90 -102.4 132.69 48.25 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.63 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 m -95.37 127.31 41.31 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -177.475 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.832 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.1 t80 -127.16 144.31 51.06 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.182 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.759 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.95 32.62 0.12 Allowed 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 124.298 1.039 . . . . 0.0 113.324 178.505 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.29 -8.43 77.44 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 178.793 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.439 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 67.9 m-80 -107.98 135.81 48.74 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 118.354 1.077 . . . . 0.0 111.859 -179.148 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -78.64 123.12 26.79 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.998 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.832 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.8 m-30 -107.59 110.7 22.66 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.84 0.829 . . . . 0.0 111.183 -178.901 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -86.28 -21.92 27.09 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.108 -1.406 . . . . 0.0 110.37 -179.619 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 p -126.1 -175.2 3.3 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.788 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.9 m -65.9 163.4 17.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.393 0.616 . . . . 0.0 109.758 178.896 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.488 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.7 t -138.22 172.84 12.32 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.269 -179.311 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.4 p -125.39 12.9 8.18 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 177.762 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.551 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -60.9 138.27 58.16 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 113.881 -1.508 . . . . 0.0 111.691 -179.697 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.15 -10.12 43.49 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.779 179.767 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.613 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.6 mtp85 . . . . . 0 C--O 1.236 0.361 0 CA-C-N 117.424 0.612 . . . . 0.0 110.96 179.567 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.613 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 8.2 mptt . . . . . 0 N--CA 1.455 -0.221 0 CA-C-O 120.722 0.296 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 43.6 mtt -86.11 150.86 24.13 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.459 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.686 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.3 p-90 -137.43 -167.91 2.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.966 0.412 . . . . 0.0 111.184 -178.548 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.7 p -161.76 142.55 10.78 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.556 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -71.69 154.45 41.35 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.102 0.477 . . . . 0.0 110.737 -179.324 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.5 p -103.5 10.11 37.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.68 0.752 . . . . 0.0 110.119 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.1 p -133.46 155.81 48.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.901 178.766 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -59.15 -35.74 74.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.906 0.384 . . . . 0.0 111.432 -179.67 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -124.98 113.09 17.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.493 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.819 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 80.3 t80 -78.06 -31.05 50.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.028 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -58.76 -34.92 71.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.527 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -79.11 -64.43 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.938 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.955 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.3 m-20 -72.86 -36.56 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.466 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 7.9 mmm-85 54.65 45.26 27.19 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.365 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.955 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 12.4 mtpt -116.74 120.4 38.47 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 176.894 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.819 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 10.4 p-90 -132.5 172.15 12.87 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.437 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.696 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -160.89 147.33 13.91 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 112.984 -1.916 . . . . 0.0 109.708 178.209 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.607 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 10.6 m-30 -58.83 163.54 3.34 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.262 0.553 . . . . 0.0 111.719 -179.862 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.581 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.2 t . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.286 179.753 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 122.07 0.938 . . . . 0.0 111.953 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -132.99 159.42 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 177.63 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.862 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 67.2 -147.45 49.1 Favored Glycine 0 C--N 1.308 -1.002 0 C-N-CA 117.587 -2.245 . . . . 0.0 111.078 -179.032 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.617 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 45.25 -144.55 2.83 Favored Glycine 0 C--N 1.328 0.108 0 N-CA-C 115.157 0.823 . . . . 0.0 115.157 177.318 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 121.19 0.519 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.188 0 CA-C-O 120.301 0.096 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -87.59 166.17 7.64 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.443 2.095 . . . . 0.0 111.697 179.409 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 71.7 m -81.13 118.77 22.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.581 179.829 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 59.6 t -82.67 117.75 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.854 -179.799 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -114.55 134.52 22.33 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.596 179.875 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.724 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 9.4 Cg_endo -85.97 136.92 20.83 Favored 'Cis proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.246 -1.564 . . . . 0.0 112.901 -0.158 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.562 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 29.9 p90 -100.96 129.42 46.8 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.778 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.5 m -91.49 127.0 36.76 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.334 0.588 . . . . 0.0 112.552 -177.395 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.784 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.4 t80 -131.3 142.32 50.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.469 178.356 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.727 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.38 38.96 0.41 Allowed 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.624 1.17 . . . . 0.0 113.665 178.278 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.37 -8.71 79.24 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 115.216 0.846 . . . . 0.0 115.216 178.426 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.566 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 68.3 m-80 -110.39 137.99 47.37 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 118.461 1.13 . . . . 0.0 112.068 -179.082 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -81.5 121.11 25.88 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.498 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.784 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.3 m-30 -104.51 104.7 14.59 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.892 0.854 . . . . 0.0 110.977 -178.129 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.724 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 27.5 mt-10 -84.47 -9.34 58.46 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.159 -1.382 . . . . 0.0 111.259 -179.231 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.0 p -137.58 -167.67 2.17 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.402 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 81.2 m -70.52 170.89 11.17 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.189 -0.605 . . . . 0.0 109.982 178.597 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.542 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 14.3 t -150.11 172.4 15.33 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.279 -179.983 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.6 p -127.11 20.53 6.89 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.07 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.527 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -65.25 142.72 58.19 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 114.067 -1.424 . . . . 0.0 112.234 -179.613 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.58 -4.3 21.47 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.892 179.396 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.678 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 20.6 mtp85 . . . . . 0 N--CA 1.449 -0.525 0 CA-C-O 121.255 0.55 . . . . 0.0 111.688 -179.216 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.678 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.875 0.369 . . . . 0.0 111.651 . . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.4 mtt -98.02 149.92 21.94 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.736 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.611 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.4 p-90 -141.11 -171.85 3.36 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.334 0.587 . . . . 0.0 111.434 -178.331 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.7 p -156.7 137.3 13.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.827 177.969 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.09 151.07 44.87 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.436 0.636 . . . . 0.0 111.458 -178.553 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.1 p -100.75 7.51 43.78 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.915 179.236 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.1 p -127.92 143.83 51.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.754 179.459 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.48 -49.33 70.37 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.916 0.389 . . . . 0.0 110.98 179.958 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -112.46 103.53 11.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.052 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.822 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 56.9 t80 -76.19 -29.25 57.59 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.274 -178.04 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -55.67 -37.77 68.73 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.562 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -86.57 -52.28 5.65 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.298 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.69 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 13.5 m-20 -77.39 -45.98 24.21 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.477 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.675 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER 61.46 37.03 16.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.895 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.69 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 5.0 mppt? -105.11 118.09 35.65 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.183 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.822 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.9 p-90 -128.66 174.88 9.03 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -174.067 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.617 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -157.68 145.9 12.62 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 112.789 -2.005 . . . . 0.0 108.733 178.274 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.862 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 6.2 m-85 -66.86 163.93 18.44 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 117.772 0.786 . . . . 0.0 112.106 -179.402 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.497 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 2.2 t . . . . . 0 C--N 1.329 -0.286 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.592 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.449 -0.519 0 CA-C-O 121.788 0.804 . . . . 0.0 112.99 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -133.23 164.01 36.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.979 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.976 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.699 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 77.19 -80.44 1.26 Allowed Glycine 0 N--CA 1.463 0.463 0 C-N-CA 118.194 -1.955 . . . . 0.0 113.928 178.932 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.8 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . -45.98 166.22 0.07 OUTLIER Glycine 0 N--CA 1.468 0.813 0 CA-C-N 114.502 -0.849 . . . . 0.0 115.174 -179.16 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.783 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.274 0 CA-C-O 120.867 0.365 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.91 147.33 68.07 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.169 2.58 . . . . 0.0 113.018 -179.724 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 86.4 m -82.47 116.5 21.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.336 178.777 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.6 t -77.27 119.32 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -116.09 137.6 23.53 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.057 0.456 . . . . 0.0 111.22 -179.591 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 87.4 Cg_endo -84.02 142.67 40.96 Favored 'Cis proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.428 -1.905 . . . . 0.0 112.795 -0.172 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.605 ' HZ ' HG22 ' A' ' 30' ' ' THR . 21.6 p90 -104.68 128.77 52.85 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.74 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.3 m -95.6 122.63 38.55 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.433 0.635 . . . . 0.0 111.967 -177.933 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.684 ' CE2' ' HZ2' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -104.44 -140.36 0.36 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.151 178.298 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.703 ' H ' HD22 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -49.67 52.81 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.825 2.05 . . . . 0.0 114.884 -177.626 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 21' ' ' PHE . . . 86.2 8.4 78.44 Favored Glycine 0 C--N 1.296 -1.654 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.613 179.562 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.487 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 53.0 m-80 -125.89 134.29 51.65 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.34 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -79.6 118.38 21.39 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.381 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.643 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.3 m-85 -105.67 109.58 21.6 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.877 0.846 . . . . 0.0 111.323 -178.522 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.416 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 31.6 mt-10 -86.75 -15.91 37.96 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.079 -179.874 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 p -128.23 179.56 5.55 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.168 179.058 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.0 m -66.42 160.45 24.82 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.891 178.963 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.605 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 10.6 t -136.62 170.95 15.23 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.021 -179.509 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.3 p -123.59 15.25 9.52 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 177.023 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.486 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -60.59 140.5 57.37 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.41 -179.893 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.25 -7.55 16.71 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.528 -179.837 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.2 mtp85 . . . . . 0 N--CA 1.449 -0.476 0 CA-C-O 120.901 0.381 . . . . 0.0 110.842 -179.8 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt . . . . . 0 CA--C 1.521 -0.166 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -101.42 148.38 25.24 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 176.616 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.684 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.8 p-90 -135.63 -167.94 2.11 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.193 0.52 . . . . 0.0 111.701 -177.89 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.0 p -162.71 142.39 9.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.253 178.851 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' A' ' 19' ' ' PHE . . . -73.39 150.78 41.51 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.927 -179.223 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.1 p -100.34 14.76 29.98 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.332 179.373 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.1 p -136.18 154.34 50.98 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.819 179.104 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.94 -41.03 95.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.079 0.466 . . . . 0.0 110.512 -179.814 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -118.31 111.87 19.31 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.58 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.783 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 76.8 t80 -79.62 -28.96 40.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.381 -177.626 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -57.76 -38.26 75.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.053 0.454 . . . . 0.0 112.013 -179.55 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -79.32 -61.05 2.13 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.578 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -81.74 -25.72 35.15 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.763 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.8 mtm180 48.81 45.56 22.07 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -110.97 118.78 37.01 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.277 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.783 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 17.1 p-90 -130.37 174.54 9.76 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -174.645 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.8 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -168.24 142.83 7.71 Favored Glycine 0 C--O 1.222 -0.652 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.04 179.113 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.699 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 13.9 m-30 -59.18 160.31 6.51 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.317 0.579 . . . . 0.0 111.804 -179.396 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.9 t . . . . . 0 C--N 1.32 -0.702 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.933 179.834 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.347 0.594 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.745 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -117.98 -173.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 177.027 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.42 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 37.27 -129.67 1.23 Allowed Glycine 0 CA--C 1.523 0.578 0 O-C-N 123.932 0.77 . . . . 0.0 113.208 178.158 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.553 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 39.96 -145.47 0.34 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 177.081 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 114.915 -0.642 . . . . 0.0 110.639 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.188 0 CA-C-O 120.929 0.395 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -86.36 174.69 5.9 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.028 2.485 . . . . 0.0 111.987 179.281 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.6 m -79.36 137.8 37.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.619 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 65.9 t -102.31 113.33 38.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.642 0.258 . . . . 0.0 110.323 179.633 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.616 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 36.6 m-85 -117.53 137.48 24.21 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-O 120.838 0.351 . . . . 0.0 111.237 -179.632 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.687 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 37.7 Cg_endo -87.04 138.88 20.09 Favored 'Cis proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.659 -1.809 . . . . 0.0 112.339 -0.744 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.616 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 34.2 p90 -105.1 -169.03 1.55 Allowed 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.041 178.121 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.464 ' OG1' ' HD2' ' A' ' 25' ' ' LYS . 86.5 m -145.81 124.05 12.25 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.738 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.811 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 66.0 t80 -116.6 129.36 56.12 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.812 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.555 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.8 mm? 33.92 45.18 0.1 Allowed 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 125.114 1.509 . . . . 0.0 113.619 175.583 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.54 -16.94 51.53 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 116.459 1.344 . . . . 0.0 116.459 178.002 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.46 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 54.1 m-80 -110.93 135.64 51.15 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 119.929 1.864 . . . . 0.0 112.73 -177.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.464 ' HD2' ' OG1' ' A' ' 20' ' ' THR . 12.3 mmmm -76.33 120.69 21.92 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.853 178.844 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.811 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.5 m-30 -112.83 118.75 35.81 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.646 0.736 . . . . 0.0 111.275 179.919 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.687 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 38.8 mt-10 -97.9 -12.71 21.78 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.999 179.798 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 p -130.66 -174.28 3.31 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.608 179.086 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.9 m -70.93 165.51 23.2 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.724 179.091 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -146.16 171.18 15.31 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.343 -178.715 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.494 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 66.0 p -123.35 18.68 9.79 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 177.061 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.69 134.62 56.36 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.872 -179.424 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.53 -3.15 60.47 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.377 -179.611 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.569 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.6 mtp85 . . . . . 0 N--CA 1.446 -0.66 0 CA-C-O 121.026 0.441 . . . . 0.0 111.182 -179.757 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.569 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 14.7 mmtp . . . . . 0 CA--C 1.518 -0.252 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.494 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 73.7 mtp -76.87 138.03 39.52 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.138 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.661 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.6 p-90 -121.85 -163.6 1.08 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.51 0.672 . . . . 0.0 111.941 -178.006 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 7.4 p -160.79 140.57 10.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.634 -179.722 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -72.68 149.38 43.87 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.113 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.4 p -104.34 13.51 31.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.465 0.65 . . . . 0.0 110.16 179.728 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.9 p -135.36 154.34 51.53 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.692 178.48 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.26 -43.37 98.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.844 0.354 . . . . 0.0 110.909 -179.809 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -117.97 106.97 13.49 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.693 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 1.003 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 25.5 t80 -77.17 -31.64 55.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.707 -179.142 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.27 -36.52 14.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.878 0.371 . . . . 0.0 111.799 179.631 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.13 -57.29 2.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -178.25 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.09 -27.4 60.87 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -176.771 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.5 mtm180 44.33 49.4 8.0 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 179.0 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -114.7 120.89 41.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.608 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 1.003 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.7 p-90 -128.47 172.85 10.74 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -175.312 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.553 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -163.82 143.96 9.06 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.737 179.751 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.745 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 10.9 m-30 -60.99 155.13 20.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 118.139 0.969 . . . . 0.0 111.864 -179.394 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.508 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 14.8 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.472 179.228 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.449 -0.508 0 CA-C-O 121.672 0.748 . . . . 0.0 112.175 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -130.79 162.81 38.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.998 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 177.652 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.809 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 69.07 -148.13 47.26 Favored Glycine 0 C--N 1.312 -0.766 0 C-N-CA 117.565 -2.255 . . . . 0.0 111.413 -179.251 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.654 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 41.58 -140.49 1.54 Allowed Glycine 0 CA--C 1.52 0.347 0 N-CA-C 115.623 1.009 . . . . 0.0 115.623 177.219 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.49 HD22 ' N ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.79 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.817 0.341 . . . . 0.0 111.401 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -85.73 164.98 10.48 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.147 2.565 . . . . 0.0 111.718 178.871 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.8 m -72.31 136.75 46.31 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.499 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.85 95.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.743 0.306 . . . . 0.0 111.564 -179.874 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.606 ' CE1' ' HE1' ' A' ' 19' ' ' PHE . 9.2 m-85 -96.61 146.41 31.26 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-O 121.416 0.627 . . . . 0.0 111.412 177.886 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.842 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.1 Cg_endo -83.44 131.3 17.52 Favored 'Cis proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.32 -1.95 . . . . 0.0 111.896 -0.507 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.606 ' HE1' ' CE1' ' A' ' 17' ' ' PHE . 0.6 OUTLIER -85.84 -160.37 0.53 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.056 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 47' ' ' TYR . 1.8 m -144.14 120.81 11.15 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -178.706 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.942 ' HB3' HD22 ' A' ' 22' ' ' LEU 0.53 0.5 OUTLIER -127.16 123.66 37.23 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 119.949 3.314 . . . . 0.0 119.949 175.152 . . . . . . . . 4 4 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.942 HD22 ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER 26.26 52.75 0.03 OUTLIER 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 108.912 -3.767 . . . . 0.0 112.92 174.723 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.51 -4.53 56.73 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 114.213 -1.358 . . . . 0.0 115.174 178.333 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.907 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 3.5 m-80 -126.16 141.6 51.87 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 118.572 1.186 . . . . 0.0 112.944 -177.779 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.409 ' HB3' ' NZ ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -81.17 119.27 23.38 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.226 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.907 ' CE1' ' HB2' ' A' ' 24' ' ' ASN . 14.2 m-30 -97.0 95.22 7.66 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.459 1.123 . . . . 0.0 111.779 -177.224 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.842 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 39.7 mt-10 -78.45 -13.12 59.98 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 113.18 -1.827 . . . . 0.0 111.877 -178.466 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p -134.01 178.65 6.79 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.721 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 98.5 m -64.88 163.07 15.05 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 119.496 -0.882 . . . . 0.0 108.8 178.172 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.2 t -141.24 177.4 8.12 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.755 -179.609 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 p -126.64 10.56 7.2 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.698 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.83 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.04 146.92 45.45 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.504 179.094 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.33 -10.99 7.15 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.229 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.546 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 21.2 mtp85 . . . . . 0 N--CA 1.451 -0.389 0 O-C-N 122.642 -0.328 . . . . 0.0 111.362 -179.86 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.546 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 3.7 mptt . . . . . 0 CA--C 1.518 -0.279 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.0 mtm -85.39 153.72 22.33 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.341 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.681 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 17.7 p-90 -132.64 -173.48 3.19 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.399 0.619 . . . . 0.0 110.92 -178.94 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.55 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 6.4 p -154.66 134.31 12.79 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.722 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.575 ' HB3' ' CB ' ' A' ' 19' ' ' PHE . . . -73.05 149.22 43.37 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.277 -179.231 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.3 p -101.07 15.68 27.9 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.608 0.718 . . . . 0.0 109.48 179.774 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 p -136.77 142.19 42.97 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.236 178.794 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -52.22 -30.77 28.94 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.363 0.414 . . . . 0.0 111.85 -179.639 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -128.18 119.27 24.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.334 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.901 ' CE2' ' HB3' ' A' ' 53' ' ' TRP . 42.8 t80 -86.23 -52.17 5.82 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.936 -178.205 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.52 -32.76 0.59 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 179.647 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.5 -60.83 1.95 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.074 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.411 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 24.3 m-20 -84.17 -25.11 29.82 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.027 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 8.4 mtm180 49.81 46.13 24.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 179.553 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.411 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 39.1 mtpt -113.56 115.34 27.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.149 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.901 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 15.4 p-90 -126.67 177.62 6.43 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.336 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.451 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -166.77 138.99 5.49 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 112.873 -1.967 . . . . 0.0 108.986 178.852 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.809 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 16.1 m-85 -59.2 150.83 24.44 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 117.62 0.71 . . . . 0.0 111.273 -179.967 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.492 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 6.1 t . . . . . 0 C--N 1.33 -0.279 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.818 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.447 -0.621 0 CA-C-O 122.114 0.959 . . . . 0.0 113.145 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -129.95 159.63 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 177.618 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.899 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.4 -154.08 51.99 Favored Glycine 0 C--N 1.307 -1.069 0 C-N-CA 117.126 -2.464 . . . . 0.0 110.664 -178.818 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.615 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 44.43 -139.13 4.56 Favored Glycine 0 C--O 1.236 0.227 0 N-CA-C 114.773 0.669 . . . . 0.0 114.773 177.004 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.475 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 CA--C 1.531 0.226 0 CA-C-O 120.355 0.121 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 12.6 Cg_exo -67.44 148.71 79.7 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.984 2.456 . . . . 0.0 112.352 179.796 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 90.5 m -79.24 122.35 26.2 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.488 179.458 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.1 t -82.15 119.8 32.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.954 -179.827 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.5 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 57.3 m-85 -119.73 135.81 24.41 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.746 179.755 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.811 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 5.3 Cg_endo -87.95 132.2 11.78 Favored 'Cis proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.273 -1.553 . . . . 0.0 112.251 -0.15 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.639 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 20.8 p90 -91.84 -170.28 2.52 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.651 -0.82 . . . . 0.0 108.908 177.98 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.8 m -144.9 125.64 14.24 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.657 -178.707 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.841 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -132.2 143.65 50.1 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.91 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.76 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.33 38.2 0.33 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.526 1.13 . . . . 0.0 113.457 178.207 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 -6.6 83.39 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 115.311 0.884 . . . . 0.0 115.311 178.296 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.45 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 66.5 m-80 -112.11 136.26 51.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 118.455 1.127 . . . . 0.0 112.013 -178.78 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -79.06 127.86 32.53 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.674 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.841 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.1 m-30 -110.38 111.88 23.45 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 121.709 0.766 . . . . 0.0 111.205 -178.969 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.811 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 36.7 mt-10 -91.17 -11.99 36.74 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.555 -179.768 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 p -133.53 178.87 6.58 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.978 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.3 m -65.92 156.08 34.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.484 179.067 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.3 t -131.88 175.56 9.11 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.11 -179.2 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.2 p -129.15 15.85 6.19 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.35 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.617 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -59.39 141.03 55.54 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.716 -179.74 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.02 -10.99 8.31 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.226 -179.952 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.512 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 25.5 mtp85 . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 120.722 0.296 . . . . 0.0 110.832 -179.992 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.512 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 4.7 mptt . . . . . 0 C--O 1.233 0.185 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -94.0 156.22 16.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.592 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.65 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 23.4 p-90 -142.98 -169.13 2.95 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.032 0.444 . . . . 0.0 110.986 -178.949 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.6 p -161.37 143.95 12.23 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.162 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.43 153.62 35.49 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.891 0.377 . . . . 0.0 110.888 -178.973 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.5 p -102.83 8.13 39.33 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.58 0.705 . . . . 0.0 109.731 179.644 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.6 p -132.55 153.69 50.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.948 178.928 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.46 94.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.432 179.972 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -113.93 109.48 18.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.765 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.859 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 82.9 t80 -83.06 -31.59 27.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.935 -178.419 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -53.18 -37.12 61.65 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.613 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.8 -66.81 0.86 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -68.05 -29.88 68.96 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.439 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.6 mmm180 47.39 46.67 17.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 179.711 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -110.46 117.31 33.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.708 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.859 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.0 p-90 -127.4 -177.52 4.11 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -174.853 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.615 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -174.03 139.85 5.19 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 113.625 -1.625 . . . . 0.0 109.885 179.375 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.899 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.7 m-85 -61.15 152.72 27.79 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.407 0.622 . . . . 0.0 112.165 -179.437 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.438 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.4 t . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.441 179.702 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 13' ' ' ALA . 20.7 p . . . . . 0 N--CA 1.442 -0.854 0 CA-C-O 122.331 1.063 . . . . 0.0 113.515 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -128.82 162.98 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 103.456 -2.794 . . . . 0.0 103.456 176.578 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.767 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.24 -142.47 42.9 Favored Glycine 0 C--N 1.308 -0.983 0 C-N-CA 117.392 -2.337 . . . . 0.0 111.45 -179.205 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.626 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 38.08 -143.81 0.23 Allowed Glycine 0 N--CA 1.467 0.733 0 N-CA-C 116.34 1.296 . . . . 0.0 116.34 177.12 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.319 0 CA-C-N 115.203 -0.498 . . . . 0.0 111.018 -179.274 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 5' ' ' THR . . . . . . . . 0 C--O 1.223 -0.298 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -81.08 128.14 6.34 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 121.777 1.651 . . . . 0.0 112.212 179.642 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 91.2 m -62.46 126.78 28.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.174 179.8 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 58.2 t -91.86 123.59 44.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.743 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.619 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 59.7 m-85 -118.76 141.03 29.3 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.14 178.925 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.99 134.11 21.28 Favored 'Cis proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.631 -1.404 . . . . 0.0 112.201 -0.492 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.619 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 28.5 p90 -105.06 128.03 53.15 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.281 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.0 m -89.63 123.34 33.6 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.755 -178.892 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.754 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 66.4 t80 -117.11 131.33 56.93 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.402 178.949 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.516 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.6 mm? 35.85 46.08 0.32 Allowed 'General case' 0 N--CA 1.427 -1.593 0 O-C-N 124.722 1.263 . . . . 0.0 113.576 175.892 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.02 -15.46 62.52 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 114.489 -1.232 . . . . 0.0 115.872 177.83 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.581 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 61.0 m-80 -111.72 135.17 52.68 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.838 1.819 . . . . 0.0 112.014 -178.376 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -78.9 121.58 25.03 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.411 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.754 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.5 m-30 -108.9 113.97 27.33 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.628 0.728 . . . . 0.0 111.556 -178.2 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -90.13 -17.33 27.85 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.482 179.481 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.2 p -127.75 -174.51 3.21 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.74 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.2 m -68.57 169.53 10.84 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.991 178.82 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.405 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.6 t -146.47 174.02 11.77 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.016 0.436 . . . . 0.0 110.15 -178.88 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.8 p -129.63 22.57 5.47 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.694 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.9 135.7 51.45 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 113.762 -1.563 . . . . 0.0 112.108 -179.255 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.0 6.52 87.41 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.99 179.563 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.596 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 9.8 mtp85 . . . . . 0 N--CA 1.452 -0.361 0 CA-C-N 117.325 0.562 . . . . 0.0 111.489 -179.645 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.596 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 17.7 mmtp . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.6 mtm -65.62 144.31 57.03 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.474 -0.49 . . . . 0.0 109.788 -179.664 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.688 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 19.0 p-90 -133.4 -169.05 2.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.394 -178.839 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.5 p -162.53 144.34 10.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.452 178.357 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.456 ' CB ' ' HD2' ' A' ' 47' ' ' TYR . . . -73.91 157.03 37.02 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.261 0.553 . . . . 0.0 110.926 -179.109 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.7 p -106.28 9.66 31.94 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.863 -179.803 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.2 p -131.88 151.17 51.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.24 178.785 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.42 -37.45 72.79 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.066 0.46 . . . . 0.0 110.891 -179.784 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -123.93 115.12 20.74 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.186 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.953 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 33.6 t80 -80.73 -31.08 36.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.878 -178.116 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -53.16 -35.71 60.09 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.64 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -84.42 -67.15 0.82 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.074 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -73.29 -27.6 61.63 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -177.275 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.661 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.6 mtm180 47.56 48.14 17.09 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.971 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -112.32 122.91 49.06 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.44 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.953 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 11.7 p-90 -131.51 174.53 10.0 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -175.778 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.626 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -169.23 141.1 6.49 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.725 178.77 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.767 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.4 m-85 -55.42 151.9 9.49 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.443 0.639 . . . . 0.0 111.632 -179.82 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.632 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 18.0 t . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.632 -179.696 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.461 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 50.4 p . . . . . 0 C--O 1.236 0.358 0 CA-C-O 121.649 0.738 . . . . 0.0 112.539 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.483 HG13 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -122.6 -53.22 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.966 0 CA-C-O 123.425 1.583 . . . . 0.0 108.545 179.232 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.816 ' H ' ' HB2' ' A' ' 55' ' ' PHE . . . -83.49 -164.25 36.18 Favored Glycine 0 C--N 1.279 -2.627 0 CA-C-N 110.503 -3.044 . . . . 0.0 111.622 178.919 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.609 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 75.94 -175.04 52.55 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.344 -0.932 . . . . 0.0 113.338 178.573 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.408 ' H ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 120.57 0.224 . . . . 0.0 111.255 179.542 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -81.17 148.89 17.06 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.174 1.916 . . . . 0.0 111.957 -179.787 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 88.0 m -80.26 138.78 36.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.746 0.308 . . . . 0.0 110.665 -179.967 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.436 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 84.9 t -99.01 125.54 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.119 -179.711 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.425 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 48.5 m-85 -124.81 139.21 32.88 Favored Pre-proline 0 N--CA 1.445 -0.707 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.958 -179.806 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -86.5 135.85 18.13 Favored 'Cis proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.558 -1.851 . . . . 0.0 111.862 -0.458 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.691 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 45.1 p90 -101.47 -171.11 1.93 Allowed 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.476 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 m -146.85 124.77 11.98 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.673 -179.022 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.861 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 63.2 t80 -118.03 130.43 56.16 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.492 179.8 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.561 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.7 mm? 33.74 45.09 0.09 Allowed 'General case' 0 N--CA 1.427 -1.611 0 O-C-N 125.075 1.484 . . . . 0.0 114.108 175.233 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.45 -15.82 49.39 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 115.903 1.121 . . . . 0.0 115.903 177.887 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.543 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 28.3 m-80 -115.82 134.84 54.59 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.789 1.795 . . . . 0.0 112.116 -178.425 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -80.53 126.37 31.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.723 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.861 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.9 m-85 -113.7 123.52 50.1 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.661 0.743 . . . . 0.0 111.531 -178.812 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -93.98 -20.83 19.61 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.181 179.926 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 p -128.38 -173.29 2.91 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.858 179.004 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 70.9 m -65.62 161.97 19.32 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.339 178.726 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -138.63 168.68 19.26 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.322 -178.461 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.2 p -124.76 23.37 7.99 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.056 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.53 136.57 57.65 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 113.912 -1.495 . . . . 0.0 111.591 -179.781 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.69 -6.3 54.37 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.727 -179.126 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.589 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.8 mtp85 . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 120.682 0.277 . . . . 0.0 110.356 179.809 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.589 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 37.6 mttp . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.9 mtm -98.76 151.35 20.87 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.064 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.7 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 28.6 p-90 -141.4 -170.23 3.04 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.035 0.445 . . . . 0.0 111.102 -178.1 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.56 149.42 11.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.277 178.461 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.468 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -73.25 148.15 43.94 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.787 -179.281 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 69.6 p -100.41 8.06 43.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.663 0.744 . . . . 0.0 109.842 179.382 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.4 p -130.88 157.97 41.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.799 -1.092 . . . . 0.0 109.112 178.542 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.65 -39.54 80.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.912 0.387 . . . . 0.0 111.144 -179.54 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -125.41 114.09 18.39 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.001 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.874 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 58.9 t80 -69.82 -40.62 75.78 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.361 -177.936 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.13 -33.19 51.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.951 0.405 . . . . 0.0 111.933 -179.117 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.29 -68.42 0.53 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.194 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.99 -18.76 29.92 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -176.819 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 24.7 mtm-85 44.4 53.79 6.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 179.434 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -117.75 118.85 33.17 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.549 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.874 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.8 p-90 -127.53 170.47 12.57 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 122.078 0.942 . . . . 0.0 113.365 -175.537 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.609 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.44 147.95 13.2 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.411 179.275 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.816 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 7.0 m-30 -64.0 160.67 17.39 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.519 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.418 179.987 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.444 -0.757 0 CA-C-O 122.234 1.016 . . . . 0.0 113.267 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.712 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -118.84 -166.8 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 176.948 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 35.58 -126.19 0.76 Allowed Glycine 0 N--CA 1.465 0.568 0 O-C-N 124.007 0.817 . . . . 0.0 113.065 177.842 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.613 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 34.05 -139.29 0.14 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 115.248 0.859 . . . . 0.0 115.248 177.384 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.404 ' N ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.056 0.455 . . . . 0.0 110.827 179.252 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.22 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -84.94 160.1 11.79 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.434 2.089 . . . . 0.0 112.344 -179.684 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.7 m -89.52 130.9 35.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.619 179.66 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -89.68 120.57 38.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.842 -179.866 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.611 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 65.2 m-85 -116.1 139.0 24.58 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-O 120.772 0.32 . . . . 0.0 110.767 179.908 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -87.05 136.84 17.72 Favored 'Cis proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.615 -1.827 . . . . 0.0 112.636 -0.135 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.611 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 26.3 p90 -101.2 129.05 47.06 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.096 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 98.9 m -92.62 123.71 36.11 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.485 0.659 . . . . 0.0 112.496 -177.972 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.904 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.5 t80 -126.42 145.46 50.46 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.714 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.694 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.28 36.59 0.2 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.442 1.097 . . . . 0.0 113.384 179.185 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.8 -2.43 87.19 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 114.85 0.7 . . . . 0.0 114.85 178.637 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.59 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 45.2 m-20 -111.33 135.74 51.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.265 1.033 . . . . 0.0 111.95 -179.007 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -81.45 118.05 22.38 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.379 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.904 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.5 m-30 -101.82 113.06 25.92 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.844 0.831 . . . . 0.0 111.492 -178.553 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -86.98 -20.56 27.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.127 179.646 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -126.44 179.66 5.19 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.37 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.1 m -64.77 162.93 15.06 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.779 179.321 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.6 t -137.48 169.34 17.95 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.222 -178.738 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.584 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 41.8 p -121.61 15.76 11.13 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.894 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.567 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.09 142.56 56.59 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.936 179.72 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.51 -16.27 6.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.893 -179.482 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 . . . . . 0 N--CA 1.445 -0.686 0 CA-C-O 120.753 0.311 . . . . 0.0 110.465 179.681 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 38' ' ' LYS . 3.1 mptt . . . . . 0 C--O 1.234 0.265 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.584 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 3.5 mpp? -99.63 153.46 19.05 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.569 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.668 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 22.0 p-90 -138.1 -168.78 2.43 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.084 0.469 . . . . 0.0 110.77 -178.815 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.3 p -163.16 141.1 7.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.39 177.826 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.88 148.53 46.02 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.304 0.573 . . . . 0.0 110.929 -178.662 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 43.9 p -98.31 11.96 36.31 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.092 179.215 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.4 p -131.01 155.19 47.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.974 179.265 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -62.02 -40.06 94.43 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.915 0.388 . . . . 0.0 110.913 -179.995 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -120.11 111.89 18.43 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.802 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.833 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 74.7 t80 -82.18 -31.62 30.33 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.072 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -57.03 -33.29 67.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.127 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -92.35 -56.05 3.18 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.153 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -74.75 -26.89 60.09 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.544 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 12.8 mtm180 43.46 50.67 6.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 179.576 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -119.61 120.35 36.41 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.432 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.833 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.4 p-90 -133.98 177.68 7.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -173.99 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.607 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -169.27 146.24 10.03 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.724 178.82 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.712 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.3 m-30 -60.29 157.78 12.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.606 0.703 . . . . 0.0 111.725 -179.08 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.468 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.5 t . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.529 -179.844 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.711 HG22 ' SG ' ' A' ' 41' ' ' CYS . 50.1 p . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.861 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -129.18 -160.47 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.668 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 34.4 -123.1 0.46 Allowed Glycine 0 N--CA 1.464 0.51 0 O-C-N 124.105 0.878 . . . . 0.0 113.182 177.679 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.551 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 34.45 -144.68 0.05 OUTLIER Glycine 0 C--N 1.337 0.615 0 N-CA-C 116.097 1.199 . . . . 0.0 116.097 177.062 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 114.844 -0.678 . . . . 0.0 110.093 179.732 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 5' ' ' THR . . . . . . . . 0 C--O 1.222 -0.364 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -65.08 131.82 29.93 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.202 1.935 . . . . 0.0 111.768 179.666 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.8 m -66.04 135.37 54.56 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.811 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 86.8 t -98.83 113.65 34.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.648 0.261 . . . . 0.0 111.109 179.871 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.502 ' CE2' ' HB2' ' A' ' 15' ' ' CYS . 99.4 m-85 -112.84 143.22 28.63 Favored Pre-proline 0 N--CA 1.446 -0.665 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.287 179.172 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -85.45 133.57 17.48 Favored 'Cis proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.38 -1.508 . . . . 0.0 112.034 -0.174 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.672 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 46.7 p90 -105.5 130.77 53.5 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.436 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.9 m -95.75 128.51 42.69 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -176.974 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.897 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.2 t80 -132.53 146.6 52.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.68 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.745 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.51 37.4 0.29 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.557 1.143 . . . . 0.0 113.466 178.535 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.14 -6.06 82.5 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 114.606 0.602 . . . . 0.0 114.606 178.929 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -111.73 133.25 54.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.351 1.075 . . . . 0.0 112.057 -178.721 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -79.03 122.81 26.66 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.889 179.187 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.897 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.5 m-85 -106.15 114.52 28.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.784 0.802 . . . . 0.0 111.504 -178.361 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -93.56 -15.65 25.23 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.288 179.434 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.3 p -130.34 178.58 6.48 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.015 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.5 m -60.9 163.69 5.55 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.566 0.698 . . . . 0.0 110.648 179.274 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.0 t -144.71 169.41 18.07 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.253 179.908 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.562 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 15.7 p -125.7 23.78 7.28 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.066 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.93 140.4 58.31 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 113.969 -1.468 . . . . 0.0 111.015 -179.944 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.02 -8.9 13.42 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.723 -179.452 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.6 mtp85 . . . . . 0 N--CA 1.448 -0.571 0 CA-C-O 120.972 0.415 . . . . 0.0 110.663 -179.699 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.596 ' N ' ' HD2' ' A' ' 38' ' ' LYS . 8.3 mptt . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 120.79 0.329 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.562 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 61.8 mtt -98.63 160.33 14.35 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.306 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.652 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 20.1 p-90 -144.08 -173.27 3.96 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.544 0.688 . . . . 0.0 111.974 -178.981 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.711 ' SG ' HG22 ' A' ' 5' ' ' THR . 8.5 p -154.81 138.57 16.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.959 -1.018 . . . . 0.0 108.85 179.769 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.466 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -76.45 153.82 35.28 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.333 179.961 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.4 p -104.55 14.29 30.21 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.851 0.834 . . . . 0.0 110.015 -179.694 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.9 p -137.3 147.5 45.69 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.592 178.89 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.668 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -51.63 -43.77 62.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.929 0.395 . . . . 0.0 111.4 -179.688 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -119.38 107.43 13.35 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.909 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.818 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 79.7 t80 -71.86 -32.04 67.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.364 -178.027 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.704 ' HA ' ' NH1' ' A' ' 51' ' ' ARG . 25.8 m-20 -66.26 -25.45 66.89 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.016 0.436 . . . . 0.0 111.523 -179.764 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -84.4 -58.99 2.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.374 -179.634 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -87.84 -19.4 27.49 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -176.681 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.704 ' NH1' ' HA ' ' A' ' 48' ' ' ASP . 7.8 mtt-85 45.97 51.0 11.1 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 179.978 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -119.84 121.76 39.81 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 176.443 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.818 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.5 p-90 -136.59 176.92 8.26 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -175.597 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.529 ' HA3' ' HB ' ' A' ' 5' ' ' THR . . . -170.07 149.14 12.5 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.289 178.237 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.861 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.6 m-30 -64.72 165.71 9.96 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.859 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 37.8 m . . . . . 0 C--N 1.325 -0.491 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 176.42 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.478 0.656 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.824 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -107.94 -168.13 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 176.793 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.56 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 40.05 -123.23 2.03 Favored Glycine 0 N--CA 1.46 0.288 0 O-C-N 123.827 0.704 . . . . 0.0 113.116 177.829 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.659 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 32.19 -143.13 0.03 OUTLIER Glycine 0 C--N 1.336 0.529 0 N-CA-C 116.836 1.495 . . . . 0.0 116.836 177.065 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.49 HD22 ' N ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 114.597 -0.801 . . . . 0.0 110.6 179.961 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 CA--C 1.521 -0.147 0 CA-C-O 120.768 0.318 . . . . 0.0 111.526 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 60.1 Cg_endo -88.38 178.61 2.9 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.133 2.556 . . . . 0.0 111.812 179.475 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.6 m -81.8 149.03 28.56 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.53 -179.88 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.6 t -115.94 118.41 58.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.516 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.615 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 59.6 m-85 -121.11 143.59 37.47 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-O 121.019 0.437 . . . . 0.0 111.878 -179.084 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.804 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 8.6 Cg_endo -87.5 135.99 15.96 Favored 'Cis proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.029 -1.655 . . . . 0.0 111.6 -0.817 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.66 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 37.6 p90 -103.02 -169.88 1.72 Allowed 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.208 178.647 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.434 ' OG1' ' HD3' ' A' ' 25' ' ' LYS . 63.6 m -147.54 126.89 13.09 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.53 -179.505 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.88 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 59.8 t80 -123.87 133.45 53.76 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.12 179.383 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.549 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 35.38 48.28 0.39 Allowed 'General case' 0 N--CA 1.427 -1.603 0 O-C-N 124.713 1.258 . . . . 0.0 113.711 175.451 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.73 -11.09 71.75 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 116.334 1.294 . . . . 0.0 116.334 177.763 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.409 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 53.7 m-80 -115.61 135.14 54.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 119.555 1.677 . . . . 0.0 112.53 -178.351 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HD3' ' OG1' ' A' ' 20' ' ' THR . 65.5 mmtt -76.44 125.15 28.7 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.943 178.875 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.88 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.8 m-85 -115.58 118.37 32.95 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.567 0.698 . . . . 0.0 111.067 -179.985 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.804 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 49.9 mt-10 -96.28 -16.08 21.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.101 179.573 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.9 p -126.19 -177.37 3.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.138 178.233 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.2 m -67.87 165.73 17.0 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.413 178.762 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 t -142.91 173.03 11.91 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.075 -178.704 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.535 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 57.8 p -129.02 22.82 5.7 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.37 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.464 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -62.92 141.05 58.87 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 114.012 -1.449 . . . . 0.0 112.35 -179.069 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.68 -1.71 36.02 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.728 179.56 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.778 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 8.4 mtp85 . . . . . 0 N--CA 1.448 -0.543 0 CA-C-O 120.829 0.347 . . . . 0.0 110.858 -179.721 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.778 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 76.7 mttt . . . . . 0 N--CA 1.461 0.123 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.535 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.5 mpt? -87.58 141.96 28.21 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.688 179.214 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 13.0 p-90 -129.99 -162.78 1.24 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.176 -178.856 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.3 p -163.58 151.09 12.71 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.75 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.445 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -83.11 144.99 29.5 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.294 179.417 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 79.6 p -99.95 13.21 34.7 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.945 0.878 . . . . 0.0 109.704 179.919 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.6 p -137.04 151.08 48.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.94 178.598 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.29 -40.95 78.86 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.891 0.377 . . . . 0.0 111.478 -179.387 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -123.71 109.84 14.2 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.599 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 1.07 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 23.7 t80 -75.83 -34.51 60.11 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.703 -178.492 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -50.75 -34.75 28.43 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.474 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -96.39 -52.69 3.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.464 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.39 -26.2 35.65 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.021 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 13.5 mtm180 45.36 50.65 9.89 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 179.117 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -114.66 121.82 44.56 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.14 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 1.07 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 12.2 p-90 -128.7 173.35 10.39 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -175.699 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.431 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.94 140.5 6.26 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.543 179.601 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.824 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 8.3 m-30 -60.16 153.29 22.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.783 0.791 . . . . 0.0 111.183 -179.661 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.46 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.7 t . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.706 -179.983 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.3 p . . . . . 0 C--O 1.236 0.348 0 CA-C-O 122.348 1.071 . . . . 0.0 113.126 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.531 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -142.58 161.8 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 178.587 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.589 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 65.5 -149.82 51.67 Favored Glycine 0 C--N 1.313 -0.695 0 C-N-CA 117.958 -2.068 . . . . 0.0 111.157 -179.453 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.713 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 50.58 -152.2 4.68 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 114.778 0.671 . . . . 0.0 114.778 177.802 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.0 p30 . . . . . 0 C--N 1.328 -0.369 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.924 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.261 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.35 147.29 18.02 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.01 1.807 . . . . 0.0 112.466 -179.891 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.2 m -78.03 115.69 17.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.504 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 55.3 t -79.83 108.83 13.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.91 0.386 . . . . 0.0 110.616 -179.604 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -109.72 138.51 20.68 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.969 -179.614 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.762 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 58.4 Cg_endo -85.34 138.58 25.6 Favored 'Cis proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.834 -1.736 . . . . 0.0 112.895 -0.327 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.605 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 35.1 p90 -105.55 132.65 51.45 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.184 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 90.3 m -93.78 128.46 40.02 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.412 0.625 . . . . 0.0 112.394 -177.57 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.748 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -130.69 142.71 50.44 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.596 -1.184 . . . . 0.0 107.83 178.166 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.747 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.37 39.54 0.3 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.757 1.223 . . . . 0.0 113.497 178.17 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.32 -5.67 84.69 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 114.859 0.704 . . . . 0.0 114.859 178.419 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.691 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 50.8 m-20 -110.76 136.39 49.91 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 118.448 1.124 . . . . 0.0 111.511 -178.723 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -82.04 120.03 24.75 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.805 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.748 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.5 m-30 -102.96 110.29 22.15 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.594 0.711 . . . . 0.0 111.38 -177.621 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.762 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 94.5 mt-10 -91.5 -4.86 55.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.131 -179.69 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.3 p -140.96 -171.43 3.25 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.325 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 87.3 m -69.65 166.17 19.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.939 178.882 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.513 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 14.1 t -146.38 175.72 10.32 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.665 -179.489 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.3 p -130.94 20.98 4.95 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.382 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.601 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -66.74 143.03 57.18 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 113.918 -1.492 . . . . 0.0 112.215 -179.346 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.33 2.27 47.7 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.659 178.67 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.691 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.5 mtp85 . . . . . 0 N--CA 1.448 -0.546 0 CA-C-N 117.349 0.574 . . . . 0.0 111.412 -179.493 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.691 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 24.9 mmtm . . . . . 0 CA--C 1.521 -0.148 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 52.1 mtm -85.49 144.08 28.16 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 179.303 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.637 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.2 p-90 -135.78 -168.6 2.24 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.371 0.605 . . . . 0.0 112.121 -177.819 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 23.8 p -153.05 138.95 18.06 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.166 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.536 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -77.97 146.73 35.28 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.795 179.97 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.2 p -101.04 17.64 21.84 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.833 0.825 . . . . 0.0 110.203 -179.695 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.89 152.97 50.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.856 178.643 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -60.19 -39.57 86.98 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.206 0.527 . . . . 0.0 111.188 -179.665 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -122.18 107.84 12.61 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.582 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.791 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 64.2 t80 -74.71 -30.44 61.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.852 -178.149 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -55.19 -37.05 66.57 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.262 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.87 -72.23 0.49 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.823 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.74 -19.49 62.73 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -177.508 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.631 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 21.6 mtm180 41.17 53.86 3.44 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 179.886 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.408 ' HG3' ' HZ2' ' A' ' 52' ' ' LYS . 48.2 mttp -112.77 118.28 34.54 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.564 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.791 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 11.9 p-90 -133.03 171.24 14.25 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -174.667 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.713 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.14 142.04 7.78 Favored Glycine 0 C--O 1.221 -0.708 0 CA-C-N 113.122 -1.854 . . . . 0.0 109.313 178.236 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.589 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 7.9 m-30 -56.21 159.34 3.53 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.777 0.789 . . . . 0.0 111.19 179.699 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.545 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 5.5 t . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.572 179.929 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 122.196 0.998 . . . . 0.0 112.874 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -139.36 164.58 24.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.047 0 N-CA-C 104.667 -2.345 . . . . 0.0 104.667 179.418 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.499 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 64.91 -149.78 51.62 Favored Glycine 0 C--N 1.313 -0.701 0 C-N-CA 118.025 -2.036 . . . . 0.0 111.367 -179.733 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.632 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 51.6 -149.26 8.5 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 114.256 0.463 . . . . 0.0 114.256 177.998 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.685 -0.258 . . . . 0.0 111.147 179.697 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 120.592 0.234 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 16.3 Cg_exo -65.7 144.49 78.27 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.604 2.203 . . . . 0.0 112.315 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.7 m -72.16 148.43 45.64 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.657 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 64.6 t -108.76 109.67 29.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.627 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.585 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 38.6 m-85 -114.69 143.09 29.33 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-O 121.229 0.538 . . . . 0.0 111.503 -179.312 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.8 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.3 Cg_endo -87.41 136.91 16.97 Favored 'Cis proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.263 -1.557 . . . . 0.0 111.469 -0.97 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.585 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 34.3 p90 -101.4 -170.77 1.88 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.27 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.8 m -148.79 127.44 12.46 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.999 -178.996 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.677 ' CG ' HD22 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -111.11 -143.73 0.39 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 118.342 -0.837 . . . . 0.0 108.915 179.111 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.677 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -49.11 55.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.916 2.086 . . . . 0.0 114.958 -177.215 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 21' ' ' PHE . . . 86.72 6.87 79.42 Favored Glycine 0 C--N 1.296 -1.651 0 CA-C-N 114.41 -1.268 . . . . 0.0 113.345 178.821 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.539 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 20.7 m-80 -127.56 135.57 50.49 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 117.862 0.831 . . . . 0.0 112.151 -178.76 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -78.75 126.64 31.0 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.26 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.626 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.9 m-85 -112.23 107.65 16.59 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 122.138 0.97 . . . . 0.0 110.91 -179.19 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.8 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 32.0 mt-10 -86.11 -19.95 29.42 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.484 -179.395 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 p -126.53 -172.99 2.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 178.386 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.5 m -68.27 160.06 30.06 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.027 179.077 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t -137.14 168.95 18.61 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.909 -179.587 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.8 p -122.82 24.55 9.02 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 122.042 0.925 . . . . 0.0 108.677 177.857 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.502 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -70.99 148.42 47.66 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.417 -179.667 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.57 -7.14 14.02 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.508 -0.769 . . . . 0.0 114.02 178.526 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.621 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 8.2 mtp-105 . . . . . 0 N--CA 1.453 -0.294 0 CA-C-N 118.2 1.0 . . . . 0.0 110.793 -179.659 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.621 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 7.5 mptt . . . . . 0 N--CA 1.447 -0.584 0 CA-C-O 121.349 0.595 . . . . 0.0 112.225 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -116.91 160.46 20.86 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.995 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.651 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.7 p-90 -146.87 -169.1 3.21 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.153 0.501 . . . . 0.0 110.924 -178.774 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 24.5 p -156.23 146.04 21.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.26 179.718 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.401 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -80.68 146.64 31.0 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.054 -0.659 . . . . 0.0 109.565 179.346 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.3 p -100.45 19.43 16.78 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.888 0.851 . . . . 0.0 109.479 179.458 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.4 p -141.15 153.71 45.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.101 179.067 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.86 -31.74 71.19 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.321 0.582 . . . . 0.0 111.252 -179.842 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -129.1 118.58 22.72 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.937 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.858 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 59.5 t80 -82.46 -32.96 28.63 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.856 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -52.32 -39.12 60.18 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.676 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.0 -74.49 0.26 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.82 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.474 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 45.7 m-20 -72.85 -19.74 61.25 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -176.292 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 35.4 mtm-85 40.11 55.69 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 179.709 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 50' ' ' ASP . 49.7 mtmt -114.54 120.42 40.15 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.941 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.858 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.6 p-90 -133.17 170.78 14.91 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.949 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.632 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.82 141.44 7.18 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.46 178.806 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.508 ' HD1' ' HB3' ' A' ' 40' ' ' TRP . 7.1 m-30 -56.98 162.01 2.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.263 0.554 . . . . 0.0 111.446 179.829 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.468 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 12.6 t . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.7 -178.46 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.378 0.609 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.885 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -107.43 -168.1 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 176.819 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.671 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 38.08 -127.26 1.59 Allowed Glycine 0 C--N 1.318 -0.438 0 O-C-N 123.846 0.716 . . . . 0.0 113.719 177.552 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.595 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 39.49 -149.55 0.11 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 116.115 1.206 . . . . 0.0 116.115 177.127 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.425 ' N ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 114.633 -0.784 . . . . 0.0 111.058 -179.755 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--O 1.223 -0.294 0 CA-C-O 120.575 0.226 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 6.2 Cg_exo -72.19 172.23 15.24 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.646 2.231 . . . . 0.0 111.71 179.284 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.7 m -85.36 150.1 24.98 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.562 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.558 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 75.8 t -108.66 110.64 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.251 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -112.34 137.9 21.71 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.969 -178.995 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.7 Cg_endo -86.11 132.15 14.61 Favored 'Cis proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.485 -1.465 . . . . 0.0 112.255 -0.18 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.644 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 43.9 p90 -98.57 124.36 43.29 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.569 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 29.9 m -87.61 121.68 30.35 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.502 0.668 . . . . 0.0 112.194 -177.261 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.879 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.4 t80 -125.7 143.81 50.88 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.527 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.698 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 39.58 32.88 0.1 Allowed 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.823 1.249 . . . . 0.0 113.582 178.364 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.91 -11.73 64.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.894 -0.67 . . . . 0.0 114.767 178.604 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.6 m-80 -110.01 133.56 53.06 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 118.406 1.103 . . . . 0.0 112.425 -178.759 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -79.83 115.31 19.35 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.124 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.879 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.0 m-85 -96.97 111.99 23.95 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.908 0.861 . . . . 0.0 111.562 -177.814 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.47 -14.36 43.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.279 179.692 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.8 p -129.92 -173.54 3.06 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.828 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.5 m -71.03 167.85 18.35 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.823 178.486 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.594 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.7 t -145.55 175.33 10.43 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.13 -179.0 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.524 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 9.8 p -129.52 18.52 5.8 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.189 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.571 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -63.52 144.41 57.01 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 113.978 -1.464 . . . . 0.0 111.879 -179.715 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.3 -1.4 34.82 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.841 179.464 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.728 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 7.7 mtp85 . . . . . 0 N--CA 1.448 -0.537 0 CA-C-N 117.056 0.428 . . . . 0.0 111.58 -179.333 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.728 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 111.306 . . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.524 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 59.8 mtm -89.25 149.15 23.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.194 0.521 . . . . 0.0 110.871 -179.531 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.613 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 13.5 p-90 -138.37 -168.33 2.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.518 0.675 . . . . 0.0 112.129 -178.435 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 21.0 p -156.16 136.64 13.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.34 178.742 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -74.75 151.35 39.17 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.442 -179.599 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 64.2 p -101.51 11.21 39.42 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.712 179.675 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.9 p -135.85 151.43 50.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.459 178.757 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.87 -48.45 79.8 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.915 0.388 . . . . 0.0 111.62 -179.537 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -111.43 104.15 12.56 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.81 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.855 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 70.7 t80 -75.49 -32.27 60.5 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.532 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.78 -36.44 64.88 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.373 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -88.75 -61.7 1.65 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.504 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.89 -34.8 78.58 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.89 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 12.9 mtm-85 48.56 47.87 20.09 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.383 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -115.25 117.8 31.5 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.737 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.855 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 11.8 p-90 -131.59 175.48 9.13 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -174.21 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.403 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -164.34 142.64 7.93 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.616 178.876 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.885 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 8.7 m-85 -59.82 158.49 10.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.065 0.933 . . . . 0.0 111.417 -179.582 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.481 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 5.6 t . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.796 -179.085 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.406 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 32.8 p . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.432 0.634 . . . . 0.0 112.357 . . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.831 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -106.46 -166.26 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 176.191 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.616 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.15 -127.1 1.19 Allowed Glycine 0 C--N 1.321 -0.281 0 O-C-N 124.072 0.857 . . . . 0.0 112.994 177.774 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.605 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 31.34 -138.66 0.07 OUTLIER Glycine 0 C--N 1.336 0.537 0 N-CA-C 116.083 1.193 . . . . 0.0 116.083 176.997 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 114.857 -0.671 . . . . 0.0 109.782 -179.986 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.536 0.207 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 98.7 Cg_endo -93.41 175.06 1.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.305 2.67 . . . . 0.0 111.254 179.097 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.8 m -84.17 142.86 30.03 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.458 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 63.4 t -107.81 121.91 61.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.81 0.338 . . . . 0.0 110.216 178.962 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -121.49 144.29 39.88 Favored Pre-proline 0 N--CA 1.447 -0.616 0 CA-C-O 120.783 0.325 . . . . 0.0 111.277 -179.446 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -85.9 137.03 21.18 Favored 'Cis proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.718 -1.784 . . . . 0.0 111.698 -0.811 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.498 ' CG ' ' HB3' ' A' ' 42' ' ' ALA . 23.3 p90 -104.87 175.35 5.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.055 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 94.7 m -130.26 124.08 31.6 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.833 -179.446 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.716 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 42.5 t80 -126.26 138.78 53.65 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.907 179.029 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.545 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.4 mm? 35.27 46.42 0.25 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 175.318 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.85 -7.01 81.81 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 114.469 -1.241 . . . . 0.0 116.157 177.738 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.531 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 62.0 m-80 -109.14 155.89 20.48 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 119.286 1.543 . . . . 0.0 111.674 -179.023 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -95.84 125.34 40.34 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.405 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.716 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 28.6 m-85 -113.64 119.7 38.35 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.809 0.814 . . . . 0.0 112.072 -177.599 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -96.58 -20.53 18.26 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.385 -1.279 . . . . 0.0 110.318 179.608 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 p -130.09 -174.03 3.21 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.333 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.9 m -68.16 163.46 22.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.605 178.837 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.1 t -142.3 163.76 31.99 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.721 -178.577 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.526 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 26.2 p -116.07 20.66 14.26 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 176.487 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.1 142.14 52.26 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.432 -179.455 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.99 -7.39 9.77 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.246 179.264 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.72 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 22.4 mtp85 . . . . . 0 N--CA 1.447 -0.619 0 CA-C-N 117.035 0.417 . . . . 0.0 111.339 -179.17 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.72 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 2.0 mptp? . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 120.781 0.324 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.526 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 44.0 mtm -83.87 143.55 29.82 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.038 179.743 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.648 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.2 p-90 -128.2 -166.98 1.7 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.565 -179.716 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 9.9 p -160.39 146.41 15.26 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.744 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.498 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -78.09 142.59 38.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.115 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 78.7 p -96.17 16.48 18.04 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.436 0.636 . . . . 0.0 110.486 -179.552 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.7 p -139.63 161.11 38.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.741 179.293 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -64.24 -30.33 71.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.002 0.43 . . . . 0.0 111.196 179.946 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -132.69 115.52 15.48 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.908 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.88 ' HE1' ' HB3' ' A' ' 53' ' ' TRP . 44.5 t80 -81.23 -38.3 27.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.196 -178.883 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -47.03 -36.36 7.85 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.536 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -95.11 -56.13 2.84 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.781 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.546 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.5 m-20 -67.22 -43.17 82.68 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -177.73 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 5.3 mmm180 57.59 40.87 26.47 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 179.415 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.546 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 4.2 mppt? -114.28 122.32 46.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.586 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.88 ' HB3' ' HE1' ' A' ' 47' ' ' TYR . 11.4 p-90 -132.67 170.8 14.7 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -175.022 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.5 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.24 143.26 8.33 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.863 179.254 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.831 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.2 m-30 -61.35 156.61 18.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.969 0.885 . . . . 0.0 111.499 -179.641 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.411 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 4.3 t . . . . . 0 C--N 1.327 -0.372 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.434 ' O ' ' HG3' ' A' ' 3' ' ' MET . 58.5 p . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 120.46 0.171 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 60.05 39.22 20.08 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.358 0.599 . . . . 0.0 109.595 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 66.3 mtt -128.29 127.44 42.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.252 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.4 m -83.24 159.69 21.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 13' ' ' ALA . 11.6 p -94.99 164.66 12.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.429 1.109 . . . . 0.0 113.494 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -127.75 164.48 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 177.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.45 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.27 -146.6 50.46 Favored Glycine 0 C--N 1.313 -0.7 0 C-N-CA 117.728 -2.177 . . . . 0.0 111.1 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.645 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 46.29 -140.23 6.38 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 114.327 0.491 . . . . 0.0 114.327 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.22 17.24 0.35 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 p -77.4 -37.66 51.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.13 0.491 . . . . 0.0 111.099 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.31 16.43 34.87 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.519 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.2 47.19 1.17 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.182 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -101.34 140.32 21.17 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.474 0.178 . . . . 0.0 110.722 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 3' ' ' MET . 37.9 Cg_exo -59.44 136.22 70.2 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.762 2.308 . . . . 0.0 112.777 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 7.2 m -67.95 128.2 35.65 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 90.1 t -95.25 112.94 28.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.643 0.259 . . . . 0.0 110.654 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.533 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 70.0 m-85 -111.51 139.96 22.61 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.264 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.2 134.51 21.51 Favored 'Cis proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.321 -1.533 . . . . 0.0 111.93 -0.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.548 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 45.8 p90 -103.59 133.57 48.4 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.93 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 76.3 m -96.53 121.32 38.21 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.349 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.755 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 45.4 t80 -115.64 130.33 56.82 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.12 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.662 HD13 ' CD1' ' A' ' 21' ' ' PHE . 6.7 mp 44.64 33.44 0.94 Allowed 'General case' 0 N--CA 1.436 -1.133 0 O-C-N 124.363 1.039 . . . . 0.0 113.685 175.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.77 -15.9 40.55 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 115.696 1.038 . . . . 0.0 115.696 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 20' ' ' THR . 62.8 m-80 -110.68 146.72 35.74 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 119.267 1.533 . . . . 0.0 112.299 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -86.76 122.17 30.27 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.755 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 28.6 m-85 -107.21 116.77 32.52 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.69 0.757 . . . . 0.0 110.63 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -92.88 -17.04 24.53 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.275 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 p -129.6 -178.12 4.55 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.28 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 81.8 m -66.6 165.23 15.11 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.706 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.421 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 9.2 t -140.4 167.64 21.66 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.314 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.485 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 12.6 p -122.03 19.65 10.8 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.86 139.66 58.34 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 113.661 -1.609 . . . . 0.0 111.263 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.95 -2.83 54.01 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.369 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.63 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.9 mtp85 -116.36 139.73 50.1 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 117.105 0.452 . . . . 0.0 110.667 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.4 m -120.12 22.35 11.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.351 0.596 . . . . 0.0 110.537 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.32 -79.84 0.53 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.006 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.5 -29.16 0.08 OUTLIER Glycine 0 C--N 1.314 -0.694 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.765 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.636 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -62.81 119.69 9.83 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.691 0.281 . . . . 0.0 111.385 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.485 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 54.4 mtt -87.91 149.66 23.95 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.633 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.4 p-90 -131.87 -166.36 1.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.13 0.49 . . . . 0.0 111.577 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 28.1 p -156.9 148.99 22.91 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.492 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -84.98 148.91 25.95 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 119.455 -0.898 . . . . 0.0 108.939 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.8 p -102.2 12.9 36.0 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.448 0.642 . . . . 0.0 110.433 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.425 HG21 ' CB ' ' A' ' 50' ' ' ASP . 76.3 p -135.89 153.97 51.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.982 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.5 85.27 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.189 0.518 . . . . 0.0 110.942 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -114.49 108.32 16.71 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 1.019 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 27.4 t80 -73.89 -35.65 64.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.009 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -48.47 -33.99 10.35 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -90.88 -64.18 1.17 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.709 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 19.8 m-20 -69.01 -34.27 74.98 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 9.3 mtm180 50.26 45.21 26.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.709 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 34.3 mttt -111.45 119.8 40.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 1.019 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 6.9 p-90 -132.17 173.17 11.52 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -175.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.645 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.26 144.11 8.77 Favored Glycine 0 C--O 1.22 -0.731 0 CA-C-N 113.732 -1.576 . . . . 0.0 110.284 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 14.8 m-30 -57.03 155.19 8.55 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.414 0.626 . . . . 0.0 112.099 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.572 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 16.6 t -69.65 143.7 92.98 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.295 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.572 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 87.3 Cg_endo -71.88 -149.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.938 2.425 . . . . 0.0 112.58 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -61.53 116.31 4.61 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.612 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -98.3 29.25 3.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.01 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.845 0 CA-C-O 118.339 -1.256 . . . . 0.0 112.019 179.728 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.487 0.184 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -86.71 130.68 34.38 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.1 ptp -81.91 72.49 8.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.181 0.515 . . . . 0.0 111.097 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.3 m -72.22 161.34 31.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.81 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.0 p -101.73 172.07 7.17 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.727 0.775 . . . . 0.0 112.244 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.738 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -113.15 -168.04 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.04 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.451 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.45 -126.28 1.28 Allowed Glycine 0 N--CA 1.46 0.274 0 O-C-N 123.955 0.784 . . . . 0.0 113.04 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.7 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 38.59 -142.94 0.33 Allowed Glycine 0 C--N 1.331 0.3 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.464 ' H ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -147.22 4.98 0.83 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.784 -0.708 . . . . 0.0 110.333 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.562 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 4.6 m -94.88 -58.12 2.25 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.801 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.16 -81.84 1.4 Allowed Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.613 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.43 -19.35 76.09 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.175 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -80.86 138.77 49.98 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.98 0.419 . . . . 0.0 110.903 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -88.55 170.17 5.57 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.183 2.589 . . . . 0.0 112.188 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.4 m -76.07 140.54 41.93 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 84.1 t -106.65 108.6 25.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.532 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 50.9 m-85 -109.66 141.32 23.41 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-O 120.831 0.348 . . . . 0.0 111.411 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.615 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 3.8 Cg_endo -85.7 134.05 17.64 Favored 'Cis proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.254 -1.561 . . . . 0.0 111.718 -0.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.532 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 43.9 p90 -102.81 -171.17 1.91 Allowed 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.356 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 96.6 m -145.56 119.17 9.13 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.242 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.623 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 72.4 t80 -109.46 131.16 55.33 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.615 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.8 mm? 35.63 44.06 0.19 Allowed 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 124.511 1.132 . . . . 0.0 113.859 175.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.2 -10.81 63.69 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 114.581 -1.191 . . . . 0.0 116.038 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.504 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 52.5 m-80 -113.23 134.01 54.8 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.887 1.843 . . . . 0.0 111.951 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -78.1 122.93 26.25 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.368 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.623 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 17.3 m-30 -110.89 118.23 35.54 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.749 0.785 . . . . 0.0 110.912 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 47.9 mt-10 -96.93 -12.81 22.93 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.356 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 p -132.69 -175.12 3.66 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 89.5 m -64.66 171.72 3.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.248 0.547 . . . . 0.0 110.052 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.4 t -151.11 173.13 14.74 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.849 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 p -133.24 24.65 4.17 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.407 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -60.53 137.48 58.16 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 113.172 -1.831 . . . . 0.0 111.786 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.87 -2.68 31.98 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.234 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.606 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.4 mtp85 -112.04 -78.59 0.58 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.762 0.315 . . . . 0.0 111.417 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.2 m 65.54 22.05 11.77 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.966 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.49 -35.54 9.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.49 0.662 . . . . 0.0 110.22 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.9 -42.41 0.92 Allowed Glycine 0 C--N 1.313 -0.741 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.771 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.606 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 44.2 mttp -65.54 106.75 1.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.503 0.192 . . . . 0.0 110.688 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.3 mtm -83.93 146.77 27.86 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.636 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 21.3 p-90 -136.97 -168.1 2.21 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.336 0.589 . . . . 0.0 111.675 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 24.5 p -160.17 156.09 26.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.075 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -84.17 145.81 28.18 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.556 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.8 p -102.07 11.12 38.9 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.494 0.664 . . . . 0.0 110.291 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 p -133.33 152.0 51.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.389 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.91 82.24 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.828 0.347 . . . . 0.0 111.415 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -120.58 109.77 15.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.999 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 28.6 t80 -70.81 -37.25 73.23 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.737 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.42 -35.48 60.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.418 . . . . 0.0 111.609 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -76.12 -69.39 0.5 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -85.74 -18.05 34.13 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 23.0 mtm180 44.57 52.34 7.65 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -113.95 122.18 46.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.999 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 7.8 p-90 -129.76 173.13 10.93 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.486 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.4 140.72 6.43 Favored Glycine 0 C--O 1.223 -0.583 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.871 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.738 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.2 m-30 -63.09 158.13 20.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.364 0.582 . . . . 0.0 111.852 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 68.5 m -95.49 130.94 30.67 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.003 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -78.52 9.37 3.21 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 C-N-CA 123.089 2.526 . . . . 0.0 114.975 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -124.78 85.41 2.41 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.394 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -79.37 157.42 27.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.077 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.578 -1.123 . . . . 0.0 112.441 179.886 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.77 0.319 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -121.97 -15.04 7.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.357 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -123.07 20.57 9.89 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.9 t 46.36 -150.64 0.09 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.509 0.671 . . . . 0.0 111.763 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.8 p -114.53 170.41 8.33 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.039 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -114.21 -165.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 176.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.57 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.27 -125.49 1.16 Allowed Glycine 0 C--N 1.319 -0.385 0 O-C-N 124.173 0.92 . . . . 0.0 113.569 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.703 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 38.15 -141.19 0.42 Allowed Glycine 0 C--N 1.333 0.387 0 N-CA-C 115.754 1.062 . . . . 0.0 115.754 177.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.24 -21.22 0.34 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.74 -0.73 . . . . 0.0 109.781 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 5.8 m -57.48 -43.69 84.3 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.805 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.73 -80.72 1.3 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.968 -0.634 . . . . 0.0 114.028 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.21 40.98 2.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.369 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -128.83 139.54 35.94 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 117.224 0.512 . . . . 0.0 110.805 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 61.2 Cg_endo -84.72 170.41 10.15 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.951 2.434 . . . . 0.0 111.942 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.5 m -79.9 138.57 37.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.509 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.0 t -100.68 109.79 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 19.2 m-30 -112.9 139.59 23.08 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.607 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.632 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.1 Cg_endo -86.72 136.79 18.58 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.097 -1.626 . . . . 0.0 112.373 -0.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 40.7 p90 -99.27 -171.58 2.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.172 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 32.2 m -142.94 127.94 18.46 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.156 0.503 . . . . 0.0 111.515 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.672 ' CE2' ' HZ2' ' A' ' 40' ' ' TRP . 1.4 t80 -133.87 140.7 47.01 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.335 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.674 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 39.46 33.92 0.12 Allowed 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 125.12 1.368 . . . . 0.0 114.103 178.023 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.94 -11.43 60.66 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.625 -0.798 . . . . 0.0 114.975 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' THR . 68.3 m-80 -109.47 154.81 22.13 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 118.513 1.156 . . . . 0.0 111.976 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.545 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.7 OUTLIER -94.31 126.04 39.32 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.614 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 20.9 m-85 -110.88 110.67 21.37 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.724 0.773 . . . . 0.0 111.213 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.632 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 54.1 mt-10 -90.43 -10.26 44.44 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.824 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 p -136.84 -170.8 2.78 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.5 m -70.2 167.12 18.56 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.802 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.44 ' HB ' ' CD2' ' A' ' 26' ' ' TYR . 9.4 t -144.35 169.03 18.7 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.768 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.417 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 19.6 p -124.41 17.12 8.98 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.603 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -60.23 142.4 54.57 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 113.736 -1.574 . . . . 0.0 111.588 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.0 -5.73 12.32 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.642 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.477 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 25.2 mtp85 -106.7 -72.92 0.7 Allowed 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 122.654 -0.321 . . . . 0.0 110.987 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m 60.87 24.59 14.57 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.313 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.54 -33.5 8.08 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.164 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.23 -61.45 0.4 Allowed Glycine 0 C--N 1.313 -0.712 0 CA-C-N 115.028 -0.987 . . . . 0.0 113.04 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.565 ' H ' ' CD ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -58.84 134.66 57.09 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.113 0.482 . . . . 0.0 112.043 -179.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.417 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 71.3 mtp -100.15 150.72 22.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.672 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.0 p-90 -135.3 -170.28 2.56 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.913 0.387 . . . . 0.0 111.303 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 20.5 p -155.68 141.58 18.13 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.439 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -76.42 145.81 39.08 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.976 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.9 p -99.33 10.47 41.35 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.377 0.608 . . . . 0.0 109.91 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.468 HG21 ' HB2' ' A' ' 50' ' ' ASP . 32.6 p -128.13 153.51 46.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.053 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.24 -38.66 77.31 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.089 0.471 . . . . 0.0 110.452 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -123.99 111.35 15.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.766 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 59.4 t80 -70.13 -40.67 74.71 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.71 -30.64 70.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.089 0.471 . . . . 0.0 111.768 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -61.13 1.9 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.751 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HB2' HG21 ' A' ' 44' ' ' THR . 68.0 m-20 -95.81 -23.85 16.74 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 5.7 mtm180 53.7 52.05 13.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -117.84 119.09 33.81 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.766 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.2 p-90 -129.84 174.28 9.88 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -175.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.405 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.38 141.41 7.19 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 113.93 -1.487 . . . . 0.0 110.024 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.726 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 4.7 m-30 -60.28 157.8 12.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.898 0.849 . . . . 0.0 111.668 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.661 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 2.1 t -64.75 150.55 94.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.661 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 60.8 Cg_endo -63.65 -146.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.476 0.468 0 C-N-CA 122.932 2.421 . . . . 0.0 114.218 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.504 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 5.7 t0 -48.64 110.9 0.39 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.921 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 74.8 mt-30 -124.19 158.91 31.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.236 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.746 0 CA-C-O 118.368 -1.24 . . . . 0.0 111.513 179.598 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.788 0.328 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -106.39 60.14 0.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.058 0.456 . . . . 0.0 110.4 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.405 ' O ' ' HB3' ' A' ' 14' ' ' PRO . 22.6 ptp -83.23 -164.54 0.9 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.246 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -107.63 164.37 12.28 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.412 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 p -111.86 171.98 7.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.722 0.772 . . . . 0.0 112.661 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.717 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -117.89 -167.26 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.044 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.45 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 36.78 -121.7 0.75 Allowed Glycine 0 N--CA 1.46 0.289 0 O-C-N 124.13 0.894 . . . . 0.0 113.248 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.666 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 30.21 -135.11 0.08 OUTLIER Glycine 0 C--N 1.337 0.632 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -161.8 34.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.815 -0.692 . . . . 0.0 110.422 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.511 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -99.36 -36.81 9.47 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.353 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.55 -68.69 2.6 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.13 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -137.02 5.43 3.62 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.827 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 10' ' ' SER . . . -73.09 147.6 88.33 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.707 0.253 . . . . 0.0 110.574 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.405 ' HB3' ' O ' ' A' ' 3' ' ' MET . 83.7 Cg_endo -86.53 171.74 7.21 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.898 2.399 . . . . 0.0 112.416 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 78.7 m -95.67 112.24 24.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 46.1 t -73.59 115.34 14.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.87 0.367 . . . . 0.0 111.544 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -113.03 141.18 25.16 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 120.91 0.386 . . . . 0.0 110.572 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -85.68 139.87 26.72 Favored 'Cis proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.386 -1.922 . . . . 0.0 111.707 -0.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 40.3 p90 -103.81 -174.32 2.52 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.147 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 94.3 m -142.67 120.03 11.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.865 0.364 . . . . 0.0 110.286 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.875 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 66.3 t80 -115.97 135.09 54.3 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.587 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 34.68 47.18 0.22 Allowed 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 124.589 1.18 . . . . 0.0 114.01 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.32 -7.74 80.03 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 116.546 1.378 . . . . 0.0 116.546 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' THR . 54.4 m-80 -112.79 143.14 44.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.567 1.684 . . . . 0.0 111.823 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -86.81 129.38 34.9 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.875 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 88.0 m-85 -116.75 118.22 31.93 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.394 0.616 . . . . 0.0 111.089 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -94.28 -16.62 23.42 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.845 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.7 p -130.67 -177.59 4.42 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.485 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 77.8 m -66.91 161.93 22.96 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -138.28 167.83 21.03 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.12 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.671 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 11.0 p -121.22 20.16 11.4 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -60.88 134.47 57.12 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 113.751 -1.568 . . . . 0.0 111.779 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.83 -5.71 37.77 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.136 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 20.4 mtp85 -110.44 -81.33 0.58 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.797 0.332 . . . . 0.0 111.282 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 68.6 m 57.84 29.44 17.51 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.829 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -103.05 -42.78 5.68 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.901 0.858 . . . . 0.0 109.732 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 168.95 -55.57 0.21 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 114.167 -1.379 . . . . 0.0 112.337 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.487 ' H ' ' CD ' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -71.79 130.69 41.71 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.147 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.671 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.2 mpt? -95.69 154.65 17.11 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.652 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.6 p-90 -139.88 -163.21 1.46 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.1 0.476 . . . . 0.0 111.144 -178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p -169.45 155.98 6.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.264 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 15' ' ' CYS . . . -79.61 152.86 29.8 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 120.911 0.386 . . . . 0.0 111.464 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.1 p -102.12 6.87 41.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.95 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.7 p -130.73 150.66 51.81 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.295 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.02 -35.44 71.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.969 0.414 . . . . 0.0 110.986 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -124.47 109.99 13.95 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 1.007 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 30.6 t80 -75.38 -34.84 61.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.345 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -52.26 -32.87 39.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.885 0.374 . . . . 0.0 111.324 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -83.17 -58.54 2.8 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.837 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 56.2 m-20 -91.31 -19.8 22.57 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 3.2 mtm105 46.57 43.72 12.69 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.837 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 22.2 mtpt -110.57 124.0 51.02 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 1.007 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 7.8 p-90 -131.58 172.66 11.97 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.566 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.65 145.78 11.3 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 113.646 -1.616 . . . . 0.0 110.255 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.717 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 7.0 m-30 -66.62 160.56 25.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.465 0.65 . . . . 0.0 112.318 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.68 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 8.8 t -84.59 149.88 55.39 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.68 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 89.9 Cg_endo -70.4 -150.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.282 1.988 . . . . 0.0 113.418 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.417 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 2.1 m-20 -56.65 134.94 55.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.073 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -80.38 95.5 6.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.484 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.616 0 CA-C-O 118.746 -1.03 . . . . 0.0 111.953 179.639 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.752 0.311 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -82.46 87.09 6.66 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.4 mtp -104.56 96.74 6.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.337 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 t 63.71 -159.88 0.3 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.05 0.453 . . . . 0.0 110.057 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -109.6 -176.64 3.07 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.723 0.773 . . . . 0.0 111.832 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -132.0 161.73 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 177.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.768 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.73 -154.33 46.15 Favored Glycine 0 C--N 1.309 -0.921 0 C-N-CA 118.068 -2.015 . . . . 0.0 111.544 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.614 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 48.94 -150.42 3.82 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 115.45 0.94 . . . . 0.0 115.45 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -153.16 31.93 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.835 -0.682 . . . . 0.0 109.625 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.837 ' HB3' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -55.69 -51.23 67.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.005 -178.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.02 45.24 6.37 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.46 62.54 1.7 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.14 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.4 144.38 17.39 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.824 0.312 . . . . 0.0 110.933 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -85.61 -177.21 2.53 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.834 2.356 . . . . 0.0 111.308 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.9 m -87.75 122.42 31.39 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.241 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 74.6 t -85.06 110.16 18.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.733 0.301 . . . . 0.0 110.329 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -116.26 138.55 24.36 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-O 120.95 0.405 . . . . 0.0 111.013 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.652 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 6.4 Cg_endo -86.47 137.85 20.67 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.136 -1.61 . . . . 0.0 112.002 -0.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.55 ' CG ' ' HB3' ' A' ' 42' ' ' ALA . 47.1 p90 -103.09 -169.66 1.68 Allowed 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.9 m -144.31 128.93 18.15 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.947 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.738 ' CG ' HD22 ' A' ' 22' ' ' LEU . 1.1 t80 -132.49 142.3 49.16 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.738 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 41.12 35.81 0.41 Allowed 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 124.557 1.143 . . . . 0.0 112.812 178.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.13 -6.6 83.31 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 115.01 0.764 . . . . 0.0 115.01 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.518 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.1 m-80 -107.07 136.87 46.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.508 1.154 . . . . 0.0 111.638 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -78.03 123.09 26.42 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.723 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 14.8 m-30 -107.03 112.17 24.99 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.805 0.812 . . . . 0.0 110.884 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.652 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 45.6 mt-10 -91.54 -18.0 24.78 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.366 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 p -129.89 -174.17 3.24 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 80.8 m -62.92 166.66 5.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.54 0.686 . . . . 0.0 110.36 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -147.65 169.5 19.52 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.32 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.586 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 55.1 p -128.55 17.7 6.39 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.644 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -59.79 138.25 57.83 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 113.96 -1.473 . . . . 0.0 111.086 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.06 -9.31 26.15 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.289 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.605 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.7 mtp85 -111.2 -39.91 4.6 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 51.1 m 78.53 -59.5 0.42 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -175.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.0 -106.13 0.32 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 175.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.501 ' O ' ' NE ' ' A' ' 34' ' ' ARG . . . 27.54 47.09 0.05 OUTLIER Glycine 0 C--O 1.209 -1.426 0 O-C-N 124.43 1.081 . . . . 0.0 114.646 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.718 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 24.7 mmmt 66.67 145.64 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 125.402 1.481 . . . . 0.0 113.728 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.586 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 60.8 mtt -81.8 149.5 28.34 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.616 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 21.6 p-90 -136.61 -172.76 3.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.563 0.697 . . . . 0.0 112.297 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 25.0 p -151.05 140.46 21.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.739 -1.118 . . . . 0.0 108.693 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.55 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -75.61 151.24 37.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.347 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.837 HG21 ' HB3' ' A' ' 10' ' ' SER . 65.1 p -108.04 14.81 24.86 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.798 0.808 . . . . 0.0 110.199 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.0 p -137.23 150.05 47.58 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.94 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.23 -42.25 76.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.879 0.371 . . . . 0.0 111.205 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -118.09 106.24 12.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.744 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 75.8 t80 -74.44 -35.28 63.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.231 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -54.44 -39.51 67.44 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -84.08 -49.78 8.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -83.02 -34.09 26.36 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 4.3 mmm-85 55.19 44.46 27.69 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -111.53 118.36 35.53 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.744 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 11.5 p-90 -129.45 174.88 9.23 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -175.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.17 141.22 7.08 Favored Glycine 0 C--O 1.221 -0.683 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.107 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.768 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 6.1 m-85 -65.75 163.38 16.74 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 117.344 0.572 . . . . 0.0 111.989 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 63.1 m -101.3 153.99 37.48 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.755 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.458 ' HB2' ' H ' ' A' ' 58' ' ' ASP . 93.5 Cg_endo -71.12 -146.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.439 2.76 . . . . 0.0 113.767 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.458 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 38.2 t70 -49.25 121.51 5.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.118 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -63.98 108.82 1.6 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.032 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.531 -1.15 . . . . 0.0 111.873 179.852 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 62.48 -145.68 0.38 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -81.74 89.56 6.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.287 0.565 . . . . 0.0 109.887 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.606 ' HB3' ' O ' ' A' ' 11' ' ' GLY . 69.1 m -127.1 -170.32 2.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.147 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -122.59 177.79 5.28 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 121.665 0.745 . . . . 0.0 111.805 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -126.74 160.76 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 177.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.831 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 68.53 -144.78 42.87 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 117.887 -2.102 . . . . 0.0 111.612 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.633 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 43.12 -145.86 1.04 Allowed Glycine 0 C--N 1.331 0.275 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.73 -30.87 1.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.878 -0.661 . . . . 0.0 109.506 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 3.4 m -58.88 -58.7 7.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.579 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' A' ' 4' ' ' SER . . . 76.08 -74.87 1.59 Allowed Glycine 0 C--O 1.225 -0.447 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.519 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.42 27.93 6.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.055 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.495 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -122.96 144.62 43.54 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -84.63 160.99 12.47 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.744 2.296 . . . . 0.0 112.43 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 91.8 m -83.37 123.12 29.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.469 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.8 t -90.31 120.02 38.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.715 0.293 . . . . 0.0 110.922 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.599 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 58.6 m-85 -114.74 141.88 27.44 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.483 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.462 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.3 Cg_endo -86.49 132.75 14.61 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.308 -1.538 . . . . 0.0 112.14 -0.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.599 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 22.5 p90 -98.56 128.03 44.73 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.525 ' OG1' ' HD2' ' A' ' 25' ' ' LYS . 13.9 m -91.38 125.64 36.21 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.432 0.634 . . . . 0.0 112.148 -177.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.871 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -130.36 145.97 51.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.41 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.728 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.24 36.88 0.21 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 124.461 1.104 . . . . 0.0 113.099 178.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.27 -5.52 84.96 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.441 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 68.6 m-80 -110.29 135.7 50.63 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.587 1.194 . . . . 0.0 112.202 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.525 ' HD2' ' OG1' ' A' ' 20' ' ' THR . 25.1 mmmt -77.42 117.13 18.6 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.871 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.5 m-30 -101.77 104.4 15.19 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.02 0.914 . . . . 0.0 111.361 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 15.5 mt-10 -84.46 -17.42 39.2 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.215 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 p -129.06 -178.45 4.64 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.639 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.9 m -66.64 159.52 27.45 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.725 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.488 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.5 t -137.74 178.48 7.08 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.703 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.7 p -128.77 17.44 6.29 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.513 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -60.87 142.96 55.78 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.107 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.06 -5.26 19.79 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.536 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.625 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 12.2 mtp85 -100.66 155.67 17.75 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 117.33 0.565 . . . . 0.0 111.565 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 p -132.17 13.06 4.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.805 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -104.92 -79.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.178 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 176.81 -31.74 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.411 -0.9 . . . . 0.0 114.418 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.643 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 5.7 mptt -63.22 135.14 56.93 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 117.633 0.716 . . . . 0.0 112.344 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.0 mtp -89.86 156.82 18.21 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.632 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 18.6 p-90 -143.85 -172.06 3.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.417 0.627 . . . . 0.0 111.332 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.549 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.4 p -159.3 139.26 11.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.044 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . . . -72.01 155.48 40.28 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.372 0.606 . . . . 0.0 111.511 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.4 p -101.93 11.24 38.88 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.767 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.9 p -133.08 151.82 52.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.912 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.96 -32.57 67.97 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.163 0.506 . . . . 0.0 111.358 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -126.69 120.2 28.84 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.861 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 64.5 t80 -86.17 -31.42 21.8 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.325 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -61.13 -30.94 70.68 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.05 -45.23 8.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -100.32 -18.51 16.76 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.1 mtm105 43.5 51.28 6.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -114.82 119.39 36.45 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.861 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.2 p-90 -132.99 176.48 8.45 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -174.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -167.28 142.55 7.63 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 112.95 -1.932 . . . . 0.0 109.222 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.831 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 12.9 m-85 -60.76 157.37 14.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.407 0.622 . . . . 0.0 112.081 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.501 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.9 t -75.25 117.03 59.99 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.055 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.422 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 6.4 Cg_endo -87.62 -162.36 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.718 2.279 . . . . 0.0 112.406 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 t0 29.18 66.71 0.1 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.061 1.345 . . . . 0.0 113.405 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 54.2 mt-30 -122.88 -68.82 0.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.051 0.453 . . . . 0.0 110.058 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.762 0 CA-C-O 118.599 -1.112 . . . . 0.0 111.401 -179.722 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.66 0.266 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.457 ' HA ' ' CE3' ' A' ' 2' ' ' TRP . 3.9 t-105 -76.54 -88.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.116 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.9 mmt -102.77 164.1 11.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.728 0.299 . . . . 0.0 110.934 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.6 m -101.5 -171.14 1.93 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -82.08 154.74 25.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.987 0.899 . . . . 0.0 112.742 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -132.75 163.91 36.58 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.032 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 178.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.533 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 65.16 -149.94 51.7 Favored Glycine 0 C--N 1.312 -0.782 0 C-N-CA 117.716 -2.183 . . . . 0.0 111.014 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.638 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 48.47 -150.51 3.34 Favored Glycine 0 C--N 1.332 0.326 0 N-CA-C 114.641 0.616 . . . . 0.0 114.641 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.491 ' H ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -130.36 -6.64 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.418 178.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 m -78.79 -51.49 9.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.44 72.03 0.64 Allowed Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.774 -0.648 . . . . 0.0 114.23 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.02 -42.69 1.29 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.835 -1.174 . . . . 0.0 113.196 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -66.11 135.3 95.06 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.809 0.338 . . . . 0.0 111.513 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 14.2 Cg_exo -65.51 154.31 74.29 Favored 'Trans proline' 0 C--N 1.334 -0.219 0 C-N-CA 122.896 2.397 . . . . 0.0 111.472 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.412 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 5.2 m -73.78 134.58 43.44 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.0 t -95.06 113.87 30.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.834 0.35 . . . . 0.0 110.426 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.614 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 47.4 m-85 -118.64 139.94 27.72 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.538 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.754 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 35.9 Cg_endo -87.06 136.12 17.05 Favored 'Cis proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.51 -1.871 . . . . 0.0 112.379 -0.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.614 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 34.3 p90 -101.93 -168.02 1.49 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 76.0 m -149.47 126.28 11.12 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.433 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.822 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 36.8 t80 -123.03 131.64 53.79 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.988 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.683 HD22 ' CE2' ' A' ' 21' ' ' PHE . 6.7 mp 41.76 33.56 0.34 Allowed 'General case' 0 N--CA 1.439 -0.991 0 O-C-N 124.531 1.144 . . . . 0.0 113.502 174.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.68 -18.16 32.41 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 115.422 0.929 . . . . 0.0 115.422 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.475 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 43.8 m-80 -112.6 132.01 55.34 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.888 1.344 . . . . 0.0 112.181 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 46.5 mtpt -78.17 127.03 31.67 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.822 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.4 m-85 -111.91 121.2 44.38 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.683 0.754 . . . . 0.0 111.223 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.754 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 99.1 mt-10 -94.87 -14.67 24.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.224 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.3 p -130.08 -175.37 3.6 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.63 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.7 m -67.1 166.29 14.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.774 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.3 t -146.15 165.36 29.38 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.098 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 p -121.53 23.8 10.13 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -66.04 139.73 58.22 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.022 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.65 -6.45 17.79 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.612 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.482 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.9 mtp85 -100.84 -78.67 0.52 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 117.401 0.601 . . . . 0.0 111.211 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 m 66.13 14.81 9.82 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.718 0.636 . . . . 0.0 109.957 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.48 -34.03 12.22 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.196 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.65 -65.73 0.31 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.224 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.836 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 1.5 mppt? -61.92 149.7 39.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.0 mtm -104.61 159.07 16.05 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.722 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.584 ' HA ' ' N ' ' A' ' 56' ' ' CYS . 13.9 p-90 -142.5 -165.7 2.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.369 0.604 . . . . 0.0 111.94 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.3 p -161.04 152.79 19.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.672 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.401 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -86.85 148.53 25.33 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.401 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.3 p -103.12 8.02 38.71 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.536 0.684 . . . . 0.0 109.877 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.9 p -130.07 152.63 49.31 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.663 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.73 -47.74 81.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.756 0.313 . . . . 0.0 111.518 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -115.4 104.61 11.94 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.96 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 43.4 t80 -69.28 -37.6 77.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.792 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -53.0 -28.82 25.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.96 0.41 . . . . 0.0 111.762 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -87.48 -70.6 0.61 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.59 -21.18 55.94 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.63 ' HB3' ' NH1' ' A' ' 51' ' ' ARG . 0.9 OUTLIER 46.98 50.77 13.53 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 179.166 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -114.13 118.37 33.83 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.96 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.8 p-90 -129.85 171.21 12.96 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -174.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.638 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.61 142.64 7.83 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 113.122 -1.854 . . . . 0.0 109.502 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 13.7 m-30 -55.15 155.65 4.63 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 117.043 0.422 . . . . 0.0 111.249 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.584 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.7 t -53.87 137.71 54.77 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.577 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' SG ' ' A' ' 15' ' ' CYS . 74.8 Cg_endo -69.77 4.97 1.89 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.029 2.486 . . . . 0.0 113.384 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -141.52 78.3 1.63 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.024 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 56' ' ' CYS . 15.6 mm100 -94.2 -44.86 7.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.956 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.293 -1.282 . . . . 0.0 111.379 -179.899 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.2 m . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 121.041 0.448 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.485 ' HE3' ' HG3' ' A' ' 14' ' ' PRO . 7.5 m0 -114.59 -109.51 0.36 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.6 mtt -90.23 163.27 14.85 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.9 m -123.92 162.04 24.16 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.995 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -120.77 161.64 21.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.35 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.71 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -116.5 -164.96 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 177.059 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.545 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.64 -125.51 1.31 Allowed Glycine 0 N--CA 1.463 0.47 0 O-C-N 123.814 0.696 . . . . 0.0 113.307 177.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.649 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 30.55 -136.4 0.07 OUTLIER Glycine 0 C--N 1.338 0.693 0 N-CA-C 116.049 1.179 . . . . 0.0 116.049 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.464 HD22 ' N ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -158.75 31.61 0.22 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.729 -0.736 . . . . 0.0 110.083 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.38 -45.66 9.31 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.516 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.19 -75.92 1.17 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.676 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.39 18.84 4.36 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.782 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.17 143.13 36.59 Favored Pre-proline 0 C--N 1.328 -0.339 0 O-C-N 122.665 -0.315 . . . . 0.0 110.598 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.485 ' HG3' ' HE3' ' A' ' 2' ' ' TRP . 71.8 Cg_endo -86.12 166.52 9.62 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.62 2.213 . . . . 0.0 112.254 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.7 m -81.08 133.92 35.56 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.531 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 82.9 t -96.48 115.76 36.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.742 0.306 . . . . 0.0 110.29 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -118.15 139.54 26.81 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.314 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.683 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 6.0 Cg_endo -85.64 136.12 20.61 Favored 'Cis proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.288 -1.547 . . . . 0.0 111.571 -0.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.649 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 43.8 p90 -104.1 -170.04 1.71 Allowed 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.364 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.7 m -148.18 126.86 12.53 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.094 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.831 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 67.9 t80 -117.95 132.73 56.37 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.599 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.614 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.8 mm? 33.28 45.45 0.08 Allowed 'General case' 0 N--CA 1.432 -1.332 0 O-C-N 124.792 1.308 . . . . 0.0 114.034 174.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.77 -19.01 51.61 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.452 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 32.4 m-80 -111.86 133.67 53.91 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.787 1.794 . . . . 0.0 112.418 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 11.4 mtmt -75.59 127.11 32.37 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.361 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.831 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.9 m-85 -115.97 109.7 17.93 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 122.244 1.021 . . . . 0.0 110.384 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.683 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 24.4 mt-10 -87.81 -10.47 50.8 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.498 -1.683 . . . . 0.0 110.648 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.5 p -133.15 -168.2 2.05 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.6 m -74.52 167.63 21.34 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.4 t -146.71 169.97 17.94 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.309 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.427 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 11.8 p -122.32 20.15 10.52 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.12 140.55 56.83 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.233 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.4 -1.07 45.16 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.51 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.659 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.6 mtp85 -108.04 -64.71 1.19 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.944 0.372 . . . . 0.0 111.076 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.4 t 66.67 15.78 10.21 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.357 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.72 -84.32 0.45 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.036 0.446 . . . . 0.0 110.548 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.62 -46.83 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.244 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.75 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 2.9 mppt? -63.56 122.18 15.68 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 120.939 0.399 . . . . 0.0 111.259 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.427 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 47.1 mtt -91.18 151.06 21.1 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.651 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.6 p-90 -130.08 -167.07 1.76 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.187 0.518 . . . . 0.0 111.533 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 10.6 p -159.72 143.97 14.81 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.505 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -76.11 149.72 37.35 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 59.8 p -104.74 13.86 30.67 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.677 0.751 . . . . 0.0 109.788 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.8 p -139.33 154.98 47.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.835 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.85 -48.01 83.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.772 0.32 . . . . 0.0 111.325 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -114.49 106.68 14.57 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 1.063 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 20.3 t80 -75.81 -34.39 60.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.196 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.13 -39.81 21.68 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.92 -35.71 11.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -89.82 -30.86 17.66 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.534 ' HB3' HH11 ' A' ' 51' ' ' ARG . 0.3 OUTLIER 48.62 47.09 20.99 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -117.77 118.07 31.06 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 1.063 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 10.2 p-90 -132.57 173.7 11.05 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -175.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.56 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.7 147.22 11.39 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 113.437 -1.711 . . . . 0.0 109.571 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.71 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 11.5 m-30 -61.04 155.71 19.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.752 0.776 . . . . 0.0 111.592 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.585 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 11.3 t -63.66 144.88 97.77 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.639 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.585 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 62.0 Cg_endo -65.63 2.59 1.52 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.164 2.576 . . . . 0.0 114.413 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -121.22 97.01 5.32 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.275 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -99.68 47.63 0.95 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.237 0.541 . . . . 0.0 110.611 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.92 0 CA-C-O 118.543 -1.143 . . . . 0.0 112.146 179.755 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.0 m . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.98 0.419 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -97.55 125.43 42.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.855 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.0 tpt -67.76 115.26 7.12 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.5 m -82.0 -161.94 0.5 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.762 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p -68.79 170.3 9.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.843 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.535 HG13 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -124.57 -50.1 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-O 123.194 1.473 . . . . 0.0 109.716 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.759 ' H ' ' HB2' ' A' ' 55' ' ' PHE . . . -83.38 -162.29 32.75 Favored Glycine 0 C--N 1.278 -2.692 0 CA-C-N 111.054 -2.794 . . . . 0.0 111.85 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 53' ' ' TRP . . . 75.62 -157.89 49.67 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.693 -0.765 . . . . 0.0 114.419 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.03 -29.84 6.55 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 m -52.15 -47.26 65.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.761 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.68 -86.83 1.52 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.493 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.06 43.55 1.68 Allowed Glycine 0 C--N 1.329 0.158 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.913 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.487 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -113.33 145.13 32.61 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 120.857 0.361 . . . . 0.0 110.807 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 3.1 Cg_exo -78.45 154.54 27.86 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.894 2.396 . . . . 0.0 112.008 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.8 m -76.99 141.75 40.26 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.0 t -109.39 92.11 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.726 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.696 ' CE1' ' HE1' ' A' ' 19' ' ' PHE . 6.5 m-85 -94.32 143.98 27.25 Favored Pre-proline 0 N--CA 1.447 -0.624 0 CA-C-O 121.657 0.741 . . . . 0.0 111.331 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.3 Cg_endo -84.14 129.91 14.73 Favored 'Cis proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.402 -1.916 . . . . 0.0 111.964 -0.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.696 ' HE1' ' CE1' ' A' ' 17' ' ' PHE . 2.0 p90 -86.7 -163.68 0.94 Allowed 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.5 m -149.19 121.75 8.56 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.992 ' HB3' HD22 ' A' ' 22' ' ' LEU 0.494 0.5 OUTLIER -104.09 -171.38 1.92 Allowed 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 119.264 3.061 . . . . 0.0 119.264 171.964 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.992 HD22 ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -52.93 45.6 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 110.086 -3.234 . . . . 0.0 113.684 -173.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.19 1.46 16.34 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.318 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.894 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 1.9 m-80 -138.67 136.57 36.0 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 118.572 1.186 . . . . 0.0 113.016 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.53 122.34 26.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 175.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.989 ' CE2' ' HB2' ' A' ' 21' ' ' PHE . 22.1 m-30 -95.42 98.35 10.49 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 122.39 1.09 . . . . 0.0 112.824 -175.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 16.4 mt-10 -78.21 -12.66 60.01 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.778 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.6 p -138.57 -179.84 6.04 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.4 m -64.6 163.28 13.97 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.503 -0.879 . . . . 0.0 109.209 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -143.92 170.27 16.22 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.599 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 61.2 p -122.77 15.63 10.16 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.439 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -64.52 147.89 51.85 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.001 -1.454 . . . . 0.0 111.336 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.94 -4.59 37.4 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.158 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.596 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 28.3 mtp85 -112.1 -64.7 1.26 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.751 0.31 . . . . 0.0 111.242 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.6 m 69.83 13.83 8.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.803 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.6 -83.75 0.34 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.145 0.498 . . . . 0.0 110.609 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.48 -35.27 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.394 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.773 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 7.1 mptt -69.8 119.96 14.82 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.732 0.301 . . . . 0.0 110.762 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.599 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 56.2 mtt -91.34 142.88 27.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.765 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 18.3 p-90 -122.93 -170.82 2.17 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.504 0.668 . . . . 0.0 110.979 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 8.3 p -157.56 134.49 10.08 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.0 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.516 ' HB3' ' CB ' ' A' ' 19' ' ' PHE . . . -72.49 149.43 44.14 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.011 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.5 p -101.99 13.74 33.93 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.538 0.685 . . . . 0.0 110.335 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.8 p -135.69 148.28 48.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.014 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -55.81 -36.64 67.66 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.894 0.378 . . . . 0.0 110.978 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -119.58 116.9 26.99 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.722 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 60.9 t80 -87.56 -43.78 11.75 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.343 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -42.94 -37.89 2.03 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -91.29 -67.88 0.83 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.451 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 2.2 m-20 -63.97 -26.13 68.44 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.9 mtm-85 44.33 52.62 7.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.451 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 25.7 mttm -116.94 115.64 25.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.722 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 16.6 p-90 -129.73 175.09 9.11 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.978 0.894 . . . . 0.0 112.758 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.488 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -164.8 142.6 7.87 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 113.617 -1.629 . . . . 0.0 109.191 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.759 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 4.3 m-30 -60.66 147.39 42.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.688 0.744 . . . . 0.0 111.0 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.442 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.6 t -57.62 133.7 82.42 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.192 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.413 ' HB2' ' H ' ' A' ' 58' ' ' ASP . 83.1 Cg_endo -73.61 -142.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.187 2.591 . . . . 0.0 112.571 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.413 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 50.6 t0 -63.1 104.59 0.59 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.057 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -79.97 101.52 8.69 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.77 0.319 . . . . 0.0 110.592 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.711 0 CA-C-O 118.619 -1.1 . . . . 0.0 111.761 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 120.677 0.275 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -83.99 153.26 23.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.161 0.505 . . . . 0.0 111.43 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 58.5 mtt -87.36 -177.21 5.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.724 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 t -77.49 175.59 9.68 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.263 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.3 p -100.64 173.27 6.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.019 0.914 . . . . 0.0 112.669 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -134.62 160.94 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.012 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.88 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 68.63 -147.54 47.02 Favored Glycine 0 C--N 1.309 -0.956 0 C-N-CA 117.487 -2.292 . . . . 0.0 111.612 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.649 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 47.25 -147.18 3.68 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 114.441 0.537 . . . . 0.0 114.441 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.82 17.61 2.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.823 0.344 . . . . 0.0 110.733 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 p -75.38 -67.45 0.66 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.56 -60.36 0.33 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.941 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.75 26.54 2.51 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.571 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.8 143.75 27.33 Favored Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 122.656 -0.32 . . . . 0.0 111.253 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -88.87 167.33 5.78 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.805 2.337 . . . . 0.0 111.932 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.7 m -76.56 141.08 41.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 88.1 t -111.4 115.1 48.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -116.43 144.16 32.58 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.935 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.629 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.7 Cg_endo -84.21 133.49 19.73 Favored 'Cis proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.485 -1.465 . . . . 0.0 111.285 -0.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.567 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 17.5 p90 -103.37 162.6 12.88 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.2 m -118.84 122.44 42.36 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.943 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.808 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 60.6 t80 -119.9 133.71 55.48 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.521 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.5 mm? 36.19 46.76 0.41 Allowed 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.5 -4.05 86.49 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 114.225 -1.352 . . . . 0.0 116.318 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 26' ' ' TYR . 40.2 m-80 -110.14 155.71 21.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.673 1.737 . . . . 0.0 111.571 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -94.65 131.33 40.56 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.157 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.808 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 88.9 m-85 -123.77 107.56 11.57 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.697 0.761 . . . . 0.0 112.041 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.629 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 93.6 mt-10 -93.39 -14.32 26.96 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.591 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.6 p -128.14 -177.06 3.99 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.605 -1.179 . . . . 0.0 108.158 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.6 m -67.08 168.91 9.28 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.284 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.6 t -143.99 169.17 18.33 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.184 0.516 . . . . 0.0 110.787 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.461 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 32.4 p -123.52 15.51 9.59 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.473 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -55.9 136.86 51.38 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.405 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.26 -18.59 3.36 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.147 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.7 mtp85 -96.25 -80.76 0.42 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.795 0.331 . . . . 0.0 110.519 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.7 m 62.42 16.16 8.38 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.943 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.37 -35.26 13.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.639 0.733 . . . . 0.0 109.569 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.52 -65.86 0.23 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.59 -1.186 . . . . 0.0 113.359 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.819 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 7.0 mptt -63.0 134.37 56.06 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.461 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.5 mpt? -96.41 152.62 18.43 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.6 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.6 p-90 -133.4 -166.08 1.72 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.326 0.584 . . . . 0.0 111.531 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 29.3 p -158.58 149.69 20.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.008 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.546 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -84.27 148.33 26.75 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.2 p -102.41 10.61 38.91 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.665 0.745 . . . . 0.0 110.32 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.2 p -133.56 151.31 51.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.924 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -55.78 -37.66 68.86 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.971 0.415 . . . . 0.0 111.077 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -125.51 112.44 16.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 1.033 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 30.6 t80 -73.95 -36.93 64.67 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.538 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -54.22 -35.08 62.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.148 0.499 . . . . 0.0 111.103 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.57 -71.42 0.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -81.47 -18.85 43.78 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 11.1 mtm180 45.2 55.65 6.17 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -119.49 120.86 38.03 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 1.033 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.7 p-90 -128.35 169.8 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.57 140.72 6.71 Favored Glycine 0 C--O 1.22 -0.78 0 CA-C-N 113.377 -1.738 . . . . 0.0 109.819 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.88 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.2 m-85 -58.93 154.41 15.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 117.59 0.695 . . . . 0.0 111.233 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.606 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 8.5 t -67.46 143.41 97.13 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.955 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.606 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 73.9 Cg_endo -67.39 -144.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.379 2.719 . . . . 0.0 113.313 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.489 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 39.0 t70 -48.03 106.62 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.871 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -83.85 135.13 34.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.503 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.76 0 CA-C-O 118.007 -1.44 . . . . 0.0 111.439 179.807 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.8 p . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.47 0.176 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 37.1 t90 65.01 105.63 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.792 0.682 . . . . 0.0 112.786 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.0 ptp -103.56 136.38 43.39 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -85.4 -178.46 6.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.191 0.52 . . . . 0.0 111.777 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -111.07 -178.53 3.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.776 0.798 . . . . 0.0 112.5 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -127.8 -168.24 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 177.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.479 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 35.84 -131.22 0.78 Allowed Glycine 0 CA--C 1.522 0.511 0 O-C-N 124.079 0.862 . . . . 0.0 113.496 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.676 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 40.31 -144.59 0.46 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 114.983 0.753 . . . . 0.0 114.983 177.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.37 -13.6 1.15 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.56 ' HB2' HG21 ' A' ' 43' ' ' THR . 0.9 OUTLIER -95.98 44.82 1.07 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.29 178.493 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -53.37 99.76 0.05 OUTLIER Glycine 0 C--N 1.333 0.381 0 O-C-N 123.668 0.605 . . . . 0.0 112.365 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.37 -29.6 3.62 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.312 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.36 145.91 69.24 Favored Pre-proline 0 CA--C 1.518 -0.27 0 CA-C-N 116.785 0.292 . . . . 0.0 110.25 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -81.74 154.36 17.76 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.118 1.879 . . . . 0.0 111.513 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.7 m -74.17 131.4 41.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.2 t -86.55 109.39 18.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.519 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 35.4 m-85 -116.59 139.31 25.33 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-O 120.749 0.309 . . . . 0.0 111.684 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.716 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 3.8 Cg_endo -86.22 134.78 17.5 Favored 'Cis proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.312 -1.537 . . . . 0.0 111.211 -1.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.519 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 43.5 p90 -96.95 -168.66 1.74 Allowed 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.437 178.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 73.9 m -144.43 122.98 12.45 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.002 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.741 ' CG ' HD22 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -125.0 142.94 51.16 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.741 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 40.91 27.94 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.758 1.223 . . . . 0.0 113.562 178.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.02 -7.02 62.35 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 114.819 0.688 . . . . 0.0 114.819 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 20' ' ' THR . 60.7 m-80 -105.5 149.33 26.31 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.512 1.156 . . . . 0.0 111.921 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -88.46 119.07 28.56 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.603 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 28.1 m-85 -104.64 112.52 25.63 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.72 0.772 . . . . 0.0 110.587 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.716 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 46.6 mt-10 -92.04 -17.75 24.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.475 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 p -129.62 -175.67 3.67 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 78.2 m -65.77 164.17 15.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.474 0.654 . . . . 0.0 110.613 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -142.34 167.71 21.47 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.867 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.706 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 27.9 p -121.95 18.57 10.93 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.554 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -64.48 139.17 58.74 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.718 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.81 -4.29 45.74 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.1 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.654 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.2 mtp85 -105.49 127.47 53.02 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 117.425 0.612 . . . . 0.0 110.844 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.0 m -96.5 5.95 49.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.784 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.72 -85.81 0.37 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 176.32 -31.58 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.317 -0.944 . . . . 0.0 114.387 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.782 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 8.8 mptt -57.04 115.89 2.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.583 0.692 . . . . 0.0 111.948 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.706 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 70.0 mtm -78.27 142.13 38.04 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.626 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.1 p-90 -128.75 -167.37 1.77 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.433 0.635 . . . . 0.0 112.04 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 17.7 p -152.7 141.86 21.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.918 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.99 148.56 38.01 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.178 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.56 HG21 ' HB2' ' A' ' 10' ' ' SER . 63.1 p -103.27 11.96 36.13 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.594 0.711 . . . . 0.0 109.712 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.3 p -137.62 153.3 49.91 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.762 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.56 -50.09 72.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 110.303 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -105.18 102.83 12.3 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.793 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 71.8 t80 -75.67 -34.31 60.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.936 -178.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.36 -38.91 55.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -85.55 -71.2 0.54 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.525 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 72.9 m-20 -63.54 -26.42 68.7 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 15.4 mtm180 44.2 52.09 7.18 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.525 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 42.8 mttt -116.35 118.93 34.1 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.793 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.7 p-90 -133.89 176.28 8.71 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.543 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.94 150.07 19.1 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.295 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.687 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.7 m-30 -65.44 162.02 18.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.96 0.88 . . . . 0.0 112.374 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.677 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 5.6 t -66.74 148.81 98.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.677 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 35.7 Cg_endo -58.7 -131.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 123.601 2.867 . . . . 0.0 114.348 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 8.4 t0 -50.85 109.46 0.32 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.352 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 78.3 mt-30 -123.43 172.16 8.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.366 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.64 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.08 -179.945 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.544 0.212 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -86.61 89.74 8.02 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 75.2 mtm -92.41 133.03 36.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.224 0.535 . . . . 0.0 111.807 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.9 m -128.16 173.07 10.42 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.958 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 p -110.58 172.73 6.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.849 0.833 . . . . 0.0 112.306 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.534 HG22 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -128.08 164.96 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 178.045 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.715 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 61.36 -149.97 44.95 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 118.229 -1.938 . . . . 0.0 111.51 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.573 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 49.79 -145.28 8.66 Favored Glycine 0 C--N 1.33 0.24 0 N-CA-C 114.169 0.428 . . . . 0.0 114.169 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.521 ' H ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -143.7 27.84 1.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.242 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.762 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 5.3 m -107.76 -65.47 1.11 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.317 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.77 -67.71 3.61 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.795 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.46 -13.55 58.28 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.305 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.762 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -84.99 138.67 37.03 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 117.092 0.446 . . . . 0.0 111.372 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 85.7 Cg_endo -90.3 169.44 4.11 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.4 2.733 . . . . 0.0 112.038 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.9 m -79.52 142.31 35.89 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.424 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.3 t -116.22 87.99 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.722 0.296 . . . . 0.0 111.318 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.543 ' CE1' ' HE1' ' A' ' 19' ' ' PHE . 8.8 m-85 -90.3 146.11 34.03 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-O 121.443 0.639 . . . . 0.0 111.082 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.67 132.26 18.69 Favored 'Cis proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.4 -1.917 . . . . 0.0 112.197 -0.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.591 ' CB ' ' HB3' ' A' ' 42' ' ' ALA . 0.4 OUTLIER -90.07 -168.19 2.05 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.2 m -151.13 124.06 8.66 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.983 ' HB2' ' CE2' ' A' ' 26' ' ' TYR 0.471 0.5 OUTLIER -96.5 -173.81 2.87 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 119.068 2.988 . . . . 0.0 119.068 171.698 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.964 HD22 ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -56.29 43.46 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 109.804 -3.362 . . . . 0.0 112.89 -173.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 21' ' ' PHE . . . 122.62 -0.48 10.19 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 114.083 -1.417 . . . . 0.0 113.014 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.849 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 1.8 m-80 -137.9 134.57 35.19 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 118.171 0.986 . . . . 0.0 112.256 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -83.65 127.86 34.09 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.983 ' CE2' ' HB2' ' A' ' 21' ' ' PHE . 6.4 m-85 -107.7 110.89 22.85 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 122.896 1.331 . . . . 0.0 113.249 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -86.27 -13.6 46.25 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 112.763 -2.017 . . . . 0.0 111.325 -178.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 p -135.57 -177.61 4.75 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.1 m -65.68 153.39 41.82 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.139 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -131.39 175.89 8.76 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.439 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 1.4 p -130.41 17.8 5.38 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.69 154.48 36.46 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.511 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.36 -2.36 15.37 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.877 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.622 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.3 mtp85 -115.89 -61.0 1.8 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.807 0.337 . . . . 0.0 111.094 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.7 m 70.9 13.35 7.06 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.031 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.98 -86.4 0.39 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.146 0.498 . . . . 0.0 110.822 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.79 -33.11 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.42 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.777 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 8.5 mptt -66.48 111.84 3.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.718 0.294 . . . . 0.0 110.291 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.439 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 80.7 mtp -84.89 149.98 25.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.038 0.447 . . . . 0.0 110.828 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.736 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 24.0 p-90 -131.15 -171.94 2.71 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.62 0.724 . . . . 0.0 111.242 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.491 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 25.6 p -156.12 137.6 14.03 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.273 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.591 ' HB3' ' CB ' ' A' ' 19' ' ' PHE . . . -76.34 144.67 40.01 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.594 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.3 p -98.17 17.2 19.1 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.669 0.747 . . . . 0.0 110.01 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.9 p -141.67 146.48 36.18 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.75 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -54.4 -32.35 56.99 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.266 0.354 . . . . 0.0 111.886 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -125.66 121.47 33.6 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 1.034 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 30.9 t80 -88.46 -43.53 11.39 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.26 -31.91 1.73 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -93.23 -63.91 1.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -73.19 -20.28 60.92 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.4 mtm-85 41.86 52.34 4.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -118.28 117.81 30.11 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 1.034 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 8.9 p-90 -130.81 174.26 10.14 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -175.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.438 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -169.3 136.84 4.23 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-N 113.673 -1.603 . . . . 0.0 110.578 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.736 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 10.8 m-30 -60.21 158.83 10.76 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.377 0.671 . . . . 0.0 112.189 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.5 m -100.86 162.84 19.37 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.349 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.44 ' HB2' ' H ' ' A' ' 58' ' ' ASP . 93.1 Cg_endo -71.46 -150.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.784 2.323 . . . . 0.0 113.625 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 42.6 t0 -44.44 110.32 0.21 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.366 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -81.92 -27.29 33.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.262 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.774 0 CA-C-O 118.493 -1.171 . . . . 0.0 112.736 179.938 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.651 ' HB3' ' OG ' ' A' ' 4' ' ' SER . 24.1 m . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.563 0.221 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -83.19 -68.92 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.0 110.27 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.9 ptp -94.2 90.84 6.5 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.333 0.587 . . . . 0.0 109.719 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.651 ' OG ' ' HB3' ' A' ' 1' ' ' SER . 70.5 m -124.27 -172.31 2.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.587 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -124.58 171.58 9.91 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.885 0.85 . . . . 0.0 111.845 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -126.39 162.93 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 177.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.763 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 67.03 -144.23 44.53 Favored Glycine 0 C--N 1.309 -0.919 0 C-N-CA 117.747 -2.168 . . . . 0.0 111.077 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.497 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 39.48 -138.08 1.14 Allowed Glycine 0 C--N 1.332 0.309 0 N-CA-C 114.888 0.715 . . . . 0.0 114.888 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.4 -26.7 0.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.465 -0.368 . . . . 0.0 111.664 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.482 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 2.5 m -57.17 -62.46 1.75 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.735 0.302 . . . . 0.0 110.426 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 4' ' ' SER . . . 89.84 -90.06 1.59 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.528 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.85 -11.43 78.19 Favored Glycine 0 CA--C 1.517 0.191 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.759 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -82.34 143.87 49.05 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 117.29 0.545 . . . . 0.0 111.33 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -89.27 161.82 5.64 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.902 2.401 . . . . 0.0 112.664 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 86.6 m -79.99 133.94 36.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.119 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.57 114.4 44.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.724 0.297 . . . . 0.0 111.254 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.458 ' CE2' ' HE1' ' A' ' 19' ' ' PHE . 90.6 m-85 -108.27 146.5 33.71 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-O 120.751 0.31 . . . . 0.0 110.639 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.21 131.63 16.93 Favored 'Cis proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.479 -1.467 . . . . 0.0 111.579 -0.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 23.9 p90 -101.22 126.65 47.97 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 86.2 m -89.85 124.77 34.97 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.386 0.612 . . . . 0.0 111.739 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.733 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.8 t80 -124.11 141.53 51.98 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.677 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.1 OUTLIER 40.64 32.26 0.14 Allowed 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 124.294 1.038 . . . . 0.0 113.03 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.26 -11.15 69.3 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 115.117 0.807 . . . . 0.0 115.117 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.528 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.5 m-80 -105.54 136.1 45.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 118.564 1.182 . . . . 0.0 112.027 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -78.82 120.45 23.46 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.733 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.9 m-30 -103.26 110.61 22.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.044 0.926 . . . . 0.0 111.181 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -88.98 -18.91 26.46 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.73 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -128.36 177.72 6.77 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.1 m -64.57 161.28 17.78 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.688 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.5 t -136.61 171.84 13.89 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.987 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.622 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 29.4 p -124.39 16.73 8.99 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.499 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.71 145.46 52.29 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.787 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.62 -16.74 29.19 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.618 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.608 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 3.6 mtp-105 -101.03 -166.75 1.34 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.671 0.735 . . . . 0.0 110.749 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 p -144.7 -24.68 0.51 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.17 -89.32 0.21 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.182 -1.007 . . . . 0.0 113.399 -178.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.45 -14.87 0.12 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 119.187 2.435 . . . . 0.0 119.187 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.608 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 10.5 mptt -69.82 152.42 44.59 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 121.756 2.778 . . . . 0.0 111.8 -178.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.622 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 51.4 mtt -119.55 147.15 44.81 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.661 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 19.9 p-90 -136.96 -168.62 2.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.493 0.663 . . . . 0.0 111.689 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.6 p -162.18 140.31 8.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.23 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -69.9 149.11 48.17 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.407 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 81.2 p -95.03 14.63 21.2 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.518 0.675 . . . . 0.0 109.936 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.3 p -137.62 160.79 38.21 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.325 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.598 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -63.3 -32.94 74.48 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.03 0.443 . . . . 0.0 111.16 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -127.04 115.81 19.76 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.783 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 66.0 t80 -81.4 -31.61 33.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -56.89 -34.26 67.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.67 -62.62 1.43 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.35 -24.68 64.84 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 9.0 mtm180 40.51 48.74 2.55 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -120.47 121.72 39.1 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.783 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.8 p-90 -135.44 174.14 10.95 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -175.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.497 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.86 141.84 7.1 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 113.513 -1.676 . . . . 0.0 110.155 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.763 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.7 m-85 -57.0 154.37 9.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.217 0.532 . . . . 0.0 111.549 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.473 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 4.6 t -58.65 133.09 86.01 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.081 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.11 4.22 3.43 Favored 'Trans proline' 0 CA--C 1.513 -0.575 0 C-N-CA 122.86 2.373 . . . . 0.0 113.558 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -133.59 105.41 6.85 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.085 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -125.31 47.88 2.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.252 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.623 0 CA-C-O 118.443 -1.198 . . . . 0.0 112.23 -179.821 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.0 t . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -64.49 -76.52 0.07 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.955 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 72.6 mtp -128.21 -178.01 4.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.142 0.496 . . . . 0.0 111.443 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 t -127.79 -171.52 2.46 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.852 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.466 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 61.7 p -105.42 162.73 13.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.242 0.544 . . . . 0.0 112.11 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.88 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -96.35 -168.1 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 176.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.691 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 39.06 -124.29 1.72 Allowed Glycine 0 C--O 1.237 0.282 0 O-C-N 123.954 0.784 . . . . 0.0 113.18 177.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.681 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 36.68 -144.57 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 176.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -161.75 33.91 0.13 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.546 -0.827 . . . . 0.0 110.391 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 2.6 p -78.22 -54.29 6.39 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.39 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.0 -43.38 1.7 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.609 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.19 40.4 0.2 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 10' ' ' SER . . . -117.49 145.77 36.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.993 -0.104 . . . . 0.0 110.725 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -91.69 175.6 2.15 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.251 2.634 . . . . 0.0 111.889 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.9 m -78.62 124.55 28.29 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 82.0 t -94.88 106.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.834 0.35 . . . . 0.0 110.102 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -104.46 139.88 20.54 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.514 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -87.32 131.98 12.52 Favored 'Cis proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.748 -1.355 . . . . 0.0 111.932 -0.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.607 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 16.3 p90 -99.42 130.75 45.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.3 m -96.24 123.44 39.87 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.537 0.684 . . . . 0.0 111.681 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.963 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 13.1 t80 -128.36 141.0 51.56 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.33 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.704 HD13 ' CD1' ' A' ' 21' ' ' PHE . 2.8 mp 48.77 31.92 3.36 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 123.794 0.684 . . . . 0.0 112.302 176.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.46 -0.6 87.05 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.683 -0.689 . . . . 0.0 114.289 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.426 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 62.6 m-80 -114.96 137.27 52.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 118.072 0.936 . . . . 0.0 112.676 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -77.43 125.08 28.76 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.336 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.963 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.5 m-30 -112.6 111.16 21.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.982 0.896 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -92.65 -6.69 48.81 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.71 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 p -138.31 -172.66 3.33 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 98.3 m -69.52 163.54 25.16 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 t -140.77 169.05 18.36 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.665 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.632 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 12.3 p -122.89 15.75 10.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.474 ' CB ' ' HD2' ' A' ' 21' ' ' PHE . . . -60.38 138.64 57.95 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.809 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.86 -8.28 23.05 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.051 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.553 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 26.0 mtp85 -110.86 -73.59 0.68 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.088 0.471 . . . . 0.0 110.528 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.2 m 60.95 18.23 8.64 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.303 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.404 ' OD1' ' HB3' ' A' ' 34' ' ' ARG . 31.7 p-10 -92.92 -54.69 3.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.717 0.77 . . . . 0.0 110.374 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.86 -52.4 0.12 Allowed Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 114.638 -1.165 . . . . 0.0 113.305 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.764 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 1.9 mptt -69.85 116.32 10.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 0.0 111.893 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.632 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 56.4 mtt -83.73 150.8 25.59 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.694 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 14.3 p-90 -130.32 -171.31 2.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.495 0.664 . . . . 0.0 112.505 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.1 p -154.02 140.7 18.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.603 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.05 156.5 27.08 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.129 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.3 p -108.19 17.93 21.7 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.838 0.828 . . . . 0.0 110.209 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.7 p -138.83 146.61 41.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.596 -1.184 . . . . 0.0 108.498 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -53.1 -46.56 68.75 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.131 0.491 . . . . 0.0 110.675 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -116.36 106.82 14.06 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.814 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 77.6 t80 -71.08 -46.2 62.3 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.866 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -44.3 -34.53 1.97 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -86.69 -62.75 1.44 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -80.63 -17.93 49.72 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.652 ' HG3' ' O ' ' A' ' 47' ' ' TYR . 21.6 mtm105 33.35 64.68 0.3 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -125.22 112.93 17.0 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.814 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.7 p-90 -120.42 177.07 5.18 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.694 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -158.59 163.52 33.1 Favored Glycine 0 C--O 1.22 -0.769 0 CA-C-N 113.314 -1.766 . . . . 0.0 108.856 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.88 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 1.9 m-85 -88.22 164.51 15.6 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 118.56 1.18 . . . . 0.0 112.683 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.891 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 3.2 t -84.43 163.12 48.73 Favored Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.891 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 89.0 Cg_endo -69.18 -153.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.964 1.776 . . . . 0.0 113.055 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -75.96 118.47 18.77 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.725 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -113.59 36.29 3.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.375 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.709 0 CA-C-O 118.584 -1.12 . . . . 0.0 112.685 -179.924 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.66 0.266 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 3.2 p-90 -75.38 -40.43 58.03 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 33.3 mtt -118.25 109.12 15.96 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.902 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.9 m -107.2 168.12 9.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.482 -0.781 . . . . 0.0 108.971 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 55' ' ' PHE . 40.7 p -91.2 155.99 18.17 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 1.1 t -127.74 6.49 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-O 122.934 1.35 . . . . 0.0 110.317 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.422 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . -158.17 -156.05 7.82 Favored Glycine 0 C--N 1.284 -2.338 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.444 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.662 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 75.05 -144.19 31.88 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.297 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.574 ' H ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -140.13 29.11 2.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.282 0.563 . . . . 0.0 109.623 179.19 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.656 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 1.8 p -87.32 -41.0 13.97 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.377 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.19 43.61 7.42 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.883 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.41 35.5 17.08 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.487 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.656 ' HB3' ' HB2' ' A' ' 10' ' ' SER . . . -92.42 148.74 37.02 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.687 0.279 . . . . 0.0 110.492 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.6 Cg_exo -73.14 126.81 11.46 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.696 2.264 . . . . 0.0 112.354 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 88.3 m -65.07 141.65 58.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.366 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 48.3 t -107.78 132.27 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.708 0.29 . . . . 0.0 111.139 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.48 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 59.8 m-85 -125.39 142.7 42.41 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.308 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.598 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 6.7 Cg_endo -84.91 130.87 14.99 Favored 'Cis proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.324 -1.531 . . . . 0.0 112.014 -0.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.696 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 31.5 p90 -102.72 130.15 49.57 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 62.6 m -93.23 121.54 34.7 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.303 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.836 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 56.1 t80 -112.95 129.45 56.47 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.598 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.733 HD22 ' CE2' ' A' ' 21' ' ' PHE . 7.4 mp 42.96 36.83 0.95 Allowed 'General case' 0 N--CA 1.435 -1.184 0 O-C-N 124.349 1.031 . . . . 0.0 112.908 175.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.0 -15.48 56.63 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 20' ' ' THR . 49.8 m-80 -109.65 129.98 55.55 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 119.367 1.583 . . . . 0.0 112.557 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.3 mtmt -77.36 119.59 21.2 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.001 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.836 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.5 m-85 -108.66 114.04 27.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.743 0.782 . . . . 0.0 111.498 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.598 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 35.0 mt-10 -89.98 -8.78 50.85 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.871 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.4 p -136.72 -177.22 4.64 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.0 m -67.05 165.24 16.17 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.064 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.555 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 9.0 t -144.45 170.09 16.7 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.131 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.735 ' HB2' ' HA ' ' A' ' 36' ' ' ASP . 22.9 p -123.78 18.6 9.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.91 136.58 58.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 113.922 -1.49 . . . . 0.0 112.045 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.31 -4.13 9.43 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.775 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.579 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 10.0 mtp85 -106.72 -176.8 3.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.578 0.704 . . . . 0.0 112.177 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 37' ' ' GLY . 1.5 m -82.36 25.21 0.63 Allowed 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.004 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.735 ' HA ' ' HB2' ' A' ' 31' ' ' SER . 0.0 OUTLIER 64.59 -27.4 0.09 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.856 2.062 . . . . 0.0 113.289 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 35' ' ' SER . . . -66.51 -77.39 0.29 Allowed Glycine 0 C--N 1.304 -1.208 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.997 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.718 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 7.9 mptt -72.83 101.71 3.21 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.464 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 50.3 mtt -75.7 153.43 37.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.689 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.7 p-90 -137.46 -165.7 1.81 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.351 0.596 . . . . 0.0 110.977 -178.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.496 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.3 p -167.9 141.32 3.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.962 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.432 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -72.3 156.15 39.42 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.025 0.44 . . . . 0.0 111.273 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.634 HG21 ' HB3' ' A' ' 10' ' ' SER . 45.8 p -104.58 13.79 31.03 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.796 0.808 . . . . 0.0 109.506 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.0 p -136.89 142.57 42.75 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.819 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.696 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -54.89 -39.89 69.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.979 0.419 . . . . 0.0 110.947 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -119.17 103.11 9.23 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 1.032 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 32.6 t80 -72.59 -32.99 66.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.177 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -51.22 -28.51 11.66 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -95.12 -60.79 1.6 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -82.19 -19.54 39.62 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 8.1 mtm180 44.3 44.67 6.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -109.13 114.96 29.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 1.032 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.6 p-90 -126.84 175.9 7.68 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -175.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.606 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -172.59 154.58 21.41 Favored Glycine 0 C--O 1.217 -0.946 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.558 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 5' ' ' THR . 15.1 m-30 -64.26 164.59 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.576 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 31.5 t -89.67 145.05 32.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.342 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.576 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 73.4 Cg_endo -67.7 -146.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 122.772 2.315 . . . . 0.0 114.078 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.468 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 2.5 m-20 -50.06 108.7 0.23 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.56 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -88.86 -34.13 17.11 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.787 0 CA-C-O 118.271 -1.294 . . . . 0.0 111.683 -179.748 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 120.548 0.213 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -109.13 82.49 1.6 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.24 56.36 3.62 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.761 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 26.3 m -71.63 156.94 38.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.505 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.512 HG22 ' SG ' ' A' ' 41' ' ' CYS . 77.5 p -69.8 173.11 6.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.53 0.566 . . . . 0.0 112.53 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.82 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 1.5 t -106.37 -67.96 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 CA-C-O 123.298 1.523 . . . . 0.0 109.88 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.86 ' H ' ' HB2' ' A' ' 55' ' ' PHE . . . -76.61 -156.23 6.83 Favored Glycine 0 C--N 1.284 -2.338 0 CA-C-N 111.167 -2.742 . . . . 0.0 112.599 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.592 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 74.14 -139.56 26.16 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.487 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.408 ' N ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -160.76 44.78 0.19 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.092 0.472 . . . . 0.0 110.421 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.861 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 3.3 p -79.58 -36.1 38.67 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.651 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.81 38.47 23.51 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.132 -1.032 . . . . 0.0 110.983 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.07 53.14 2.1 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.433 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.861 ' HB3' ' HB2' ' A' ' 10' ' ' SER . . . -129.78 144.94 54.98 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.597 0.237 . . . . 0.0 110.608 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 72.0 Cg_endo -83.05 170.69 12.11 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.512 2.142 . . . . 0.0 112.144 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.7 m -85.49 135.14 33.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.578 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 65.5 t -97.14 115.58 37.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.401 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 61.9 m-85 -113.53 138.67 22.65 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-O 120.886 0.374 . . . . 0.0 111.246 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -85.45 136.5 21.66 Favored 'Cis proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.466 -1.889 . . . . 0.0 112.654 -0.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.578 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 28.5 p90 -102.26 136.4 42.16 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 91.3 m -98.48 122.28 41.47 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.614 -0.835 . . . . 0.0 112.618 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.753 ' CG ' HD22 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -123.37 147.34 47.17 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.753 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 37.25 37.06 0.08 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.276 1.03 . . . . 0.0 113.676 178.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.15 -1.01 87.66 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.112 0.805 . . . . 0.0 115.112 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 20' ' ' THR . 68.7 m-80 -112.38 144.34 41.98 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 118.617 1.208 . . . . 0.0 111.985 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -87.46 120.44 28.77 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.628 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 16.6 m-85 -102.19 116.41 32.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.645 0.736 . . . . 0.0 111.315 -177.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -89.8 -24.17 21.53 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.616 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.8 p -126.12 -176.76 3.73 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.3 m -65.28 164.82 12.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.512 0.672 . . . . 0.0 109.891 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.524 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.5 t -139.61 171.57 14.06 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.272 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.2 p -126.07 19.7 7.66 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.49 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -67.24 138.46 56.93 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 113.503 -1.68 . . . . 0.0 112.009 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.67 -1.08 59.37 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.182 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 12.8 mtp85 -107.23 129.33 54.88 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.534 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 68.6 m -104.62 8.01 35.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.155 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 1.5 p-10 -93.87 -85.88 0.28 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.951 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.415 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 176.51 -26.61 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.934 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 62.4 mmtt -64.86 136.69 57.15 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 117.798 0.799 . . . . 0.0 111.664 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 52.1 mtt -92.27 145.2 24.67 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.672 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.5 p-90 -133.23 -167.75 1.97 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.299 0.571 . . . . 0.0 111.881 -177.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.512 ' SG ' HG22 ' A' ' 5' ' ' THR . 3.4 p -158.34 138.34 12.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.677 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.478 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -71.72 151.18 43.81 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.911 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.63 HG21 ' HB3' ' A' ' 10' ' ' SER . 67.9 p -102.44 15.82 28.09 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.564 0.697 . . . . 0.0 110.58 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.7 p -138.39 156.34 47.68 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.32 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.38 -35.01 76.31 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.056 0.455 . . . . 0.0 110.941 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -124.53 113.3 17.91 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.687 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 58.8 t80 -80.58 -33.61 35.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.985 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -56.22 -34.48 66.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -83.9 -62.3 1.6 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.15 -29.6 61.87 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 4.0 mtm180 45.55 45.91 10.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.841 0.829 . . . . 0.0 113.052 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -115.24 119.7 37.23 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.687 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.6 p-90 -131.14 179.97 5.69 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -174.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -170.31 151.32 16.22 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 113.873 -1.512 . . . . 0.0 109.323 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.86 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 11.6 m-85 -65.74 162.77 17.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 118.625 1.212 . . . . 0.0 112.718 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.456 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.5 t -71.17 126.28 91.95 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.783 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.433 ' HB3' ' O ' ' A' ' 4' ' ' SER . 12.2 Cg_endo -85.06 -161.06 0.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.883 2.389 . . . . 0.0 112.917 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.7 t0 34.35 56.52 0.66 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.307 1.005 . . . . 0.0 112.219 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -99.74 40.67 1.21 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.225 0.536 . . . . 0.0 110.686 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.772 0 CA-C-O 118.891 -0.949 . . . . 0.0 111.343 179.28 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.935 0.398 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -95.12 105.9 17.87 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.249 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.737 ' HG3' ' HB3' ' A' ' 14' ' ' PRO . 19.3 ptm -91.89 36.16 0.97 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.555 0.693 . . . . 0.0 109.637 178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -77.61 162.46 27.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.195 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.507 HG22 ' SG ' ' A' ' 41' ' ' CYS . 76.2 p -106.17 169.98 8.19 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 122.336 1.065 . . . . 0.0 113.844 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.753 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -112.87 -152.89 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 176.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.712 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 28.66 -122.28 0.07 OUTLIER Glycine 0 N--CA 1.463 0.456 0 O-C-N 124.671 1.232 . . . . 0.0 114.099 176.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.695 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 39.59 -144.7 0.34 Allowed Glycine 0 C--N 1.331 0.284 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.19 10.13 0.38 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.49 -0.855 . . . . 0.0 109.94 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.6 m -96.88 19.59 12.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.64 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.04 -98.27 0.63 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.999 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.08 36.39 1.67 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.77 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -76.96 149.22 79.87 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.311 0.1 . . . . 0.0 110.911 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.737 ' HB3' ' HG3' ' A' ' 3' ' ' MET . 11.9 Cg_exo -70.27 157.15 60.28 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.085 2.523 . . . . 0.0 112.727 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.6 m -79.82 135.51 36.49 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.7 t -100.16 112.43 32.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.673 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 55.0 m-85 -108.39 141.94 24.3 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.852 0.358 . . . . 0.0 111.408 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.4 Cg_endo -86.87 136.03 17.42 Favored 'Cis proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.531 -1.445 . . . . 0.0 111.981 -0.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.673 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 33.5 p90 -103.29 129.18 50.22 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.7 m -92.43 127.25 37.85 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.233 0.539 . . . . 0.0 112.124 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.85 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.2 t80 -130.36 144.21 51.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.761 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 40.37 36.86 0.38 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.462 1.105 . . . . 0.0 112.899 178.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.23 -9.84 73.49 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 114.709 0.644 . . . . 0.0 114.709 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.412 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 72.9 m-80 -107.6 134.45 50.58 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.453 1.127 . . . . 0.0 111.827 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -79.71 121.14 24.96 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.791 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.85 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.2 m-30 -104.52 110.31 22.54 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.982 0.896 . . . . 0.0 111.086 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 33.2 mt-10 -88.04 -16.69 32.94 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.295 -1.321 . . . . 0.0 110.742 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 p -129.28 -175.24 3.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.9 m -65.43 163.42 15.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.465 0.65 . . . . 0.0 110.177 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.422 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.9 t -138.73 -176.78 4.6 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.645 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.45 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 10.1 p -141.07 18.62 2.28 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -64.84 145.69 55.92 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 113.281 -1.781 . . . . 0.0 112.503 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.09 5.13 32.05 Favored Glycine 0 C--O 1.235 0.198 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.847 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 34' ' ' ARG . 0.1 OUTLIER -107.57 -76.12 0.62 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.128 0.464 . . . . 0.0 110.982 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.2 m 75.78 25.8 1.12 Allowed 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -112.14 -88.1 0.54 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.223 0.92 . . . . 0.0 111.3 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.58 -45.08 0.06 OUTLIER Glycine 0 CA--C 1.528 0.859 0 N-CA-C 116.081 1.193 . . . . 0.0 116.081 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.71 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 3.9 mptt -64.63 -158.43 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.45 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 87.8 mtp -158.42 145.55 17.76 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.63 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 23.5 p-90 -135.59 -174.64 3.7 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.507 ' SG ' HG22 ' A' ' 5' ' ' THR . 6.5 p -152.76 136.85 16.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.161 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . . . -73.04 151.14 41.84 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.013 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.3 p -100.61 17.67 21.22 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.733 0.777 . . . . 0.0 109.275 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.7 p -135.6 151.7 50.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.213 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.666 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -60.72 -37.67 82.52 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.121 0.486 . . . . 0.0 110.878 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -124.26 107.85 11.62 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.708 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 56.4 t80 -74.75 -32.31 62.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.301 -0.408 . . . . 0.0 112.047 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -55.97 -33.66 65.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -94.96 -56.87 2.6 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -77.54 -20.93 53.4 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.588 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 17.5 mtm180 39.63 52.45 2.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -122.47 117.9 27.05 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.708 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.2 p-90 -125.73 172.73 9.56 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.561 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -158.64 154.13 25.23 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.29 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.753 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 1.0 OUTLIER -80.34 156.79 26.58 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -178.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 81.7 m -97.63 124.56 47.97 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -78.43 -159.24 0.1 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.393 2.062 . . . . 0.0 113.771 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.1 t70 40.87 60.2 2.02 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.628 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -113.16 19.61 16.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.038 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.567 0 CA-C-O 118.499 -1.167 . . . . 0.0 111.893 -179.934 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.966 0.413 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -97.44 -137.42 0.27 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.657 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.4 mtt -89.87 67.48 7.21 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 m -70.43 162.39 28.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.946 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 p -108.11 173.92 6.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.666 0.746 . . . . 0.0 112.47 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -116.78 -168.23 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.072 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.455 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 36.73 -122.7 0.82 Allowed Glycine 0 N--CA 1.462 0.4 0 O-C-N 124.056 0.848 . . . . 0.0 113.076 178.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.712 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 35.15 -141.36 0.13 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 115.616 1.006 . . . . 0.0 115.616 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.89 -0.31 0.82 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.205 -0.497 . . . . 0.0 110.213 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.586 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 5.3 m -91.39 -63.82 1.21 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.856 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.61 -74.4 2.12 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.098 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.27 -11.83 82.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.233 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -92.91 140.98 23.65 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.913 0.387 . . . . 0.0 111.165 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 73.1 Cg_endo -87.04 167.75 8.02 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.927 2.418 . . . . 0.0 112.015 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.7 m -79.73 139.75 37.2 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.312 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.1 t -107.5 112.42 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -114.02 143.7 30.16 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.723 0.297 . . . . 0.0 111.103 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -85.75 137.25 21.97 Favored 'Cis proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.495 -1.46 . . . . 0.0 111.836 -0.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 41.3 p90 -102.79 -178.36 3.65 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.453 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.8 m -135.03 126.2 28.02 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.664 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.645 ' CE2' ' HZ2' ' A' ' 40' ' ' TRP . 1.9 t80 -134.24 141.58 47.05 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.655 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 40.87 38.42 0.65 Allowed 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.746 1.219 . . . . 0.0 113.706 178.607 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.17 -1.65 88.57 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -107.89 154.88 20.94 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 118.439 1.119 . . . . 0.0 111.26 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -94.83 126.36 40.11 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.606 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 21.8 m-85 -113.88 111.92 22.51 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.68 0.752 . . . . 0.0 111.784 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -96.03 -8.33 33.88 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.09 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 p -136.57 -172.75 3.23 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.8 m -69.31 168.64 13.86 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.128 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.511 ' HG1' ' HE2' ' A' ' 26' ' ' TYR . 10.2 t -144.48 167.12 23.25 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.594 0.711 . . . . 0.0 110.738 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.512 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 61.3 p -120.54 12.64 11.58 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.586 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -56.05 136.74 52.08 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.67 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.37 -10.86 19.99 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.018 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.7 mtp85 -111.21 -71.73 0.75 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.059 0.457 . . . . 0.0 110.272 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.7 m 56.78 27.58 13.02 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.41 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -100.25 -63.41 1.13 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.356 0.598 . . . . 0.0 110.641 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.26 -49.05 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.498 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.677 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -73.24 108.63 6.23 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -179.427 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.512 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 80.9 mtp -80.6 148.37 30.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.665 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.5 p-90 -128.31 -165.11 1.45 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.382 0.61 . . . . 0.0 111.627 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.5 p -159.68 146.9 16.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.968 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -81.0 143.57 32.42 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.473 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.0 p -97.14 13.97 27.43 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.778 0.799 . . . . 0.0 110.113 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.411 HG23 ' HB2' ' A' ' 52' ' ' LYS . 38.1 p -134.09 158.76 42.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.157 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -65.39 -26.54 68.04 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.193 0.52 . . . . 0.0 110.624 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -132.71 117.44 17.85 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.814 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 65.6 t80 -86.18 -34.78 20.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -54.36 -37.06 64.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.967 0.413 . . . . 0.0 111.791 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.76 -66.37 0.93 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.33 -20.37 63.0 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 26.2 mtt180 38.55 51.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.411 ' HB2' HG23 ' A' ' 44' ' ' THR . 89.8 mttt -113.71 119.22 36.64 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 176.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.814 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 5.3 p-90 -132.25 171.68 13.39 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -174.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.562 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -166.07 143.9 8.76 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 113.3 -1.773 . . . . 0.0 109.838 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.684 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.4 m-30 -60.51 151.51 28.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.399 0.6 . . . . 0.0 111.63 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.497 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 4.5 t -62.56 128.41 91.52 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.66 5.08 2.62 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 C-N-CA 122.856 2.371 . . . . 0.0 114.61 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -154.8 116.51 4.13 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.352 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -100.39 116.35 32.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.713 0.292 . . . . 0.0 110.482 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.714 0 CA-C-O 118.684 -1.064 . . . . 0.0 112.075 179.975 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.442 ' OG ' ' HG2' ' A' ' 3' ' ' MET . 40.4 p . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -91.52 15.39 12.51 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.442 ' HG2' ' OG ' ' A' ' 1' ' ' SER . 19.1 ptp -82.15 129.85 34.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.9 m -96.28 169.55 9.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.26 0.552 . . . . 0.0 111.299 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.0 p -91.14 176.61 6.52 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.605 0.717 . . . . 0.0 111.851 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.792 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -113.77 -166.54 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 176.376 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.646 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 34.7 -126.11 0.58 Allowed Glycine 0 N--CA 1.463 0.47 0 O-C-N 124.069 0.856 . . . . 0.0 114.117 177.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.579 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 40.74 -149.1 0.2 Allowed Glycine 0 C--N 1.337 0.611 0 N-CA-C 115.77 1.068 . . . . 0.0 115.77 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.422 ' H ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -143.73 5.22 1.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.826 -0.687 . . . . 0.0 110.435 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -84.41 -45.8 12.35 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.175 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.45 -105.28 3.23 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.802 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.69 32.48 3.68 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.674 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.01 144.24 28.34 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.979 0.39 . . . . 0.0 110.196 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -87.86 167.13 7.12 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.914 2.409 . . . . 0.0 112.136 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.2 m -83.44 129.67 34.99 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 92.7 t -96.87 112.25 28.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.707 0.289 . . . . 0.0 110.305 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -107.0 138.37 19.8 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.562 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -86.25 132.25 14.48 Favored 'Cis proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.21 -1.579 . . . . 0.0 112.263 -0.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.605 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 17.9 p90 -99.93 126.28 46.06 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.244 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 91.2 m -91.67 122.46 34.25 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.963 0.411 . . . . 0.0 110.565 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.867 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 68.3 t80 -115.2 130.09 56.82 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.604 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.552 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.7 mm? 35.28 45.11 0.19 Allowed 'General case' 0 N--CA 1.428 -1.536 0 O-C-N 124.775 1.297 . . . . 0.0 113.319 175.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.72 -23.07 32.21 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 116.497 1.359 . . . . 0.0 116.497 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -111.26 132.51 54.31 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 120.027 1.914 . . . . 0.0 113.12 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 39.7 mtpt -77.71 126.67 31.22 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.867 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.3 m-85 -110.77 118.67 36.79 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.898 0.856 . . . . 0.0 111.643 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -89.62 -12.44 39.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.76 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.4 p -136.08 -171.21 2.82 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.0 m -70.19 166.24 20.41 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.499 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -143.91 171.22 14.54 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.335 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.478 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 71.3 p -125.41 20.88 7.97 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.45 132.83 55.13 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.971 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.02 -8.04 40.12 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.095 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.0 mtp85 -108.85 -79.16 0.58 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.594 0.235 . . . . 0.0 111.28 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.7 p 52.5 31.31 9.64 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.031 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -105.36 -37.28 6.9 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.728 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.28 -65.35 0.16 Allowed Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.829 -1.078 . . . . 0.0 113.279 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.647 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 2.0 mptt -71.8 135.72 46.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.478 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 58.2 mtt -94.71 153.21 17.9 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.651 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.8 p-90 -133.6 -166.51 1.79 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.216 0.532 . . . . 0.0 111.777 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 8.4 p -160.07 143.99 14.28 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 19' ' ' PHE . . . -78.77 152.57 31.38 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.563 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.0 p -102.98 9.94 38.44 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.656 0.741 . . . . 0.0 110.553 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.0 p -133.03 153.12 51.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.989 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.44 -42.01 81.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 111.341 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -120.83 111.36 17.46 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 1.051 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 34.3 t80 -77.16 -31.82 55.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.938 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -51.94 -32.8 34.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -90.08 -71.55 0.61 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.25 -27.81 68.24 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.692 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 24.0 mtm-85 45.15 51.0 9.31 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -117.04 119.04 34.04 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 1.051 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.8 p-90 -127.42 172.09 10.97 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -175.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.576 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.44 147.38 13.8 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 113.292 -1.777 . . . . 0.0 109.466 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.792 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 6.1 m-30 -62.84 158.37 19.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.329 1.065 . . . . 0.0 110.989 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.529 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 25.2 t -64.74 130.74 94.91 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.167 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -78.89 11.46 2.54 Favored 'Trans proline' 0 CA--C 1.515 -0.427 0 C-N-CA 123.178 2.585 . . . . 0.0 112.321 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -121.56 59.48 0.97 Allowed 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.419 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -126.8 -149.12 0.41 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.002 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.91 0 CA-C-O 118.683 -1.065 . . . . 0.0 112.173 179.669 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.8 p . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.883 0.373 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -103.54 76.75 1.43 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.858 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.1 ptm -135.9 133.28 37.53 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.351 0.595 . . . . 0.0 111.086 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.5 t -136.91 -171.37 2.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.701 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.41 166.96 10.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.328 1.061 . . . . 0.0 112.95 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.613 HG22 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -129.9 163.45 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 178.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.725 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 62.12 -141.35 47.23 Favored Glycine 0 C--N 1.316 -0.561 0 C-N-CA 118.059 -2.02 . . . . 0.0 111.861 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.625 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 39.67 -139.09 1.03 Allowed Glycine 0 C--N 1.334 0.468 0 N-CA-C 115.676 1.03 . . . . 0.0 115.676 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.16 28.07 0.25 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.273 -0.463 . . . . 0.0 110.569 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.67 -52.24 7.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.311 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.68 -69.33 0.46 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.942 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.58 31.68 2.3 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.351 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.27 139.05 19.76 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.799 0.333 . . . . 0.0 111.168 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -84.25 164.41 13.01 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.726 2.284 . . . . 0.0 111.527 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.459 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.9 m -72.33 138.39 47.29 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 59.7 t -107.88 113.32 43.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.581 0.229 . . . . 0.0 110.681 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -115.82 140.24 25.91 Favored Pre-proline 0 N--CA 1.454 -0.268 0 CA-C-O 120.845 0.355 . . . . 0.0 110.963 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.453 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 5.4 Cg_endo -87.0 132.88 13.84 Favored 'Cis proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.292 -1.545 . . . . 0.0 111.754 -0.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.457 ' CG ' ' HB3' ' A' ' 42' ' ' ALA . 46.3 p90 -98.48 -175.11 3.0 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.844 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 18.9 m -140.0 119.58 13.19 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.727 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.85 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 68.3 t80 -117.83 133.21 56.15 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.504 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.6 mm? 34.62 47.53 0.24 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.697 1.248 . . . . 0.0 113.797 175.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.99 -9.11 75.79 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 116.402 1.321 . . . . 0.0 116.402 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 20' ' ' THR . 51.5 m-80 -110.12 150.01 29.23 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.821 1.811 . . . . 0.0 112.363 -178.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -91.57 125.74 36.41 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.85 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 88.7 m-85 -115.59 114.3 24.75 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.612 0.72 . . . . 0.0 111.574 -178.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.453 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 41.3 mt-10 -93.21 -12.82 29.33 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.234 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.5 p -133.05 -166.47 1.76 Allowed 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.7 m -76.35 170.17 16.86 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.863 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.5 t -147.76 169.5 19.61 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.346 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.9 p -123.59 20.28 9.48 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.411 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -59.85 133.15 55.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 113.523 -1.672 . . . . 0.0 112.101 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.73 -0.22 45.39 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.468 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 22.3 mtp85 -106.5 -81.99 0.54 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.9 m 62.27 25.91 15.5 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.366 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -98.73 -35.03 10.29 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.644 0.735 . . . . 0.0 110.418 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.95 -41.75 0.76 Allowed Glycine 0 C--N 1.313 -0.716 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.895 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.439 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 21.8 mmmt -84.91 131.71 34.46 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -90.28 147.05 23.76 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.645 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.5 p-90 -128.59 -169.61 2.11 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.303 0.573 . . . . 0.0 111.834 -178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.0 p -154.41 142.2 20.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.761 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -76.76 143.13 40.09 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.509 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.1 p -99.07 10.35 41.63 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.581 0.705 . . . . 0.0 110.043 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.5 p -136.14 146.85 47.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.729 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.32 -48.24 79.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.768 0.318 . . . . 0.0 111.146 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 48' ' ' ASP . 20.1 t-20 -109.24 99.68 8.92 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.884 ' CE2' ' HB3' ' A' ' 53' ' ' TRP . 47.5 t80 -72.16 -32.91 67.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.559 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.413 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . 54.2 m-20 -45.48 -39.83 7.68 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.8 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -95.97 -55.69 2.9 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -69.23 -35.04 75.76 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.2 mmm180 51.15 37.98 19.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -107.57 118.67 37.33 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.884 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 11.0 p-90 -128.66 174.22 9.61 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.404 -175.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.612 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.08 142.05 7.47 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.751 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.725 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 9.2 m-85 -59.03 154.13 16.23 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.376 0.608 . . . . 0.0 111.639 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.771 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 5.1 t -66.62 153.43 93.46 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.771 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 61.0 Cg_endo -64.18 -143.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.951 2.434 . . . . 0.0 114.055 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 33.7 t70 -61.21 114.92 3.42 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.867 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.591 ' NE2' ' HB3' ' A' ' 56' ' ' CYS . 38.0 mt-30 -129.47 -55.49 1.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.071 178.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.759 0 CA-C-O 118.253 -1.304 . . . . 0.0 111.3 -179.706 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.441 0.163 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -82.18 124.93 30.33 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.5 mtm -83.92 133.81 34.7 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.493 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.1 m -72.45 160.61 32.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.358 179.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.439 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 11.0 p -97.3 162.6 13.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.676 0.75 . . . . 0.0 112.639 -179.43 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.771 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -110.07 -163.44 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.119 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.427 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 34.62 -121.86 0.44 Allowed Glycine 0 N--CA 1.463 0.447 0 O-C-N 124.282 0.988 . . . . 0.0 112.999 177.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.698 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 29.36 -135.28 0.06 OUTLIER Glycine 0 C--N 1.338 0.66 0 N-CA-C 115.986 1.154 . . . . 0.0 115.986 176.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -144.23 -31.89 0.44 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.722 -0.739 . . . . 0.0 109.214 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.427 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 5.0 m -56.76 -66.89 0.37 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.557 179.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.5 -70.77 1.34 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.18 179.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.29 -12.94 69.95 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.917 -0.658 . . . . 0.0 113.213 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -96.15 140.81 22.43 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 117.27 0.535 . . . . 0.0 110.983 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 42.0 Cg_endo -85.78 165.56 10.31 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.941 2.427 . . . . 0.0 112.721 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 5.6 m -71.79 127.7 33.41 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.3 t -102.68 101.83 12.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.033 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.655 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 47.7 m-85 -103.45 143.3 26.34 Favored Pre-proline 0 N--CA 1.45 -0.45 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.751 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.83 136.02 22.55 Favored 'Cis proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.578 -1.843 . . . . 0.0 112.355 -0.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.655 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 29.9 p90 -102.77 -171.97 2.04 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.289 177.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.2 m -145.76 127.43 15.22 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.705 -177.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.791 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.5 t80 -134.42 143.02 47.33 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.69 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 41.75 35.41 0.5 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 124.416 1.087 . . . . 0.0 112.976 178.953 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.34 -9.46 77.42 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.506 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 70.7 m-80 -107.73 138.13 44.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 118.368 1.084 . . . . 0.0 112.294 -178.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -79.5 123.31 27.44 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.791 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 15.3 m-30 -106.01 114.52 28.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.762 0.791 . . . . 0.0 110.821 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -86.81 -24.75 24.89 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.068 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 p -122.75 -173.24 2.65 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.306 179.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.1 m -72.32 166.92 21.52 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.937 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.9 t -141.61 166.03 25.87 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.408 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.405 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 12.9 p -120.8 18.77 11.85 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.618 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -59.91 139.07 57.63 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 113.656 -1.611 . . . . 0.0 111.466 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.01 -1.45 68.99 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.2 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.572 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 24.2 mtp85 -115.87 149.12 39.17 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 p -118.68 2.94 11.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.046 0.45 . . . . 0.0 110.897 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.08 -82.96 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.339 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.06 -14.62 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.569 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.572 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 66.4 mttt -64.27 102.55 0.53 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 122.276 0.23 . . . . 0.0 110.9 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.405 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 43.8 mtt -75.01 143.04 43.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.98 0.419 . . . . 0.0 110.271 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.704 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.1 p-90 -131.24 -167.68 1.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.432 -178.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 15.1 p -157.68 149.54 22.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.006 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.9 151.75 27.12 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.66 178.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 34.5 p -116.23 10.08 14.76 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.016 -178.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.565 HG21 ' HE2' ' A' ' 52' ' ' LYS . 73.4 p -123.03 12.08 9.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . 70.01 -35.99 0.33 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.336 0.655 . . . . 0.0 111.45 -178.449 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 44' ' ' THR . 21.5 t-20 -129.49 110.48 11.9 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.898 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 49.5 t80 -87.85 -28.68 21.45 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -177.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -58.23 -34.7 70.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -92.94 -53.28 4.21 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.0 OUTLIER -74.64 -43.98 52.71 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.203 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER 61.34 39.55 15.25 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.868 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.565 ' HE2' HG21 ' A' ' 44' ' ' THR . 4.6 mppt? -113.76 118.71 35.04 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.898 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.5 p-90 -130.73 174.96 9.42 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -174.246 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.602 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.4 148.04 13.35 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 113.194 -1.821 . . . . 0.0 109.615 178.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.771 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 7.1 m-30 -60.81 157.81 14.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.58 0.705 . . . . 0.0 111.787 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.494 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 29.3 t -70.78 126.13 92.12 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.823 -178.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -80.75 6.04 5.76 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.814 2.342 . . . . 0.0 111.758 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -131.47 68.16 1.5 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.81 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.442 ' OE1' ' HB3' ' A' ' 56' ' ' CYS . 14.8 mm100 -80.67 162.96 23.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.192 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.868 0 CA-C-O 118.432 -1.204 . . . . 0.0 111.661 -179.735 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 120.836 0.35 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -126.35 143.73 51.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -174.39 0.79 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.669 0.271 . . . . 0.0 111.559 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.5 t 67.51 -169.26 0.19 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.566 -178.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -101.86 158.02 16.43 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.273 1.035 . . . . 0.0 113.222 -179.039 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.501 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -137.9 161.33 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 178.188 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.638 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 62.42 -147.78 49.29 Favored Glycine 0 C--N 1.311 -0.816 0 C-N-CA 118.254 -1.927 . . . . 0.0 111.306 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.745 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 49.3 -148.27 5.58 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 121.607 -0.33 . . . . 0.0 113.766 178.127 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.432 HD22 ' N ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -133.83 -10.53 2.7 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.51 178.8 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.432 ' N ' HD22 ' A' ' 9' ' ' ASN . 11.3 m -74.68 -55.27 6.06 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.302 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.92 69.54 1.24 Allowed Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.228 -0.442 . . . . 0.0 113.758 178.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.45 -32.43 1.96 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.45 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -78.09 147.06 72.57 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.1 Cg_endo -81.56 149.78 16.66 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.636 2.224 . . . . 0.0 112.323 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 72.3 m -77.3 126.14 30.46 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 43.9 t -95.92 121.43 46.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.871 0.367 . . . . 0.0 110.924 -178.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.535 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 52.7 m-85 -115.86 139.43 24.92 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-O 121.248 0.547 . . . . 0.0 111.308 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.664 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 27.7 Cg_endo -86.79 137.53 19.27 Favored 'Cis proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.669 -1.804 . . . . 0.0 112.359 -0.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.643 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 42.8 p90 -102.87 129.38 49.55 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.662 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 5.4 m -91.84 127.75 37.41 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.27 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.874 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.1 t80 -129.61 144.81 51.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.769 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 40.36 35.97 0.32 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.15 0.98 . . . . 0.0 113.243 178.381 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.0 -10.06 75.25 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.033 -0.603 . . . . 0.0 114.502 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -111.98 133.62 54.04 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 118.438 1.119 . . . . 0.0 111.794 -179.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.689 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 3.7 mptt -82.07 123.22 28.75 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.548 -179.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.874 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 15.7 m-85 -104.91 110.9 23.46 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.72 0.771 . . . . 0.0 111.031 -178.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.664 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 48.7 mt-10 -84.95 -15.76 43.28 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.86 -179.487 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p -130.97 -176.45 4.0 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 68.6 m -67.47 162.62 22.8 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.28 179.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.542 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.7 t -139.13 -177.48 4.92 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.7 p -135.88 22.15 3.3 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.61 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.493 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -66.72 150.18 49.46 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 113.91 -1.496 . . . . 0.0 113.096 -178.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.97 7.53 50.16 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 114.963 -1.017 . . . . 0.0 114.468 178.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.601 ' HB3' ' CZ ' ' A' ' 34' ' ' ARG . 5.4 mtp-105 -101.72 -158.45 0.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.148 0.974 . . . . 0.0 112.557 -179.398 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 p -133.34 -40.67 0.89 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -178.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.578 ' CG ' HH22 ' A' ' 34' ' ' ARG . 1.2 p-10 -98.11 -93.2 0.24 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.237 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' N ' HH12 ' A' ' 34' ' ' ARG . . . -162.86 21.05 0.17 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 116.426 1.331 . . . . 0.0 116.426 -178.597 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.667 ' HD3' ' CZ ' ' A' ' 55' ' ' PHE . 45.0 mttp -78.46 137.05 37.77 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 119.159 1.48 . . . . 0.0 108.569 177.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -99.47 144.98 27.94 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.601 -0.839 . . . . 0.0 108.88 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.691 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 18.6 p-90 -139.68 -172.09 3.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.224 0.535 . . . . 0.0 111.519 -178.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.6 p -156.94 139.5 14.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.206 178.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -72.78 152.68 41.46 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 120.989 0.423 . . . . 0.0 110.856 -179.293 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.7 p -100.27 16.39 24.49 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.641 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.448 HG21 ' CB ' ' A' ' 50' ' ' ASP . 70.8 p -135.21 154.83 51.46 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.179 179.271 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -62.18 -35.06 77.69 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.254 0.55 . . . . 0.0 110.399 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -125.77 110.24 13.49 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.717 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 61.9 t80 -76.6 -33.97 58.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.281 -177.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -53.67 -36.23 61.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.27 -63.72 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.448 ' CB ' HG21 ' A' ' 44' ' ' THR . 32.7 m-20 -72.53 -36.51 68.33 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -177.47 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.8 mmm180 54.67 50.77 15.14 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -120.92 116.61 25.46 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 176.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.717 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.9 p-90 -129.71 172.67 11.38 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -174.012 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.745 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -160.43 146.69 12.9 Favored Glycine 0 C--O 1.221 -0.701 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.969 178.421 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.667 ' CZ ' ' HD3' ' A' ' 38' ' ' LYS . 3.9 m-30 -61.27 163.29 6.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.578 0.704 . . . . 0.0 112.69 -179.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.413 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 6.6 t -83.44 134.21 45.75 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.417 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.88 10.06 1.18 Allowed 'Trans proline' 0 N--CA 1.481 0.764 0 C-N-CA 123.364 2.709 . . . . 0.0 114.152 -179.085 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.36 5.71 46.23 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.743 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -104.62 -135.05 0.34 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.922 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.658 -1.079 . . . . 0.0 111.871 -179.915 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 64.64 -86.0 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.596 0.56 . . . . 0.0 111.371 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.91 176.32 9.92 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.847 0.356 . . . . 0.0 111.163 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -93.36 -173.36 3.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.495 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.9 p -86.68 -179.73 6.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.919 0.866 . . . . 0.0 112.589 -179.083 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.79 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -127.48 -171.06 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.153 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.567 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.49 -120.6 0.79 Allowed Glycine 0 CA--C 1.521 0.412 0 O-C-N 123.786 0.679 . . . . 0.0 113.306 177.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.705 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 25.88 -136.12 0.02 OUTLIER Glycine 0 C--N 1.343 0.926 0 N-CA-C 116.383 1.313 . . . . 0.0 116.383 177.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.406 HD22 ' N ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -160.0 41.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.62 -0.79 . . . . 0.0 110.133 179.704 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.21 -42.19 5.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.755 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.12 -79.14 1.94 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.835 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -121.52 32.59 4.61 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.125 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.23 144.73 30.34 Favored Pre-proline 0 C--N 1.328 -0.349 0 O-C-N 122.383 -0.481 . . . . 0.0 110.034 179.161 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -86.22 167.96 9.1 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.54 2.16 . . . . 0.0 112.4 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 74.9 m -87.81 133.23 33.92 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.564 179.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.2 t -95.49 125.9 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.668 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.588 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 49.5 m-85 -122.63 138.97 30.18 Favored Pre-proline 0 N--CA 1.444 -0.727 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.592 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -86.66 133.27 14.87 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.415 -1.494 . . . . 0.0 112.328 -0.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.588 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 27.3 p90 -99.77 130.4 45.97 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.239 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.4 m -91.19 125.39 35.95 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.375 0.607 . . . . 0.0 111.894 -178.031 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.828 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 2.1 t80 -129.7 141.58 50.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.642 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 42.11 36.95 0.76 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.129 0.971 . . . . 0.0 113.078 178.678 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.37 -6.15 83.9 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.83 -0.7 . . . . 0.0 114.751 178.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.553 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.3 m-80 -112.27 136.46 51.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.434 1.117 . . . . 0.0 111.947 -178.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -80.35 122.36 26.83 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.828 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 15.4 m-30 -104.99 111.2 23.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.779 0.799 . . . . 0.0 111.104 -177.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -89.38 -19.55 25.08 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.608 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.9 p -127.33 -179.34 4.84 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.6 m -67.04 156.55 35.76 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.683 178.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.451 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 14.0 t -131.25 173.28 11.21 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.936 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.453 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 24.1 p -127.42 18.34 6.95 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 176.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.457 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -63.4 151.48 40.88 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 113.808 -1.542 . . . . 0.0 111.403 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.69 -1.53 57.66 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.205 178.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.666 ' NH1' ' H ' ' A' ' 38' ' ' LYS . 1.8 mtp-105 -116.23 -173.55 2.38 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 117.17 0.485 . . . . 0.0 111.223 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.6 t -130.64 -28.5 2.03 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.42 ' CG ' HH12 ' A' ' 34' ' ' ARG . 1.4 p-10 -91.48 -92.55 0.14 Allowed 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.627 -0.671 . . . . 0.0 111.323 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.21 25.74 0.09 OUTLIER Glycine 0 CA--C 1.526 0.76 0 C-N-CA 119.109 -1.52 . . . . 0.0 116.753 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.666 ' H ' ' NH1' ' A' ' 34' ' ' ARG . 40.9 mttp -83.58 85.82 7.2 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 119.169 1.484 . . . . 0.0 109.528 178.368 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.453 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 49.7 mtm -59.32 137.05 58.12 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.142 0.496 . . . . 0.0 110.746 -178.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.682 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.8 p-90 -133.51 -169.4 2.28 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.213 -178.591 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.2 p -160.43 138.12 9.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.006 178.237 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.83 155.11 41.03 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.107 0.479 . . . . 0.0 111.019 -178.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.3 p -102.87 13.65 33.86 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.037 0.922 . . . . 0.0 109.559 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.41 HG21 ' CB ' ' A' ' 50' ' ' ASP . 65.8 p -133.55 153.5 51.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.969 179.118 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -59.92 -37.25 78.93 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.057 0.456 . . . . 0.0 110.842 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -123.23 110.45 15.25 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.758 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 64.8 t80 -76.75 -33.14 58.11 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.085 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -57.35 -31.9 66.21 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -88.83 -62.07 1.57 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.41 ' CB ' HG21 ' A' ' 44' ' ' THR . 2.4 m-20 -74.13 -27.38 60.84 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 3.1 mmm180 48.58 49.24 18.78 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -120.59 117.53 27.83 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.758 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.9 p-90 -129.19 177.6 7.03 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -174.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.608 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.44 147.19 11.44 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.638 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.79 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 6.0 m-30 -62.66 157.6 20.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.704 0.752 . . . . 0.0 112.293 -179.056 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.509 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 27.0 t -73.94 135.37 77.28 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.599 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -76.25 6.18 4.1 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.715 2.277 . . . . 0.0 113.73 -179.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -151.09 97.46 2.45 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.12 179.555 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -113.43 57.95 0.67 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.87 0.367 . . . . 0.0 110.676 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.751 0 CA-C-O 118.67 -1.072 . . . . 0.0 111.653 179.913 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.496 0.189 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.415 ' CD1' ' HB3' ' A' ' 58' ' ' ASP . 5.6 m-90 -117.49 -176.72 3.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.567 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 ptp -77.84 -167.57 1.02 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.053 0.454 . . . . 0.0 111.26 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.6 m -79.18 -162.82 0.43 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.704 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.404 HG21 ' HA3' ' A' ' 54' ' ' GLY . 68.7 p -65.63 169.51 6.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.594 -178.591 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.18 5.98 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 CA-C-O 122.561 1.172 . . . . 0.0 111.2 -179.3 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.439 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . -154.75 -155.24 7.2 Favored Glycine 0 C--N 1.282 -2.448 0 CA-C-N 113.319 -1.764 . . . . 0.0 111.651 -178.161 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.724 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 72.2 -168.35 52.35 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.846 179.007 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.62 ' H ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -105.69 -1.08 24.94 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.937 0.399 . . . . 0.0 110.542 178.783 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.9 m -88.08 -61.86 1.62 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.83 -63.26 4.5 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.913 178.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.26 -18.25 43.34 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.927 -178.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -78.65 139.82 58.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 117.419 0.609 . . . . 0.0 111.614 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 3.4 Cg_exo -76.8 164.91 29.46 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.452 2.768 . . . . 0.0 112.055 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 84.5 m -87.4 142.93 27.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.864 0.364 . . . . 0.0 110.769 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -108.52 120.86 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.952 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.502 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 62.9 m-85 -118.6 143.8 34.12 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-O 121.016 0.436 . . . . 0.0 111.223 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.679 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 28.5 Cg_endo -87.47 140.22 20.72 Favored 'Cis proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.706 -1.789 . . . . 0.0 111.98 -0.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.633 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 35.6 p90 -104.26 -174.06 2.45 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.518 178.064 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.1 m -141.56 127.1 18.91 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.86 -179.033 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.757 ' CG ' HD22 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -131.7 144.9 51.33 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.033 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.757 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.17 35.02 0.08 Allowed 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.61 1.164 . . . . 0.0 113.837 178.022 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.12 -3.74 84.45 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 115.026 0.77 . . . . 0.0 115.026 178.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.579 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 59.0 m-80 -110.2 138.7 46.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.371 1.086 . . . . 0.0 111.508 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -79.46 122.0 25.89 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.709 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.4 m-30 -108.35 106.9 17.25 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.836 0.827 . . . . 0.0 110.902 -178.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.679 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 92.1 mt-10 -91.23 -15.55 29.05 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.363 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -129.15 -177.78 4.37 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.5 m -66.19 164.61 15.36 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.684 178.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.0 t -141.99 175.53 9.66 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.772 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.428 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 23.3 p -128.64 17.54 6.35 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.522 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -65.26 153.75 40.15 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 114.118 -1.401 . . . . 0.0 112.025 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.28 -0.1 42.4 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.69 -0.686 . . . . 0.0 114.082 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.772 ' NH1' ' H ' ' A' ' 38' ' ' LYS . 2.3 mtp-105 -112.24 -176.47 2.93 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 117.781 0.791 . . . . 0.0 111.428 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 p -130.37 -14.95 3.7 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.462 ' OD2' ' HG3' ' A' ' 38' ' ' LYS . 2.6 p-10 -108.21 -96.17 0.38 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.365 0.53 . . . . 0.0 111.476 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.26 39.99 0.18 Allowed Glycine 0 CA--C 1.523 0.584 0 C-N-CA 119.169 -1.491 . . . . 0.0 116.521 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.772 ' H ' ' NH1' ' A' ' 34' ' ' ARG . 66.0 mttm -99.44 85.23 3.12 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.268 1.034 . . . . 0.0 109.066 177.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.428 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.1 mpt? -56.57 137.42 53.67 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.587 0.708 . . . . 0.0 111.36 -178.048 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.699 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.6 p-90 -134.34 -165.21 1.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.295 -178.149 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.5 p -162.99 145.16 10.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.977 178.419 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.36 149.8 45.68 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.172 -178.534 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.3 p -97.95 7.44 46.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.453 0.644 . . . . 0.0 109.869 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.9 p -129.35 155.7 45.22 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.284 178.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.633 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -61.54 -32.34 72.41 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.978 0.418 . . . . 0.0 110.942 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -127.49 111.36 13.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.846 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 65.2 t80 -78.39 -35.25 47.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.92 -177.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -53.75 -29.74 41.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.134 0.493 . . . . 0.0 112.05 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -85.04 -71.15 0.54 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.518 -179.238 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.98 -29.69 63.24 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 4.4 mtm180 51.61 47.45 24.78 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -114.05 118.22 33.46 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.846 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.2 p-90 -129.38 177.29 7.29 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 40' ' ' TRP . . . -171.7 150.33 13.21 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.619 179.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 14.5 m-30 -61.42 159.24 13.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -177.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.512 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 8.5 t -68.8 143.73 95.15 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 114.299 -1.318 . . . . 0.0 108.83 178.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.512 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 90.7 Cg_endo -68.6 -148.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.644 2.229 . . . . 0.0 113.412 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.415 ' HB3' ' CD1' ' A' ' 2' ' ' TRP . 44.0 t0 -64.0 104.86 0.76 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.199 -179.359 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -79.59 162.67 25.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.235 -179.142 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.783 0 CA-C-O 118.696 -1.058 . . . . 0.0 112.124 179.946 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 71.45 130.15 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.639 0.776 . . . . 0.0 111.953 -179.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.14 51.53 0.82 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.4 t 71.28 -167.36 0.15 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.697 -177.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.7 p -113.26 164.24 13.79 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.298 0.57 . . . . 0.0 111.963 -178.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.809 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -105.05 -166.31 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 176.155 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.645 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 39.57 -123.96 1.93 Allowed Glycine 0 C--N 1.319 -0.404 0 O-C-N 123.903 0.752 . . . . 0.0 113.112 177.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.633 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 37.2 -148.64 0.05 OUTLIER Glycine 0 C--N 1.334 0.464 0 N-CA-C 116.198 1.239 . . . . 0.0 116.198 177.144 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.06 -26.94 0.34 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.502 -0.849 . . . . 0.0 110.795 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -47.96 -59.55 3.27 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 123.548 0.53 . . . . 0.0 111.249 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.67 82.82 0.09 OUTLIER Glycine 0 C--N 1.329 0.194 0 CA-C-N 116.234 -0.439 . . . . 0.0 113.492 178.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.35 -25.36 5.72 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.863 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -88.26 141.33 30.8 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.749 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 56.8 Cg_endo -84.33 166.4 12.42 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.764 2.309 . . . . 0.0 111.538 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 2.7 m -74.69 120.83 20.77 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.22 105.28 16.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.092 0.472 . . . . 0.0 110.516 179.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.659 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 46.2 m-85 -100.47 139.23 20.48 Favored Pre-proline 0 N--CA 1.447 -0.588 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.416 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 7.2 Cg_endo -87.68 127.98 9.2 Favored 'Cis proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.377 -1.51 . . . . 0.0 112.711 -0.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.659 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 15.6 p90 -92.26 127.07 37.6 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.279 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 14.8 m -90.65 121.65 32.75 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.428 0.632 . . . . 0.0 112.455 -177.408 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.903 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.9 t80 -127.8 142.94 51.16 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.681 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 43.5 35.55 0.98 Allowed 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.187 0.995 . . . . 0.0 112.674 178.896 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.71 -6.27 83.69 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.935 -0.575 . . . . 0.0 114.466 179.244 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.55 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 66.4 m-80 -109.96 132.87 53.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.319 1.06 . . . . 0.0 111.942 -178.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -83.9 118.32 23.9 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.903 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 12.4 m-85 -99.66 112.03 24.3 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.811 0.815 . . . . 0.0 112.191 -177.343 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -83.23 -17.62 42.08 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.615 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 p -131.42 -173.25 3.06 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 70.7 m -64.22 166.2 8.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.595 0.712 . . . . 0.0 110.395 179.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.535 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 14.5 t -144.65 171.42 14.41 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.137 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 15.8 p -129.19 19.02 5.92 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.181 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.562 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.7 138.25 58.3 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 113.74 -1.573 . . . . 0.0 111.122 179.628 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.89 -3.4 44.79 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.935 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.427 ' HD2' ' HE1' ' A' ' 55' ' ' PHE . 17.0 mtp85 -114.35 -81.28 0.6 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.649 0.261 . . . . 0.0 110.763 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.5 m 57.03 32.55 21.87 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.233 -178.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.72 -28.28 8.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.212 -179.052 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 156.78 -66.72 0.3 Allowed Glycine 0 C--N 1.315 -0.611 0 CA-C-N 114.9 -1.045 . . . . 0.0 113.314 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.825 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 3.8 mptt -66.37 135.37 54.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.12 0.486 . . . . 0.0 112.047 -178.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.492 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 47.2 mtt -98.15 154.2 17.92 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.006 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.605 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 20.3 p-90 -136.46 -172.6 3.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.591 0.71 . . . . 0.0 112.461 -178.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 12.3 p -154.11 143.28 21.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.658 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 15' ' ' CYS . . . -81.88 158.34 24.03 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.31 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.1 p -107.74 16.38 23.68 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.542 0.687 . . . . 0.0 110.387 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.7 p -137.2 148.51 46.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.431 178.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -55.91 -42.11 75.56 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.152 0.501 . . . . 0.0 110.821 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -116.31 104.7 11.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.475 178.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.76 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 69.0 t80 -75.96 -29.21 58.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.526 -178.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -57.26 -34.65 68.85 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -96.02 -53.6 3.6 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.068 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -81.13 -19.24 43.97 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -177.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 13.1 mtm180 38.04 55.97 1.65 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -117.89 120.54 38.18 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.76 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.0 p-90 -132.94 177.35 7.72 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -174.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.54 146.74 11.44 Favored Glycine 0 C--O 1.22 -0.745 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.959 179.206 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.809 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.1 m-85 -70.17 159.6 33.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.787 0.794 . . . . 0.0 111.919 -179.104 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.682 ' HB3' ' HD2' ' A' ' 57' ' ' PRO . 32.9 m -94.38 172.48 5.59 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.08 178.057 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.682 ' HD2' ' HB3' ' A' ' 56' ' ' CYS . 57.1 Cg_endo -63.92 2.8 0.9 Allowed 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.684 2.256 . . . . 0.0 115.084 -178.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 63.94 150.11 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.593 178.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 -74.12 -41.3 61.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.275 -179.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.673 0 CA-C-O 118.515 -1.158 . . . . 0.0 112.366 179.949 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 76.2 p . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.617 0.246 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 30.5 t90 -82.96 -44.98 14.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.033 0.444 . . . . 0.0 110.488 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -86.53 82.15 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.236 0.541 . . . . 0.0 111.235 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.2 m -89.64 171.74 9.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.621 -179.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.436 HG22 ' SG ' ' A' ' 41' ' ' CYS . 23.2 p -84.3 177.56 8.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 122.156 0.979 . . . . 0.0 113.4 -178.629 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.758 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -136.08 -162.98 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.256 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 44.64 -87.05 0.01 OUTLIER Glycine 0 N--CA 1.465 0.586 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 176.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.612 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . -36.77 161.89 0.01 OUTLIER Glycine 0 N--CA 1.465 0.621 0 N-CA-C 116.77 1.468 . . . . 0.0 116.77 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.43 HD22 ' N ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -74.23 -7.71 53.67 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -178.918 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m -71.11 -18.83 62.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.2 0.455 . . . . 0.0 111.143 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.92 -105.97 1.99 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.526 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.97 46.72 1.13 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.805 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.436 ' O ' HG23 ' A' ' 5' ' ' THR . . . -93.84 148.54 35.49 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.941 0.37 . . . . 0.0 110.429 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.9 Cg_exo -77.66 143.23 21.15 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.523 2.148 . . . . 0.0 111.84 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 5.2 m -72.32 117.52 14.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.023 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.61 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 73.1 t -83.18 108.89 16.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.57 0.224 . . . . 0.0 110.625 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.405 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 50.8 m-85 -107.4 138.51 19.95 Favored Pre-proline 0 N--CA 1.45 -0.444 0 CA-C-O 120.59 0.233 . . . . 0.0 110.768 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.11 134.1 21.0 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.493 -1.461 . . . . 0.0 111.988 -0.642 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.61 ' HB3' ' O ' ' A' ' 16' ' ' VAL . 23.7 p90 -103.39 136.45 43.12 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.121 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 88.9 m -99.07 121.32 40.83 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.596 -178.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.808 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 77.0 t80 -112.06 131.24 55.55 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.609 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.532 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 34.25 44.62 0.1 Allowed 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 124.851 1.345 . . . . 0.0 113.727 175.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.48 -19.23 45.83 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 116.96 1.544 . . . . 0.0 116.96 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.534 ' O ' ' HA ' ' A' ' 20' ' ' THR . 54.0 m-80 -109.16 146.44 34.1 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 120.042 1.921 . . . . 0.0 111.866 -178.522 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 25.3 mtmt -89.07 125.83 35.18 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.653 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.808 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 39.3 m-85 -112.85 116.41 30.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.815 0.816 . . . . 0.0 111.43 -178.316 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -90.85 -22.18 21.09 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.679 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.4 p -123.28 -176.63 3.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.633 179.026 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.6 m -64.37 169.42 4.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.438 0.637 . . . . 0.0 110.562 179.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.488 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.5 t -147.6 176.27 10.21 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.315 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.1 p -139.14 25.48 2.48 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.133 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.76 139.38 58.76 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 113.063 -1.881 . . . . 0.0 112.558 -179.108 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.15 -5.64 40.74 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.694 -0.685 . . . . 0.0 113.069 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.647 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 14.3 mtp85 -95.81 149.72 21.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.244 0.545 . . . . 0.0 111.478 -179.039 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.1 p -120.77 3.03 10.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.92 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 p30 -96.51 -78.23 0.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.39 0.614 . . . . 0.0 110.996 179.761 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.95 -9.02 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.368 -0.833 . . . . 0.0 113.303 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.647 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 33.9 mmtt -67.58 140.55 56.93 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 117.532 0.666 . . . . 0.0 110.087 -179.724 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 68.9 mtm -97.92 144.04 27.88 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.699 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.9 p-90 -138.09 -167.18 2.11 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.396 0.617 . . . . 0.0 111.63 -178.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 22.3 p -159.65 148.94 18.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.115 179.836 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.547 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -81.84 144.13 31.24 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.552 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.8 p -101.69 17.12 23.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.789 0.804 . . . . 0.0 110.69 -178.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.4 p -136.14 152.78 51.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.976 178.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.63 -39.44 84.34 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.133 0.492 . . . . 0.0 110.823 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -122.5 109.83 14.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.465 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.87 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 46.7 t80 -75.61 -35.1 60.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.206 -178.932 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -48.86 -37.9 20.89 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -86.61 -63.46 1.31 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.488 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 0.9 OUTLIER -77.68 -24.4 49.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -176.98 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.705 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 13.6 mtm180 44.2 50.48 7.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 56.6 mttt -108.99 119.34 39.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 177.531 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.87 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 15.3 p-90 -131.82 172.54 12.18 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -175.251 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.612 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -170.78 146.04 9.42 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.804 178.765 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.758 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 14.9 m-30 -62.28 158.68 16.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.339 0.57 . . . . 0.0 111.396 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.1 m -88.25 151.24 48.56 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.311 178.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.3 5.59 2.23 Favored 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.017 2.478 . . . . 0.0 114.322 -178.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -98.12 103.61 15.57 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.766 179.308 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -116.06 39.67 3.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.163 -179.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.868 0 CA-C-O 118.533 -1.148 . . . . 0.0 112.674 179.869 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.811 0.339 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -130.14 83.42 2.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.311 -179.672 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.4 ' SD ' ' N ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -112.66 169.78 8.65 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.181 -179.108 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 m -85.4 -178.6 6.76 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.029 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -102.13 170.18 8.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.202 1.001 . . . . 0.0 113.654 -178.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -138.08 164.61 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 179.098 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.526 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.19 -149.16 51.35 Favored Glycine 0 C--N 1.315 -0.599 0 C-N-CA 118.23 -1.938 . . . . 0.0 111.853 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.479 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 50.33 -146.61 8.48 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 114.134 0.414 . . . . 0.0 114.134 177.728 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.49 -29.73 1.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.166 -0.517 . . . . 0.0 110.36 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.0 m -53.53 -37.73 63.11 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.986 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.84 -86.52 0.44 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.748 179.116 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.5 31.65 2.22 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.445 -179.623 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -80.07 141.13 53.98 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.491 0.186 . . . . 0.0 110.955 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 24.2 Cg_exo -61.05 137.35 71.18 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.757 2.304 . . . . 0.0 112.148 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.2 m -75.06 126.87 31.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.832 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 75.8 t -87.1 121.68 38.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.702 0.287 . . . . 0.0 111.121 -179.518 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.62 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 51.5 m-85 -116.96 139.2 25.49 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.307 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.8 Cg_endo -86.21 129.89 12.15 Favored 'Cis proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.641 -1.399 . . . . 0.0 112.303 -0.363 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.62 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 19.7 p90 -94.59 128.58 41.31 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.056 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 28.8 m -92.19 123.66 35.69 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.521 0.677 . . . . 0.0 112.652 -177.63 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.869 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.1 t80 -127.49 143.83 51.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.642 178.012 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.747 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 42.41 31.35 0.27 Allowed 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.168 0.987 . . . . 0.0 113.16 178.636 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.33 -1.33 79.39 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 178.464 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.5 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 65.4 m-80 -113.21 135.59 53.66 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.195 0.998 . . . . 0.0 111.675 -179.033 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -77.76 119.36 21.16 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.869 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.2 m-30 -103.56 105.88 16.25 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.88 0.848 . . . . 0.0 110.775 -179.179 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -83.84 -15.35 48.55 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.668 -179.571 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 p -132.96 -175.86 3.92 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.194 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.5 m -66.21 163.73 17.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.532 0.682 . . . . 0.0 109.895 179.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.467 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 15.3 t -139.83 176.36 8.81 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.158 -179.388 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.445 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 13.0 p -128.52 16.49 6.5 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.429 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.541 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -63.29 139.89 58.82 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.496 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.2 -11.84 21.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.276 -179.68 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.612 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.3 mtp85 -105.58 -72.02 0.73 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.92 0.39 . . . . 0.0 110.244 179.38 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.8 t 61.74 32.0 18.38 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.469 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' OD1' ' HB3' ' A' ' 34' ' ' ARG . 27.2 p-10 -112.11 -62.76 1.52 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.39 0.614 . . . . 0.0 110.875 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.75 -53.93 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.27 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.872 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 2.2 mppt? -69.03 110.66 4.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.757 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.445 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 55.6 mtm -77.45 158.44 29.99 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.556 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.665 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 19.5 p-90 -141.98 -169.57 2.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.14 0.495 . . . . 0.0 111.28 -178.784 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.521 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 4.0 p -160.61 144.15 13.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.982 177.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.95 153.91 34.13 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.425 -178.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 64.5 p -101.71 9.1 41.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.748 0.785 . . . . 0.0 109.672 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.7 p -130.81 153.94 48.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.253 178.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -59.84 -48.89 79.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 111.452 -179.564 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -111.45 108.77 18.43 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.832 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 71.6 t80 -78.47 -30.36 47.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.031 -178.503 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.61 -32.7 65.54 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -90.59 -57.87 2.68 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -178.649 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -77.73 -30.94 51.93 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 7.9 mmm180 49.49 44.95 24.24 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -110.75 117.77 34.34 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.832 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 10.1 p-90 -133.57 174.92 9.9 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -173.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.479 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.3 144.03 9.31 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 113.219 -1.81 . . . . 0.0 109.907 178.479 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.548 ' HD1' ' HB3' ' A' ' 40' ' ' TRP . 5.3 m-30 -60.0 158.55 10.77 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.516 0.674 . . . . 0.0 112.681 -179.533 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.5 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 10.6 t -87.55 113.28 53.49 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.451 179.386 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -79.98 3.62 7.44 Favored 'Trans proline' 0 CA--C 1.513 -0.537 0 C-N-CA 122.619 2.213 . . . . 0.0 113.48 -178.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -144.71 75.42 1.45 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.065 -1.425 . . . . 0.0 109.485 179.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -76.86 -37.64 55.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.534 -179.218 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.729 0 CA-C-O 118.388 -1.229 . . . . 0.0 111.997 179.922 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.727 0.299 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -75.78 85.92 2.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.9 ptm -106.73 45.89 0.96 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.844 -179.312 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.419 ' O ' ' HB3' ' A' ' 57' ' ' PRO . 7.6 m -74.38 -176.51 2.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.136 179.537 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.3 p -105.48 169.62 8.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.466 1.126 . . . . 0.0 113.688 -178.315 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.681 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -127.49 -166.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.25 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.417 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 36.04 -127.89 0.9 Allowed Glycine 0 N--CA 1.465 0.617 0 O-C-N 123.818 0.698 . . . . 0.0 113.61 177.436 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.592 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 42.61 -148.54 0.54 Allowed Glycine 0 C--N 1.334 0.458 0 N-CA-C 115.796 1.078 . . . . 0.0 115.796 177.127 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.529 HD21 ' HA ' ' A' ' 52' ' ' LYS . 10.9 p30 -133.48 -31.71 1.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.875 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.5 m -59.14 -29.2 67.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.489 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.95 -103.22 2.55 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.073 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -127.42 40.14 1.81 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.133 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.35 138.5 32.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.742 0.306 . . . . 0.0 111.122 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -56.84 132.59 52.65 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.888 2.392 . . . . 0.0 112.368 179.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 52.6 m -74.78 130.59 39.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.789 0.328 . . . . 0.0 111.009 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.8 t -83.22 117.89 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -118.28 142.08 30.63 Favored Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-O 120.947 0.403 . . . . 0.0 111.353 -179.406 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.6 Cg_endo -85.63 139.32 25.89 Favored 'Cis proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.038 -1.651 . . . . 0.0 111.763 -0.594 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.548 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 19.5 p90 -99.83 -166.48 1.34 Allowed 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.79 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.0 m -148.87 126.38 11.64 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.055 0.455 . . . . 0.0 111.115 -178.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.801 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 29.5 t80 -129.4 139.15 51.76 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.652 179.072 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.541 HD23 ' CG ' ' A' ' 21' ' ' PHE . 3.5 mm? 34.08 47.49 0.2 Allowed 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 124.65 1.218 . . . . 0.0 114.24 174.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.18 -12.21 70.17 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 114.345 -1.298 . . . . 0.0 116.022 177.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.455 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 61.1 m-80 -115.19 134.53 55.06 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 119.224 1.512 . . . . 0.0 112.387 -178.525 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -78.98 125.05 28.87 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.359 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.801 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.4 m-30 -109.79 118.81 37.5 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.831 0.824 . . . . 0.0 111.219 -178.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 28.3 mt-10 -91.7 -8.61 46.51 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.903 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.3 p -140.67 -164.86 1.81 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.159 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.5 m -72.5 168.2 19.03 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.849 178.531 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.4 t -149.75 166.71 28.61 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.229 -179.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.523 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 29.6 p -120.52 21.6 11.53 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 176.755 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.474 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -60.77 140.49 57.56 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 113.826 -1.533 . . . . 0.0 112.167 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.36 -8.03 10.44 Favored Glycine 0 N--CA 1.454 -0.122 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.778 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.634 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 22.8 mtp85 -105.35 -65.74 1.03 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.818 0.342 . . . . 0.0 110.845 -179.375 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.7 m 64.0 15.79 9.46 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.614 -179.553 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.67 -71.34 0.65 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.466 0.65 . . . . 0.0 110.712 179.133 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.34 -33.68 0.06 OUTLIER Glycine 0 C--N 1.308 -1.0 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.524 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.814 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 4.3 mptt -73.66 114.19 11.64 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 -179.726 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.523 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 52.1 mtt -87.9 146.42 25.57 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.618 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.624 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.3 p-90 -134.32 -164.42 1.5 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.142 0.496 . . . . 0.0 111.158 -178.47 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.2 p -169.58 155.85 6.27 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.41 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.86 146.26 29.0 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.113 -179.268 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 71.0 p -97.93 11.84 36.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.743 0.782 . . . . 0.0 109.853 179.339 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.6 p -134.76 158.91 42.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.549 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -61.81 -44.9 95.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.922 0.392 . . . . 0.0 111.238 -179.615 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -116.61 106.88 14.04 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.907 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 72.7 t80 -72.0 -39.42 69.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.86 -178.707 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -49.82 -37.39 30.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.559 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -87.65 -58.49 2.55 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.36 -23.77 54.18 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -177.089 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 7.5 mtm180 45.1 49.32 9.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 179.247 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.529 ' HA ' HD21 ' A' ' 9' ' ' ASN . 28.4 mtpp -116.93 117.62 30.18 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.537 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.907 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.3 p-90 -129.15 172.15 11.71 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -175.258 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.591 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.05 144.93 9.73 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 113.58 -1.645 . . . . 0.0 110.578 179.353 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.681 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.6 m-30 -63.39 158.45 20.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.327 0.563 . . . . 0.0 111.879 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.491 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 4.8 t -73.81 142.46 80.15 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.843 178.592 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.491 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 60.4 Cg_endo -74.31 -152.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.778 2.318 . . . . 0.0 113.168 -179.125 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -64.64 108.46 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.441 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -89.09 108.04 19.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.775 -179.579 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.635 -1.091 . . . . 0.0 112.276 -179.98 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 121.135 0.493 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.457 ' HE3' ' HA ' ' A' ' 2' ' ' TRP . 3.8 m95 -95.36 156.53 16.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.831 179.407 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.3 mmt -77.09 160.99 28.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.0 m -67.49 154.85 40.44 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.5 p -83.27 169.61 15.52 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.876 0.846 . . . . 0.0 112.284 -179.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -129.21 163.97 32.91 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 178.226 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.755 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.85 -145.14 46.29 Favored Glycine 0 C--N 1.308 -0.984 0 C-N-CA 117.434 -2.317 . . . . 0.0 111.148 -179.136 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.628 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 43.47 -149.41 0.67 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 116.077 1.191 . . . . 0.0 116.077 176.717 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.61 30.19 0.67 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.836 -0.682 . . . . 0.0 110.073 -179.576 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.726 ' HB3' HG21 ' A' ' 43' ' ' THR . 0.1 OUTLIER -69.03 -59.97 2.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.492 -179.681 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.29 48.28 2.64 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.082 -179.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.55 16.96 40.72 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.146 179.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.402 ' HB3' ' HB2' ' A' ' 10' ' ' SER . . . -102.29 140.76 21.42 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 117.111 0.456 . . . . 0.0 110.945 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -85.15 171.36 9.14 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.772 2.315 . . . . 0.0 111.404 179.254 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.3 m -75.58 148.24 39.0 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.194 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 98.7 t -114.23 117.43 55.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.241 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.612 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 66.0 m-85 -114.22 139.04 23.28 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.944 0.402 . . . . 0.0 111.117 -179.509 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -86.13 131.82 14.22 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.409 -1.496 . . . . 0.0 112.187 -0.17 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.623 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 27.9 p90 -99.59 128.92 45.71 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.194 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 m -91.72 123.03 34.81 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.335 -178.648 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.863 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 62.0 t80 -117.94 129.98 55.94 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.826 178.547 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.533 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.5 mm? 35.87 49.03 0.54 Allowed 'General case' 0 N--CA 1.424 -1.738 0 O-C-N 125.055 1.472 . . . . 0.0 113.33 175.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.09 -19.82 51.46 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 114.354 -1.294 . . . . 0.0 116.298 178.099 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -114.99 133.62 55.87 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 120.075 1.937 . . . . 0.0 113.523 -177.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -77.67 125.67 29.7 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.645 178.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.863 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 17.3 m-30 -111.06 118.64 36.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.794 0.807 . . . . 0.0 112.037 -178.559 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -89.27 -19.33 25.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.938 179.454 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 p -127.7 -178.29 4.43 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.167 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 87.7 m -67.79 170.47 7.93 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.908 179.181 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -146.96 173.28 12.58 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.254 0.549 . . . . 0.0 110.615 -178.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.611 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 17.4 p -125.4 19.58 8.11 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.057 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -59.85 135.47 57.71 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.745 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.83 -8.34 11.61 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.252 -179.494 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.9 mtp85 -109.73 -92.04 0.45 Allowed 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.038 0.446 . . . . 0.0 111.225 -179.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 t 65.89 33.73 7.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.186 -178.601 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.01 -30.49 10.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.928 -179.722 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 154.84 -48.73 0.5 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.299 -1.319 . . . . 0.0 112.311 -179.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 27.1 mmtm -79.4 123.58 27.64 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.783 0.291 . . . . 0.0 111.472 -179.532 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.611 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 71.5 mtm -89.55 146.56 24.5 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.235 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.644 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.3 p-90 -129.11 -167.38 1.78 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.4 0.619 . . . . 0.0 112.655 -177.224 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 21.8 p -158.92 143.4 15.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.697 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 19' ' ' PHE . . . -78.44 151.54 32.64 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.424 -0.911 . . . . 0.0 109.605 179.45 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.726 HG21 ' HB3' ' A' ' 10' ' ' SER . 70.0 p -103.4 13.22 34.12 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.582 0.706 . . . . 0.0 109.914 -179.573 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.8 p -135.0 149.01 50.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.508 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.78 -37.47 68.61 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.98 0.419 . . . . 0.0 111.498 -179.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -125.04 111.32 15.24 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.52 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.864 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 48.5 t80 -76.26 -34.5 59.16 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.91 -178.274 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -53.94 -31.17 49.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.714 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -89.3 -58.73 2.43 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -179.308 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.27 -19.29 28.5 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.671 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 11.3 mtm180 44.89 49.54 9.1 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 179.558 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -108.63 117.15 33.42 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.32 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.864 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.4 p-90 -126.63 173.31 9.57 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -175.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.566 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.77 138.37 5.11 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.587 179.248 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.755 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 12.2 m-85 -56.61 153.67 9.96 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.33 0.586 . . . . 0.0 110.995 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.639 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 9.1 t -68.92 145.7 96.89 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.236 -179.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.639 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 58.4 Cg_endo -74.25 -157.09 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.242 1.961 . . . . 0.0 111.768 179.378 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.3 t70 61.28 12.67 4.35 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 122.179 0.99 . . . . 0.0 110.036 -179.07 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -145.8 -172.42 3.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.846 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.453 -1.193 . . . . 0.0 112.479 179.196 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.884 0.373 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -77.81 109.68 12.04 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.276 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.2 mtp -98.82 175.56 5.91 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -177.608 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.8 m -108.86 -158.41 0.65 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.915 179.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.5 p -107.5 171.64 7.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 122.008 0.908 . . . . 0.0 113.132 -178.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.474 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -138.04 160.68 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 177.518 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.573 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.38 -154.92 44.41 Favored Glycine 0 C--N 1.313 -0.726 0 C-N-CA 117.804 -2.141 . . . . 0.0 110.637 -178.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.693 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 40.52 -141.68 0.84 Allowed Glycine 0 N--CA 1.464 0.558 0 N-CA-C 114.311 0.484 . . . . 0.0 114.311 177.625 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.5 -98.46 0.15 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.859 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m 34.41 31.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.304 1.441 . . . . 0.0 114.878 178.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.04 -87.33 0.04 OUTLIER Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.32 -0.467 . . . . 0.0 112.549 -179.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.31 30.36 0.37 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 178.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -73.6 145.1 84.29 Favored Pre-proline 0 C--O 1.224 -0.245 0 CA-C-N 115.307 -0.446 . . . . 0.0 111.521 -179.06 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 5.4 Cg_exo -76.02 149.68 32.95 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.019 2.479 . . . . 0.0 111.895 179.181 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 94.9 m -71.85 129.87 39.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.621 0.248 . . . . 0.0 110.372 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 65.2 t -100.32 128.22 52.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.938 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.0 143.28 35.03 Favored Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.432 179.253 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.0 Cg_endo -84.0 131.96 17.73 Favored 'Cis proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.446 -1.481 . . . . 0.0 111.958 -0.33 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.632 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 48.6 p90 -100.24 131.62 46.07 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.79 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.0 m -92.37 123.79 35.94 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -176.41 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.757 ' CG ' HD22 ' A' ' 22' ' ' LEU . 0.9 OUTLIER -125.56 144.17 50.68 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.264 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.757 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.88 35.16 0.11 Allowed 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.456 1.102 . . . . 0.0 113.26 178.896 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.86 -4.65 84.92 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 115.018 0.767 . . . . 0.0 115.018 178.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.601 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 62.4 m-80 -108.69 137.7 46.21 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 118.623 1.211 . . . . 0.0 112.031 -178.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -79.02 118.81 21.35 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.673 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.722 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.3 m-30 -103.25 108.44 19.66 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.71 0.767 . . . . 0.0 111.378 -178.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -88.77 -17.01 30.73 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.392 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 p -129.5 175.04 9.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.4 m -62.0 162.9 8.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.534 178.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -138.91 179.46 6.48 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.083 -178.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 p -133.38 15.93 4.08 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 177.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.641 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -59.98 139.04 57.69 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.384 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.99 -5.94 29.98 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.299 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 28.5 mtp85 -109.49 -75.97 0.62 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.612 0.206 . . . . 0.0 111.102 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.3 m 60.87 37.66 18.35 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.727 0.642 . . . . 0.0 110.317 -179.242 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -115.16 -32.34 5.72 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.788 0.804 . . . . 0.0 110.976 -178.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.81 -39.12 1.49 Allowed Glycine 0 C--N 1.309 -0.963 0 CA-C-N 114.282 -1.327 . . . . 0.0 111.849 -179.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.527 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 39.4 mttp -73.62 111.2 8.53 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.413 0.285 . . . . 0.0 110.907 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.6 mtt -85.49 146.61 26.85 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.271 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.689 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 21.4 p-90 -135.68 -169.78 2.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.408 0.623 . . . . 0.0 112.041 -178.466 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.0 p -159.86 145.26 15.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.143 178.823 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -77.82 151.46 33.94 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.477 -179.363 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 38.4 p -96.7 8.87 43.26 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.495 0.664 . . . . 0.0 110.382 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.4 p -133.07 155.56 49.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.221 179.256 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -62.34 -28.91 70.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.41 . . . . 0.0 111.025 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -125.93 114.42 18.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.412 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.879 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 66.4 t80 -89.03 -29.12 19.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.288 -179.305 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -52.61 -38.8 60.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.859 0.362 . . . . 0.0 111.526 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -92.97 -63.94 1.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.605 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.5 m-20 -64.36 -28.34 69.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -177.408 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER 42.96 49.46 5.24 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 179.306 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.605 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 9.5 mtpp -114.81 116.85 29.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.879 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.6 p-90 -128.85 176.97 7.42 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -175.278 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.693 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -172.32 145.83 8.84 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 113.107 -1.861 . . . . 0.0 108.94 179.002 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 13.6 m-30 -59.78 160.69 7.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 117.346 0.573 . . . . 0.0 111.853 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.457 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 1.8 t -59.23 134.27 88.02 Favored Pre-proline 0 CA--C 1.527 0.078 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 177.188 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.474 ' HA ' ' CG1' ' A' ' 6' ' ' VAL . 68.1 Cg_endo -73.03 -163.45 0.16 Allowed 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.024 1.816 . . . . 0.0 115.303 -176.049 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 34.04 63.4 0.41 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.14 -1.846 . . . . 0.0 112.845 -178.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -106.15 144.56 32.68 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.037 179.209 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.72 0 CA-C-O 118.297 -1.279 . . . . 0.0 112.184 179.949 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 120.862 0.363 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -106.16 115.41 30.18 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.022 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.497 ' HG3' ' HE2' ' A' ' 17' ' ' PHE . 0.6 OUTLIER -69.01 136.33 52.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -177.388 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.422 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 70.6 m -107.18 -173.58 2.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.922 177.16 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.421 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 24.2 p -122.96 152.0 41.29 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -178.681 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.76 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -121.72 -164.5 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 175.588 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.433 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 33.85 -123.45 0.39 Allowed Glycine 0 N--CA 1.465 0.61 0 O-C-N 123.903 0.752 . . . . 0.0 113.528 177.654 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.635 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 36.44 -145.38 0.08 OUTLIER Glycine 0 C--N 1.335 0.517 0 N-CA-C 115.744 1.057 . . . . 0.0 115.744 176.945 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.424 ' H ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -143.79 -11.18 0.68 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.251 -0.475 . . . . 0.0 111.542 179.963 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.42 ' N ' HD22 ' A' ' 9' ' ' ASN . 5.9 m -73.63 -21.18 60.38 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.921 0.391 . . . . 0.0 111.021 -179.7 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.57 -104.88 3.13 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.108 -179.909 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.21 39.94 1.77 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.467 179.875 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -84.87 140.84 37.63 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.787 0.327 . . . . 0.0 110.691 179.659 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 23.4 Cg_exo -61.6 131.36 35.36 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.698 2.266 . . . . 0.0 112.14 179.792 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 53.7 m -71.7 120.73 17.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.175 179.462 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 62.3 t -76.65 116.24 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 111.893 -179.301 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.559 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 40.5 m-85 -118.49 139.89 27.54 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.043 179.866 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.442 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.9 Cg_endo -83.4 138.15 31.99 Favored 'Cis proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.311 -1.537 . . . . 0.0 111.99 -0.447 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.559 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 40.4 p90 -102.97 -173.54 2.34 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.182 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.4 m -140.54 123.64 16.61 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.195 -179.508 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.693 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 56.8 t80 -122.46 133.33 54.6 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.99 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.56 HD23 ' CE1' ' A' ' 21' ' ' PHE . 3.8 mm? 32.61 47.76 0.11 Allowed 'General case' 0 N--CA 1.432 -1.357 0 O-C-N 124.915 1.384 . . . . 0.0 114.238 175.685 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.39 -11.92 66.75 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 116.205 1.242 . . . . 0.0 116.205 177.544 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.531 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 59.6 m-80 -109.47 154.94 21.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.417 1.608 . . . . 0.0 112.15 -178.585 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -95.66 126.98 41.31 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.107 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.693 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 37.9 m-85 -119.08 122.42 42.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.542 0.687 . . . . 0.0 112.054 -178.253 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.442 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 82.9 mt-10 -100.02 -18.06 17.21 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.904 178.987 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.3 p -129.04 -173.33 2.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.743 179.423 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.98 167.34 13.99 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 120.297 -0.561 . . . . 0.0 109.586 178.764 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.451 ' HG1' ' HE2' ' A' ' 26' ' ' TYR . 13.6 t -145.76 170.09 17.22 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.459 -178.895 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.793 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 56.6 p -122.21 18.66 10.72 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.752 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -58.92 133.69 56.27 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 113.963 -1.471 . . . . 0.0 111.748 -179.922 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.6 -5.01 54.34 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.315 -179.774 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 23.0 mtp85 -114.13 -58.17 2.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.083 0.468 . . . . 0.0 110.402 -179.443 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.9 p 54.48 28.32 9.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.334 -179.552 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.13 -88.84 0.47 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.024 0.44 . . . . 0.0 110.824 179.371 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -160.93 -21.16 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.785 179.45 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.5 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 89.4 mttt -79.06 76.16 5.56 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 122.328 0.251 . . . . 0.0 110.83 179.778 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.793 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 77.0 mtm -64.15 134.49 54.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 109.934 179.693 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.72 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.1 p-90 -125.12 -161.28 1.01 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.387 -177.518 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 3.5 p -169.53 154.52 5.64 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.594 178.189 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.412 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -78.8 147.81 33.14 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 120.835 0.35 . . . . 0.0 110.998 -179.252 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 66.0 p -100.88 7.06 43.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.636 0.731 . . . . 0.0 109.843 179.545 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.5 p -128.4 157.87 39.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.005 178.402 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.86 99.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.101 0.476 . . . . 0.0 110.759 -179.937 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -119.57 106.07 11.84 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.32 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.989 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 34.2 t80 -71.58 -38.33 70.92 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.91 -179.078 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -45.59 -36.76 4.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.437 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.79 -63.74 1.23 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -179.28 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.39 -18.64 59.89 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.815 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 34.74 56.3 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -179.868 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -114.32 116.25 28.66 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.492 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.989 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 8.4 p-90 -125.27 169.51 12.21 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -174.859 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.635 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.51 146.68 10.89 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.345 179.339 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.76 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 14.8 m-30 -62.06 163.23 8.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.366 0.603 . . . . 0.0 112.328 -179.21 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.3 t -76.48 139.32 67.48 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.5 179.241 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.653 ' O ' ' HG3' ' A' ' 59' ' ' GLN . 87.6 Cg_endo -71.11 -146.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.366 2.711 . . . . 0.0 112.944 -179.486 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.421 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 9.0 t70 -57.11 112.04 1.24 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.617 179.754 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.653 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 57.0 mt-30 -108.12 -154.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.372 0.606 . . . . 0.0 111.944 -177.958 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.702 0 CA-C-O 118.735 -1.036 . . . . 0.0 111.776 -179.958 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -82.87 129.95 35.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.015 0.436 . . . . 0.0 110.561 -179.766 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.2 mtp -94.69 -121.18 0.1 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.199 0.523 . . . . 0.0 111.238 -179.484 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -49.51 156.99 0.57 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.181 -179.202 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 p -69.78 175.09 4.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.306 1.051 . . . . 0.0 113.762 -178.553 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -132.07 163.52 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 104.945 -2.242 . . . . 0.0 104.945 178.728 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.62 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 64.14 -145.55 49.75 Favored Glycine 0 C--N 1.313 -0.714 0 C-N-CA 118.067 -2.016 . . . . 0.0 110.725 -179.369 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.643 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 44.35 -145.94 1.73 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 114.724 0.65 . . . . 0.0 114.724 177.791 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.21 -4.81 1.13 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.895 0.379 . . . . 0.0 110.686 178.681 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.497 ' HB2' HG21 ' A' ' 43' ' ' THR . 1.0 OUTLIER -95.07 52.28 1.43 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.705 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.12 96.04 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.255 -179.317 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.89 -17.68 3.87 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.358 -179.478 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.85 143.04 26.07 Favored Pre-proline 0 C--O 1.223 -0.294 0 CA-C-N 117.091 0.446 . . . . 0.0 110.584 179.532 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -85.67 170.86 8.74 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.768 2.312 . . . . 0.0 111.997 179.662 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.2 m -74.81 142.96 44.16 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.954 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 92.6 t -111.63 117.38 54.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 178.767 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.563 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 47.3 m-85 -114.69 142.08 27.73 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.752 -179.778 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.23 136.65 28.62 Favored 'Cis proline' 0 N--CA 1.464 -0.259 0 C-N-CA 123.369 -1.513 . . . . 0.0 112.005 -0.498 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.563 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 32.3 p90 -107.08 132.56 52.84 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.315 178.387 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 68.1 m -94.41 124.46 38.45 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.438 -179.239 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.743 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 41.7 t80 -124.76 137.38 54.33 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.901 178.995 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.545 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.4 mm? 37.0 49.23 0.78 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 175.293 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.92 -8.97 73.98 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 114.312 -1.313 . . . . 0.0 116.351 177.626 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 20' ' ' THR . 62.7 m-80 -113.69 153.85 28.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 119.515 1.658 . . . . 0.0 112.287 -178.614 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -93.37 122.48 35.83 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.804 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.743 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 15.0 m-85 -110.22 121.81 46.15 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.857 0.837 . . . . 0.0 111.56 -178.272 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -95.44 -21.06 18.57 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.883 179.676 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p -127.26 -174.67 3.22 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.894 179.953 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.6 m -66.64 170.35 6.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.3 0.571 . . . . 0.0 109.558 178.604 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.537 ' HG1' ' HE2' ' A' ' 26' ' ' TYR . 12.1 t -148.43 169.18 20.78 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.592 -179.693 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.0 p -121.98 17.72 10.9 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.21 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.32 137.07 58.19 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.721 -179.473 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.08 -0.09 63.84 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.718 179.862 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.448 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.0 mtp85 -107.71 -77.28 0.6 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.508 0.154 . . . . 0.0 111.297 -179.581 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.9 m 69.04 31.74 4.0 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.914 0.759 . . . . 0.0 110.663 -179.176 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.63 -84.13 0.59 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.662 179.36 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -158.51 -35.19 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.542 179.414 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 31.1 mmtm -82.32 143.7 31.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 117.413 0.606 . . . . 0.0 111.801 -179.049 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.8 mtm -102.96 151.17 22.78 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.523 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.657 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 11.3 p-90 -137.09 -170.08 2.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.288 0.566 . . . . 0.0 112.35 -178.082 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 21.4 p -155.85 146.84 22.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.966 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.98 149.42 30.8 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.754 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.497 HG21 ' HB2' ' A' ' 10' ' ' SER . 81.1 p -100.22 16.02 25.63 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.77 0.795 . . . . 0.0 110.056 -179.775 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.2 p -143.77 152.88 41.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.059 178.372 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.81 -40.71 80.58 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.963 0.411 . . . . 0.0 111.515 -179.351 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -119.44 107.04 12.85 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.918 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.89 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 58.1 t80 -73.58 -39.8 64.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.68 -178.494 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -49.75 -38.37 33.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.47 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.44 -38.9 12.29 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -178.482 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -93.5 -24.45 17.99 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.524 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 14.4 mtm180 43.17 49.57 5.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 178.977 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -116.91 120.12 37.47 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.014 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.89 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 12.6 p-90 -130.66 169.33 15.78 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -175.647 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.643 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.16 145.6 11.19 Favored Glycine 0 C--O 1.22 -0.772 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.629 178.732 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.62 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 4.8 m-30 -63.44 159.71 17.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.313 0.578 . . . . 0.0 111.849 179.938 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.742 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 2.7 t -71.43 155.98 92.09 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.272 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.742 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 6.0 Cg_exo -30.37 -111.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.1 1 C-N-CA 125.595 4.197 . . . . 0.0 116.756 -178.942 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.541 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 6.4 t70 -82.4 101.55 10.7 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.074 -177.724 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.439 ' OE1' ' HB3' ' A' ' 56' ' ' CYS . 3.4 mm100 -109.07 -77.8 0.6 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.574 179.604 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.46 -1.189 . . . . 0.0 112.031 -179.764 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -145.2 94.03 2.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.425 -179.788 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.508 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . 16.1 ptm -115.86 42.08 2.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.399 0.618 . . . . 0.0 109.962 179.279 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 16.7 m -82.07 -174.31 5.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.184 -179.335 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 55' ' ' PHE . 27.5 p -94.58 159.9 14.88 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.459 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 1.0 OUTLIER -127.2 6.62 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 CA-C-O 122.799 1.285 . . . . 0.0 109.964 179.922 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.42 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . -156.16 -160.12 9.82 Favored Glycine 0 C--N 1.282 -2.421 0 CA-C-N 112.874 -1.966 . . . . 0.0 111.008 -178.138 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.713 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 74.38 168.33 19.19 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.635 178.572 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.538 HD22 ' N ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -75.74 -7.64 54.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.55 -0.325 . . . . 0.0 111.527 178.782 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.6 m -80.63 -53.97 6.06 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.997 0.427 . . . . 0.0 109.931 179.419 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.38 78.87 0.11 Allowed Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.689 178.652 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.27 -35.05 2.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.074 179.099 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.54 148.88 98.13 Favored Pre-proline 0 CA--C 1.521 -0.167 0 CA-C-N 116.771 0.286 . . . . 0.0 110.915 -179.579 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 73.6 Cg_endo -82.03 151.01 16.11 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.219 1.946 . . . . 0.0 112.252 -179.967 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 72.3 m -78.33 138.55 38.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.218 179.668 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 47.9 t -104.83 118.08 51.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.578 0.228 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.418 ' CE2' ' HE1' ' A' ' 19' ' ' PHE . 69.6 m-85 -111.27 146.34 34.37 Favored Pre-proline 0 N--CA 1.447 -0.577 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.42 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -82.64 134.37 24.81 Favored 'Cis proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.431 -1.487 . . . . 0.0 112.106 -0.237 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.64 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 20.8 p90 -108.27 127.79 54.16 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.473 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 91.7 m -91.69 127.09 37.01 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.105 0.479 . . . . 0.0 111.39 -178.81 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.844 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 56.3 t80 -123.32 135.06 54.01 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.789 179.282 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.555 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 35.1 46.92 0.25 Allowed 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 124.491 1.119 . . . . 0.0 113.799 175.197 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.27 -20.7 49.45 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 116.237 1.255 . . . . 0.0 116.237 177.71 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -112.14 134.11 53.88 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 119.545 1.673 . . . . 0.0 112.644 -178.138 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 34.7 mtpt -79.04 125.33 29.24 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.709 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.844 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 17.9 m-85 -109.91 123.15 49.1 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.608 0.718 . . . . 0.0 111.589 -178.588 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 51.6 mt-10 -100.61 -9.96 21.43 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.817 179.283 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 p -130.88 172.12 12.4 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.3 m -63.72 160.87 16.16 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.616 179.285 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 t -138.74 174.06 10.92 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.159 -178.761 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 p -127.42 21.99 6.55 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 177.039 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.02 138.8 58.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.025 -179.384 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.01 -6.15 28.99 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.047 179.639 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.642 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 13.8 mtp85 -103.39 152.82 21.15 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 117.169 0.484 . . . . 0.0 111.224 -179.678 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.9 t -125.43 3.17 7.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.53 179.831 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.95 -76.81 0.41 Allowed 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.389 0.614 . . . . 0.0 110.758 179.389 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.5 -23.47 0.1 OUTLIER Glycine 0 C--N 1.307 -1.075 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.012 179.437 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.649 ' H ' ' CD ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -61.0 125.82 25.11 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 122.378 0.271 . . . . 0.0 110.843 -179.52 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.4 mtt -89.44 143.91 26.46 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.779 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.666 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 12.3 p-90 -132.17 -165.57 1.61 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.49 0.662 . . . . 0.0 111.39 -178.725 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -169.32 150.21 4.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.068 179.447 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.41 149.86 36.85 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.786 -179.23 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.2 p -96.42 9.08 42.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.777 0.798 . . . . 0.0 109.383 179.442 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.0 p -132.67 150.9 52.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.38 178.71 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.64 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.09 -36.48 72.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.07 0.462 . . . . 0.0 111.218 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -123.19 112.03 17.2 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.393 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.908 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 51.9 t80 -76.11 -39.06 56.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.806 -178.411 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -46.38 -35.96 5.99 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.956 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -82.52 -77.99 0.22 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -179.742 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.638 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 1.4 m-20 -67.83 -20.69 65.19 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -176.84 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 18.9 mtm180 43.24 50.73 5.8 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.943 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.638 ' HD2' ' HB3' ' A' ' 50' ' ' ASP . 59.1 mttt -111.69 118.24 35.09 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.113 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.908 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.6 p-90 -128.88 177.31 7.18 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -175.072 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.52 ' HA3' ' CG2' ' A' ' 5' ' ' THR . . . -176.76 154.63 16.67 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 113.691 -1.595 . . . . 0.0 110.013 179.227 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 15.4 m-30 -66.11 161.12 22.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.106 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.424 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 18.8 t -76.49 140.49 68.5 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.393 178.729 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.508 ' HG3' ' HA ' ' A' ' 3' ' ' MET . 89.9 Cg_endo -68.78 -149.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.475 0.383 0 C-N-CA 122.965 2.443 . . . . 0.0 114.265 -178.39 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.427 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 44.8 t0 -65.01 111.58 2.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.848 -179.119 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 47.2 mt-30 -108.15 -120.22 0.26 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.09 -179.881 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.846 -0.975 . . . . 0.0 111.596 179.293 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.2 p . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.514 0.197 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -74.99 140.76 43.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.894 0.378 . . . . 0.0 110.548 -179.923 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 81.1 mtp -103.11 -179.29 3.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.414 179.865 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.3 m -128.47 156.46 43.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.005 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 p -109.06 177.99 4.6 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.936 0.874 . . . . 0.0 112.138 -179.128 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -131.32 165.39 31.7 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.035 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 178.091 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.581 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 61.07 -148.34 46.2 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 118.187 -1.958 . . . . 0.0 111.667 -179.935 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.57 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 51.97 -152.54 6.3 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 114.801 0.68 . . . . 0.0 114.801 177.352 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.449 ' H ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -148.14 19.02 1.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.889 0.376 . . . . 0.0 111.025 179.763 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 3.9 m -81.75 -28.89 33.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.164 -179.172 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.06 -74.66 2.5 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.762 179.307 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.54 60.46 0.65 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.553 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -131.25 144.92 55.47 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.677 0.275 . . . . 0.0 111.241 -179.662 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.43 174.4 5.98 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.93 2.42 . . . . 0.0 111.852 179.888 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.8 m -85.02 128.21 34.53 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.817 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 99.3 t -95.45 108.26 20.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.048 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -110.22 142.14 25.36 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.141 -179.081 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -82.55 139.37 38.96 Favored 'Cis proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.821 -1.741 . . . . 0.0 111.276 -0.783 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.54 ' HZ ' HG22 ' A' ' 30' ' ' THR . 36.3 p90 -105.98 135.76 46.85 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.703 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 41.4 m -96.76 120.32 36.87 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.376 0.608 . . . . 0.0 110.76 -179.139 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.723 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 50.2 t80 -116.34 134.07 55.3 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.741 178.951 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.538 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.7 mm? 33.36 45.41 0.08 Allowed 'General case' 0 N--CA 1.435 -1.224 0 O-C-N 124.872 1.358 . . . . 0.0 114.224 174.789 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.04 -10.86 62.12 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 116.584 1.394 . . . . 0.0 116.584 177.331 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.502 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 41.0 m-80 -115.35 156.43 25.53 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.87 1.835 . . . . 0.0 112.8 -178.123 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -91.66 122.2 34.01 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.788 179.047 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.723 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 42.8 m-85 -115.22 111.25 20.67 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.725 0.774 . . . . 0.0 111.141 -179.414 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -91.26 -9.21 46.0 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.899 -179.769 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 p -138.91 -166.55 2.04 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.43 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.4 m -71.38 167.28 19.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.416 0.627 . . . . 0.0 110.52 179.018 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.54 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.5 t -146.85 173.22 12.6 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.601 179.979 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 p -127.03 19.33 7.07 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.386 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -62.49 139.6 58.59 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.43 -179.124 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.9 -0.64 44.11 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.036 179.437 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.641 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.8 mtp85 -105.56 142.46 35.26 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.155 0.503 . . . . 0.0 111.741 -179.194 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -109.58 -0.97 18.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.777 179.575 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.67 -85.81 0.24 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.267 0.556 . . . . 0.0 111.551 -179.897 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.95 -8.55 0.04 OUTLIER Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.68 -179.765 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.641 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 44.6 mmtt -73.58 114.13 11.48 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 117.282 0.541 . . . . 0.0 110.0 179.785 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -73.85 149.98 41.24 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.922 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.618 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 13.0 p-90 -137.26 -163.81 1.49 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.152 0.501 . . . . 0.0 111.375 -178.527 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 23.5 p -160.09 153.79 22.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.846 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.38 144.73 25.84 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.318 178.347 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -99.56 13.54 33.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.804 0.812 . . . . 0.0 110.349 -179.353 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.9 p -136.76 147.52 46.71 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.501 178.212 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.16 -48.99 64.64 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.166 0.507 . . . . 0.0 111.053 -179.439 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -113.6 112.09 22.94 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.086 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.875 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 56.7 t80 -73.23 -40.2 64.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.837 -178.432 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -48.22 -36.07 13.1 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.086 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.46 -68.4 0.68 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.716 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.84 -23.16 52.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.87 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 24.7 mtm180 45.4 50.57 10.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -179.617 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -112.51 117.13 31.52 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.019 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.875 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.1 p-90 -127.78 169.7 13.57 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.297 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.493 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -159.2 137.51 5.19 Favored Glycine 0 C--O 1.221 -0.688 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.473 178.647 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.581 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 2.5 m-30 -58.47 158.28 7.76 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.289 0.636 . . . . 0.0 111.738 179.686 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.712 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 10.0 t -90.7 148.5 38.61 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.674 179.983 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.712 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 60.9 Cg_endo -64.48 -113.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.29 2.66 . . . . 0.0 112.626 179.139 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.406 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 29.3 t70 -58.21 104.15 0.19 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.618 179.808 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 68.6 mt-30 -96.98 -9.41 28.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.461 -179.585 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.898 0 CA-C-O 118.701 -1.055 . . . . 0.0 112.11 179.939 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 2' ' ' TRP . 3.1 p . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.317 0.103 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.443 ' HB3' ' O ' ' A' ' 1' ' ' SER . 64.5 t-105 72.55 148.36 0.09 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.778 0.674 . . . . 0.0 110.709 -179.064 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -76.4 59.56 1.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.518 -179.107 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.07 176.36 6.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.187 0.518 . . . . 0.0 111.211 -179.737 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -110.77 172.63 6.76 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.832 -179.715 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.758 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -113.67 -166.93 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 176.8 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 36.99 -125.98 1.08 Allowed Glycine 0 N--CA 1.462 0.419 0 O-C-N 124.038 0.836 . . . . 0.0 113.226 177.592 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.683 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 31.85 -141.42 0.04 OUTLIER Glycine 0 C--N 1.335 0.474 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 176.801 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.516 HD22 ' N ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -154.51 27.67 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.693 -0.753 . . . . 0.0 109.792 179.894 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.46 ' HB3' HG21 ' A' ' 43' ' ' THR . 0.3 OUTLIER -87.12 -32.87 19.67 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.934 -179.222 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.82 -75.89 2.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.437 -178.628 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -137.16 17.66 3.57 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.78 179.41 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 10' ' ' SER . . . -81.52 141.81 49.23 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.757 0.313 . . . . 0.0 111.198 179.754 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -84.03 165.74 13.12 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.533 2.155 . . . . 0.0 111.688 179.486 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.5 m -79.93 136.7 36.7 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.829 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.3 t -96.39 107.35 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.688 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.552 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 38.0 m-85 -111.44 138.23 21.34 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-O 121.046 0.45 . . . . 0.0 111.066 -179.59 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.606 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 9.4 Cg_endo -88.5 134.15 12.38 Favored 'Cis proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.239 -1.567 . . . . 0.0 112.415 -0.555 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.594 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 37.3 p90 -97.26 -168.32 1.67 Allowed 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 119.707 -0.797 . . . . 0.0 108.85 178.063 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.4 m -147.36 127.46 13.74 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.421 -179.006 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.818 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -129.91 144.07 51.13 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.704 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.758 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.06 36.32 0.11 Allowed 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.863 1.265 . . . . 0.0 113.343 178.733 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.4 -12.63 69.24 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 115.19 0.836 . . . . 0.0 115.19 178.667 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -106.0 135.72 46.94 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 118.667 1.234 . . . . 0.0 111.923 -178.932 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 19' ' ' PHE . 88.8 mttt -78.94 126.15 30.32 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.915 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.818 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.4 m-30 -108.57 114.6 28.56 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.763 0.792 . . . . 0.0 111.199 -179.123 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.606 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 50.8 mt-10 -90.49 -20.34 22.81 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.586 -179.568 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 p -125.61 -175.71 3.41 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.501 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.5 m -67.64 162.54 23.37 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.451 179.039 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -138.12 171.07 14.94 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.173 -179.349 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.6 p -126.18 21.95 7.3 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.244 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.634 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -66.26 140.61 58.15 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.299 -179.63 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.92 -3.59 50.17 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.553 179.579 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.687 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 16.9 mtp85 -109.47 135.28 50.74 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.155 0.502 . . . . 0.0 110.823 -179.341 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.8 t -102.36 0.91 34.81 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.67 179.876 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.32 -82.85 0.33 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.391 0.615 . . . . 0.0 111.677 179.847 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 168.34 -12.61 0.06 OUTLIER Glycine 0 C--N 1.311 -0.82 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.204 -179.852 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.687 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 81.2 mttt -62.04 98.91 0.11 Allowed 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 122.662 0.385 . . . . 0.0 110.872 179.494 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.7 mtm -69.87 139.04 52.98 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.202 -179.604 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.659 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.1 p-90 -129.08 -165.96 1.58 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.411 -178.899 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.4 p -157.37 150.02 23.12 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.304 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.461 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -84.97 148.05 26.4 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.396 179.596 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.46 HG21 ' HB3' ' A' ' 10' ' ' SER . 49.7 p -102.98 10.97 37.92 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.841 0.829 . . . . 0.0 109.732 179.805 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.5 p -131.0 149.88 52.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.884 178.149 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.38 -43.28 83.46 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.124 0.488 . . . . 0.0 111.036 -179.572 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -117.26 109.05 16.37 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.225 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.843 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 73.7 t80 -77.12 -34.97 56.61 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.866 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -51.12 -35.03 33.43 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.791 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -86.57 -76.8 0.34 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.343 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.74 -19.2 65.81 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -176.824 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 45.2 mtm-85 39.24 54.6 2.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 179.253 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -112.88 119.21 37.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.525 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.843 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 8.5 p-90 -129.55 173.13 10.87 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -174.701 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.562 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -164.32 144.61 9.56 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 113.327 -1.76 . . . . 0.0 109.529 178.793 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.758 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.3 m-30 -61.89 156.75 20.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 117.69 0.745 . . . . 0.0 111.843 -179.646 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.456 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 7.6 t -70.65 140.78 87.03 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.404 178.365 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.456 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 65.7 Cg_endo -65.63 -143.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.476 2.784 . . . . 0.0 112.76 -179.544 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.416 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 68.3 m-20 -63.16 85.56 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.451 179.953 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.451 ' HG2' ' H ' ' A' ' 59' ' ' GLN . 2.6 pt20 -80.96 -13.8 58.55 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.042 -178.474 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.752 0 CA-C-O 118.596 -1.113 . . . . 0.0 111.601 179.594 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.516 0.198 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -74.83 164.88 26.08 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.886 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.472 ' HB3' ' HG3' ' A' ' 57' ' ' PRO . 1.8 mpt? -50.14 104.89 0.08 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.329 0.393 . . . . 0.0 111.557 -179.141 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.8 m -77.13 159.58 29.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.986 179.968 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 p -93.18 163.57 13.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.605 1.193 . . . . 0.0 114.026 -178.084 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -138.71 162.36 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 177.844 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.607 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 63.89 -147.47 50.72 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 117.629 -2.224 . . . . 0.0 111.512 -179.46 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.696 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 47.88 -137.87 12.51 Favored Glycine 0 N--CA 1.461 0.309 0 N-CA-C 114.111 0.404 . . . . 0.0 114.111 177.788 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.63 20.67 0.4 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.3 m -96.15 -12.77 24.23 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.702 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.77 -79.2 1.14 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.57 179.545 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.54 23.09 0.74 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.761 -179.628 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.61 146.37 95.91 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.506 0.193 . . . . 0.0 110.654 179.622 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -77.3 139.67 18.88 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.994 1.796 . . . . 0.0 112.474 -179.831 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 87.9 m -71.14 124.49 24.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.246 179.468 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.502 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 64.1 t -89.95 122.13 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.184 -179.57 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.477 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 54.1 m-85 -117.89 140.36 27.65 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.02 179.422 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -86.19 133.21 15.66 Favored 'Cis proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.181 -1.591 . . . . 0.0 112.136 0.152 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.665 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 37.7 p90 -102.4 132.69 48.25 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.63 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 m -95.37 127.31 41.31 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -177.475 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.832 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.1 t80 -127.16 144.31 51.06 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.182 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.759 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.95 32.62 0.12 Allowed 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 124.298 1.039 . . . . 0.0 113.324 178.505 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.29 -8.43 77.44 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 178.793 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.439 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 67.9 m-80 -107.98 135.81 48.74 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 118.354 1.077 . . . . 0.0 111.859 -179.148 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -78.64 123.12 26.79 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.998 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.832 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.8 m-30 -107.59 110.7 22.66 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.84 0.829 . . . . 0.0 111.183 -178.901 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -86.28 -21.92 27.09 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.108 -1.406 . . . . 0.0 110.37 -179.619 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 p -126.1 -175.2 3.3 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.788 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.9 m -65.9 163.4 17.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.393 0.616 . . . . 0.0 109.758 178.896 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.488 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.7 t -138.22 172.84 12.32 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.269 -179.311 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.4 p -125.39 12.9 8.18 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 177.762 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.551 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -60.9 138.27 58.16 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 113.881 -1.508 . . . . 0.0 111.691 -179.697 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.15 -10.12 43.49 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.779 179.767 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.613 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.6 mtp85 -105.74 139.66 39.98 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 117.424 0.612 . . . . 0.0 110.96 179.567 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.3 m -110.4 3.4 19.7 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.798 179.846 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -93.77 -77.8 0.45 Allowed 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -179.483 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.53 -32.42 0.1 OUTLIER Glycine 0 C--N 1.308 -0.993 0 C-N-CA 120.457 -0.877 . . . . 0.0 114.173 179.745 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.836 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 8.2 mptt -60.08 126.16 26.46 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.405 0.602 . . . . 0.0 111.126 -178.926 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 43.6 mtt -86.11 150.86 24.13 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.459 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.686 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.3 p-90 -137.43 -167.91 2.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.966 0.412 . . . . 0.0 111.184 -178.548 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.7 p -161.76 142.55 10.78 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.556 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -71.69 154.45 41.35 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.102 0.477 . . . . 0.0 110.737 -179.324 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.5 p -103.5 10.11 37.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.68 0.752 . . . . 0.0 110.119 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.1 p -133.46 155.81 48.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.901 178.766 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -59.15 -35.74 74.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.906 0.384 . . . . 0.0 111.432 -179.67 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -124.98 113.09 17.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.493 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.819 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 80.3 t80 -78.06 -31.05 50.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.028 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -58.76 -34.92 71.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.527 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -79.11 -64.43 1.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.938 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.955 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.3 m-20 -72.86 -36.56 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -177.466 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 7.9 mmm-85 54.65 45.26 27.19 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.365 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.955 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 12.4 mtpt -116.74 120.4 38.47 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 176.894 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.819 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 10.4 p-90 -132.5 172.15 12.87 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.437 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.696 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -160.89 147.33 13.91 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 112.984 -1.916 . . . . 0.0 109.708 178.209 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.607 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 10.6 m-30 -58.83 163.54 3.34 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.262 0.553 . . . . 0.0 111.719 -179.862 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.581 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.2 t -61.88 134.39 94.13 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.286 179.753 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.472 ' HG3' ' HB3' ' A' ' 3' ' ' MET . 91.9 Cg_endo -70.02 -146.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.304 2.669 . . . . 0.0 113.537 -179.071 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.426 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 9.0 t70 -56.0 108.24 0.44 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.872 -179.41 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 70.2 mt-30 -102.55 95.21 6.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.754 -179.853 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.738 0 CA-C-O 118.622 -1.099 . . . . 0.0 111.948 179.91 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.358 0.123 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 6.3 m0 64.2 99.54 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.284 0.564 . . . . 0.0 111.424 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.83 68.94 7.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.758 -179.587 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.8 m 42.7 -134.6 0.42 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.296 0.569 . . . . 0.0 112.14 178.134 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.8 p -103.18 177.68 4.77 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 122.07 0.938 . . . . 0.0 111.953 -179.226 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -132.99 159.42 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 177.63 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.862 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 67.2 -147.45 49.1 Favored Glycine 0 C--N 1.308 -1.002 0 C-N-CA 117.587 -2.245 . . . . 0.0 111.078 -179.032 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.617 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 45.25 -144.55 2.83 Favored Glycine 0 C--N 1.328 0.108 0 N-CA-C 115.157 0.823 . . . . 0.0 115.157 177.318 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.82 29.16 0.32 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.19 0.519 . . . . 0.0 110.863 179.95 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -79.28 -34.44 42.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.913 -179.759 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.38 -64.32 2.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.254 -179.324 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.9 29.7 0.91 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.133 179.573 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 10' ' ' SER . . . -100.64 144.26 28.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.86 -0.17 . . . . 0.0 111.11 179.804 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -87.59 166.17 7.64 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.443 2.095 . . . . 0.0 111.697 179.409 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 71.7 m -81.13 118.77 22.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.581 179.829 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 59.6 t -82.67 117.75 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.854 -179.799 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -114.55 134.52 22.33 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.596 179.875 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.724 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 9.4 Cg_endo -85.97 136.92 20.83 Favored 'Cis proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.246 -1.564 . . . . 0.0 112.901 -0.158 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.562 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 29.9 p90 -100.96 129.42 46.8 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.778 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.5 m -91.49 127.0 36.76 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.334 0.588 . . . . 0.0 112.552 -177.395 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.784 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.4 t80 -131.3 142.32 50.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.469 178.356 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.727 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.38 38.96 0.41 Allowed 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.624 1.17 . . . . 0.0 113.665 178.278 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.37 -8.71 79.24 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 115.216 0.846 . . . . 0.0 115.216 178.426 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.566 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 68.3 m-80 -110.39 137.99 47.37 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 118.461 1.13 . . . . 0.0 112.068 -179.082 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -81.5 121.11 25.88 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.498 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.784 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.3 m-30 -104.51 104.7 14.59 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.892 0.854 . . . . 0.0 110.977 -178.129 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.724 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 27.5 mt-10 -84.47 -9.34 58.46 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.159 -1.382 . . . . 0.0 111.259 -179.231 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.0 p -137.58 -167.67 2.17 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.402 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 81.2 m -70.52 170.89 11.17 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.189 -0.605 . . . . 0.0 109.982 178.597 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.542 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 14.3 t -150.11 172.4 15.33 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.279 -179.983 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.6 p -127.11 20.53 6.89 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.07 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.527 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -65.25 142.72 58.19 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 114.067 -1.424 . . . . 0.0 112.234 -179.613 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.58 -4.3 21.47 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.892 179.396 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.678 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 20.6 mtp85 -101.69 133.21 46.76 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.255 0.55 . . . . 0.0 111.688 -179.216 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 p -105.85 1.1 26.55 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.753 178.833 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.539 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 1.2 p-10 -88.08 -83.78 0.21 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.728 179.807 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.64 -30.64 0.11 Allowed Glycine 0 C--N 1.311 -0.832 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.588 179.466 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.678 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 0.1 OUTLIER -59.19 143.55 48.61 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.875 0.369 . . . . 0.0 111.651 -179.285 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.4 mtt -98.02 149.92 21.94 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.736 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.611 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.4 p-90 -141.11 -171.85 3.36 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.334 0.587 . . . . 0.0 111.434 -178.331 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 1.7 p -156.7 137.3 13.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.827 177.969 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.09 151.07 44.87 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.436 0.636 . . . . 0.0 111.458 -178.553 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.1 p -100.75 7.51 43.78 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.915 179.236 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.1 p -127.92 143.83 51.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.754 179.459 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.48 -49.33 70.37 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.916 0.389 . . . . 0.0 110.98 179.958 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -112.46 103.53 11.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.052 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.822 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 56.9 t80 -76.19 -29.25 57.59 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.274 -178.04 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -55.67 -37.77 68.73 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.562 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -86.57 -52.28 5.65 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.298 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.69 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 13.5 m-20 -77.39 -45.98 24.21 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.477 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.675 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER 61.46 37.03 16.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.895 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.69 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 5.0 mppt? -105.11 118.09 35.65 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.183 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.822 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 13.9 p-90 -128.66 174.88 9.03 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -174.067 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.617 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -157.68 145.9 12.62 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 112.789 -2.005 . . . . 0.0 108.733 178.274 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.862 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 6.2 m-85 -66.86 163.93 18.44 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 117.772 0.786 . . . . 0.0 112.106 -179.402 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.889 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 2.2 t -69.41 161.21 75.26 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.592 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.889 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 43.6 Cg_endo -60.45 -143.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.671 2.247 . . . . 0.0 114.636 -178.407 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.49 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 36.0 t0 -60.92 116.99 4.89 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.631 -178.158 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -120.87 162.57 19.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.527 179.669 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.758 0 CA-C-O 118.705 -1.053 . . . . 0.0 111.788 179.897 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.5 t . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 120.65 0.262 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.609 ' HB2' ' HB3' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -74.24 -174.7 2.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.119 0.485 . . . . 0.0 111.505 179.992 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 1.2 pmm? -71.23 145.7 49.46 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.674 179.738 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 m -91.6 163.53 14.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.131 179.872 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 p -109.21 152.65 24.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.788 0.804 . . . . 0.0 112.99 -178.53 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -133.23 164.01 36.26 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.979 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.976 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.699 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 77.19 -80.44 1.26 Allowed Glycine 0 N--CA 1.463 0.463 0 C-N-CA 118.194 -1.955 . . . . 0.0 113.928 178.932 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.8 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . -45.98 166.22 0.07 OUTLIER Glycine 0 N--CA 1.468 0.813 0 CA-C-N 114.502 -0.849 . . . . 0.0 115.174 -179.16 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.497 HD22 ' N ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -74.27 -11.67 60.34 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.783 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.536 ' HB2' HG21 ' A' ' 43' ' ' THR . 0.9 OUTLIER -99.55 32.6 2.75 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.551 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -44.87 98.47 0.01 OUTLIER Glycine 0 C--N 1.338 0.642 0 O-C-N 124.002 0.814 . . . . 0.0 113.112 -178.725 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.77 -25.72 4.14 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.039 -179.69 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.76 142.53 34.57 Favored Pre-proline 0 C--O 1.224 -0.274 0 CA-C-N 117.622 0.711 . . . . 0.0 111.213 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.609 ' HB3' ' HB2' ' A' ' 2' ' ' TRP . 13.6 Cg_exo -68.91 147.33 68.07 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.169 2.58 . . . . 0.0 113.018 -179.724 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 86.4 m -82.47 116.5 21.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.336 178.777 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.6 t -77.27 119.32 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -116.09 137.6 23.53 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.057 0.456 . . . . 0.0 111.22 -179.591 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 87.4 Cg_endo -84.02 142.67 40.96 Favored 'Cis proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.428 -1.905 . . . . 0.0 112.795 -0.172 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.605 ' HZ ' HG22 ' A' ' 30' ' ' THR . 21.6 p90 -104.68 128.77 52.85 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.74 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.3 m -95.6 122.63 38.55 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.433 0.635 . . . . 0.0 111.967 -177.933 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.684 ' CE2' ' HZ2' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -104.44 -140.36 0.36 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.151 178.298 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.703 ' H ' HD22 ' A' ' 22' ' ' LEU . 0.5 OUTLIER -49.67 52.81 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.825 2.05 . . . . 0.0 114.884 -177.626 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 21' ' ' PHE . . . 86.2 8.4 78.44 Favored Glycine 0 C--N 1.296 -1.654 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.613 179.562 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.487 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 53.0 m-80 -125.89 134.29 51.65 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.34 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -79.6 118.38 21.39 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.381 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.643 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.3 m-85 -105.67 109.58 21.6 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.877 0.846 . . . . 0.0 111.323 -178.522 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.416 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 31.6 mt-10 -86.75 -15.91 37.96 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.079 -179.874 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 p -128.23 179.56 5.55 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.168 179.058 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.0 m -66.42 160.45 24.82 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.891 178.963 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.605 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 10.6 t -136.62 170.95 15.23 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.021 -179.509 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.3 p -123.59 15.25 9.52 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 177.023 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.486 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -60.59 140.5 57.37 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.41 -179.893 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.25 -7.55 16.71 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.528 -179.837 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.2 mtp85 -110.2 -68.11 0.95 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.901 0.381 . . . . 0.0 110.842 -179.8 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.7 p 52.99 31.15 10.51 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.74 -179.091 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.13 -79.2 0.55 Allowed 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.631 179.281 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.26 -36.48 0.03 OUTLIER Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.332 179.768 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -88.73 141.01 28.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.226 0.513 . . . . 0.0 112.31 -178.438 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -101.42 148.38 25.24 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 176.616 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.684 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 20.8 p-90 -135.63 -167.94 2.11 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.193 0.52 . . . . 0.0 111.701 -177.89 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.0 p -162.71 142.39 9.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.253 178.851 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' A' ' 19' ' ' PHE . . . -73.39 150.78 41.51 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.927 -179.223 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.536 HG21 ' HB2' ' A' ' 10' ' ' SER . 70.1 p -100.34 14.76 29.98 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.332 179.373 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.1 p -136.18 154.34 50.98 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.819 179.104 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.94 -41.03 95.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.079 0.466 . . . . 0.0 110.512 -179.814 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -118.31 111.87 19.31 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.58 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.783 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 76.8 t80 -79.62 -28.96 40.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.381 -177.626 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -57.76 -38.26 75.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.053 0.454 . . . . 0.0 112.013 -179.55 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -79.32 -61.05 2.13 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.578 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -81.74 -25.72 35.15 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.763 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.8 mtm180 48.81 45.56 22.07 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -110.97 118.78 37.01 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.277 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.783 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 17.1 p-90 -130.37 174.54 9.76 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -174.645 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.8 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -168.24 142.83 7.71 Favored Glycine 0 C--O 1.222 -0.652 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.04 179.113 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.699 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 13.9 m-30 -59.18 160.31 6.51 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.317 0.579 . . . . 0.0 111.804 -179.396 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.437 ' C ' ' H ' ' A' ' 58' ' ' ASP . 5.9 t -70.45 136.81 86.16 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.933 179.834 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HG3' ' HB2' ' A' ' 3' ' ' MET . 94.3 Cg_endo -72.6 5.78 2.69 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.705 2.27 . . . . 0.0 112.168 179.427 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 56' ' ' CYS . 10.7 t70 -138.45 84.6 2.04 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 112.936 -1.938 . . . . 0.0 108.869 179.281 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -94.55 -20.54 19.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.923 -178.817 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.64 0 CA-C-O 118.478 -1.179 . . . . 0.0 111.936 -179.184 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.885 0.374 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -125.63 132.99 52.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.485 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.0 mmt -97.97 77.48 2.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.196 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 t 61.02 -167.67 0.19 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 123.554 0.534 . . . . 0.0 111.513 179.296 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -104.61 -177.93 3.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.999 179.971 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.745 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -117.98 -173.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 177.027 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.42 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 37.27 -129.67 1.23 Allowed Glycine 0 CA--C 1.523 0.578 0 O-C-N 123.932 0.77 . . . . 0.0 113.208 178.158 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.553 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 39.96 -145.47 0.34 Allowed Glycine 0 C--N 1.337 0.591 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 177.081 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.01 28.72 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.915 -0.642 . . . . 0.0 110.639 179.86 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.22 -53.14 7.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.356 179.915 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.35 -63.83 0.46 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.937 -179.397 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.23 30.92 2.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.441 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.53 139.19 21.32 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 111.4 179.802 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -86.36 174.69 5.9 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.028 2.485 . . . . 0.0 111.987 179.281 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.6 m -79.36 137.8 37.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.619 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 65.9 t -102.31 113.33 38.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.642 0.258 . . . . 0.0 110.323 179.633 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.616 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 36.6 m-85 -117.53 137.48 24.21 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-O 120.838 0.351 . . . . 0.0 111.237 -179.632 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.687 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 37.7 Cg_endo -87.04 138.88 20.09 Favored 'Cis proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.659 -1.809 . . . . 0.0 112.339 -0.744 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.616 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 34.2 p90 -105.1 -169.03 1.55 Allowed 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.041 178.121 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.464 ' OG1' ' HD2' ' A' ' 25' ' ' LYS . 86.5 m -145.81 124.05 12.25 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.738 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.811 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 66.0 t80 -116.6 129.36 56.12 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.812 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.555 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.8 mm? 33.92 45.18 0.1 Allowed 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 125.114 1.509 . . . . 0.0 113.619 175.583 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.54 -16.94 51.53 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 116.459 1.344 . . . . 0.0 116.459 178.002 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.46 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 54.1 m-80 -110.93 135.64 51.15 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 119.929 1.864 . . . . 0.0 112.73 -177.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.464 ' HD2' ' OG1' ' A' ' 20' ' ' THR . 12.3 mmmm -76.33 120.69 21.92 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.853 178.844 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.811 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.5 m-30 -112.83 118.75 35.81 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.646 0.736 . . . . 0.0 111.275 179.919 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.687 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 38.8 mt-10 -97.9 -12.71 21.78 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.999 179.798 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 p -130.66 -174.28 3.31 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.608 179.086 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.9 m -70.93 165.51 23.2 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.724 179.091 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -146.16 171.18 15.31 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.343 -178.715 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.494 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 66.0 p -123.35 18.68 9.79 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 177.061 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.69 134.62 56.36 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.872 -179.424 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.53 -3.15 60.47 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.377 -179.611 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.569 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.6 mtp85 -116.14 146.76 42.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.026 0.441 . . . . 0.0 111.182 -179.757 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.0 m -128.78 7.71 5.68 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.178 178.195 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.65 ' OD2' ' HG2' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -91.02 -42.42 10.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.066 -178.51 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.75 -35.42 2.05 Favored Glycine 0 C--N 1.315 -0.583 0 C-N-CA 120.145 -1.026 . . . . 0.0 115.131 178.631 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 14.7 mmtp -60.36 110.64 1.3 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 118.122 0.961 . . . . 0.0 111.83 -178.792 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.494 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 73.7 mtp -76.87 138.03 39.52 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.138 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.661 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 16.6 p-90 -121.85 -163.6 1.08 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.51 0.672 . . . . 0.0 111.941 -178.006 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 7.4 p -160.79 140.57 10.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.634 -179.722 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -72.68 149.38 43.87 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.113 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.4 p -104.34 13.51 31.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.465 0.65 . . . . 0.0 110.16 179.728 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.9 p -135.36 154.34 51.53 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.692 178.48 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.26 -43.37 98.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.844 0.354 . . . . 0.0 110.909 -179.809 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -117.97 106.97 13.49 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.693 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 1.003 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 25.5 t80 -77.17 -31.64 55.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.707 -179.142 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.27 -36.52 14.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.878 0.371 . . . . 0.0 111.799 179.631 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.13 -57.29 2.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -178.25 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.09 -27.4 60.87 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -176.771 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.5 mtm180 44.33 49.4 8.0 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 179.0 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -114.7 120.89 41.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.608 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 1.003 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 9.7 p-90 -128.47 172.85 10.74 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -175.312 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.553 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -163.82 143.96 9.06 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.737 179.751 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.745 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 10.9 m-30 -60.99 155.13 20.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 118.139 0.969 . . . . 0.0 111.864 -179.394 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.508 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 14.8 t -66.92 113.98 15.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.472 179.228 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -83.91 5.42 6.36 Favored 'Trans proline' 0 CA--C 1.513 -0.546 0 C-N-CA 122.957 2.438 . . . . 0.0 114.657 -177.925 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -143.17 93.66 2.52 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.646 179.683 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -123.64 27.49 7.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 -179.686 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.479 -1.178 . . . . 0.0 112.147 -179.956 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 120.581 0.229 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -84.11 58.7 4.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.729 0.3 . . . . 0.0 111.504 -179.303 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.457 ' HG3' ' HB3' ' A' ' 14' ' ' PRO . 13.9 ptp -144.93 167.53 22.4 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.882 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.0 m -144.9 -177.25 5.43 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.241 179.85 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 p -115.33 178.27 4.35 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.672 0.748 . . . . 0.0 112.175 -179.192 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -130.79 162.81 38.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.998 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 177.652 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.809 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 69.07 -148.13 47.26 Favored Glycine 0 C--N 1.312 -0.766 0 C-N-CA 117.565 -2.255 . . . . 0.0 111.413 -179.251 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.654 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 41.58 -140.49 1.54 Allowed Glycine 0 CA--C 1.52 0.347 0 N-CA-C 115.623 1.009 . . . . 0.0 115.623 177.219 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.49 HD22 ' N ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -159.23 40.5 0.21 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.79 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.683 ' HB3' HG21 ' A' ' 43' ' ' THR . 0.1 OUTLIER -77.85 -75.46 0.22 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.885 -179.139 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.29 61.11 0.67 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.694 -179.507 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.51 17.81 63.4 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 121.179 -0.534 . . . . 0.0 111.84 -179.343 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.487 ' HB3' ' HB2' ' A' ' 10' ' ' SER . . . -103.31 138.16 19.46 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.341 . . . . 0.0 111.401 -179.637 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.457 ' HB3' ' HG3' ' A' ' 3' ' ' MET . 67.6 Cg_endo -85.73 164.98 10.48 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.147 2.565 . . . . 0.0 111.718 178.871 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.8 m -72.31 136.75 46.31 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.499 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.85 95.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.743 0.306 . . . . 0.0 111.564 -179.874 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.606 ' CE1' ' HE1' ' A' ' 19' ' ' PHE . 9.2 m-85 -96.61 146.41 31.26 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-O 121.416 0.627 . . . . 0.0 111.412 177.886 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.842 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 1.1 Cg_endo -83.44 131.3 17.52 Favored 'Cis proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.32 -1.95 . . . . 0.0 111.896 -0.507 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.606 ' HE1' ' CE1' ' A' ' 17' ' ' PHE . 0.6 OUTLIER -85.84 -160.37 0.53 Allowed 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.056 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 47' ' ' TYR . 1.8 m -144.14 120.81 11.15 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -178.706 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.942 ' HB3' HD22 ' A' ' 22' ' ' LEU 0.53 0.5 OUTLIER -127.16 123.66 37.23 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 119.949 3.314 . . . . 0.0 119.949 175.152 . . . . . . . . 4 4 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.942 HD22 ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER 26.26 52.75 0.03 OUTLIER 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 108.912 -3.767 . . . . 0.0 112.92 174.723 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.51 -4.53 56.73 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 114.213 -1.358 . . . . 0.0 115.174 178.333 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.907 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 3.5 m-80 -126.16 141.6 51.87 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 118.572 1.186 . . . . 0.0 112.944 -177.779 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.409 ' HB3' ' NZ ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -81.17 119.27 23.38 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.226 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.907 ' CE1' ' HB2' ' A' ' 24' ' ' ASN . 14.2 m-30 -97.0 95.22 7.66 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.459 1.123 . . . . 0.0 111.779 -177.224 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.842 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 39.7 mt-10 -78.45 -13.12 59.98 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 113.18 -1.827 . . . . 0.0 111.877 -178.466 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p -134.01 178.65 6.79 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.721 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 98.5 m -64.88 163.07 15.05 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 119.496 -0.882 . . . . 0.0 108.8 178.172 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.2 t -141.24 177.4 8.12 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.755 -179.609 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 p -126.64 10.56 7.2 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.698 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.83 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.04 146.92 45.45 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.504 179.094 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.33 -10.99 7.15 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.229 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.546 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 21.2 mtp85 -111.46 -82.2 0.58 Allowed 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 122.642 -0.328 . . . . 0.0 111.362 -179.86 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.5 m 63.61 29.42 15.15 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.744 -178.657 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.74 -29.7 8.55 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.738 -178.834 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.84 -64.96 0.35 Allowed Glycine 0 C--N 1.316 -0.571 0 CA-C-N 114.877 -1.056 . . . . 0.0 113.156 179.312 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.837 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 3.7 mptt -65.67 125.87 26.61 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.596 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 54.0 mtm -85.39 153.72 22.33 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.341 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.681 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 17.7 p-90 -132.64 -173.48 3.19 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.399 0.619 . . . . 0.0 110.92 -178.94 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.55 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 6.4 p -154.66 134.31 12.79 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.722 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.575 ' HB3' ' CB ' ' A' ' 19' ' ' PHE . . . -73.05 149.22 43.37 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.277 -179.231 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.683 HG21 ' HB3' ' A' ' 10' ' ' SER . 68.3 p -101.07 15.68 27.9 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.608 0.718 . . . . 0.0 109.48 179.774 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 p -136.77 142.19 42.97 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.236 178.794 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -52.22 -30.77 28.94 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.363 0.414 . . . . 0.0 111.85 -179.639 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -128.18 119.27 24.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.334 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.901 ' CE2' ' HB3' ' A' ' 53' ' ' TRP . 42.8 t80 -86.23 -52.17 5.82 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.936 -178.205 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.52 -32.76 0.59 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 179.647 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.5 -60.83 1.95 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.074 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.411 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 24.3 m-20 -84.17 -25.11 29.82 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.027 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 8.4 mtm180 49.81 46.13 24.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 179.553 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.411 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 39.1 mtpt -113.56 115.34 27.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.149 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.901 ' HB3' ' CE2' ' A' ' 47' ' ' TYR . 15.4 p-90 -126.67 177.62 6.43 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.336 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.451 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -166.77 138.99 5.49 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 112.873 -1.967 . . . . 0.0 108.986 178.852 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.809 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 16.1 m-85 -59.2 150.83 24.44 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 117.62 0.71 . . . . 0.0 111.273 -179.967 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.492 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 6.1 t -66.29 119.26 60.73 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.818 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.41 4.35 4.51 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.692 2.262 . . . . 0.0 114.473 -178.093 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -150.44 103.45 3.14 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.189 179.149 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -122.04 99.12 6.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.633 179.833 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.852 0 CA-C-O 118.331 -1.261 . . . . 0.0 112.146 -179.991 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.74 0.305 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.466 ' CH2' ' HG3' ' A' ' 14' ' ' PRO . 21.9 t90 -71.82 123.12 21.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.319 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 45.8 mtm -59.91 98.25 0.05 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.146 0.498 . . . . 0.0 112.285 -177.962 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -102.71 -174.66 2.61 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.1 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -109.86 157.1 19.56 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.114 0.959 . . . . 0.0 113.145 -179.247 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -129.95 159.63 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 177.618 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.899 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.4 -154.08 51.99 Favored Glycine 0 C--N 1.307 -1.069 0 C-N-CA 117.126 -2.464 . . . . 0.0 110.664 -178.818 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.615 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 44.43 -139.13 4.56 Favored Glycine 0 C--O 1.236 0.227 0 N-CA-C 114.773 0.669 . . . . 0.0 114.773 177.004 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.449 ' CG ' ' H ' ' A' ' 10' ' ' SER . 11.9 p-10 -141.89 -103.78 0.14 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.475 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.449 ' H ' ' CG ' ' A' ' 9' ' ' ASN . 5.5 m 39.37 15.4 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 176.749 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.23 16.04 47.2 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.986 -179.723 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.15 28.94 26.74 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.829 -179.604 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -73.55 152.76 89.69 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 122.05 0.14 . . . . 0.0 110.945 179.585 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.466 ' HG3' ' CH2' ' A' ' 2' ' ' TRP . 12.6 Cg_exo -67.44 148.71 79.7 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.984 2.456 . . . . 0.0 112.352 179.796 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 90.5 m -79.24 122.35 26.2 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.488 179.458 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.1 t -82.15 119.8 32.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.954 -179.827 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.5 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 57.3 m-85 -119.73 135.81 24.41 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.746 179.755 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.811 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 5.3 Cg_endo -87.95 132.2 11.78 Favored 'Cis proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.273 -1.553 . . . . 0.0 112.251 -0.15 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.639 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 20.8 p90 -91.84 -170.28 2.52 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.651 -0.82 . . . . 0.0 108.908 177.98 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.8 m -144.9 125.64 14.24 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.657 -178.707 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.841 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -132.2 143.65 50.1 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.91 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.76 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.33 38.2 0.33 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.526 1.13 . . . . 0.0 113.457 178.207 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 -6.6 83.39 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 115.311 0.884 . . . . 0.0 115.311 178.296 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.45 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 66.5 m-80 -112.11 136.26 51.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 118.455 1.127 . . . . 0.0 112.013 -178.78 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -79.06 127.86 32.53 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.674 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.841 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.1 m-30 -110.38 111.88 23.45 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 121.709 0.766 . . . . 0.0 111.205 -178.969 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.811 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 36.7 mt-10 -91.17 -11.99 36.74 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.555 -179.768 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 p -133.53 178.87 6.58 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.978 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.3 m -65.92 156.08 34.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.484 179.067 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.3 t -131.88 175.56 9.11 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.11 -179.2 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.2 p -129.15 15.85 6.19 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.35 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.617 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -59.39 141.03 55.54 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.716 -179.74 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.02 -10.99 8.31 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.226 -179.952 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.512 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 25.5 mtp85 -103.2 -69.52 0.79 Allowed 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.722 0.296 . . . . 0.0 110.832 -179.992 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.0 p 52.63 28.99 6.7 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.475 -178.74 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -109.01 -38.52 5.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.544 0.688 . . . . 0.0 110.025 -179.836 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.87 -68.49 0.21 Allowed Glycine 0 C--N 1.313 -0.74 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.466 179.111 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.8 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 4.7 mptt -57.02 130.99 48.49 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.786 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -94.0 156.22 16.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.592 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.65 ' HZ2' ' CE2' ' A' ' 21' ' ' PHE . 23.4 p-90 -142.98 -169.13 2.95 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.032 0.444 . . . . 0.0 110.986 -178.949 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.6 p -161.37 143.95 12.23 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.162 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.43 153.62 35.49 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.891 0.377 . . . . 0.0 110.888 -178.973 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.5 p -102.83 8.13 39.33 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.58 0.705 . . . . 0.0 109.731 179.644 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.6 p -132.55 153.69 50.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.948 178.928 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.46 94.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.432 179.972 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -113.93 109.48 18.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.765 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.859 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 82.9 t80 -83.06 -31.59 27.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.935 -178.419 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -53.18 -37.12 61.65 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.613 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.8 -66.81 0.86 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -68.05 -29.88 68.96 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.439 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 2.6 mmm180 47.39 46.67 17.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 179.711 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 53.9 mtmt -110.46 117.31 33.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.708 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.859 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.0 p-90 -127.4 -177.52 4.11 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -174.853 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.615 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -174.03 139.85 5.19 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 113.625 -1.625 . . . . 0.0 109.885 179.375 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.899 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.7 m-85 -61.15 152.72 27.79 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.407 0.622 . . . . 0.0 112.165 -179.437 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.438 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.4 t -69.67 132.81 88.9 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.441 179.702 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.64 6.77 2.61 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.738 2.292 . . . . 0.0 113.83 -179.293 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -123.59 65.08 1.02 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.916 179.771 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -70.45 162.41 28.76 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.109 -179.572 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.594 0 CA-C-O 118.704 -1.054 . . . . 0.0 111.546 -179.987 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.463 0.173 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -82.11 178.1 8.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 0.0 110.645 179.28 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -86.07 53.19 2.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.981 178.987 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m -64.47 157.23 27.16 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.556 -179.662 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 13' ' ' ALA . 20.7 p -97.26 156.97 16.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 122.331 1.063 . . . . 0.0 113.515 -178.278 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -128.82 162.98 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 103.456 -2.794 . . . . 0.0 103.456 176.578 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.767 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 66.24 -142.47 42.9 Favored Glycine 0 C--N 1.308 -0.983 0 C-N-CA 117.392 -2.337 . . . . 0.0 111.45 -179.205 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.626 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 38.08 -143.81 0.23 Allowed Glycine 0 N--CA 1.467 0.733 0 N-CA-C 116.34 1.296 . . . . 0.0 116.34 177.12 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.66 29.95 0.75 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.203 -0.498 . . . . 0.0 111.018 -179.274 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.566 ' HB3' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -82.58 -59.8 2.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.816 -179.624 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.76 45.29 1.22 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.074 -179.481 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.46 32.45 34.31 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.411 -179.85 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 5' ' ' THR . . . -90.91 149.95 41.12 Favored Pre-proline 0 C--O 1.223 -0.298 0 CA-C-N 116.599 0.2 . . . . 0.0 110.482 179.605 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 3' ' ' MET . 57.9 Cg_endo -81.08 128.14 6.34 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 121.777 1.651 . . . . 0.0 112.212 179.642 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 91.2 m -62.46 126.78 28.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.174 179.8 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 58.2 t -91.86 123.59 44.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.743 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.619 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 59.7 m-85 -118.76 141.03 29.3 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.14 178.925 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.99 134.11 21.28 Favored 'Cis proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.631 -1.404 . . . . 0.0 112.201 -0.492 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.619 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 28.5 p90 -105.06 128.03 53.15 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.281 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.0 m -89.63 123.34 33.6 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.755 -178.892 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.754 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 66.4 t80 -117.11 131.33 56.93 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.402 178.949 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.516 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.6 mm? 35.85 46.08 0.32 Allowed 'General case' 0 N--CA 1.427 -1.593 0 O-C-N 124.722 1.263 . . . . 0.0 113.576 175.892 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.02 -15.46 62.52 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 114.489 -1.232 . . . . 0.0 115.872 177.83 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.581 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 61.0 m-80 -111.72 135.17 52.68 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.838 1.819 . . . . 0.0 112.014 -178.376 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -78.9 121.58 25.03 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.411 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.754 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 16.5 m-30 -108.9 113.97 27.33 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.628 0.728 . . . . 0.0 111.556 -178.2 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -90.13 -17.33 27.85 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.482 179.481 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.2 p -127.75 -174.51 3.21 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.74 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.2 m -68.57 169.53 10.84 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.991 178.82 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.405 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 11.6 t -146.47 174.02 11.77 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.016 0.436 . . . . 0.0 110.15 -178.88 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.8 p -129.63 22.57 5.47 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.694 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.9 135.7 51.45 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 113.762 -1.563 . . . . 0.0 112.108 -179.255 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.0 6.52 87.41 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.99 179.563 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.596 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 9.8 mtp85 -107.63 149.06 28.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.325 0.562 . . . . 0.0 111.489 -179.645 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.8 t -106.79 -6.58 17.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.293 -179.701 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.98 -88.0 0.37 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.0 0.428 . . . . 0.0 111.077 179.689 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.61 -2.91 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.649 179.811 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.596 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 17.7 mmtp -68.36 105.15 2.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.568 0.684 . . . . 0.0 109.171 179.617 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.6 mtm -65.62 144.31 57.03 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.474 -0.49 . . . . 0.0 109.788 -179.664 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.688 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 19.0 p-90 -133.4 -169.05 2.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.394 -178.839 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 1.5 p -162.53 144.34 10.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.452 178.357 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.456 ' CB ' ' HD2' ' A' ' 47' ' ' TYR . . . -73.91 157.03 37.02 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.261 0.553 . . . . 0.0 110.926 -179.109 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.566 HG21 ' HB3' ' A' ' 10' ' ' SER . 63.7 p -106.28 9.66 31.94 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.863 -179.803 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.2 p -131.88 151.17 51.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.24 178.785 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.42 -37.45 72.79 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.066 0.46 . . . . 0.0 110.891 -179.784 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -123.93 115.12 20.74 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.186 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.953 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 33.6 t80 -80.73 -31.08 36.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.878 -178.116 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -53.16 -35.71 60.09 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.64 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -84.42 -67.15 0.82 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.074 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -73.29 -27.6 61.63 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -177.275 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.661 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 10.6 mtm180 47.56 48.14 17.09 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.971 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -112.32 122.91 49.06 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.44 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.953 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 11.7 p-90 -131.51 174.53 10.0 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -175.778 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.626 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -169.23 141.1 6.49 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 113.496 -1.684 . . . . 0.0 109.725 178.77 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.767 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 11.4 m-85 -55.42 151.9 9.49 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.443 0.639 . . . . 0.0 111.632 -179.82 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.632 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 18.0 t -68.54 133.22 90.92 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.632 -179.696 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.94 5.13 4.13 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.508 2.139 . . . . 0.0 112.651 179.709 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -125.77 75.94 1.54 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.914 179.571 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.515 ' HG3' ' O ' ' A' ' 56' ' ' CYS . 87.8 mt-30 -112.2 -30.69 7.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.721 -179.634 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.45 -1.194 . . . . 0.0 112.139 179.922 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 120.479 0.181 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 53.5 m95 57.99 -92.93 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.087 0.555 . . . . 0.0 111.659 179.65 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.4 ptt? -78.71 70.19 5.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.622 0.725 . . . . 0.0 110.39 179.167 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 m -137.42 -165.2 1.72 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.722 -179.427 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.461 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 50.4 p -68.32 160.59 29.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.649 0.738 . . . . 0.0 112.539 -179.391 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.483 HG13 ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -122.6 -53.22 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.966 0 CA-C-O 123.425 1.583 . . . . 0.0 108.545 179.232 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.816 ' H ' ' HB2' ' A' ' 55' ' ' PHE . . . -83.49 -164.25 36.18 Favored Glycine 0 C--N 1.279 -2.627 0 CA-C-N 110.503 -3.044 . . . . 0.0 111.622 178.919 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.609 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 75.94 -175.04 52.55 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.344 -0.932 . . . . 0.0 113.338 178.573 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.408 ' H ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -98.83 -8.19 26.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.57 0.224 . . . . 0.0 111.255 179.542 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.8 m -75.61 -61.63 1.85 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.851 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.1 88.39 0.06 OUTLIER Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.333 178.517 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.62 -23.11 22.89 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.087 -1.054 . . . . 0.0 113.548 179.088 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.96 144.82 80.18 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 117.349 0.574 . . . . 0.0 110.27 179.408 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -81.17 148.89 17.06 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.174 1.916 . . . . 0.0 111.957 -179.787 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 88.0 m -80.26 138.78 36.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.746 0.308 . . . . 0.0 110.665 -179.967 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.436 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 84.9 t -99.01 125.54 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.119 -179.711 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.425 ' HE1' ' HE2' ' A' ' 19' ' ' PHE . 48.5 m-85 -124.81 139.21 32.88 Favored Pre-proline 0 N--CA 1.445 -0.707 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.958 -179.806 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -86.5 135.85 18.13 Favored 'Cis proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.558 -1.851 . . . . 0.0 111.862 -0.458 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.691 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 45.1 p90 -101.47 -171.11 1.93 Allowed 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.476 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 m -146.85 124.77 11.98 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.673 -179.022 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.861 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 63.2 t80 -118.03 130.43 56.16 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.492 179.8 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.561 ' H ' HD22 ' A' ' 22' ' ' LEU . 3.7 mm? 33.74 45.09 0.09 Allowed 'General case' 0 N--CA 1.427 -1.611 0 O-C-N 125.075 1.484 . . . . 0.0 114.108 175.233 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.45 -15.82 49.39 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 115.903 1.121 . . . . 0.0 115.903 177.887 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.543 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 28.3 m-80 -115.82 134.84 54.59 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.789 1.795 . . . . 0.0 112.116 -178.425 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -80.53 126.37 31.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.723 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.861 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.9 m-85 -113.7 123.52 50.1 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.661 0.743 . . . . 0.0 111.531 -178.812 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -93.98 -20.83 19.61 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.181 179.926 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 p -128.38 -173.29 2.91 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.858 179.004 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 70.9 m -65.62 161.97 19.32 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.339 178.726 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -138.63 168.68 19.26 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.322 -178.461 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.2 p -124.76 23.37 7.99 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.056 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.53 136.57 57.65 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 113.912 -1.495 . . . . 0.0 111.591 -179.781 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.69 -6.3 54.37 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.727 -179.126 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.589 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 18.8 mtp85 -110.17 165.48 11.72 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.682 0.277 . . . . 0.0 110.356 179.809 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.8 p -146.39 15.47 1.29 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.073 179.897 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.79 -81.15 0.44 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.609 0.718 . . . . 0.0 111.396 179.97 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.18 -16.03 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.187 -179.821 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.589 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 37.6 mttp -68.12 122.03 17.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.129 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.9 mtm -98.76 151.35 20.87 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.064 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.7 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 28.6 p-90 -141.4 -170.23 3.04 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.035 0.445 . . . . 0.0 111.102 -178.1 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.56 149.42 11.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.277 178.461 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.468 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -73.25 148.15 43.94 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.787 -179.281 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 15' ' ' CYS . 69.6 p -100.41 8.06 43.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.663 0.744 . . . . 0.0 109.842 179.382 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.4 p -130.88 157.97 41.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.799 -1.092 . . . . 0.0 109.112 178.542 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -58.65 -39.54 80.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.912 0.387 . . . . 0.0 111.144 -179.54 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -125.41 114.09 18.39 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.001 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.874 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 58.9 t80 -69.82 -40.62 75.78 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.361 -177.936 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.13 -33.19 51.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.951 0.405 . . . . 0.0 111.933 -179.117 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.29 -68.42 0.53 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.194 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.99 -18.76 29.92 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -176.819 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 24.7 mtm-85 44.4 53.79 6.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 179.434 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -117.75 118.85 33.17 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.549 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.874 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.8 p-90 -127.53 170.47 12.57 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 122.078 0.942 . . . . 0.0 113.365 -175.537 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.609 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.44 147.95 13.2 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.411 179.275 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.816 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 7.0 m-30 -64.0 160.67 17.39 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.519 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.542 ' SG ' ' HD2' ' A' ' 57' ' ' PRO . 3.7 t -71.41 144.56 89.32 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.418 179.987 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.542 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 87.5 Cg_endo -70.13 -147.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.475 0.435 0 C-N-CA 123.253 2.635 . . . . 0.0 114.038 -179.165 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.439 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 46.6 t0 -54.78 130.62 41.51 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.166 -179.422 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -103.56 -70.28 0.77 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.766 -179.996 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.74 0 CA-C-O 118.363 -1.243 . . . . 0.0 112.289 179.569 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.731 0.301 . . . . 0.0 111.418 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -164.97 177.79 7.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.63 178.837 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.2 mmt -102.66 129.79 49.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.376 179.589 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' ' 57' ' ' PRO . 10.4 m -80.76 162.46 24.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.865 0.364 . . . . 0.0 110.509 -179.724 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 p -101.55 164.32 11.81 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 122.234 1.016 . . . . 0.0 113.267 -178.763 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.712 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -118.84 -166.8 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 176.948 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 55' ' ' PHE . . . 35.58 -126.19 0.76 Allowed Glycine 0 N--CA 1.465 0.568 0 O-C-N 124.007 0.817 . . . . 0.0 113.065 177.842 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.613 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 34.05 -139.29 0.14 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 115.248 0.859 . . . . 0.0 115.248 177.384 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.404 ' N ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -156.38 30.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.056 0.455 . . . . 0.0 110.827 179.252 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 19.3 m -101.95 -45.91 5.05 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.983 -179.716 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.48 -102.04 2.23 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.382 -179.68 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.67 32.72 6.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.267 179.917 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -93.61 145.88 30.75 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.799 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -84.94 160.1 11.79 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.434 2.089 . . . . 0.0 112.344 -179.684 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.7 m -89.52 130.9 35.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.619 179.66 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -89.68 120.57 38.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.842 -179.866 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.611 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 65.2 m-85 -116.1 139.0 24.58 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-O 120.772 0.32 . . . . 0.0 110.767 179.908 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -87.05 136.84 17.72 Favored 'Cis proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.615 -1.827 . . . . 0.0 112.636 -0.135 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.611 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 26.3 p90 -101.2 129.05 47.06 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.096 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 98.9 m -92.62 123.71 36.11 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.485 0.659 . . . . 0.0 112.496 -177.972 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.904 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.5 t80 -126.42 145.46 50.46 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.714 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.694 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.28 36.59 0.2 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.442 1.097 . . . . 0.0 113.384 179.185 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.8 -2.43 87.19 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 114.85 0.7 . . . . 0.0 114.85 178.637 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.59 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 45.2 m-20 -111.33 135.74 51.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.265 1.033 . . . . 0.0 111.95 -179.007 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -81.45 118.05 22.38 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.379 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.904 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 19.5 m-30 -101.82 113.06 25.92 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.844 0.831 . . . . 0.0 111.492 -178.553 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -86.98 -20.56 27.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.127 179.646 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -126.44 179.66 5.19 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.37 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.1 m -64.77 162.93 15.06 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.779 179.321 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.6 t -137.48 169.34 17.95 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.222 -178.738 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.584 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 41.8 p -121.61 15.76 11.13 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.894 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.567 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.09 142.56 56.59 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.936 179.72 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.51 -16.27 6.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.893 -179.482 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -103.51 -74.43 0.64 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 120.753 0.311 . . . . 0.0 110.465 179.681 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m 60.02 23.21 12.36 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.158 -179.83 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -103.4 -35.02 8.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.656 0.741 . . . . 0.0 110.108 -179.548 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.87 -70.18 0.21 Allowed Glycine 0 C--N 1.312 -0.772 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.405 179.634 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.936 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 3.1 mptt -58.55 137.3 57.51 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.704 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.584 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 3.5 mpp? -99.63 153.46 19.05 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.569 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.668 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 22.0 p-90 -138.1 -168.78 2.43 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.084 0.469 . . . . 0.0 110.77 -178.815 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.3 p -163.16 141.1 7.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.39 177.826 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.88 148.53 46.02 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.304 0.573 . . . . 0.0 110.929 -178.662 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 43.9 p -98.31 11.96 36.31 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.092 179.215 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.4 p -131.01 155.19 47.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.974 179.265 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -62.02 -40.06 94.43 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.915 0.388 . . . . 0.0 110.913 -179.995 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -120.11 111.89 18.43 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.802 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.833 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 74.7 t80 -82.18 -31.62 30.33 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.072 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -57.03 -33.29 67.04 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.127 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -92.35 -56.05 3.18 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.153 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -74.75 -26.89 60.09 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.544 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 12.8 mtm180 43.46 50.67 6.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 179.576 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -119.61 120.35 36.41 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.432 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.833 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.4 p-90 -133.98 177.68 7.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -173.99 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.607 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -169.27 146.24 10.03 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.724 178.82 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.712 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.3 m-30 -60.29 157.78 12.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.606 0.703 . . . . 0.0 111.725 -179.08 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.468 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 8.5 t -63.2 135.99 96.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.529 -179.844 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 4' ' ' SER . 97.3 Cg_endo -73.38 -149.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.166 2.578 . . . . 0.0 112.922 -179.735 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' H ' ' HB2' ' A' ' 57' ' ' PRO . 9.7 t70 -57.38 120.72 8.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.208 179.879 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 57' ' ' PRO . 63.1 mt-30 -114.14 14.06 18.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.128 -179.152 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.787 0 CA-C-O 118.472 -1.182 . . . . 0.0 112.045 179.984 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -101.3 164.95 11.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.846 -179.859 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 73.0 mtm -94.17 42.37 1.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.125 0.488 . . . . 0.0 110.727 179.553 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.1 m -99.66 178.87 4.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.8 179.25 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.711 HG22 ' SG ' ' A' ' 41' ' ' CYS . 50.1 p -97.57 168.09 10.58 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.028 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.861 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -129.18 -160.47 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.775 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.668 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 34.4 -123.1 0.46 Allowed Glycine 0 N--CA 1.464 0.51 0 O-C-N 124.105 0.878 . . . . 0.0 113.182 177.679 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.551 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 34.45 -144.68 0.05 OUTLIER Glycine 0 C--N 1.337 0.615 0 N-CA-C 116.097 1.199 . . . . 0.0 116.097 177.062 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.31 -26.76 0.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.844 -0.678 . . . . 0.0 110.093 179.732 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 m -60.85 -20.79 62.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.203 179.581 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.53 -114.81 4.79 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.308 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.91 46.91 1.08 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.022 179.221 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 5' ' ' THR . . . -83.41 148.4 55.45 Favored Pre-proline 0 C--O 1.222 -0.364 0 CA-C-N 116.92 0.36 . . . . 0.0 110.562 179.835 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -65.08 131.82 29.93 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.202 1.935 . . . . 0.0 111.768 179.666 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.8 m -66.04 135.37 54.56 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.811 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 86.8 t -98.83 113.65 34.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.648 0.261 . . . . 0.0 111.109 179.871 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.502 ' CE2' ' HB2' ' A' ' 15' ' ' CYS . 99.4 m-85 -112.84 143.22 28.63 Favored Pre-proline 0 N--CA 1.446 -0.665 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.287 179.172 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -85.45 133.57 17.48 Favored 'Cis proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.38 -1.508 . . . . 0.0 112.034 -0.174 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.672 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 46.7 p90 -105.5 130.77 53.5 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.436 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.9 m -95.75 128.51 42.69 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -176.974 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.897 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.2 t80 -132.53 146.6 52.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.68 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.745 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 39.51 37.4 0.29 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.557 1.143 . . . . 0.0 113.466 178.535 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.14 -6.06 82.5 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 114.606 0.602 . . . . 0.0 114.606 178.929 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -111.73 133.25 54.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.351 1.075 . . . . 0.0 112.057 -178.721 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -79.03 122.81 26.66 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.889 179.187 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.897 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.5 m-85 -106.15 114.52 28.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.784 0.802 . . . . 0.0 111.504 -178.361 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -93.56 -15.65 25.23 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.288 179.434 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.3 p -130.34 178.58 6.48 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.015 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.5 m -60.9 163.69 5.55 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.566 0.698 . . . . 0.0 110.648 179.274 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.0 t -144.71 169.41 18.07 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.253 179.908 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.562 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 15.7 p -125.7 23.78 7.28 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.066 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -61.93 140.4 58.31 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 113.969 -1.468 . . . . 0.0 111.015 -179.944 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.02 -8.9 13.42 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.723 -179.452 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.6 mtp85 -108.73 -82.4 0.56 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.972 0.415 . . . . 0.0 110.663 -179.699 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.1 t 62.81 19.07 11.23 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.658 -179.448 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.2 -31.55 12.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.726 0.774 . . . . 0.0 109.946 179.983 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.66 -58.22 0.38 Allowed Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.635 179.78 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.827 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 8.3 mptt -65.54 134.9 54.35 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.79 0.329 . . . . 0.0 111.653 -179.116 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.562 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 61.8 mtt -98.63 160.33 14.35 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.306 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.652 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 20.1 p-90 -144.08 -173.27 3.96 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.544 0.688 . . . . 0.0 111.974 -178.981 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.711 ' SG ' HG22 ' A' ' 5' ' ' THR . 8.5 p -154.81 138.57 16.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.959 -1.018 . . . . 0.0 108.85 179.769 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.466 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -76.45 153.82 35.28 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.333 179.961 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.4 p -104.55 14.29 30.21 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.851 0.834 . . . . 0.0 110.015 -179.694 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.9 p -137.3 147.5 45.69 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.592 178.89 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.668 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -51.63 -43.77 62.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.929 0.395 . . . . 0.0 111.4 -179.688 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -119.38 107.43 13.35 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.909 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.818 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 79.7 t80 -71.86 -32.04 67.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.364 -178.027 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.704 ' HA ' ' NH1' ' A' ' 51' ' ' ARG . 25.8 m-20 -66.26 -25.45 66.89 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.016 0.436 . . . . 0.0 111.523 -179.764 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -84.4 -58.99 2.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.374 -179.634 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -87.84 -19.4 27.49 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -176.681 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.704 ' NH1' ' HA ' ' A' ' 48' ' ' ASP . 7.8 mtt-85 45.97 51.0 11.1 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 179.978 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -119.84 121.76 39.81 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 176.443 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.818 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 9.5 p-90 -136.59 176.92 8.26 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -175.597 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.529 ' HA3' ' HB ' ' A' ' 5' ' ' THR . . . -170.07 149.14 12.5 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.289 178.237 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.861 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 13.6 m-30 -64.72 165.71 9.96 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.859 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.564 ' HB3' ' HD2' ' A' ' 57' ' ' PRO . 37.8 m -101.57 169.05 8.19 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 176.42 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.564 ' HD2' ' HB3' ' A' ' 56' ' ' CYS . 94.3 Cg_endo -68.56 -152.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.083 1.855 . . . . 0.0 113.8 -178.541 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.97 138.69 58.4 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.029 -178.425 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -99.51 -58.53 1.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.229 179.345 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.847 0 CA-C-O 118.333 -1.259 . . . . 0.0 111.655 -179.62 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 120.863 0.363 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -157.55 106.07 2.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.253 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -90.21 113.16 24.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.879 0.371 . . . . 0.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m -90.19 158.51 17.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.655 179.916 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p -82.8 170.39 15.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.478 0.656 . . . . 0.0 112.207 -179.674 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.824 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -107.94 -168.13 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 176.793 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.56 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 40.05 -123.23 2.03 Favored Glycine 0 N--CA 1.46 0.288 0 O-C-N 123.827 0.704 . . . . 0.0 113.116 177.829 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.659 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 32.19 -143.13 0.03 OUTLIER Glycine 0 C--N 1.336 0.529 0 N-CA-C 116.836 1.495 . . . . 0.0 116.836 177.065 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.49 HD22 ' N ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -157.03 24.34 0.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.597 -0.801 . . . . 0.0 110.6 179.961 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.631 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -88.39 -23.32 23.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.316 -179.87 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.2 -76.57 2.14 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.61 -179.75 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -126.96 9.56 7.1 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.162 -1.018 . . . . 0.0 113.436 -179.436 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 10' ' ' SER . . . -79.7 141.63 56.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 117.341 0.57 . . . . 0.0 111.526 -179.859 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 60.1 Cg_endo -88.38 178.61 2.9 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.133 2.556 . . . . 0.0 111.812 179.475 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.6 m -81.8 149.03 28.56 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.53 -179.88 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.6 t -115.94 118.41 58.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.516 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.615 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 59.6 m-85 -121.11 143.59 37.47 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-O 121.019 0.437 . . . . 0.0 111.878 -179.084 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.804 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 8.6 Cg_endo -87.5 135.99 15.96 Favored 'Cis proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.029 -1.655 . . . . 0.0 111.6 -0.817 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.66 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 37.6 p90 -103.02 -169.88 1.72 Allowed 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.208 178.647 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.434 ' OG1' ' HD3' ' A' ' 25' ' ' LYS . 63.6 m -147.54 126.89 13.09 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.53 -179.505 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.88 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 59.8 t80 -123.87 133.45 53.76 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.12 179.383 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.549 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.6 mm? 35.38 48.28 0.39 Allowed 'General case' 0 N--CA 1.427 -1.603 0 O-C-N 124.713 1.258 . . . . 0.0 113.711 175.451 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.73 -11.09 71.75 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 116.334 1.294 . . . . 0.0 116.334 177.763 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.409 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 53.7 m-80 -115.61 135.14 54.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 119.555 1.677 . . . . 0.0 112.53 -178.351 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HD3' ' OG1' ' A' ' 20' ' ' THR . 65.5 mmtt -76.44 125.15 28.7 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.943 178.875 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.88 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.8 m-85 -115.58 118.37 32.95 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.567 0.698 . . . . 0.0 111.067 -179.985 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.804 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 49.9 mt-10 -96.28 -16.08 21.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.101 179.573 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.9 p -126.19 -177.37 3.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.138 178.233 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.2 m -67.87 165.73 17.0 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.413 178.762 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 t -142.91 173.03 11.91 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.075 -178.704 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.535 ' HB3' ' HG3' ' A' ' 39' ' ' MET . 57.8 p -129.02 22.82 5.7 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.37 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.464 ' HB1' ' CD2' ' A' ' 21' ' ' PHE . . . -62.92 141.05 58.87 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 114.012 -1.449 . . . . 0.0 112.35 -179.069 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.68 -1.71 36.02 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.728 179.56 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.778 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 8.4 mtp85 -101.72 126.75 48.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.829 0.347 . . . . 0.0 110.858 -179.721 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 m -95.09 5.22 52.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.116 -179.83 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.42 -86.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.211 0.529 . . . . 0.0 110.915 179.275 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 179.12 -24.79 0.05 OUTLIER Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.233 179.975 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.778 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 76.7 mttt -49.81 120.49 4.35 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.925 0.49 . . . . 0.0 111.648 179.933 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.535 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 2.5 mpt? -87.58 141.96 28.21 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.688 179.214 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 13.0 p-90 -129.99 -162.78 1.24 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.176 -178.856 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 26.3 p -163.58 151.09 12.71 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.75 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.445 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -83.11 144.99 29.5 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.294 179.417 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 79.6 p -99.95 13.21 34.7 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.945 0.878 . . . . 0.0 109.704 179.919 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.6 p -137.04 151.08 48.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.94 178.598 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -57.29 -40.95 78.86 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.891 0.377 . . . . 0.0 111.478 -179.387 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -123.71 109.84 14.2 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.599 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 1.07 ' HE2' ' HB3' ' A' ' 53' ' ' TRP . 23.7 t80 -75.83 -34.51 60.11 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.703 -178.492 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -50.75 -34.75 28.43 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.474 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -96.39 -52.69 3.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.464 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.39 -26.2 35.65 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.021 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 13.5 mtm180 45.36 50.65 9.89 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 179.117 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -114.66 121.82 44.56 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.14 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 1.07 ' HB3' ' HE2' ' A' ' 47' ' ' TYR . 12.2 p-90 -128.7 173.35 10.39 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -175.699 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.431 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -167.94 140.5 6.26 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.543 179.601 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.824 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 8.3 m-30 -60.16 153.29 22.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.783 0.791 . . . . 0.0 111.183 -179.661 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.541 ' HB3' ' HG2' ' A' ' 59' ' ' GLN . 8.7 t -66.29 116.08 30.09 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.706 -179.983 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.01 2.12 8.25 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.713 2.275 . . . . 0.0 113.373 -178.439 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -150.0 77.88 1.33 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.632 179.751 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.541 ' HG2' ' HB3' ' A' ' 56' ' ' CYS . 47.4 mt-30 -81.55 139.95 34.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.988 -179.094 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.719 0 CA-C-O 118.743 -1.031 . . . . 0.0 111.922 -179.846 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.68 0.276 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -90.11 -15.64 31.23 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.408 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.454 ' SD ' ' HB2' ' A' ' 57' ' ' PRO . 26.2 ptm -69.94 168.31 15.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.3 0.571 . . . . 0.0 112.113 -179.005 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 m -95.94 -175.69 3.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.1 -179.77 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.3 p -86.47 177.91 7.27 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.348 1.071 . . . . 0.0 113.126 -178.974 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.531 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -142.58 161.8 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 178.587 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.589 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 65.5 -149.82 51.67 Favored Glycine 0 C--N 1.313 -0.695 0 C-N-CA 117.958 -2.068 . . . . 0.0 111.157 -179.453 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.713 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 50.58 -152.2 4.68 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 114.778 0.671 . . . . 0.0 114.778 177.802 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -125.36 -29.43 3.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.924 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 m -56.29 -42.96 78.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.031 -179.803 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.47 -90.77 1.62 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.888 -0.673 . . . . 0.0 113.322 178.946 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.16 49.44 0.85 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.275 -179.404 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.35 152.73 44.08 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.979 0.39 . . . . 0.0 110.116 179.159 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.35 147.29 18.02 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.01 1.807 . . . . 0.0 112.466 -179.891 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 3.2 m -78.03 115.69 17.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.504 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 55.3 t -79.83 108.83 13.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.91 0.386 . . . . 0.0 110.616 -179.604 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -109.72 138.51 20.68 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.969 -179.614 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.762 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 58.4 Cg_endo -85.34 138.58 25.6 Favored 'Cis proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.834 -1.736 . . . . 0.0 112.895 -0.327 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.605 ' CE1' ' HD2' ' A' ' 26' ' ' TYR . 35.1 p90 -105.55 132.65 51.45 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.184 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 90.3 m -93.78 128.46 40.02 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.412 0.625 . . . . 0.0 112.394 -177.57 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.748 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -130.69 142.71 50.44 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.596 -1.184 . . . . 0.0 107.83 178.166 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.747 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER 38.37 39.54 0.3 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.757 1.223 . . . . 0.0 113.497 178.17 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.32 -5.67 84.69 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 114.859 0.704 . . . . 0.0 114.859 178.419 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.691 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 50.8 m-20 -110.76 136.39 49.91 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 118.448 1.124 . . . . 0.0 111.511 -178.723 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -82.04 120.03 24.75 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.805 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.748 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 18.5 m-30 -102.96 110.29 22.15 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.594 0.711 . . . . 0.0 111.38 -177.621 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.762 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 94.5 mt-10 -91.5 -4.86 55.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.131 -179.69 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.3 p -140.96 -171.43 3.25 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.325 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 87.3 m -69.65 166.17 19.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.939 178.882 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.513 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 14.1 t -146.38 175.72 10.32 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.665 -179.489 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.3 p -130.94 20.98 4.95 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.382 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.601 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -66.74 143.03 57.18 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 113.918 -1.492 . . . . 0.0 112.215 -179.346 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.33 2.27 47.7 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.659 178.67 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.691 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 15.5 mtp85 -105.04 121.53 43.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 117.349 0.574 . . . . 0.0 111.412 -179.493 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 m -85.51 -4.34 59.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.17 179.106 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.588 ' OD2' ' HG2' ' A' ' 38' ' ' LYS . 2.3 p-10 -90.64 -84.68 0.24 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.586 179.73 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.444 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . 164.08 -14.95 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.853 -0.689 . . . . 0.0 114.589 179.484 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.691 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 24.9 mmtm -65.0 132.12 48.39 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 118.206 1.003 . . . . 0.0 110.278 -179.549 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 52.1 mtm -85.49 144.08 28.16 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 179.303 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.637 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 14.2 p-90 -135.78 -168.6 2.24 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.371 0.605 . . . . 0.0 112.121 -177.819 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 23.8 p -153.05 138.95 18.06 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.166 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.536 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -77.97 146.73 35.28 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.795 179.97 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.2 p -101.04 17.64 21.84 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.833 0.825 . . . . 0.0 110.203 -179.695 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.89 152.97 50.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.856 178.643 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -60.19 -39.57 86.98 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.206 0.527 . . . . 0.0 111.188 -179.665 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -122.18 107.84 12.61 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.582 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.791 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 64.2 t80 -74.71 -30.44 61.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.852 -178.149 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -55.19 -37.05 66.57 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.262 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.87 -72.23 0.49 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.823 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.74 -19.49 62.73 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -177.508 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.631 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 21.6 mtm180 41.17 53.86 3.44 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 179.886 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.408 ' HG3' ' HZ2' ' A' ' 52' ' ' LYS . 48.2 mttp -112.77 118.28 34.54 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.564 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.791 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 11.9 p-90 -133.03 171.24 14.25 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -174.667 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.713 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -161.14 142.04 7.78 Favored Glycine 0 C--O 1.221 -0.708 0 CA-C-N 113.122 -1.854 . . . . 0.0 109.313 178.236 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.589 ' CD2' ' HA3' ' A' ' 7' ' ' GLY . 7.9 m-30 -56.21 159.34 3.53 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.777 0.789 . . . . 0.0 111.19 179.699 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.545 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 5.5 t -59.68 139.76 89.58 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.572 179.929 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.457 ' HD2' ' SG ' ' A' ' 56' ' ' CYS . 65.0 Cg_endo -66.38 -0.11 3.95 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.035 2.49 . . . . 0.0 113.88 -179.187 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -136.98 97.27 3.47 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.485 178.434 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -102.37 -175.86 2.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.859 -179.392 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.892 0 CA-C-O 118.618 -1.101 . . . . 0.0 111.925 -179.899 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.459 0.171 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -75.27 108.26 7.92 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.611 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.434 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 70.2 mtp -66.56 83.27 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.517 -178.506 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.2 m -86.95 163.52 17.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.434 179.957 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -107.31 174.64 5.8 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 122.196 0.998 . . . . 0.0 112.874 -179.178 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -139.36 164.58 24.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.047 0 N-CA-C 104.667 -2.345 . . . . 0.0 104.667 179.418 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.499 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 64.91 -149.78 51.62 Favored Glycine 0 C--N 1.313 -0.701 0 C-N-CA 118.025 -2.036 . . . . 0.0 111.367 -179.733 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.632 ' HA3' ' HA2' ' A' ' 54' ' ' GLY . . . 51.6 -149.26 8.5 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 114.256 0.463 . . . . 0.0 114.256 177.998 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.409 HD22 ' N ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -141.97 -4.03 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.685 -0.258 . . . . 0.0 111.147 179.697 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.409 ' N ' HD22 ' A' ' 9' ' ' ASN . 5.9 m -86.37 9.51 17.78 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.968 0.413 . . . . 0.0 110.608 179.768 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.9 -106.48 1.97 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.134 -179.804 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.53 36.01 2.46 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.563 179.774 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -75.36 143.51 76.48 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.76 0.28 . . . . 0.0 110.662 179.486 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 3' ' ' MET . 16.3 Cg_exo -65.7 144.49 78.27 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.604 2.203 . . . . 0.0 112.315 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.7 m -72.16 148.43 45.64 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.657 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 64.6 t -108.76 109.67 29.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.627 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.585 ' HE1' ' HE1' ' A' ' 19' ' ' PHE . 38.6 m-85 -114.69 143.09 29.33 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-O 121.229 0.538 . . . . 0.0 111.503 -179.312 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.8 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.3 Cg_endo -87.41 136.91 16.97 Favored 'Cis proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.263 -1.557 . . . . 0.0 111.469 -0.97 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.585 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 34.3 p90 -101.4 -170.77 1.88 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.27 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.8 m -148.79 127.44 12.46 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.999 -178.996 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.677 ' CG ' HD22 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -111.11 -143.73 0.39 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 118.342 -0.837 . . . . 0.0 108.915 179.111 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.677 HD22 ' CG ' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -49.11 55.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.916 2.086 . . . . 0.0 114.958 -177.215 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 21' ' ' PHE . . . 86.72 6.87 79.42 Favored Glycine 0 C--N 1.296 -1.651 0 CA-C-N 114.41 -1.268 . . . . 0.0 113.345 178.821 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.539 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 20.7 m-80 -127.56 135.57 50.49 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 117.862 0.831 . . . . 0.0 112.151 -178.76 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -78.75 126.64 31.0 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.26 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.626 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.9 m-85 -112.23 107.65 16.59 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 122.138 0.97 . . . . 0.0 110.91 -179.19 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.8 ' HG2' ' HB3' ' A' ' 18' ' ' PRO . 32.0 mt-10 -86.11 -19.95 29.42 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.484 -179.395 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 p -126.53 -172.99 2.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 178.386 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.5 m -68.27 160.06 30.06 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.027 179.077 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t -137.14 168.95 18.61 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.909 -179.587 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.8 p -122.82 24.55 9.02 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 122.042 0.925 . . . . 0.0 108.677 177.857 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.502 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -70.99 148.42 47.66 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.417 -179.667 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.57 -7.14 14.02 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.508 -0.769 . . . . 0.0 114.02 178.526 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.621 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 8.2 mtp-105 -91.88 -171.4 2.85 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.2 1.0 . . . . 0.0 110.793 -179.659 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.6 m -133.59 -23.98 1.8 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.672 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.603 ' CG ' HH22 ' A' ' 34' ' ' ARG . 1.3 p-10 -107.29 -90.81 0.43 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -178.083 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.488 ' N ' HH12 ' A' ' 34' ' ' ARG . . . -149.23 -9.68 0.15 Allowed Glycine 0 CA--C 1.53 0.982 0 N-CA-C 119.402 2.521 . . . . 0.0 119.402 -176.593 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.621 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 7.5 mptt -71.99 164.04 26.81 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 121.996 2.898 . . . . 0.0 112.225 -179.751 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -116.91 160.46 20.86 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.995 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.651 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 17.7 p-90 -146.87 -169.1 3.21 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.153 0.501 . . . . 0.0 110.924 -178.774 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 24.5 p -156.23 146.04 21.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.26 179.718 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.401 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -80.68 146.64 31.0 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.054 -0.659 . . . . 0.0 109.565 179.346 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.3 p -100.45 19.43 16.78 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.888 0.851 . . . . 0.0 109.479 179.458 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.4 p -141.15 153.71 45.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.101 179.067 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.86 -31.74 71.19 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.321 0.582 . . . . 0.0 111.252 -179.842 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -129.1 118.58 22.72 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.937 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.858 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 59.5 t80 -82.46 -32.96 28.63 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.856 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -52.32 -39.12 60.18 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.676 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.0 -74.49 0.26 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.82 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.474 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 45.7 m-20 -72.85 -19.74 61.25 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -176.292 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 35.4 mtm-85 40.11 55.69 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 179.709 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 50' ' ' ASP . 49.7 mtmt -114.54 120.42 40.15 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.941 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.858 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.6 p-90 -133.17 170.78 14.91 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -174.949 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.632 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -162.82 141.44 7.18 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.46 178.806 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.508 ' HD1' ' HB3' ' A' ' 40' ' ' TRP . 7.1 m-30 -56.98 162.01 2.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.263 0.554 . . . . 0.0 111.446 179.829 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.588 ' SG ' ' HG2' ' A' ' 59' ' ' GLN . 12.6 t -77.66 130.33 74.05 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.7 -178.46 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -76.05 -147.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.066 2.511 . . . . 0.0 111.676 178.762 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -54.25 105.41 0.15 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.49 0.494 . . . . 0.0 110.36 179.752 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.588 ' HG2' ' SG ' ' A' ' 56' ' ' CYS . 57.1 mt-30 -91.24 159.43 16.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.04 0.448 . . . . 0.0 111.938 -178.736 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.861 0 CA-C-O 118.289 -1.284 . . . . 0.0 111.749 179.228 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.543 ' HB3' ' SD ' ' A' ' 3' ' ' MET . 14.1 m . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -111.32 55.32 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.728 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.543 ' SD ' ' HB3' ' A' ' 1' ' ' SER . 0.0 OUTLIER -83.8 105.72 14.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.503 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.2 m -75.58 155.38 36.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.934 0.397 . . . . 0.0 111.189 -179.255 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.4 p -87.57 167.02 14.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.378 0.609 . . . . 0.0 111.894 -179.986 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.885 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -107.43 -168.1 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 176.819 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.671 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 38.08 -127.26 1.59 Allowed Glycine 0 C--N 1.318 -0.438 0 O-C-N 123.846 0.716 . . . . 0.0 113.719 177.552 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.595 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 39.49 -149.55 0.11 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 116.115 1.206 . . . . 0.0 116.115 177.127 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.425 ' N ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -154.54 12.17 0.39 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.633 -0.784 . . . . 0.0 111.058 -179.755 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.0 m -84.98 0.17 52.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.427 -179.378 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.82 -97.78 2.33 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.267 179.708 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.66 40.27 1.39 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.734 179.899 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -91.3 148.12 36.98 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.575 0.226 . . . . 0.0 110.874 -179.843 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 6.2 Cg_exo -72.19 172.23 15.24 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.646 2.231 . . . . 0.0 111.71 179.284 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 2.7 m -85.36 150.1 24.98 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.562 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.558 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 75.8 t -108.66 110.64 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.251 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -112.34 137.9 21.71 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.969 -178.995 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 26' ' ' TYR . 2.7 Cg_endo -86.11 132.15 14.61 Favored 'Cis proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.485 -1.465 . . . . 0.0 112.255 -0.18 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.644 ' CE2' ' HD2' ' A' ' 26' ' ' TYR . 43.9 p90 -98.57 124.36 43.29 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.569 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 29.9 m -87.61 121.68 30.35 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.502 0.668 . . . . 0.0 112.194 -177.261 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.879 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 1.4 t80 -125.7 143.81 50.88 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.527 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.698 ' H ' HD13 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 39.58 32.88 0.1 Allowed 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.823 1.249 . . . . 0.0 113.582 178.364 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.91 -11.73 64.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.894 -0.67 . . . . 0.0 114.767 178.604 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 69.6 m-80 -110.01 133.56 53.06 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 118.406 1.103 . . . . 0.0 112.425 -178.759 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -79.83 115.31 19.35 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.124 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.879 ' CE2' ' HB3' ' A' ' 21' ' ' PHE . 20.0 m-85 -96.97 111.99 23.95 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.908 0.861 . . . . 0.0 111.562 -177.814 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.47 -14.36 43.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.279 179.692 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.8 p -129.92 -173.54 3.06 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.828 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.5 m -71.03 167.85 18.35 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.823 178.486 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.594 HG22 ' HZ ' ' A' ' 19' ' ' PHE . 12.7 t -145.55 175.33 10.43 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.13 -179.0 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.524 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 9.8 p -129.52 18.52 5.8 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.189 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.571 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . . . -63.52 144.41 57.01 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 113.978 -1.464 . . . . 0.0 111.879 -179.715 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.3 -1.4 34.82 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.841 179.464 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.728 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 7.7 mtp85 -105.06 127.59 52.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 117.056 0.428 . . . . 0.0 111.58 -179.333 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.4 m -95.37 1.58 54.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.586 179.556 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.12 -85.15 0.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.954 0.407 . . . . 0.0 111.166 179.755 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.03 -23.15 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.433 179.682 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.728 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 1.0 OUTLIER -61.1 130.01 44.2 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 117.255 0.527 . . . . 0.0 111.306 -179.445 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.524 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 59.8 mtm -89.25 149.15 23.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.194 0.521 . . . . 0.0 110.871 -179.531 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.613 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 13.5 p-90 -138.37 -168.33 2.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.518 0.675 . . . . 0.0 112.129 -178.435 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 21.0 p -156.16 136.64 13.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.34 178.742 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -74.75 151.35 39.17 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.442 -179.599 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 64.2 p -101.51 11.21 39.42 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.712 179.675 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.9 p -135.85 151.43 50.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.459 178.757 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.87 -48.45 79.8 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.915 0.388 . . . . 0.0 111.62 -179.537 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -111.43 104.15 12.56 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.81 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.855 ' CE1' ' HB3' ' A' ' 53' ' ' TRP . 70.7 t80 -75.49 -32.27 60.5 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.532 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.78 -36.44 64.88 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.373 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -88.75 -61.7 1.65 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.504 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.89 -34.8 78.58 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.89 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 12.9 mtm-85 48.56 47.87 20.09 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.383 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -115.25 117.8 31.5 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.737 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.855 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 11.8 p-90 -131.59 175.48 9.13 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -174.21 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.403 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -164.34 142.64 7.93 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.616 178.876 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.885 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 8.7 m-85 -59.82 158.49 10.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.065 0.933 . . . . 0.0 111.417 -179.582 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.481 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 5.6 t -64.15 123.8 83.43 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.796 -179.085 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -81.56 5.75 6.08 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.313 2.675 . . . . 0.0 114.618 -178.744 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -131.77 94.71 3.56 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.199 179.626 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -137.14 -86.87 0.3 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.59 -179.844 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.138 -1.368 . . . . 0.0 111.428 -179.671 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -73.03 116.75 13.93 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 111.224 179.864 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 mmt -104.06 149.79 24.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.389 -179.83 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.7 t -89.55 169.83 11.01 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.764 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.406 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 32.8 p -80.81 163.59 23.34 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.432 0.634 . . . . 0.0 112.357 -179.213 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.831 ' HB ' ' HB2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -106.46 -166.26 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 176.191 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.616 ' HA3' ' CD2' ' A' ' 55' ' ' PHE . . . 37.15 -127.1 1.19 Allowed Glycine 0 C--N 1.321 -0.281 0 O-C-N 124.072 0.857 . . . . 0.0 112.994 177.774 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.605 ' HA2' ' CE2' ' A' ' 53' ' ' TRP . . . 31.34 -138.66 0.07 OUTLIER Glycine 0 C--N 1.336 0.537 0 N-CA-C 116.083 1.193 . . . . 0.0 116.083 176.997 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.36 37.06 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.857 -0.671 . . . . 0.0 109.782 -179.986 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.548 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -63.55 -65.09 0.73 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.819 -178.748 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 105.1 49.21 1.01 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.085 -179.608 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.83 37.01 10.68 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.926 -179.622 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -121.0 148.88 49.87 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.536 0.207 . . . . 0.0 111.308 -179.353 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 98.7 Cg_endo -93.41 175.06 1.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.305 2.67 . . . . 0.0 111.254 179.097 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 1.8 m -84.17 142.86 30.03 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.458 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 63.4 t -107.81 121.91 61.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.81 0.338 . . . . 0.0 110.216 178.962 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -121.49 144.29 39.88 Favored Pre-proline 0 N--CA 1.447 -0.616 0 CA-C-O 120.783 0.325 . . . . 0.0 111.277 -179.446 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -85.9 137.03 21.18 Favored 'Cis proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.718 -1.784 . . . . 0.0 111.698 -0.811 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.498 ' CG ' ' HB3' ' A' ' 42' ' ' ALA . 23.3 p90 -104.87 175.35 5.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.055 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 94.7 m -130.26 124.08 31.6 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.833 -179.446 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.716 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 42.5 t80 -126.26 138.78 53.65 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.907 179.029 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.545 HD23 ' CD1' ' A' ' 21' ' ' PHE . 3.4 mm? 35.27 46.42 0.25 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 175.318 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.85 -7.01 81.81 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 114.469 -1.241 . . . . 0.0 116.157 177.738 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.531 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 62.0 m-80 -109.14 155.89 20.48 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 119.286 1.543 . . . . 0.0 111.674 -179.023 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -95.84 125.34 40.34 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.405 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.716 ' CE1' ' HB3' ' A' ' 21' ' ' PHE . 28.6 m-85 -113.64 119.7 38.35 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.809 0.814 . . . . 0.0 112.072 -177.599 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -96.58 -20.53 18.26 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.385 -1.279 . . . . 0.0 110.318 179.608 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.7 p -130.09 -174.03 3.21 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.333 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.9 m -68.16 163.46 22.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.605 178.837 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.1 t -142.3 163.76 31.99 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.721 -178.577 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.526 ' HB3' ' HG2' ' A' ' 39' ' ' MET . 26.2 p -116.07 20.66 14.26 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 176.487 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.1 142.14 52.26 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.432 -179.455 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.99 -7.39 9.77 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.246 179.264 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.72 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 22.4 mtp85 -101.37 147.23 26.57 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 117.035 0.417 . . . . 0.0 111.339 -179.17 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 t -109.81 -4.99 15.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.25 179.976 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.65 -81.7 0.24 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.24 0.543 . . . . 0.0 111.223 179.902 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.17 -26.06 0.11 Allowed Glycine 0 C--N 1.308 -1.014 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.733 179.851 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.72 ' O ' ' HD3' ' A' ' 34' ' ' ARG . 2.0 mptp? -53.69 117.84 3.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 122.644 0.378 . . . . 0.0 111.172 179.796 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.526 ' HG2' ' HB3' ' A' ' 31' ' ' SER . 44.0 mtm -83.87 143.55 29.82 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.038 179.743 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.648 ' CE3' ' HB2' ' A' ' 53' ' ' TRP . 15.2 p-90 -128.2 -166.98 1.7 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.565 -179.716 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 15' ' ' CYS . 9.9 p -160.39 146.41 15.26 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.744 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.498 ' HB3' ' CG ' ' A' ' 19' ' ' PHE . . . -78.09 142.59 38.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.115 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 78.7 p -96.17 16.48 18.04 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.436 0.636 . . . . 0.0 110.486 -179.552 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 45.7 p -139.63 161.11 38.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.741 179.293 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 19' ' ' PHE . . . -64.24 -30.33 71.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.002 0.43 . . . . 0.0 111.196 179.946 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -132.69 115.52 15.48 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.908 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.88 ' HE1' ' HB3' ' A' ' 53' ' ' TRP . 44.5 t80 -81.23 -38.3 27.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.196 -178.883 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -47.03 -36.36 7.85 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.536 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -95.11 -56.13 2.84 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.781 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.546 ' HB3' ' HD3' ' A' ' 52' ' ' LYS . 1.5 m-20 -67.22 -43.17 82.68 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -177.73 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 47' ' ' TYR . 5.3 mmm180 57.59 40.87 26.47 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 179.415 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.546 ' HD3' ' HB3' ' A' ' 50' ' ' ASP . 4.2 mppt? -114.28 122.32 46.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.586 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.88 ' HB3' ' HE1' ' A' ' 47' ' ' TYR . 11.4 p-90 -132.67 170.8 14.7 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -175.022 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.5 ' HA2' ' HA3' ' A' ' 8' ' ' GLY . . . -165.24 143.26 8.33 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.863 179.254 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.831 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 12.2 m-30 -61.35 156.61 18.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.969 0.885 . . . . 0.0 111.499 -179.641 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.411 ' N ' ' HA ' ' A' ' 40' ' ' TRP . 4.3 t -67.53 126.78 93.04 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.992 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -81.31 -160.68 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.007 1.804 . . . . 0.0 113.63 -177.696 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 t70 36.88 63.14 0.71 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.627 179.982 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -109.27 117.83 35.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.366 179.576 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.73 0 CA-C-O 118.778 -1.012 . . . . 0.0 112.029 179.98 . . . . . . . . 0 0 . 1 stop_ save_